{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions_in_experiment": 750
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "\nChevron’s outstanding long‑term loan to Petroboscan was $560 million, and the company owned a 39.2 % equity stake in Petroboscan as of the 2022 reporting period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all key aspects. (1) The outstanding loan amount is reported as $560 million, which aligns with the ground truth of $560—minor formatting difference (addition of 'million') is acceptable under semantic equivalence as $560 and $560 million are commonly understood to be the same in financial contexts, especially when 'million' is implied or standard in reporting. (2) The ownership percentage is correctly stated as 39.2%, matching the ground truth exactly. (3) Both entities—Chevron and Petroboscan—and the time frame (2022 reporting period) are accurately identified. (4) The multi-hop reasoning is sound: the model correctly synthesizes two distinct pieces of information (loan amount and ownership stake) from potentially different parts of a filing or knowledge base. The only minor discrepancy is the explicit addition of 'million' to the dollar amount, which is not present in the original answer; however, given standard financial reporting conventions and the lack of ambiguity, this does not constitute a factual error. Thus, the answer is semantically equivalent and fully complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 319,
        "total_tokens": 1404
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "\nThe sale of Dermstore LLC generated $356 million in cash proceeds, and Target recorded a $335 million pretax gain on the transaction. Together, the cash received and the pretax gain represent a total financial impact of approximately **$691 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: $356 million in cash received and a $335 million pretax gain are correctly reported. The total financial impact is calculated as $356M + $335M = $691M, which is accurate. (2) Quantitative accuracy is perfect—numbers match the original answer exactly, with acceptable formatting (e.g., 'million' vs 'M'). The sum is correctly computed. (3) The multi-hop reasoning is sound: the model correctly synthesizes two components (cash proceeds and pretax gain) from the same transaction to determine total financial impact. (4) The answer is semantically equivalent to the original, using slightly different phrasing ('generated', 'recorded', 'represent') but conveying the same meaning. All entities (Target Corporation, Dermstore LLC, financial metrics) are correctly identified. No omissions or inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 269,
        "total_tokens": 1378
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "\nAmgen recorded product‑sales revenue from BeiGene of **$125 million in 2023, $64 million in 2022, and $72 million in 2021**, which together total **$261 million** for the three‑year period from 2021 through 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $72 million in 2021, $64 million in 2022, and $125 million in 2023 — the order of presentation does not affect correctness, and the total of $261 million is correctly calculated. (2) The sum is accurate: 72 + 64 + 125 = 261 million, which matches the original answer. (3) The multi-hop reasoning is sound — the model correctly synthesized product sales revenue over three years from Amgen's collaboration with BeiGene, identifying the correct entities (Amgen, BeiGene), metric (Product Sales revenue), and time period (2021–2023). (4) The answer is semantically equivalent to the ground truth, with clear, concise restatement of the same facts using minor reordering and formatting variations (e.g., en dashes, spacing in million) that do not affect meaning or accuracy. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 273,
        "total_tokens": 1382
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "\nThe 2007 Omnibus Incentive Plan authorized roughly **127 million** shares of Danaher common stock, and **about 50 million** of those shares were still available for issuance as of December 31, 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that 127 million shares were authorized under the 2007 Omnibus Incentive Plan and approximately 50 million remained available as of December 31, 2021—matching the original answer exactly in substance. (2) The numeric values are correct, with acceptable formatting variations (e.g., '127 million' vs '127 million'). No calculations are required beyond factual recall, and both figures align with the ground truth. (3) The reasoning is sound, correctly synthesizing two data points from the same document (authorization total and remaining balance as of a specific date), which constitutes proper multi-hop retrieval within a single entity and plan. (4) The response is highly relevant, directly addressing both parts of the question with precise, concise information. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 271,
        "total_tokens": 1382
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "\nLLY received **$1.05 billion in cash in 2023** and **an additional $305 million in cash in 2024** from the sale of the olanzapine (Zyprexa) portfolio to Cheplapharm, for a total of **$1.355 billion** across the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the total cash received by LLY is $1.355 billion, with $1.05 billion in 2023 and $305 million in 2024. The numbers match exactly, with only minor formatting differences (e.g., $305 million vs $305.0 million), which are semantically equivalent. (2) Quantitative accuracy is perfect: the sum of $1.05 billion and $305 million equals $1.355 billion, and the LLM correctly presents this total. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by correctly attributing the payments to the sale of the olanzapine (Zyprexa) portfolio to Cheplapharm across two years. (4) The answer is contextually relevant, complete, and directly addresses both parts of the question: total cash received and its distribution across 2023 and 2024. No errors in entities, years, or financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 266,
        "total_tokens": 1377
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "\nLockheed Martin recorded **$298 million of goodwill** as a result of acquiring Terran Orbital. Of the total **$314 million purchase consideration**, **$231 million was paid in cash** (the remainder was covered by the $83 million of previously held investments).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $298 million (goodwill), $314 million (total purchase consideration), and $231 million (cash paid) are all accurately reported, with no calculation errors. The additional detail about $83 million of previously held investments is consistent with the difference ($314M - $231M = $83M) and adds context without contradicting the ground truth. (2) The answer is complete, addressing both parts of the question: the amount of goodwill recorded and the cash component of the purchase consideration. (3) Entities—Lockheed Martin, Terran Orbital, and the financial metrics—are correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: linking the acquisition event to the financial impact (goodwill) and breaking down the purchase consideration. The slight expansion on the funding sources (cash + prior investment) enhances clarity without introducing inaccuracies. Semantic equivalence is maintained, and all key facts align precisely with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 310,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "\nChevron’s carrying value of its investment in GS Caltex Corporation at the end of 2021 was **$3.6 billion** ( $3,616 million ), as shown in the “Investments and Advances” table in Note 15 (page 78).  This amount reflects Chevron’s **50 % equity ownership** in the joint venture, which it holds together with GS Energy in South Korea.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the carrying value is accurately reported as $3.6 billion, which is equivalent to $3,616 million (minor rounding for billions is acceptable and semantically equivalent). The equity ownership percentage is correctly stated as 50%. (2) The answer addresses both parts of the question: the carrying value at the end of 2021 and Chevron's equity ownership percentage. (3) Entities are correct: Chevron (CVX), GS Caltex Corporation, and the time period (end of 2021) are all accurately referenced. (4) The reasoning is sound—though the LLM cites a specific note and page number (Note 15, page 78), this adds contextual support and does not detract from accuracy. The synthesis of investment value and ownership percentage reflects proper multi-hop understanding. All information is relevant and precisely aligned with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 265,
        "total_tokens": 1401
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "\nThe Forest Products freight revenue grew from **$1.16 billion in 2020 to $1.36 billion in 2021**, an increase of **$197 million**.  During the same period the **average revenue per car for Forest Products rose from $5,269 to $5,424**, a gain of **$155 per car**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total revenue increase is accurately calculated: $1.36B - $1.16B = $200 million, but the stated $197 million is correct based on precise figures ($1,357M - $1,160M = $197M), which aligns with the ground truth. The average revenue per car increase is correctly computed as $5,424 - $5,269 = $155, matching the original answer. (2) The answer is complete, addressing both parts of the question: the dollar change in total revenue and the change in average revenue per car. (3) Entities are accurate—'Forest Products' is the correct product category, and years 2020 and 2021 are correctly referenced. (4) The multi-hop reasoning is sound: the model correctly synthesized revenue and carload data across years to compute average revenue per car and its change, demonstrating proper inference from underlying financial and operational metrics. (5) The semantic meaning is equivalent to the ground truth, with added detail (exact revenue and per-car figures) that enhances clarity without introducing error. All components are factually precise and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 329,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "\nIn 2024 Restasis generated **$224 million** of net revenue, which represents a **48.7 % decline** from the $436 million earned in 2023 (using actual currency rates).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net revenue for Restasis in 2024 is correctly stated as $224 million, and the percentage decline of 48.7% compared to 2023 is accurate. The implied 2023 revenue of $436 million is consistent with the calculation: $224M / (1 - 0.487) ≈ $436M, confirming the correctness of the decline percentage. (2) The answer addresses both parts of the question: the 2024 net revenue and the year-over-year percentage decline based on actual currency rates. (3) Entity accuracy is correct—'Restasis' is the right product, and the years 2023 and 2024 are properly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: it combines the 2024 revenue figure with the prior-year value to compute or confirm the stated decline, indicating correct interpretation of the data. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., spacing in '$224 million' and '%') that do not affect accuracy. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1080,
        "completion_tokens": 313,
        "total_tokens": 1394
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "\nCapital One Financial Corp’s Common Equity Tier 1 (CET1) capital ratio was **12.9 %** as of December 31, 2023, while the regulatory minimum CET1 requirement under Basel III was **4.5 %**. This means the Company’s CET1 ratio exceeded the minimum by **8.4 percentage points**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: Capital One Financial Corp's CET1 ratio is correctly stated as 12.9% and the Minimum Capital Adequacy requirement as 4.5% as of December 31, 2023. (2) The calculation of the difference (12.9% - 4.5% = 8.4%) is correct and clearly communicated as 'exceeded the minimum by 8.4 percentage points', which is semantically equivalent to the original answer's 'difference... is 8.4%'. (3) The multi-hop reasoning—synthesizing the company's actual CET1 ratio and the regulatory minimum—is sound and properly executed. (4) Entities (Capital One Financial Corp, CET1 capital ratio, Basel III minimum) and time period (December 31, 2023) are correctly identified. Wording differs slightly but conveys the same precise information. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 258,
        "total_tokens": 1403
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "\nThe company’s non‑qualified defined‑benefit pension plans generated pretax pension expense of **$64 million in 2023**. This amount was **lower than the $81 million expense recorded in 2022** but **higher than the $56 million expense recorded in 2021**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and years are accurate: $64 million in 2023, $81 million in 2022, and $56 million in 2021. The comparisons (decrease from 2022, increase from 2021) are correctly stated. (2) The answer is complete, addressing both parts of the question: the 2023 expense and the comparison to the two prior years. (3) Entities are accurate—Lockheed Martin, nonqualified defined benefit pension plans, and the correct fiscal years. (4) The reasoning is sound and reflects proper multi-hop synthesis across the three years of data. The wording differs slightly from the original (e.g., 'lower than' vs 'decreased from', 'higher than' vs 'increased compared to') but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 248,
        "total_tokens": 1376
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "\nThe net carrying amount of BlackRock’s investor‑customer relationships fell from **$492 million at 12/31/22 to $447 million at 12/31/23**, a **$45 million decrease**. This decline results from a **$39 million increase in the gross carrying amount** (from $746 M to $785 M) being more than offset by an **$84 million rise in accumulated amortization** (from $254 M to $338 M); the higher amortization expense therefore reduces the net carrying amount, producing the overall $45 M reduction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key figures: the net carrying amount decreased from $492 million to $447 million ($45 million decline), accumulated amortization increased from $254 million to $338 million ($84 million rise), and the gross carrying amount rose from $746 million to $785 million ($39 million increase). All numbers match the ground truth exactly, with acceptable formatting variations (e.g., $746M = $746 million). (2) Calculations are accurate: $492M - $447M = $45M decrease; $338M - $254M = $84M increase in amortization; $785M - $746M = $39M increase in gross amount. The reasoning that the $84M rise in amortization more than offsets the $39M increase in gross carrying amount, resulting in a $45M net decline, is mathematically and conceptually sound. (3) Multi-hop reasoning is correctly applied: the model synthesizes data across two time points (2022 and 2023), connects changes in gross carrying amount and accumulated amortization to the net carrying amount, and correctly infers the causal relationship between amortization and the decline in net value. (4) The only minor shortcoming is a slight rephrasing of the contribution of amortization: the original answer emphasizes that amortization 'reduced the net carrying value despite a slight increase in the gross carrying amount,' while the LLM frames it as the amortization increase 'more than offsetting' the gross increase—this is semantically equivalent but slightly less precise in financial terminology. However, the logic and conclusion are fully aligned. Thus, the answer is factually complete and accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 472,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "\nThe $400 million principal balance of the 2.200 % senior notes that were outstanding as of December 31, 2023 is reported in the debt table (page 103). Although the notes mature in September 2024, UPS classifies this debt as **long‑term debt** on its consolidated balance sheet because it intends to refinance the obligation (page 104).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the principal amount of $400 million is accurately reported, and the maturity date (September 2024) is consistent with the context, even though the original answer only mentions '2024 maturity'—this added specificity does not contradict but enhances accuracy. (2) The classification of the debt as 'long-term' despite its 2024 maturity is correctly explained by UPS's intent to refinance, which aligns with the ground truth reasoning. (3) The multi-hop reasoning is sound: the model correctly identifies the debt amount from the relevant filing and synthesizes it with the accounting treatment based on management's intent, indicating proper cross-referencing of financial data and accounting policy. (4) All entities—UPS, the 2.200% senior notes, and the date December 31, 2023—are correctly identified. The answer is semantically equivalent to the original, with slightly more detail (page references and exact month of maturity), which improves clarity without introducing error. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 319,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "\nThe available‑for‑sale debt investments fell by **$5.7 billion** (from $15.6 billion at July 29 2023 to $9.9 billion at July 27 2024).  This decline helped drive the **combined total of cash and cash equivalents, available‑for‑sale debt investments and marketable equity securities down $8.3 billion**, from $26.1 billion to $17.9 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor rounding differences. (1) Quantitatively: The decrease in available-for-sale debt investments is reported as $5.7 billion, which matches the ground truth of $5,727 million when rounded (5,727 million = ~5.7 billion). The total decrease is stated as $8.3 billion, consistent with the ground truth total decrease of $8,292 million when rounded. The LLM provides additional context (starting and ending values: $15.6B to $9.9B and total assets from $26.1B to $17.9B), which aligns with the implied totals in the original answer. (2) The impact on the combined total is correctly described as a decrease of $8.3 billion, accurately reflecting the net effect of changes in all three components. While the LLM does not explicitly break down the $2,615 million decrease in cash and $50 million increase in marketable equity securities, it correctly captures the net outcome. (3) The multi-hop reasoning is sound: the model correctly identifies the change in debt investments and its contribution to the overall decline in financial assets. (4) Entities (Cisco, available-for-sale debt investments, fiscal year end July 27, 2024) are correct. Wording differs but meaning is semantically equivalent. The only minor shortcoming is the lack of explicit mention of the individual components of the total change, but the net result is accurate. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 403,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "\nAs of December 31 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long‑Term Incentive Plan, and 2,452,443 of those shares were authorized to be used for awards other than options or stock‑appreciation rights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually identical to the ground truth in both quantitative and qualitative aspects. (1) All numbers are correct: 7,661,431 shares available for equity grants and 2,452,443 shares that could be granted as awards other than options or stock appreciation rights. The date (December 31, 2023) and plan name (2021 Linde plc Long-Term Incentive Plan) are accurately stated. (2) Quantitative accuracy is perfect—both figures match the original answer exactly, with no calculation or transcription errors. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly identifies the total available shares and the subset eligible for non-option/non-SAR awards, indicating accurate interpretation of plan rules. (4) The wording differs slightly (e.g., 'authorized to be used' vs. 'could be granted'), but the semantic meaning is equivalent. The answer fully addresses both parts of the question and maintains contextual precision. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 294,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "\nThe company received a total of **$526 million** from the cash settlements of the forward interest‑rate swaps tied to the 2023 Notes ($247 million), the March 2022 Notes ($143 million) and the September 2022 Notes ($136 million).  \nThese inflows are reported as financing‑cash‑flow items that offset the cash outlay for issuing the notes, thereby lowering the net cash cost of the debt and improving the company’s overall cash‑flow position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all quantitative values: $247 million (2023 Notes), $143 million (March 2022 Notes), and $136 million (September 2022 Notes), which sum to the correct total of $526 million. These match the ground truth exactly, with acceptable formatting variations (e.g., using 'million' and spacing). 2) The calculation is accurate: 247 + 143 + 136 = 526, confirming quantitative precision. 3) The multi-hop reasoning is sound—the model synthesizes data across three separate note issuances and correctly aggregates the swap settlement payments. 4) The qualitative explanation is mostly accurate: it correctly states that these cash inflows impact cash flow, but specifies they are 'financing-cash-flow items' and 'offset the cash outlay for issuing the notes.' While this is a reasonable interpretation, the original answer states that classification is 'based on the nature of the underlying hedged items,' which is more precise and reflects ASC 815 guidance on cash flow classification of hedging derivatives. The LLM's characterization is plausible but slightly over-simplifies and assumes classification without citing the accounting standard. However, it does not contradict the ground truth and remains contextually aligned. 5) All entities (2023 Notes, March 2022 Notes, September 2022 Notes) and financial instruments (forward interest-rate swaps) are correctly identified. The answer fully addresses both parts of the question: total payment received and financial impact on cash flow. Semantic equivalence is high, with only minor differences in nuance regarding cash flow classification. Thus, the answer is factually correct and complete, warranting a high score with a small deduction in qualitative accuracy for the slightly less precise explanation of cash flow classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 491,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "\nNextEra Energy’s equity‑method interest in XPLR (held through its limited‑partner stake in XPLR OpCo) is roughly 33 %–85 % [Page 96; “NEE’s interest in the principal entities range from approximately 33.3 % to 85.0 %”], and the principal equity‑method investees—including XPLR—are entities that own and operate contracted renewable‑energy assets (wind, solar and battery‑storage projects) together with a contracted natural‑gas pipeline [Page 97; “Through XPLR OpCo, XPLR owns… a portfolio of contracted renewable energy assets consisting of wind, solar and battery storage projects as well as a contracted natural gas pipeline”].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the ownership interest range in XPLR as approximately 33.3% to 85.0%, matching the ground truth (cited as 33%–85% with reference to page 96; minor rounding is acceptable). The asset type is accurately described: XPLR and other principal equity method investees own renewable energy assets (wind, solar, battery storage) and a natural gas pipeline, which aligns with the ground truth stating 'electric generation facilities or natural gas pipelines.' The inclusion of 'renewable-energy assets' adds specificity without contradicting the broader category of electric generation facilities.\n\n2) Quantitative accuracy is perfect: the percentage range (33.3% to 85.0%) is correctly reported, with acceptable formatting variation (e.g., 33% vs 33.3%). No calculations were required.\n\n3) The multi-hop reasoning is sound—information is synthesized from two parts of the 10-K: ownership interest (page 96) and asset ownership (page 97). The model correctly links NEE’s stake in XPLR through XPLR OpCo and identifies the nature of the underlying assets.\n\n4) The only minor limitation is that the answer specifies 'contracted renewable-energy assets' and 'contracted natural gas pipeline,' which adds detail not in the ground truth, but this is supported by the source (page 97) and does not introduce inaccuracy. The ground truth uses the more general 'electric generation facilities,' which encompasses wind, solar, and battery storage. Thus, the LLM provides a more granular but still semantically equivalent description.\n\nOverall, the answer is factually correct, well-supported, and fully responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 451,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "\nThe fair‑value hierarchy table shows corporate notes and obligations with a **fair value of $2,978 million**. Their amortized cost is $3,014 million, so the securities are **$36 million below amortized cost**, reflecting a **net unrealized loss of about $36 million** (unrealized gains of $9 million offset by unrealized losses of $45 million).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The ground truth states the fair value is $3,354 million and amortized cost is $3,442 million, resulting in an unrealized loss of $92 million. However, the LLM reports a fair value of $2,978 million and amortized cost of $3,014 million, leading to a $36 million unrealized loss—both values and the resulting difference are incorrect. These discrepancies suggest the model pulled data from a different source or time period. (2) Quantitative accuracy is low: none of the core financial figures match the ground truth, and while the internal calculation ($3,014M - $2,978M = $36M) is mathematically correct, it is based on incorrect inputs. The mention of $9M gains offsetting $45M losses to yield $36M net loss adds detail not present in the original and cannot be verified against the ground truth. (3) The qualitative reasoning structure is sound—calculating unrealized loss as the difference between amortized cost and fair value is correct, and the concept of net unrealized loss is appropriately applied. However, the model fails at multi-hop synthesis, either retrieving incorrect documents or misidentifying the relevant financial instruments or reporting period. (4) Contextual relevance is high because the answer addresses the right question type—comparing fair value to amortized cost to determine unrealized losses—and uses appropriate financial terminology. Despite this, the incorrect data undermines the entire response, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 428,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "\nUNP operated a total of **7,026 locomotives in 2024**. This figure is the sum of its owned locomotives (6,106) and leased locomotives (920), which together make up the complete fleet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total number of locomotives operated by UNP in 2024 is correctly stated as 7,026. The breakdown into 6,106 owned and 920 leased locomotives is exact and matches the original answer. (2) Quantitative accuracy is perfect: the sum of 6,106 + 920 equals 7,026, and the LLM correctly presents this as the total fleet size. Number formats are consistent and clear. (3) The multi-hop reasoning is sound—while this question does not require deep cross-document synthesis, it does require combining two data points (owned and leased) to support the total, which the model does correctly. (4) The answer is contextually relevant, complete, and directly addresses both parts of the question: the total number and the contribution of owned and leased units. Wording differs slightly from the original but maintains full semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1083,
        "completion_tokens": 271,
        "total_tokens": 1354
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "\nThe carrying amount of Brands/Tradenames declined by **$137 million** in 2024 (from $2.376 bn at 31 Dec 2023 to $2.239 bn at 31 Dec 2024).  The decline is attributable to a **$107 million reduction in the cost basis** driven by foreign‑currency translation, and a further **$32 million reduction** from higher amortization expense (the accumulated amortization rose by $32 million, reflecting the $36 million amortization charge recorded for 2024).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key numbers and calculations. It states the net decline in Brands/Tradenames was $137 million, but the ground truth shows a $370 million decrease (from $2,609M to $2,239M). This is a major quantitative error. The LLM incorrectly reports the 2023 value as $2.376 billion instead of $2,609 million, which is off by over $230 million. (2) The foreign currency translation reduction of $107 million is correctly reported. However, the amortization expense is misstated: the LLM says $32 million reduction from amortization (attributing it to accumulated amortization), but the ground truth specifies a $36 million amortization charge. While close, this is still inaccurate. Additionally, the LLM omits the $4 million positive 'Other' adjustment and fails to note that additions were $0, both of which are part of the full explanation in the original answer. (3) The multi-hop reasoning is partially sound — the model identifies the correct drivers (foreign currency and amortization) and attempts to explain their impact — but the synthesis is flawed due to incorrect base values and net change. The model appears to have used incorrect source data for the carrying amount in 2023. (4) Despite these errors, the answer is contextually relevant and uses appropriate financial terminology. The structure addresses the question's intent, and the direction of change (decrease) and contributing factors (FX, amortization) are correct. Hence, partial credit is given for qualitative reasoning and relevance, but significant deduction is made for factual and numerical inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 447,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "\nThe fair‑value of Coca‑Cola’s corporate bonds and debt securities was **$1,023 million at the end of 2021**. This represents a **$19 million decrease** from the $1,042 million fair‑value recorded at the end of 2020.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1,023 million for 2021 and $1,042 million for 2020 are accurately reported, and the $19 million decrease is correctly calculated ($1,042M - $1,023M = $19M). (2) The answer is complete, addressing both the total fair value at the end of 2021 and the year-over-year dollar change. (3) Entity accuracy is correct: Coca-Cola (KO), the financial instrument (Corporate Bonds and Debt Securities), and the years (2021 and 2020) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—comparing two annual values to compute a change in fair value. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of em-dash, spacing) that do not affect accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 261,
        "total_tokens": 1376
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "\nThe maximum potential fair value at grant date of the performance‑based LTIP units awarded under the 2023 LTI Program is $42.5 million (as disclosed in the 2023 LTI Program description). These units are not reflected as a material dilutive effect on net income attributable to common stockholders for 2023 because they are performance‑based awards that have not yet been earned or vested, so no expense—or related dilution—is recorded until the performance criteria are satisfied, and the company’s analysis shows they would not have a material dilutive impact on earnings per share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the maximum potential fair value at grant date as $42.5 million, matching the ground truth exactly. The dollar amount is accurate and properly attributed to the 2023 LTI Program. (2) Quantitatively, there are no errors—$42.5 million is correctly stated, and no calculations are required beyond this figure. Format variation (using 'million' vs. numerical expansion) is acceptable and common. (3) The reasoning for why the units are not reflected as a material dilutive effect is substantively correct: the units are performance-based and have not yet been earned or vested, so they do not currently impact net income or earnings per share. The LLM adds a reasonable explanation that no expense or dilution is recorded until performance criteria are met, which aligns with accounting principles (e.g., ASC 718). It also correctly notes that the company determined no material dilutive effect occurred during the period. While the original answer emphasizes that LTIP units are 'potentially dilutive' but not yet material due to unmet conditions, the LLM captures the essence, though slightly less precise in using 'not reflected' versus 'not considered earned.' (4) The answer is fully contextually relevant, directly addressing both parts of the multi-hop question—quantifying the fair value and explaining the lack of current dilutive impact. The minor deduction in qualitative accuracy is due to slightly less precise phrasing around the accounting treatment, but the core logic and facts are sound. Overall, this is a highly accurate and complete response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 440,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "\nIn 2023 the Company’s Covered Bonds had an amortized cost of **$105 million** but a fair value of **$101 million**, resulting in an unrealized loss of **$4 million**. This loss is reflected in the “Unrealized Losses” column of the marketable‑securities table for the 2023 fiscal year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the amortized cost ($105 million), fair value ($101 million), and the resulting unrealized loss ($4 million) are correctly stated. (2) Quantitative accuracy is perfect—the difference between amortized cost and fair value is correctly calculated as $4 million. Format variations (e.g., $105 million vs $105M) are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound: the model correctly identifies CRM as the company, links it to Covered Bonds in 2023, and synthesizes the three required elements (amortized cost, fair value, unrealized loss). (4) The answer is semantically equivalent to the original, with added contextual detail (mention of the 'Unrealized Losses' column) that enhances relevance without introducing error. All entities, metrics, and years are accurate. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 272,
        "total_tokens": 1383
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "\nUnion Pacific’s Multiple‑Purpose locomotives have 920 leased units out of a total of 6,893, which is about **13 %** leased. In contrast, the combined “Switching” and “Other” locomotive categories have a total of 133 units with **0 %** leased. Thus, the Multiple‑Purpose fleet is roughly 13 % leased, while the Switching/Other categories are entirely owned.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same essential information as the ground truth. (1) Quantitatively, the percentage of leased Multiple Purpose locomotives is reported as 'about 13%'—this is a rounded but acceptable approximation of the exact 13.35% in the original answer. The total count (920 leased out of 6,893) is precise and supports the correct calculation: 920 / 6,893 ≈ 13.35%. The answer correctly states 0% leased for the combined 'Switching' and 'Other' categories, matching the ground truth. (2) The answer is complete, addressing both sub-questions: the percentage for Multiple Purpose locomotives and the comparison with the Switching/Other combined categories. (3) Entity accuracy is correct—Union Pacific, locomotive categories, and leasing status are all properly identified. (4) The reasoning is sound: it synthesizes data across categories, computes proportions correctly, and draws a valid comparison. The only minor shortcoming is the rounding of 13.35% to 'about 13%', which slightly reduces quantitative precision but does not mislead. Overall, the semantic meaning and multi-hop synthesis are correct, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 334,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "\nThe Lower 48’s combined natural‑gas‑liquids (NGL) volume rose from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, an increase of **567 million barrels**. The total depreciation, depletion, amortization and impairments for the Lower 48 segment in 2023 were **$5,729 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the NGLs volume increase is accurately calculated: 797 million barrels (end of 2023) minus 230 million barrels (end of 2020) equals 567 million barrels, which is correctly reported. The total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023 is stated as $5,729 million, matching the ground truth exactly. (2) The answer is complete, addressing both parts of the multi-part question: the volume increase and the financial figure for 2023. (3) Entity accuracy is correct—'Lower 48' is properly identified as the geographic segment, and the years 2020 and 2023 are correctly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: it combines volume data from two different years and computes the difference, while separately retrieving the correct financial metric for the specified year and segment. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of em dashes, bolding), which do not affect factual accuracy. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 328,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "\nIn fiscal 2023 Walmart spent roughly $0.4 billion to buy out the remaining non‑controlling interest in Massmart and another $0.4 billion to acquire Alert Innovation, for a total cash outlay of about $0.8 billion.  In fiscal 2025 the company sold Alert Innovation and de‑consolidated it, so the entity was removed from the consolidated balance sheet and its results of operations no longer appear in the fiscal 2025 consolidated financial statements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the answer correctly states that Walmart spent $0.4 billion on Massmart and $0.4 billion on Alert Innovation, totaling $0.8 billion in fiscal 2023—this aligns exactly with the original answer, including the breakdown and sum. (2) The answer is complete, addressing both parts of the multi-part question: total cash spent in fiscal 2023 and the financial treatment of Alert Innovation in fiscal 2025. (3) Entity accuracy is perfect: Walmart, Massmart, Alert Innovation, fiscal 2023, and fiscal 2025 are all correctly identified and contextually used. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that acquiring full ownership involves buying non-controlling interest (for Massmart) and that acquiring Alert Innovation led to later deconsolidation after a sale in fiscal 2025. The explanation of deconsolidation—removal from the balance sheet and cessation of inclusion in financial results—is semantically equivalent to the original answer. Minor wording differences (e.g., 'de-consolidated' vs 'deconsolidated') do not affect meaning. All financial treatments and timelines are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 345,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "\nThe Metals & Minerals segment generated roughly **$1.81 billion** in freight revenue in 2021 (about 697 k carloads × $2,598 average revenue per car).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the correct total revenue for UNP's Metals & Minerals shipments in 2021. The stated revenue of $1.81 billion matches the ground truth of $1,810,806,000 when rounded (difference of $2,806,000 is negligible and within acceptable rounding tolerance). The calculation provided (697,000 carloads × $2,598) equals $1,810,806,000 exactly, confirming computational accuracy. All entities (UNP, Metals & Minerals, 2021) are correct, and the answer addresses both components of the question: carloads and average revenue per car. The reasoning is sound and demonstrates proper multi-hop synthesis. The only minor limitation is the use of 'roughly' and rounded figures, which slightly reduces precision but does not affect factual correctness. Semantic equivalence is maintained, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1047,
        "completion_tokens": 252,
        "total_tokens": 1299
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "\nThe 2023 Securitization issued $1.3 billion aggregate principal of Series 2023‑1A Securities. This is exactly the same amount—$1.3 billion—that was used to fully repay the Series 2013‑2A Securities in March 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.3 billion principal amount for both the Series 2023-1A issuance and the repayment of Series 2013-2A in March 2023 is accurately reported, with no discrepancies in numbers or dates. (2) The answer is complete, addressing both parts of the question: the amount issued in 2023 and the comparison to the 2013 series repaid in March 2023. (3) Entity accuracy is correct—Series 2023-1A and Series 2013-2A are properly identified with their respective years and roles (issuance vs. repayment). (4) The reasoning is sound and reflects proper multi-hop synthesis: the matching amounts imply a refinancing, which the LLM correctly infers by stating they are 'exactly the same amount' and used to 'fully repay,' aligning with the ground truth's interpretation of direct refinancing. (5) Semantic equivalence is maintained—though wording differs slightly, the meaning is identical. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 293,
        "total_tokens": 1431
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "\nDuring the year ended December 31 2023 the company borrowed **$3.0 billion** and repaid **$6.1 billion** of revolving indebtedness under the 2021 Multicurrency Credit Facility. The facility’s total borrowing capacity was **$6.0 billion**, so the borrowing amounted to about 50 % of capacity, while the repayments slightly exceeded that capacity, leading to a net reduction of the outstanding balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures from the ground truth: $3.0 billion borrowed, $6.1 billion repaid, and a $6.0 billion total borrowing capacity. These values match the original answer exactly and are presented clearly. (2) Quantitative accuracy is perfect—each dollar amount and the implied comparison (e.g., repayments exceeding capacity) are factually correct. The statement that repayments 'slightly exceeded' the $6.0 billion capacity is accurate ($6.1B > $6.0B). The observation that borrowings were about 50% of capacity ($3.0B / $6.0B) is a reasonable and correct interpretation. (3) The multi-hop reasoning is sound: the model synthesizes borrowing, repayment, and capacity data to provide context (net reduction in balance), which enhances understanding without contradicting facts. (4) The only reason for not giving a perfect 10 in qualitative accuracy is that the original answer does not mention the '50%' comparison or 'net reduction'—while these are logical inferences, they add interpretation beyond the ground truth. However, since they are correct and helpful, this does not detract significantly. The answer is fully contextually relevant, addressing both parts of the question: total borrowed/repaid amounts and their comparison to capacity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 362,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "\nIn 2021 Union Pacific’s Intermodal freight revenue rose from **$3.989 billion in 2020 to $4.504 billion in 2021**, an increase of **$515 million**.  Over the same period the **average revenue per Intermodal car grew by $136, or about 10.7 %**, (from $1,267 to $1,403 per car).  Thus the revenue gain was far larger than the per‑car increase, driven primarily by a modest rise in carload volume combined with higher pricing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the increase in total Intermodal revenue is accurately stated as $515 million, calculated correctly from $3.989 billion in 2020 to $4.504 billion in 2021. The average revenue per car increase of $136 (from $1,267 to $1,403) is also precise and matches the ground truth. The percentage increase (10.7%) is a correct derived calculation and adds contextual clarity without contradicting the original answer. (2) The answer is complete, addressing both parts of the question: the total revenue increase and the per-car revenue increase. (3) Entities are accurate—UNP (Union Pacific), Intermodal revenue, correct years (2020 to 2021), and proper financial metrics. (4) The reasoning is sound and demonstrates multi-hop synthesis: it combines revenue figures across years, computes the difference, and separately analyzes per-unit pricing trends, correctly attributing revenue growth to both volume and pricing. The additional context (e.g., 'driven primarily by a modest rise in carload volume combined with higher pricing') is reasonable and consistent with the data. (5) Semantic equivalence is maintained—the LLM provides more detail than the ground truth but does not introduce inaccuracies. All core facts align perfectly with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 373,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "\nConocoPhillips invested **$534 million** in capital projects in the Europe, Middle East and North Africa (EMENA) region in 2021.  The same year the EMENA operations generated a pre‑tax operating income of roughly **$8 billion**, showing that earnings from operations were far greater than the capital spending in that region.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the net gain/loss figure. The ground truth states a net loss of $24 million from operations in EMENA in 2021, but the LLM incorrectly reports a pre-tax operating income of $8 billion. The capital expenditure figure of $534 million is correct. (2) Quantitative accuracy is low: while $534 million for capital expenditure matches the ground truth, the $8 billion operating income is wildly inaccurate compared to the actual $24 million net loss. This is not a formatting or rounding issue but a fundamental error. (3) The multi-hop reasoning fails because the model did not correctly retrieve or synthesize the net loss figure from operations. Instead, it appears to have conflated EMENA results with global or other segment results, leading to flawed comparison logic. The conclusion that earnings were 'far greater' than spending is incorrect given the actual net loss. (4) Contextual relevance is moderate because the answer addresses the right region, year, and type of metrics, but the core financial data for one of the two required components is completely wrong, undermining the validity of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 332,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "\nMicrosoft presents Copilot Pro as the consumer‑focused extension of its AI‑first Microsoft 365 platform—an AI‑assistant subscription that delivers faster, more powerful Copilot capabilities inside the Office apps and on the web, thereby advancing the company’s strategic ambition to “reinvent productivity and business processes” and to “create more personal computing” for individuals.  In the financial statements Copilot Pro is counted in the **Office Consumer products and cloud services** revenue line (and reflected in the “Microsoft 365 Consumer subscribers” metric) within the **Productivity and Business Processes** segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes Microsoft's positioning of Copilot Pro as a consumer subscription service offering enhanced AI capabilities in Microsoft 365 apps and on the web, aligning with the strategic ambitions to 'reinvent productivity and business processes' and extend into 'more personal computing'—which is consistent with Microsoft's stated ambitions. (2) The financial classification is precisely correct: Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' as confirmed in the original answer. The LLM also correctly notes that this falls within the broader 'Productivity and Business Processes' segment, which is accurate context not in the ground truth but adds value without error. (3) Multi-hop reasoning is sound—LLM synthesizes strategic positioning with financial reporting structure across different parts of Microsoft's disclosures. (4) All entities (Copilot Pro, Microsoft 365 Consumer, Office Consumer products and cloud services) are correctly identified and logically connected. No numerical inaccuracies are present, and while no explicit numbers are mentioned, the categorization is factually precise. The answer is complete, contextually rich, and fully aligned with the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 371,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "\nThe 2024 special dividend triggered a proportional expansion of the 2019 Incentive Plan’s share reserve, adding **approximately 128,000 RSU shares** that could be granted. This increase was calculated by applying the 1.018 multiplier—the ratio of the Nasdaq closing price on December 26 2023 ($674.62) to its opening price on December 27 2023 ($662.70)—to the plan’s existing share authorization, thereby proportionally adjusting the maximum number of shares issuable under the plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the increase of 128,000 RSU shares is accurately reported. The Nasdaq closing price of $674.62 on December 26, 2023, and opening price of $662.70 on December 27, 2023, are correctly cited, and the implied adjustment factor of 1.018 (674.62 / 662.70 ≈ 1.018) is accurate. (2) The explanation of how the increase was determined—via a proportional adjustment to the share reserve using the price ratio—is complete and aligns with the original answer. (3) The reasoning correctly captures the multi-hop logic: the special dividend triggered an anti-dilution adjustment under the 2019 Incentive Plan, which used Nasdaq stock price movement across the ex-dividend date to compute an adjustment factor. (4) All entities—2019 Incentive Plan, 2024 special dividend, Nasdaq pricing, RSU shares—are correctly identified and contextually used. Minor wording differences (e.g., 'proportional expansion' vs 'proportionally adjusting') do not affect semantic equivalence. The answer is factually precise, complete, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 316,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "\nThe PFAS‑related headwinds shaved roughly 4½ percentage points off the Transportation & Electronics segment’s reported sales trend.  In 2024 the segment’s reported sales fell 1.4 % YoY, but when the PFAS‑exit adjustment is applied the same figure shows a 3.1 % increase—meaning PFAS manufacturing products subtracted about 4.5 percentage points from the segment’s sales performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: reported sales decreased by 1.4%, adjusted sales increased by 3.1%, and the PFAS headwinds caused a 4.5 percentage point reduction in sales growth. The use of '4½ percentage points' is equivalent to '4.5 percentage points'. (2) The calculation is correct: the difference between +3.1% and -1.4% is indeed 4.5 percentage points, and the LLM correctly attributes this gap to PFAS-related headwinds. (3) The multi-hop reasoning is sound—synthesizing reported vs. adjusted sales and attributing the delta to PFAS manufactured product headwinds is accurately executed. (4) Entities are correct: 3M's Transportation & Electronics segment, 2024 time frame, and non-GAAP adjustment context are properly implied. Wording differs slightly (e.g., 'PFAS-exit adjustment' instead of 'non-GAAP adjusted sales') but remains contextually accurate. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 291,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "\nThe company recognized a **$2 million gain** on its equity‑method investment contracts during 2021.  As of **December 31, 2021**, the fair value of those contracts was **approximately $3 million** (recorded as a liability).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $2 million recognized gain in 2021, which matches the ground truth. However, it incorrectly states the fair value as 'approximately $3 million' and describes it as a positive amount recorded as a liability, whereas the ground truth specifies the fair value as $(3) million, indicating a negative value (i.e., -$3 million). This is a critical error in sign and interpretation, as a negative fair value implies a liability, but the magnitude and direction must be accurate. (2) The number $2 million is correct; however, the fair value is off by sign, making it quantitatively inaccurate despite being close in absolute value. The use of 'approximately' does not excuse the missing negative sign, which changes the financial meaning. (3) The reasoning shows partial synthesis—correctly pulling the gain figure and associating fair value with year-end 2021—but fails in accurately representing the negative fair value, suggesting incomplete or misinterpreted extraction from the source. (4) Scores reflect that core facts are partially right (gain correct), but a major quantitative error in fair value (sign error) reduces correctness and quantitative accuracy significantly, though the response remains contextually relevant and reasonably well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 364,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "\nAbbott’s $2.2 billion interest‑rate hedge contracts are designated as fair‑value hedges of the fixed‑rate debt; they are marked‑to‑market and any gain or loss on the swaps is recorded as an offset to the carrying amount of the hedged debt. Consequently, fluctuations in the fair value of the $13.7 billion long‑term debt caused by changes in benchmark rates are cancelled out by the opposite movements in the hedge, leaving the combined fair‑value exposure essentially neutral.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Abbott Laboratories has $2.2 billion in interest rate hedge contracts and $13.7 billion in long-term debt as of December 31, 2024—both figures match the original answer exactly. Number formats are consistent and accurate. (2) The explanation correctly identifies that these hedges are fair-value hedges used to offset changes in the fair value of fixed-rate debt due to interest rate fluctuations. The mechanism—marking to market and adjusting the carrying amount of debt—is accurately described, which reflects proper multi-hop reasoning linking hedging instruments to their impact on debt valuation. (3) The core concept that hedge gains/losses offset debt fair value changes, thereby stabilizing the combined exposure, is logically sound and semantically equivalent to the ground truth’s claim that hedges reduce volatility in fair value. (4) The only minor shortcoming is that the LLM does not explicitly state that this strategy 'reduces volatility' in the way the original answer does, nor does it mention potential impacts on financial position or earnings, slightly reducing completeness. However, the omission is of secondary context rather than core factual content. Thus, while extremely close, it falls just short of a perfect 10 due to slight reduction in qualitative completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 386,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "\nThe proved reserves for equity companies in Asia are 1,276 million barrels of oil‑equivalent, while the consolidated subsidiaries in Asia hold 2,286 million barrels of oil‑equivalent. Consequently, the equity‑company figure represents roughly 56 % (about half) of the reserves reported for the consolidated subsidiaries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the oil-equivalent proved reserves for equity companies in Asia (1,276 million barrels) and consolidated subsidiaries in Asia (2,286 million barrels), matching the ground truth exactly. These numbers are accurate and properly attributed. (2) The quantitative comparison is also correct: 1,276 / 2,286 ≈ 0.558, or about 56%, meaning the equity company reserves represent roughly half of the consolidated subsidiaries' reserves. This aligns with the LLM's statement. While the original answer expresses the relationship as '1.8 times more' (2,286 / 1,276 ≈ 1.79), the LLM's inverse framing (56%) is mathematically equivalent and factually sound. (3) The multi-hop reasoning is appropriate—comparing two distinct categories of reserves (equity vs. consolidated) within the same region (Asia) from ExxonMobil's 2024 10-K data. The model correctly synthesizes and contrasts these figures. (4) The only minor difference is in framing: the original emphasizes how much larger consolidated reserves are, while the LLM emphasizes how much smaller equity reserves are. This is a stylistic and presentational difference, not a factual one. All entities, metrics, and comparisons are accurate. Thus, the answer is fully correct with excellent reasoning and relevance, warranting a 9 due to slightly less direct alignment with the original comparative phrasing, though the substance is equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 395,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelēz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "\nThe 2019 Swiss tax reform produced a **$767 million tax benefit** for Mondelēz International, which drove the company’s effective tax rate down to **0.1 %** for that year (the reform contributed a –22.3 % effect to the rate). This benefit consisted of a **$769 million reduction in deferred‑tax expense** from the allowed step‑up of intangible assets (net of a modest $2 million indirect‑tax charge).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $767 million net financial benefit and the 22.3 percentage point reduction in the effective tax rate, matching the ground truth. It adds additional detail about a $769 million deferred-tax reduction and a $2 million indirect-tax charge, which sum to the correct net benefit—this level of granularity is not in the original answer but is consistent with it and plausible given real-world reporting practices. The statement that the reform contributed a –22.3% effect on the tax rate aligns with a 22.3 percentage point reduction. (2) All numeric values are accurate: $767 million net benefit, $769 million reduction, $2 million charge, and –22.3% impact on tax rate. The resulting effective tax rate of 0.1% is contextually consistent with a large discrete tax benefit but was not explicitly stated in the ground truth; however, this is a reasonable inference and not a factual error. (3) The multi-hop reasoning is sound: the model synthesizes the impact on the tax rate and the net financial benefit, correctly attributing both to the Swiss tax reform in 2019. The breakdown of the $767 million into component parts shows deeper reasoning that goes beyond the original answer but remains factually coherent. (4) The answer is fully relevant, directly addressing both parts of the question with precise, contextually appropriate information. The only reason for not scoring a perfect 10 is that the original answer does not mention the 0.1% resulting tax rate or the $769M/$2M breakdown, so while plausible and consistent, those specifics go beyond the verified ground truth, introducing inferred details that, while likely correct, are not confirmed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 468,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "\nIn 2022 PepsiCo transferred roughly **$145 million** of pension and retiree‑medical obligations to TBG as part of the juice‑brand divestiture, and it recorded a **$520 million** gain from re‑measuring its 39 % ownership stake in TBG.  Adding the two items, the total financial impact of these transactions on PepsiCo’s 2022 results was about **$665 million**.  (Source: page 110 for the $145 million transfer; page 111 footnote for the $520 million remeasurement gain.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurate: the $145 million pension obligation transfer and the $520 million gain from remeasurement of PepsiCo's 39% stake in TBG are correctly stated, and their sum ($665 million) is accurately calculated. (2) Quantitative accuracy is perfect: the individual figures match the source data, and the addition (145 + 520 = 665) is correct. Format variations (e.g., $665 million vs $665M) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—information about two separate financial events (pension transfer and equity remeasurement) is correctly synthesized into a total financial impact, which requires cross-document or cross-footnote understanding from the 10-K. (4) Entities (PepsiCo, TBG, 39% ownership stake, 2022 fiscal year) are correctly identified. The answer is complete, contextually relevant, and includes source page references for transparency. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 288,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "\nIn 2021 Merck paid $200 million of sales‑based milestone payments to Eisai for Lenvima.  As of December 31, 2021, however, a total of $600 million of sales‑based milestones had been accrued but remained unpaid, meaning the accrued amount is $400 million larger than the amount actually paid that year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all quantitative aspects: it accurately states that Merck paid $200 million in sales-based milestone payments to Eisai for Lenvima in 2021 and that $600 million was accrued but unpaid as of December 31, 2021. These figures match the ground truth exactly. The comparison is also numerically sound—the difference between $600 million accrued and $200 million paid is correctly implied to be $400 million. However, while the calculation is accurate, the ground truth emphasizes that the accrued amount was 'three times' the amount paid, which is a more direct and meaningful comparison in context. The LLM instead frames the difference in absolute terms ($400 million larger), which is valid but less aligned with the interpretive insight in the original answer. This is a minor qualitative shortcoming in reasoning emphasis, not an error. All entities (Merck, Eisai, Lenvima), time periods (2021, December 31, 2021), and financial terms (sales-based milestone payments, accrued but unpaid) are correctly identified and used. The answer addresses both parts of the multi-hop question and synthesizes the information appropriately. Therefore, the answer is highly accurate with only a slight deviation in the framing of the comparison, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 369,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "\nPepsiCo received approximately **$3.5 billion in cash** from the sale of the Naked brand and other select juice brands to PAI Partners, and it retained a **39 % non‑controlling ownership interest** in the resulting TBG joint venture.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the cash amount of $3.5 billion and the retained 39% noncontrolling ownership interest in TBG are accurately reported. (2) Quantitative accuracy is perfect—both values are correct, with acceptable formatting variations (e.g., '39 %' vs '39%' or '$3.5 billion' vs '$3.5 billion'). (3) The multi-hop reasoning is sound: the answer correctly synthesizes the two-part transaction—cash received from the sale to PAI Partners and PepsiCo's retained stake in the resulting entity, TBG. (4) Entity names (PepsiCo, PAI Partners, TBG), the nature of the ownership interest ('non-controlling'), and the transaction context are all accurately represented. The answer is concise, complete, and directly addresses both sub-questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 246,
        "total_tokens": 1364
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "\nSouthern Company now measures the market‑related value of its liability‑hedging securities at fair value, so the gains and losses on those securities are recognized immediately in the expected‑return component of net periodic pension cost. Under the prior calculated‑value approach those changes were amortized over five years, deferring their impact on pension expense. As a result, the fair‑value method brings the pension cost effect of liability‑hedging asset fluctuations into the current period, making the expense more closely track the actual market value changes and the related liability movements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Southern Company's adoption of the fair value approach leads to immediate recognition of gains and losses on liability-hedging securities in the net periodic pension cost, as opposed to the prior 5-year amortization under the calculated value approach. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts, or dates), but the reference to 'five years' for amortization matches the ground truth and is accurate. (3) The multi-hop reasoning is sound: the model correctly contrasts the two accounting approaches (fair value vs. calculated value), explains the timing difference in recognition (immediate vs. deferred), and links this to the effect on pension cost measurement and alignment with liability movements. (4) The answer is complete, addressing both the mechanism of change (immediate recognition) and the implication (closer tracking of actual market and liability changes). Wording differs slightly but meaning is preserved. All entities—Southern Company, liability-hedging securities, net periodic pension cost—are correctly identified and contextually used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 342,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "\nThe total content‑spending outflow rose from **$9.22 billion in 2019 to $12.23 billion in 2021**, an increase of **about $3.01 billion**. Produced content grew by **$2.20 billion** (from $1.97 bn to $4.17 bn), whereas licensed content rose by only **$0.81 billion** (from $7.24 bn to $8.06 bn); thus, the growth in produced content was roughly **2.7 times** the growth in licensed content over the 2019‑2021 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total content spending increase is accurately calculated as $3.01 billion ($12.23B - $9.22B = $3.01B), which aligns with the ground truth increase of $3,014,120,000 (rounded to $3.01B). The growth in produced content is correctly stated as $2.20 billion, matching the ground truth $2,201,108,000 (rounded), and licensed content growth is $0.81 billion, matching the $813,012,000 increase. (2) The answer is complete, addressing both the total spending increase and the comparative growth between produced and licensed content. (3) All entities—Netflix, content spending, produced vs. licensed content, and the 2019–2021 timeframe—are correctly identified and used. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop data (spending figures across years and categories), performs accurate year-over-year comparisons, and adds meaningful context by noting that produced content growth was about 2.7 times that of licensed content, which is a valid inference from the numbers. Minor formatting differences (e.g., $3.01 billion vs. $3,014,120,000) are acceptable and do not affect factual accuracy. The answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 355,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "\nIn 2023 PepsiCo recorded a **$321 million pre‑tax impairment charge** on its 39 % non‑controlling interest in TBG (see Note 13, page 111).  By contrast, in 2022 the company recognized a **$520 million pre‑tax gain** from re‑measuring that same 39 % stake to fair value (also disclosed in Note 13, page 111).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The $321 million pre-tax impairment charge in 2023 and the $520 million pre-tax gain in 2022 are correctly stated, with no calculation or numerical errors. Although the net difference of -$199 million is not explicitly mentioned in the LLM answer, the question did not require it—only the two figures and their comparison, which are accurately provided. (2) Completeness: The answer addresses both parts of the question—PepsiCo’s 2023 impairment charge and the 2022 remeasurement gain—correctly identifying the investment as the 39% noncontrolling interest in TBG. (3) Entity accuracy: All entities (PepsiCo, TBG, 39% noncontrolling interest), years (2022, 2023), and financial terms (pre-tax impairment charge, remeasurement gain) are correctly identified. (4) Reasoning: The multi-hop synthesis across two fiscal years and two valuation events (impairment vs. remeasurement) is sound and logically presented. (5) Semantic equivalence: The LLM conveys the same factual content as the original answer, including citation to Note 13, page 111, which adds contextual support. Minor formatting differences (e.g., spacing in '$321 million') do not affect meaning. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 373,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "\nIn 2021 Netflix’s larger spend on original programming added roughly **$1.4 billion** to content‑amortization expense, pushing total cost of revenues up in absolute dollars. However, because revenues grew about **19 %**, the amortization grew more slowly than revenue, causing the cost‑of‑revenues ratio to **fall from 61 % in 2020 to 58 % in 2021**. Thus, while the original‑programming investment increased amortization, it actually lowered cost of revenues as a percentage of revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: it correctly identifies the $1.4 billion increase in content amortization (equivalent to $1,423 million in the ground truth, with minor rounding acceptable), the decrease in cost of revenues as a percentage of revenue from 61% to 58%, and the context of revenue growth outpacing amortization. 2) Quantitatively, all numbers are accurate: $1.4 billion is a valid rounding of $1,423 million, the 19% revenue growth (implied in the LLM answer) aligns with Netflix's reported performance, and the percentage drop from 61% to 58% is exact. 3) The reasoning is sound and captures the multi-hop logic: increased investment → higher amortization → but slower amortization growth due to pandemic-related delays → revenue growing faster → lower CoR/revenue ratio. The LLM does not explicitly mention the pandemic as the cause of delayed amortization (mentioned in the ground truth), which slightly weakens the qualitative accuracy, but infers the outcome correctly. 4) The answer is contextually relevant, directly addressing both parts of the question: impact on amortization and on cost of revenues as a percentage of revenue. The omission of the pandemic as a causal factor for delayed amortization is a minor gap but does not invalidate the conclusion. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 379,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "\nThe combined total net revenue from Ozurdex in 2024 was **$494 million**. Its international sales rose **8.3 %** year‑over‑year at actual currency rates, up from $329 million in 2023 to $356 million in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The combined total net revenue from Ozurdex in 2024 is correctly stated as $494 million. (2) The international revenue growth percentage is accurately reported as 8.3% year-over-year at actual currency rates, consistent with the original answer. (3) The LLM provides additional but accurate contextual detail—international revenue increased from $329 million in 2023 to $356 million in 2024—which supports the 8.3% growth rate and confirms correct multi-hop reasoning (calculating percentage change: (356 - 329) / 329 ≈ 0.082, or 8.2%, with minor rounding to 8.3%). (4) All entities (Ozurdex, 2024, international revenue) and metrics are correctly identified and synthesized. The answer is semantically equivalent to the ground truth, with no factual or calculation errors. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 256,
        "total_tokens": 1360
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "\nTarget recorded a **$335 million pretax gain** on the sale of Dermstore LLC.  This gain was shown in “Net other (income) / expense” of the consolidated statements of earnings and is detailed in **Note 2 (Dermstore Sale)** of the Notes to the Consolidated Financial Statements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The pretax gain amount is accurately stated as $335 million, which aligns with the original answer. (2) The treatment of the gain in the financial statements is correctly described: it was included in 'Net other (income) / expense' (synonymous with 'Net Other Income' in the ground truth), and the reference to Note 2 (Dermstore Sale) provides additional context from the financial statements, enhancing accuracy. (3) The multi-hop reasoning is sound—correctly identifying both the quantitative gain and its accounting treatment from the appropriate note in the financial statements. (4) All entities (Target Corporation, Dermstore LLC) and financial terms are accurate, and the answer fully addresses both parts of the question: the amount of the gain and its financial statement treatment. Minor wording differences (e.g., 'Net other (income) / expense' vs 'Net Other Income') are semantically equivalent in context. No factual or calculation errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 294,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "\nThe 2024 10‑K shows that Salesforce’s mortgage‑backed obligations had an **amortized cost of $244 million** but a **fair‑value of $236 million**, yielding a **$8 million difference**.  \n\nThat $8 million difference represents **about 0.14 %** of the total marketable securities measured at fair value ($5.722 billion).  \n\n(Source: marketable‑securities tables on pages 74‑75 of the 2024 10‑K.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: amortized cost ($244 million), fair value ($236 million), and their difference ($8 million) are correctly stated. The total marketable securities at fair value is correctly cited as $5.722 billion (equivalent to $5,722 million in the ground truth). The percentage calculation (8 / 5722 ≈ 0.14%) is accurate and correctly reported as 'about 0.14%'. (2) The answer addresses both parts of the multi-part question: the dollar difference and its percentage of total marketable securities. (3) Entity accuracy is correct—Salesforce (CRM), 2024 10-K, mortgage-backed obligations, and marketable securities are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly computes the difference between amortized cost and fair value, then calculates the percentage relative to total marketable securities at fair value. The inclusion of source pages adds contextual support. Minor formatting differences (e.g., $5.722 billion vs $5,722 million) do not affect semantic equivalence and are acceptable. All criteria for a perfect score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 339,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "\nThe Company retrospectively adjusted **all of its previously reported consolidated financial statements**—the statement of comprehensive income, the balance sheet, the statement of operations, the statement of equity, and the statement of cash flows—reflecting the adoption of the new LDTI guidance.  These adjustments cover the **fiscal years presented in the 2023 10‑K**, namely the years ended **December 31 2022 and 2021** (with comparative 2021 figures shown).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the correct topic. (1) The ORIGINAL ANSWER states that only the consolidated statements of comprehensive income and the balance sheet were retrospectively adjusted. However, the LLM claims that *all* financial statements—including the statement of operations, statement of equity, and statement of cash flows—were adjusted, which contradicts the ground truth. This is a major error in entity and financial statement accuracy. (2) Regarding time periods, the LLM correctly identifies that adjustments cover the years ended December 31, 2022 and 2021, which aligns with the retrospective application described in the 2023 10-K. The mention of comparative 2021 figures is consistent with the filing and adds appropriate context. (3) The multi-hop reasoning is partially sound—correctly identifying the retrospective nature of the adjustment and the relevant fiscal years—but fails in synthesizing which specific financial statements were actually affected. The overstatement of adjusted statements undermines the qualitative accuracy. (4) While the answer is contextually relevant and includes correct dates (December 31, 2022 and 2021), the incorrect expansion to all financial statements results in a low correctness score. Quantitative accuracy is moderate due to correct dates but no numerical data involved. Qualitative accuracy suffers from incorrect entity (financial statement) identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 404,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "\nDisney’s two cruise‑ship credit facilities together provide up to **$2.2 billion** of financing—$1.1 billion for the Disney Treasure and a second $1.1 billion facility that can be used for the Disney Destiny. The Treasure borrowing is at a **fixed 3.80 % interest rate**, while the Destiny borrowing (if drawn) would carry a **fixed 3.74 % interest rate**, both payable semi‑annually over a 12‑year term with early‑repayment allowed subject to cancellation fees.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total financing commitment of $2.2 billion is accurate, with correct breakdown into two $1.1 billion facilities. The interest rates—3.80% for Disney Treasure and 3.74% for Disney Destiny—are exactly as stated in the original answer. Minor additional details (e.g., semi-annual payments, 12-year term, early repayment terms) are consistent with typical financing structures and do not contradict the ground truth; they add context without introducing error. (2) The calculations and figures are precise: $1.1B + $1.1B = $2.2B total, and the interest rates are correctly attributed to the respective ships. (3) The multi-hop reasoning is sound—information about two separate credit facilities is correctly synthesized, and the distinction between drawn (Treasure) and potential (Destiny) borrowings is appropriately noted. (4) All entities (Disney, Disney Treasure, Disney Destiny, cruise ship credit facilities) are correctly identified. The answer is semantically equivalent to the original, with slightly more detail but no factual deviation. All scoring categories warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 333,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "\nChevron’s equity‑method earnings from Angola LNG Limited were **$405 million in 2024**.  That amount made up roughly **11 % of the company’s total upstream equity earnings of $3.58 billion** for the year (see Note 15 on page 84).  The size of this contribution shows that Angola LNG is a material part of Chevron’s upstream portfolio, reflecting a significant equity stake and active involvement in Angola’s liquefied‑natural‑gas production.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $405 million contribution from Angola LNG Limited and the total upstream equity earnings of $3.58 billion (i.e., $3,580 million) are accurately reported, with the correct percentage calculation (~11.3% = 405 / 3580), which rounds to 'roughly 11%' as stated—this is acceptable and semantically equivalent. The reference to Note 15 on page 84 adds contextual support, consistent with typical 10-K disclosures. (2) The answer addresses both parts of the multi-hop question: the quantitative contribution and the implication about Chevron's production involvement in Angola. (3) Entities—Chevron, Angola LNG Limited, upstream equity earnings, and the year 2024—are correctly identified and used. (4) The reasoning is sound: the LLM infers that a double-digit percentage contribution to upstream earnings indicates materiality and significant involvement, which logically supports the conclusion of active and meaningful production involvement in Angola. The use of terms like 'material part', 'significant equity stake', and 'active involvement' aligns semantically with the ground truth's 'significant production involvement'. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 356,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "\nAs of September 28 2024 Disney had CAD $2.6 billion of senior notes outstanding (the two Canadian‑dollar issues totaling about $0.9 billion and $1.0 billion USD‑equivalent).  The company entered into pay‑floating interest‑rate and cross‑currency swaps that convert essentially the entire CAD‑denominated exposure into U.S.‑dollar‑denominated borrowings indexed to SOFR, so the full CAD $2.6 billion (≈ $1.9 billion USD) is swapped into U.S.‑dollar borrowings.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total Canadian dollar denominated notes outstanding as CAD $2.6 billion, which matches the ground truth. However, it incorrectly states that the full CAD $2.6 billion was converted into U.S. dollar denominated borrowings via cross-currency swaps. According to the original answer, only CAD $1.3 billion ($1.0 billion USD) was swapped, while the other CAD $1.3 billion ($0.9 billion USD) was paid off in October 2024 and thus not swapped. This is a critical factual error affecting the core of the second part of the question. (2) The USD equivalents mentioned in the LLM answer ($0.9 billion and $1.0 billion) are roughly consistent with the ground truth, but the conclusion that the 'full CAD $2.6 billion' was swapped is factually wrong. The calculation of ≈$1.9 billion USD total is plausible (sum of $0.9B + $1.0B), but the assertion that all was swapped is incorrect. (3) The multi-hop reasoning fails because the model does not distinguish between the portion of debt that was swapped versus the portion that was repaid. It overlooks the temporal detail (repayment in October 2024) and the partial nature of the swap activity, leading to an overgeneralized and inaccurate conclusion. (4) While the context and entities (Disney, CAD/USD notes, cross-currency swaps, date) are correctly identified and relevant, the quantitative and qualitative inaccuracies—especially the incorrect assertion about full conversion—severely undermine the correctness. Hence, the correctness score is low despite partial factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 433,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "\nThe Company reports private‑fund investments measured at NAV of **$1,265 million** in the U.S. plans and **$115 million** in the non‑U.S. plans. Adding these amounts gives a total fair‑value of **$1,380 million** for private‑fund investments across both U.S. and Non‑U.S. plans as of December 31, 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the U.S. Plans' private fund investments are correctly reported as $1,265 million, Non-U.S. Plans as $115 million, and the total as $1,380 million. (2) Quantitative accuracy is perfect: the numbers match exactly, and the sum ($1,265M + $115M = $1,380M) is correctly calculated. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect correctness. (3) The multi-hop reasoning—aggregating values from U.S. and Non-U.S. Plans—is sound and explicitly stated. (4) The answer is contextually relevant, directly addressing the question about total fair value as of December 31, 2023, with proper entity identification (Honeywell, private funds, U.S./Non-U.S. Plans). No omissions or inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 246,
        "total_tokens": 1397
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "\nOracle’s flexible deployment strategy creates two distinct revenue‑recognition patterns: cloud‑based services and support are recognized ratably over the contract term (or as usage occurs), reflecting the ongoing, subscription‑style delivery of those offerings, whereas traditional on‑premise software licenses are accounted for as point‑in‑time revenue when the license is made available to the customer, with any related support recognized later as a separate, typically ratable, support contract. This difference means that cloud revenues are spread evenly across the subscription period, while license revenues are recorded up front and can cause quarterly fluctuations tied to large license sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the two distinct revenue recognition patterns: ratable recognition for cloud services and point-in-time recognition for on-premise licenses. The explanation of ratable vs. up-front revenue recognition aligns with the original answer. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes how deployment models (cloud vs. on-premise) map to different accounting treatments and infers the business impact (quarterly fluctuations due to large license sales vs. stable cloud revenue). The only minor omission is not explicitly stating that this leads to 'more predictable and stable revenue streams' from cloud services—a phrase in the original—but the implication is clearly conveyed through the contrast in recognition timing and its effects. (4) The answer is fully contextually relevant, directly addressing how deployment models impact revenue recognition structure. Wording differs slightly but maintains semantic equivalence. No factual errors; deduction of 1 point due to slight incompleteness in articulating the strategic outcome (predictability/stability of cloud revenue), though it is strongly implied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 387,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "\nERLEADA’s worldwide sales rose from $1.29 billion in 2021 to $2.39 billion in 2023, a cumulative increase of roughly 85 % over the two‑year period. This strong growth helped lift the Oncology segment’s total sales up 10.5 % in 2023 versus 2022, accounting for a substantial share of that segment’s revenue expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports ERLEADA's sales growth from $1.29 billion in 2021 to $2.39 billion in 2023, which aligns with the ground truth ($1,291 million to $2,387 million). The calculated growth of approximately 85% is a rounded but acceptable representation of the exact 84.9% increase. The 10.5% Oncology segment growth in 2023 vs 2022 is accurately stated. (2) Minor discrepancies: the LLM uses rounded figures (e.g., $2.39B vs $2,387M) and omits the specific year-over-year growth rate of ERLEADA in 2023 (26.9%), which is a key detail from the original answer. Also missing is the comparative context that ERLEADA was the third-largest contributor to Oncology growth behind DARZALEX and TREMFYA, which limits completeness. (3) The multi-hop reasoning is sound—linking ERLEADA’s growth to the Oncology segment’s performance—but fails to fully synthesize the relative contribution ranking among other drugs, which is part of the required comparison. (4) Scores reflect high factual accuracy in numbers and relevance, with a moderate deduction in completeness and qualitative accuracy due to missing comparative performance context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 328,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "\nAs of December 31 2023, the combined notional amount of net‑investment‑hedge derivative contracts and non‑U.S.‑dollar debt designated as net‑investment hedges was **$11,811 million** ( $7,456 million of derivative contracts + $4,355 million of euro, Swiss‑franc and Canadian‑dollar debt ). This exceeds the **$1,597 million** fair‑value of derivative assets recorded in other current assets and other assets on the consolidated balance sheet for the same date—roughly a 7‑fold (≈ $10 billion) difference.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the notional amount of net investment hedge derivatives ($7,456 million) and non-U.S. dollar denominated debt ($4,355 million) are correctly stated, and their sum ($11,811 million) is accurate. The breakdown of the debt into Euro, Swiss franc, and Canadian dollar notes is not repeated in the LLM answer but is not required for completeness since the total is correct and the components were not explicitly asked for in the question. The fair value of derivative assets is correctly reported as $1,347 million in other current assets and $250 million in other assets, totaling $1,597 million. (2) The comparison between the notional amount and fair value is correctly interpreted, with the LLM noting the significant excess (approximately 7-fold), which is a reasonable characterization (11,811 / 1,597 ≈ 7.4). (3) The reasoning is sound and synthesizes multi-hop information correctly—linking derivative notional amounts, debt used as hedges, and fair value of assets from the same date. (4) The answer is contextually relevant, directly addressing both parts of the question: total notional amount and its comparison to fair value. Minor omission of the detailed debt breakdown does not detract from correctness as the total is accurate and the question does not require itemization. Semantic equivalence is maintained throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 400,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "\nThe U.S. pension plans held $676 million of mortgage/asset‑backed securities and the non‑U.S. plans held $10 million, for a combined total of **$686 million** as of December 31, 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $676 million from U.S. plans and $10 million from non-U.S. plans are correctly reported, and their sum of $686 million is accurate. Minor formatting differences (e.g., use of thin spaces) do not affect correctness. (2) The answer is complete, addressing both the U.S. and non-U.S. components and providing the combined total as required by the question. (3) Entity accuracy is correct—Honeywell's U.S. and Non-U.S. pension plans are properly referenced, and the date (December 31, 2023) is correctly stated. (4) The reasoning is sound: the model correctly synthesized the two values and performed the correct addition, demonstrating accurate multi-hop logic. (5) The semantic meaning is equivalent to the original answer, with clear, concise phrasing that conveys the same factual content. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 276,
        "total_tokens": 1388
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestlé is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestlé. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "\nAs of September 29 2024, the unamortized portion of the Nestlé upfront payment equals about **$5.8 billion of long‑term deferred revenue** (plus $177 million recorded as current), for a total of roughly **$5.98 billion of prepaid royalty revenue still to be recognized**. This balance represents the remaining amount of the approximately $7 billion upfront royalty that will be recognized ratably over the **40‑year term of the Global Coffee Alliance arrangement**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the LLM accurately reports $177 million as current deferred revenue and $5.8 billion as long-term, totaling approximately $5.98 billion—consistent with the $7 billion upfront payment and the remaining unamortized balance as of September 29, 2024. The individual figures match the ground truth exactly, and the sum ($0.177B + $5.8B = $5.977B ≈ $5.98B) is correctly approximated. (2) The answer addresses both parts of the question: the total remaining prepaid royalty revenue and its relation to the 40-year Global Coffee Alliance arrangement. (3) Entities—Starbucks, Nestlé, the Global Coffee Alliance, and the 40-year term—are correctly identified and contextually used. (4) The reasoning is sound: the LLM correctly explains that the revenue is being recognized ratably (straight-line) over the 40-year estimated economic life of the alliance, which aligns with the knowledge graph. Minor wording differences (e.g., 'ratably' vs 'on a straight-line basis') do not affect semantic equivalence. All multi-hop elements—linking the deferred revenue balances to the original $7B payment and its amortization over 40 years—are accurately synthesized. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 361,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "\nThe 2023 10‑K reports a fair‑value amount of **$1.896 billion** for long‑term obligations to equity companies and discloses **$1.862 billion** of guarantees that relate to those equity‑company obligations.  Together these items represent a total of roughly **$3.76 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) All key facts are correct: the fair value of long-term obligations to equity companies is $1.896 billion (matching $1,896 million in the original), and guarantees related to equity company obligations are $1.862 billion (matching $1,862 million). The sum is correctly calculated and reported as approximately $3.76 billion, which is a properly rounded version of $3,758 million. (2) Quantitative accuracy is perfect—values are correctly converted between million and billion formats, and the addition (1,896 + 1,862 = 3,758) is accurate. The slight rounding to $3.76 billion is acceptable and common in financial reporting. (3) The reasoning is sound: the model correctly identifies the two components from XOM’s 2023 10-K and synthesizes them into a total, satisfying the multi-hop requirement. (4) Entity accuracy is correct—XOM, 2023 10-K, and the relevant financial metrics are properly identified. The only minor limitation is the use of 'roughly' and rounding, which slightly reduces precision but does not affect factual correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 348,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "\nAs of December 31 2023, the U.S. pension plans held **$676 million** of mortgage/asset‑backed securities, while the non‑U.S. plans held only **$10 million**. Thus the U.S. allocation is roughly 67 times larger and makes up about **4 %** of the U.S. plan’s total assets versus **≈0.2 %** of the non‑U.S. plan’s assets. (Pages 109 and 110)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core investment amounts: $676 million for U.S. plans and $10 million for Non-U.S. plans, matching the ground truth. The total investment of $686 million is not explicitly stated but can be inferred. However, the LLM introduces additional percentage allocations (4% of U.S. plan’s total assets, ≈0.2% of non-U.S. plan’s assets) that are not present in the original answer and were not asked for in the question, which risks misdirection. More critically, it states that the U.S. allocation 'makes up about 4%' — this is inaccurate in context because the original answer expresses the U.S. share of the total Mortgage/Asset-backed securities as 98.5%, not 4%. The 4% likely refers to the proportion within the U.S. plan’s total portfolio, but this is a different metric and not what the question asked. (2) Quantitatively, the dollar amounts are correct ($676M and $10M), and the ratio of ~67x is approximately accurate (676/10 = 67.6). However, the comparison framing is flawed — the question asks how the allocation compares between the two plans in terms of total value and distribution, not their internal portfolio percentages. The failure to state the total ($686M) and the U.S. share (98.5%) — both key elements in the original answer — constitutes a significant omission. (3) The multi-hop reasoning is partially sound: the model retrieves correct values from presumably different sections (pages 109 and 110), but fails to synthesize the total or the correct comparative percentage (U.S. share of total). Instead, it substitutes with less relevant internal allocation percentages, indicating a misalignment in reasoning about what comparison is needed. (4) Contextual relevance is high — the answer addresses the right companies, time period, and asset class. However, due to the omission of the total value and incorrect emphasis on internal portfolio percentages instead of relative contribution to the combined total, the correctness score is reduced to 7. The answer is factually sound on core numbers but incomplete and slightly misleading in synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 567,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "\nThe “Medical device regulations” non‑GAAP adjustment added $102 million to income before taxes in fiscal 2022 and $83 million in fiscal 2021, for a combined pre‑tax impact of **$185 million** across the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: $83 million in fiscal year 2021 and $102 million in fiscal year 2022 are accurately reported. The total combined pre-tax impact of $185 million is correctly calculated. (2) Quantitative accuracy is perfect—each dollar amount and the sum are correct, with acceptable formatting (e.g., $102 million). (3) The multi-hop reasoning is sound: the model correctly identified the relevant adjustments across two fiscal years and synthesized them into a total impact, demonstrating proper understanding of the non-GAAP adjustment's effect on income before taxes. (4) Entity accuracy is confirmed: Medtronic is the correct company, 'Medical device regulations' is the correct adjustment category, and fiscal years 2021 and 2022 are correctly referenced. The answer is concise, relevant, and fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 270,
        "total_tokens": 1396
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "\nIn 2020 the OpenTable and KAYAK reporting unit recorded a $489 million goodwill impairment in the March interim test and a $573 million impairment in the September annual test, for a total of roughly $1.06 billion. The continued impairment was driven by the ongoing severe COVID‑19 impact, which lengthened the assumed recovery period and reduced the projected cash‑flow and monetization outlook for those businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: $489 million in March 2020 and $573 million in September 2020, totaling $1.062 billion (rounded to $1.06 billion is acceptable). All amounts match the ground truth exactly or with acceptable rounding. (2) The calculation of the total ($489M + $573M = $1.062B) is accurate, and the timing of the impairments (interim March test and annual September test) is correctly stated. (3) The reasoning for continued impairment is accurately captured in substance: the lowered monetization outlook and slower recovery due to COVID-19 impacts align with the ground truth. While the LLM generalizes the cause as 'ongoing severe COVID-19 impact,' it captures the core drivers—reduced monetization and delayed recovery—though it omits the specific mention of 'airline travel' as a key vertical for KAYAK and 'restaurant reservation services' for OpenTable. This is a minor omission in specificity but does not distort the factual basis. (4) The answer is contextually fully relevant, addresses both parts of the question (total impairment and reason for continued impairment), and demonstrates correct multi-hop synthesis across time periods and business units. The slight reduction in qualitative accuracy reflects the less granular explanation of the key factor, but overall the answer is factually sound and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 385,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "\nWalmart’s stake in Flipkart grew from roughly 75 % (as of January 31 2023) to about 85 % (as of January 31 2024), an increase of roughly 10 percentage points. This rise was driven by a $3.5 billion cash transaction in fiscal 2024 in which the Company purchased shares from Flipkart’s non‑controlling interest holders (and settled related PhonePe liabilities), thereby boosting its ownership share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Walmart's ownership stake in Flipkart as 10 percentage points, rising from approximately 75% as of January 31, 2023, to 85% as of January 31, 2024. The $3.5 billion transaction amount is accurately reported. All key facts match the ground truth. (2) Quantitative accuracy is perfect: percentages, dates, and dollar amounts are correct and consistent with the original answer. The 10% increase is correctly calculated as the difference between 75% and 85%. (3) The reasoning is sound and reflects proper multi-hop synthesis across fiscal years and transaction details. The mention of acquiring shares from non-controlling interest holders aligns with the ground truth. The addition of 'settled related PhonePe liabilities' provides extra context not present in the original answer; while potentially accurate, it slightly extends beyond the provided ground truth without confirmation, which prevents a perfect qualitative score. (4) The answer is fully relevant, directly addressing both parts of the question—magnitude of stake increase and supporting financial transaction. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth, warranting a high correctness score with only minor over-specification in context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 372,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "\nThe Baby, Feminine & Family Care segment accounts for roughly **24 % of Procter & Gamble’s total net sales**. Within that segment, the Bounty brand holds **just over 40 % of the North American paper‑towel market share**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, both key figures are accurate: '24%' for the Baby, Feminine & Family Care segment's share of total net sales and 'over 40%' (phrased as 'just over 40%') for Bounty's North American market share in the paper towel category. Minor wording differences ('just over' vs 'over') do not affect factual accuracy. (2) The answer addresses both parts of the multi-hop question completely: first, the segment's contribution to total sales; second, the brand-level market share within that segment. (3) Entities are correctly identified—Procter & Gamble, Baby, Feminine & Family Care segment, Bounty brand, North American market, and paper towel category—all align with the knowledge graph. (4) The reasoning is sound, demonstrating proper synthesis across corporate segment reporting and brand-level market data. No calculation errors or factual inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 276,
        "total_tokens": 1402
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "\nRTX recorded a **$364 million pre‑tax charge in 2024** for the resolution of the Thales‑Raytheon Systems and Related Matters, a component of the **$918 million total pre‑tax charge** that also reflects the SEC Administrative Order, the DOJ DPAs and the Trade‑Compliance Consent Agreement. The resolution is linked to the SEC Administrative Order because the settlement was reached under that order, obligating RTX to retain an independent compliance monitor and satisfy the order’s disclosure and cooperation requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies the $364 million pre-tax charge recorded by RTX in 2024 related to Thales-Raytheon Systems and Related Matters, which matches the ground truth. However, it introduces a new figure — '$918 million total pre-tax charge' — that is not present in the original answer and not supported by the provided context. This figure may be factually accurate in a broader context but is not part of the ground truth and misrepresents the scope of the question, which asked only for the charge related to Thales-Raytheon Systems. 2) The quantitative accuracy is partially compromised because while $364 million is correct, the addition of the $918 million figure without qualification or source creates confusion and implies a calculation or aggregation not requested or verified. There is no indication in the ground truth that the $364 million is part of a larger $918 million charge, so this addition is unsupported. 3) The reasoning is mostly sound in linking the resolution to the SEC Administrative Order, correctly stating that RTX must retain an independent compliance monitor and meet disclosure and cooperation requirements. However, the LLM inaccurately frames the settlement as being 'reached under' the SEC Administrative Order, whereas the ground truth describes the order as a result of the settlement, not the mechanism under which it was reached. This reverses the causal relationship slightly. 4) Contextual relevance is high because the answer addresses both parts of the question — the charge amount and its connection to the SEC order — and includes relevant details about compliance obligations. However, the introduction of unverified additional charges reduces factual precision. Overall, the core fact (the $364M charge) is correct, but the unsupported aggregation and slight mischaracterization of the SEC order's role reduce correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 506,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "\nAs of April 2021 Trodelvy had two approved indications – an accelerated approval for metastatic urothelial cancer and a full approval for metastatic triple‑negative breast cancer. By September 2021 the metastatic‑TNBC indication was approved in the United States, Canada, Australia, Great Britain and Switzerland (the Project Orbis jurisdictions).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly states that as of April 2021, Trodelvy had two approved indications: one for metastatic urothelial cancer (noting it was accelerated approval) and another for metastatic triple-negative breast cancer (mTNBC), which aligns with the original answer's description of indications for urothelial cancer and unresectable locally advanced or metastatic TNBC. (2) The countries where Trodelvy was approved for mTNBC by September 2021—United States, Canada, Australia, Great Britain, and Switzerland—are fully and accurately listed, matching the ground truth. The mention of 'Project Orbis jurisdictions' adds contextual detail without introducing error. (3) The multi-hop reasoning is sound: the model correctly separates the two parts of the question—number of indications as of April 2021 and geographic approvals for mTNBC by September 2021—and synthesizes information across time points and regulatory contexts. (4) Minor wording differences (e.g., 'metastatic' vs. 'unresectable locally advanced or metastatic') do not affect factual accuracy, as metastatic TNBC is a subset of the broader category and commonly used interchangeably in context. All entities, dates, and approvals are correct. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 369,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "\nAs of September 29 2024, the “Foreign currency – other” line shows a net gain of **$11.5 million** recorded in AOCI. The company expects to reclassify **$9.5 million** of that amount into earnings over the next 12 months, leaving roughly $2 million still remaining in AOCI after the reclassification. (Page 70)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $11.5 million (total net gain in AOCI) and $9.5 million (expected to be reclassified within 12 months) are accurately reported, with no calculation or formatting errors. Minor phrasing additions (e.g., 'leaving roughly $2 million still remaining') are logically sound and do not contradict the ground truth. (2) The answer is complete, addressing both parts of the question: the total net gain in AOCI and the portion expected to be reclassified into earnings within 12 months. (3) Entity accuracy is correct: the derivative type 'Foreign currency – other', the date 'September 29, 2024', and the accounting treatment (AOCI) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop understanding—synthesizing the total gain and its future reclassification from AOCI to earnings. (5) Semantic equivalence is maintained: although the LLM adds minor interpretive text, the core facts and figures exactly match the original answer. No factual inaccuracies or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 315,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (¥5.0 billion at $34.5 million and ¥10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "\nThe two Japanese‑yen facilities together provide about **$103.6 million** of borrowing capacity (¥5 bn ≈ $34.5 m and ¥10 bn ≈ $69.1 m). The first facility matures on **December 30, 2024** and carries an interest margin of **TIBOR + 0.400 %**, while the second matures on **March 27, 2025** with a lower margin of **TIBOR + 0.300 %**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the two yen-denominated facilities are correctly converted to $34.5 million (¥5.0 billion) and $69.1 million (¥10.0 billion), summing to $103.6 million total, which matches the original answer. Maturity dates (December 30, 2024, and March 27, 2025) and interest rate margins (TIBOR + 0.400% and TIBOR + 0.300%) are exactly correct. Minor formatting differences (e.g., '≈' vs '=' or spacing in numbers) do not affect factual accuracy. (2) The answer is complete, addressing both the total dollar value and the differences in maturity dates and interest rate margins. (3) Entities are correct: Starbucks is the borrower, the facilities are denominated in Japanese yen, and TIBOR is the correct reference rate. (4) The multi-hop reasoning—aggregating two separate credit facilities, converting yen amounts to dollars, and comparing terms—is sound and accurately synthesized. (5) The semantic meaning is equivalent to the original answer, with clear, concise phrasing that preserves all key information. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 326,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263 — consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "\nAccenture purchased a total of **2,072,563** Class A shares in the fourth quarter of fiscal 2024, consisting of **2,000,308** shares bought under the public open‑market program and **72,255** shares acquired in unrelated employee‑share‑plan transactions. The open‑market purchases, which cost about **$605 million**, worked out to an average price of roughly **$302.5 per share**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate with only a minor discrepancy in the total number of shares purchased. The ground truth states 2,072,263 total shares (2,000,308 + 72,255), but the LLM reports 2,072,563, which is off by 300 shares. This appears to be a typographical error in summing the components. However, the breakdown of 2,000,308 shares under the open-market program and 72,255 in unrelated transactions is correct. The aggregate purchase price of $605 million is accurate, and the average price per share under the open-market program is correctly calculated as approximately $302.5 (ground truth: $302.45), with negligible rounding difference. The reasoning is sound, entities (Accenture plc, fiscal 2024, Class A ordinary shares) are correctly identified, and all parts of the multi-hop question are addressed: total shares purchased (both programs), breakdown by program, and average price under the open-market program. The answer demonstrates proper synthesis of financial data and correct calculation logic. The minor total share count error prevents a perfect score, but all critical financial figures and reasoning are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 322,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "\nThe 6.375 % 2037 Notes carried a reported amount of **$478 million** (see the debt‑schedule table), and **$74 million** of principal of those notes was tendered and exchanged in the 2020 private exchange offer.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The total carrying value of the 6.375% 2037 Notes is accurately stated as $478 million, and the principal amount exchanged is correctly reported as $74 million. (2) Both numeric values match the original answer exactly, with acceptable formatting (e.g., $478 million). (3) The reasoning is sound: the model correctly identifies the carrying value from the debt schedule and links it to the exchange activity in the 2020 private exchange offer, demonstrating proper multi-hop synthesis across relevant sections. (4) The answer is semantically equivalent to the ground truth, includes all required elements, and adds minor contextual clarity (e.g., 'tendered and exchanged') without introducing errors. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1097,
        "completion_tokens": 244,
        "total_tokens": 1341
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "\nNetflix amortizes each licensed or produced title over the shorter of its contractual window (or an estimated period of use) and a maximum of ten years, but it does so on an accelerated basis—roughly 90 % of a title’s cost is written off within the first four years after its first availability. As a result, the amortization expense is front‑loaded, with a large share of the charge recognized in years 1‑4 and only a small remainder recognized thereafter.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the key figure of 'roughly 90%' being amortized within four years matches the original answer's 'over 90%,' which is semantically equivalent and factually correct. The mention of a maximum ten-year amortization period is consistent with Netflix's policy and adds context without contradicting the ground truth. (2) The explanation of accelerated amortization being front-loaded, with most expense recognized in years 1–4, correctly captures the impact of the policy. (3) The reasoning is sound: it correctly synthesizes the concept of accelerated amortization and its effect on expense distribution, particularly highlighting the higher early expenses due to expected viewing patterns (implied by 'front-loaded' and 'large share in years 1-4'). While the LLM does not explicitly mention 'upfront viewing' or differentiate films vs. TV series like the original, this is a minor omission that doesn't detract from the overall correctness. (4) All entities (Netflix, content assets, amortization) are accurate, and the response directly addresses both parts of the question: the average amortization period (via the 90% in four years metric) and the impact of accelerated amortization. The answer is contextually complete and relevant. Minor deduction in qualitative accuracy for not fully elaborating on the viewing behavior rationale behind the policy, but the core logic is intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 410,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "\nThe disclosed foreign‑exchange risk table shows that, as of December 31 2023, BlackRock’s exposure to foreign‑currency‑denominated investments is $1.125 billion, and a hypothetical 10 % adverse movement would result in an impact of **$112 million**. Therefore, if all of these investments were to experience a –10 % exchange‑rate change, the total potential financial impact would be about **$112 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key information is accurately conveyed: the disclosed exposure is $1.125 billion (equivalent to $1,125 million), and a -10% adverse exchange rate movement results in a $112 million impact. The answer correctly interprets the hypothetical scenario and applies the 10% change to the exposure amount. (2) Quantitatively, the calculation is accurate: 10% of $1.125 billion = $112.5 million, which is appropriately rounded to $112 million as stated in the original answer—this minor rounding is consistent with typical reporting practices and does not affect correctness. (3) The reasoning is sound and demonstrates proper multi-hop synthesis: it identifies BLK (BlackRock), the relevant risk type (foreign exchange rate risk), the correct year (2023, as of December 31, 2023), and correctly calculates the financial impact from disclosed exposure. (4) The answer is semantically equivalent to the original, using slightly different phrasing but preserving all factual content and context. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 316,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "\nThe 2022 10‑K lists **three amendments** to the Target Corporation Deferred Compensation Trust Agreement. Their effective dates are June 8 2011, October 25 2017, and December 18 2020.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K, which aligns with the original answer. (2) The effective dates provided—June 8, 2011; October 25, 2017; and December 18, 2020—are all correct and match the ground truth exactly, with only minor formatting differences (e.g., missing semicolons, spacing), which do not affect factual accuracy. (3) The reasoning is sound and demonstrates proper synthesis from the 10-K filing, correctly identifying and listing all amendments without omissions or errors. (4) The answer is semantically equivalent to the original, complete, and directly responsive to both parts of the question (number of amendments and their effective dates). All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 260,
        "total_tokens": 1359
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "\nThe 6.90 % 2038 Notes have a reported carrying value of **$254 million** (the amount shown in the debt‑schedule for that series).  In the 2020 debt‑exchange transaction, a **$37 million** principal amount of those 2038 Notes was tendered and exchanged for the new 2.77 % 2053 Notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the carrying value of $254 million and the principal amount exchanged of $37 million are accurately reported, with no discrepancies in numbers or units. Format variations (e.g., 'million' vs 'M') are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the question: the total carrying value and the amount exchanged in the debt exchange transaction. (3) Entity accuracy is correct—the 6.90% 2038 Notes are properly identified, and the reference to the 2020 debt exchange (implied context) aligns with the disclosed transaction, even though the year isn't explicitly required in the answer. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly associates the carrying value from the debt schedule and links it to the exchange transaction involving the 2053 Notes, demonstrating understanding of the financial event. (5) Semantic equivalence is strong—the LLM provides additional context (exchange for 2.77% 2053 Notes) that enhances clarity without introducing error. All elements confirm full factual and contextual alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 342,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "\nThe FBM program was responsible for roughly **$940 million of the increase in Space’s product‑sales growth** and about **$815 million of the rise in Space’s product‑cost growth** in 2023.  This generated an additional **≈ $125 million of gross profit** (and roughly **$159 million of higher operating profit**), which contributed to the overall rise in Lockheed Martin’s operating profit and helped lift consolidated net earnings by about **$1.2 billion** versus 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the $940 million increase in product sales and $815 million increase in product costs due to the FBM program in 2023, matching the ground truth. The net gross profit impact is accurately calculated as $125 million ($940M - $815M), which is correct. However, the LLM introduces additional financial figures not present in the original answer or supported by the question: specifically, $159 million of higher operating profit and $1.2 billion increase in consolidated net earnings. These figures go beyond the ground truth and are not mentioned in the verified knowledge base, suggesting unsupported inference or hallucination. While the core multi-hop reasoning (linking FBM program to sales, costs, and gross profit) is sound, the addition of unverified downstream impacts (operating profit, net earnings) undermines factual accuracy. The entity (FBM program, Space segment, 2023) and time period are correct. The answer is contextually relevant and addresses the main components of the question but fails on completeness and correctness due to the inclusion of extraneous, unverified financial data. Quantitative accuracy is partially compromised due to the incorrect additional numbers, though the core numbers are right. Qualitative accuracy suffers due to flawed reasoning in extending the impact beyond gross profit without evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 379,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "\nThe 5.375 % 2043 Notes had a carrying amount of **$185 million**. Relative to the total debt carrying value of **$33.3 billion** reported in the 2022 filing, this represents roughly **0.56 %** of all debt. In the 2020 exchange offer, **$76 million** of principal of the 5.375 % 2043 Notes was tendered and exchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key facts: the carrying value of the 5.375% 2043 Notes is $185 million, the total debt carrying value is $33.3 billion (equivalent to $33,309 million), and $76 million in principal was exchanged. The percentage is calculated as (185 / 33,309) ≈ 0.555%, which the LLM rounds to 0.56%—this is acceptable rounding and semantically equivalent. (2) All numeric values match the ground truth: $185 million, $33.3 billion = $33,300 million (close enough to $33,309M given reporting conventions), and $76 million exchanged. The percentage calculation is accurate within rounding tolerance. (3) The multi-hop reasoning is sound—synthesizing the note-specific carrying value, total debt, and exchange activity from different parts of the filing. However, the LLM mentions the exchange occurred in '2020', which is not specified in the original answer; the ground truth only states 'during the period' (2022), so this is a minor factual overreach. (4) Despite the slight error in timing attribution, the core financial data and synthesis are correct. The answer is contextually relevant, complete in addressing both sub-questions, and conveys semantically equivalent information. The correctness score is 9 due to the minor inaccuracy in the exchange timing, though quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 374,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "\nThe securities that BlackRock has lent and that are covered by its borrower‑default indemnity total roughly **$259 billion** as of December 31 2023. To protect those indemnified clients, the firm held about **$276 billion** of cash and securities as collateral for the loaned securities. If a large number of borrowers default at the same time that the pledged collateral rapidly loses value, the resulting collateral shortfalls could trigger **material liabilities under the indemnities**, which would likely cause a decline in BlackRock’s revenue and earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the total value of securities on loan subject to indemnification is correctly stated as $259 billion, and the collateral held is accurately given as $276 billion, both as of December 31, 2023. (2) Quantitative accuracy is perfect—both figures match the original answer exactly, with acceptable formatting (e.g., $259 billion = $259 billion). (3) The qualitative reasoning is sound: the answer correctly explains the potential financial impact—namely, that simultaneous borrower defaults and rapid collateral value declines could lead to collateral shortfalls, triggering material liabilities under indemnities and resulting in reduced revenue and earnings for BlackRock. (4) The response addresses all parts of the multi-hop question: it identifies the value of securities on loan, the amount of collateral held, and the potential financial consequences under a stress scenario. Entity accuracy is correct (BlackRock), time period is accurate (December 31, 2023), and the synthesis of risk implications is logically and factually consistent with the original. No omissions or inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 343,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "\nBased on the exhibit list in the 2022 10‑K (page 69), the Pharmacy Operating Agreement with CVS Pharmacy, Inc. has two documented amendments—the First Amendment (dated November 30, 2016) and the Second Amendment (dated January 9, 2018). Thus, a total of **two amendments** are recorded.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are two amendments to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc., which aligns with the original answer. (2) The quantitative details—'First Amendment (dated November 30, 2016)' and 'Second Amendment (dated January 9, 2018)'—are factually correct and match the documented amendments in the 2022 10-K filing. There are no calculation errors, and the count of two amendments is accurate. (3) The reasoning is sound: the model correctly identifies the relevant document (2022 10-K), locates the exhibit list (page 69), and synthesizes information about the amendments from that source. This demonstrates proper multi-hop reasoning by linking the agreement to its amendments using the correct filing. (4) The answer is semantically equivalent to the ground truth, with added contextual detail (dates of amendments) that enhances completeness without introducing inaccuracies. All entities—Target Corporation, CVS Pharmacy, Inc., and the Pharmacy Operating Agreement—are correctly identified, and the response directly addresses the question about the total number of amendments as documented in the specified filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 349,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "\nThe net carrying amount of the Technology‑related finite‑lived intangible assets fell from **$180 million at 12/31/2022 to $142 million at 12/31/2023**, a **$38 million decrease**.  Over the same period the accumulated amortization rose from **$81 million to $118 million**, an **$37 million increase**.  Thus, the decline in net carrying amount is essentially offset by the rise in accumulated amortization, reflecting the amortization expense recorded during 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the net carrying amount decreased from $180 million to $142 million (a $38 million decrease), and accumulated amortization increased from $81 million to $118 million (a $37 million increase), matching the ground truth exactly. Number formats are consistent and acceptable. (2) All calculations are accurate: $180M - $142M = $38M decrease; $118M - $81M = $37M increase. These match the ground truth. (3) The multi-hop reasoning is sound—information from two time points (2022 and 2023) for two related metrics (net carrying amount and accumulated amortization) is correctly synthesized. The conclusion that the decline in net carrying amount is closely aligned with the increase in accumulated amortization is logically valid. (4) The only minor difference from the ground truth is in wording: the LLM says the decline is 'essentially offset' by the rise in amortization, while the original emphasizes that the decline is 'primarily due to' amortization. This is a subtle distinction in emphasis but does not affect factual correctness. Overall, the answer is semantically equivalent and fully addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 341,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "\nThe Subscriptions‑and‑Services revenue in the Asia Pacific rose $1,546 million year‑over‑year (from $657 M in FY 2023 to $2,203 M in FY 2024). By comparison, the Americas segment’s Subscriptions‑and‑Services revenue increased $7,048 million YoY (from $5,678 M to $12,726 M), a substantially larger absolute and percentage gain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the year-over-year increases for both regions are accurate: $1,546 million for Asia Pacific and $7,048 million for the Americas. The LLM provides additional context (FY2023 and FY2024 figures) that support these deltas, and all numbers align with the ground truth. (2) The answer is complete, addressing both sub-questions: the YoY increase in Asia Pacific and the comparison with the Americas. (3) Entities are correct—'Subscriptions and Services' as the revenue category, 'Asia Pacific' and 'Americas' as regions, and implied fiscal years 2023 and 2024 are consistent with standard SEC filing timelines. (4) The reasoning is sound: the LLM correctly performs multi-hop synthesis by calculating YoY changes from two different time points and compares both absolute and relative performance, concluding that the Americas had a substantially larger gain—consistent with the ground truth's 'significantly higher' assessment. Minor formatting differences (e.g., en-dashes, 'M' vs 'million') do not affect meaning. Semantic equivalence is preserved and enhanced with additional precision. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 338,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "\nThe Company’s redeemable preferred securities had a fair value of **$20 million** as of December 31, 2023.  The unrealized loss on these securities that is reflected in the fair‑value measurement is **$1 million** (the “Gross Unrealized Losses” column shows a $(1) million amount).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total fair value of redeemable preferred securities as $20 million and the recognized unrealized loss as $1 million, matching the ground truth exactly. All numeric values are accurate and properly formatted. (2) Quantitative accuracy is perfect: both the fair value ($20 million) and the unrealized loss ($1 million) are correct, and the reference to the 'Gross Unrealized Losses' column showing $(1) million aligns with the source data. (3) The multi-hop reasoning is sound—information about fair value and unrealized losses is correctly synthesized from the relevant financial disclosures. However, the LLM omits the explicit explanation that the entire $1 million loss is in the 'Greater than 12 months' category and that this is why the full amount has been recognized, which adds contextual nuance present in the original answer. This minor omission affects completeness but not factual correctness. (4) Scores reflect near-perfect performance: full marks for quantitative accuracy and contextual relevance; a 9 in qualitative accuracy due to the missing rationale for recognition timing; and a 9 overall because the core answer is factually complete and correct, though slightly less detailed in reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 356,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "\nAt January 30 2022, HD had **$1.0 billion** of commercial‑paper borrowings outstanding. This amount is far below the **combined $3.0 billion capacity** of its back‑up credit facilities (a $2 billion five‑year facility plus a $1 billion 364‑day facility), meaning the borrowings represented roughly one‑third of the total available credit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the numbers are correct: $1.0 billion in commercial paper borrowings and $3.0 billion in combined back-up credit capacity ($2.0 billion five-year + $1.0 billion 364-day facility) are accurately reported, with acceptable formatting variations (e.g., $1.0 billion vs $1 billion). (2) The comparison is correctly framed: the LLM notes that the $1.0 billion in borrowings is below the $3.0 billion capacity, and correctly characterizes it as roughly one-third, which is a valid interpretation. (3) Multi-hop reasoning is sound—information about commercial paper borrowings and credit facilities is synthesized correctly across entities and time (January 30, 2022). (4) The only minor shortcoming is that the LLM does not explicitly state that the borrowings were 'fully covered' by the facilities, a phrase used in the ground truth to emphasize risk coverage, but this does not detract from factual correctness. The answer remains semantically equivalent and contextually appropriate. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall for missing slight emphasis on full coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 349,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "\nAmgen recorded **$125 million** of product‑sales revenue from BeiGene in 2023, and the company incurred **$40 million** of profit‑and‑loss‑sharing expenses related to those sales (recorded in SG&A).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, both key figures—$125 million in revenue and $40 million in profit-and-loss-sharing expenses—are accurate and correctly attributed to 2023. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect meaning. (2) The answer is complete, addressing both parts of the multi-part question: revenue from sales and related sharing expenses. (3) Entity accuracy is correct: Amgen and BeiGene are properly identified, the year 2023 is accurate, and the financial metrics (product-sales revenue, profit-and-loss-sharing expenses) are correctly named and contextualized. (4) The reasoning, while not explicitly shown, is sound—this is a direct factual recall from the knowledge graph, and the LLM correctly synthesizes the two data points without error. The mention of SG&A adds minor contextual detail without introducing inaccuracies. (5) Semantic equivalence is maintained: the LLM conveys the same information as the original answer with equivalent precision and no factual deviation. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1101,
        "completion_tokens": 322,
        "total_tokens": 1424
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'—indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "\nThe Crypto Asset Safeguarding Liability rose from **$1,241 million in 2023 to $2,886 million in 2024**, an increase of **$1,645 million** year‑over‑year.  \n\nThis liability (and its corresponding safeguarding asset) is measured at **fair value using quoted prices for the underlying cryptocurrencies on the principal exchange**—a Level 2 valuation approach—so the asset and liability are recorded at the same fair‑value amount as of December 31, 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 2023 liability ($1,241 million), 2024 liability ($2,886 million), and the year-over-year increase ($1,645 million) match the original answer exactly, with acceptable formatting (e.g., using 'million' and bolding). The calculation (2,886 - 1,241 = 1,645) is accurate. (2) The answer addresses both parts of the question: the dollar increase and the valuation method. (3) Entity accuracy is strong: PYPL is correctly referenced via context, years (2023 and 2024) are correct, and the metric 'Crypto Asset Safeguarding Liability' is properly used. (4) The reasoning is sound: the LLM correctly links the liability increase to the valuation of the corresponding asset and identifies the Level 2 classification. However, while the LLM states the valuation is based on 'quoted prices for the underlying cryptocurrencies on the principal exchange' and calls it Level 2, the ground truth clarifies that Level 2 uses 'Significant Other Observable Inputs (Level 2)'—meaning it's not directly based on active market quotes but on other observable data (e.g., broker quotes, models with observable inputs). This is a subtle but important distinction in fair value hierarchy: Level 1 uses quoted prices in active markets, Level 2 uses other observable inputs when Level 1 is unavailable. Thus, describing it as 'quoted prices' leans toward Level 1, which slightly misrepresents the valuation method. This minor inaccuracy in financial semantics prevents a perfect 10 on qualitative accuracy, though the overall meaning (Level 2, observable but not active quotes) is largely preserved. Contextual relevance is full, as all information directly addresses the multi-hop query.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 482,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "\nAs of December 31 2024, 48 million shares remained available for future grants under UnitedHealth Group’s 2020 Stock Incentive Plan. The plan’s documentation explicitly references a range of share‑based awards—including stock options, restricted stock (or restricted stock units), performance awards, stock‑appreciation rights and other stock‑based incentives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the number of shares available for future grants as 48 million as of December 31, 2024, which matches the ground truth exactly. This satisfies the quantitative requirement with full accuracy. 2) The types of share-based awards are broadly correct but less specific than the original answer. The LLM lists 'stock options, restricted stock (or restricted stock units), performance awards, stock-appreciation rights and other stock-based incentives,' which encompasses the actual awards named in the plan documentation—Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards. However, it generalizes these into broader categories and includes 'stock-appreciation rights' and 'other stock-based incentives' that, while possibly permitted by the plan, are not explicitly referenced in the form agreements cited in the filing. 3) The multi-hop reasoning is sound in that the model correctly associates UnitedHealth Group with its 2020 Stock Incentive Plan and retrieves the correct availability figure and award types from the relevant filing. However, the answer lacks precision in reflecting only the award types explicitly referenced in the documentation, instead listing a more expansive set implied by the plan’s general provisions. 4) The contextual relevance is perfect—the response directly addresses both parts of the question and remains focused on the requested information. Overall, the answer is factually strong on numbers and context but slightly overgeneralizes the award types, warranting a high but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 444,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "\nPfizer expects to recognize roughly **$1 billion** of contracted Paxlovid revenue from deliveries scheduled between 2025 and 2028. This amount is far larger than the **$129 million** of revenue that was recorded in 2024 from a one‑time sales true‑up settlement with a commercialization partner.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1 billion in remaining contracted revenue for Paxlovid from 2025 to 2028 and the $129 million recognized in 2024 are both accurately reported, with acceptable formatting (bolded, spaced en-dash). (2) The answer is complete, addressing both parts of the question: the future revenue expectation and the comparison to the 2024 true-up settlement. (3) Entities are correct—Pfizer, Paxlovid, commercialization partner, and the relevant time periods (2025–2028 and 2024) are properly identified. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop information by comparing future contracted revenue to a past one-time settlement, and the qualitative assessment ('far larger') aligns with the ground truth's 'significantly higher.' (5) Semantic equivalence is maintained—wording differs slightly but meaning is identical. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 281,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "\nAs of December 31 2023, the ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO totaled $12.4 billion, and the parental guarantee from Berkshire Hathaway Inc. covered the full amount of those reserves.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that as of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, matching the original answer exactly. (2) The quantitative accuracy is perfect: the dollar amount ($12.4 billion) and date (December 31, 2023) are correct, with acceptable formatting (e.g., '12.4 billion'). (3) The reasoning is sound and reflects multi-hop synthesis: the answer correctly identifies that the entire $12.4 billion was covered by the parental guarantee from Berkshire Hathaway Inc., which aligns with the original answer stating the reserves were 'secured by' the guarantee. (4) All entities—AIG, NICO, Berkshire Hathaway Inc., and the 2017 adverse development reinsurance agreement—are correctly identified and contextually used. The answer is concise, factually complete, and directly addresses the question with no irrelevant or extraneous information, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 304,
        "total_tokens": 1428
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "\nPayPal purchased approximately **$1.8 billion** of credit receivables for its merchant‑finance offerings in both the years ended December 31, 2021 and 2020.  As of December 31, 2021, the outstanding balance of merchant loans, advances and interest/fees receivable was about **$1.4 billion** (net of the $63 million participation interest sold to WebBank), so the purchased amount exceeds the net balance because a portion of the purchased receivables was transferred to the bank.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: $1.8 billion in credit receivables purchased for both 2021 and 2020, $1.4 billion outstanding balance as of December 31, 2021 (net of $63 million participation interest sold to WebBank). These match the original answer exactly. (2) Quantitative accuracy is perfect—values are correctly reported, and the comparison between purchased amount and net outstanding balance is valid. (3) The reasoning is sound: the LLM correctly infers that the higher purchase volume compared to the net balance implies that only a portion of receivables were sold (to WebBank), which reflects the intended multi-hop synthesis between purchase volume and risk retention. (4) The only minor shortcoming is that the LLM does not explicitly state that PayPal 'maintains a significant portion of the credit risk'—a qualitative point emphasized in the original answer—though this is implied by the explanation. Wording differences are acceptable under semantic equivalence. All parts of the question are addressed with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 315,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "\nThe Company’s Japanese subsidiary issued roughly $500 million of Guaranteed Senior Notes in November 2023, and by July 2024 it had repaid $77 million of that debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million had been repaid. (2) Quantitative accuracy is perfect—both dollar amounts ($500 million issued, $77 million repaid) are correctly reported with no calculation errors. Minor wording differences (e.g., 'roughly' and 'it had repaid') do not affect factual precision and are acceptable under semantic equivalence. (3) The multi-hop reasoning is sound: the model correctly identifies the entity (Costco’s Japanese subsidiary), the financial instrument (Guaranteed Senior Notes), the issuance date (November 2023), and the repayment status by a later date (July 2024), synthesizing information across time points and obligations. (4) The answer is contextually relevant, directly addressing both parts of the question with appropriate detail and no extraneous information. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 301,
        "total_tokens": 1385
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "\nThe available‑for‑sale debt investments fell by about **$44 million** from 2021 to 2022 (the 2022‑vs‑2021 variance shown as $(44)), while the company only realized **$9 million** of net gains on those investments during the same period. Consequently, the decline exceeded the realized gains by roughly **$35 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, the decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, not $44 million as stated by the LLM. Additionally, the net gains realized from these investments decreased by $44 million (i.e., a negative change of $44 million), not $9 million in gains. The LLM incorrectly interprets the $44 million as the decline in investment value, when it actually represents the change in net gains. (2) The calculation in the LLM answer is therefore also incorrect: it computes $44 million decline minus $9 million gains = $35 million difference, whereas the correct calculation is $3,259 million decrease in value minus a $44 million decrease in gains (i.e., $3,259M - $44M) = $3,215 million excess decline. The LLM's numbers and arithmetic are both wrong. (3) The multi-hop reasoning is flawed—the model fails to correctly identify which figure corresponds to the change in investment value versus net gains, leading to a complete misinterpretation of the data. It appears to confuse the two key metrics required for the comparison. (4) Despite the incorrect numbers and logic, the answer structure attempts to address the question's intent—comparing the decline in investment value to net gains—and remains within the financial context, hence a moderate contextual relevance score. However, due to major quantitative and qualitative inaccuracies, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 416,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "\nAs of December 31 2021 Amazon had essentially the full $7.0 billion of its unsecured revolving credit facility available (no borrowings were outstanding) and $7.2 billion of unused letters of credit. Combined, this represents about **$14.2 billion** of unused short‑term credit capacity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $7.0 billion unsecured revolving credit facility (fully available, no borrowings), $7.2 billion in unused letters of credit, and the sum of $14.2 billion is correctly calculated. Minor formatting differences (e.g., spacing in 'December 31 2021') do not affect accuracy. (2) The answer is complete, addressing both components of unused short-term credit capacity—revolving credit and letters of credit—and correctly combining them. (3) Entity accuracy is perfect: Amazon is the correct company, the date is precisely December 31, 2021, and the financial terms (unsecured revolving credit facility, unused letters of credit) are correctly used. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that with no borrowings, the full $7.0 billion is available and adds it to the $7.2 billion in unused letters of credit to arrive at the total capacity. (5) The semantic meaning is equivalent to the original answer, with only slight rewording (e.g., 'essentially the full' instead of 'the full') that does not alter factual content. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 346,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "\nIn 2023 Thermo Fisher spent a total of **$3.61 billion** on acquisitions, comprising the $2.70 billion cash used to acquire **The Binding Site Group** and $0.91 billion for CorEvitas, LLC. Thus, **$2.70 billion** of that total cash outflow was specifically allocated to The Binding Site Group.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total cash outflow for TMO (Thermo Fisher Scientific) in 2023 was $3.61 billion, with $2.70 billion allocated to The Binding Site Group. The answer correctly identifies the remaining $0.91 billion as related to CorEvitas, LLC, which is consistent with the knowledge graph and adds contextual completeness without introducing error. (2) Quantitative accuracy is perfect: $2.70B + $0.91B = $3.61B, and all values match the ground truth exactly. Format variations (e.g., $2.70 billion vs $2.7B) are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound—the model correctly synthesized acquisition components and attributed the correct portion to The Binding Site Group. (4) The answer addresses both parts of the question: total outflow and the specific allocation. Entity names (Thermo Fisher, The Binding Site Group), metric (cash outflow), and year (2023) are all accurate. The answer is contextually relevant, precise, and fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 308,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "\nAbout 36 % of Union Pacific’s chassis units are leased (17,705 of 48,340 total), whereas only roughly 1 % of its highway revenue‑equipment containers are leased (545 of 47,984 total). Thus, the leased share of chassis is more than three‑times higher than the leased share of containers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key numbers are correct: 17,705 leased chassis out of 48,340 total (36.6% leased), and 545 leased containers out of 47,984 total (1.1% leased). The LLM rounds these to 'about 36%' and 'roughly 1%', which is acceptable and preserves semantic equivalence. (2) Calculations are accurate: 17,705 / 48,340 ≈ 36.6%, and 545 / 47,984 ≈ 1.1%. The LLM correctly identifies the much higher leased proportion for chassis. (3) The multi-hop reasoning is sound—comparing leasing proportions across two types of equipment (chassis vs containers) within Union Pacific’s fleet. (4) The only minor shortcoming is that the LLM states the chassis leased share is 'more than three-times higher' than containers (36 / 1.1 ≈ 33x, not 3x), which is a slight mischaracterization—though 'much higher' would have been more accurate. However, this does not undermine the factual correctness of the percentages or the overall conclusion. All entities (Union Pacific, chassis, containers, highway revenue equipment) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 319,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "\nTwo supplemental indentures that reference a 2035‑Note tranche were identified – the Fifth Supplemental Indenture (dated September 14 2015) and the Tenth Supplemental Indenture (dated November 20 2024). The most recent of these agreements was entered into with **Computershare Trust Company, National Association**, which served as the trustee.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitative accuracy: The two supplemental indentures are correctly identified with exact dates (September 14, 2015, and November 20, 2024), and the 2035 Note is properly referenced. (2) Completeness: The answer addresses both parts of the question—correctly stating the number of indentures (two) and identifying the trustee in the most recent agreement. (3) Entity accuracy: The trustee 'Computershare Trust Company, National Association' is correctly named. However, the LLM omits the detail that it is 'as successor to Wells Fargo Bank,' which is present in the original answer and adds legal context about the trustee's role. This is a minor but relevant omission in entity provenance. (4) Reasoning: The multi-hop synthesis—linking the 2035 Note to specific supplemental indentures and determining the most recent one with its trustee—is sound and logically executed. (5) Semantic equivalence: The meaning is effectively preserved, with only slight reduction in detail regarding the trustee's succession status. Overall, the answer is factually correct and well-aligned with the ground truth, warranting a high score with a small deduction for incomplete entity context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 352,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "\nThe 2023 non‑employee director deferred‑stock units are **expensed over the service period on a straight‑line basis** (they are not recognized as expense on the grant date), whereas awards granted before 2022 **vested immediately and were expensed on the grant date**.  \n\nFor the 2023 awards, **vesting occurs on the earlier of the first anniversary of the grant date and the day immediately preceding the next Annual Meeting of Shareholders** (subject to possible acceleration), so the units generally become vested after about one year, but no later than the next shareholder meeting.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the expensing methodology: 2023 awards are expensed on a straight-line basis over the service period, while pre-2022 awards were expensed in full on the grant date due to immediate vesting. (2) The vesting timeline for 2023 awards is correctly stated as the earlier of the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with a note on acceleration—matching the original answer exactly. (3) The multi-hop reasoning is sound, correctly contrasting two different time periods (2023 vs. prior to 2022) in terms of both accounting treatment and vesting conditions. (4) All entities (non-employee director deferred stock units, 2023 grants, pre-2022 grants) are accurately identified and correctly contextualized. Minor rephrasing (e.g., 'recognized as expense on the grant date' vs. 'expensed in full on the grant date') does not affect factual accuracy. No numerical or qualitative errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 299,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "\nThe 2023 operating profit for the Oral, Personal and Home Care business in the Africa/Eurasia region was **$254 million**. The excerpt provided does not include the corresponding total identifiable‑asset figure for that region and business unit, so the percentage of assets represented by that profit cannot be calculated from the given pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the operating profit of $254 million for the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, which matches the ground truth. However, it failed to provide the second part of the answer — the percentage of identifiable assets — by incorrectly stating that the asset figure was not available. The ground truth confirms that the identifiable assets were $698 million and the profit represented approximately 36.4% of those assets. (2) Quantitative accuracy is perfect: the $254 million figure is correct, and had the calculation been attempted, 254 / 698 ≈ 36.4% is accurate. (3) The multi-hop reasoning is flawed because the model did not synthesize the asset data that should have been accessible in the context (assuming full document access as per knowledge graph). The failure to retrieve or reference the $698 million in identifiable assets breaks the chain of reasoning required for a complete answer. (4) While the first part is fully correct and contextually relevant, the omission of a calculable, fact-based second component significantly reduces overall correctness. The model’s claim of missing data — when the ground truth implies it should be available — undermines the qualitative accuracy, though the response remains relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 371,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "\nIn fiscal 2024 AMD purchased $1.7 billion of inventory from the ATMP joint venture and, in return, sold $121 million of inventory back to it. The $100 million term loan AMD extended to the JV during the same year is only about 6 % of the purchase amount and is roughly comparable to the resale figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key financial figures: $1.7 billion in purchases from ATMP JV, $121 million in resales to ATMP JV, and the $100 million loan provided in fiscal year 2024. These match the ground truth exactly. (2) Quantitative accuracy is perfect: numbers are correct, and the implied comparison (loan being ~6% of purchase amount) is mathematically accurate (100/1700 ≈ 5.88%). The resale comparison is appropriately framed as 'comparable' to the loan amount since both are around $120M. (3) Multi-hop reasoning is sound: the model synthesizes purchase, resale, and loan data involving AMD and the ATMP JV in fiscal 2024, correctly contextualizing their relative magnitudes. (4) The only minor shortcoming is that the LLM does not explicitly state the combined total of $1.821 billion, though it reports both components. Since the question asks for the 'total amount' of purchases and resales, this combined sum is implied but not directly provided, justifying a 9 instead of 10 on qualitative accuracy. However, the omission does not distort meaning, and the core facts and comparisons are accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 325,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "\nThe Analytical and physical instrumentation product line grew from $2.464 billion in 2019 to $2.620 billion in 2021, an increase of **$0.156 billion** over the two‑year period. In contrast, the Research and medical products segment rose from $13.512 billion in 2019 to $24.802 billion in 2021, an increase of **$11.290 billion**—making its growth roughly **73 times larger** than the increase seen in the Analytical and physical instrumentation line.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the Analytical and physical instrumentation revenue increased from $2,464 million ($2.464 billion) in 2019 to $2,620 million ($2.620 billion) in 2021, resulting in a $156 million ($0.156 billion) increase. The Research and medical products segment grew from $13,512 million ($13.512 billion) to $24,802 million ($24.802 billion), a $11,290 million ($11.290 billion) increase—both figures match the original answer. (2) The calculation of the relative growth (73 times larger) is accurate: $11.290 billion / $0.156 billion ≈ 72.37, which rounds to about 73 times, supporting the qualitative comparison. (3) The multi-hop reasoning is sound: the model correctly identified and synthesized revenue figures across two different product lines and two years, computing both absolute increases and their relative magnitude. (4) The answer is semantically equivalent to the ground truth, using consistent data and drawing a valid comparative conclusion. All entities (product lines, time periods, financial metrics) are correctly identified. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 340,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "\nSQL Server is part of the “Server products and cloud services” group that forms the core of Microsoft’s Intelligent Cloud segment, and its licensing (volume‑licensing, OEM sales and CALs) together with its cloud‑based offerings such as Azure SQL drive a sizable share of the segment’s revenue.  In fiscal 2022 the Intelligent Cloud segment generated $75.3 billion in revenue—up from $48.4 billion in FY 20—with Server products and cloud services (which include SQL Server) contributing $67.3 billion of that total, underscoring SQL Server’s importance as a revenue driver for the segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several specific financial figures—$75.3 billion for Intelligent Cloud revenue in FY2022 and $67.3 billion for Server products and cloud services—that are not present in the original ground truth answer and cannot be verified from the provided context. These numbers appear fabricated or misattributed, as the original answer does not include any quantitative data. This severely undermines factual accuracy. (2) There is no mention in the ground truth of fiscal year 2022 or 2020 revenue figures, nor a breakdown of $67.3 billion from the total $75.3 billion. These specific numbers are incorrect or unsubstantiated, leading to a low quantitative accuracy score. (3) Qualitatively, the LLM correctly identifies SQL Server as part of the Intelligent Cloud segment under 'Server products and cloud services' and accurately describes its revenue contributions through licensing models (volume licensing, OEM, CALs) and cloud integration via Azure SQL. This reflects sound multi-hop reasoning in linking SQL Server to licensing models and segment-level revenue drivers, aligning with the original answer’s emphasis on licensing and CALs. (4) Contextually, the response is highly relevant, directly addressing how SQL Server contributes to the Intelligent Cloud segment. However, the inclusion of false quantitative data significantly reduces overall correctness despite accurate conceptual framing. The answer would have scored much higher without the invented figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 415,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "\nThe insurance‑buy‑in contracts were recorded at **$950 million** on December 31 2022, rose to **$1,605 million** at the end of 2023, and then fell to **$1,390 million** at the end of 2024.  This represents a net increase of **$440 million** over the 2022‑2024 period, with the 2023 year‑end balance of $1.605 B and the 2024 year‑end balance of $1.390 B reflecting the subsequent decline.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values are accurate: $950 million (2022), $1,605 million (2023), and $1,390 million (2024). The net change is correctly calculated as $1,390M - $950M = $440M, which matches the ground truth. The use of $1.605B and $1.390B is an acceptable format variation (equivalent to $1,605 million and $1,390 million). (2) The answer is complete, addressing both the total change over the period and the year-end balances for 2023 and 2024 as required. (3) Entities (Insurance Buy-in Contracts, correct dates, and financial metric) are accurately identified and used. (4) The reasoning is sound: it correctly captures the increase in 2023 followed by a decrease in 2024, and synthesizes the net effect over the two-year period. The conclusion about the 'subsequent decline' is a valid qualitative interpretation. All multi-hop elements (tracking value across three time points and computing net change) are handled correctly. Semantic equivalence is maintained despite minor wording differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 308,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "\nAs of December 31 2024, the company’s defined‑contribution plans held a total of **about $886 million of TI common stock** – $852 million in the U.S. plans (5 million shares valued at $852 million) plus $34 million in non‑U.S. plans.  \n\nDividends paid on those shares during 2024 were **$26 million** on the U.S. holdings; dividends on the non‑U.S. holdings were reported as “not material.”",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as $886 million as of December 31, 2024, matching the ground truth. It breaks this down into $852 million (U.S.) and $34 million (non-U.S.), which sum correctly to $886 million. The dividends paid during 2024 are reported as $26 million on U.S. holdings, with non-U.S. dividends noted as 'not material.' While the original answer states $26 million in total dividends without specifying geography, the LLM's $26 million aligns with the total amount, and the clarification that non-U.S. dividends were immaterial supports treating the total as effectively $26 million. (2) All numeric values are accurate: $886 million total stock value, $852M + $34M = $886M (correct sum), and $26 million in dividends. Format variations (e.g., 'about $886 million') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound—information is synthesized across U.S. and non-U.S. plans for both stock value and dividends. The LLM correctly aggregates the total stock value and reports the only material dividend component, which aligns with the intent of the question. (4) The answer is semantically equivalent to the ground truth, with slightly more detail. The only minor limitation is the lack of explicit confirmation that total dividends were $26 million (since non-U.S. were immaterial), but this is reasonably implied. Thus, the answer is fully factually correct with excellent reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 428,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "\nThe 5.300 % Senior Notes due 2050 had a disclosed principal amount of **$1.25 billion**. Together, the 3.900 %, 4.450 % and 5.200 % Senior Notes total **$2.25 billion** in principal, so the 5.300 % issue is about **55 % of that combined amount** (roughly $1 billion less). (See UPS 2022 10‑K, page 53.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the principal amount of the 5.300% Senior Notes due 2050 as $1.25 billion (equivalent to $1,250 million), matching the ground truth. The combined principal of the 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) notes was accurately calculated as $2.25 billion (i.e., $2,250 million), which is correct. The percentage comparison stating that the 5.300% note is 'about 55%' of the combined amount is a rounded but reasonable approximation of the exact 55.6% (1,250 / 2,250 = 0.555...), so this is acceptable. (2) All numeric values are factually correct, with appropriate unit conversions (billion vs million). The calculation of the sum ($1,000M + $750M + $500M = $2,250M) and the ratio (1,250 / 2,250 ≈ 55.6%) are accurate. (3) The multi-hop reasoning—extracting multiple note amounts from the same filing and comparing them via summation and percentage—is sound and correctly executed. The model synthesizes across multiple debt instruments as required. (4) The only minor shortcoming is the use of 'about 55%' instead of the more precise '55.6%', which slightly reduces qualitative accuracy but does not affect overall correctness. The answer is contextually complete, cites the correct document (UPS 2022 10-K, page 53), and addresses both parts of the question. Thus, the answer is highly accurate with only a minor rounding clarification needed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 394,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "\nThe company had 1,807 (thousand) Service‑Based RSUs that were outstanding at the start of 2024 and remained outstanding at year‑end after adding the 922 thousand granted, subtracting the 844 thousand that vested and the 98 thousand that were forfeited.  Those remaining awards have a weighted‑average grant‑date fair value of **$183.41 per share**, giving an aggregate grant‑date fair‑value of roughly **$331 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the final aggregate value. While it correctly identifies the weighted-average grant-date fair value per share as $183.41 (matching the ground truth), it incorrectly calculates the total aggregate value as $331 million. The correct total, according to the ground truth, is $183.41 million — not per share. The LLM misinterprets $183.41 as the per-share value rather than the total, leading to a significant overestimation. (2) The quantitative breakdown of RSU movements (1,807 thousand outstanding at start, +922 granted, -844 vested, -98 forfeited) appears numerically consistent with typical multi-hop reasoning, but the final calculation is flawed because it multiplies 1,807,000 shares by $183.41/share ≈ $331 million, which contradicts the ground truth. The ground truth states the total value — not per share — is $183.41 million, implying the per-share fair value was likely much lower. (3) The reasoning is partially sound in tracking RSU activity across the year (grants, vesting, forfeitures), showing an attempt at multi-hop synthesis. However, the model fails to correctly interpret what the 'weighted-average grant-date fair value' represents — it is a total dollar amount for the cohort, not a per-share metric in this context. (4) Contextual relevance is high because the answer addresses the right time period (2024), the correct award type (Service-Based RSUs), and considers all relevant events (grants, vesting, forfeitures). However, due to the fundamental misinterpretation of the key financial metric, the correctness and quantitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 450,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "\nUPS first determines whether a tax position is “more likely than not” to be sustained on audit; only positions that meet this recognition threshold are considered for measurement.  When a position is recognized, the amount of tax benefit that can be recorded is the largest benefit that has a greater than 50 % probability of realization upon ultimate settlement, and this estimate is reassessed each quarter based on new facts, tax‑law changes, audit developments, or other relevant circumstances.  Consequently, a shift in the assessment of likelihood or in the estimated realizable amount can result in either the recognition of additional tax benefits or the recording of an extra charge to the tax provision.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the two-step process: first, the 'more likely than not' threshold for recognition, and second, the measurement of the largest tax benefit with greater than 50% probability of realization—this matches the ground truth's 'more likely than not to be realized upon settlement' standard. The 50% threshold is correctly implied as the quantitative benchmark, consistent with accounting standards (ASC 740). (2) All quantitative elements are accurate: while no specific dollar amounts or dates are involved, the probabilistic threshold (greater than 50%) is correctly stated and aligns with the 'more likely than not' criterion. (3) The multi-hop reasoning is sound—LLM synthesizes the recognition and measurement criteria, links them to the impact on tax provision (benefits or charges), and notes the quarterly reassessment based on new facts, tax law changes, or audit developments, which is explicitly mentioned in the original. (4) The only minor shortcoming is that the LLM does not explicitly mention the recording of the difference as a liability, which is part of the complete accounting treatment described in the ground truth. However, the implication of recording benefits or charges covers the economic effect. Wording differs but semantic meaning is equivalent. No incorrect entities or facts are introduced. The answer is fully contextually relevant and focused on UPS’s process as described in both financial notes and management discussion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 429,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "\nThe total capital expenditure in Africa/Eurasia in 2021 was **$33 million**, and organic sales in that region increased **7.0 %** during the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Both numeric values are accurate: $33 million for capital expenditure and 7.0% for organic sales increase in Africa/Eurasia in 2021. (2) The numbers are presented with minor formatting differences (e.g., thin spaces in '$33 million' and '7.0 %'), but these do not affect meaning or accuracy—$33 million and 7.0% are semantically equivalent to the original. (3) The question requires a two-part response involving multi-hop data retrieval (capital expenditure and organic sales for a specific region and year), and the LLM correctly identifies and synthesizes both metrics for Africa/Eurasia in 2021. (4) All entities—region (Africa/Eurasia), year (2021), financial metrics (capital expenditure, organic sales)—are correctly identified and matched. The answer is complete, factually precise, and contextually appropriate, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1075,
        "completion_tokens": 269,
        "total_tokens": 1345
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "\nContact‑Lenses/Other sales rose from **$2.99 billion in 2020 to $3.44 billion in 2021**, an increase of roughly **$0.45 billion (≈14.9 %)**.  This growth was a key driver of the **Vision segment’s overall sales jump of 19.6 %**, taking the segment from $3.92 billion in 2020 to $4.69 billion in 2021.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the increase in Contact Lenses/Other sales from $2,994 million in 2020 to $3,440 million in 2021, reporting it as $2.99 billion to $3.44 billion—an acceptable rounding and format variation. The calculated increase of $0.45 billion (~$450 million) is close to the exact $446 million, with minor rounding acceptable. Vision segment sales growth is reported as rising from $3.92 billion to $4.69 billion, matching the ground truth of $3,919 million to $4,688 million when rounded. (2) The percentage growth in Vision segment sales is stated as 19.6%, which is accurate based on the reported figures. However, the LLM does not explicitly calculate or mention that the $446 million increase in Contact Lenses/Other accounted for approximately 58% of the total $769 million Vision segment growth—a key part of the original answer. This omission affects completeness and reasoning. (3) The multi-hop reasoning is partially sound: the model correctly pulls data for Contact Lenses/Other and Vision segment sales across years, but fails to synthesize the contribution of the former to the latter’s growth, which is central to the question. (4) Scores reflect high factual accuracy in numbers and entities (Johnson & Johnson, correct years, correct metrics), strong contextual relevance, and only moderate deduction for missing the proportional contribution analysis, which is a required element of the full answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 401,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "\nIn 2023, following the Heritage AspenTech consolidation, the Control Systems & Software segment’s earnings rose 21 % to **$529 million** (from $437 million in 2022), yet its margin fell **3.1 percentage points** to **11.6 %** (from 14.7 %). The margin decline was driven mainly by roughly **$249 million of additional intangible‑amortization** associated with the AspenTech acquisition, which offset the segment’s underlying sales growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the segment earnings in 2023 ($529 million) and 2022 ($437 million), the segment margin decline of 3.1 percentage points from 14.7% to 11.6%, and the negative impact on margins — all of which align with the ground truth. However, it incorrectly attributes the margin decline to $249 million in intangible amortization, which is not mentioned in the original answer. More critically, the original answer states that AspenTech’s performance deteriorated from $12 million in earnings in 2022 to a $107 million loss in 2023 — a $119 million swing — which directly explains the margin pressure despite flat earnings growth. The LLM answer misses this key multi-hop insight and instead introduces an unsupported explanation (intangible amortization), which changes the causal reasoning. (2) While the dollar figures for segment earnings and margins are accurate, the $249 million amortization figure is not present in the ground truth and appears to be fabricated or misattributed. The calculation of the 21% earnings increase is numerically correct (from $437M to $529M), but the original answer states that segment earnings were flat in 2023 compared to 2022 — a contradiction. Upon verification: $529M - $437M = $92M increase, which is indeed ~21%, so the original answer’s claim of 'flat' is inaccurate. However, the original answer explicitly states 'remained flat at $529 million in 2023 compared to $437 million in 2022', which is factually incorrect. This creates ambiguity: the LLM reports a correct calculation, while the ground truth contains a factual error in characterization. Despite this, the LLM still fails to explain the AspenTech-specific earnings swing, which is central to the question. (3) The multi-hop reasoning is partially sound — it connects AspenTech’s consolidation to margin decline — but fails to synthesize the actual financial contribution shift of AspenTech itself ($12M profit to -$107M loss), which is the core of the original answer’s logic. Instead, it substitutes a different financial driver not present in the source. (4) Scores reflect partial correctness: numbers for segment earnings and margins are accurate, but key causal explanation is wrong and a critical $119M deterioration in AspenTech’s performance is omitted. Contextual relevance is high as the answer addresses the right segment, timeframe, and direction of impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 643,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "\nVisa recorded a **$1.44 billion accrual** for U.S. covered litigation at the end of fiscal 2022 (the balance shown in the “Accrual Summary‑U.S. Covered Litigation” table).  Under the U.S. Retrospective Responsibility Plan, this liability is recovered by a **downward adjustment to the conversion rate of its class B preferred stock into class A common stock**, rather than by direct cash out‑flows.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains major factual errors in the key quantitative figure and in the description of the stock conversion mechanism. The original answer states that Visa recorded a $861 million liability in fiscal 2022 for U.S. covered litigation, but the LLM claims a $1.44 billion accrual, which is incorrect. Additionally, the LLM incorrectly refers to 'class B preferred stock' when the correct term is 'class B common stock'—a significant entity error affecting the accuracy of the recovery mechanism description. (2) The dollar amount is off by over $500 million, and while the accrual may have evolved over time, the question specifically asks for the amount recorded *in* fiscal 2022, not the ending balance. The $1.44 billion figure likely reflects a later balance or cumulative accrual, not the fiscal 2022 recorded liability. (3) The reasoning around the recovery mechanism is partially correct—liability recovery via adjustment to conversion rate is accurate—but the misidentification of the stock class (preferred vs. common) undermines the correctness of the multi-hop synthesis. The U.S. Retrospective Responsibility Plan applies to class B common stock, not preferred stock, so the model fails in precise entity mapping. (4) Despite these critical errors, the answer is contextually relevant and addresses both parts of the question, showing understanding of non-cash recovery and the general mechanism. Hence, moderate score for contextual relevance, low for quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 415,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "\nPfizer’s 2021 results were hit by a $345 million pre‑tax charge in Q2 related to a legal matter involving Meridian and, after the December 31 sale of the subsidiary, an after‑tax loss of $167 million.  These items together represent an approximate $512 million adverse financial impact for the year, which is reflected in the discontinued‑operations net‑of‑tax loss of about $435 million reported for 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $345 million pre-tax legal charge in Q2 and the $167 million after-tax loss from the sale in Q4 are accurately reported, and their sum ($512 million total adverse impact) is correctly calculated. (2) Quantitative accuracy is perfect—numbers, timing (Q2 and post-sale in Q4), and financial metrics match the original answer. Format variations (e.g., using 'adverse' instead of 'negative') are semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct financial events related to Pfizer's historical ownership of Meridian in 2021 and combines them into a total impact. (4) The only minor issue is the mention of a 'discontinued-operations net-of-tax loss of about $435 million,' which is not in the original answer and may confuse rather than clarify, but it does not contradict the main conclusion. This slight addition does not detract significantly from correctness but prevents a perfect 10. Contextual relevance is excellent—the response directly addresses the total financial impact, including both operational and post-closing components as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 344,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "\nBank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of **5.0 %** under Basel III – this regulatory minimum already incorporates the required **2.0‑percentage‑point leverage buffer**. In contrast, its insured depository‑institution subsidiaries (e.g., BANA) must hold a **higher SLR of at least 6.0 %** to be considered well‑capitalized under the PCA framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, all numbers are accurate: Bank of America Corporation's SLR requirement is correctly stated as 5.0%, combining the 3.0% minimum plus a 2.0% leverage buffer. The subsidiaries' requirement of 6.0% is also correct. (2) The answer addresses both parts of the multi-hop question: the parent company's SLR under Basel III with buffer, and the higher requirement for insured depository subsidiaries under the PCA framework. (3) Entities are accurately referenced—Bank of America Corporation and its subsidiaries (e.g., BANA, though not required, adds clarity). (4) The reasoning is sound: it correctly distinguishes between Basel III requirements for the holding company and PCA standards for subsidiaries, reflecting proper synthesis across regulatory frameworks. Minor wording differences (e.g., 'to avoid restrictions' omitted) do not affect factual accuracy. All key information is preserved with precise numerical and conceptual alignment to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 302,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "\nThe 2020 credit‑loss guidance replaced MetLife’s prior “incurred‑loss” model with an expected‑credit‑loss model for its mortgage‑loan portfolio. Under the new rule the company must record an allowance for credit loss (ACL) at acquisition based on the lifetime expected loss and subsequently adjust that allowance in earnings (within net‑investment gains / losses) as forecasts change, rather than waiting for an actual default to recognize a loss. This shifts the timing of loss recognition to the period in which the loan is purchased and updates thereafter, making the allowance a forward‑looking, continuously‑updated component of the loan’s carrying value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies the key change in accounting treatment due to the adoption of the credit loss guidance on January 1, 2020, noting the shift from an incurred loss model to an expected credit loss model. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the date '2020' is correctly cited as the effective year, consistent with the ground truth. (3) The multi-hop reasoning is sound: the answer synthesizes the impact on mortgage loans, the establishment of an allowance for credit losses (ACL) at acquisition, the basis on lifetime expected losses, and the implications for timing of loss recognition. It correctly explains that losses are now recognized earlier—upon purchase and updated through earnings—rather than delayed until default or probable loss. (4) The terminology is precise (e.g., 'allowance for credit loss', 'forward-looking', 'carrying value'), and the explanation captures all key elements of the original answer: the change in model, timing of recognition, and presentation of loans at net collectible amount. Minor wording differences (e.g., 'net amount expected to be collected' vs. 'carrying value') do not affect factual equivalence. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 374,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "\nThe January 1 2020 credit‑loss guidance replaced the prior incurred‑loss (other‑than‑temporary‑impairment) model with an expected‑lifetime‑loss approach, so credit losses on leveraged‑lease receivables and mortgage loans are now estimated and recorded as an allowance each reporting period rather than only when a loss is deemed probable.  Under the new methodology the Company estimates lifetime credit loss for leveraged leases using a probability‑of‑default/loss‑given‑default model that incorporates third‑party credit ratings and historical default data, while for mortgage loans it projects expected cash‑flows over the loan’s contractual term adjusted for prepayments and current/forecasted economic conditions.  Key inputs include credit‑rating information, historical default experience, macro‑economic forecasts, prepayment assumptions and the discount rate used in the cash‑flow analysis.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the adoption date (January 1, 2020), the shift from an incurred loss model to an expected lifetime credit loss model, and the application to both leveraged lease receivables and mortgage loans. (2) Quantitative and temporal elements are accurate—no numerical values are incorrect, and the date of adoption is correctly stated. (3) The multi-hop reasoning is sound: the answer correctly synthesizes the change in timing (from incurred to expected) and methodology (different models per asset type), and specifies the correct models—probability of default/loss given default for leveraged leases, and cash flow projections adjusted for prepayments and economic conditions for mortgage loans. (4) Inputs are accurately described: third-party credit ratings, historical default data, macroeconomic forecasts, prepayment assumptions, and discount rates are all valid and align with the original answer. The LLM adds slight elaboration (e.g., mention of discount rate and allowance recording) that are consistent with ASC 326-20 but not contradicted by the ground truth. No factual errors, omissions, or misstatements. The answer fully addresses all parts of the question with precise, relevant, and correct information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 372,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "\nTexas Instruments’ investment in 300‑millimeter wafer fabs gives its analog chips roughly 40 % lower unit cost than 200‑millimeter wafers, which lifts gross margins (to 67.5 % in 2021) and operating‑profit share, generating about $8.8 billion of operating cash flow and $6.3 billion of free cash flow. Because fixed manufacturing costs are spread over a larger output, the lower variable cost and higher capacity utilization amplify profitability, providing the cash that the company returns to shareholders through dividends and share‑repurchase programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 40% cost reduction from using 300-mm wafers vs. 200-mm wafers, which matches the original answer. (2) It adds specific financial figures—$8.8 billion in operating cash flow and $6.3 billion in free cash flow—which are not in the original answer but are factually consistent with Texas Instruments' 2021 SEC filings and do not contradict the ground truth. The 67.5% gross margin in 2021 is also accurate per public data. (3) The reasoning correctly traces the multi-hop logic: larger wafers → lower unit cost → higher gross margins → greater cash flow generation → ability to return cash to shareholders. This synthesis of manufacturing advantage to financial outcomes is sound and complete. (4) Minor deduction in quantitative accuracy is due to the introduction of specific dollar amounts and a margin figure not present in the ground truth, which, while accurate, go beyond the provided knowledge; however, they do not distort the truth. The core facts, percentages, and causal chain are correct. Contextual relevance is perfect—the answer directly addresses how the cost advantage enables cash generation and return.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 342,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "\nAs of December 31 2021, the carrying amount of the 1.5‑year floating‑rate senior notes (SOFR + 0.35%) was **$1.0 billion**, while the 2‑year floating‑rate senior notes (SOFR + 0.39%) due on October 18 2023 had a carrying amount of **$0.5 billion**. Therefore, the 1.5‑year notes were twice the value of the 2‑year notes at that date.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the carrying amounts of both the 1.5-Year and 2-Year Floating Rate Senior Notes as $1.0 billion and $0.5 billion, respectively, which matches the ground truth values of $1,000 million and $500 million. The comparison stating that the 1.5-Year notes are twice the value of the 2-Year notes is accurate and correctly derived. (2) All numeric values are correct and presented in equivalent formats ($1.0 billion = $1,000 million; $0.5 billion = $500 million). The date (December 31, 2021) and maturity date (October 18, 2023) are accurately referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about two different notes (different tenors, rates, and maturities) issued by TMO and compares their values on the same date. (4) The answer is semantically equivalent to the ground truth, with no omissions or inaccuracies. All aspects of the question are addressed completely and correctly, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 294,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "\nAs of December 31 2023, the 2020 Stock Incentive Plan had ≈ 53 million shares left for future issuance, while the 1993 Employee Stock Purchase Plan had ≈ 17 million shares available; together they total ≈ 70 million shares. Thus, the 2020 Stock Incentive Plan had the greater number of shares available.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key information is accurately conveyed: 53 million shares available under the 2020 Stock Incentive Plan, 17 million under the ESPP, totaling 70 million combined. The use of '≈' is acceptable as it still conveys approximate precision consistent with reporting standards. (2) The quantitative values match exactly: 53M + 17M = 70M, and the comparison correctly identifies the 2020 Stock Incentive Plan as having more shares. (3) The reasoning is sound—information from two plans is correctly synthesized across entities and time (as of December 31, 2023), satisfying the multi-hop requirement. (4) Entities (plan names, dates, stock type) are correctly identified. The answer is fully relevant and complete, addressing both the total availability and the comparative component of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 258,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "\nCaterpillar’s post‑employment benefit liability shown on the balance sheet was **$701 million** as of December 31 2023. The 2019 freeze of all U.S. pension benefits eliminated the “rate of compensation increase” assumption from the actuarial calculations (the assumption column is shown as “‑ %”), so that assumption no longer influences the measurement of benefit obligations or the net periodic benefit cost in the financial statements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The total liability for postemployment benefits reported by CAT in 2023 is stated as $701 million, but the ground truth is $621 million. This $80 million discrepancy is substantial and incorrect. Additionally, the breakdown in the original answer specifies $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans, which the LLM answer omits entirely, reducing completeness and accuracy. (2) The date of the pension freeze (2019) is correctly identified, and the impact on actuarial assumptions is partially accurate—the LLM correctly notes that the 'rate of compensation increase' assumption was eliminated due to the freeze. However, the ground truth specifies broader implications: the freeze eliminated service cost and rendered *certain actuarial assumptions* (not just one) no longer applicable. The LLM narrows this to a single assumption, missing the broader impact. (3) The multi-hop reasoning is partially sound—the model connects the pension freeze to changes in actuarial assumptions, showing synthesis between events and financial reporting impacts. However, it fails to correctly aggregate the liability components or reference the correct total, indicating a failure in data retrieval or synthesis across financial statement items. (4) The contextual relevance is high—the answer addresses both parts of the question (total liability and impact on assumptions) and uses appropriate financial terminology. However, the major numerical error in the liability figure severely undermines factual correctness, warranting a low correctness and quantitative accuracy score despite reasonable qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 476,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "\nIn 2024 the fair‑value of developed‑markets equities in Merck’s U.S. pension plans was **$4.73 billion** – $2.56 billion held through investment funds and $2.17 billion held as direct equity securities (page 122).  This is marginally below the **$4.87 billion** reported for 2023 (page 122), a reduction of roughly $0.14 billion (about 3%).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor formatting differences. (1) Quantitatively: The values reported are $2.56 billion (vs $2,555 million) for investment funds and $2.17 billion (vs $2,171 million) for equity securities in 2024 — these are correctly rounded versions of the original figures. The total $4.73 billion matches $4,726 million when rounded. For 2023, $4.87 billion corresponds to $4,868 million, again accurate upon rounding. The decrease of $0.14 billion (i.e., $140 million) aligns closely with the actual $142 million drop — the $2 million difference is due to rounding and is negligible. (2) Completeness: The answer fully addresses both parts of the question — the 2024 total fair value across both investment types and the comparison to the prior year. (3) Entity accuracy: 'Merck', 'developed markets equities', 'U.S. Pension Plans', and years 2024/2023 are all correctly identified. (4) Reasoning: The multi-hop synthesis — aggregating across investment funds and equity securities across two years and computing the year-over-year change — is sound and logically presented. (5) Semantic equivalence: Despite using 'billion' and rounded figures, the meaning is preserved. Only a perfect 10 would require exact unrounded figures and precise $142M difference; the minor rounding justifies a 9. Contextual relevance is perfect — all content directly addresses the query.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 398,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "\nThe 2007 Omnibus Incentive Plan has authorized **approximately 135 million shares** of Danaher common stock for issuance since the plan’s inception. As of **December 31, 2024**, about **47 million shares** remain available for future issuance (excluding shares underlying outstanding awards).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total authorized shares (135 million) and the remaining available shares (47 million) as of December 31, 2024), which matches the ground truth. The wording differs slightly—'approximately 135 million' and 'about 47 million'—but these are semantically equivalent and acceptable given typical reporting conventions. (2) All numeric values are accurate: 135 million authorized and 47 million remaining. No calculations are required beyond what is stated, and the figures align with the original answer. Format variations (e.g., 'approximately' vs. exact) are reasonable and do not affect factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about the plan's inception authorization and current availability, accounting for usage via stock options, RSUs, and PSUs, even though the LLM answer does not explicitly mention these instruments in the response. However, the omission of 'after accounting for shares issued through stock options, RSUs, and PSUs' slightly reduces completeness in qualitative terms, though the core synthesis is implied by the context. (4) The answer is fully contextually relevant, directly addressing both parts of the question. The correctness score is 9 instead of 10 due to the minor omission of explicitly stating that the remaining shares reflect deductions for all award types under the plan, which is part of the original answer’s explanatory depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 410,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenues—including those from Google Play, hardware, and Google Cloud—are increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "\nThe rise of Google Play as a source of non‑advertising revenue can weigh on Google’s overall profit margins because earnings from that business—derived from app sales, in‑app purchases and related fees—are typically lower‑margin than the high‑margin advertising revenues that dominate Google’s traditional business. Consequently, as the share of low‑margin non‑advertising income grows, the company’s average profitability is pressured unless it can offset the decline with cost reductions, pricing improvements, or higher‑margin growth elsewhere.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Google Play as a source of non-advertising revenue derived from app sales, in-app purchases, and related fees, aligning with the original answer. (2) There are no specific numeric values, dates, or percentages in the question or ground truth that require verification—only qualitative financial reasoning—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes that advertising revenues have high margins, non-advertising revenues (including Google Play) tend to have lower margins, and thus a growing share of the latter can pressure overall profit margins unless offset by efficiencies or higher-margin growth. This matches the logic in the 2022 10-K referenced in the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly name other non-advertising segments like Google Cloud or hardware, nor does it cite the 2022 10-K filing directly. However, this omission does not detract from the core correctness, as the focus is on Google Play and margin dynamics. The answer remains contextually precise, logically coherent, and factually aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 352,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "\nCVS hedges credit‑quality risk primarily through a suite of derivative instruments—including interest‑rate swaps, treasury‑rate locks, forward and futures contracts, warrants, put options and credit‑default swaps—that are tied to credit ratings and spreads. Management expects these hedging tools to offset credit‑related fluctuations and thereby lower the company’s overall exposure to interest‑rate and credit‑market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All financial instruments listed—interest-rate swaps, treasury-rate locks, forward contracts, futures contracts, warrants, put options, and credit-default swaps—are correctly identified from the original answer. There are no numerical values in the question or answers, so quantitative accuracy is not applicable beyond correct naming of instruments, which is accurate. (2) The LLM correctly addresses both parts of the question: the specific instruments used (completeness) and their expected impact on risk exposure. It states that these tools 'lower the company’s overall exposure to interest-rate and credit-market volatility,' which aligns semantically with the original answer’s claim that hedging reduces overall risk despite introducing other risks. (3) The multi-hop reasoning is sound: the model synthesizes the use of derivatives for hedging credit quality risk and correctly infers the net risk-reducing intent of management. (4) Minor deduction in qualitative accuracy due to slightly rephrased emphasis—original explicitly notes that these instruments introduce interest rate, equity price, and credit risk when viewed separately, which the LLM omits. However, the core conclusion about net risk reduction is preserved. Wording differences are acceptable under semantic equivalence. No entity errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 389,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "\nThe company held $682 million in hedge funds/limited partnerships within its U.S. pension plans and $9 million within its other postretirement benefit plans in 2021, for a combined total of $691 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans are correctly reported. (2) The total of $691 million is correctly calculated (682 + 9 = 691), with no arithmetic or formatting errors. Number formats ($682 million, $9 million, $691 million) are consistent and acceptable. (3) The multi-hop reasoning is sound—information from two distinct plan types is correctly synthesized to produce the total investment amount. (4) The answer is semantically equivalent to the original, conveying the same data and conclusion with clear, concise wording. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 224,
        "total_tokens": 1346
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "\nUNP had a combined fleet of **56,176 freight cars** (33,704 owned + 22,472 leased) as of December 31 2024.  In its 2024 capital program the company invested **about $788 million** in locomotives and freight‑car acquisitions, which includes roughly **$143 million** of lease‑buyout payments for freight cars.  Thus, the total spend on acquiring freight cars in 2024 is approximately **$788 million**.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the total number of freight cars (56,176) as the sum of owned (33,704) and leased (22,472) units, which matches the ground truth. This part is quantitatively and factually accurate. However, the answer incorrectly states that the total spend on acquiring freight cars in 2024 is $788 million, which includes both locomotives and freight cars, while the ground truth specifies that only $143 million was spent on acquiring freight cars via lease buyouts. The LLM conflates the broader capital program expenditure ($788 million for locomotives and freight cars) with the specific amount for freight car acquisitions. Although it correctly notes that $143 million was for lease buyouts, it fails to isolate this as the correct figure for freight car acquisition spending, instead presenting the larger, incorrect total. This is a critical error in quantitative accuracy and reasoning, especially for a multi-hop question requiring synthesis of capital plan details and lease buyout figures. The entities (UNP, 2024, freight cars) and time frame are correct, and the response is contextually relevant. However, due to the significant error in the financial figure for freight car spending, the correctness and accuracy scores are reduced. The reasoning is partially sound but fails in final synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 369,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "\nThe increase in other income (expense), net that was attributable to the non‑marketable equity securities was roughly **$6.9 billion** (≈ $6,951 million) – the rise in unrealized gains on those securities (from $3.0 bn in 2020 to $9.97 bn in 2021) drove the bulk of the overall increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $6.9 billion contribution from changes in non-marketable equity securities to the increase in other income (expense), net, matching the ground truth exactly. The use of ≈$6,951 million is a precise conversion of $6.9 billion and is factually accurate. The explanation that unrealized gains rose from $3.0 billion in 2020 to $9.97 billion in 2021 correctly supports the $6.97 billion increase, which rounds to $6.9 billion. (2) All numeric values are correct: the $6.9 billion figure is accurate, and the implied calculation ($9.97B - $3.0B = $6.97B) aligns with the reported contribution. The ground truth notes this as the primary driver of the $5.2 billion net increase in other income, which the LLM does not explicitly mention but does not contradict. (3) The multi-hop reasoning is sound—linking the change in unrealized gains on non-marketable securities to the overall increase in other income is correctly executed. However, the LLM omits mention of the $1.3 billion increase in accrued performance fees that partially offset the gain, which is part of the full causal picture in the original answer. This is a minor omission affecting completeness but not the core correctness. (4) The answer is contextually fully relevant, accurately addressing Google's equity portfolio and the role of non-marketable securities. The qualitative accuracy is slightly reduced due to the missing offsetting factor, but the core reasoning and data synthesis are strong. Overall, the answer is factually correct and conveys the key point with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 438,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "\nThe forward contracts tied to the 2022 $1.5 billion ASR and the 2023 $2.0 billion ASR had notional values of $0.3 billion and $0.4 billion, respectively—a combined $0.7 billion.  These contracts were initially recorded as equity instruments in capital surplus and, upon final settlement of the ASRs, were re‑classified from capital surplus into treasury stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the values are correct: $0.3 billion in 2022 and $0.4 billion in 2023, totaling $0.7 billion—matching the original answer exactly. Format variations (e.g., $0.3 billion vs $0.3B) are acceptable and semantically equivalent. (2) The answer addresses both parts of the question: total value of forward contracts and their classification upon settlement. (3) Entity accuracy is strong: CVS is correctly implied as the company executing the ASRs, years 2022 and 2023 are correctly referenced, and financial terms like 'forward contracts', 'equity instruments', 'capital surplus', and 'treasury stock' are used accurately. (4) The multi-hop reasoning is sound—information is synthesized across two years and two financial treatments (initial classification and reclassification upon settlement). The only minor issue is the mention of '$1.5 billion ASR' and '$2.0 billion ASR' in 2022 and 2023, which were not in the ground truth and could be misleading if those total ASR amounts were not part of the source data; however, since the focus is on the forward contract values (which are correct), this does not undermine the core accuracy. Overall, the answer conveys the same information as the original with excellent precision and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 374,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "\nThe Lowe’s Companies Benefit Restoration Plan—amended and referenced in the 2024 10‑K—is a supplemental defined‑contribution arrangement that provides additional employer matching contributions to participants whose benefits under the primary 401(k) plan are limited by certain Internal Revenue Code 1986 restrictions. By doing so, the Restoration Plan ensures that eligible employees who would otherwise be curtailed by those IRS provisions still receive comparable retirement benefits.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly explains the purpose of the Benefit Restoration Plan in relation to the 401(k) Plan and IRS Code restrictions, capturing the core multi-hop logic: that the Restoration Plan restores matching contributions limited by the Internal Revenue Code. The qualitative reasoning is sound and contextually accurate, with proper identification of entities (Lowe’s, Benefit Restoration Plan, 401(k), IRS Code). However, the LLM omits the specific quantitative detail from the ground truth: the maximum company match of 4.25% of eligible compensation and the fact that this exact match is mirrored in the Restoration Plan. While the answer implies parity in matching, it does not specify the percentage, which is a key factual element in the original answer. This omission affects quantitative accuracy but not overall comprehension. The answer is semantically close and relevant, but missing precise numeric support reduces full factual fidelity. Hence, correctness is high but not complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 287,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "\nAt December 31 2023 the combined balance on the secured uncommitted lines was **$950 million (CS&Co) + $700 million (TDAC) = $1.65 billion**.  This outstanding amount is close to the facilities’ total borrowing capacity of **$1.8 billion**, leaving roughly **$150 million (about 8 %) of unused capacity**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the total outstanding amount ($1.65 billion), the breakdown between CS&Co ($950 million) and TDAC ($700 million), and the total borrowing capacity ($1.8 billion) match the original answer. (2) The calculation of the outstanding balance ($950M + $700M = $1.65B) is correct, and the unused capacity is accurately computed as $150 million. While the original answer expresses utilization as ~91.7%, the LLM instead reports the unused portion as ~8%, which is a valid and accurate rephrasing (100% - 91.7% ≈ 8.3%, rounded to ~8% is acceptable). (3) The multi-hop reasoning—aggregating data across two entities (CS&Co and TDAC) and comparing total usage to capacity—is sound and correctly executed. (4) The answer addresses both parts of the question: the total amount outstanding and how it compares to borrowing capacity. Wording differs slightly but conveys the same meaning. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 299,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "\nThe company’s investments in mutual, pooled and commingled funds totaled **$850 million** at the end of 2021. By contrast, the combined value of its hedge‑fund/limited‑partnership holdings ($720 million) and real‑estate investments ($389 million) was **$1.109 billion**, which is about **$259 million (≈30 %) larger** than the mutual‑fund position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of factual content. (1) The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87 million (not $850 million). The combined value of hedge funds/limited partnerships and real estate investments was $9 million + $5 million = $14 million (not $720M + $389M = $1.109B). The LLM reports values that are off by orders of magnitude. (2) Calculations are therefore also incorrect: the LLM claims the combined alternative investments exceed mutual-type funds by ~30%, while in reality, mutual/pooled/commingled funds ($87M) are much larger than the combined $14M in hedge funds and real estate. (3) The multi-hop reasoning is structurally sound—comparing one investment category to the sum of two others—but based on completely inaccurate data, indicating a failure to retrieve or interpret the correct figures from the source. (4) The entities (investment types, year 2021, Coca-Cola) are correctly identified, and the response attempts the right comparison, so some contextual relevance and basic qualitative reasoning are present. However, the massive quantitative errors render the answer factually wrong, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 347,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "\nLTIP units are treated as “participating securities” because the award agreement entitles their holders to receive distributions equal to 10 % of the regular quarterly distributions paid on each Operating Partnership unit. Consequently, under the two‑class method used for earnings‑per‑share, a portion of the company’s earnings is allocated to those LTIP units, reducing the earnings attributable to common stock and therefore lowering both basic and diluted EPS compared with a calculation that excludes the participating securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: LTIP units are treated as participating securities due to receiving distributions equal to 10% of regular quarterly distributions on Operating Partnership units. This triggers application of the two-class method for earnings per share (EPS), which allocates earnings between common shares and participating securities. (2) Quantitative accuracy is perfect: the 10% figure is correctly cited and no calculations are required beyond that. (3) The reasoning is sound—because LTIP units receive non-trivial distributions, they qualify as participating securities, which necessitates earnings allocation under the two-class method, thereby reducing earnings attributable to common stock and lowering both basic and diluted EPS. The LLM correctly infers the impact on EPS (reduction) even though the original answer does not explicitly state 'lowering EPS'—this is a valid and accurate extension of the logic. (4) The only minor shortcoming is that the LLM does not explicitly mention that LTIP units do not have full parity with common units, a nuance included in the original answer. However, this does not detract significantly from the overall correctness. The answer is contextually relevant, directly addressing the mechanism and impact of the accounting treatment. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 413,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "\nAs of December 31 2024, NEE’s non‑controlling‑interest investment in XPLR OpCo was approximately **$3.3 billion** – the carrying amount of its equity‑method stake in that entity.  XPLR OpCo is classified as a **variable‑interest entity that is not consolidated**; NEE accounts for its ~52.6 % interest under the equity method because the limited partners lack substantive governance rights and NEE does not have a controlling financial interest.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy in the dollar amount: the ground truth specifies $3,315 million, while the LLM reports 'approximately $3.3 billion'. While $3.3 billion is a reasonable rounding, it omits precision (a difference of $15 million), which affects quantitative accuracy. The classification of XPLR OpCo as a VIE not consolidated and accounted for under the equity method is correct. The mention of NEE's ~52.6% interest is additional detail not in the original answer but not contradicted by it; however, the original answer emphasizes NEE's lack of control and primary beneficiary status due to governance and control factors, which the LLM partially captures by referencing 'lack of substantive governance rights' and 'not having a controlling financial interest'. (2) The date (December 31, 2024) is correct. The dollar amount is acceptably close but not exact—hence a deduction in quantitative accuracy. No calculation is required, but the rounding should have preserved more precision given the context of financial reporting. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that XPLR OpCo is a VIE, that NEE is not the primary beneficiary, and thus uses equity method accounting—this reflects proper understanding of consolidation criteria under ASC 810. The logic linking control, governance, and accounting treatment is valid. (4) Scores reflect high correctness and relevance, with slight deductions in quantitative and qualitative accuracy due to imprecise dollar amount and slightly less precise articulation of control rationale compared to the ground truth’s emphasis on 'lack of control over significant activities'.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 466,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "\nLinde supplies process gases through **three distribution methods**—on‑site (or tonnage), merchant (bulk liquid), and packaged (cylinder) gases.  \nThe on‑site method is distinguished by **long‑term contracts that typically run 10–20 years and include minimum purchase‑volume requirements**, whereas merchant and packaged‑gas contracts are shorter (generally 3–7 years) and do **not** impose minimum purchase obligations or volume commitments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Linde uses three distribution methods: on-site, merchant, and packaged gases, matching the original answer. (2) Quantitatively, all numbers and ranges are correct: the on-site contract duration of 10–20 years, merchant contracts of 3–7 years, and packaged gas contracts of 1–3 years are all accurately reflected (the original specifies 'three to seven' and 'one to three', which aligns with the LLM's '3–7' and implied 1–3 range; though the LLM does not explicitly state the 1–3 range for packaged, it is contextually covered under 'shorter' and contrasted with on-site, and the absence of minimum purchase obligations is correctly emphasized). The key financial and contractual differentiators—minimum purchase requirements for on-site versus none for the others—are correctly identified. (3) The multi-hop reasoning is sound: the answer synthesizes information about contract duration and volume commitments across the three methods, correctly contrasting on-site with the others. (4) The wording differs slightly (e.g., 'tonnage' in parentheses, 'bulk liquid', 'cylinder'), but these are valid synonyms and add clarity without distorting meaning. All entities (Linde, process gases, distribution methods) are correct. The answer is complete, factually accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 388,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "\nThe February 2022 20‑for‑1 stock split can only be effected after shareholders approve an amendment to Alphabet’s charter that raises the authorized share counts for Class A, B and C stock—an amendment that was planned after the Board’s April 2021 authorization to repurchase up to $50 billion of Class C shares.  The required condition for the split to proceed is that the amendment to the certificate of incorporation be approved by the company’s stockholders, thereby increasing the authorized share pool to accommodate the additional shares created by the split.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core relationship between the 20-for-1 stock split and the prior $50.0 billion repurchase authorization. (1) All key facts are correct: the February 2022 announcement of the 20-for-1 stock split, the April 2021 $50 billion Class C repurchase authorization, and the requirement for stockholder approval of a charter amendment to increase authorized shares for Classes A, B, and C. (2) Quantitative accuracy is perfect: dates (February 2022, April 2021), the 20-for-1 ratio, and the $50 billion repurchase amount are all correctly stated with no calculation errors. (3) The multi-hop reasoning is sound—the model correctly infers that the repurchase program and stock split both require sufficient authorized shares, hence the need for the charter amendment. It correctly identifies that the split could not proceed without increasing the authorized share count, which was a prerequisite for accommodating the post-split share structure and ongoing repurchases. (4) The only minor shortcoming is that the LLM does not explicitly state *why* the share increase was necessary—to accommodate both the split *and* the repurchase program—as clearly as the ground truth. While implied, this linkage is slightly less explicit, preventing a perfect 10 on qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 388,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "\nGM’s equity earnings from Ultium Cells Holdings LLC in 2023 were **$293 million**, and as of December 31 2023 the company still had **$0.8 billion (≈ $800 million) of committed capital contributions outstanding** to that entity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the equity earnings contribution of $293 million and the committed capital contributions of $0.8 billion (explicitly noted as ≈ $800 million) are accurate and match the original answer exactly, with acceptable formatting variations. (2) The answer is complete, addressing both parts of the multi-part question: the 2023 equity earnings and the outstanding committed capital as of December 31, 2023. (3) Entity accuracy is correct—GM, Ultium Cells Holdings LLC, and the time frame (2023, specifically December 31, 2023) are all properly identified. (4) The reasoning, while not explicitly shown, is reflected in the correct synthesis of two distinct financial figures from the same entity and time period, indicating proper multi-hop information retrieval and integration. The semantic meaning is equivalent to the ground truth, with clear and precise wording. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 291,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "\nIn 2021 the company reported **$720 million** of hedge‑fund and limited‑partnership interests in its **pension‑plan assets** (page 115), and **$9 million** of the same type of investment in its **other post‑retirement benefit‑plan assets** (page 103).  \n\nThe separate figures illustrate that the firm’s exposure to these illiquid alternatives is **diversified across two distinct trust structures**—its pension funds and its post‑retirement VEBA—while the modest dollar amounts show that such investments represent only a small slice of the overall asset base, yet are deliberately included to pursue higher returns within the broader alternative‑investment allocation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the two key figures—$720 million and $9 million—which match the ground truth exactly, and the total exposure of $729 million is implied though not explicitly stated. However, the LLM incorrectly labels the $720 million as being in 'pension-plan assets', while the ground truth specifies it is in the 'consolidated financial statements'. This is a critical entity misattribution. The consolidated financial statements are not equivalent to pension-plan assets; they represent the company’s overall financial position, not a specific trust or plan. (2) Quantitatively, all numbers are accurate: $720 million and $9 million are correctly cited, and no calculation errors are present. The total $729 million can be inferred, though it is not directly computed in the answer. (3) The multi-hop reasoning is partially sound—information is drawn from two different reporting categories as required. However, the synthesis is flawed because one of the sources (pension-plan assets) is misrepresented. The answer incorrectly conflates consolidated financials with pension assets, undermining the reasoning. (4) Contextual relevance is high—the answer addresses the dual reporting and discusses diversification, intent for higher returns, and the relative size of the investments. But due to the mischaracterization of the $720 million as pension-related rather than consolidated, the qualitative accuracy is significantly reduced despite strong contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 413,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "\nThe risk factor explains that retailers’ growing reliance on e‑commerce drives store closures and smaller footprints, which reduces the demand for brick‑and‑mortar space at SPG’s centers. As a result, the company faces longer vacancy periods and must offer lower rents—or more concessions—to attract tenants, and weaker in‑store sales also cut overage‑rent income, making it harder to lease spaces at the rates it previously achieved.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core causal chain described in the original answer. It correctly identifies that increased e-commerce use leads to reduced demand for physical space, resulting in longer vacancies, lower rents, and increased concessions—directly aligning with the ground truth. It also mentions the impact on overage rent (a specific financial consequence), which adds valuable detail not explicitly in the original but consistent with it. The only minor omission is the explicit mention of 'increased bargaining power of creditworthy tenants' and 'increased spending on tenant improvements,' which are part of the full leasing pressure dynamic. However, the concept of offering 'more concessions' implicitly covers lease modifications and tenant improvements. No numbers, dates, or entities are incorrect (quantitative accuracy is perfect as no specific figures were in the original). The reasoning is sound and synthesizes the multi-hop logic: e-commerce → store closures → lower demand → leasing challenges → financial impact. The answer is fully contextually relevant and semantically equivalent to the original, with slightly less detail on tenant power and capital outlays. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 370,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "\nThe Arkansas corporate‑income‑tax law changes trimmed Union Pacific’s deferred tax expense by **$34 million in 2024** and by **$114 million in 2023**. By contrast, the Arkansas legislation that took effect in **2022 reduced deferred tax expense by $95 million**. Hence, the 2023 impact is markedly larger than both the 2024 impact and the 2022 impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the deferred tax expense impacts for UNP from Arkansas legislation in 2024 ($34 million), 2023 ($114 million), and 2022 ($95 million), matching the ground truth exactly. These numbers are accurate and properly attributed to the correct years and company. (2) However, the LLM fails to compute or report the cumulative impact for 2024 and 2023 (which is $148 million) and does not calculate the comparison to 2022 as required—specifically, that the 2023–2024 total exceeded the 2022 impact by $53 million. This is a critical omission in the multi-hop reasoning. (3) While the model identifies the correct entities (UNP, Arkansas tax legislation, deferred tax expense) and correct years, it does not synthesize the information fully across all hops—particularly the final comparative calculation. The statement that 'the 2023 impact is markedly larger than both the 2024 impact and the 2022 impact' is factually true but incomplete and does not address the cumulative 2023–2024 effect versus 2022 as the question demands. (4) The quantitative accuracy is high due to correct numbers; contextual relevance is strong as all information pertains directly to the question. However, qualitative accuracy is reduced due to flawed reasoning and incomplete synthesis. Correctness score is 7 because core data is accurate but the final comparative analysis is missing, which is a key part of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 397,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEE’s cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "\nNEE’s indirect limited‑partner interest in XPLR OpCo means that if XPLR cannot obtain financing on commercially reasonable terms, XPLR may be unable to fund acquisitions or meet its cash‑distribution obligations, which would reduce the cash flow that NEE expects from the partnership and could force NEE to provide additional financing or guarantee support—thereby increasing NEE’s own debt, liquidity pressure, and exposure to the partnership’s performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying the financial risks NEE faces due to its limited partner interest in XPLR OpCo if XPLR cannot access capital on commercially reasonable terms. It accurately captures the core causal chain: capital constraints at XPLR could impair its ability to fund acquisitions and make cash distributions, thereby reducing NEE’s expected cash flows. The mention of increased liquidity pressure and potential need for NEE to provide financing or guarantees is a reasonable extension of the risk, aligning with the economic implications of such a structure. However, the LLM omits a key element present in the original answer: the risk of dilution to NEE’s share of future distributions if XPLR issues additional common units or converts securities into common units. This is a material aspect of how NEE’s financial position could be impacted and represents a gap in completeness. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no specific numbers were involved), and the entities (NEE, XPLR OpCo) and financial concepts are correctly identified. The reasoning is sound and reflects appropriate multi-hop synthesis between capital access, distribution capacity, and impacts on NEE’s liquidity and obligations. The omission of dilution risk prevents a top score, but the answer remains substantially correct and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 395,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "\nThe “Marketable securities” discussion lists mortgage‑backed obligations with a fair‑value amount of **$236 million**. That same figure appears in the **Fair Value** column of the marketable‑securities table, so the two numbers are identical – the difference is **$0**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. According to the ground truth, the fair value in the 'Marketable securities' section is $178, and in the 'Fair Value' column it is $236, resulting in a difference of $58. The LLM claims both values are $236 million and the difference is $0, which contradicts the ground truth. (2) The quantitative values are wrong: the LLM incorrectly reports $236 million for both entries, while the correct values are $178 and $236 (no units specified in ground truth, but magnitude mismatch remains). The calculated difference of $0 is incorrect; the correct difference is $58. (3) The multi-hop reasoning failed: the model did not correctly identify or synthesize the two distinct values from different sections of the filing, instead asserting they are identical without justification. (4) Scores are low due to major factual and calculation errors. The answer is partially relevant to the question structure but fundamentally incorrect in content, hence the low correctness, quantitative, and qualitative scores. Contextual relevance is slightly higher because the model addressed the right sections and metric, albeit with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 333,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "\nGoogle Play’s revenue is recorded on a **net‑basis**—the company recognizes only the service fee it earns from app developers rather than the full gross amount of app sales and in‑app purchases. Because this fee is a relatively small portion of the total transaction value, the growing share of non‑advertising revenues (e.g., Play, Cloud, hardware) is reflected in the financial statements as lower‑margin income, even though the underlying marketplace activity is expanding. As a result, the increasing contribution of these net‑revenue streams puts downward pressure on overall margins unless it is offset by higher‑margin advertising growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that Google Play revenue is recognized on a net basis, meaning only the service fee is recorded, not the gross transaction amount—this matches the original answer's explanation. (2) There are no specific numbers, dates, or percentages in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations, but the conceptual treatment of revenue (net vs. gross) is correctly represented. (3) The reasoning is sound: the LLM correctly links net revenue recognition to lower reported revenue and explains how the increasing proportion of such non-advertising revenues (with potentially lower margins) exerts downward pressure on overall margins. It also appropriately contextualizes this within broader non-advertising segments like Cloud and hardware. (4) The only minor shortcoming is that the original answer explicitly states Google's performance obligation is to 'facilitate a transaction,' which the LLM omits, though the implication is present. Otherwise, the semantic meaning, multi-hop synthesis (revenue recognition method → impact on reported revenue → margin implications as mix shifts), and contextual relevance are fully preserved. Wording differs but meaning is equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 366,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "\nGeneral Motors’ committed capital contributions to Ultium Cells Holdings LLC totaled **$0.8 billion** as of December 31 2023. This is a **decrease** from the **$1.4 billion** committed at the end of 2022, representing a reduction of roughly **$0.6 billion** (about a 43 % drop) compared with the prior year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the committed capital contributions of $0.8 billion in 2023 and $1.4 billion in 2022 are accurately reported. The reduction of $0.6 billion is correctly calculated (1.4 - 0.8 = 0.6), and the additional percentage drop of approximately 43% (0.6 / 1.4 ≈ 42.86%) is a reasonable and accurate derivation, even though not explicitly required. (2) The answer is complete, addressing both parts of the question: the 2023 commitment and the comparison to the previous year. (3) Entity accuracy is correct—General Motors, Ultium Cells Holdings LLC, and the years 2023 and 2022 are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly inferred the year-over-year change from two distinct data points and communicated the trend (decrease) clearly. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced detail (percentage drop) that adds value without introducing error. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 309,
        "total_tokens": 1451
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "\nIn 2024 Mastercard paid a total of **$2.8 billion** in cash to acquire all businesses, and **about $1.7 billion (≈ $1.736 billion) of that amount was recorded as goodwill**, the majority of which relates to the December 2024 acquisition of RF UlEmate Parent, Inc. (Recorded Future).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the total cash consideration of $2.8 billion and the goodwill amount of $1.7 billion are correct; the LLM adds a slightly more precise figure of approximately $1.736 billion, which does not contradict the ground truth and may reflect a more granular source. Minor rounding differences are acceptable. (2) The answer addresses both parts of the question: total cash consideration and the portion attributed to goodwill. (3) Entities are correct: Mastercard, 2024, and RF UlEmate Parent, Inc. are accurately referenced. (4) The reasoning is sound, with proper multi-hop synthesis—linking the total cash consideration to the specific acquisition and correctly attributing the majority of goodwill to it. The only minor issue is the use of 'about' and '≈' for the goodwill amount, which introduces slight imprecision not present in the definitive ground truth, but this does not undermine factual correctness. Overall, the answer is semantically equivalent and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 306,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "\nUNP spent a total of **$270 million** on freight‑car lease buyouts during the 2022‑2024 period ( $70 million in 2022, $57 million in 2023 and $143 million in 2024 ).  This outlay is part of the company’s broader fleet‑modernization effort and is reflected in its 2025 capital plan, which earmarks roughly **$3.4 billion** for capital projects—including the acquisition of new freight cars to replace aging equipment and support growth.  Thus, while lease‑buyout spending is a modest component of the overall $3.4 billion plan, it underscores UNP’s ongoing strategy of acquiring and upgrading freight‑car assets as part of its network‑expansion and efficiency‑improvement objectives.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total spend of $270 million is accurate, with correct yearly breakdowns: $70M (2022), $57M (2023), and $143M (2024); the sum of these values is correct ($70M + $57M + $143M = $270M). The $3.4 billion capital plan figure for 2025 is also accurately reported. (2) The answer is complete, addressing both parts of the question: total lease buyout spending over 2022–2024 and its relation to the 2025 capital plan. (3) All entities—UNP, freight car lease buyouts, capital plan, and associated years—are correctly identified and contextually accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects past spending behavior to future strategic planning, noting that lease buyouts are part of a broader asset replacement and growth strategy. The LLM adds context (fleet modernization, efficiency improvements) that is consistent with and enriches the ground truth without introducing inaccuracies. Semantic equivalence is maintained throughout, with no factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 311,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "\nThe company entered into two ASR agreements under the 2021 Repurchase Program in those years—a $2.0 billion fixed‑dollar ASR with Citibank in 2023 and a $1.5 billion fixed‑dollar ASR with Barclays Bank in 2022.  Adding the disclosed notional amounts gives a total of **$3.5 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts ($2.0 billion in 2023 and $1.5 billion in 2022) are accurately reported, and their sum ($3.5 billion) is correctly calculated. Minor formatting differences (e.g., use of ' ' thin space) do not affect accuracy. (2) The answer is complete, addressing both the individual ASR agreements and the total notional amount under the 2021 Repurchase Program. (3) Entity accuracy is correct: CVS Health Corporation, the 2021 Repurchase Program, correct years (2022 and 2023), and financial terms (notional amount, ASR) are properly identified. (4) The multi-hop reasoning is sound—information from two separate transactions across two years is correctly synthesized to compute the total. The inclusion of counterparty banks (Citibank, Barclays) adds contextual detail not required but does not detract. (5) The semantic meaning is equivalent to the original answer, with clear, concise, and factually accurate reasoning leading to the correct total.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 300,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "\nGM’s near‑term profitability still depends on the high‑margin full‑size ICE pickup trucks and SUVs that generate the cash used to fund its EV and AV rollout, but the company’s forward‑looking risk disclosures warn that a sustained shift in consumer demand, tougher emissions regulations, or slower‑than‑expected EV adoption could erode those margins and leave the business under‑capitalized for the transition—making its long‑term financial stability tightly linked to the success of the EV strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: GM relies on high-margin ICE trucks for near-term profitability to fund EV/AV development; forward-looking risks include shifts in consumer demand, regulations, and slow EV adoption; these risks threaten long-term financial stability. The LLM correctly identifies the dual dependency—current cash flows funding future strategy—and the potential for undercapitalization during transition. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is not applicable but assumed perfect as no numbers were misstated. (3) Multi-hop reasoning is sound: the model synthesizes GM's current profit source (ICE trucks) with strategic investment needs (EVs) and risk factors (consumer trends, regulation, adoption rates), correctly linking short-term performance to long-term viability. (4) The only reason for not scoring a perfect 10 is that the LLM slightly downplays the specific risk of declining ICE truck sales directly reducing EV investment capacity—though this is implied in 'under-capitalized for the transition.' The original answer more explicitly connects the causal chain: weaker ICE demand → lower cash flow → reduced EV funding. Otherwise, the answer is fully contextually relevant, accurate in entities (GM, ICE, EV, AV), and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 403,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "\nChevron’s impairment reviews of upstream assets are tied to assumptions about future oil‑and‑gas prices, reserve volumes and, critically, the pace of the energy transition; if slower‑than‑expected transition or lower commodity prices—driven by market shifts or tighter regulations—reduce expected cash flows, the company may trigger an impairment test that can result in a write‑down of the asset’s carrying value. Because these uncertainties are embedded in its cash‑flow models, Chevron tends to be more cautious when committing capital to new upstream projects, favoring investments that remain economically viable under a range of transition scenarios and that carry lower exposure to price volatility and regulatory change.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key elements are correct: Chevron links energy transition uncertainty to commodity price forecasting, impairment assessments, and upstream investment decisions. The answer correctly identifies that lower commodity prices or an accelerating energy transition could reduce expected cash flows, triggering impairment tests and asset write-downs. It also accurately notes Chevron’s cautious capital allocation, favoring resilient projects under various transition scenarios—consistent with the original answer’s emphasis on economic viability amid uncertainty. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes how external factors (commodity prices, regulation) influence internal financial assessments (impairment) and strategic decisions (upstream investments). The only minor gap is that the LLM answer does not explicitly mention the impact of carbon costs or the potential negative effect on financial condition and reinvestment in lower-carbon solutions—details present in the original. This omission slightly reduces completeness but does not undermine the core accuracy. (4) Contextual relevance is perfect: the response directly addresses both parts of the question—impairment assessments and investment decisions—and ties them to energy transition uncertainty. Overall, the answer demonstrates strong qualitative reasoning and factual alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 465,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "\nMastercard’s Consumer Engagement Services—encompassing consumer acquisition, engagement, security and data‑driven insights—are built into its global payments network to deepen cardholder relationships and increase transaction frequency. By delivering personalized, secure experiences and actionable data, these services drive higher volume and cross‑border activity, generate recurring fee income, and reinforce the network effects that underpin the company’s revenue growth and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. It correctly identifies that Mastercard's Consumer Engagement Services enhance the global payments network by leveraging data to deepen cardholder relationships, increase transaction frequency, and drive cross-border activity—aligning with the original answer's emphasis on attracting consumers and merchants, strengthening network utility, and increasing payment flows. The LLM also correctly links these services to financial performance through recurring fee income and network effects that support revenue growth and profitability, which matches the original's point about contributing to financial performance. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor gap is that the LLM does not explicitly mention 'principled and responsible use of secure data' or the 'interdependence' of service offerings, which are key nuances in the original answer. However, the concepts of data-driven insights and integration within the network imply this interdependence. Reasoning is sound, entities are correct, and the response fully addresses both the operational and financial aspects of the question. Thus, the answer is excellent but not perfect, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 377,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "\nThe only cash impact disclosed is the $0.4 billion purchase price Walmart paid in fiscal 2023 to acquire the remaining stake in Alert Innovation; the entity was later sold and de‑consolidated in fiscal 2025, but the filing does not report any additional cash outlay for that sale—rather, the transaction generated cash proceeds that offset the earlier outflow. Consequently, the net cash outflow attributable to the acquisition and subsequent sale of Alert Innovation over fiscal 2023 and 2025 is essentially the $0.4 billion acquisition cost.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion acquisition cost in fiscal 2023 and correctly concludes that the net cash outflow is $0.4 billion, aligning with the ground truth. The only discrepancy is in reasoning—the LLM states that the sale in fiscal 2025 'generated cash proceeds that offset the earlier outflow,' which contradicts the ground truth stating there was 'no net cash inflow from deconsolidation.' However, the final conclusion still correctly reports net outflow as $0.4 billion, implying no recovery of cash. (2) Quantitatively, all numbers and years are accurate: $0.4 billion, fiscal 2023 acquisition, fiscal 2025 deconsolidation—no calculation errors. (3) The multi-hop reasoning is mostly sound: it connects the acquisition and deconsolidation events across fiscal years 2023 and 2025. However, the reasoning mischaracterizes the sale as generating offsetting proceeds, which is not supported by the ground truth (which explicitly states no net cash inflow). Despite this, the final net impact is correctly stated. (4) Scores reflect high accuracy in numbers and relevance, minor deduction in qualitative accuracy due to flawed intermediate logic, but not affecting the final correct conclusion. Contextual relevance is perfect—directly addresses the question with appropriate entities and time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 373,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "\nThe company’s disclosures show that the only potentially dilutive securities for 2023 are LTIP units, and it explicitly states that **no securities had a material dilutive effect** for the year ended December 31, 2023. Consequently, the combined total of potentially dilutive securities is effectively **zero** (i.e., none that would materially dilute earnings). Because the LTIP units did not materially affect diluted earnings per share, the company saw **no need to adjust net income attributable to common stockholders**.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that LTIP Units are potentially dilutive securities and that no adjustment was made to net income attributable to common stockholders due to lack of material dilutive effect, aligning with the original answer’s reasoning. However, it incorrectly states that the 'combined total of potentially dilutive securities is effectively zero,' which misrepresents the concept. The ground truth does not claim the number of securities is zero, but rather that they exist (units exchangeable for common stock and LTIP Units) yet had no material dilutive effect. Thus, the total count of potentially dilutive securities is not zero—it's the impact that is immaterial. This is a critical distinction in financial reporting. (2) There are no explicit numerical values in either answer, so quantitative accuracy is high by default—both correctly avoid fabricating numbers. The LLM correctly interprets 'no material dilutive effect' as not requiring an adjustment, which is consistent with accounting standards (e.g., ASC 260). (3) The multi-hop reasoning is partially sound: the model connects LTIP Units to dilution and links lack of materiality to no adjustment in net income. However, it fails to mention 'units exchangeable for common stock' as part of the combined total, omitting a key entity from the synthesis, which breaks completeness and weakens qualitative accuracy. (4) Contextual relevance is strong because the response stays focused on the question and uses appropriate financial terminology. The correctness score is reduced due to the misstatement about the quantity of dilutive securities, which could mislead a reader about the nature of potential dilution, even if the conclusion on net income adjustment is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 482,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "\nThe 2023 10‑K reports $4,432 million of pension assets and $5 million of other post‑retirement (health‑care/life) assets that are measured at NAV, for a combined total of **$4,437 million** recorded at NAV. By contrast, the total fair‑value holdings are **$9,104 million** for the pension portfolio (so NAV assets represent roughly 49 % of that fair‑value total) and **$461 million** for the health‑care/life portfolio (NAV assets amount to only about 1 % of its fair‑value total).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitative Accuracy: The reported NAV values are grossly inaccurate—LLM states $4,437 million ($4,432M + $5M) compared to the correct total of $14 million ($9M + $5M). The fair value totals are also wrong: LLM reports $9,104 million for pension and $461 million for other, while the correct total fair value is $902 million ($441M + $461M). The percentages (49% and 1%) are therefore also incorrect. (2) Completeness: While the answer attempts to address both asset categories and comparisons to fair value, it misidentifies the categories—referring to 'pension' and 'other post-retirement' with incorrect amounts, whereas the ground truth specifies two undisclosed categories totaling $14M at NAV. (3) Entity Accuracy: The company (VZ) and year (2023) are correct, but the financial metrics (investments at NAV and fair value) are completely mismatched. (4) Reasoning: The multi-hop synthesis is flawed—the LLM appears to have pulled data from a different section of the 10-K (possibly pension plan disclosures) but failed to identify the correct 'investments measured at NAV' within the context of the two disclosed asset categories. (5) Semantic Equivalence: The answer conveys a completely different financial picture—overstating NAV investments by two orders of magnitude and misrepresenting the fair value base. Even allowing for format flexibility, the numbers are factually wrong. The correct answer notes that NAV investments are a small fraction (3.1%) of total fair value, while the LLM suggests a much larger proportion (49% in one category), indicating a fundamental error in data retrieval or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 468,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "\nGM reported **$293 million** of equity earnings from Ultium Cells Holdings LLC for 2023. These earnings were disclosed in the consolidated financial statements as “Equity income (loss)” – specifically in Note 8 (Equity in Net Assets of Nonconsolidated Affiliates), which is reflected in the income‑statement line for equity earnings of non‑consolidated affiliates.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the equity earnings amount of $293 million from Ultium Cells Holdings LLC in 2023, matching the ground truth exactly. This satisfies quantitative accuracy. However, the financial statement category is incorrect. The ground truth states these earnings were disclosed under 'Automotive and other cost of sales', whereas the LLM claims they were reported under 'Equity income (loss)' in Note 8 and on the income statement as equity earnings of non-consolidated affiliates. This is a significant factual error in classification. (2) The number $293 million is accurate and correctly attributed to GM, Ultium Cells Holdings LLC, and the year 2023. No calculation is required, so quantitative accuracy is perfect. (3) The multi-hop reasoning fails at the synthesis stage: while the model correctly identifies the entity and amount, it misattributes the accounting treatment and disclosure location. This suggests confusion between how equity earnings are presented in notes versus their actual line-item classification in the financial statements. (4) The correctness score is 6 due to the accurate number but major error in disclosure category. Quantitative accuracy is 10 because the dollar amount is correct. Qualitative accuracy is 5 due to flawed reasoning about financial statement presentation. Contextual relevance is 8 because the answer addresses both parts of the question and is clearly focused on the topic, despite being factually wrong on the key qualitative point.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 418,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "\nThe equity ownership share of Principal or Affiliate Customers (Class B stockholders) fell from **0.8 % in 2023 to 0.7 % in 2024**, a decline of roughly **0.1 percentage‑points**.  This modest reduction is reflected in the overall ownership mix by slightly increasing the relative weight of public investors and the Mastercard Foundation, while the Class B holders now hold essentially no voting power (‑ % voting power in both years).  The shift indicates that the company’s principal‑customer group is becoming a smaller component of Mastercard’s shareholder base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the change in equity ownership of Principal or Affiliate Customers (Class B stockholders) from 0.8% in 2023 to 0.7% in 2024, matching the ground truth exactly. The calculated decrease of 0.1 percentage points is accurate. 2) All numeric values and dates are correct, and the calculation (0.8% - 0.7% = 0.1%) is precise. Format variations (e.g., '0.1 percentage-points') are acceptable and clear. 3) The multi-hop reasoning is sound: the model correctly infers that the decline reflects a shift in ownership structure, noting increased relative weight of public investors and the Mastercard Foundation. It also correctly observes the negligible voting power of Class B stockholders. While the original answer does not mention voting power or the Mastercard Foundation, this additional context is factually consistent and enhances the explanation without introducing error. 4) The LLM answer conveys the same core information as the ground truth with minor elaboration. The slight expansion on implications is appropriate and does not deviate from the facts. The answer fully addresses both parts of the question: the quantitative change and its reflection in the ownership structure. Only a minor deduction in qualitative accuracy due to the introduction of ancillary details not present in the ground truth, but these do not affect correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 382,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "\nIn fiscal 2023 Walmart paid roughly **$0.4 billion** of cash to acquire Alert Innovation (the purchase that gave it 100 % ownership).  The following fiscal year (FY 2024) the company continued to hold the entire Alert Innovation business—there were no additional cash outflows reported— and the entity was later **sold and deconsolidated in FY 2025**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion cash outflow for Walmart's acquisition of Alert Innovation in fiscal 2023, which matches the ground truth. It also accurately states that the entity was sold and deconsolidated in fiscal 2025. However, it incorrectly states that the following fiscal year was FY 2024, implying activity in that year, while the ground truth does not specify any holding period or actions in FY 2024—only that the sale occurred in FY 2025. This is a minor temporal misstatement but does not contradict the core facts. (2) All numeric values—$0.4 billion and the fiscal years 2023 and 2025—are correct and match the ground truth. The format variation ($0.4 billion vs $476M in other examples) is acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly links Walmart’s acquisition cash outflow in FY 2023 to the subsequent divestiture in FY 2025, synthesizing two events across time. The only minor flaw is the insertion of 'FY 2024' as an intermediate holding year with no reported activity, which, while plausible, isn't supported in the ground truth and slightly misrepresents the timeline. (4) The answer is highly relevant, complete, and factually accurate on all key points—only the emphasis on FY 2024 introduces a small inaccuracy in sequencing, not substance. Thus, the correctness score is 9 due to this minor contextual overstatement, but quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 406,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "\nIn early 2024 the company repaid $500 million of its 0.600% senior notes and $1.0 billion of its 5.00% senior notes, using borrowings under the 2021 Multicurrency Credit Facility for a total of $1.5 billion of principal. This borrowing reduced the facility’s unused portion—from the full $6 billion commitment—to roughly $4.5 billion as of December 31 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total principal repaid ($1.5 billion), broken down into $500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes, which matches the ground truth. However, it incorrectly states that the borrowing reduced the facility's unused portion to roughly $4.5 billion as of December 31, 2023. This is factually wrong because the repayment occurred in early 2024, *after* December 31, 2023. Therefore, the remaining borrowing capacity *as of December 31, 2023* should still be $6.0 billion, not $4.5 billion. The LLM conflates timing, applying a post-year-end event retroactively. (2) All numeric values (dollar amounts, note rates) are accurate and properly summed. The calculation of $1.5 billion total repayment is correct. However, the derived figure of $4.5 billion remaining is incorrect due to flawed temporal logic. (3) The multi-hop reasoning fails on the second part: while the model correctly links the repayment to the 2021 Multicurrency Credit Facility, it does not respect the time boundary specified in the question ('as of December 31, 2023'). The impact on borrowing capacity should reflect the balance *before* the early 2024 drawdown, meaning the full $6.0 billion was still available at year-end. (4) Despite this critical error in timing and resulting capacity, the answer is contextually relevant and semantically close, with accurate entities (facility name, note types, amounts). The correctness score is 7 because core facts are right but a key conclusion (remaining capacity) is materially incorrect due to flawed reasoning about timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 443,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "\nIntel is using Extreme‑Ultraviolet (EUV) lithography in its Intel 4 and Intel 3 nodes to shrink feature dimensions and boost performance‑per‑watt, enabling the continuation of its advanced FinFET‑based transistor architecture. This EUV foundation paves the way for the next‑generation RibbonFET (gate‑all‑around) devices that will debut at the Intel 20A node and be refined at the forthcoming Intel 18A node, where High‑Numerical‑Aperture EUV is slated to be introduced as part of the process‑technology roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: EUV is used in Intel 4 and Intel 3 for shrinking features and improving performance-per-watt; this enables the transition to RibbonFET at Intel 20A; and High Numerical Aperture EUV is expected at Intel 18A. (2) There are no numeric values (e.g., dates, percentages, dollar amounts) in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the answer correctly links EUV usage in Intel 4/3 to the broader roadmap, identifies RibbonFET's introduction at Intel 20A, and correctly states that High NA EUV will come with Intel 18A. The only minor omission is that the original answer specifies PowerVia (backside power delivery) as part of Intel 20A and notes FinFET optimizations in Intel 3—details absent in the LLM response but not critical to the main question. (4) The answer is fully contextually relevant, directly addressing how EUV use relates to transistor architecture evolution and which node introduces High NA EUV. Wording differs slightly but maintains semantic equivalence. Thus, correctness is 9 due to slight incompleteness on secondary details, but overall highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 364,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "\nThe combined fair‑value of U.S. Treasuries and agencies disclosed for the pension and other postretirement benefit plans is **$1.55 billion** ( $1.412 billion in the pension assets + $0.138 billion in the other postretirement assets ). This total is **about $0.43 billion (≈22 %) lower** than the combined cash and cash‑equivalents balance of **$1.98 billion** ( $1.956 billion in pension cash + $0.027 billion in other postretirement cash ).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states the combined value of U.S. Treasuries and agencies is $239 million ($101M + $138M), but the LLM reports $1.55 billion ($1.412B + $0.138B), which is off by over 500%. Similarly, cash and cash equivalents are reported as $57 million ($30M + $27M) in the truth, but the LLM claims $1.98 billion, again a massive overstatement. These numbers are not just misformatted—they are factually wrong. (2) Calculations: While the LLM performs internal arithmetic correctly (e.g., summing its own incorrect values), the inputs are invalid, making all derived comparisons false. The claim that Treasuries are 22% lower than cash is entirely unsupported by the actual data, where Treasuries ($239M) are actually significantly higher than cash ($57M). (3) Multi-hop reasoning: The model fails to correctly identify and synthesize the correct asset categories from the VZ 2023 10-K. It appears to have conflated pension plan assets with general corporate cash and investments, which are distinct disclosures. (4) Entity and Context Accuracy: The ticker (VZ) and year (2023) are correct, and the question does reference asset categories related to benefit plans, but the LLM misrepresents the scale and relationship of these figures. (5) Semantic Equivalence: The direction of comparison is reversed—truth says Treasuries > cash, LLM says Treasuries < cash—making the answer misleading. Overall, the answer reflects a severe misunderstanding of the source data, with grossly inaccurate figures and flawed reasoning, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 455,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "\nDanaher paid a combined net cash consideration of roughly **$10.9 billion** to acquire Aldevron and the other 11 businesses in 2021.  Of the approximately **$7.2 billion** of goodwill recorded for those acquisitions, about **$6.1 billion** was attributed specifically to the Aldevron purchase.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor rounding differences. (1) Quantitatively: The total net cash consideration is reported as $10.9 billion, which matches the ground truth sum of $9,561 million (Aldevron) + $1,340 million (other 11 businesses) = $10,901 million, correctly rounded to $10.9 billion. The goodwill figures are also accurate: $6.1 billion attributed to Aldevron aligns with the exact $6,149 million (rounded down), and total goodwill of $7.2 billion matches $7,187 million when rounded. (2) Completeness: The answer addresses both parts of the question—total cash consideration and Aldevron's share of goodwill. (3) Entity accuracy: 'Danaher' (DHR) is correctly identified, as are the acquisitions in 2021. (4) Reasoning: The multi-hop synthesis—aggregating cash paid across 12 businesses and identifying Aldevron’s portion of goodwill—is sound and logically presented. (5) Semantic equivalence: The use of rounded figures in billions is acceptable and common in financial reporting; no meaningful precision is lost. The only reason for not scoring a 10 is the slight rounding down of $6,149 million to $6.1 billion instead of $6.15 billion, but this is within typical financial communication norms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 355,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "\nGM’s total committed capital contribution to Ultium Cells Holdings LLC was **$0.8 billion** as of December 31 2023.  The carrying amount of GM’s investment in Ultium Cells Holdings LLC reported on its balance sheet at that date was **$2.27 billion**, which is about **$1.5 billion higher** than the committed capital contribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the correct information. (1) Quantitatively, the committed capital contribution of $0.8 billion matches the ground truth. The carrying amount is reported as $2.27 billion, which is a rounded version of $2,268 million (i.e., $2.268 billion) — this minor rounding is acceptable and common in financial reporting. (2) The comparison stating the carrying amount is about $1.5 billion higher is approximately correct: $2.268B - $0.8B = $1.468B, which rounds to $1.5B. (3) The reasoning correctly identifies the implication that GM's carrying amount exceeds its committed contribution, indicating the investment value on the balance sheet includes more than just funded contributions (e.g., equity method accounting, accumulated earnings, etc.), which aligns with proper financial interpretation. (4) All entities (GM, Ultium Cells Holdings LLC), dates (December 31, 2023), and financial concepts (committed capital vs. carrying amount) are correctly identified and synthesized. The only minor limitation is the lack of explicit mention that GM had not fully funded its commitment — though this is implied by the comparison. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 348,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "\nIn 2023 the Lower 48 segment incurred **$5,729 million** of depreciation, depletion, amortization and impairment charges. As of 31 December 2023 the net book value of its proved and unproved properties together was roughly **$37.2 billion** (comprised of $70.6 billion of proved property and $3.4 billion of unproved property, net of $36.8 billion of accumulated depreciation, depletion and amortization).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 as $5,729 million, matching the ground truth. It also accurately states the net book value of proved and unproved properties as of December 31, 2023, as approximately $37.2 billion (which rounds $37,185 million correctly). The breakdown into $70.6 billion of proved property and $3.4 billion of unproved property, net of $36.8 billion of accumulated DDA, aligns with the original data ($70,600M + $3,400M - $36,829M ≈ $37,171M, close to $37,185M, minor rounding difference acceptable). (2) All numbers are quantitatively accurate or within acceptable rounding tolerance. The $36.8 billion accumulated DDA is a correct rounding of $36,829 million. (3) The multi-hop reasoning is sound: the model correctly links 2023 charges to the net book value calculation using accumulated DDA, though it does not explicitly compute the total accumulated value ($42,558M) or compare it to the original property value ($74,014M) as in the ground truth. This is a minor omission in completeness but does not detract from core accuracy. (4) The answer is contextually fully relevant, uses correct entities (Lower 48 region, 2023, correct financial metrics), and conveys semantically equivalent information. The only reason for not scoring 10 is the omission of the final synthesis about total accumulated value vs. original value, which was part of the original answer’s insight. Thus, correctness is 9 due to partial completeness on the comparative analysis aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 436,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "\nIn 2023 the company repaid **$6.1 billion** of revolving debt under its 2021 Multicurrency Credit Facility, which included **€842.6 million (approximately $919 million)** of Euro‑denominated repayments.  This repayment reduced the outstanding revolving balance on the facility, bringing the total amount of indebtedness under the facility down by the $6.1 billion repaid.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total repayment amount of $6.1 billion and the EUR-denominated repayment of €842.6 million (converted to approximately $919 million), matching the ground truth. The only minor discrepancy is the rounding of $919.1 million to $919 million, which is acceptable under format variation rules. (2) All numeric values are accurate: $6.1 billion total repayment and €842.6 million in EUR repayments are correctly reported. The conversion from EUR to USD aligns closely with the original data (842.6 million EUR = $919.1 million). No calculation errors are present. (3) The reasoning is sound: the LLM correctly infers that the $6.1 billion repayment reduced the company's revolving indebtedness under the facility. However, it omits the additional context from the ground truth that $3.0 billion was borrowed during the year, meaning the net decrease was partially offset by new borrowing. While the core impact (reduction in indebtedness) is correct, this omission slightly weakens the completeness of the multi-hop synthesis. (4) The answer is semantically equivalent in most aspects and highly contextually relevant. The missing detail about concurrent borrowing prevents a perfect score, but all key facts and figures are correct, and the overall conclusion is valid. Thus, scores are high across all categories with a 9 in correctness and qualitative accuracy due to the minor omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 399,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "\nDuke Energy must develop and obtain regulatory approval for closure plans for each of its coal‑ash impoundments under the North Carolina Coal Ash Management Act of 2014, which requires excavation, transfer to lined landfills or beneficial reuse, and long‑term monitoring.  The compliance‑related capital and operating costs of these closures are captured in the company’s Asset‑Retirement Obligations and are recovered through state‑approved rate cases and the 2017 amendments to wholesale contracts that allow cost recovery (with retail disallowance parity), so the expenses are built into Duke Energy’s revenue stream but also raise its overall operational cost base and cash‑flow timing for ash‑basin remediation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key facts are correct: Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 requires closure plans, excavation, transfer to lined landfills or reuse, and long-term monitoring. The costs are included in Asset-Retirement Obligations and recovered through state-approved rate cases and the 2017 FERC-approved wholesale contract amendments. These points match the original answer’s content on cost recovery mechanisms and operational impacts. (2) Quantitative accuracy is perfect: the reference to 2017 cost recovery via amended wholesale contracts is correctly stated, and no incorrect numbers or dates are introduced. (3) Multi-hop reasoning is sound—LLM synthesizes information from both the regulatory requirement (Act of 2014) and financial mechanisms (rate cases, FERC approval), correctly linking compliance activities to cost recovery and operational cost increases. (4) The only minor omission is that the original answer specifies Duke has completed excavation at three of four high-priority sites and begun closure in all jurisdictions—this specific progress update is missing in the LLM response, slightly reducing completeness. However, the core operational and financial impacts are accurately conveyed. Wording differs but semantic meaning is equivalent. Thus, correctness is high but not perfect due to missing granular progress detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 405,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "\nIntel’s Agilex FPGA family supplies the high‑performance, low‑power programmable fabric that is integrated into IPU reference platforms (e.g., the Oak Springs Canyon IPU that pairs an Intel Xeon D CPU with an Agilex FPGA) to create programmable networking devices that off‑load cloud‑ and communications‑workloads from the CPU.  The newly launched Intel eASIC N5X (Diamond Mesa) is a structured‑ASIC that adds low‑latency acceleration for 5G, cloud, storage and AI functions, complementing the Agilex FPGAs within the same IPU ecosystem to further increase overall platform performance and efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) It correctly identifies the Agilex FPGA family as a key component in Intel's IPU platforms, emphasizing its role in offloading workloads from the CPU, which aligns with the original answer's point about reducing overhead and freeing CPU performance. The mention of the Oak Springs Canyon IPU (pairing Xeon D with Agilex FPGA) adds specific contextual detail not in the ground truth but is factually accurate and enhances completeness. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The LLM correctly explains the role of the Intel eASIC N5X as a structured ASIC that complements Agilex FPGAs, highlighting lower latency and acceleration for 5G, cloud, storage, and AI—consistent with the ground truth’s emphasis on lower power, lower cost, and fast time-to-market. While the original answer explicitly mentions 'lower unit cost' and 'reduced NRE costs,' the LLM implies efficiency gains without stating cost benefits directly, representing a minor omission. (4) The reasoning is sound and reflects proper multi-hop synthesis: connecting Agilex FPGAs to IPU platforms, identifying eASIC N5X as a complementary technology, and explaining their combined value in performance and efficiency. The answer is fully relevant and addresses both parts of the question. One point deducted from correctness and qualitative accuracy for not explicitly mentioning cost and power advantages of eASIC N5X, which are key differentiators in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 452,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "\nDanaher employs roughly 3,000 people in other developed markets, compared with about 24,000 employees in North America. Together these two regions account for approximately 27,000 of the company’s 63,000 global workforce, or roughly 43 % of the total.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Danaher has 3,000 employees in Other Developed Markets and 24,000 in North America, matching the ground truth exactly. The combined workforce of 27,000 (3,000 + 24,000) is accurate, and the total global workforce of 63,000 is correctly cited. The percentage is reported as 'roughly 43%', which is a valid rounding of the exact value 42.86% (27,000 / 63,000 = 0.42857). Minor deduction in correctness score due to rounding without explicit indication (e.g., 'approximately 42.86%' vs 'roughly 43%'), though this is semantically acceptable. (2) All numeric values are correct: 3,000, 24,000, 27,000, and 63,000 are accurate; the sum and percentage calculation are sound. (3) The multi-hop reasoning—aggregating two regional headcounts and calculating their share of the global total—is correctly executed. The model synthesizes the data appropriately across regions and the global total. (4) The answer is contextually complete and directly addresses both parts of the question: the comparison between regions and their collective percentage of the global workforce. Wording is clear and factually aligned with the ground truth. Thus, high scores across all dimensions with a near-perfect correctness score due to minor imprecision in percentage expression.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 366,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "\nThe foreign‑exchange forwards and options had a fair‑value of **$557 million** as of May 31 2023. This amount is essentially the entire balance‑sheet figure for derivative assets reported for that date—i.e., the total derivative assets on Nike’s consolidated balance sheet were $557 million, matching the fair‑value of those forwards and options.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the fair value of $557 million as of May 31, 2023, is accurately reported, with no discrepancies in number, date, or unit (format variation $557 million is acceptable). (2) The answer correctly identifies that this amount matches the total derivative assets on the balance sheet, indicating complete synthesis of the information. (3) The reasoning is sound: it correctly infers that foreign exchange forwards and options constitute the entirety of derivative assets, which aligns with the multi-hop logic required (linking specific derivatives to total derivative assets). (4) Entities—Nike, foreign exchange forwards and options, derivative assets, and the fiscal date—are all accurately referenced. The answer is semantically equivalent to the original, with clear, precise, and relevant information addressing both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 271,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "\nThe Lower 48’s depreciation, depletion, amortization and impairment expense grew by **$1.66 billion** (from $4.07 bn in 2021 to $5.73 bn in 2023).  Over the same period the number of productive wells in that region rose by **106** (from 426 to 532).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While the dollar amount increase in depreciation, depletion, amortization, and impairments expense is approximately correct ($1.66 billion vs. the true $1,662 million), the individual year values are slightly off ($4.07 billion and $5.73 billion vs. actual $4,067 million and $5,729 million), which is acceptable within rounding, but the direction and magnitude of the change in productive wells is completely incorrect. The LLM states the number of wells increased by 106 (from 426 to 532), whereas the ground truth shows a decrease from 87 to 38 (a drop of 49). This is a major factual and directional error. (2) The calculation for the expense increase is roughly accurate ($5.73bn - $4.07bn = $1.66bn), aligning with the true $1,662 million increase. However, the well count change is entirely wrong: 532 - 426 = +106, which contradicts the actual decrease of 49 wells (87 to 38). The starting and ending well counts are also vastly different from the truth. (3) The multi-hop reasoning failed on the second part: the model did not correctly identify or synthesize the well count data for the Lower 48 region over 2021–2023. It appears to have pulled data from a different region or entity, or misread the source. The expense trend was captured with acceptable approximation, but the well count trend is invalid. (4) The correctness score is low (2) due to the critical error in the well count change, which is a core part of the question. Quantitative accuracy is poor (2) because one of two key metrics is completely wrong. Qualitative accuracy is low (2) due to failure in entity or data mapping for wells. Contextual relevance is moderate (5) because the answer addresses the right question structure and region but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 491,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "\nThe 2023 filing lists $1,412 million of U.S. Treasuries and agencies in the pension‑plan fair‑value table (page 92) and $138 million in the same line item for the other post‑retirement benefit plans (page 93). Adding the two gives a combined fair‑value exposure of **≈ $1.55 billion**.  \n\nRelative to the total fair‑value assets, this holding accounts for about **15 %** of the pension portfolio’s $9.1 billion total, but roughly **30 %** of the other post‑retirement portfolio’s $0.46 billion total, indicating a markedly higher allocation in the latter.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The ground truth states that the two tables report $1,412 million and $1,541 million in U.S. Treasuries and agencies, totaling $2,953 million. However, the LLM incorrectly identifies the second amount as $138 million (which is actually the Level 2 portion of the first table, not the total of the second table). This leads to a grossly incorrect combined total of approximately $1.55 billion instead of $2,953 million. (2) The calculation is therefore flawed: $1,412M + $138M = $1,550M is wrong because the $138M is not a separate investment total but part of the first table’s breakdown. The correct sum is $1,412M + $1,541M = $2,953M. Additionally, the percentages cited (15% and 30%) are not requested in the question and are based on incorrect assumptions about which portfolios are being compared. (3) The multi-hop reasoning fails because the model misidentifies the second data point—it confuses a subcomponent (Level 2 value) with the total from the second table. It also introduces portfolio allocation percentages not asked for, while omitting the required comparison between Level 1 and Level 2 distributions across the two tables. (4) The contextual relevance is moderate because the answer addresses fair value and references the correct filing and types of investments, but the core quantitative and comparative analysis is incorrect. Due to major factual and computational errors, the correctness score is low at 3, with similarly low scores for quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 430,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "\nNike’s timed‑deposit balance that is classified as cash and cash equivalents fell from **$502 million in fiscal 2023** to **$347 million in fiscal 2024**, a decrease of **$155 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the decrease in Nike's timed deposits classified as cash and equivalents from fiscal year 2023 to 2024 is correctly stated as $155 million. (2) Quantitative accuracy is perfect — the LLM provides the exact starting value ($502 million in 2023) and ending value ($347 million in 2024), and the calculated difference ($502M - $347M = $155M) is correct. Minor formatting with thin spaces ( ) does not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies Nike, the specific financial item (timed deposits classified as cash and equivalents), and compares the values across the two fiscal years. (4) The answer is semantically equivalent to the original, with added detail (specific year values) that improves clarity without introducing error. All entities (Nike, fiscal years 2023 and 2024, cash equivalents classification) are accurate. No errors in reasoning, calculation, or relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1066,
        "completion_tokens": 292,
        "total_tokens": 1358
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "\nIn 2023 the combined depreciation, depletion, amortization and impairments for the Alaska and Lower 48 segments were $1,061 million + $5,729 million = $6,790 million. In 2022 the same combined total was $941 million + $4,854 million = $5,795 million, representing an increase of $995 million (about 17 %).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 2023 total of $6,790 million is accurately calculated from the sum of $1,061 million (Alaska) and $5,729 million (Lower 48), and the 2022 total of $5,795 million is correctly derived from $941 million + $4,854 million. The year-over-year increase of $995 million is accurate ($6,790M - $5,795M = $995M), and the added percentage increase of ~17% is a reasonable approximation (995 / 5795 ≈ 17.17%), which enhances the answer without contradicting the ground truth. (2) The answer is complete, addressing both the 2023 total, the 2022 total, and their comparison. (3) Entities—Alaska and Lower 48 operations, the correct financial metric (depreciation, depletion, amortization, and impairments), and the years 2022 and 2023—are all correctly identified and used. (4) The multi-hop reasoning is sound: the model correctly pulled segment-level data for two years, summed across segments, and computed the year-over-year change, demonstrating accurate synthesis across multiple data points. The answer is semantically equivalent to the ground truth, with added clarity in showing the component values. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 343,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "\nAs of December 31 2022, the crypto‑asset safeguarding liability and the related safeguarding asset were each recorded at a fair value of **$604 million**. In the fair‑value disclosures (Note 9), these items appear in the “Financial assets and liabilities measured at fair value on a recurring basis” table under Level 2, listed as “Crypto asset safeguarding asset” and “Crypto asset safeguarding liability,” each shown at $604 million, and they are reflected on the balance sheet in prepaid expenses/other current assets and accrued expenses/other current liabilities, respectively.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022, is accurate, with proper formatting. (2) The answer correctly identifies that both items are reported in the fair value disclosures (Note 9) under 'Financial assets and liabilities measured at fair value on a recurring basis' and are categorized within Level 2 (Significant Other Observable Inputs), which aligns with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about the balance sheet classification (prepaid expenses/other current assets and accrued expenses/other current liabilities) and links it to the fair value hierarchy disclosure, demonstrating understanding across financial statements and notes. (4) The answer is semantically equivalent to the ground truth, providing additional but accurate contextual detail (e.g., balance sheet line items) without introducing errors. All entities—PayPal Holdings, Inc., the correct date, the correct financial instruments, and disclosure location—are accurately identified and correctly used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 346,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "\nWalmart paid $3.5 billion to acquire additional PhonePe shares (and settle related liabilities) during fiscal 2024, but it also received $0.7 billion from new equity‑funding rounds in PhonePe.  The net cash result of those ownership‑change transactions was therefore a **$2.8 billion cash outflow** for the year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Walmart paid $0.9 billion to increase its ownership in PhonePe, but the LLM claims it paid $3.5 billion, which is materially incorrect. The inflow from new equity funding ($0.7 billion) is correctly stated. However, due to the incorrect outflow figure, the net cash outflow is calculated as $2.8 billion instead of the correct $0.2 billion. (2) Quantitative accuracy is severely compromised: the $3.5 billion outflow is unsupported by the ground truth and introduces a major calculation error. The correct calculation should be $0.9B outflow - $0.7B inflow = $0.2B net outflow, not $2.8B. (3) While the model correctly identifies the two components of the transaction (cash outflow for ownership increase and inflow from equity funding), it fails in the multi-hop synthesis of accurate figures from the source data. The reasoning structure is sound—calculate net impact from two cash flows—but based on incorrect data. (4) Contextual relevance is high because the answer addresses the right entities (Walmart, PhonePe), time period (fiscal 2024), and financial events (ownership change, equity funding). However, the severe numerical inaccuracies drastically reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 361,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "\nTotal wholesale revenues fell by roughly **$8 million** (from $484 million in 2023 to $476 million in 2024). The IIC‑approved affiliate sales mechanism drove a **$79 million increase** in affiliate wholesale revenue, but this was more than offset by a **$87 million decline** in non‑affiliate wholesale revenue, producing the modest overall decrease.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that total wholesale revenues decreased by $8 million, whereas the ground truth indicates a net increase of $69 million. This fundamental error in direction (decrease vs. increase) and magnitude ($8M vs. $69M) severely undermines factual correctness. The LLM correctly identifies a $79 million increase in affiliate sales and an $87 million decrease in non-affiliate sales, but fails to incorporate the additional $77 million increase in wholesale revenues from another segment mentioned in the ground truth, leading to an incomplete and incorrect total. (2) Numeric values for the $79M affiliate increase and $87M non-affiliate decrease are accurate, but the absence of the $77M increase from another segment results in a flawed net calculation. The LLM’s implied net change of -$8M (from $484M to $476M) does not align with the ground truth’s $69M increase. (3) The multi-hop reasoning is partially sound in recognizing the offsetting effect between affiliate and non-affiliate sales, but fails to synthesize all three revenue components required for the correct total. The model misses a critical segment of revenue growth, indicating incomplete information integration across sources. (4) While the IIC-approved mechanism is correctly linked to the $79M affiliate increase and described as influencing pricing, the explanation lacks mention of the 165.5% volume increase in KWH sales and marginal cost pricing stabilization, reducing qualitative accuracy. Contextually, the answer addresses the core question elements—revenue change and mechanism impact—but with significant factual errors, warranting moderate relevance but low correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 462,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "\nIntel’s IDM 2.0 manufacturing expansion calls for roughly **$20 billion for two new fabs in Arizona**, **more than $20 billion for two leading‑edge fabs in Ohio**, and **about $10.5 billion to equip its Rio Rancho (New Mexico) and Malaysia advanced‑packaging sites**.  Altogether, these announced investments total **approximately $50 billion (over $50.5 billion)** in capital spending for the company’s global manufacturing footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only minor imprecision in the total sum. (1) All individual investment figures are correct: $20 billion for Arizona, more than $20 billion for Ohio, and $10.5 billion for Rio Rancho and Malaysia packaging sites. (2) The total is stated as 'approximately $50 billion (over $50.5 billion)', which is slightly less precise than the exact $50.5 billion in the ground truth. While the components sum correctly ($20B + $20B + $10.5B = $50.5B), the final total is downrounded and described as 'approximately $50 billion', which underrepresents the precision of the source data. However, the parenthetical note 'over $50.5 billion' aligns closely with the truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes investments across three geographic and operational segments (Arizona, Ohio, and global packaging sites) under the IDM 2.0 strategy. (4) Entities (Intel, IDM 2.0, locations, fab types) are accurately identified. The answer is fully relevant and addresses all parts of the question. The minor loss in quantitative accuracy is due to rounding the total, though the component numbers are exact. Hence, a 9/10 correctness score is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 348,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "\nDanaher recorded roughly **$3.9 billion of goodwill** in connection with its acquisition of Abcam.  \n\nPrior to the Veralto distribution, the separation generated about **$2.6 billion of net cash** to Danaher, which it used to redeem approximately **$1 billion of commercial paper** and to help meet bond‑maturity and dividend obligations, thereby strengthening the company’s cash position before the distribution date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $3.9 billion goodwill from Abcam acquisition and $2.6 billion net cash received from Veralto prior to distribution, with $1 billion used to redeem commercial paper—these match the original answer exactly, allowing for format variation. (2) The answer addresses both parts of the multi-hop question: goodwill from Abcam and cash impact of Veralto separation. (3) Entities are correctly identified: Danaher, Abcam, and Veralto, with accurate financial terms (goodwill, net cash, commercial paper). (4) The reasoning is sound: it correctly links the cash inflow from Veralto to the redemption of debt and other obligations, which strengthens the cash position—this is consistent with the original answer’s implication of cash usage. The only minor difference is the addition of 'bond-maturity and dividend obligations' as additional uses of cash, which is plausible and contextually reasonable but not explicitly stated in the ground truth. This slight expansion does not contradict the original and adds minor contextual detail without introducing error. Thus, the answer is factually correct and complete, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 348,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "\nThe company recognized a **$24 million net gain in income** from foreign‑exchange forwards and options during fiscal 2024.  This gain is modest relative to the fair‑value of the derivatives on the balance sheet—**$343 million of derivative assets and $151 million of derivative liabilities** (combined roughly $494 million) as of May 31, 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $24 million net gain from foreign exchange forwards and options in fiscal year 2024, which matches the ground truth. However, the fair value of derivative assets and liabilities is incorrect: the LLM reports $343 million in assets and $151 million in liabilities, whereas the ground truth states $557 million in assets and $180 million in liabilities. These numbers are significantly off, affecting the quantitative accuracy. (2) The calculation of the combined fair value is arithmetically correct in the LLM answer ($343M + $151M = $494M), but since the inputs are wrong, the conclusion about relative size is based on inaccurate data. The ground truth combined value is $737 million ($557M + $180M), which is much higher than the $494M cited. (3) The multi-hop reasoning is sound in structure—linking income statement gains to balance sheet fair values—and the qualitative assessment that the gain is 'modest relative to' the fair value aligns with the original answer’s logic. However, the incorrect balance sheet figures undermine the validity of the comparison. (4) The entity (Nike, implied by context), metric (foreign exchange derivatives), and fiscal year (2024) are all accurate. The answer is well-structured and relevant, but the major error in quantitative data limits correctness. Thus, correctness is partially compromised due to incorrect asset/liability values despite correct gain figure and reasonable interpretation framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 412,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "\nThe 2022 discounted future net cash flows for the Lower 48 region total $55,912 million (all from consolidated operations; equity affiliates contribute none), which is about 11.5 times the $4,854 million of depreciation, depletion, amortization and impairments recorded for that region in 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key figures—$55,912 million for discounted future net cash flows and $4,854 million for depreciation, depletion, amortization, and impairments—are accurately reported, with acceptable formatting (e.g., using 'million' and comma-free large numbers). The comparison ratio of approximately 11.5 times is correctly calculated: 55,912 / 4,854 ≈ 11.52, which rounds to 11.5. (2) The answer is complete, addressing both parts of the question: the combined total of cash flows (noting zero contribution from equity affiliates) and the comparison to DD&A and impairments. (3) Entity and metric accuracy is perfect—'Lower 48 region', '2022', 'consolidated operations', and 'equity affiliates' are all correctly referenced. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it combines data from consolidated operations and equity affiliates (with correct attribution of zero for the latter), then compares the total future cash flows to the historical cost figure, correctly interpreting the relationship. (5) The semantic meaning is equivalent to the original answer, even though the wording is more concise and includes the explicit ratio (which adds clarity). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 369,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "\nPayPal reported **$563 million** of Loans and Interest Receivable — Held for Sale as of December 31 2023.  This fair‑value amount is classified as Level 3 in the hierarchy, meaning it is derived from significant unobservable inputs (e.g., the price the company expects to receive from the global investment firm under the sale agreement).  Consequently, the reported figure reflects a fair‑value estimate based on those non‑market, judgment‑heavy inputs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023, is accurate, with proper formatting and date. (2) The answer correctly identifies that this amount is classified as Level 3 in the fair value hierarchy, meaning it is based entirely on significant unobservable inputs—this aligns precisely with the original answer. (3) The reasoning is sound: the LLM correctly synthesizes that the fair value measurement relies on non-market, judgment-based inputs (e.g., expected sale price to an investment firm), which is consistent with Level 3 classification. (4) The response addresses both parts of the multi-hop question: the total value and its comparison to fair value based on unobservable inputs. Semantic equivalence is maintained, with slightly expanded context (e.g., mention of a sale agreement) that does not introduce inaccuracies. All entities—PayPal, the financial metric, the date, and the fair value hierarchy level—are correctly identified and used. No errors in fact, calculation, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 325,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "\nDuring 2023 the company borrowed **$3.0 billion** and repaid **$6.1 billion** of revolving indebtedness under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility it borrowed **$3.1 billion** and repaid **$2.6 billion** of revolving indebtedness. Thus, the Multicurrency facility experienced a net repayment of about $3.1 billion, whereas the Credit Facility resulted in a modest net borrowing of roughly $0.5 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $3.0 billion borrowed and $6.1 billion repaid under the 2021 Multicurrency Credit Facility, and $3.1 billion borrowed and $2.6 billion repaid under the 2021 Credit Facility. These match the original answer exactly. (2) Calculations are correct: net repayment of $3.1 billion ($6.1B - $3.0B) for the Multicurrency facility and net borrowing of $0.5 billion ($3.1B - $2.6B) for the Credit Facility are accurately reflected, with appropriate rounding language ('about', 'roughly') semantically acceptable. (3) Multi-hop reasoning is sound—the response correctly distinguishes between two separate credit facilities and synthesizes borrowing and repayment data for each during the same period (year ended December 31, 2023), as required by the question. (4) Entities are correctly identified: both facilities are named accurately, and the time period is correctly referenced. (5) The answer is complete, addressing both parts of the question: amounts borrowed/repaid for each facility and their comparison via net activity. Wording differs slightly but maintains full semantic equivalence. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 351,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "\nThe auditors tested the effectiveness of each company’s controls over management’s assessment of the likelihood that incurred costs would be recovered in future rates, would be subject to refunds, or would be disallowed, and they read the relevant regulatory orders and other public filings to evaluate those judgments; they also inspected the underlying cost records for regulatory‑asset/‑liability balances and obtained management representations on recoverability. These steps highlight the inherent subjectivity, because the outcome depends on uncertain future regulatory decisions and assumptions about how the Commissions will treat similar costs under comparable circumstances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies the audit procedures applied to both Georgia Power and Mississippi Power: testing management's controls over the assessment of cost recovery, refunds, or disallowances; reviewing regulatory orders and public filings; inspecting cost records for regulatory assets/liabilities; and obtaining management representations. These align with the ground truth, which emphasizes control testing and review of regulatory precedents. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes that similar procedures were applied across both entities and links them to the subjectivity in forecasting future regulatory outcomes. The only minor shortcoming is that the LLM adds detail not present in the original (e.g., 'inspected underlying cost records', 'obtained management representations') which, while plausible and consistent with auditing standards, are not explicitly stated in the ground truth. This slightly affects qualitative precision but does not introduce inaccuracy. (4) The answer fully addresses both parts of the question—specific procedures and their reflection of subjectivity—and clearly explains how future regulatory uncertainty introduces judgment into the process. Thus, it is contextually excellent and semantically equivalent to the original, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 435,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "\nThe 2023 collapse of Comirnaty sales—down roughly 70 % to $11.2 bn (from $37.8 bn in 2022)—cut total revenue by about $26 bn, forced a $9.4 bn reduction in cost of sales and triggered a $6.2 bn non‑cash inventory write‑down, sharply lowering Pfizer’s margins and prompting a shift to commercial‑market pricing.  Under the BioNTech collaboration, Pfizer shares R&D costs, records gross vaccine revenue in the markets it commercializes, and pays BioNTech tiered royalties (14‑22 % of sales) plus up‑to $100 m in sales milestones; these royalty and milestone obligations, together with the equity stakes held in BioNTech and the profit‑sharing arrangement, create ongoing cash‑outflows that will affect future earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses both parts of the multi-hop question: the impact of Comirnaty's revenue decline on Pfizer's operational results and the financial obligations stemming from the BioNTech collaboration. (1) Quantitatively, the LLM correctly identifies the 70% drop in Comirnaty revenue, with accurate figures: $11.2 billion in 2023 vs. $37.8 billion in 2022 (matching ground truth: $11,220M and $37,806M). The implied $26.6 billion revenue drop is reasonable. It adds specific financial impacts—$9.4 billion reduction in cost of sales and a $6.2 billion inventory write-down—which are plausible and contextually relevant but not present in the original answer; these are not incorrect but represent additional detail not confirmed in the ground truth, slightly reducing quantitative precision. (2) The royalty range (14–22%) and up to $100 million in sales milestones are not explicitly in the original answer, which only mentions 'tiered royalties' and 'profit sharing' without specifics. These details may be accurate but are not supported by the provided ground truth, introducing unverified specifics. (3) The qualitative reasoning is sound: the LLM correctly links declining revenue with margin pressure and commercial transition, and accurately describes Pfizer's ongoing obligations (profit sharing, royalties, R&D cost sharing) despite revenue drop. It correctly notes Pfizer's global commercialization rights (with exclusions implied via context). (4) Contextual relevance is excellent—the answer directly addresses operational impacts and future financial obligations as required. Minor deductions in quantitative and qualitative accuracy are due to inclusion of unverified specifics (exact royalty rates, milestone amounts, inventory write-down) not in the ground truth, though they do not contradict it. Overall, core facts and synthesis are correct, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 519,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "\nThe Company held $35 million of U.S. Agency securities in short‑term investments as of May 31 2024, down from $46 million held as of May 31 2023. This represents a year‑over‑year decrease of $11 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $35 million as of May 31, 2024, down from $46 million as of May 31, 2023, resulting in an $11 million year-over-year decrease. The calculation (46 - 35 = 11) is correct. (2) The answer is complete, addressing the year-over-year change, the two relevant dates, and the specific asset class (U.S. Agency securities) held as short-term investments by NKE. (3) Entity accuracy is correct: NKE is properly identified, and the time periods (May 31, 2024 and May 31, 2023) match the question. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by comparing values across two fiscal years and computing the change. (5) The semantic meaning is equivalent to the original answer, with only minor wording differences (e.g., 'down from' vs 'decreased by'). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1100,
        "completion_tokens": 272,
        "total_tokens": 1372
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "\nThe Guaranteed Senior Notes issued by Costco’s Japanese subsidiary did not have any new issuances during 2024; the only movement was a repayment of $77 million. Consequently, the total principal amount of those notes fell by $77 million in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states there was a net increase of $423 million in the total principal amount of Guaranteed Senior Notes in 2024 due to new issuances and repayments. The LLM incorrectly claims there were no new issuances and only a $77 million repayment, leading to a decrease. This contradicts the ground truth. (2) The quantitative values are wrong: the LLM reports a $77 million repayment and no issuances, while the correct net change is an increase of $423 million. Even if partial data were correct, the direction of change (decrease vs. increase) is fundamentally wrong. (3) The multi-hop reasoning failed: the model did not correctly synthesize information about both issuances and repayments for Costco's Japanese subsidiary in 2024. It missed the new issuances entirely, which are critical to computing the net change. (4) The contextual relevance is low but not zero because the answer addresses the right entity (Costco’s Japanese subsidiary) and the right instrument (Guaranteed Senior Notes) and time period (2024), but all substantive content is incorrect. Hence, correctness, quantitative, and qualitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1106,
        "completion_tokens": 340,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "\nThe Company had $0.5 billion of stand‑alone letters of credit, bank guarantees and other similar instruments outstanding at December 31 2024 [page 68], whereas cash, cash equivalents and marketable securities held in the United States were about $4.2 billion [page 67]. In other words, the letters‑of‑credit amount is roughly 12 % of the U.S. cash and marketable‑securities balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) All key facts are correct: $0.5 billion in stand-alone instruments and $4.2 billion in U.S. cash, cash equivalents, and marketable securities as of December 31, 2024, are correctly reported. (2) The percentage calculation is accurate: 0.5 / 4.2 ≈ 11.9%, and the LLM's 'roughly 12%' is a reasonable rounding and semantically equivalent. (3) The multi-hop reasoning—comparing two distinct figures from different parts of the filing (pages 68 and 67 cited)—is sound and correctly synthesized. (4) Entity accuracy is perfect: 3M (implied as 'The Company'), correct date, correct financial instruments and liquidity categories. The only minor shortcoming is the lack of explicit attribution to 3M in the answer (though contextually clear), and 'letters-of-credit amount' slightly underspecifies the full set of instruments, but this does not detract from correctness. Overall, the answer is factually complete, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 297,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "\nIn Q4 2023 Meta estimated that duplicate accounts accounted for roughly **10 %** of its worldwide MAUs, while false accounts made up about **4 %** of worldwide MAUs. Thus, duplicate accounts were estimated to be roughly **6 percentage points higher** (about two‑and‑a‑half times) the share of false accounts in that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key percentages from the ground truth: 10% for duplicate accounts and 4% for false accounts of Meta's worldwide MAUs in Q4 2023. These values are factually accurate and match the original answer exactly. (2) The quantitative accuracy is perfect—both percentages are correct, and the statement that duplicate accounts were '6 percentage points higher' is mathematically accurate (10% - 4% = 6 pp). The claim that duplicates were 'about two-and-a-half times' the share of false accounts is a reasonable approximation (10 / 4 = 2.5), though the original answer stated 'more than twice as prevalent,' which is also correct but slightly more conservative. This minor difference in phrasing does not constitute an error but reflects a slightly different way of expressing the ratio. (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct metrics (duplicate vs. false account prevalence) for the same company (Meta), same time period (Q4 2023), and same user base (worldwide MAUs), then compares them appropriately. (4) All entities—Meta, MAUs, Q4 2023, duplicate accounts, false accounts—are correctly identified and contextualized. The answer is fully relevant and conveys the same core information as the ground truth with only slight variation in comparative phrasing. Thus, the answer earns a 9/10 for correctness due to the precise match in data and logic, with only a minor stylistic difference in interpretation of the ratio.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 414,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "\nPfizer paid a $75 million upfront cash payment to BioNTech for the shingles mRNA‑vaccine collaboration, whereas the upfront cash payment it made to Biohaven for exclusive migraine‑treatment rights outside the United States was $150 million—roughly double the BioNTech amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the $75 million upfront payment to BioNTech for the shingles mRNA vaccine collaboration and the $150 million upfront to Biohaven for migraine treatment rights outside the U.S. are correctly stated. (2) Quantitative accuracy is perfect—both amounts match the ground truth, and the comparison (double the BioNTech amount) correctly reflects the 2x difference, which aligns with the $75 million difference noted in the original answer. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two separate deals involving Pfizer, BioNTech, and Biohaven, identifying the correct context for each transaction. (4) The answer is contextually relevant, complete, and conveys the same core conclusion as the original—namely, that the Biohaven upfront payment was larger by $75 million, or twice the amount paid to BioNTech. Minor wording differences (e.g., 'double' vs. 'resulting in a $75 million difference') do not affect factual equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 308,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "\nAs of May 31 2024, the company’s consolidated balance sheet reports a **$120 million liability** for foreign‑exchange forwards and options. This total includes **$115 million** for derivatives that are designated as hedging instruments and **$5 million** for those that are not designated as hedges.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the total liability amount. The ground truth states the total is $115 million ($110M hedging + $5M non-hedging), but the LLM reports $120 million ($115M + $5M), incorrectly summing to $120M instead of $115M. This indicates a miscalculation or misreporting of the components. (2) While the non-hedging instrument liability is correctly stated as $5 million, the hedging portion is reported as $115 million—$5 million too high—and contradicts the original answer’s $110 million. The total should have been $115 million, not $120 million. (3) The multi-hop reasoning is partially sound: the model correctly distinguishes between hedging and non-hedging instruments and attempts to aggregate them, showing understanding of the required synthesis. However, the incorrect assignment of values undermines the conclusion. (4) Contextual relevance is perfect—the response addresses the exact question, time period (May 31, 2024), and instrument types. Due to the significant quantitative error in both the total and the component values, the correctness score is reduced to 6, reflecting partial accuracy with major factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 334,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "\nPayPal records a “crypto‑asset safeguarding liability” equal to the fair value of the crypto that customers hold on its platform, and it must maintain a corresponding safeguarding asset to meet that obligation; this liability is highlighted in the “Risk Concentrations” note together with its cash, customer‑account and loan exposures.  Because a sizable share of the company’s liabilities is tied to customer‑held crypto, any decline in crypto prices or failure of custodial partners creates a credit‑risk exposure that mirrors the risk it already reports for cash and customer balances—i.e., the company could be required to absorb losses if it cannot recover or reimburse those crypto assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and implication, particularly regarding the source of PayPal's credit risk. (1) The answer correctly identifies that PayPal recognizes a crypto-asset safeguarding liability and links it to risk concentrations, which aligns with the original answer. It also correctly notes that this liability is disclosed alongside other financial exposures. However, it incorrectly implies that PayPal faces direct credit risk from crypto price declines or custodial partner failures, which contradicts the ground truth. The original answer clarifies that crypto assets themselves are not PayPal's assets nor a source of credit risk to the company; instead, the risk arises from where customer funds (fiat) are held—i.e., in financial institutions whose balances may exceed FDIC insurance limits. (2) There are no numerical values in the question or answers, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning fails: the LLM incorrectly synthesizes the connection between crypto price volatility and PayPal’s credit risk, when in fact the company’s exposure is to institutional credit risk via cash holdings, not crypto valuation or custodial failure of digital assets. The safeguarding asset/liability mechanism is symmetrical and does not expose PayPal to net loss unless the fiat reserves backing the crypto are lost. (4) Despite correct terminology and contextual placement, the core implication about credit risk is flawed, warranting a moderate correctness score. The answer is contextually relevant and uses accurate financial language, but the qualitative inaccuracy in risk attribution reduces its overall reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 470,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "\nThe company issued **689,202 LTIP units net of forfeitures** under the 2019 Stock Incentive Plan. For the year ended December 31 2024, the filing states that “no securities had a material dilutive effect,” so these LTIP units did not materially increase diluted shares or require an adjustment to weighted‑average shares outstanding.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that 689,202 LTIP units were issued net of forfeitures under the 2019 Plan, matching the original answer exactly. (2) The quantitative accuracy is perfect: the number 689,202 is correct, and the date (year ended December 31, 2024) is correctly referenced. (3) The qualitative reasoning is sound: the LLM correctly identifies that while LTIP units are considered potentially dilutive securities, they did not have a material dilutive effect, citing the exact language from the filing (\"no securities had a material dilutive effect\"). This demonstrates proper multi-hop synthesis—linking the issuance of units to their accounting treatment and impact on dilution. (4) The answer is contextually relevant, addressing both parts of the question: the number of units issued and their impact on stock dilution. Minor wording differences (e.g., 'did not materially increase diluted shares' vs. 'did not have a material dilutive effect') do not affect factual equivalence. All entities—2019 Plan, LTIP units, December 31, 2024—are correctly identified and used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 327,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "\nIn 2024, manufactured PFAS products contributed $0.28 to earnings per diluted share, whereas in 2022 the same items added $0.90 per share—so the 2024 impact was roughly $0.62 lower.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of the financial impact. The ground truth states that PFAS products reduced earnings per diluted share by $0.20 in 2024 and $0.90 in 2022. However, the LLM claims PFAS contributed positively—$0.28 in 2024 and $0.90 in 2022—implying a benefit rather than a cost, which is factually wrong. This reverses the entire meaning of the financial impact. (2) The numbers themselves are inaccurate: $0.28 (LLM) vs $0.20 (truth) for 2024, and while $0.90 matches for 2022, the interpretation as a positive addition is wrong. The calculated difference of $0.62 lower in 2024 is based on incorrect premises and does not align with the actual reduction of $0.70 less impact in 2024 vs 2022 ($0.90 - $0.20). (3) The multi-hop reasoning fails: the model does not recognize that the impact is negative (a reduction) in both years, and thus cannot correctly compare them. It also omits the combined $1.10 total impact mentioned in the original answer. (4) Scores are low due to major factual and directional errors in financial impact, though the answer is contextually relevant by addressing the right company, metric, and years, and attempting a comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 344,
        "total_tokens": 1450
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "\nThe 2024 volume of KWH sold to non‑affiliates fell 30.8 % (about a $87 million hit to wholesale revenue), while the volume sold to affiliates jumped 165.5 % (adding roughly $79 million).  Because these sales are governed by the Intercompany Interchange Contract, the loss of non‑affiliate volume outweighed the affiliate gain, leaving total wholesale revenue essentially flat (down slightly from $484 million in 2023 to $476 million in 2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 30.8% drop in non-affiliate KWH volume and the $87 million decrease in revenue, as well as the 165.5% increase in affiliate volume and $79 million revenue gain. These figures match the ground truth. However, the LLM introduces a specific total wholesale revenue figure of $476 million in 2024 (down from $484 million), which is not present in the original answer and cannot be verified from the provided ground truth. While the direction of the net impact (slight decline) aligns with the original, the exact totals are unsupported, representing a minor factual overreach. (2) All percentages and dollar impacts are accurate and consistent with the ground truth. The calculation of net revenue change (~$87M loss offset by ~$79M gain) is reasonable, but the derivation of exact totals ($484M to $476M) is speculative and not in the original. (3) The reasoning correctly synthesizes the multi-hop elements: volume changes, revenue impacts, and the role of the IIC in enabling affiliate sales. However, it omits the key contextual detail that the non-affiliate decline was due to power agreements ending in May 2023, and that the IIC is FERC-approved—important for explaining *why* the affiliate sales could increase. This weakens the qualitative depth. (4) The answer is contextually relevant and addresses the core question about volume changes and overall revenue impact. Scores reflect high quantitative accuracy but partial completeness and reasoning due to unsupported totals and missing explanatory context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 430,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of €1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "\nThe Irish Data Protection Commission levied an administrative fine of **€1.2 billion** and issued corrective orders that require Meta Ireland to suspend the relevant cross‑border data transfers and bring its processing into compliance with Chapter V of the GDPR (including ceasing the unlawful storage of EU‑EEA user data in the United States).  To meet those orders Meta will need to redesign its data‑transfer mechanisms, implement additional technical and organisational safeguards, and maintain ongoing compliance monitoring—steps that are expected to **raise its operational costs in Europe** through higher legal, engineering and compliance expenditures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) Quantitative accuracy: The financial penalty of €1.2 billion is correctly stated, matching the original answer. No other numerical values or calculations are involved. (2) Completeness: The LLM addresses both parts of the question—first, the total financial penalty (€1.2 billion), and second, the impact on Meta's operational costs in Europe. (3) Entity accuracy: 'Irish Data Protection Commission', 'Meta Ireland' (referring to Meta Platforms Ireland), 'Chapter V of the GDPR', and 'EU-EEA user data' are all correctly identified and contextually accurate. (4) Reasoning: The LLM correctly synthesizes the implications of the corrective orders—suspending unlawful data transfers and ceasing processing of EEA data in the U.S.—and logically infers that compliance would require operational changes (e.g., redesigning data-transfer mechanisms, implementing safeguards, ongoing monitoring), which would increase legal, engineering, and compliance costs. This aligns with and expands upon the original answer’s statement about increased cost and complexity. (5) Semantic equivalence: While the LLM provides slightly more detail (e.g., specifying types of expenditures), the core information and meaning match the ground truth exactly. No factual discrepancies or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 377,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "\nThe Home Depot’s deep, job‑lot‑size product assortments give professional customers the breadth and quantity of specialized items they need for complex projects, reinforcing its positioning as the product authority for Pros. The company warns that if this depth and availability are not maintained, it would lose its competitive edge, reduce demand from Pros, shrink market share and profitability, and expose the business to reputational and supplier‑relationship risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor additions that do not contradict the original. (1) Correctness: The core elements—product depth and job lot quantities supporting Pros' complex needs—are accurately captured. The risks of not maintaining these offerings (reduced demand, lower profitability) align with the original. The LLM adds 'market share' and 'reputational and supplier-relationship risks,' which are reasonable inferences consistent with the document's tone but not explicitly stated in the ground truth; this does not make the answer incorrect but slightly extends beyond the provided facts. (2) Quantitative Accuracy: No specific numbers, dates, or calculations are involved in the question or answers, so this criterion is fully satisfied by both. (3) Reasoning: The multi-hop logic—linking product depth and job lot sizes to Pro customer needs, then identifying competitive risks if not maintained—is sound and correctly synthesized from the implied strategy and risk factors. (4) Contextual Relevance: The response directly addresses both parts of the question: how product depth supports Pros and the risks of failing to maintain it. Overall, the answer is highly accurate, complete, and relevant, warranting a 9 due to the slight expansion on risks without overstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 374,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the company’s ability to readily redeem these investments.",
      "llm_answer": "\nThe participating interest in the insurance annuity contracts is reported at $83 million as of December 31 2021 and $94 million as of December 31 2020, for a combined total of $177 million. Because these interests are valued using a mix of market data, recent transactions and actuarial present‑value calculations with limited observable inputs, they are excluded from the regular fair‑value hierarchy, indicating that valuing them involves considerable complexity and significant judgment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $94 million (as of December 31, 2020) and $83 million (as of December 31, 2021) are accurately reported, and their sum ($177 million) is correctly calculated. Minor formatting differences (e.g., use of thin space) do not affect accuracy. (2) The answer addresses both parts of the question: it provides the total value and explains the implication of the exclusion. (3) Entities—specifically the time periods (December 31, 2020 and 2021) and the nature of the investments (participating interest in insurance annuity contracts)—are correctly identified. (4) The reasoning is sound: the explanation that these investments are excluded due to limited observable inputs and the use of actuarial models aligns with the ground truth’s emphasis on complexity and lack of market data. The LLM correctly synthesizes multi-hop information across two reporting periods and infers the rationale for exclusion, demonstrating strong qualitative and contextual accuracy. All elements are factually correct and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 325,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "\nPayPal projects credit‑loss allowances by overlaying historical loss‑curve patterns with externally‑sourced macro‑economic forecasts; the resulting loss‑rate estimates are applied to the outstanding principal of each portfolio. For merchant receivables the forecasts focus on macro indicators such as unemployment trends and retail‑e‑commerce sales (used over a 2.5‑ to 3.5‑year horizon), while for consumer receivables—particularly revolving credit—the models incorporate household disposable‑income trends, unemployment rates and retail‑e‑commerce sales (applied over roughly 5‑ to 7‑year periods) to set the allowance for expected credit losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in specificity. (1) Correctly identifies that PayPal uses loss curves combined with macroeconomic forecasts to estimate credit loss allowances for both merchant and consumer receivables. The key macroeconomic factors are accurately reported: unemployment trends and retail e-commerce sales for merchant receivables; household disposable income, unemployment rates, and retail e-commerce sales for consumer revolving credit. This matches the original answer, though the LLM adds unemployment rates to consumer receivables, which is not explicitly stated in the ground truth but is not incorrect—just slightly broader. (2) The LLM introduces time horizons (2.5–3.5 years for merchant, 5–7 years for consumer), which are not present in the original answer. While plausible and consistent with financial modeling practices, these specific durations are not verifiable from the ground truth and represent an addition. This prevents a perfect score but does not undermine correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes the use of loss curves, application by receivable type, linkage to macroeconomic factors, and the ultimate impact on allowance calculations. (4) Semantic equivalence is strong—wording differs but meaning aligns. The answer is fully contextually relevant, directly addressing how loss curves and macroeconomic forecasts impact allowances and specifying the factors per category. Minor over-specification of time horizons and inclusion of unemployment in consumer models (not explicitly stated) are small deviations but do not introduce factual errors. Thus, high scores across all dimensions with correctness docked slightly for unverified quantitative additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 493,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operations—such as extreme weather, pandemics, or labor issues—could delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "\nCostco’s heavy reliance on the Kirkland Signature brand and on the manufacturing and distribution facilities that produce its private‑label goods makes the company vulnerable: a quality issue, recall, or supply‑chain disruption can quickly damage member trust and reduce the loyalty that drives repeat visits, while any resulting need to raise prices or offer discounts to protect that trust will compress the higher‑margin private‑label sales that the brand is meant to generate. Consequently, threats to brand loyalty can directly erode the gross‑margin advantage that Kirkland Signature is supposed to deliver.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: Costco's investment in Kirkland Signature supports higher margins and differentiation; reliance on manufacturing and distribution facilities creates vulnerability; disruptions could affect product availability, quality, brand loyalty, and gross margins. The LLM correctly identifies risks such as supply-chain disruptions, quality issues, and recalls—consistent with the types of operational disruptions (e.g., extreme weather, pandemics, labor issues) mentioned in the original. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly links Costco’s private-label strategy (Kirkland Signature) to margin performance, connects reliance on third-party production to operational risk, and synthesizes how damage to brand loyalty could undermine financial performance. The logic chain—disruption → quality/availability issues → loss of trust → reduced loyalty → margin pressure—is fully aligned with the original. (4) The only reason for not scoring a perfect 10 is that the LLM omits explicit mention of 'processing, packaging, and manufacturing facilities' and specific examples like 'pandemics or labor issues', though it captures the essence with 'supply-chain disruption'. It also does not explicitly state that Kirkland Signature is a 'growing portion of overall sales', which slightly weakens completeness. However, the core causal mechanism and business impact are accurately conveyed. Contextual relevance is perfect—the response directly addresses both brand loyalty and gross margin exposure as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 491,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "\nThe performance‑based LTIP units awarded under the 2021 and 2022 LTI programs had a combined grant‑date fair value of **$39.0 million** ($18.4 million for 2021 plus $20.6 million for 2022), whereas the time‑based restricted stock units granted in those same years totaled **$11.2 million** ($4.3 million in 2021 plus $6.9 million in 2022). Thus, the LTIP units were roughly **$27.8 million (about two‑and‑a‑half times)** larger than the time‑based RSUs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $18.4 million (2021) and $20.6 million (2022) for performance-based LTIP units sum to $39.0 million, and $4.3 million (2021) and $6.9 million (2022) for time-based RSUs sum to $11.2 million—both totals are correctly calculated. (2) The comparison is quantitatively sound: the difference of $27.8 million ($39.0M - $11.2M) is accurate, and stating it is 'about two-and-a-half times' larger is a reasonable approximation (39.0 / 11.2 ≈ 3.48, so 'two-and-a-half times' is slightly conservative but contextually acceptable as a qualitative comparison). (3) The multi-hop reasoning—aggregating values across two years and two types of awards, then comparing them—is correctly executed. (4) All entities (performance-based LTIP units, time-based restricted stock units, 2021 and 2022 LTI Programs) are accurately identified and synthesized. (5) The answer fully addresses both parts of the question: total grant date fair value for performance-based units and comparison to time-based units. Wording differs slightly from the original but maintains full semantic equivalence. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 346,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "\nAs of December 31 2024, the fair‑value of 3M’s U.S. municipal securities is **$20 million**. Because these securities are valued using the carrying value of the related finance‑lease obligation rather than quoted market prices, they are classified as **Level 3** in the fair‑value hierarchy. (Pages 67, 81 & 82)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the fair value of U.S. municipal securities as $20 million, whereas the ground truth is $16 million. This is a significant factual error affecting the core of the question. However, the classification of these securities as Level 3 in the fair value hierarchy is correct. (2) The quantitative inaccuracy is clear: $20 million vs. $16 million is a 25% overstatement with no indication of approximation or rounding. No calculation is required in the question, but the reported figure must match the source. (3) The reasoning for Level 3 classification is sound and reflects correct multi-hop understanding: the valuation methodology relies on the carrying value of the finance lease obligation, which is a non-observable input, justifying Level 3. This shows accurate synthesis of valuation methodology and fair value hierarchy criteria. (4) The contextual relevance is high because the answer addresses both parts of the question and cites relevant pages. However, the incorrect dollar amount severely undermines factual correctness, warranting a low-to-mid correctness score despite accurate reasoning on classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 331,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "\nIn Q4 2023 Meta estimated that roughly 3 percent of its worldwide MAP consisted solely of accounts it classified as “violating” (i.e., accounts used for purposes that breach its terms of service). Because WhatsApp’s end‑to‑end encryption provides only limited data signals—mainly phone numbers and device information—the company must infer violating accounts from indirect cues and cannot count a user who also holds a non‑violating account, making the measurement inherently uncertain and subject to significant variation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 3% figure for violating accounts among Meta's worldwide Monthly Active Users (MAU, referred to as MAP in the question) in Q4 2023 is correct. The percentage matches the original answer exactly, and no other numerical inaccuracies are present. (2) The answer addresses both parts of the multi-hop question: it provides the percentage and explains the challenges in identifying violating accounts on encrypted platforms like WhatsApp. (3) Entity accuracy is strong: Meta, Q4 2023, violating accounts, and WhatsApp are all correctly identified and contextually used. The term 'MAP' is treated appropriately as Monthly Active Users, consistent with Meta's reporting. (4) The reasoning is sound: the LLM correctly explains that end-to-end encryption limits data signals to phone numbers and device information, making detection harder and measurement uncertain—this reflects the core challenge in the ground truth. The addition of 'inherent uncertainty and significant variation' is a slight expansion but is logically consistent with the source. The only minor gap is that the original emphasizes 'reliance on fewer data signals' as increasing difficulty at scale, while the LLM focuses on inference from indirect cues and double-counting limitations. This nuance is present but slightly less emphasized. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 412,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "\nPfizer’s only upfront cash outlay and equity investment to BioNTech were the $75 million upfront payment plus a $150 million equity investment made in the shingles‑vaccine collaboration (a total of $225 million), and no comparable upfront cash or equity payment was made by Pfizer in the Comirnaty (COVID‑19) program; therefore the combined amount for both collaborations remains $225 million (see Collaboration with BioNTech on page 74).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The ground truth states that the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty program was $375 million. However, the LLM claims the total is $225 million, citing only the shingles collaboration ($75 million upfront + $150 million equity investment) and asserting that no upfront or equity payment was made in the Comirnaty program. This contradicts the known facts: in the Comirnaty (COVID-19 vaccine) collaboration, Pfizer did not make an upfront payment, but BioNTech received significant milestone and development payments, and more critically, the knowledge graph ground truth explicitly aggregates both programs to $375 million, implying that the Comirnaty program involved additional financial commitments beyond what the model acknowledges. The LLM fails to account for $150 million of documented investment or payments. The reasoning is flawed, as it does not correctly synthesize the multi-hop information across both collaborations. While the shingles program details ($75M + $150M) may be accurate, the conclusion that the total remains $225M is wrong. The model omits key financial components included in the ground truth, resulting in a major factual and quantitative error. Contextual relevance is moderate as it addresses the right companies and programs, but the core answer is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 400,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "\nOver 2019‑2021 the EMENA segment contributed roughly $31 million to net income (a $24 million credit in 2021, a $6 million charge in 2020 and a $1 million charge in 2019). In contrast, the Lower 48 region posted a net loss of about $1.20 billion during the same period, making EMENA’s contribution negligible compared with the large loss in Lower 48.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that EMENA contributed $31 million to net income, when in fact it had a cumulative net loss of $17 million ($1M + $6M - $24M = -$17M). The characterization of the 2021 EMENA result as a '$24 million credit' is misleading—it was a net loss, not income. Similarly, the Lower 48 region is falsely reported as having a net loss of $1.20 billion, when it actually generated a total net income of $1,206 million. The LLM reverses the performance narrative: Lower 48 was strongly profitable, not loss-making. (2) Calculations are entirely incorrect: EMENA’s total is misrepresented as positive $31M instead of negative $17M; Lower 48’s $1,206M income is wrongly stated as a $1.20B loss. The comparison conclusion is therefore invalid. (3) Multi-hop reasoning failed: the model did not correctly synthesize the annual figures across regions and years, and mischaracterized the direction (profit vs. loss) of results. (4) Scores are low due to severe quantitative and qualitative inaccuracies. Contextual relevance is moderate because the answer addresses the right regions and time frame, but factual correctness is extremely poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 343,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "\nThe “Other noncontrolling redeemable interests” line fell from **$172,912 (thousands) in 2023 to $169,192 (thousands) in 2024**, a **decrease of $3,720 (thousands) – i.e., about $3.7 million**.  \n\nThat $3.7 million reduction is a component of the overall drop in the combined “Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties,” which fell from **$195,949 (thousands) in 2023 to $184,729 (thousands) in 2024**, a total decline of **$11,220 (thousands) ($11.2 million)**; thus the reduction in other noncontrolling redeemable interests accounts for roughly one‑third of the total decrease.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar decrease in 'Other noncontrolling redeemable interests' is accurately calculated as $3,720 thousand (from $172,912k to $169,192k), and the total decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' is correctly identified as $11,220 thousand (from $195,949k to $184,729k). The LLM correctly notes that the $3.7 million reduction accounts for roughly one-third of the total $11.2 million decline, which aligns with the ground truth percentage of approximately 33.1% (3,720 / 11,220 ≈ 0.3315 or 33.15%). (2) The answer addresses both parts of the multi-part question: the specific dollar decrease in the sub-component and its contribution to the overall decrease. (3) All entities—financial line items and years—are correctly identified. (4) The reasoning is sound: the LLM correctly performs multi-hop synthesis by comparing two line items across two years and contextualizes the partial decrease within the larger total decrease. Minor formatting differences (e.g., expressing $3,720 thousand as ~$3.7 million) are acceptable and do not affect factual accuracy. Semantic equivalence is preserved throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 355,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "\nAs of December 31 2024, the combined fair value of foreign corporate debt and asset‑backed securities held by MMM was **$55 million** ($31 million for foreign corporate debt + $24 million for asset‑backed securities).  In the prior year (December 31 2023) the same two categories were reported as **$0 million**, meaning the 2024 balance represents a $55 million increase.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $31 million in foreign corporate debt and $24 million in asset-backed securities sum to $55 million as of December 31, 2024, which is correctly calculated. The prior year (December 31, 2023) combined value is correctly reported as $0 million, with no values in either category. The implied $55 million increase is a valid conclusion. (2) The answer is complete, addressing both parts of the question: the total fair value as of 2024 and the comparison to the prior year. (3) Entities are accurate—MMM is correctly identified, and the asset categories (foreign corporate debt, asset-backed securities) and dates (December 31, 2024 and 2023) are correct. (4) The multi-hop reasoning is sound: the model correctly synthesized data across two asset classes and two years, noting the absence of values in 2023 and the emergence in 2024. (5) The semantic meaning is equivalent to the original answer, with clear, concise, and factually precise wording. Minor phrasing differences (e.g., stating the $55 million increase) add clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 331,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "\nTechnical errors and data limitations—such as incomplete signals from encrypted WhatsApp, reliance on IP and self‑reported location, and the difficulty of matching multiple accounts to unique individuals—cause the machine‑learning models used to estimate Family MAP and ARPP to be uncertain. Meta’s own analysis indicates that the statistical error in these estimates is roughly **3 % of worldwide MAP**, meaning the reported MAP (and the ARPP derived from it) can vary by several percentage points, potentially more in specific markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 3% error margin in Meta's Family metrics estimation process, matching the original answer's key quantitative claim. This percentage is explicitly stated and correctly attributed to Meta's own analysis. (2) The LLM correctly notes that this 3% applies to worldwide MAP, and while it does not compute the 99 million user variance (3.3 billion × 3%), this omission is minor given that the core percentage-based margin is present and sufficient for the question's scope. (3) The reasoning is sound: it acknowledges the use of machine learning models, data limitations (e.g., encrypted WhatsApp, IP reliance, multi-account matching), and the impact on both MAP and ARPP—correctly linking MAP inaccuracies to downstream effects on ARPP calculations. (4) All entities (Meta, Family metrics, MAP, ARPP) are accurate, and the answer addresses all parts of the question: causes of inaccuracies, their effect on metrics, and the approximate margin of error. The only minor shortcoming is the lack of a concrete numerical example (e.g., 99 million users) to illustrate the 3% margin, which slightly reduces completeness but does not undermine factual correctness. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 366,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "\nThe Home Depot defines BOPIS as “Buy Online, Pickup In Store,” and includes it among its four omni‑channel fulfillment options (BOSS, BOPIS, BODFS, BORIS). By routing online orders to the nearest store for in‑store pickup, BOPIS enables roughly half of U.S. online purchases to be completed at a store location, leveraging the company’s store footprint to speed delivery, cut shipping costs, and meet customer demand—directly driving the 50 % fulfillment‑through‑stores figure cited in the supply‑chain section.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 50% figure for U.S. online orders fulfilled through stores is correctly cited and matches the original answer. The use of 'roughly half' is semantically equivalent and acceptable. (2) The LLM correctly identifies BOPIS as 'Buy Online, Pickup In Store' and situates it within The Home Depot's omni-channel strategy, referencing other fulfillment options (BOSS, BODFS, BORIS), which adds context not in the ground truth but is factually consistent. (3) The reasoning is sound: it explains how BOPIS leverages store networks to fulfill online orders, reduces shipping costs, and improves speed—key drivers behind achieving the 50% fulfillment target. This constitutes correct multi-hop synthesis between the glossary definition and the supply chain section. (4) The only minor shortcoming is that the original answer emphasizes 'interconnected retail program' and 'optimize inventory distribution' as strategic elements, which the LLM mentions implicitly but could have stated more directly. However, the core facts, entities (The Home Depot, BOPIS, U.S. online orders), and logic are correct. Wording differs but meaning is semantically equivalent. No factual errors or calculation issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 357,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "\nMorgan Stanley records DCP expense over the award’s vesting period — the expense is calculated from the notional value of the award and adjusted for changes in the fair value of the referenced investments, with retirement‑eligible awards accrued in the calendar year prior to grant (see pages 90‑91). By contrast, carried‑interest compensation is recognized as a component of compensation expense only when the firm records carried‑interest revenue, i.e., when performance‑based fees are earned, so its timing is tied to the realization of investment gains rather than a fixed vesting schedule (see pages 93‑94).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the timing and nature of compensation expense recognition for DCP and carried interest, with no numeric errors (quantitative accuracy is perfect, though no specific numbers like dollar amounts or percentages are present). It correctly states that DCP expense is recognized over the vesting period and adjusted for changes in fair value, and notes the accrual timing for retirement-eligible awards. It also correctly identifies that carried interest compensation is recognized when the firm records carried-interest revenue, tied to performance-based fee realization. However, the LLM answer diverges from the ground truth in emphasis and completeness: the original answer highlights that carried interest compensation is recognized immediately for both realized and unrealized allocations to employees, without a vesting schedule, underscoring the immediate and performance-driven nature. In contrast, the LLM answer frames carried interest recognition around the firm's revenue recognition, which, while contextually related, shifts the rationale from employee allocation timing (the focus of the question) to firm revenue timing, potentially missing the core distinction about vesting versus immediate recognition at the employee level. This affects qualitative accuracy, as the multi-hop reasoning is sound but the synthesis slightly misaligns with the ground truth’s emphasis on vesting conditions versus performance-based allocations. Contextual relevance is high, as all content directly addresses the question. Thus, the answer is mostly correct but lacks full precision in capturing the nature of carried interest compensation recognition relative to employee allocations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 471,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "\nThe noncontrolling redeemable interests in properties that are classified as temporary equity total **$169,192 (thousands)**, i.e., approximately **$169.2 million** as of December 31, 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, because neither entity reported any such interests redeemable at amounts in excess of fair value. The LLM incorrectly reports a value of $169.2 million. This is a major factual error. (2) The quantitative inaccuracy is significant: $169,192,000 vs $0 is a complete mismatch. There is no indication in the ground truth of any non-zero amount, so the number provided by the LLM has no basis. Even if the number came from a misread table, it contradicts the explicit conclusion in the original answer. (3) The multi-hop reasoning failed. The question requires synthesizing information from both Simon Property Group and the Operating Partnership, and the correct inference is that no such interests are reported by either entity. The LLM either misidentified the relevant data or pulled a number from an unrelated context without proper synthesis. (4) The contextual relevance is moderate because the LLM addressed the right topic (noncontrolling redeemable interests, temporary equity, correct date), but the core factual claim is entirely wrong, leading to a very low correctness and quantitative accuracy score. The qualitative accuracy is slightly above minimum because the terminology and structure are appropriate, but the reasoning is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 419,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "\nThe combined estimated fair value of NEE’s nuclear decommissioning fund assets ($8,846 million) and FPL’s storm fund assets ($76 million) is $8,922 million. This exceeds the $5,511 million carrying amount of NEE’s special use funds reported on its consolidated balance sheet as of December 31 2021.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value components: $8,846 million for NEE's nuclear decommissioning fund and $76 million for FPL's storm fund, and correctly calculates their sum as $8,922 million. However, it incorrectly states the carrying amount of NEE's special use funds as $5,511 million, whereas the ground truth reports $2,505 million. This is a significant factual error affecting the comparison. (2) Number verification: $8,846M + $76M = $8,922M — calculation is correct. But the carrying amount is wrong: $5,511M vs. correct $2,505M — this is off by over $3 billion. No explanation or source for this incorrect figure is given. (3) Multi-hop reasoning: The model correctly synthesizes fair value data from two entities (NEE and FPL) and combines them, showing proper understanding of fund composition. However, it fails in the second hop by reporting an incorrect carrying amount from the consolidated balance sheet, undermining the comparative analysis. (4) The contextual relevance is high because the structure and intent of the answer match the question, and the qualitative reasoning (comparing fair value to carrying amount) is sound — only the key number is wrong. Due to the major quantitative error in the carrying amount, the correctness and quantitative accuracy scores are reduced significantly, though not to zero due to correct fair value synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 387,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Cisco’s consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Cisco’s overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "\nAPJC is one of Cisco’s three geographic operating segments and is also reported separately in its consolidated financial statements. Because the CODM evaluates segment performance only on revenue and gross‑margin (excluding most corporate‑level expenses), Cisco’s internal performance measurement for APJC is driven by those segment‑level metrics, which shape resource allocation and the assessment of the region’s contribution to overall results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately identifies APJC as one of Cisco’s three geographic segments and correctly explains its role in both operational reporting and consolidated financial statements. The answer correctly notes that Cisco’s Chief Operating Decision Maker (CODM) evaluates segment performance based on revenue and gross margin, excluding corporate-level expenses such as R&D and restructuring charges—this aligns with the original answer’s point about certain expenses not being allocated to segments. The explanation of how this influences internal performance measurement (e.g., resource allocation and contribution assessment) is logically sound and captures the core intent of the question. There are no numeric inaccuracies (quantitative accuracy is perfect, even though no specific numbers are cited, which is appropriate given the question). The only minor shortcoming is that the LLM answer does not explicitly name the other two segments (Americas, EMEA), but this omission does not detract from addressing the central focus on APJC’s dual role. Multi-hop reasoning is correctly applied by linking APJC’s segment reporting to internal decision-making and consolidated financial reporting. Overall, the response is concise, accurate, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 372,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "\nIn 2024, Business Markets and Other generated about **$13.1 billion** of the Verizon Business Group’s **$29.5 billion** total revenue—roughly **44 %** of the segment’s sales. This sub‑segment sells fixed‑wireless access (FWA) broadband—using the company’s 5G/4G LTE networks—to small‑ and medium‑size businesses, offering them a landline‑free internet connectivity option that complements its wireless, voice and networking services.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figure of $13.1 billion and the percentage (44%) are accurate. The implied total revenue of $29.5 billion is consistent with the ground truth ($13.1B / 0.44 ≈ $29.77B; minor rounding difference is acceptable). (2) The answer completely addresses both parts of the question: it correctly identifies the revenue contribution percentage and explains how FWA broadband is incorporated into the Business Markets and Other segment. (3) Entity accuracy is correct: 'Verizon Business Group', 'Business Markets and Other', '2024', and 'FWA broadband' are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it connects FWA as a wireless service offered to small and medium businesses using 5G/4G LTE, aligning with the tailored fixed connectivity described in the original. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual content, including the target customer segment and the role of FWA within the broader service portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 313,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "\nThe interest‑rate hedge contracts had a recorded fair‑value of $1 million (a $1 million receivable offset by a $51 million payable), while the total notional amount of all foreign‑currency forward exchange contracts was $16.2 billion. Consequently, the notional amount of the currency forwards is roughly 16,000 times larger than the fair‑value of the interest‑rate hedges.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numeric values. The total fair value of Abbott's interest rate hedge contracts is incorrectly stated as $1 million; the ground truth is $50 million (a $51 million payable offset by a $1 million receivable, resulting in a net $50 million liability). The LLM reversed the net value and misrepresented the components. Additionally, the total notional amount of foreign currency forward contracts is reported as $16.2 billion, whereas the correct figure from the ground truth is $23.2 billion. These are material quantitative discrepancies. (2) Calculations: The comparison ratio of ~16,000x is based on incorrect inputs and is therefore invalid. Using correct figures, $23.2 billion / $50 million = 464x, not 16,000x. The LLM’s calculation compounds the error by using a net fair value of $1 million instead of $50 million. (3) Multi-hop reasoning: While the LLM attempts to synthesize fair value and notional amounts across different derivative types (interest rate vs. foreign exchange), it fails to retrieve or compute the correct values from the source data, indicating a breakdown in multi-hop retrieval or internal knowledge accuracy. (4) Despite incorrect numbers, the answer structure is relevant and addresses both parts of the question, correctly identifying the comparison direction (notional amount much larger than fair value). Wording and logic framework are sound, but factual foundation is flawed. Hence, contextual relevance is high, but correctness and quantitative accuracy are severely impacted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 435,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "\nThe equity‑partnered assets in Asia carry roughly 272 MMbbl of undeveloped oil + 194 MMbbl of NGL and about 6.3 trillion cf of gas on only ~152 k net acres, giving a reserve‑to‑acre ratio that is several‑times higher than the Consolidated subsidiaries, which hold ~1.19 B bbl of undeveloped oil and 640 bcf of gas on ~227 k net acres.  This disproportionate reserve base relative to the smaller land footprint signals that Equity Companies have strong development upside per acre in the region, whereas the broader Consolidated portfolio spreads its reserves over a larger acreage with a lower reserve density, reflecting less efficient land utilisation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and entities. It reports 272 MMbbl of oil, 194 MMbbl of NGL, and 6.3 trillion cf of gas for Equity Companies, while the ground truth states 1,503 million barrels of total proved undeveloped reserves (without breakdown). The net acreage is reported as ~152k, but the correct figure is 19 thousand net acres. For consolidated subsidiaries (XOM), the LLM reports ~1.19 Bbbl and 640 bcf of gas on ~227k net acres, but the correct figures are 1,315 million barrels on 640 thousand net acres. These numeric discrepancies are severe and materially alter the analysis. (2) Calculations are incorrect due to wrong inputs: the LLM implies a much higher reserve-to-acre ratio for Equity Companies based on false data, while the correct ratio is ~79.1 million per thousand acres (1,503 / 19 * 1,000), not the several-times-higher claim without basis. The consolidated ratio is ~2.05 million per thousand acres (1,315 / 640 * 1,000), which the LLM fails to compute correctly. (3) Multi-hop reasoning is partially sound in structure—comparing reserve density to infer development potential and land efficiency—but it is built on entirely incorrect data, undermining the conclusion. The model attempts the right type of analysis (reserves per acre comparison between equity and consolidated operations), but fails to retrieve accurate figures from the knowledge graph. (4) Contextual relevance is moderate because the answer addresses the right concepts (development potential, land use efficiency, reserve-to-acre comparison), but the severe quantitative errors render the conclusion misleading. Correctness score is low due to fundamental inaccuracies in core data points, despite correct intent in reasoning structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 486,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "\nThe Parent Company’s **unconditional guarantee** means that the securities issued by Morgan Stanley Finance LLC are fully backed by the Parent, so any shortfall by the finance subsidiary must be satisfied by the Parent without limitation.  \nBecause this guarantee is a core element of the **amended and restated support agreement**, the Parent (and its Funding IHC) are contractually required—under a resolution scenario—to contribute all of their contributable assets to the supported entities and to provide the capital and liquidity needed to meet those obligations. In other words, the guarantee triggers the Parent’s senior‑level duty to fund and honor the subsidiary’s debt, using its pledged assets to satisfy the broader support‑agreement commitments in a resolution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Parent Company's unconditional guarantee of Morgan Stanley Finance LLC's securities is properly described as a full backing by the Parent, ensuring credit support. The connection to the amended and restated support agreement is accurately framed, including the Parent's obligation to contribute contributable assets and the role of the Funding IHC in providing capital and liquidity during a resolution scenario. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links the guarantee (a financial commitment) with the contractual obligations under the support agreement, recognizing that the guarantee could be triggered in resolution and that the support agreement governs the distribution of resources. The only minor shortcoming is that the LLM slightly overstates the integration by implying the guarantee is 'a core element' of the support agreement, whereas the original answer presents them as 'interconnected' but not necessarily structurally nested. This is a subtle distinction and does not undermine the overall correctness. (4) The answer is fully contextually relevant, directly addressing both parts of the multi-part question: the significance of the guarantee and its relationship to the support agreement in resolution. Wording differs but semantic equivalence is maintained.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 426,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klépierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klépierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "\nThe 2015 Bipartisan Budget Act shifts any IRS audit adjustment to the partnership level, so if a joint‑venture in which SPG holds an interest—such as its investments in Klépierre or The Taubman Realty Group, LLC—is audited and an adjustment is issued, the partnership must pay the resulting tax, interest and penalties; SPG, as a partner, will then be responsible for its share of those amounts even though the REITs themselves would not incur corporate‑level tax on the same income. As a result, audit outcomes can increase SPG’s cash‑outflows and may require it to fund additional capital or absorb reduced distributions from those joint‑venture investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial and legal implications of the Bipartisan Budget Act of 2015 on Simon Property Group's (SPG) joint venture investments. (1) All factual elements are correct: the Act applies partnership-level audit adjustments, and SPG, as a partner in joint ventures like Klépierre and The Taubman Realty Group, LLC, may bear the economic burden of resulting taxes, interest, and penalties. The answer correctly notes that SPG’s REIT structure typically avoids corporate-level taxes, but through these partnership rules, it could still face cash outflows via its equity method investments. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., dollar amounts, percentages) appear in the original or LLM answer, the reference to the 2015 Act is correct, and no erroneous figures are introduced. (3) Multi-hop reasoning is sound—LLM correctly links the federal tax rule change to SPG’s investment structure, accounting method (implied via equity method treatment), and financial exposure across third-party-managed joint ventures. (4) The only minor omission is the specific mention of SPG’s 84 joint venture properties, which appears in the ground truth and adds contextual completeness. However, this does not detract from the core reasoning or correctness. The LLM captures the material risk and mechanism of financial impact, making the answer semantically equivalent and contextually fully relevant. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 438,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "\nThe 2020 non‑cash impairment of the Advanced Military Maintenance, Repair & Overhaul Center (AMMROC) reduced net earnings from continuing operations by roughly **$96 million after‑tax**, which translated to a **$0.34‑per‑share** drag on diluted earnings. In 2021, the **$36 million severance and restructuring charge** recorded in the RMS segment lowered net earnings by about **$28 million after‑tax**, or **$0.10‑per‑share**. Together, these items shaved $0.34 from 2020 EPS and $0.10 from 2021 EPS, contributing to the decline in earnings per share from $24.50 in 2020 to $22.76 in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: the $128 million noncash impairment in 2020 leading to a $96 million after-tax reduction in net earnings and $0.34 per-share impact, and the 2021 $36 million restructuring charge in RMS resulting in a $28 million after-tax and $0.10 per-share impact, are all correctly reported. These figures align exactly with the original answer, and formatting variations (e.g., $96 million vs $96 million) are acceptable. The multi-hop synthesis across two years and business units (AMMROC in 2020, RMS in 2021) is sound and correctly attributed. The only minor issue is the addition of contextual information not present in the ground truth—the claim that EPS declined from $24.50 in 2020 to $22.76 in 2021 'due to' these items—introduces a causal implication not supported in the original answer, which only states the isolated impacts. While the per-share impacts are correct, the LLM overreaches slightly by embedding them in a broader earnings trend without confirming attribution. This does not make the answer factually wrong but adds unsupported inference. Thus, while quantitative accuracy and contextual relevance are perfect, qualitative accuracy is slightly reduced due to this minor overextension. Overall, the answer correctly addresses all parts of the question with precise, multi-hop financial reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 387,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "\nThe balance of channel‑partner financing subject to guarantees fell from **$1.7 billion at the end of fiscal 2023 to $1.2 billion at the end of fiscal 2024**, a year‑over‑year decline of about **$0.5 billion (≈ 29 %)**.  This reduction in contingent cash outflows supports Cisco’s liquidity position, matching the MD&A’s view that the company’s cash, investments and access to capital markets will comfortably satisfy its liquidity and capital‑resource requirements and that such financing guarantees are not expected to have a material impact on overall liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year change in channel partner financing subject to guarantees, stating a decrease from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, which matches the ground truth. The calculated decrease of $0.5 billion is accurate, and the added percentage drop of ~29% (0.5 / 1.7 ≈ 29.4%) is a correct and reasonable derivation not present in the original but factually sound. (2) All numeric values, fiscal years, and calculations are precise and consistent with the ground truth. Format variations (e.g., $1.7 billion vs $1.7 billion) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is strong: the model correctly links the quantitative change in financing guarantees to Cisco’s broader liquidity position as discussed in the MD&A. It accurately reflects Cisco’s stated confidence that existing cash, investments, and operational cash flows are sufficient to meet obligations, including guarantees. The conclusion that the reduction supports liquidity and that guarantees are not expected to materially impact liquidity aligns semantically with the original answer. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'cash generated from operations' as a source (though 'access to capital markets' is mentioned, which is not in the original), slightly deviating from the exact phrasing of the MD&A summary in the ground truth. However, the overall meaning and intent are preserved. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for minor wording divergence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 461,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "\nThe “Investments measured at NAV” for the pension‑plan asset category total $4,432 million, while the other post‑retirement‑benefit‑plan category reports only $5 million; therefore the pension‑plan category is higher by roughly $4,427 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states the two values are $2,656 million and $3 million, with a difference of $2,653 million. The LLM reports $4,432 million and $5 million, with an implied difference of $4,427 million—none of which match the actual data. (2) Quantitative accuracy is severely lacking: the numbers are off by over $1.7 billion in one case, and the difference is misstated by nearly $1.8 billion. Calculations based on incorrect inputs are also wrong. (3) While the LLM attempts the correct multi-hop reasoning—identifying two benefit plan categories, extracting 'Investments measured at NAV', computing a difference, and determining which is higher—the underlying data is entirely inaccurate, indicating failure to retrieve or synthesize from the correct source. (4) Contextual relevance is moderate because the model understands the structure of the question (comparing NAV investments across two benefit plans in a 10-K) and attempts proper financial reasoning, but the answer is not grounded in the correct filing or data. This suggests either a hallucination or retrieval of data from a different company/year.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 338,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "\nAbbott’s strategic push to grow its Diabetes Care device portfolio—especially its continuous‑glucose‑monitoring (CGM) systems—produced an 18.1 % increase in Diabetes Care net sales in 2024 (from $5.76 bn to $6.81 bn). This revenue is recognized under Abbott’s revenue‑recognition policy (Note 1), which records product sales when control transfers—generally upon shipment—and allocates the transaction price to each performance obligation, ensuring revenue is recorded at the point of shipment or when the related service obligations are satisfied.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the 18.1% revenue increase in Abbott's Diabetes Care business in 2024, with accurate figures: $6.81 billion (rounded from $6.805 billion in the ground truth) and prior-year revenue of $5.76 billion, which aligns with a correct calculation of an 18.1% increase. The revenue recognition policy is accurately described as recognizing revenue upon transfer of control, generally upon shipment, in accordance with Note 1 of the 10-K, which matches the original answer. 2) Quantitatively, the numbers are correct within acceptable rounding: $6.805 billion is appropriately rounded to $6.81 billion. The prior-year revenue of $5.76 billion is consistent with a base that, when increased by 18.1%, yields ~$6.805 billion. The percentage increase is accurate. 3) The reasoning correctly links Abbott's production focus on Diabetes Care Devices—especially CGMs—to the revenue growth, and ties the accounting policy (revenue recognition at transfer of control) to the timing of revenue recognition, demonstrating sound multi-hop synthesis between business strategy, financial performance, and accounting policy. 4) The only minor shortcoming is that the LLM answer adds specificity (e.g., mentioning CGMs and Note 1) not present in the ground truth, but this is contextually appropriate and likely from the actual 10-K. It does not introduce inaccuracies. The ground truth does not mention the prior-year dollar amount, so including $5.76 billion is an enhancement, not an error. Overall, the answer is factually correct, complete, and contextually precise, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 439,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "\nThe 2024 10‑K makes clear that professional customers (“Pros”) expect “project‑planning tools” as a core part of their purchase experience — a point emphasized both in the “Our Customers” description and again in the “Competition and Seasonality” section (page 14). By investing in those planning tools and integrating them with its inventory, fulfillment and digital capabilities, Home Depot can meet Pros’ demand for tailored, end‑to‑end project support, differentiating it from other retailers and reinforcing its competitive positioning with this customer group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies that The Home Depot's investment in project planning tools addresses Pros' expectations, as explicitly stated in both the 'Our Customers' and 'Competition and Seasonality' sections of the 2024 10-K (page 14 referenced correctly). The answer captures the core purpose of these tools — meeting demand for end-to-end project support — and links this capability to competitive differentiation, which matches the original answer’s emphasis on competitive positioning. The LLM correctly synthesizes information across sections (multi-hop reasoning) and uses semantically equivalent language (e.g., 'tailored, end-to-end project support' ≈ 'tailored solutions and streamlined purchasing processes'). No quantitative data (e.g., dollar amounts, percentages) is present in either answer, so quantitative accuracy is not applicable but assumed correct by absence. The only minor shortcoming is that the LLM does not explicitly mention 'dedicated sales support, product depth, and job-lot quantities' — specific elements from the original — which slightly reduces completeness in qualitative detail, but the overall meaning and intent are preserved. Thus, the answer is highly accurate, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 365,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "\nThe 2003 Incentive Program had 47,088,821 shares remaining, the 2004 Non‑Employee Director Restricted Stock Plan had 238,700 shares remaining, and the Pioneer Natural Resources Company Amended and Restated 2006 Long‑Term Incentive Plan had 9,362,383 shares remaining. Adding these together gives a total of **56,689,904 shares** available for award under the three plans as of the end of 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: 47,088,821 shares for the 2003 Incentive Program, 238,700 for the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 for the Pioneer LTIP—all match the original answer. (2) The total sum is correctly calculated: 47,088,821 + 238,700 + 9,362,383 = 56,689,904, which is the exact total stated in the ground truth. (3) The multi-hop reasoning is sound—information from three separate plans is correctly synthesized to compute the aggregate available shares as of the end of 2024. (4) Entity names are accurately referenced, including full and correct plan titles, and the time frame (end of 2024) is properly addressed. (5) The semantic meaning and factual content are equivalent to the original answer, with only minor rewording for clarity. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 262,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "\nThe 2023 re‑classification of Customer receivables required a $4.432 billion adjustment that lowered **interest income by $4.432 million and also lowered interest expense by the same $4.432 million**, with the entire $4.432 million impact recorded in the Institutional Securities segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in unit conversion: it states '$4.432 million' instead of '$4,432 million' (i.e., $4.432 billion), which is a 1,000x underreporting of the actual adjustment. This mistake occurs twice—both for interest income and interest expense—making the quantitative response severely inaccurate. The original answer correctly identifies a $4,432 million (equivalent to $4.432 billion) adjustment, so while the LLM uses numerically equivalent digits, the unit 'million' is incorrectly applied. (2) Number verification: $4,432 million = $4.432 billion, but not $4.432 million. The LLM confuses billions with millions, leading to a major factual error. The segment and direction of impact (decrease in both interest income and expense) are correct, and the fact that the full adjustment was recorded in the Institutional Securities segment is accurately noted. (3) Multi-hop reasoning is partially sound: the model correctly identifies that the reclassification affected both interest income and expense equally, understands it had no net effect on net interest income (implied by equal reduction), and correctly assigns the impact to the Institutional Securities segment. However, the failure to report the correct magnitude undermines the reasoning. (4) Correctness score is 4 due to significant numerical inaccuracy despite correct directional and qualitative understanding. Quantitative accuracy is low (3) due to the unit error. Qualitative accuracy is moderate (6) because entities, logic, and structure are mostly correct. Contextual relevance is high (8) as the response directly addresses the question’s components with appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 461,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "\nThe amounts excluded from hedge effectiveness for net‑investment hedge derivatives were $133 million in 2019 and $75 million in 2021, giving a combined total of **$208 million**. According to the disclosures, the “net‑investment hedge” category comprises **cross‑currency interest‑rate swaps and forward contracts**, as well as **non‑U.S.‑dollar‑denominated debt that is designated to hedge a portion of the company’s net investments abroad**.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the amounts excluded from hedge effectiveness: $133 million in 2019 and $75 million in 2021, with a combined total of $208 million, matching the ground truth exactly. The calculation is accurate and all numbers are correctly reported.\n\n2) The types of contracts included in net investment hedge derivatives are mostly correct. The LLM correctly includes cross-currency interest rate swaps and forward contracts. However, it adds 'non-U.S.-dollar-denominated debt that is designated to hedge a portion of the company’s net investments abroad' as part of the derivative category, which is not mentioned in the ground truth. While such debt may be used in net investment hedging strategies, the original answer specifies only derivatives (swaps and forwards), and non-derivative instruments like debt are not listed in the category. This is a minor overextension of the disclosed category.\n\n3) The multi-hop reasoning is sound: the model correctly retrieves data from two different years (2019 and 2021), sums them accurately, and synthesizes the contract types from disclosures. The error does not affect the quantitative conclusion but adds a detail not present in the ground truth.\n\n4) The answer is highly relevant and factually strong. The correctness score is 8 due to the minor overinclusion in the derivative types, despite perfect numerical accuracy. The qualitative accuracy is slightly reduced for this reason, but contextual relevance remains high as all parts of the question are addressed appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 424,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "\nAfter the 2021 amendments the Credit Facility was expanded to a **$5.0 billion** aggregate commitment and the Supplemental Facility to a **$4.5 billion** aggregate commitment, giving the two facilities a **combined borrowing capacity of $9.5 billion**.  The greatest aggregate balance actually outstanding on these facilities during the year ended December 31, 2021 was **$2.1 billion**, meaning the peak usage represented only about 22 % of the total capacity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $5.0 billion for the Credit Facility, $4.5 billion for the Supplemental Facility, and a combined capacity of $9.5 billion, which aligns with the ground truth calculation. The maximum aggregate outstanding balance of $2.1 billion is correctly stated. The derived percentage (22%) is accurate (2.1 / 9.5 ≈ 0.221 or 22.1%), and while not present in the original answer, it adds valid context without introducing error. (2) The answer is complete, addressing both parts of the question: total borrowing capacity post-amendment and its relation to peak usage in 2021. (3) Entities are correct—Simon Property Group, Credit Facility, Supplemental Facility, and the year 2021 are all properly identified. (4) The reasoning is sound: the model correctly synthesizes the amended capacities and compares the peak drawdown to total capacity, demonstrating multi-hop understanding across financial instruments and time periods. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced clarity through the inclusion of a percentage, which does not distort or misrepresent the facts. All criteria are met with high precision and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 356,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "\nThe higher risk retirements on the Black Hawk and CH‑53K helicopter programs lifted RMS’s operating profit by roughly **$140 million** in 2021.  This gain helped drive the segment’s total operating‑profit increase of **$183 million** (an 11 % rise) compared with 2020.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $140 million contribution from risk retirements on the Black Hawk and CH-53K programs is correctly stated, as is the total $183 million (11%) increase in RMS' operating profit in 2021 compared to 2020. (2) Quantitative accuracy is perfect: both dollar amounts and the percentage increase match the original answer exactly, with acceptable formatting (e.g., '11 %' vs '11%'). (3) The multi-hop reasoning is sound—the answer correctly identifies the causal relationship between the risk retirements and the overall profit increase, and situates the $140 million as a component of the larger $183 million gain, implying proper synthesis across contributing factors. (4) Entity accuracy is complete: RMS, Black Hawk, CH-53K, and the correct year (2021 vs 2020 comparison) are all correctly referenced. The answer is concise but complete, addressing both the specific dollar contribution and its role in the broader profit increase, fulfilling all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 310,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "\nIn 2021 the energy‑related derivatives cut Southern Company’s natural‑gas revenues by **$117 million** and its cost of natural gas by **$27 million**, producing a **combined negative impact of $144 million**. In 2019 the same derivatives added **$223 million** to revenues and **$10 million** to cost, for a **combined positive impact of $233 million**. Thus the impact swung from a $233 million gain in 2019 to a $144 million loss in 2021, a net change of roughly **$377 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: the $144 million loss in 2021 is correctly broken down into a $117 million reduction in revenues and $27 million reduction in costs (summing to $144 million loss). For 2019, the $233 million gain is accurately composed of $223 million increase in revenues and $10 million in cost increases. The net change of $377 million ($233 million gain to $144 million loss) is correctly calculated as a swing of $377 million. Minor discrepancies in component values (e.g., $223M vs. implied $233M - $10M = $223M) are consistent with the total and plausible rounding or reporting variations. (2) The answer is complete, addressing both years, the total impact, and the comparison between them. (3) Entities are correct: Southern Company (SO), energy-related derivatives, natural gas revenues and costs, and the years 2019 and 2021 are all accurately referenced. (4) The multi-hop reasoning is sound—information from two different years is synthesized to compute the net change in financial impact. (5) The semantic meaning is equivalent to the original answer, with added detail that enhances clarity without introducing error. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 357,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "\nThe loss recorded on Cisco’s privately‑held investments narrowed from **$193 million in fiscal 2023 to $164 million in fiscal 2024**, an improvement of **$29 million**.  Because this component became less negative, the overall “Net gains (losses) on investments” line also shifted upward—from a **$177 million loss in 2023 to a $166 million loss in 2024**, a **$11 million reduction in the overall loss** (the smaller private‑investment loss was a key contributor to that net improvement).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: losses from privately held investments were $193 million in 2023 and $164 million in 2024, resulting in a $29 million improvement. The overall net gains (losses) on investments improved from a $177 million loss in 2023 to a $166 million loss in 2024, a $11 million positive shift—both calculations are correct. (2) The answer is complete, addressing both parts of the question: the change in losses from privately held investments and its impact on overall net gains (losses). (3) Entity accuracy is perfect: Cisco is correctly identified, fiscal years 2023 and 2024 are properly referenced, and the financial metrics (losses on privately held investments, net gains/losses on investments) are correctly used. (4) The reasoning is sound and reflects proper multi-hop synthesis: the answer correctly infers that the reduction in losses (i.e., a less negative value) in the private investments component contributed to the improvement in the overall net investment result, even though other components may have played a role. The explanation that the smaller loss in private investments was a 'key contributor' aligns with the ground truth's causal implication. (5) Semantic equivalence is maintained: phrasing such as 'narrowed from', 'improvement of', and 'reduction in the overall loss' accurately convey the financial improvement without distorting meaning. Minor wording differences (e.g., 'fiscal 2023' vs '2023') are acceptable and do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 434,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "\nIn 2024 VZ repaid **$4.5 billion** of principal on ABS notes in connection with anticipated redemptions. This repayment amount is far smaller than the **combined $13.0 billion** aggregate outstanding balance of the 2021 and 2022 ABS financing facilities that remained on the books as of December 31 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $4.5 billion principal repayment by VZ in 2024 is correctly stated. (2) The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities is correctly synthesized: $8.0 billion + $5.0 billion = $13.0 billion, which matches the ground truth. The comparison between the repayment amount ($4.5 billion) and the total outstanding balance ($13.0 billion) is accurately framed as the repayment being 'far smaller'—a valid qualitative interpretation of the quantitative difference. (3) Multi-hop reasoning is sound: the model correctly combines information across two facilities (2021 and 2022) and performs the correct summation to derive the total outstanding balance as of December 31, 2024. (4) Entities (VZ, ABS Notes, 2021 and 2022 Financing Facilities, 2024 time frame) are correctly identified and contextualized. Minor wording differences (e.g., 'combined $13.0 billion' instead of listing individual balances) do not affect factual accuracy and are acceptable under semantic equivalence. All scores are maximized due to complete factual correctness, accurate calculations, proper synthesis, and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 349,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "\nThe CECL capital‑transition provisions require that certain First Republic‑related exposures be treated with the **Standardized approach** for risk‑based capital calculations, and the allowance for credit losses on those exposures (≈ $541 m in 2024) is included in the Tier 2‑capital calculation and in the Standardized Tier 1 and Total‑capital ratios. Because the transition rules add the First Republic off‑balance‑sheet items to the **total leverage exposure** and adjust the “adjusted average assets” used in the Tier 1 leverage ratio (by deducting goodwill and other intangibles), the leverage denominator rises and the Tier 1 leverage ratio is consequently lower than it would be under the full Advanced approach. These adjustments are reflected in the leverage‑ratio tables on page 303 and in the RWA roll‑forward notes (pages 301‑305).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, most notably the $541 million allowance for credit losses in 2024, which is not mentioned or supported by the original answer. This figure cannot be verified against the ground truth and appears to be hallucinated or derived from external data, significantly undermining quantitative accuracy. Additionally, the LLM references specific page numbers (e.g., page 303, pages 301–305), which are absent from the original and cannot be confirmed, further reducing quantitative reliability. (2) While the ground truth confirms that CECL transition provisions affect Tier 1 leverage ratio calculations by adjusting average assets and allowing the Standardized approach for First Republic-related assets, it does not mention Tier 2 capital, Standardized Tier 1/Total capital ratios, or off-balance-sheet items. These additions extend beyond the scope of the verified information and introduce unverified complexity. (3) The multi-hop reasoning is partially sound: the LLM correctly links CECL provisions to adjustments in the leverage ratio denominator and the use of the Standardized approach for First Republic assets. It also correctly infers that adjusted average assets impact the Tier 1 leverage ratio. However, the causal chain involving off-balance-sheet items and capital ratio impacts goes beyond the original synthesis, introducing unsupported inferences. (4) Despite the overreach in specifics, the core qualitative elements—CECL affecting leverage ratio via asset adjustments and enabling Standardized treatment of First Republic assets—are consistent with the ground truth. The answer remains contextually relevant and addresses the key regulatory mechanisms, but the inclusion of unverified numbers and technical details reduces overall correctness. Hence, a score of 6 is justified: partially correct with significant factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 525,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSE’s additional independence and financial expert requirements.",
      "llm_answer": "\nSimon’s governance framework requires that a majority of its directors be “independent” under NYSE rules—i.e., they may not be affiliated with the Simon family or have any material relationship with the company—and its Audit, Compensation and Human‑Capital committees are composed entirely of such independent directors, each of whom also satisfies the NYSE’s additional independence and financial‑expert qualifications. These policies are codified in Simon’s governance principles, board charters and Code of Business Conduct and Ethics, ensuring that board oversight remains objective and that the company meets the NYSE’s listing standards for director independence and ethical conduct.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key elements are correctly addressed: Simon's governance principles, board independence under NYSE rules, the requirement for a majority of independent directors unaffiliated with the Simon family, and the composition of the Audit and Compensation and Human Capital Committees entirely of independent members who meet additional NYSE independence and financial expert requirements. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information about Simon’s internal governance policies (governance principles, board charters, Code of Business Conduct and Ethics) with external regulatory requirements (NYSE listing standards), demonstrating alignment between company policy and exchange rules. (4) The LLM uses slightly different phrasing (e.g., 'material relationship with the company', 'objective oversight') not in the original, but these are reasonable inferences and do not introduce inaccuracies. All entities—Simon, NYSE, Audit Committee, Compensation and Human Capital Committee, Simon family affiliation—are correctly identified and contextualized. The answer fully addresses both parts of the question: governance policies for independence/ethics and their alignment with NYSE requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 408,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "\nThe percentage‑of‑completion cost‑to‑cost method ties revenue recognition to the ratio of costs incurred to total estimated costs, so profit‑booking rates are continuously revised as those cost estimates change. When risk retirements lower the estimated total cost (or when cost overruns raise it), the booking rate is increased or decreased respectively, and the resulting profit adjustment is recorded in the same reporting period in which the estimate is updated, directly affecting segment operating profit and margin.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the original answer. It accurately explains that under the percentage-of-completion cost-to-cost method, changes in cost estimates directly affect profit booking rates: lower total estimated costs (e.g., due to risk retirements) increase the rate, while higher estimates decrease it. It correctly states that these changes are recognized in the period they are determined and impact segment operating profit and margin. The answer captures the inception-to-date effect implicitly by stating the adjustment is recorded when the estimate is updated, which aligns with GAAP requirements for cumulative catch-up accounting. There are no numeric inaccuracies (quantitative accuracy is perfect, though no specific numbers are present). The only minor shortcoming is that it does not explicitly mention 'inception-to-date effect' or 'technical, schedule, and cost risks' in full, slightly reducing qualitative completeness, but the core reasoning and synthesis across the financial impact, estimation changes, and timing of recognition are sound. Contextual relevance is excellent as all parts of the question are addressed with precise financial reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 340,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "\nFrom FY 2023 to FY 2024, APJC’s Services Revenue rose $89 million, about a 4 % increase. At the same time, the region’s goodwill (the “Total Balance”) grew $2.83 billion, so the combined increase is roughly $2.92 billion—far larger than the modest 4 % Services‑Revenue growth rate.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $89 million increase in Services Revenue and the 4% growth rate, which are accurate per the ground truth. However, it incorrectly reports the Total Balance increase as $2.83 billion ($2,830 million), whereas the ground truth states an $8,358 million increase—this is a major quantitative error. Consequently, the combined increase is stated as $2.92 billion, but the correct value is $8,447 million; thus, the sum is significantly understated. (2) The calculation of the combined increase ($89M + $2,830M = $2.92B) is arithmetically correct but based on a wrong input for Total Balance. The percentage growth in Services Revenue (4%) is correctly reported. (3) The multi-hop reasoning is partially sound—the model identifies both metrics and attempts to combine them and compare the dollar increase to the percentage growth. However, due to the incorrect Total Balance figure, the synthesis fails on a key component. It also mislabels 'Total Balance' as 'goodwill', which is a conceptual error unless Total Balance refers to goodwill (not indicated in the original answer). (4) Correctness score is 4 due to one correct major figure ($89M Services Revenue increase and 4%), but a critical error in the Total Balance amount that invalidates the combined total. Quantitative accuracy is low (3) due to the large discrepancy in the Total Balance number. Qualitative accuracy is moderate (5) because reasoning structure is present but based on flawed data and a possible misinterpretation of 'Total Balance'. Contextual relevance is high (8) as the answer addresses all parts of the question and follows the correct logical flow.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 457,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "\nAbbott’s interest‑rate hedge contracts had a notional amount of **$2.2 billion** as of December 31, 2024, while its foreign‑currency forward contracts totaled **$23.191 billion** (the “contract amount” shown in the table on page 41).  Combined, these instruments represent roughly **$25.4 billion** of notional exposure.  By hedging both the interest‑rate sensitivity of its debt and its foreign‑currency positions, Abbott limits earnings volatility caused by market‑rate fluctuations and aligns its financial‑risk management strategy with its goal of stabilizing cash flows and protecting profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, the interest rate hedge notional value is correctly stated as $2.2 billion. The foreign currency forward contracts are reported as $23.191 billion, which is a precise figure likely rounded to $23.2 billion in the original answer; this minor discrepancy (0.009 billion or $9 million) is negligible and within acceptable rounding tolerance. The combined total is correctly calculated as $25.4 billion. (2) The answer addresses both parts of the question: the total notional value and Abbott's risk management strategy. (3) Entities (Abbott, December 31, 2024, interest rate hedges, foreign currency forwards) are correct. (4) The reasoning is sound: the LLM correctly infers that these instruments are used to manage interest rate and foreign exchange risk, reduce earnings volatility, and stabilize cash flows—consistent with the original answer’s explanation. The only minor shortcoming is the lack of breakdown within the $23.2 billion (i.e., $7.0 billion for intercompany purchases and $16.2 billion for loans/payables), which is present in the ground truth and adds contextual completeness. However, this omission does not undermine the core accuracy. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 369,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "\nMcDonald’s consolidates only those franchise‑related entities in which it holds a controlling financial interest; otherwise franchisees are accounted for under the equity method or as separate legal entities and are not included in the consolidated balance sheet or income statement. Because virtually all operating costs, property taxes, insurance and site‑maintenance for franchised restaurants are borne by the franchisees themselves, the Company’s exposure to the financial performance of the franchise system is limited to the relatively immaterial gains, goodwill and intangible assets that arise when it purchases restaurants from franchisees. Consequently, franchisee operations are considered immaterial to the consolidated financial statements, and the Company’s consolidation policy reflects this limited, non‑material impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description and captures the key point that franchisee operations are not consolidated due to immateriality and lack of controlling financial interest. It correctly notes that franchisees bear most operating costs and that McDonald's exposure is limited to gains, goodwill, and intangible assets from buy/sell transactions, which are deemed immaterial. However, it misses a critical element from the ground truth: McDonald's explicitly applies a scope exception under variable interest entity (VIE) consolidation guidance and does not consolidate VIEs such as franchisees, joint ventures, and licensees. This is a specific accounting policy referenced in the 10-K and represents a key part of the consolidation policy. While the LLM mentions lack of controlling interest, it does not reference the VIE scope exception, which is a significant omission in terms of completeness and technical accuracy. There are no numerical inaccuracies (hence perfect quantitative accuracy), and the reasoning is sound where present, but the absence of the VIE framework weakens the qualitative accuracy. The answer remains contextually relevant and correctly addresses operational materiality and the general consolidation approach, just not the full technical basis stated in the 2024 10-K.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 368,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "\nThe Supplementary Leverage Ratio is calculated as Tier 1 capital divided by **total leverage exposure**, which equals **adjusted average assets** (after deductions such as goodwill and CECL‑related adjustments) **plus** a portfolio of **off‑balance‑sheet exposures** that are added back to the denominator. Because both the adjusted‑asset figure and the off‑balance‑sheet items increase the exposure figure, they push the ratio downward—i.e., the larger the denominator, the lower the SLR percentage. If the resulting SLR falls below the regulatory minimum (the 3 % baseline plus the additional 2 % leverage buffer that JPMorgan must hold, effectively a 5 %‑plus requirement), the firm becomes subject to supervisory limitations on capital distributions (dividends, share repurchases) and on discretionary bonus payments for certain senior officers. (See pages 103‑104 for the SLR definition and the consequences of not meeting the threshold.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key components of the SLR calculation are correctly identified: Tier 1 capital in the numerator, and total leverage exposure in the denominator, which includes adjusted average assets (with appropriate deductions like goodwill) and off-balance sheet exposures. The explanation that these elements increase the denominator and thus reduce the SLR is logically sound. (2) Quantitatively, the regulatory threshold is correctly stated as a 3% minimum plus a 2% leverage buffer, resulting in an effective 5% requirement—matching the original answer exactly. There are no calculation errors or incorrect figures. (3) The multi-hop reasoning is correct: the model synthesizes how both adjusted assets and off-balance sheet items affect the SLR, and then correctly links falling below the 5% threshold to specific regulatory consequences—restrictions on dividends, share repurchases, and discretionary bonuses. (4) Entity accuracy is precise (JPMorgan Chase, SLR, Tier 1 capital), and contextual relevance is high, with added value from referencing specific report pages (103–104), which enhances credibility without introducing error. Minor wording differences (e.g., '5%–plus requirement' vs '5.0%') do not affect meaning. All aspects of the question are fully addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 376,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "\nAs of December 31 2021 the Operating Partnership had $125 million outstanding under its $4 billion revolving Credit Facility and $1.05 billion outstanding under the Supplemental Facility, for a combined total borrowing of $1.175 billion. The Supplemental Facility’s amended terms raise its maximum borrowing capacity to $4.5 billion, so the $1.05 billion drawn represents only about 23 percent of that ceiling, leaving roughly $3.35 billion of unused capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key figures: $125 million under the Credit Facility, $1.05 billion under the Supplemental Facility, and a total of $1.175 billion in borrowings as of December 31, 2021—matching the ground truth exactly. The maximum borrowing capacity under the amended Supplemental Facility is stated as $4.5 billion, which aligns with the ground truth (which notes it could be increased to $4.5 billion). (2) Quantitative accuracy is perfect: the sum ($125M + $1.05B = $1.175B) is correct, and the percentage (23%) and unused capacity ($3.35B) are accurate calculations based on $1.05B / $4.5B. (3) The multi-hop reasoning is sound—correctly synthesizing data from two facilities and comparing total drawdown to the maximum capacity. However, the ground truth also mentions the base maximum capacity of $3.5 billion before potential increase to $4.5 billion, which the LLM omits. This is a minor but relevant detail about the 'amended terms' as asked in the question. (4) Despite this omission, the answer is factually correct, well-reasoned, and directly responsive. The contextual relevance is full, and qualitative accuracy is high—only docked slightly for missing the $3.5 billion baseline capacity detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 351,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "\nThe aggregate notional amount of Lockheed Martin’s outstanding interest‑rate swaps was **$500 million at the end of 2021**. This represents a **decrease of about 12.6 %** from the $572 million reported at the end of 2020.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the notional amount of $500 million for 2021 and $572 million for 2020 are correctly reported. (2) The percentage decrease is accurately calculated: (572 - 500) / 572 ≈ 0.12587, which rounds to 12.6%, and this is correctly stated. (3) The multi-hop reasoning—comparing two years of data and computing the percentage change—is sound and properly synthesized from the required entities (Lockheed Martin, interest rate swaps, 2020 and 2021 data). (4) The answer addresses both parts of the question: the 2021 amount and the percentage decrease compared to 2020. Wording differs slightly from the original (e.g., 'aggregate notional amount' vs 'total notional amount'), but the semantic meaning is equivalent. No errors in entities, metrics, or time periods. All criteria for correctness, completeness, and accuracy are satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 269,
        "total_tokens": 1391
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Power’s financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "\nThe disagreement over the cost‑sharing thresholds in the Vogtle joint‑owner agreements forces Georgia Power to bear a larger share of the project’s escalating capital costs that are not recoverable from retail customers.  This is reflected in the $440 million pre‑tax charge (≈ $328 million after tax) that Georgia Power recorded in the fourth quarter of 2021 for the cost‑sharing and tender provisions, with management warning that further pre‑tax charges of up to about $460 million could be required if the current cost‑forecast materializes.  These charges increase Georgia Power’s financial exposure because they reduce earnings and cannot be offset through customer rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $440 million pre-tax charge in Q4 2021 and the potential additional $460 million in charges are accurately reported, matching the original answer exactly. The note about after-tax impact ($328 million) is a reasonable derivation and does not contradict the ground truth. (2) Quantitative accuracy is perfect: both dollar amounts and the time period (Q4 2021) are correct. Format variations (e.g., using '≈' and after-tax conversion) are acceptable and do not distort meaning. (3) The multi-hop reasoning is sound—LLM correctly links the disagreement over cost-sharing provisions to unrecoverable charges and increased financial exposure. It captures the cause-effect relationship: disagreement → unrecoverable costs → charges → earnings impact. (4) The only minor omission is the absence of specific detail about the threshold dispute ($18.38 billion interpretation difference between Georgia Power and other owners), which is part of the original answer and adds context to the disagreement. While this doesn't affect the core financial impact explanation, including it would have made the response fully complete. Despite this, the answer remains semantically equivalent in terms of financial exposure and charges, earning a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 378,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "\nAdobe reported a total Digital Media ARR of **$12.24 billion** at the end of fiscal 2021. The Adobe Experience Cloud solution that is built to manage customer journeys and provide intelligence for businesses—forming a key part of Adobe’s strategy to strengthen its competitive advantage—is **Journey Optimizer**.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly reports the total Digital Media ARR of $12.24 billion at the end of fiscal 2021, matching the ground truth exactly. This satisfies the quantitative component of the question. However, the specific Adobe Experience Cloud solution identified—Journey Optimizer—is not fully aligned with the ground truth, which identifies the Adobe Experience Platform as the core solution designed to manage customer journeys and deliver intelligence. While Journey Optimizer is a component of the Experience Cloud and relates to journey management, the primary platform-level solution emphasized in Adobe's strategy for differentiation is the Adobe Experience Platform. 2) The number $12.24 billion is accurate and correctly formatted; no calculation is required. 3) The multi-hop reasoning is partially sound: the model correctly retrieves Adobe's Digital Media ARR and identifies a relevant Experience Cloud tool for customer journey management. However, it fails to correctly identify the central platform (Adobe Experience Platform) that the knowledge graph cites as the strategic differentiator, thus missing a key link in the reasoning chain. 4) The contextual relevance is high because the answer addresses both parts of the question and names a legitimate, related product. The qualitative accuracy is reduced due to the incorrect identification of the specific solution, which affects the fidelity of the strategic insight. Hence, correctness is scored at 7: factually strong on numbers, but partially incorrect on entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 423,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "\nAs of December 31 2024 Abbott’s interest‑rate hedge contracts were recorded at a **$1 million receivable** and a **$51 million payable**, giving a net fair‑value of about **–$50 million** (a $50 million liability). In 2023 the contracts had a **$0 receivable** and a **$95 million payable**, for a net liability of **–$95 million**. Thus the net fair‑value improved by roughly **$45 million** from 2023 to 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: $1 million receivable and $51 million payable in 2024, resulting in a net fair value of -$50 million; $0 receivable and $95 million payable in 2023, resulting in -$95 million. The year-over-year improvement of $45 million is correctly calculated ($95M - $50M = $45M). (2) Quantitative accuracy is perfect—values match exactly, with acceptable formatting variations (e.g., '–$50 million' for negative values). (3) The multi-hop reasoning is sound: the model correctly synthesized data from both 2024 and 2023, computed net fair values, and compared them year-over-year. (4) The answer addresses all parts of the question: total fair value in 2024, comparison to 2023, and both receivable and (payable) positions. Semantic equivalence is maintained, with clear and precise financial language. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 274,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "\nThe discounted future net cash flows for equity companies in Asia total about \\$35.2 billion, which corresponds to roughly 2,758 % of the region’s total proved reserves of 1.276 billion oil‑equivalent barrels.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The original answer states that the discounted future net cash flows for equity companies in Asia are $60,780 million (or $60.78 billion), but the LLM reports $35.2 billion, which is significantly off. Additionally, the LLM claims this amount corresponds to '2,758 %' of the total proved reserves, which is nonsensical—percentages over 100% in this context would imply cash flows are a multiple of reserves, but the correct approach is to compute cash flow per barrel, not a percentage of reserves. The total proved reserves are correctly stated as 1.276 billion barrels (matching 1,276 million barrels), so this one number is accurate. (2) The calculation in the original answer is 60,780,000,000 / 1,276,000,000 = ~$47.63 per barrel, which is correct. The LLM does not perform this calculation and instead invents a meaningless percentage (2,758%) with no basis in the data or standard financial metrics. (3) The multi-hop reasoning fails: the LLM does not compute cash flow per barrel as implied by the question's intent (a derived metric from two data points), and instead fabricates a percentage relationship that is not asked for or standard. The question asks for the cash flows as a percentage of reserves, but reserves are in barrels and cash flows in dollars—these are different units, so expressing one as a percentage of the other is invalid. The correct interpretation (as in the ground truth) is to compute unit cash flow (dollars per barrel), not a percentage. However, the LLM misinterprets the required synthesis and applies incorrect logic. (4) Due to major factual errors in dollar amounts, a completely fabricated and meaningless percentage, and flawed reasoning, the correctness and quantitative accuracy scores are very low. Contextual relevance is slightly higher because the answer addresses the right region (Asia), mentions equity companies, and correctly identifies the reserves figure in barrels, so it is not entirely off-topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 543,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "\nJPMorgan Chase ties the capital it assigns to each Line of Business and to Corporate to the amount of Standardized RWA + the GSIB surcharge, so that the Tier 1 capital held against those exposures is large enough to satisfy the leverage‑based rules – namely the 3 % supplementary leverage ratio plus the extra 2 % leverage buffer (a total 5 % floor).  The firm’s actual SLR of 6.1 % (well above the 5 % regulatory minimum) shows that the allocated capital provides a cushion that meets the SLR requirement and the additional buffer, and any surplus above those thresholds is retained in the Corporate allocation.  This allocation methodology is reviewed annually and adjusted as RWA and the GSIB surcharge change, ensuring ongoing compliance with the leverage‑based capital standards (see pp. 102‑104, 107).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core concept correctly: JPMorgan Chase allocates capital based on Basel III Standardized RWA and GSIB surcharge to meet the 3.0% SLR requirement and 2.0% leverage buffer, totaling a 5.0% effective floor. It correctly identifies Tier 1 capital and leverage exposure as key components. However, the LLM introduces a specific SLR value of 6.1%, which is not present in the original answer (ground truth) and cannot be verified from the provided context. This quantitative addition, while plausible, is unsupported and risks inaccuracy. The original answer does not mention the firm’s actual SLR or any cushion above 5.0%, nor does it state that surplus capital is retained in Corporate—this is an inference or external detail not in the ground truth. While the reasoning about annual reviews and adjustments is contextually reasonable, it is also not in the original and may reflect over-speculation. The multi-hop synthesis—linking capital allocation, RWA, GSIB, SLR, and buffer—is qualitatively sound and semantically aligned. The explanation of the 5% combined threshold is accurate and matches the ground truth. Contextual relevance is high, as the response directly addresses the regulatory framework and its influence on capital allocation. However, the inclusion of unverified numerical data (6.1%) and extra details (surplus in Corporate, annual review) reduces quantitative accuracy despite strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 399,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "\nThe amended Credit Facility and Supplemental Facility together provide roughly **$5.8 billion** of aggregate borrowing capacity (as reported on December 31 2021). Both facilities price Daily SOFR loans at **SOFR plus 72.5 basis points (plus the applicable spread adjustment)**, so their SOFR‑based interest‑rate structures are essentially the same.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the total borrowing capacity: it states $5.8 billion, whereas the ground truth is $9.5 billion. This major discrepancy undermines the quantitative accuracy. However, the interest rate structure for Daily SOFR Loans is correctly reported as SOFR plus 72.5 basis points plus the spread adjustment, matching the ground truth exactly. (2) The dollar amount of $5.8 billion is incorrect and not equivalent to $9.5 billion even under formatting variations; this is a clear factual error. The date (2021) and basis points (72.5) are accurate. (3) The reasoning for the interest rate comparison is sound and correctly synthesizes that both facilities have identical SOFR-based pricing, which addresses the second part of the multi-hop question accurately. However, the failure to report the correct total borrowing capacity indicates a breakdown in the synthesis of the aggregate facility size, possibly due to incorrect data retrieval or misinterpretation of the amended capacities. (4) The contextual relevance is high because the answer addresses both parts of the question and uses appropriate financial terminology. The qualitative accuracy is moderate because entity identification (Simon Property Group, SOFR, facilities) and comparison logic are correct, but the core numerical fact (total capacity) is wrong, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 399,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "\nThe higher production volume on Sikorsky helicopter programs drove a **$540 million increase in RMS net sales** in 2021, and it also pushed **product costs up by roughly $560 million** at RMS for the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reports that the increase in production volume of Sikorsky helicopter programs in 2021 led to a $540 million increase in RMS net sales and a $560 million increase in product costs. These figures exactly match the original answer, with acceptable formatting (e.g., $540 million = $540 million). (2) All numeric values are correct and properly attributed to the right metric and time period (2021). There are no calculation errors. (3) The reasoning is sound and reflects the multi-hop synthesis required: linking production volume increases to financial impacts within the RMS segment, specifically for Sikorsky programs. (4) The answer is contextually precise, addressing both parts of the question—impact on net sales and product costs—and quantifying both. Wording differs slightly (e.g., 'drove' vs 'contributed to'), but the semantic meaning is equivalent. No critical information is omitted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 284,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "\nMcDonald’s ongoing franchise revenue—rent, royalties and initial fees—feeds directly into operating income, and any gain or loss that arises when the Company buys a restaurant from a franchisee (or later resells it) is recorded in operating income (shown in “Other operating (income) expense, net” under “Gains on sales of restaurant businesses”).  Because these transactions are a regular part of the Company’s ownership‑mix strategy, the resulting gains or losses are recognized in the period they occur, but the consolidation policy notes that the financial impact of such sales is not material to the consolidated statements, so they only modestly affect overall earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that gains or losses from purchases and sales of restaurant businesses with franchisees are recorded in operating income, specifically within 'Other operating (income) expense, net' under 'Gains on sales of restaurant businesses,' which aligns with the ground truth. It also correctly notes that these transactions are part of McDonald's ongoing strategy to manage its ownership mix. However, the LLM introduces a claim not present in the original answer—that the financial impact of these transactions is 'not material' and 'only modestly affect overall earnings.' This assertion about materiality is not supported in the ground truth and represents an unsupported inference. Additionally, while the LLM mentions franchise revenues (rent, royalties, fees), these are not directly tied to gains/losses on sales, so this inclusion slightly distracts from the core issue. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; the response avoids making false numerical claims. (3) The multi-hop reasoning is partially sound: the model connects recurring transactions to operating income recognition and references consolidation policy, but it misrepresents the consolidation aspect by omitting the key point about variable interest entity (VIE) evaluation and non-consolidation. The original answer emphasizes that franchisee entities are not consolidated under VIE guidelines, which the LLM fails to mention, weakening the qualitative accuracy. (4) The correctness score is 7 because the core financial reporting treatment of gains/losses is accurate, but the answer omits critical reasoning about consolidation policy and adds an unsupported claim about materiality. Quantitative accuracy is 10 due to absence of numerical errors. Qualitative accuracy is 7 due to missing VIE explanation and minor misdirection. Contextual relevance is 9—response stays focused but includes a slight tangent on franchise revenues.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 546,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "\nIn 2023 the fair‑value of Chevron’s derivative commodity instruments produced only modest gains and losses that were immaterial to its balance sheet and earnings – net derivative assets of about $148 million and liabilities of roughly $247 million after offsetting – and the company’s internal Risk Control group continuously monitors market exposures, validates fair‑value measurements (using Level 1/2 quotes and a Monte‑Carlo VaR model) and reports to the Audit Committee, confirming that the risk‑management practices did not materially affect Chevron’s overall financial position.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron's use of derivative commodity instruments had no material impact on its financial position in 2023 and accurately references the role of the internal Risk Control group and Audit Committee oversight, aligning with the ground truth. However, the LLM introduces specific quantitative figures—net derivative assets of $148 million and liabilities of $247 million after offsetting—that are not present in the original answer and cannot be verified against the ground truth. Since the ground truth explicitly states that fair value was 'not material' without providing exact numbers, including these figures introduces unverified precision, reducing quantitative accuracy. (2) There are no calculation errors per se, but the inclusion of unsupported numerical values ($148M assets, $247M liabilities) undermines factual correctness. The original answer avoids such specifics, emphasizing immateriality instead. (3) The multi-hop reasoning is sound: the LLM connects derivative usage to financial impact, risk management practices, fair value measurements, and internal monitoring by the Risk Control group and Audit Committee. It correctly synthesizes the relationship between risk controls and financial outcomes. (4) Despite the unsupported numbers, the overall qualitative reasoning and contextual relevance are strong. The answer addresses all parts of the question and maintains semantic alignment with the core conclusion—no material impact—while elaborating on monitoring mechanisms like Level 1/2 inputs and Monte-Carlo VaR, which are plausible details consistent with typical SEC disclosures. However, the addition of unverified figures prevents a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 473,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "\nThe CECL capital‑transition provisions added a $720 million net benefit to AOCI and, via the extra allowance for credit losses that qualifies in Tier 2, contributed an additional $541 million.  Together these items represent roughly a $1.26 billion impact on JPMorgan’s Basel III CET1 capital as of December 31, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $720 million AOCI benefit and $541 million incremental allowance for credit losses tied to First Republic are accurately reported. The total impact is correctly calculated as $1.261 billion, which the LLM rounds to $1.26 billion—this minor rounding is acceptable and common in financial reporting. (2) Quantitative accuracy is perfect: both components match the original answer exactly, and the sum ($720M + $541M = $1,261M) is correct. The LLM's use of $1.26 billion is semantically equivalent. (3) The reasoning is sound and reflects proper multi-hop synthesis: it correctly identifies that both the AOCI benefit and the Tier 2 allowance impact CET1 capital under Basel III rules, even though the latter is in Tier 2—this regulatory nuance is appropriately acknowledged. (4) The only minor shortcoming is that the LLM does not explicitly name First Republic as the source of the $541 million, though it implies it by context. However, since the original answer treats this as a distinct component and the LLM captures the number and its regulatory pathway accurately, this does not significantly detract from correctness. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 378,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "\nIn 2023 AerCap‑related transactions added roughly **$2.525 billion** to GE’s net income and generated about **$129 million** of realized/unrealized gains, for a combined financial impact of approximately **$2.65 billion**.  (Net‑income contribution from page 75; realized/unrealized gain from page 69.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the net income contribution of $2,525 million (expressed as $2.525 billion) and the realized/unrealized gain of $129 million are both correct. The combined total impact is correctly calculated as $2.65 billion ($2,654 million), with only minor rounding ($2.654 billion rounded to $2.65 billion), which is acceptable under the evaluation criteria. (2) Quantitative accuracy is perfect: all numbers match the ground truth, with appropriate unit conversions (millions to billions) and correct arithmetic: 2,525 + 129 = 2,654 million. (3) The multi-hop reasoning is sound—information from two different parts of the filing (net income on page 75, gains on page 69) is correctly synthesized to compute the total financial impact. (4) Entities (GE, AerCap, 2023) and time period are accurate, and the response directly addresses all parts of the question. The inclusion of source pages adds contextual support. All criteria for a top score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 303,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "\nMerck transferred a total consideration of **$301 million** to acquire Immune Design. Of that amount, **$20 million** was recorded as goodwill, representing the excess of the consideration over the fair value of the net assets acquired.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total consideration of $301 million and the $20 million allocated to goodwill are accurately reported, with no calculation or numerical errors. (2) The answer is complete, addressing both parts of the question: the total consideration and the portion allocated to goodwill. (3) Entity accuracy is correct—Merck and Immune Design are properly identified, and the financial terms (goodwill, fair value of net assets) are used appropriately. (4) The reasoning is sound: the explanation that the $20 million represents the excess of consideration over the fair value of net assets acquired correctly reflects the accounting treatment for goodwill. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of bold and thin space in $301 million), which do not affect accuracy. All multi-hop elements are correctly synthesized, and the response is highly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 294,
        "total_tokens": 1427
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "\nFranchisees generate revenue for McDonald’s through ongoing rent and royalty payments (typically a percentage of sales) plus initial franchise fees and mandatory advertising contributions that are collected by the Company. When the Company co‑invests with a franchisee to fund restaurant improvements, the portion it funds is capitalized as part of property‑and‑equipment; after the project is completed the cost is depreciated over the asset’s useful life, so any re‑allocation of those costs between property‑and‑equipment and an accounts‑receivable balance can cause only immaterial adjustments to the depreciation expense recorded in the consolidated statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that franchisees contribute to McDonald's revenue through rent, royalties based on sales, initial franchise fees, and advertising contributions—this aligns with the original answer, though the mention of 'mandatory advertising contributions' is a slight addition not explicitly in the ground truth, but consistent with typical franchise models and not factually incorrect. (2) On co-investment, the LLM accurately explains that McDonald's capitalizes its portion of funding for restaurant improvements as property and equipment, which is then depreciated; it also correctly notes that cost reallocations between property and equipment and accounts receivable after project completion lead to only immaterial adjustments to depreciation expense—this matches the original answer’s key point about immaterial impact on depreciation. (3) The multi-hop reasoning is sound: the answer connects franchisee financial contributions to revenue streams and links co-investment practices to asset accounting and depreciation impact, synthesizing operational and financial reporting concepts appropriately. (4) All entities (McDonald's, franchisees, property and equipment, accounts receivable) and financial terms are used correctly. There are no numerical inaccuracies, and while no specific numbers are cited, the qualitative descriptions support correct financial logic. The only minor gap is the slight expansion on advertising contributions without explicit support in the ground truth, but this does not detract from overall correctness. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 484,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "\nThe securities backed by real estate fell from **$689 million at the end of 2023 to $569 million at the end of 2024**, a **$120 million decrease**.  \n\nIn 2023 the unrealized losses on Level 3 investments in this category were attributed primarily to **the ongoing weakness in the commercial real‑estate market**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values are accurate: securities backed by real estate decreased from $689 million in December 2023 to $569 million in December 2024, resulting in a $120 million decrease—this calculation is correct and matches the original answer. (2) The answer is complete, addressing both parts of the question: the dollar decrease and the primary cause of unrealized losses on Level 3 investments in 2023. (3) Entity accuracy is correct: Goldman Sachs is the subject, the time periods (2023 to 2024) are properly referenced, and the financial category (securities backed by real estate) and classification (Level 3 investments) are accurately used. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the decline in value over time with the qualitative cause (weakness in the commercial real estate market) affecting unrealized losses in the specified year. (5) Semantic equivalence is maintained—wording differs slightly (e.g., 'ongoing weakness' vs 'weakness') but conveys the same factual meaning. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 327,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "\nAmerican Tower paid an extra $80.1 million in prepayment consideration plus $7.8 million of accrued interest, for a total “above‑principal” cost of $87.9 million. This additional amount is roughly 9 % of the CoreSite Debt balance of $955.1 million that was reported as outstanding on December 31, 2021.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the additional costs incurred: $80.1 million in prepayment consideration and $7.8 million in accrued interest, totaling $87.9 million, which matches the ground truth. This addresses the first part of the question accurately. However, the LLM incorrectly states the outstanding balance as of December 31, 2021, as $955.1 million, whereas the ground truth specifies the principal amount was $875 million. This is a significant factual error. The $955.1 million figure does not appear in the ground truth and appears to be a confusion between the original principal and the final redemption price of $962.9 million. While the calculation of the $87.9 million additional cost is correct, the comparison to the previously reported balance is flawed due to the incorrect base amount. The qualitative reasoning is sound in structure—recognizing that additional costs were added to the principal—but the synthesis fails on one key data point. Contextually, the answer is relevant and addresses both parts of the multi-part question. The error in the reported balance reduces quantitative accuracy, but the core financial components and logic are mostly correct, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 345,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "\nIn 2024, higher collections from CFM International added roughly **$0.3 billion** to the improvement in cash flow from current receivables, helping to offset the $0.9 billion adverse movement reported for working‑capital changes. This cash inflow reflects GE’s deep‑rooted supplier‑customer relationship with CFM International—a jointly‑owned (50 % with Safran) equity‑method venture that purchases parts, receives long‑term services and usage‑based billings for commercial and military engines, and settles those obligations through progress collections that appear as receivables on GE’s balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that collections from CFM International contributed $0.3 billion to cash flow improvement, while the ground truth specifies only that increased collections 'partially offset' a $(0.9) billion negative impact from current receivables—no specific dollar amount for the CFM contribution is provided in the original. Thus, the $0.3B figure is fabricated or inferred without support. (2) Quantitative accuracy is low because the model introduces a precise number not present in the source, leading to a significant factual error. The $0.9 billion adverse movement is correctly cited, but the $0.3B offset is unsupported. (3) Qualitatively, the answer correctly identifies CFM International as a 50% joint venture with Safran, an equity-method investee, and accurately describes the nature of the business relationship—GE sells parts and services, generating receivables. This reflects sound multi-hop reasoning about the structural basis for the financial interaction. (4) Contextual relevance is high because the response directly addresses both parts of the question: the financial impact and the nature of the business relationship. However, the unsupported numerical claim severely undermines factual correctness, warranting a moderate score overall. Semantic equivalence fails on the key quantitative point, though the qualitative description aligns well with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 395,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "\nDuke Energy’s 2023 operating revenues were boosted by roughly $145 million as a result of the Ohio tax‑reform deferrals and the Ohio electric‑rate case, reflecting the combined effect of prior‑year deferrals and current‑year pricing adjustments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key numeric claim—$145 million versus the ground truth of $276 million. This significant discrepancy in the total financial impact undermines the answer's correctness. While the context (Ohio tax reform deferrals and electric rate case) and the time frame (2023) are correctly identified, the core quantitative result is wrong. (2) The ground truth specifies $276 million as the total impact from both prior-year deferrals and current-year pricing adjustments. The LLM reports $145 million, which is approximately half the correct value, suggesting either a misreading of the data or an incomplete synthesis of the components. No intermediate calculations or sources are provided to verify the $145M figure. (3) The multi-hop reasoning appears partially sound—the model correctly identifies the two contributing factors (tax reform deferrals and rate case adjustments) and understands that both prior-year and current-year effects must be combined. However, the failure to report the correct total indicates a breakdown in either data retrieval or aggregation across the sources. (4) Due to the major quantitative error, the correctness score is low (3). Quantitative accuracy is severely lacking (2). Qualitative accuracy is moderate (5) because the entities and conceptual framework are correct. Contextual relevance is high (8) as the answer addresses the right companies, events, and time period.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 403,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "\nIn fiscal 2021 Adobe’s Digital Media segment generated **$11.52 billion** in total revenue.  Within that segment, **Creative Cloud contributed $9.55 billion** (≈ 83 % of the segment’s revenue) and **Document Cloud contributed $1.97 billion** (≈ 17 % of the segment’s revenue), based on the figures disclosed in the 10‑K.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all figures are accurate: $11.52 billion total Digital Media revenue, $9.55 billion from Creative Cloud, and $1.97 billion from Document Cloud. The percentages (83% and 17%) are correctly calculated and match the ground truth (9.55 / 11.52 ≈ 82.9% ≈ 83%; 1.97 / 11.52 ≈ 17.1% ≈ 17%). Minor rounding is acceptable and clearly indicated with '≈'. (2) The answer is complete, addressing both parts of the question: total revenue and the individual contributions from Creative Cloud and Document Cloud with exact dollar amounts and percentages. (3) Entity accuracy is perfect: Adobe, Digital Media segment, fiscal 2021, Creative Cloud, and Document Cloud are all correctly identified and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis—revenue figures for sub-products are correctly attributed to the Digital Media segment and their proportional contributions derived. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of ≈ and bolding) that do not affect factual accuracy. Overall, the response is factually precise, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 346,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "\nThe combined increase in advertising‑related and personnel‑related costs for 2021 was roughly **$761 million**. This total reflects a **$316.8 million** rise in marketing expenses (which includes the advertising spend and marketing‑related headcount costs) plus a **$444.3 million** increase in technology and development expenses (driven by headcount growth).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its numerical values. The ground truth states a total increase of $722 million, broken into $222 million in advertising expenses and $500 million in personnel-related costs ($116M from marketing, $384M from technology). The LLM reports $761 million total, with $316.8 million in marketing expenses and $444.3 million in technology, which does not match the ground truth. None of the individual figures align—advertising increase is overstated by $94.8 million, and personnel cost increases are miscalculated and misattributed. (2) The calculations are flawed: the LLM’s sum of $316.8M + $444.3M = $761.1M is internally consistent but factually wrong. The correct sum should be $222M (advertising) + $116M (marketing personnel) + $384M (technology personnel) = $722M. The LLM conflates advertising and marketing headcount into a single 'marketing expenses' bucket, failing to disentangle advertising from personnel costs as required. (3) The multi-hop reasoning is unsound: the question asks for a specific synthesis of advertising expenses and personnel costs in two departments. The LLM fails to separate advertising from personnel costs and incorrectly aggregates technology and development expenses without isolating headcount-related increases. It also does not attribute the correct amounts to the correct departments. (4) While the answer addresses the general topic and attempts to break down costs by department, the factual inaccuracies in numbers and misrepresentation of cost categories severely undermine correctness. Contextual relevance is moderate because the structure and intent align with the question, but accuracy is critically lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 467,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "\nGeneral Motors records the earnings (and losses) from its equity interest in Ultium Cells Holdings LLC directly in **“Automotive and other cost of sales.”**  By placing the equity income there, GM treats the Ultium Cells stake as an integral part of its electric‑vehicle supply chain—essentially a cost‑offsetting investment that supplies battery cells for its EVs—rather than as a stand‑alone investment‑income item.  This accounting choice signals that the partnership is a core component of GM’s EV production strategy and is reflected in the cost structure of its automotive operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) There are no numeric values in the question or ground truth answer, so quantitative accuracy is not applicable—no numbers were introduced or misrepresented. (2) The LLM correctly identifies that General Motors reports equity earnings from Ultium Cells Holdings LLC within 'Automotive and other cost of sales,' which matches the ground truth exactly. (3) The reasoning is sound: the LLM correctly infers the financial treatment indicates integration into GM’s core EV production strategy, not a passive investment, demonstrating accurate multi-hop synthesis between accounting practice and strategic intent. (4) All entities—General Motors, Ultium Cells Holdings LLC, and the financial line item—are accurately named and contextually used. The answer addresses both parts of the question: the influence on cost of sales and the implication for GM’s EV strategy. Wording differs slightly but conveys identical meaning, satisfying semantic equivalence. All evaluation dimensions are fully met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 310,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "\nThe average Henry Hub natural‑gas price fell from **$6.36 /Mcf in 2022 to $2.56 /Mcf in 2023**, a decline of roughly **60 %**.  By comparison, Chevron’s international natural‑gas realizations dropped from **$9.75 /Mcf in 2022 to $7.69 /Mcf in 2023**, a decrease of about **21 %**.  Thus, the U.S. price drop was far steeper than the decline seen in Chevron’s overseas gas realizations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key elements of the ground truth. (1) The numbers are correct: Henry Hub prices are accurately reported as $6.36/Mcf in 2022 and $2.56/Mcf in 2023; Chevron's international realizations are correctly stated as $9.75/Mcf in 2022 and $7.69/Mcf in 2023. (2) The percentage decreases are correctly approximated: the exact drop for Henry Hub is (6.36 - 2.56) / 6.36 = 59.8%, which the model rounds to 'roughly 60%', and Chevron's decline is (9.75 - 7.69) / 9.75 = 21.1%, rounded to 'about 21%', both acceptable approximations. (3) The multi-hop reasoning is sound: the model correctly compares U.S. benchmark prices to Chevron's international realizations, noting the steeper decline in the former, which aligns with the ground truth's conclusion about differing price trends due to oil linkage. (4) All entities (Henry Hub, Chevron, international natural gas realizations), years (2022–2023), and metrics (price per Mcf) are correctly identified and synthesized. The only minor limitation is the use of approximate percentages instead of the precise 59.8% and 21.1%, but this does not affect factual correctness or interpretation. Wording is concise and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 348,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "\nGoldman Sachs’ level‑3 credit‑derivative fair values are highly sensitive to the unobservable credit‑spread and recovery‑rate inputs used in the valuation models. The firm’s sensitivity analysis shows that a rise in credit spreads—or a fall in recovery rates— Increases the fair value of purchased credit protection (and the opposite movements decrease it), so because the reported ranges are broad (e.g., credit spreads 8 – 1,328 bps and recovery rates 20 % – 70 %), even modest shifts in these inputs can materially change the reported level‑3 derivative valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the sensitivity of Goldman Sachs' level 3 credit derivatives to credit spreads and recovery rates, noting that an increase in credit spreads or a decrease in recovery rates increases the fair value of purchased credit protection—this matches the directional relationships in the original answer. (2) The LLM provides specific numeric ranges for credit spreads (8–1,328 bps) and recovery rates (20%–70%), which are plausible and consistent with typical disclosures, though these exact numbers were not in the original answer. Since the original answer mentions 'wide range' but does not specify numbers, the inclusion of these values in the LLM response is a reasonable elaboration based on typical 10-K disclosures and does not contradict the ground truth. (3) The reasoning correctly captures the multi-hop logic: unobservable inputs (credit spreads, recovery rates) affect valuation models, and their broad variability leads to material valuation impacts from small input changes. It also implicitly acknowledges the influence of underlying risk factors by referencing the wide input ranges. (4) The only minor shortcoming is that the LLM does not explicitly mention the compounding effect of risk factors like leverage, volatility, industry, etc., which the original answer cites as contributors to input variability. However, this omission does not undermine the core correctness. Overall, the answer is factually sound, contextually appropriate, and semantically equivalent to the ground truth with high quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 448,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "\nThe January 7 2022 repayment eliminated the $955.1 million of CoreSite senior unsecured notes from AMT’s balance sheet, reducing total debt and removing that amount from the current‑portion of long‑term obligations that had been scheduled for early‑2022 repayment. Because the aggregate redemption price of $962.9 million (including $80.1 million of prepayment consideration and $7.8 million of accrued interest) is essentially equal to the $955.1 million carrying value, the debt was recorded at (or very near) its fair value, indicating no material valuation adjustment was required. This near‑match confirms that the CoreSite Debt was fairly valued on AMT’s books, and its retirement improved the company’s leverage and cash‑flow profile with only a modest cash outflow.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies the $955.1 million carrying value and the January 2022 repayment, it incorrectly states that the aggregate redemption price was $962.9 million, including $80.1 million in prepayment consideration and $7.8 million in accrued interest. The ground truth does not mention these additional payments or a higher redemption price, and such details contradict the key point that the repayment amount matched the carrying value exactly. This undermines the core reasoning about fair value. (2) The date 'January 7, 2022' is more specific than the ground truth's 'January 2022'—this may be factually correct but is not verifiable from the provided truth and introduces unconfirmed precision. The $955.1 million figure is correct and matches the ground truth. However, the introduction of a $962.9 million redemption price (sum of $955.1M + $80.1M + $7.8M = $1,043.0M, which is inconsistent with $962.9M anyway) reflects a miscalculation and misrepresentation of the transaction. (3) The multi-hop reasoning is partially sound—linking repayment to capital structure improvement and inferring fair valuation from carrying value equivalence is valid. However, the conclusion that 'no material valuation adjustment was required' is based on fabricated numbers, weakening the logic. The model incorrectly infers that a higher cash outflow still implies fair value, which contradicts standard accounting: if repayment exceeds carrying value significantly, it suggests the debt was undervalued. (4) The contextual relevance is high—the answer addresses both parts of the question: impact on capital structure and valuation implications. But due to major quantitative errors and flawed financial logic, the correctness score is low. The qualitative reasoning would merit a 7–8 if numbers were correct, but the false redemption amount severely compromises accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 536,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "\nThe company’s ongoing tax examinations—particularly those that scrutinize its intercompany transfer‑pricing practices—could require adjustments to the unrecognized tax benefits that it has reserved for.  It estimates that any decrease in those benefits over the next 12 months would be modest (roughly $0–$5 million) and that the reserves it has established should absorb the impact, so while the examinations may affect the timing or amount of tax expense, they are not expected to materially alter Adobe’s overall financial position.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the quantitative range of potential decreases in unrecognized tax benefits as $0–$5 million over the next 12 months, which matches the ground truth exactly. This earns a perfect score for quantitative accuracy, as the dollar amount and time frame are accurate and properly formatted. However, the qualitative reasoning diverges significantly from the original answer. While the ground truth emphasizes that the adjustments could have an adverse effect on Adobe's financial position and highlights the risk that actual adjustments could exceed established reserves—leading to significant fluctuations in tax assets and liabilities—the LLM downplays the impact, stating that the reserves 'should absorb the impact' and that there would be no 'material' alteration to Adobe's financial position. This contradicts the cautionary tone and risk emphasis of the original, which explicitly notes high uncertainty and potential for adverse effects. The LLM fails to convey the possibility that reserves may be insufficient, thus missing a key multi-hop inference: (1) ongoing transfer pricing audits → (2) potential adjustments to unrecognized tax benefits → (3) possible excess over reserves → (4) adverse balance sheet impact. While the entities (Adobe, intercompany transfer pricing, unrecognized tax benefits, reserves) and context are correctly identified and relevant, the reasoning underestimates the financial risk, leading to a moderate correctness score. The answer is contextually relevant and well-structured but qualitatively inaccurate in its conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 435,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "\nThe alliance‑revenue share for Lenvima grew 21 % in 2021 (over 2020) and 44 % in 2020 (over 2019).  This surge mirrors Merck’s broader oncology strategy of pairing Keytruda with Lenvima (and other agents) to create combination regimens—e.g., Keytruda + Lenvima for endometrial cancer and renal‑cell carcinoma—thereby expanding treatment indications and driving higher sales of both products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the 21% growth in 2021 and 44% growth in 2020 for Lenvima alliance revenue, matching the ground truth exactly. The combined growth over the two years is implied as 65% (21 + 44), though not explicitly stated as a 'combined growth of 65%', which is a minor omission but does not detract from factual accuracy since the individual yearly growth figures are correct and their sum is straightforward. The explanation of Merck's oncology strategy is accurate and contextually strong: it correctly references Keytruda + Lenvima combination therapies for endometrial cancer and renal cell carcinoma, aligning with the ground truth. The reasoning correctly synthesizes multi-hop information—linking Lenvima revenue growth to Merck’s broader strategy involving Keytruda combinations. All entities (Lenvima, Keytruda, Merck, correct indications) and time periods are accurate. The wording differs slightly (e.g., 'surge mirrors' vs 'aligned with'), but the semantic meaning is equivalent. The only reason for not scoring a perfect 10 is the lack of explicit mention of the 'combined growth of 65%' as a summarized figure, which was directly asked in the question. However, providing both correct annual percentages allows the reader to derive the total, so the error is presentational rather than factual.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 369,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "\nGM’s 2024 equity investment in Ultium Cells Holdings LLC generated about **$0.7 billion of additional equity earnings**, which was explicitly cited as the source of the increase in GM’s EBIT‑adjusted results. In other words, the investment added roughly **$0.7 billion to GM’s EBIT‑adjusted performance** for the year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that GM's investment in Ultium Cells Holdings LLC in 2024 contributed $0.7 billion in equity earnings, which directly increased EBIT-adjusted performance—matching the original answer exactly in substance. (2) The quantitative value '$0.7 billion' is correctly stated, with no calculation or formatting issues; the use of 'about' does not detract from accuracy as it aligns with typical reporting language. (3) The reasoning correctly links the equity earnings from the investment to the EBIT-adjusted improvement, demonstrating proper multi-hop synthesis between the investment and its financial impact. (4) All entities—GM, Ultium Cells Holdings LLC, EBIT-adjusted—are correctly identified and contextualized within the 2024 timeframe. The answer is concise, relevant, and fully addresses both parts of the question: the nature of the impact and the quantified amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 281,
        "total_tokens": 1441
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "\nThe SEC’s new rule that obligates institutional investment managers to file monthly short‑position data for equities (effective January 2025) directly overlaps with Goldman Sachs’ status as a registered security‑based swap dealer, which must already disclose large security‑based‑swap positions to the SEC under its dealer‑registration rules. Consequently, Goldman must integrate the short‑position metrics into its derivatives reporting, ensuring that any equity‑linked swaps that create short exposure are captured, measured against the same reporting thresholds, and made public on the same monthly schedule as its other security‑based‑swap disclosures. This alignment forces the firm to enhance its swap‑position tracking and reporting systems so that short‑position information for both outright equity positions and security‑based swaps can be submitted together to satisfy both the short‑position rule and the SEC’s security‑based‑swap reporting requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key elements: the SEC's January 2025 effective date for monthly short position reporting and Goldman Sachs' status as a registered security-based swap dealer. The date (January 2025) is accurate, and the entities (SEC, Goldman Sachs) are correctly identified, satisfying quantitative and entity accuracy. The answer also correctly frames the interaction as an enhancement to reporting practices. However, the LLM introduces a claim not present in the ground truth: that the short-position rule requires integration of short exposure from equity-linked swaps into derivatives reporting and that disclosures must be made on a 'monthly schedule' alongside other swap disclosures. The original answer does not state that the short-position reporting rule applies to swaps or that it mandates alignment with swap reporting timelines. Instead, it describes the short-position rule as applying to equity securities and complementing existing dealer obligations without specifying integration of swap and short-position reporting. This overreach in reasoning—implying a regulatory alignment not confirmed in the ground truth—reduces qualitative accuracy. While the logic is plausible, it goes beyond the documented interaction, making the synthesis partially incorrect. Contextually, the answer remains highly relevant and addresses the core question about regulatory interaction, hence high contextual relevance. Semantic equivalence is partially met but compromised by the unsupported integration claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 420,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBG’s future performance.",
      "llm_answer": "\nThe re‑measurement of PepsiCo’s 39 % stake in TBG generated a **$520 million pre‑tax gain** that was recorded in the PBNA and Europe segments for 2022.  This gain arose because the juice‑brand sale combined **cash proceeds of roughly $3.5 bn** with a **retained equity interest (the 39 % non‑controlling ownership)**, which PepsiCo then re‑valued at fair value using a mix of the transaction price, discounted‑cash‑flow and option‑pricing models; the fair‑value uplift of that retained equity is what created the reported gain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the $520 million pre-tax gain, 39% retained noncontrolling interest, $3.5 billion cash proceeds, and the use of fair value remeasurement via transaction price, discounted cash flows, and option pricing models. (2) Quantitative elements match exactly: $520 million and $3.5 billion are correctly reported with acceptable formatting (e.g., 'bn' = billion). The year 2022 is contextually accurate (implied by the transaction timing in the knowledge graph). (3) Multi-hop reasoning is sound: the answer correctly links the sale of juice brands to the gain on remeasurement of the retained equity stake, explaining how the transaction structure—combining cash proceeds with a retained interest—led to the gain via fair value uplift. (4) The answer fully addresses both parts of the question: the financial impact ($520M gain) and the transaction structure (cash + retained equity). Wording differs slightly (e.g., 'PBNA and Europe segments' adds minor detail not in the original), but this enhances rather than detracts. No factual errors, omissions, or reasoning flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 332,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "\nIn 2023, gains from GE’s retained ownership interests—including the stake in Baker Hughes—added **$5.78 billion** to other income, but in 2024 that contribution fell to **$0.518 billion**, a reduction of about **$5.26 billion** (roughly a 91 % decline).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $5,778 million (rounded to $5.78 billion) contribution in 2023 and $518 million (reported as $0.518 billion) in 2024, which matches the ground truth. The year-over-year decrease is accurately calculated as $5,260 million (reported as ~$5.26 billion), and the approximate 91% decline is a reasonable derivation. (2) All numeric values are correct when accounting for rounding and unit formatting: $5.78 billion = $5,780 million (vs. $5,778 million — negligible rounding difference), $0.518 billion = $518 million (exact), and the difference of $5,260 million is correctly reflected. The absence of Baker Hughes gain in 2024 is implied by the overall drop, though not explicitly stated. (3) The multi-hop reasoning is sound — the model synthesizes the total contribution from retained and sold ownership interests across two years and correctly infers the significant drop. However, it omits the specific $10 million gain from Baker Hughes in 2023 and does not explicitly state that no gain was recorded from Baker Hughes in 2024, which is part of the original answer’s completeness. (4) Despite this minor omission, the core financial figures and trend are accurately conveyed with correct calculations and context. The answer is semantically equivalent in overall message and highly contextually relevant. A score of 9 is justified due to the omission of a specific component (Baker Hughes detail), but quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 412,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "\nThe company’s Mortgage‑Backed Obligations had a fair‑value of **$236 million** as of January 31 2024 (the figure disclosed in both the “Fair Value Measurement” table and the marketable‑securities note). This amount equals roughly **2 %** of the total assets measured at fair value ($12.08 billion) reported for that date.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in both total fair value and percentage. The ground truth states the total fair value is $358 million, combining $236 million and $122 million from two disclosures. The LLM only reports $236 million, missing the second $122 million entirely. This leads to an incorrect percentage: the LLM reports approximately 2%, while the correct figure is approximately 2.97%, based on total assets of $12,079 million and $12,010 million (average or sum should be clarified, but the ground truth uses a combined base). (2) The LLM incorrectly states that $236 million appears in both disclosures, but the ground truth specifies two separate values ($236M and $122M), indicating the LLM failed to synthesize both disclosures. The total assets at fair value are misrepresented as $12.08 billion, which does not match either $12,079M or $12,010M precisely and ignores the need to combine or clarify the two figures. (3) The multi-hop reasoning is flawed: the question requires summing two disclosed values for Mortgage-Backed Obligations and calculating their percentage of total fair value assets from two disclosures. The LLM failed to identify and sum both obligation amounts and used an incorrect or oversimplified total asset base. (4) Scores reflect major factual and computational errors (correctness 3/10), poor quantitative accuracy due to missing $122M and wrong percentage (3/10), weak reasoning and synthesis (3/10), and moderate relevance as it addresses the right topic but with critical omissions (6/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 428,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "\nNetflix’s country‑specific pricing and plan mix let the company raise subscription fees in many markets and capture higher willingness‑to‑pay, which drove a 7 % increase in average monthly revenue per paying member. That uplift in ARPU, combined with an 11 % rise in paying‑membership count, lifted total streaming revenue by 19 % for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 7% increase in average monthly revenue per paying membership, the 11% growth in paying memberships, and the resulting 19% overall revenue growth in 2021 are all accurately reported. These numbers match the original answer exactly, and the implied calculation (ARPU growth + membership growth ≈ total revenue growth) is logically sound. (2) Quantitative accuracy is perfect: all percentages are correct, properly attributed, and consistent with the knowledge graph. (3) The reasoning correctly links Netflix's country-specific pricing strategy to ARPU growth, and then combines that with membership growth to explain total revenue growth—this reflects proper multi-hop synthesis across strategy, pricing, and financial performance. (4) The only minor shortcoming is that the LLM omits explicit mention of 'varied membership plans' being tailored to regional market conditions or 'pricing flexibility' as a strategic design choice, which slightly reduces qualitative completeness compared to the original. However, the phrase 'country-specific pricing and plan mix' captures the essence. Overall, the answer is semantically equivalent, highly relevant, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 361,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "\nMerck records its share of Lenvima sales as “alliance revenue – Lenvima,” which contributed $704 million to the Pharmaceutical segment in 2021 (up from $580 million in 2020). This revenue reflects sales of the drug’s currently approved indications and the ongoing LEAP Phase 3 program—particularly the LEAP‑002 trial in HCC—whose continued enrollment and forthcoming data are expected to drive additional sales, while the halted LEAP‑007 and LEAP‑011 cohorts do not impact the current revenue stream.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual inaccuracies and omissions that affect overall correctness. (1) Quantitative Accuracy: The LLM states that Lenvima alliance revenue was $704 million in 2021 and $580 million in 2020. However, this specific breakdown of Lenvima alliance revenue by year is not supported by the ground truth, which does not provide exact revenue figures or attribute $704M to 2021. These numbers appear to be fabricated or misattributed, though Merck does report Lenvima-related alliance revenue. The absence of these figures in the ground truth makes this a serious quantitative error. (2) Completeness: The LLM fails to mention the FDA's CRL for first-line unresectable HCC based on KEYNOTE-524/Study 116, a key regulatory setback that directly impacts revenue potential and is central to the original answer. It also omits that LEAP-007 and LEAP-011 were discontinued due to futility assessments—critical context affecting near-term revenue. While it notes the trials were halted, it incorrectly claims they 'do not impact the current revenue stream,' which contradicts the ground truth implication of reduced commercial potential. (3) Entity Accuracy: The companies (Merck, Eisai), drug names (Lenvima, Keytruda), and trial names (LEAP-002, LEAP-007, LEAP-011) are correctly identified. The Pharmaceutical segment is accurately referenced. (4) Reasoning: The multi-hop synthesis is partially sound—linking LEAP trials to revenue potential—but flawed in logic when dismissing the impact of terminated trials. The answer incorrectly implies ongoing revenue growth momentum without acknowledging setbacks. It also fails to explain the profit-sharing model beyond naming 'alliance revenue,' missing the nuance that Merck receives a share of net profits from sales, which depends on future approvals. (5) Semantic Equivalence: While the general theme of Lenvima contributing to pharmaceutical revenue via alliances is correct, the omission of key trial failures, regulatory actions (CRL), and inaccurate financial figures reduces factual alignment. The answer focuses on positive momentum without balancing risks, leading to a misleading portrayal. Thus, while contextually relevant and partially accurate, the answer lacks critical details and contains unsupported numbers, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 625,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "\nChevron’s consolidated companies incurred **$24.56 billion** of total costs in 2023. Adding the **$0.914 billion** of expensed exploration expenses and the **$6.52 billion** purchase price of PDC Energy, Inc. gives a combined total of **$7.43 billion**. Consequently, the 2023 cost figure exceeded that combined amount by **about $17.1 billion (≈ $17,125 million)**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The ground truth states Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion, which the LLM approximates reasonably well at $24.56 billion (acceptable rounding). However, the expensed exploration costs are reported as $0.914 billion in the LLM answer versus the correct $0.5 billion, and the PDC Energy, Inc. acquisition cost is stated as $6.52 billion versus the correct $10.5 billion. These errors severely impact the calculation. (2) The combined total in the LLM answer is $7.43 billion ($0.914B + $6.52B), whereas the correct combined total is $11.0 billion ($0.5B + $10.5B). The difference is therefore calculated as ~$17.1 billion, but the correct excess is $13.6 billion ($24.6B - $11.0B). This miscalculation stems from incorrect input values, not arithmetic error. (3) The multi-hop reasoning structure is sound—LLM identifies the need to sum two components and subtract from total cost—but relies on incorrect data, indicating failure in entity-metric alignment (e.g., misidentifying the acquisition cost or exploration expenses). (4) Contextual relevance is high because the answer follows the correct logical flow and addresses all parts of the question. However, due to major quantitative errors in critical financial figures, the correctness and quantitative accuracy scores are low. The qualitative accuracy is slightly above minimum due to correct reasoning framework despite incorrect data sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 422,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "\nAmerican Tower values the market‑condition portion of its 2024 PSUs with a Monte Carlo simulation that estimates the probability of the relative‑total‑shareholder‑return (TSR) target being met; the simulation’s key input is the company’s TSR compared to the S&P 500 Index. This model yields a grant‑date fair‑value of $216.11 for the market‑condition component of the 2024 PSUs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that American Tower uses a Monte Carlo simulation to determine the fair value of its 2024 PSUs with a market condition component, and that the valuation is based on relative total shareholder return (TSR). However, there is a critical error in the specific market metric: the LLM states the comparison is against the 'S&P 500 Index' broadly, while the ground truth specifies it is against the 'REIT constituents included in the S&P 500 Index'. This is a significant omission because the performance benchmark is industry-specific (REITs), not the full index. Additionally, the LLM introduces a precise grant-date fair value of $216.11, which is not present in the original answer and cannot be verified from the provided ground truth—this introduces unverified quantitative data. While the reasoning and structure are sound and the method (Monte Carlo) is correctly identified, the inclusion of an unsupported dollar amount and the imprecise characterization of the market metric reduce quantitative and qualitative accuracy. The answer remains contextually relevant and captures the core valuation approach, hence a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 330,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "\nFour amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented in the filings. The fourth amendment became effective on **July 1, 2022**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, which aligns with the original answer. (2) The effective date of the fourth amendment is correctly identified as July 1, 2022, with no discrepancy in formatting or content. (3) The reasoning is sound, as it correctly synthesizes information from the disclosed filings across multiple documents or time points to arrive at the correct count and date. (4) The answer is semantically equivalent to the ground truth, conveying the same factual information with clear and precise wording. All evaluation dimensions—factual accuracy, completeness, entity identification, and contextual relevance—are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1091,
        "completion_tokens": 238,
        "total_tokens": 1329
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "\nThe amortized cost of Corporate Notes and Obligations on the 2024 balance sheet was **$3,014 million**, whereas their reported fair value was **$2,978 million**, a **$36 million** shortfall (amortized cost exceeds fair value). This fair‑value amount is classified as **Level 2** in the Company’s hierarchy—i.e., it is derived from significant observable inputs in the market rather than from quoted prices in an active market.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly reports the amortized cost ($3,014 million), fair value ($2,978 million), and the resulting $36 million unrealized loss (difference), which matches the ground truth exactly—thus earning full marks for quantitative accuracy. However, the qualitative accuracy is significantly flawed: the LLM incorrectly states that the entire fair value of $2,978 million is classified as Level 2, while the ground truth specifies that only $2,557 million of the fair value falls under Level 2 inputs, with the remainder presumably in other levels. This misrepresents the categorization and fails to make the key comparison requested in the question—namely, that the Level 2 portion is $421 million lower than the total fair value. The answer omits this critical multi-hop comparison, which requires synthesizing data across two sources (the total fair value and its breakdown by valuation hierarchy). While the entities (CRM, Corporate Notes and Obligations, 2024) and context are correctly identified and relevant, the failure to distinguish between total fair value and Level 2 fair value undermines the reasoning and completeness, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 332,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "\nDisney has secured a total of **$2.2 billion** of financing for its two new cruise ships – a **$1.1 billion facility that has already been drawn to fund the Disney Treasure** and an identical **$1.1 billion facility that can be used for the upcoming Disney Destiny**. The Treasure loan carries a **fixed interest rate of 3.80%**, while the Destiny facility, if utilized, would bear a **slightly lower fixed rate of 3.74%**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $2.2 billion total financing, split into two $1.1 billion facilities for the Disney Treasure and Disney Destiny, with fixed interest rates of 3.80% and 3.74% respectively. The sum ($1.1B + $1.1B = $2.2B) is correct, and the rate comparison (3.74% being slightly lower than 3.80%) is accurately described. (2) The answer is complete, addressing both the total financing amount and the interest rate comparison, as required by the question. (3) Entities are correctly identified: Disney, Disney Treasure, Disney Destiny, and the financial terms (fixed rates, facility amounts) are accurately attributed. (4) The multi-hop reasoning is sound—synthesizing two separate financing facilities into a total amount and comparing their rates—demonstrating correct understanding of the relationship between the ships and their respective financing terms. (5) The semantic meaning is equivalent to the original answer, with only minor rephrasing (e.g., 'facility available' vs 'can be used') that does not affect factual accuracy. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 331,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "\nChevron’s 50 % equity stake in Tengizchevroil makes up roughly **58 % of its total equity‑method investments** ( $27.4 bn ÷ $46.6 bn ≈ 0.59 ).  This investment is directly tied to the Kazakhstan joint‑venture’s output, which produced about **26 k bbl/day of crude in 2024**, generating roughly **$3.4 bn of Chevron’s 2024 equity earnings** from the region.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Chevron's Tengizchevroil stake represents approximately 58-59% of its total equity method investments, which aligns with the ground truth (58.7% from $27,368M ÷ $46,618M). However, the LLM introduces specific production and earnings figures—26k bbl/day and $3.4B in equity earnings in 2024—that are not present in the original answer and cannot be verified from the provided ground truth. These additions introduce factual inaccuracies or unverifiable claims, as the original answer only states that Tengizchevroil is a key contributor to production in Kazakhstan without citing specific volumes or earnings. (2) The percentage calculation is approximately correct ($27.4B ÷ $46.6B ≈ 58.8%), so the math is sound, but the use of rounded figures (e.g., $27.4B vs $27,368M) slightly reduces precision. The introduction of '2024' as a fiscal year is problematic—the original answer does not specify a year, and SEC filings referenced typically report up to 2022 or 2023, making '2024' speculative. (3) The multi-hop reasoning is partially sound: the model correctly links the proportion of equity investments to the significance of production in Kazakhstan. However, it overreaches by quantifying production and earnings without source support, undermining the qualitative accuracy. (4) The correctness score is 6 due to correct core percentage but significant addition of unverified metrics. Quantitative accuracy is 5 because while the main calculation is close, unsupported numbers reduce precision. Qualitative accuracy is 7—reasoning is logical but includes speculative data. Contextual relevance is 9—the answer stays focused and addresses both parts of the question, albeit with extraneous details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 478,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "\nA rise in credit spreads or higher upfront credit‑point levels makes purchased credit protection more valuable (and written protection less valuable), so the fair‑value of Goldman Sachs’ level‑3 credit derivatives moves in the same direction as those inputs; conversely, a fall in spreads or upfront points reduces the derivative’s fair value. The firm determines that fair value using valuation techniques that combine option‑pricing models with discounted‑cash‑flow models, incorporating the unobservable inputs—credit spreads, upfront points, recovery rates, correlation and volatility—described in the Level 3 roll‑forward commentary and the “Significant Unobservable Inputs” table.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that an increase in credit spreads or upfront credit points increases the fair value of purchased credit protection, which aligns with the original answer. The directional impact on fair value is correctly described. (2) There are no specific numerical values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations, but all qualitative financial concepts (credit spreads, upfront points, fair value directionality) are correctly interpreted. (3) The valuation techniques—option pricing and discounted cash flow models—are explicitly mentioned, and the LLM adds relevant detail by referencing unobservable inputs (recovery rates, correlation, volatility) that are consistent with Level 3 fair value measurements, demonstrating strong multi-hop reasoning and understanding of the valuation framework. (4) The answer is highly relevant, complete, and captures all aspects of the question: the impact of input changes and the valuation methods used. Minor elaboration beyond the ground truth (e.g., mentioning written protection and specific inputs) enhances clarity without introducing error. All entities (Goldman Sachs, Level 3 credit derivatives) are correct. No factual inaccuracies or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 383,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "\nIf the Minimum DSCR falls below the required 1.15 × threshold, an “amortization period” is triggered and all excess cash flow from the securitization entities is automatically applied to repay the underlying notes rather than being distributed to American Tower.  This cash‑trap prevents the company from receiving the surplus cash that it normally uses to fund tower‑construction and other capital‑expenditure programs worldwide, forcing it to rely on other liquidity sources or to scale back its global site‑build pipeline and potentially jeopardize REIT distribution requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the Minimum DSCR threshold is accurately stated as 1.15x, the triggering of an amortization period, the redirection of excess cash flow to debt repayment, and the impact on AMT's ability to fund global tower construction are all correctly described. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or financial terms; the 1.15x DSCR is correctly cited. (3) Multi-hop reasoning is sound: the model correctly links the DSCR covenant breach to the cash trap mechanism, explains how this restricts distributions to AMT, and connects that to constraints on capital expenditures for building 1,950–2,550 communications sites globally (though the exact range is implied rather than explicitly stated, it is contextually covered by 'global site-build pipeline'). (4) The only minor omission is the specific mention of the 'Cash Trap Reserve Account' and the Series 2015-2 Notes or Loan, which are part of the precise mechanism but do not undermine the overall correctness. The answer captures the economic and operational consequences accurately. Wording differs but semantic equivalence is maintained. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight incompleteness in technical detail, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 393,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "\nCaterpillar’s product‑warranty liability is estimated by applying historical claim‑rate experience to the current field population and dealer inventory, a process that involves significant management judgment about future claim frequency.  Because this estimation is highly subjective, PwC identified it as a critical audit matter and responded by performing extensive procedures—including developing an independent actuarial estimate and evaluating the reasonableness of the historical claim‑rate assumptions.  The liability was recorded at **$1.7 billion as of December 31, 2024**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: Caterpillar uses historical claim rates applied to current field population and dealer inventory to estimate warranty liability, a process involving significant management judgment. PwC identified this as a critical audit matter due to subjectivity and auditor effort, which aligns with the original. (2) The financial estimate is correctly stated as $1.7 billion as of December 31, 2024, which matches the ground truth value of $1,700 million (equivalent formats). (3) The multi-hop reasoning is sound—linking Caterpillar's estimation method to auditor scrutiny and the resulting financial figure—demonstrating proper synthesis across audit judgment, methodology, and financial reporting. (4) The answer addresses both parts of the question: the influence of historical claim rates on the critical audit matter and the resulting liability amount. Wording differs slightly (e.g., 'extensive procedures' and 'independent actuarial estimate' add detail not in the original but do not contradict it), but the core information is factually precise and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 333,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "\nThe Asia Theme Parks borrowings are quoted at a **stated coupon of about 7.9 %**, but after the effect of interest‑rate and cross‑currency swaps, purchase‑accounting adjustments and other issuance costs the **effective rate falls to roughly 5.8 %**.  \nBy comparison, the Company’s senior unsecured notes carry a **stated coupon of about 4.1 %**, yet the **effective rate rises to roughly 4.7 %** once swaps, discounts and issuance costs are taken into account.  \n\nThus, the **effective cost of capital for the park‑specific debt is actually lower than that of the broader unsecured debt**, reflecting the cheaper financing that the parks enjoy (e.g., sovereign‑linked loans and hedge structures) relative to the market‑based cost embedded in the Company’s senior notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the stated interest rate on Asia Theme Parks borrowings is 7.93%, and the effective interest rate on Disney's senior unsecured notes is 4.71%. However, the LLM claims the effective rate on Asia Theme Parks debt is 5.8%, which is lower than the senior notes' effective rate of 4.7%, concluding that park-specific debt is cheaper—this directly contradicts the ground truth. The correct difference is 7.93% - 4.71% = 3.22 percentage points, indicating higher cost for Asia Theme Parks debt, but the LLM reverses this relationship. (2) The quantitative values are incorrect: the LLM reports an effective rate of 5.8% for Asia Theme Parks debt and 4.7% for senior notes, but the original answer does not provide an effective rate for Asia Theme Parks debt—only a stated rate of 7.93%. The LLM fabricates an adjusted effective rate not present in the ground truth, introducing unsupported data about swaps and purchase-accounting adjustments. (3) The multi-hop reasoning is flawed: instead of comparing stated vs. effective rates across debt categories to assess cost of capital, the LLM incorrectly introduces hedging impacts and concludes the opposite of the correct interpretation. It fails to recognize that the higher stated rate on Asia Theme Parks debt reflects a higher cost of capital. (4) While the response addresses the question's structure and attempts to compare debt costs, its core facts and conclusion are inverted, warranting a low correctness and quantitative accuracy score. Qualitative accuracy is slightly higher because it attempts financial reasoning, but with incorrect inputs. Contextual relevance is acceptable as it stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 478,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "\nChevron capitalized $88 million of costs related to the 2023 PDC acquisition, and that acquisition was the primary source of the 2.2 TCF of purchases recorded in the United States during 2023, specifically in the DJ basin.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its quantitative claim—Chevron's capitalized cost was $10,487 million, not $88 million. This is a major factual error. The 2.2 TCF of purchases and the DJ Basin are correctly identified, which preserves some contextual and qualitative accuracy. (2) The dollar amount is off by over $10 billion, which is a critical miscalculation or misstatement. No acceptable format variation explains this discrepancy (e.g., $88M vs $10,487M). The 2.2 TCF and 'DJ Basin' match the ground truth exactly. (3) The multi-hop reasoning partially succeeds: the model correctly links the PDC acquisition to the 2.2 TCF of reserves and correctly attributes it to the DJ Basin. However, the failure to report the correct capitalized cost—a central part of the question—undermines the core of the answer. (4) Correctness and quantitative accuracy are severely penalized due to the incorrect dollar figure. Qualitative accuracy is slightly higher because the model identifies the correct basin and links the acquisition to the volume increase. Contextual relevance is high because the answer addresses both parts of the question and uses appropriate terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 338,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "\nMetLife restated its consolidated **statements of comprehensive income (operations), balance sheet, equity and cash‑flow statement** to give effect to the new LDTI guidance.  The retrospective adjustments—most notably a $2.7 billion increase in 2022 net income and corresponding changes to future policy benefits, DAC, accumulated other‑comprehensive income and retained earnings—show how the LDTI framework reshapes the presentation of revenues, expenses, reserves and equity in MetLife’s consolidated financial reporting.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the general topic. (1) The ORIGINAL ANSWER states that MetLife retrospectively adjusted the consolidated statement of operations and consolidated statements of comprehensive income. However, the LLM claims adjustments were made to the balance sheet, equity, cash-flow statement, and all comprehensive income (operations), which goes beyond the ground truth and incorrectly expands the scope. The original source does not mention retrospective adjustments to the balance sheet, cash-flow statement, or statement of equity as a whole—only specific line items (e.g., retained earnings, AOCI) would be affected, not full statement restatements. (2) The LLM introduces a specific quantitative claim—'a $2.7 billion increase in 2022 net income'—that is not present in the ground truth and cannot be verified from the provided information. This number may be fabricated or misattributed, severely undermining quantitative accuracy. (3) While the question asks which statements were adjusted, the LLM incorrectly lists more than were specified and fails to clearly distinguish between full statement adjustments and line-item changes within them. (4) The reasoning about the impact of LDTI on financial reporting—reshaping presentation of revenues, expenses, reserves, and equity—has qualitative merit and aligns with the conceptual impact described in the original answer, hence partial credit for qualitative accuracy. (5) Contextually, the response remains focused on the retrospective application of LDTI and its effect on financial reporting, satisfying relevance. However, the overstatement of adjusted statements and introduction of unverified figures reduce correctness significantly. Overall, the answer is partially correct in intent but factually flawed in execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 497,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "\nThe filing documents **two amendments** to the Solar Turbines Incorporated Managerial Retirement Objective Plan. The most recent amendment became effective on **January 1, 2022**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that there are two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan documented in the Caterpillar Inc. 2024 10-K filing, which matches the ground truth. It also accurately states the effective date of the most recent amendment as January 1, 2022, which is correct. The quantitative accuracy is perfect—both the count (two amendments) and the date are factually correct and match the original answer. The only minor omission is that the LLM does not explicitly name the most recent amendment as the 'Second Amendment,' which is included in the ground truth and adds slight contextual precision. However, since the question only asks for the number of amendments and the effective date of the most recent one, this detail, while helpful, is not essential to answering the core query. The reasoning appears sound, and the model correctly synthesizes information from the relevant filing. The answer is semantically equivalent to the original and fully contextually relevant. Thus, the answer is highly accurate with only a minor reduction in qualitative accuracy due to the omitted amendment name.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 327,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "\nThe North Carolina Rate Case Order trimmed Duke Energy’s “Impairment of assets and other charges” by roughly **$35 million in the aggregate**—about **$13 million** lower for Duke Energy Carolinas and **$22 million** lower for Duke Energy Progress.  In the consolidated statements of operations this appears as a **$35 million reduction in the impairment expense line**, which lifts operating income (and ultimately net income) by that same amount.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and direction of the financial impact. The ground truth states a total *increase* in Impairment of Assets and Other Charges of $68 million ($35M by Duke Energy Carolinas and $33M by Duke Energy Progress), whereas the LLM claims a *reduction* of $35 million in aggregate, with $13M and $22M decreases respectively. This reverses the nature of the impact and misstates the total by $33 million. (2) Quantitative accuracy is severely lacking: the correct total is $68M, not $35M; the individual amounts are $35M and $33M, not $13M and $22M. There is no indication in the LLM answer that the impairments were *added* to expenses, not reduced. The calculation error is fundamental. (3) The multi-hop reasoning fails: the model must synthesize data from both subsidiaries and correctly reflect the consolidated impact. Instead, it incorrectly aggregates lower values and mischaracterizes the direction of the impact (reduction vs. increase), suggesting a misunderstanding of the regulatory outcome. (4) Contextual relevance is moderate—the answer addresses the right financial line item (Impairment of Assets and Other Charges) and mentions the consolidated statements of operations, but the core facts are wrong. The explanation of how it affects operating income is conceptually correct (lower expense increases income), but since the premise is inverted, the overall reasoning collapses. Thus, correctness and quantitative accuracy are very low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 423,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "\nLicensed stores contribute about 12 percent of Starbucks’ total net revenue, but because the company’s earnings from these locations come mainly from a markup on the coffee, food, equipment and other supplies it sells to the licensee plus royalties and license‑fee income—while the licensees absorb most operating and capital costs—the arrangement delivers a higher operating margin for Starbucks even though the gross margin on the store’s own sales is lower. In short, the 12 % revenue share is offset by a relatively low‑cost, high‑margin income stream that still adds a modest but profitable contribution to overall earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 12% figure for licensed stores' contribution to total net revenues is correctly stated and matches the original answer. No other numerical values (e.g., dollar amounts, years) are introduced, so there are no discrepancies. (2) The answer correctly identifies the structure of payments: product markups (margins on coffee, food, equipment, supplies), royalties, and license fees—exactly as in the ground truth. It also accurately notes that licensees bear most operating and capital costs, which is a key point in understanding the financial impact. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects the lower per-store revenue with the higher operating margin outcome due to cost shifting, concluding that the 12% revenue stream is profitable and margin-enhancing despite lower gross sales. This mirrors the original answer’s logic. (4) The only minor shortcoming is that the LLM does not explicitly mention 'fiscal 2024' as the time period, which is included in the ground truth—hence a slight deduction in qualitative accuracy. However, since the percentage and mechanisms are correct and the context is clearly current, this omission does not undermine the overall correctness. The answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 381,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands—which represent approximately one-third of its overall sales and generally carry higher margins—its results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "\nTarget’s owned‑and‑exclusive brands generate roughly one‑third of sales and carry higher margins, so any failure to develop, source, or market them can sharply cut revenue and profit.  Because these products require longer lead times and involve greater responsible‑sourcing risks, mis‑steps can cause supply‑chain disruptions, stock‑outs or excess inventory, forcing markdowns and eroding margins—ultimately delivering an adverse hit to Target’s results of operations and overall financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial risk Target faces if it fails to develop, source, and market its owned and exclusive brands. (1) Quantitatively, the statement that these brands account for 'roughly one-third of sales' matches the ground truth exactly—no numerical discrepancies. (2) The reasoning correctly identifies that longer lead times increase exposure to supply chain disruptions and demand forecasting errors, and that responsible sourcing risks are elevated due to vendor selection. It also correctly links these operational risks to financial consequences: stock-outs, excess inventory, markdowns, margin erosion, and adverse impacts on results of operations. (3) The multi-hop synthesis is sound—connecting brand importance (1/3 of sales, higher margins) with sourcing complexity and financial outcomes. (4) The only minor shortcoming is that the LLM does not explicitly mention 'longer-term forecasting of consumer demand' as a specific risk factor tied to early ownership in the supply chain, which is emphasized in the original. However, the implication is present through references to supply chain disruptions and inventory mismanagement. Overall, the answer is factually correct, contextually precise, and semantically equivalent to the ground truth with only slight omission of nuance in the forecasting aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 377,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "\nFour amendments to the Caterpillar Inc. Deferred Employees’ Investment Plan were incorporated into the 2024 10‑K by reference to earlier filings. The most recent two amendments—the Third Amendment (effective January 1 2022) and the Fourth Amendment (effective July 1 2022)—are cited in the 2021 Form 10‑K (for the third amendment) and the 2022 Form 10‑Q (for the fourth amendment).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the correct core information. (1) Quantitatively, all numbers and dates are correct: four amendments, Third Amendment effective January 1, 2022, Fourth Amendment effective July 1, 2022. The referencing filings are correctly identified by form type and year—2021 Form 10-K and 2022 Form 10-Q. (2) The answer correctly identifies the number of amendments and the two most recent ones with accurate effective dates. (3) The multi-hop reasoning is sound: it links the amendments to the correct prior filings by form and year. However, the LLM omits the specific exhibit numbers (Exhibit 10.28 in the 2021 10-K and Exhibit 10.6 in the 2022 10-Q) and the exact reporting periods (year ended December 31, 2021, and quarter ended September 30, 2022), which are part of the ground truth. While the form types and years are correct, the lack of exhibit numbers and precise periods constitutes a minor but notable omission in qualitative completeness. (4) Despite this, the answer is contextually relevant, factually correct in all key aspects, and semantically equivalent in intent and substance. The omission prevents a perfect 10 but does not undermine the core accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 338,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "\nAs of January 31 2025, 73 million shares remained reserved for future grant or issuance under the 2013 Equity Incentive Plan.  The plan also had outstanding equity awards comprising roughly 8 million shares of stock options and 26 million shares of restricted‑stock awards and performance‑based stock units.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its quantitative claims. The ground truth states that 73 shares (not million) remain available for future grant under the 2013 Equity Incentive Plan. The LLM incorrectly reports '73 million shares', which is off by a factor of one million. Additionally, the ground truth does not provide specific numbers for outstanding awards (e.g., 8 million options or 26 million restricted stock), so the LLM invents figures not present in the original data. (2) The date mentioned, 'January 31, 2025', is incorrect and not supported by the 2024 10-K filing, which would report data as of a fiscal year-end prior to that date. (3) While the LLM correctly identifies the 2013 Equity Incentive Plan and attempts to describe outstanding award types—options, restricted stock awards, and performance-based units—it adds granularity (specific share counts) that is not in the original answer and misrepresents the completeness of the data. The original answer only lists the types of awards without quantities. (4) The contextual relevance is moderate because the response addresses the right plan and attempts to answer both parts of the question, but the fabricated numbers and massive overstatement of available shares (73 million vs 73) severely undermine factual accuracy. The qualitative reasoning fails on multi-hop synthesis, as it appears to hallucinate data rather than extract or infer correctly from the source. The answer would mislead a user on both scale and detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 418,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "\nIn fiscal 2024 the Channel Development segment generated $1.77 billion of net revenue, and Starbucks notes that “most” of these revenues come from product sales and royalty payments from Nestlé under the Global Coffee Alliance. Consequently, the bulk—i.e., the majority (more than 50 %) of the segment’s $1.77 billion—is derived from that partnership.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that 'most' of Starbucks' Channel Development revenues in fiscal 2024 come from the Global Coffee Alliance with Nestlé, which matches the original answer's assertion that the majority (>50%) of revenues are derived from this partnership. (2) The LLM adds a specific revenue figure—$1.77 billion—for the Channel Development segment in fiscal 2024. While this number is not present in the original answer, it is consistent with external knowledge from Starbucks' 2024 10-K filing and does not contradict the ground truth; thus, its inclusion enhances detail without introducing inaccuracy. (3) The reasoning is sound: the model correctly infers that 'most' implies a majority (>50%) and applies this to the revenue stream, demonstrating proper multi-hop synthesis between the revenue segment and the Nestlé partnership. (4) The exact percentage is not disclosed in either the original or LLM answer, so the qualitative conclusion is appropriately cautious. The only minor limitation is that the $1.77 billion figure, while accurate, was not in the original answer and could be seen as over-precision if not verifiable from the same source—but given its correctness, it does not reduce accuracy. All entities (Starbucks, Nestlé, Global Coffee Alliance, Channel Development, fiscal 2024) are correctly identified. The answer is fully relevant and responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 403,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "\nThe Company retrospectively adjusted its consolidated statements of income (comprehensive income), consolidated balance sheets, consolidated statements of equity and consolidated statements of cash flows as of December 31, 2022 (and 2021) to reflect the new LDTI accounting guidance. The tables on pages 164, 162, 163, 165 and 167 of the 2023 10‑K illustrate the resulting impacts—e.g., the increase to net income and retained earnings, the re‑classification of future policy benefits and market‑risk benefits, the related adjustments to deferred acquisition costs and deferred tax balances, and the corresponding changes to accumulated other‑comprehensive income and cash‑flow categories.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly identifies that retrospective adjustments were made due to the adoption of the LDTI accounting guidance and mentions tables in the 2023 10-K, it incorrectly expands the list of adjusted financial statements. The original answer specifies only the consolidated statement of operations and consolidated statements of cash flows were retrospectively adjusted. However, the LLM answer includes consolidated balance sheets, consolidated statements of equity, and consolidated statements of income (comprehensive income), which are not mentioned in the ground truth. This overstatement of adjusted statements constitutes a major factual error. The mention of specific pages (164, 162, etc.) and detailed effects like reclassification of future policy benefits and changes to deferred acquisition costs adds detail not present in the ground truth and cannot be verified as correct based on the provided information. While the reference to December 31 aligns with the question and the general context of retrospective adjustment is appropriate, the inclusion of additional financial statements and unverified specifics reduces correctness. The quantitative accuracy is partially acceptable because no explicit numbers are wrong—just additional unconfirmed details are added. The qualitative accuracy suffers due to incorrect entity identification (wrong financial statements adjusted). Contextual relevance is high because the response addresses the topic, timing, and general nature of the adjustments, even if specifics are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 443,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "\nIn 2022 the equity‑method investment contracts were recorded at a fair‑value of roughly **$(3 million)**, while the combined fair‑value of all derivative assets was about **$790 million**.  This means the equity‑method contracts accounted for less than 0.5 % of the total derivative assets, indicating they are essentially immaterial to MDLZ’s overall derivative portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the value of equity method investment contracts was $3 million (correct), but the total asset derivatives were $393 million, not $790 million as stated by the LLM. The LLM incorrectly uses 'combined fair-value of all derivative assets' ($790M), which appears to include both asset and liability derivatives or misclassifies total derivative assets. This leads to a wrong percentage calculation: less than 0.5% (based on $3M / $790M ≈ 0.38%) vs. the correct figure of less than 1% ($3M / $393M ≈ 0.76%). (2) The calculation error stems from using an incorrect total for asset derivatives. While the numerator is correct, the denominator is nearly double the true value, severely undermining quantitative accuracy. (3) The reasoning structure is sound—comparing the value of equity method investment contracts to total asset derivatives and interpreting relative significance—and the entities (MDLZ, 2022, equity method investment contracts) are correctly identified. The conclusion about minimal significance is directionally correct but overstated due to the flawed denominator. (4) Correctness score is 4 due to major numerical inaccuracy affecting the core comparison, though some facts are right and the logical framework is appropriate. Quantitative accuracy is low (3) due to incorrect total derivative asset value. Qualitative accuracy is moderate (6) because reasoning and entity identification are correct, but synthesis uses wrong data. Contextual relevance is high (8) as the answer addresses the right concepts and question intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 451,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "\nThe December 31 2019 freeze eliminated any future salary growth for U.S. pension participants, so the “expected rate of compensation increase” assumption is removed (effectively set to 0 percent) in all subsequent actuarial calculations for those plans. Consequently, the benefit‑obligation and net‑periodic‑cost measurements no longer incorporate a compensation‑increase factor, simplifying the projection of obligations and reducing the sensitivity of pension costs to that assumption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the key impact of the U.S. pension benefit freeze as of December 31, 2019: the removal of the 'expected rate of compensation increase' assumption in actuarial calculations. The date (December 31, 2019) is correct, and the implication—that future salary growth is no longer considered—is accurately described. (2) There are no numerical values requiring calculation, but the date and conceptual zeroing of the compensation increase assumption are correctly represented. (3) The reasoning is sound: freezing benefits eliminates future salary-based accruals, making compensation growth irrelevant in projecting obligations. The LLM correctly infers that this simplifies accounting and reduces sensitivity to that assumption, which is a logical extension consistent with accounting principles. (4) The only minor gap is that the original answer emphasizes the discontinuation of the assumption as 'no longer applicable,' while the LLM frames it as 'set to 0 percent'—a slight nuance in terminology, but functionally equivalent in practice. Overall, the answer is factually correct, complete, and contextually precise, warranting a high score with only a small deduction in qualitative accuracy due to slight rewording that doesn't affect meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 377,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "\nOracle’s decision to concentrate its hardware revenue on higher‑margin Oracle Engineered Systems—while scaling back low‑margin commodity products—lets the company allocate its limited supply‑chain capacity and manufacturing resources to the more profitable, strategically important platforms. This focus improves its ability to manage disruptions for those key systems, but it also makes the hardware business more dependent on a narrow set of specialized components and suppliers, so any interruption in those supply chains can still sharply depress revenue and erode profitability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of qualitative reasoning and correctly identifies Oracle's strategic focus on Oracle Engineered Systems and its implications for supply chain and profitability. It accurately reflects that this focus creates both benefits (efficient resource allocation to high-margin products) and risks (vulnerability to supply chain disruptions due to reliance on specialized components). However, the LLM answer omits key details present in the original answer that are critical for full completeness and depth: (1) it does not mention the actual consequences reported in the 10-K filing, such as increased production costs, higher inventory purchases, inventory excess and obsolescence risk, or negative impacts on operating cash flows; (2) it fails to note that Oracle cannot always pass cost increases to customers, which directly affects profitability. These omissions reduce the qualitative accuracy despite sound logic. There are no numerical values in either answer, so quantitative accuracy is scored as 10 by default. The answer is contextually relevant and addresses the core of the question, but lacks the full multi-hop synthesis of cause-effect链条 from strategy to financial impact as detailed in the ground truth. Thus, while the reasoning is plausible and directionally correct, it misses specific evidence from the source material that would demonstrate full fidelity to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 402,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "\nThe 2023 global sales of the two Pulmonary‑Hypertension products together are $1.582 billion (UPTRAVI) + $1.973 billion (OPSUMIT) = $3.555 billion. This combined figure grew about 14.5 % year‑over‑year, which outpaces the overall Pulmonary‑Hypertension category growth of 11.6 % reported for 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the individual sales figures for UPTRAVI ($1.582 billion) and OPSUMIT ($1.973 billion), and their sum ($3.555 billion), which matches the ground truth in absolute terms. However, it introduces a critical error by stating a 'combined growth of 14.5%'—a figure not present in the original data and incorrectly calculated. The ground truth reports separate growth rates: 10.6% for OPSUMIT and 19.7% for UPTRAVI, with both compared individually to the category growth of 11.6%. The LLM incorrectly aggregates these into a single combined growth rate, which misrepresents the analysis. (2) While all dollar amounts are accurate (with acceptable format variation: billion vs million), the percentage calculation is factually wrong. There is no indication in the ground truth that the combined growth is 14.5%, and such a figure would require weighted average logic not provided or justified. (3) The multi-hop reasoning fails at the synthesis stage: instead of comparing individual product growth rates to the category, the model invents a new metric (combined growth) that distorts the conclusion. It misses that both drugs individually grew faster than the category, which is the key insight. (4) Contextual relevance is high—the answer addresses the therapeutic area, products, year, and comparison to category growth. However, due to the incorrect growth calculation and flawed reasoning, the correctness and qualitative accuracy scores are significantly reduced. Quantitative accuracy is partially preserved due to correct revenue figures but penalized for the erroneous percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 445,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "\nThe legacy PDC Energy assets added roughly **$2.2 billion** to Chevron’s U.S. upstream earnings in 2024, and that incremental production lifted net oil‑equivalent output by about **250,000 BOE per day (≈19 % higher)**.  (Page 44)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $2.2 billion increase in U.S. upstream earnings for CVX in 2024 from legacy PDC Energy assets is correctly stated. The impact on net oil-equivalent production is accurately given as 250,000 barrels per day, with the ≈19% increase clearly noted. (2) Quantitative accuracy is perfect: $2.2 billion, 250,000 BOE/day, and 19% all match the original answer exactly, with acceptable formatting variations (e.g., '≈19%' vs '19%'). (3) The multi-hop reasoning is sound—linking the PDC Energy acquisition to both financial and production impacts on CVX in 2024 requires synthesis across entities and metrics, which the model correctly performs. (4) The answer is contextually precise, directly addressing both parts of the question (earnings impact and production impact) with no extraneous or irrelevant information. The citation of 'Page 44' further supports its grounding in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 291,
        "total_tokens": 1415
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "\nThe retrospective adoption of the new LDTI guidance required MetLife to recast **all of its core consolidated financial statements**—the statement of comprehensive income (income‑statement), the balance sheet, the statement of equity, and the statement of cash flows—adjusting amounts such as net income, reserves, deferred acquisition costs, market‑risk benefits and accumulated other‑comprehensive income. This breadth of adjustments shows that the LDTI framework has a **company‑wide impact on financial reporting**, affecting revenue recognition, liability measurement, equity balances and cash‑flow presentation, not just isolated line items.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant overstatement in scope. The original answer states that MetLife adjusted the consolidated statements of equity and comprehensive income. The LLM claims adjustments were made to *all* core financial statements, including the balance sheet, statement of cash flows, and others—information not supported by the ground truth. While LDTI (Long-Duration Targeted Improvements) guidance generally affects multiple statements, the specific retrospective adjustments cited in the ground truth are limited to the statements of equity and comprehensive income. Thus, the LLM extrapolates beyond the provided facts, introducing unsupported breadth (e.g., cash flow statement adjustments) without evidence. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is flawed due to overgeneralization, reducing qualitative accuracy. Contextual relevance is high because the response addresses the question’s intent about scope and implications. However, the claim of 'company-wide impact' and adjustments to *all* statements exceeds the evidence, undermining factual correctness despite plausible domain knowledge.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 343,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "\nAs of December 31 2022, the derivatives fair‑value table shows a **$(3 million)** fair value for equity‑method investment contracts, while net‑investment‑hedge contracts have a **$24 million** fair value; thus the equity‑method contracts are $27 million lower (the net‑investment‑hedge contracts are $27 million higher).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of equity method investment contracts as $(3) million and net investment hedge contracts as $24 million, matching the ground truth exactly. (2) The calculation of the difference ($27 million) is accurate: $24 million - (-$3 million) = $27 million, and the interpretation (equity-method contracts being $27 million lower) is factually and logically sound. (3) The multi-hop reasoning is correct—information from the derivatives fair value table as of December 31, 2022, is properly synthesized across two types of contracts. (4) The answer is semantically equivalent to the original, with added precision in quantifying the difference, enhancing clarity without introducing error. All entities, dates, and financial metrics are accurate and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 247,
        "total_tokens": 1436
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "\nThe net assets of Universal Beijing Resort fell from about **$0.6 billion** ( $7.8 bn assets – $7.2 bn liabilities ) at 31 Dec 2023 to roughly **$0.3 billion** ( $7.3 bn assets – $7.0 bn liabilities ) at 31 Dec 2024—a decline of roughly **$0.3 billion**.  \nThis reduction is captured on Comcast’s consolidated balance sheet in the Theme‑Parks line items (e.g., goodwill and accumulated‑impairment balances shrink), reflecting the consolidation of the VIE’s assets and liabilities and the resulting lower net‑asset figure reported for the resort.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the starting and ending net asset values of Universal Beijing Resort as $0.6 billion and $0.3 billion, respectively, and accurately derives these from the reported assets and liabilities in the ground truth. However, it incorrectly calculates the change in net assets as a $0.3 billion decrease, when the correct change is $0.6B - $0.3B = $0.3B decrease — wait, this actually matches the ground truth's stated $0.5B decrease? Let's recheck: Ground truth says 'decreased by $0.5 billion' but computes $0.6B to $0.3B, which is a $0.3B drop. There is an inconsistency in the original answer: $0.6B - $0.3B = $0.3B decrease, not $0.5B. Therefore, the LLM’s $0.3B decrease is mathematically correct based on the provided figures, while the original answer contains a calculation error in the summary (claims $0.5B drop). This means the LLM is actually quantitatively more accurate than the ground truth. However, since we must score against the provided 'ground truth', and it states '$0.5 billion' as the change despite incorrect arithmetic, there is a conflict. Upon closer inspection: $7.8B - $7.2B = $0.6B (correct), $7.3B - $7.0B = $0.3B (correct), so change is $0.3B decrease. The original answer incorrectly states '$0.5 billion' decrease. Thus, the LLM is factually correct in stating a $0.3B decline, contradicting the ground truth’s erroneous $0.5B claim. This suggests the ground truth has a mistake. Assuming the knowledge graph is authoritative despite arithmetic inconsistency, we must penalize the LLM for disagreeing with it. But given that the numbers used by the LLM are consistent and correct, and only the final delta differs due to the ground truth's arithmetic error, this creates ambiguity. Resolving: The LLM's calculation is mathematically sound and matches the derived values; the original answer likely contains a typo. However, per evaluation rules, we follow the ground truth strictly. Since the ground truth explicitly states 'decreased by $0.5 billion', and LLM says $0.3 billion, this is a quantitative discrepancy. But the component numbers (assets/liabilities/net) are all correct. So the error is only in the summary delta — possibly due to misreading. (2) All individual numbers — $7.8B, $7.2B, $7.3B, $7.0B, resulting $0.6B and $0.3B net — are correct. Only the magnitude of the change is misstated in the LLM ($0.3B vs ground truth's $0.5B). But again, $0.3B is arithmetically correct. Given this contradiction, we conclude the ground truth likely has an error in the delta statement. Still, to adhere to instructions, we treat the original answer as authoritative. Thus, stating a $0.3B decrease instead of $0.5B is a factual deviation, even if mathematically justified. (3) The multi-hop reasoning is sound: LLM links Universal Beijing Resort's financials to Comcast’s consolidated balance sheet via VIE consolidation and references Theme Parks line items like goodwill and impairment, which shows understanding of how such entities are reported. This adds qualitative depth beyond the original answer. (4) Final scores: Correctness 7 — core numbers are right, but final delta contradicts ground truth (even if ground truth may be wrong); Quantitative Accuracy 6 — because the final change amount is incorrect relative to the expected answer, despite internal consistency; Qualitative Accuracy 8 — strong reasoning, correct entity mapping, good use of accounting concepts; Contextual Relevance 9 — fully addresses both parts of the question with relevant financial reporting context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 929,
        "total_tokens": 2170
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "\nAs of September 29 2024, Starbucks’ Japanese‑yen‑denominated credit lines total roughly **$34.5 million + $69.1 million ≈ $103.6 million in U.S. dollars**.  \n\nThe 2021 Revolving Credit Agreement explicitly backs the commercial‑paper program by stating that any commercial‑paper borrowings must be “backstopped by available commitments” under the $3 billion revolving facility, and it clarifies that the program’s proceeds can be used for working‑capital, capital‑expenditures, acquisitions, dividend payments and share‑repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total value of Starbucks' Japanese yen-denominated credit facilities as $103.6 million, accurately breaking it down into $34.5 million (¥5.0 billion) and $69.1 million (¥10.0 billion), which matches the ground truth. The calculation ($34.5M + $69.1M = $103.6M) is precise and correctly formatted. (2) All numeric values, including the yen amounts, USD equivalents, and the $3.0 billion revolving facility, are factually correct and consistent with the original answer. Date references (implied by the facilities' maturities in 2024 and 2025) are not contradicted and align with the September 29, 2024, reporting date. (3) The multi-hop reasoning is sound: the LLM correctly links the 2021 Revolving Credit Agreement to the commercial paper program by stating that commercial paper borrowings must be 'backstopped by available commitments' under the credit facility, which is a key point in the ground truth. It also accurately summarizes the permitted uses of proceeds (working capital, capital expenditures, dividends, share repurchases), though it adds 'acquisitions'—a minor deviation not explicitly mentioned in the original answer. (4) The answer is semantically equivalent to the ground truth, with only slight rewording and no material omissions. The inclusion of 'acquisitions' as a use of proceeds is a minor overreach but does not significantly detract from accuracy. Overall, the response is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 446,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "\nOracle’s emphasis on Engineered Systems makes them a key driver of its infrastructure‑technologies revenue—these highly engineered servers, storage and database appliances are marketed as premium, high‑margin hardware that underpins the company’s cloud and license offerings. However, because many of the components are sourced from single‑vendor suppliers and production is outsourced, the same focus heightens Oracle’s exposure to supply‑chain disruptions, leading to potential cost spikes, inventory‑excess risks, and delays that can erode the profitability of its hardware business.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's strategic focus on Engineered Systems as a driver of infrastructure technologies revenue and acknowledges the associated supply chain risks, including single-vendor dependencies, outsourcing, inventory risks, and delays. These points align with the ground truth. However, the LLM answer omits key quantitative and contextual details present in the original answer, such as the specific contribution of infrastructure cloud services and license support revenues (58% of total cloud services and license support revenues in fiscal 2022), which is a critical data point demonstrating the financial significance of these systems. It also does not mention that supply chain disruptions were specifically tied to the COVID-19 pandemic or that they negatively impacted operating cash flows—important consequences highlighted in the ground truth. (2) There are no numerical inaccuracies in the LLM response because it avoids citing specific numbers; thus, quantitative accuracy is high by default. It neither misstates nor fabricates figures. (3) The multi-hop reasoning is partially sound: the model correctly links Engineered Systems to revenue and to supply chain exposure, but it fails to fully synthesize the evidence from fiscal 2022, including the actual impact (delays, increased inventory purchases) and the broader financial context (58% revenue contribution). This weakens the qualitative depth and completeness of the reasoning. (4) The contextual relevance is strong because the answer addresses both parts of the question—revenue impact and supply chain risk—and uses appropriate terminology. However, the lack of specific supporting data from the source material reduces its factual completeness, warranting a correctness score of 7 rather than higher.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 493,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "\nUniversal Beijing Resort’s debt fell slightly from **$3.5 billion in 2023 to $3.4 billion in 2024**, a reduction of about **$0.1 billion**. Because this line is part of the “Debt Not Guaranteed” total, the overall “Debt Not Guaranteed” amount also slipped from **$5.0 billion in 2023 to $4.8 billion in 2024**, decreasing by roughly **$0.2 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all key numerical values: Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a $0.1 billion reduction. The 'Debt Not Guaranteed' total decreased from $5.0 billion to $4.8 billion, a $0.2 billion drop, which is accurately reported. All numbers match the ground truth and calculations are correct. The answer addresses both parts of the question: the change in Universal Beijing Resort's debt and its impact on the 'Debt Not Guaranteed' category. The reasoning is sound—correctly linking the resort's debt reduction to the overall category decrease. However, the original answer includes an additional detail that 'Other' debt decreased from $1.5 billion to $1.4 billion, contributing to the total drop in 'Debt Not Guaranteed'. This contextual nuance is missing in the LLM response, slightly reducing completeness and qualitative accuracy. Despite this omission, the core facts, numbers, and logic are fully correct, and the answer remains semantically aligned with the ground truth. Thus, the correctness score is 9 due to minor incompleteness, not inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 321,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "\nHoneywell’s revenue on long‑term contracts is recognized over time with the cost‑to‑cost input method, which requires management to estimate total contract costs and the degree of completion using many subjective assumptions (e.g., future cost trends, schedule risk, inflation, performance). Because these estimates drive the timing and amount of revenue recognized, auditors must perform extensive testing of the controls and assumptions behind them—evaluating the consistency of methods, probing management’s cost‑at‑completion calculations, and applying analytical procedures to detect bias—making the audit of such contracts especially complex.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Honeywell uses the cost-to-cost input method for long-term contracts, which impacts audit complexity due to reliance on management's estimates of total contract costs and progress toward completion. The key factors influencing estimates—such as inflation, schedule risk, and performance—are correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer, so quantitative accuracy is not compromised; the absence of specific numbers is consistent with the original. (3) The multi-hop reasoning is sound: the model correctly links the cost-to-cost method to revenue recognition over time, explains how subjective assumptions affect estimates, and connects this to increased audit complexity through control testing, assumption validation, and bias detection. (4) The LLM answer is semantically equivalent to the original, though slightly less detailed in mentioning 'subcontractor performance' and 'labor agreements' explicitly, and does not reference 'contracts with longer durations or significant gross margin changes'—minor omissions that do not detract from the overall correctness. These small gaps prevent a perfect 10 but do not undermine the accuracy or relevance. Contextual relevance is full, as the response directly addresses how the method influences audit complexity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 402,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "\nThe NEER non‑qualifying hedge gains were about **$1.73 billion**, compared with **$0.30 billion** for FPL—a difference of roughly **$1.43 billion**. This gap reflects that NEER records its non‑qualifying derivatives – which do not meet hedge‑accounting criteria – directly in earnings, while FPL’s derivative gains are deferred as regulatory assets/liabilities and only recognized through fuel‑cost recovery clauses, so they enter net income far more modestly.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: NEER's non-qualifying hedge gains of $1,729 million (rounded to $1.73 billion), FPL's $300 million (rounded to $0.30 billion), and the difference of $1,429 million (rounded to $1.43 billion). These values match the ground truth exactly when accounting for rounding. (2) The calculation of the difference is accurate: $1,729M - $300M = $1,429M, and the LLM's $1.43 billion is a valid rounding. All numeric values are correct and properly formatted. (3) The reasoning correctly captures the multi-hop synthesis: NEER records non-qualifying hedges directly in earnings, leading to higher volatility and immediate income impact, while FPL defers most derivative gains as regulatory assets/liabilities, recognizing them only through fuel-cost recovery mechanisms. This aligns with the 10-K disclosure about differing regulatory treatments. (4) The answer is semantically equivalent to the ground truth, though slightly less detailed in explaining that FPL's $300M was 'passed through' due to specific recovery clauses rather than being the full extent of deferral. However, the core reasoning and factual content are sound. Minor deduction in qualitative accuracy for slightly less elaboration on the regulatory framework nuance, but no factual errors. Contextual relevance is perfect—directly addresses both the quantitative difference and the accounting treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 396,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcast’s consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcast’s maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "\nComcast consolidates 100 % of Universal Beijing Resort’s assets and liabilities—so the resort’s $7.3 billion of assets and $7.0 billion of liabilities are recorded on Comcast’s consolidated balance sheet as of 31 Dec 2024 even though Comcast owns only a 30 % stake.  Because there are no guarantees or other financial commitments, Comcast’s maximum loss is limited to its 30 % equity interest, which translates to roughly $1 billion of the resort’s $3.4 billion debt—about 30 % of that debt (approximately 1 % of Comcast’s total consolidated debt).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitative accuracy: All numbers are correct—$7.3 billion in assets, $7.0 billion in liabilities, $3.4 billion in debt, and Comcast’s 30% interest equating to $1.02 billion (rounded to ~$1 billion is acceptable; 'roughly $1 billion' is semantically equivalent). The 30% ownership and proportion of debt are correctly calculated. (2) Completeness: The answer addresses both parts of the question—how the ownership affects consolidation (full inclusion of assets/liabilities due to VIE consolidation) and Comcast’s maximum risk of loss (limited to 30% equity interest, or $1.02 billion of the $3.4 billion debt). (3) Entity accuracy: Comcast, Universal Beijing Resort, and the date (December 31, 2024) are correctly identified. (4) Reasoning: The multi-hop logic is sound—despite 30% ownership, full consolidation occurs due to VIE status, and financial loss is capped at equity interest. The only minor shortcoming is that the LLM mentions 'about 30% of that debt (approximately 1% of Comcast’s total consolidated debt)', which introduces a new figure (1%) not in the original answer and not requested by the question. While not incorrect per se, it adds extraneous information and slightly deviates from the required synthesis. However, this does not detract from the core correctness. Overall, the answer is factually precise, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 401,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "\nIn 2020 Booking recorded a total goodwill impairment of $489 million (interim) plus $573 million (annual) on OpenTable, amounting to about $1.06 billion. This figure is far larger than the modest revenue OpenTable contributed to the advertising‑and‑other segment in 2021, which was only a small fraction of that segment’s earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the two goodwill impairment charges ($489 million in Q1 and $573 million in Q3 2020), and their sum is accurately stated as approximately $1.06 billion, which aligns with the ground truth of $1,062 million. This satisfies quantitative accuracy for the impairment amount. However, the LLM incorrectly characterizes OpenTable’s 2021 revenue contribution as a 'small fraction' of the advertising-and-other segment’s earnings. The ground truth states that OpenTable contributed to the 'advertising and other' segment, which totaled $1.1 billion — implying that OpenTable’s contribution was substantial and nearly equivalent to the $1.06 billion impairment. The LLM’s claim that OpenTable’s revenue was a 'modest' or 'small fraction' contradicts the ground truth, which emphasizes near equivalence. (2) Number verification: $489M + $573M = $1,062M — correct. The $1.1 billion segment revenue is not disputed, but the LLM fails to state or imply that the impairment was nearly equal to that revenue. (3) Multi-hop reasoning is partially sound — the model connects 2020 impairment to 2021 revenue, but draws an incorrect qualitative conclusion. It should have noted the similarity in magnitude, not contrasted them. (4) Correctness score is 5 due to accurate numbers but major error in synthesis and conclusion. Quantitative accuracy is 8 because all numbers and calculations are correct or acceptably rounded. Qualitative accuracy is 5 due to flawed reasoning in comparing the two figures. Contextual relevance is 7 — the answer addresses the right entities and timeframes but misrepresents the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 450,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "\nExxonMobil embeds estimated greenhouse‑gas emission costs in the cash‑flow forecasts that are used for recoverability testing of asset groups under its Corporate Plan—even in jurisdictions that lack a formal carbon price.  These cost assumptions reflect the Company’s 2030 emissions‑reduction roadmap and its specific goal of achieving net‑zero Scope 1 and 2 greenhouse‑gas emissions from unconventional assets in the Permian Basin.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: ExxonMobil incorporates estimated greenhouse gas emission costs into cash flow forecasts for recoverability testing of asset groups, even in jurisdictions without current carbon pricing. (2) The specific future emission-reduction goal—net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin by 2030—is accurately stated. The mention of '2030 emissions-reduction roadmap' aligns with the original answer's reference to '2030 greenhouse gas emission-reduction plans.' (3) Multi-hop reasoning is sound: the answer correctly links the inclusion of emission costs in financial assessments with forward-looking corporate goals, demonstrating synthesis between financial planning and environmental targets. (4) No numerical or entity errors exist; all entities (ExxonMobil, Scope 1 and 2 emissions, Permian Basin, 2030 timeline) are correct. Minor wording differences (e.g., 'roadmap' vs 'plans') do not affect factual meaning. The answer is fully complete, contextually relevant, and precisely accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 331,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "\nAs of December 31 2023, $1.2 billion of the $2.4 billion CECL‑Transition capital addition remains to be phased in—$600 million will be added in 2024 and the remaining $600 million in 2025. Because this unphased amount will be incorporated into the Company’s regulatory capital next year, it will raise its CET1 ratio and help it stay above the stress‑capital‑buffer‑derived conservation‑buffer requirements of 9.3 % CET1, 10.8 % Tier 1 and 12.8 % total capital for the period October 1 2023 through September 30 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that $1.2 billion of Capital One's $2.4 billion CECL Transition capital addition remains to be phased in as of December 31, 2023, and accurately states that $600 million will be phased in each in 2024 and 2025. This quantitative information is correct and matches the ground truth. However, the LLM makes a critical error in describing the capital conservation buffer requirements. It incorrectly states that the conservation buffer requirements are 9.3% CET1, 10.8% Tier 1, and 12.8% total capital, which conflates the stress capital buffer with the capital conservation buffer. The ground truth clarifies that the capital conservation buffer is a flat 2.5% for CET1, Tier 1, and total capital under Federal Reserve rules, while the stress capital buffer for the period October 1, 2023–September 30, 2024 is 4.8%. The LLM appears to have added the stress capital buffer to the standard conservation buffer or misunderstood regulatory tiers, leading to materially incorrect percentages. Additionally, the answer implies that the unphased capital will help meet a 9.3% CET1 requirement, which is not supported by the original answer—Capital One exceeds requirements, but the specific thresholds cited are wrong. While the phasing timeline and dollar amounts are correct (supporting partial credit), the misrepresentation of regulatory capital requirements and failure to distinguish between stress capital buffer and capital conservation buffer constitutes a significant qualitative and quantitative error. The reasoning is partially sound in terms of phasing mechanics but flawed in regulatory interpretation. Contextually, the answer addresses both parts of the question and remains focused, hence a moderate contextual relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 479,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "\nFrom 2022 to 2023 MDLZ’s U.S. dollar‑denominated notes and term loans fell by **$1,713 million** (from $11.27 bn to $9.56 bn). In contrast, the Euro‑denominated notes rose by roughly **$250 million** (from $7.67 bn to $7.92 bn), so the USD reduction was far larger and moved in the opposite direction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the decrease in U.S. dollar notes and term loans is correctly calculated as $1,713 million (from $11,275M to $9,562M), and the increase in Euro notes is accurately stated as $250 million (from $7,666M to $7,916M). The LLM uses rounded values ($11.27 bn → $11,270M, $9.56 bn → $9,560M, etc.), which are within acceptable rounding tolerance and do not affect factual accuracy. (2) Quantitative accuracy is perfect: the difference in USD debt ($11,275M - $9,562M = $1,713M) and EUR debt ($7,916M - $7,666M = $250M) are correctly reflected. (3) The multi-hop reasoning—comparing the reduction in USD instruments to the increase in EUR notes—is sound and correctly concludes that the USD reduction was significantly larger and in the opposite direction. (4) All entities (MDLZ, U.S. dollar notes and term loans, Euro notes, 2022–2023 period) are correctly identified and contextualized. The answer is concise, relevant, and captures all aspects of the question with precise, factually correct information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 318,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "\nThe indemnification agreement requires the Resideo subsidiary to pay **up to $140 million per year** to Honeywell.  This payment is equal to **90 % of Honeywell’s annual net spending on environmental matters** at the covered sites, but the amount is capped at $140 million (and the obligation lasts until the earlier of Dec 31 2043 or the third consecutive year when the payment falls below $25 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $140 million annual cap and 90% of Honeywell's net spending are accurately reported, with no discrepancies in numbers or percentages. The format variations (e.g., $140 million vs $140M) are acceptable and semantically equivalent. (2) The answer is complete: it correctly identifies the maximum annual payment and its relationship to Honeywell's environmental spending, which are the two core components of the question. (3) Entity accuracy is perfect—Resideo subsidiary, Honeywell, and the environmental indemnification context are all correctly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the payment is tied to 90% of net spending but capped at $140 million, which aligns with the contractual logic in the ground truth. The additional context about the termination date (Dec 31, 2043) and the $25 million threshold, while not required for the question, adds accuracy without introducing error. (5) The semantic meaning is equivalent to the original answer, with slightly more detail but no factual deviation. All scoring categories warrant the highest marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 337,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "\nThe fair‑value liability attached to the FPL cost‑recovery hedges fell from about **$16 million at 12/31/22 to $12 million at 12/31/23**, a $4 million reduction that lowered NEE’s regulatory‑liability burden and modestly improved the consolidated financial position of the FPL and NEER segments.  At the same time, the VaR‑based market‑risk measure for those hedges declined from roughly **$145 million to $114 million**, indicating a smaller exposure to commodity‑price movements and further easing the financial risk profile of the segments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3M to $2M (a $1M drop), but the LLM incorrectly states a reduction from $16M to $12M ($4M drop). For NEER, the correct decrease is from $148M to $114M ($34M), which the LLM partially captures by mentioning a $145M to $114M decline—close but still inaccurate. The combined total reduction should be $35M, but the LLM does not calculate or mention this total. (2) The numbers are not quantitatively accurate: FPL's liability is off by over 400% in magnitude, and NEER's starting value is slightly wrong ($145M vs $148M). The $4M and $31M drops cited do not match the correct $1M and $34M changes. (3) The reasoning is flawed—instead of aggregating the impact on NEE's total financial position across FPL and NEER segments as required, the LLM focuses on 'regulatory-liability burden' and 'VaR-based market-risk measure', which were not mentioned in the original data. It fails to synthesize the correct multi-hop information: combining FPL and NEER changes to assess NEE’s overall position. (4) Contextual relevance is moderate—the response discusses hedges and financial impacts related to FPL and NEER, so it stays on topic, but introduces unverified metrics like VaR and misrepresents the core financial figures. Overall, major factual and quantitative errors severely undermine correctness despite some topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 416,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "\nUniversal Beijing Resort’s net assets declined from about **$0.6 billion** at the end of 2023 to **$0.3 billion** at the end of 2024, a reduction of roughly **$0.3 billion**.  During the same period its outstanding debt fell from **$3.5 billion** to **$3.4 billion**, a decline of about **$0.1 billion**.  Consequently, the drop in net assets was three times larger than the drop in its debt obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both net assets and debt obligations. According to the ground truth, Universal Beijing Resort's net assets decreased from $0.6 billion in 2023 to -$0.3 billion in 2024, a decline of $0.9 billion, not $0.3 billion as stated. The LLM incorrectly reports 2024 net assets as $0.3 billion (positive) instead of -$0.3 billion (negative), which is a critical error in financial interpretation. Additionally, the LLM states debt decreased from $3.5 billion to $3.4 billion ($0.1 billion drop), but the ground truth shows liabilities decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction. These numbers are entirely incorrect and not supported by the data. (2) Calculations are flawed: the claimed $0.3 billion drop in net assets is wrong (actual: $0.9 billion), and the comparison that net asset decline was 'three times' the debt decline is based on false inputs. The actual decrease in net assets ($0.9B) was 4.5 times the decrease in debt ($0.2B), but even this is misleading since net assets turned negative. (3) Multi-hop reasoning is partially present—the model attempts to compare changes in net assets and debt—but uses incorrect data from the start, undermining the entire analysis. It fails to correctly identify the relationship between assets, liabilities, and net assets across years. (4) Contextual relevance is acceptable because the structure addresses the question’s intent: comparing changes in net assets and debt. However, due to severe quantitative inaccuracies and misrepresentation of financial position (especially missing the negative net assets in 2024), the answer is mostly incorrect. Minor credit is given for attempting the correct type of comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 478,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "\nThe 2023 10‑K states that EDURANT (rilpivirine) was approved for a new pediatric indication—treatment of children 2 to 12 years old with HIV—making this age‑group newly eligible for the drug.  The company had submitted filings for this pediatric use in both the United States and the European Union.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the new patient population as pediatric patients aged 2 to 12 years with HIV, matching the original answer. (2) The regulatory regions—United States and European Union (EU)—are correctly stated, with no discrepancies in entity names or regions. (3) The reasoning is sound and reflects proper synthesis from JNJ's 2023 10-K filing, correctly linking the new indication to the targeted regulatory submissions. (4) All information is relevant and directly addresses both parts of the question: the new patient population and the regulatory regions for filing. Minor wording differences (e.g., 'submitted filings' vs 'targeted for filing') do not affect factual accuracy, as submitting a filing implies targeting that region. No numerical or qualitative inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 258,
        "total_tokens": 1402
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "\nThe merchant‑based transaction model raises Booking Holdings’ operating costs—through higher payment‑processing, fraud‑loss and charge‑back expenses—thereby compressing operating margins even as it generates incremental revenue. At the same time, EU antitrust probes of parity clauses and the Swiss regulator’s investigation into Booking.com’s commissions threaten to force commission cuts and tighter compliance, prompting the company to adjust its pricing, invest in a more integrated “Connected‑Trip” platform and accept near‑term margin pressure while reshaping its longer‑term growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: the merchant-based model increases costs (payment processing, chargebacks, fraud losses), which compresses operating margins despite incremental revenues. Regulatory pressures in Switzerland (commission investigation) and the EU (antitrust probes, parity clauses) are correctly identified as contributing to margin pressure and strategic shifts. (2) There are no numeric values in the question or answers requiring verification—both responses are qualitative and consistent in that regard, so quantitative accuracy is not compromised. (3) Multi-hop reasoning is sound: the model correctly synthesizes the financial impact of the transaction model with regulatory risks in two jurisdictions and links them to strategic responses like the Connected Trip platform. The only minor omission is the absence of explicit mention of the Digital Markets Act and its specific implications (e.g., gatekeeper designation, data usage restrictions), which slightly reduces completeness but does not undermine the core accuracy. (4) The answer remains contextually precise, directly addressing how both factors impact margins and strategy in 2022. Wording differs but meaning aligns closely with the original. Thus, a score of 9 is justified—excellent but not fully exhaustive of all regulatory details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 388,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "\nThe maximum total duration of a petroleum‑retention licence in Papua New Guinea is **15 years** – a five‑year initial term that may be extended twice, with the combined extension period capped at ten years, for a total of up to 15 years. This regulatory horizon gives ExxonMobil a stable, long‑term hold on gas resources, which it can leverage for its major LNG projects (e.g., the PNG LNG and related downstream developments) and supports the company’s strategy of securing feedstock for deep‑water and LNG investments as described in its 2022 10‑K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: the initial 5-year term, up to two extensions, and a maximum total duration of 15 years are accurately stated. The explanation that extensions are capped at 10 years total (implying two 5-year extensions) aligns with the 'up to two extensions at the Minister's discretion' in the original, though the discretion aspect is slightly underemphasized. (2) The calculation of total duration (5 + 10 = 15 years) is correct and clearly implied. (3) The reasoning is sound: the LLM correctly links the 15-year license window to ExxonMobil's long-term LNG strategy, referencing the 2022 10-K and mentioning specific projects like PNG LNG. It captures the strategic value of holding non-commercial resources for future development. (4) Minor deduction in qualitative accuracy because the original emphasizes 'selective development of attractive natural gas resources' and 'may become commercially viable'—nuances slightly downplayed in the LLM version, which focuses more on feedstock security. However, the core multi-hop synthesis—linking PNG license rules to ExxonMobil’s LNG strategy using the 10-K—is fully achieved. Wording differs but semantic meaning is equivalent. No irrelevant content; contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 370,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "\nThe Company’s Level 2 investment in mutual, pooled and commingled funds grew from **$202 million in 2022 to $257 million in 2023**, an increase of **$55 million** (about 27 %). By contrast, its hedge‑fund/limited‑partnership holdings rose from **$936 million to $1,057 million**, a **$121 million** increase. Thus, the hedge‑fund investment grew by more than double the dollar change seen in the Level 2 mutual‑fund position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, Coca-Cola's investment in Mutual, pooled and commingled funds under Level 2 assets decreased from $83 million in 2022 to $37 million in 2023 (a $46 million decrease), whereas the LLM claims an increase from $202 million to $257 million ($55 million increase). Similarly, for Hedge funds/limited partnerships, the ground truth shows a minor increase from $14 million to $18 million ($4 million), but the LLM reports a massive rise from $936 million to $1,057 million ($121 million). These numbers are completely inconsistent with the original data. (2) All calculations are therefore wrong: the LLM reports a 27% growth and a $55M increase in Level 2 funds and a $121M increase in hedge funds, while the correct figures are a $46M decrease and a $4M increase respectively. The comparison between the two shifts is thus fundamentally flawed. (3) The multi-hop reasoning fails entirely — the model does not synthesize the correct entities (investments, categories, years) or pull accurate values across years and asset types. It appears to have fabricated or misattributed data, possibly from a different company or context. (4) The contextual relevance is low but not zero because the answer addresses the general structure of the question (year-over-year change and comparison between two investment types), but the factual inaccuracies render it misleading. Hence, correctness and quantitative accuracy are near zero; qualitative accuracy is minimal due to correct terminology usage but incorrect application.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 445,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "\nThe regulatory disallowances at Nicor Gas reduced Southern Company Gas' net income by $29 million in its gas‑distribution operations, and an additional $88 million was recorded as an estimated loss on regulatory disallowance, for a total adverse impact of $117 million on 2023 net income.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that regulatory disallowances at Nicor Gas impacted Southern Company Gas' net income in 2023, the numeric values are incorrect. The LLM states a $29 million reduction in gas distribution operations (which matches the ground truth), but then cites an additional $88 million estimated loss, resulting in a total impact of $117 million. This contradicts the ground truth, which reports an additional earnings adjustment of $24 million, not $88 million, for a total impact of $53 million. (2) Quantitative accuracy is low: the $29 million figure is correct, but the $88 million is a substantial overstatement compared to the actual $24 million adjustment. The total calculated impact of $117 million is therefore incorrect, whereas the correct sum is $29M + $24M = $53M. (3) The multi-hop reasoning is partially sound— the model recognizes that the total impact must combine two components from different parts of the financial statements—but fails in accurately retrieving the second component. It likely confused the $88 million figure with another item or misread the source document. (4) Contextual relevance is high because the answer addresses the right entities (Nicor Gas, Southern Company Gas), the correct year (2023), and the correct type of financial impact (reduction in net income due to regulatory disallowances). However, due to major quantitative errors and partial failure in synthesis, the correctness and accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 425,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&T’s comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "\nIn addition to WarnerMedia, AT&T also classified **Vrio, Xandr and Playdemic** as discontinued operations.  By moving these units out of the continuing‑operations results, AT&T signaled a deliberate strategic shift away from non‑core media and entertainment assets and toward a streamlined focus on its core telecommunications businesses—mobility, wireline and Latin‑America—thereby simplifying its portfolio and reallocating capital to its core network and growth initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all businesses classified as discontinued operations—Vrio, Xandr, and Playdemic—in addition to WarnerMedia, matching the ground truth. There are no numeric values in the question or answer that require quantitative verification, so quantitative accuracy is scored as 10. The qualitative accuracy is high: the LLM accurately captures the significance of the classification as part of AT&T’s strategic shift to focus on core telecommunications operations (mobility, wireline, Latin America) and exit non-core media assets. It correctly conveys the intent behind treating these divestitures as discontinued operations—streamlining the business and reallocating capital. However, it omits a key nuance present in the original answer: that these businesses were grouped as a single strategic shift despite not all individually meeting the materiality threshold for discontinued operations. This is a minor but relevant detail regarding accounting treatment and the rationale for aggregation. The answer remains semantically equivalent in intent and meaning, with strong multi-hop reasoning demonstrated by linking the divestitures to broader restructuring goals. Contextual relevance is perfect—the response directly addresses both parts of the multi-part question: (1) which businesses were classified as discontinued, and (2) the significance of that classification in the context of restructuring.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 394,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "\nThe fair‑value of Medtronic’s auction‑rate securities was $33 million at both April 30 2021 and April 29 2022, so there was essentially no change ($0 million) in their fair value over the period. Because the auction‑rate securities represent only a small portion of the portfolio, this $0 million change had a negligible effect on the overall $364 million decline in the total available‑for‑sale debt securities’ fair value (from $7,257 million to $6,893 million) during the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022, matching the ground truth. It accurately notes no change ($0 million) in value. It also correctly reports the total available-for-sale debt securities' fair value decreasing from $7,257 million to $6,893 million, a $364 million decline, which aligns with the original answer. (2) All numeric values—$33 million (auction rate securities), $7,257 million, $6,893 million, and the $364 million difference—are factually correct and consistent with the ground truth. The calculation of the decline in total available-for-sale securities is accurate: 7,257 - 6,893 = 364. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that since auction rate securities did not change, their stability contrasts with other components of the portfolio that must have driven the overall decline. The conclusion that the auction rate securities had a negligible impact due to their small size relative to the total portfolio is logically valid and consistent with the implications in the original answer. (4) The LLM answer is semantically equivalent to the ground truth, conveying the same core facts and analytical insight with only rephrased wording. All evaluation dimensions—factual accuracy, completeness, entity recognition, and logical reasoning—are fully satisfied, justifying perfect scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 415,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "\nThe 2020 annual goodwill impairment test forced a $573 million charge to the OpenTable and KAYAK reporting unit, lowering the combined goodwill balance to **$1.0 billion as of September 30, 2020**. When combined with the $489 million interim impairment recorded in March 2020, the total goodwill write‑down for these businesses in 2020 amounted to roughly **$1.06 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $489 million interim impairment in March 2020 and the $573 million annual test charge in September 2020 are correctly stated. The adjusted carrying value of goodwill is correctly identified as $1.0 billion as of September 30, 2020. (2) The cumulative impairment is calculated as $489M + $573M = $1,062 million, which the LLM correctly rounds to 'roughly $1.06 billion'—an acceptable and accurate representation. (3) The multi-hop reasoning is sound: the answer synthesizes two separate impairment charges (interim and annual) affecting the same reporting unit (OpenTable and KAYAK) and correctly computes their combined impact on the carrying value. (4) Entities (OpenTable, KAYAK, goodwill, 2020, September 30) and financial terms (impairment charge, carrying value) are used accurately. The answer addresses both parts of the question: the adjusted carrying value and the cumulative impact. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 306,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "\nNicor Gas’s regulatory disallowances forced Southern Company Gas to record an $88 million estimated loss, which directly shaved that amount off the segment’s net income and was cited as a key factor behind the $29 million decline in net income at gas‑distribution operations. At the same time, the disallowance contributed to the $1.3 billion (21 %) drop in operating revenue for 2023, as lower volumes and the loss of recoverable revenues under the Nicor Gas rate case reduced total sales. Consequently, the disallowance hurt both top‑line revenue and the bottom‑line profitability of Southern Company Gas in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. While the ground truth states that Nicor Gas's regulatory disallowances led to a $29 million decrease in net income, the LLM incorrectly claims an $88 million estimated loss that 'shaved' that amount off net income, conflating or misrepresenting the actual impact. The $88 million figure does not appear in the original answer and is unsupported. Additionally, the LLM asserts a $1.3 billion (21%) drop in operating revenue directly tied to the disallowances, but the original answer only notes that disallowances contributed to revenue declines alongside lower volumes—without specifying the magnitude. These quantitative errors severely undermine factual correctness. (2) Number verification: The only correct number is the $29 million decline in net income at gas distribution operations, which the LLM correctly mentions but misattributes as a consequence of an $88 million loss rather than directly from the disallowances. The $1.3 billion revenue drop and 21% decline are not present in the ground truth and appear to be fabricated or misattributed. (3) Multi-hop reasoning: The LLM correctly identifies the causal chain—regulatory disallowances at Nicor Gas affecting Southern Company Gas’s financials—and links the impact to both revenue (top line) and net income (bottom line), which aligns with the original answer’s dual-impact conclusion. This shows sound qualitative understanding of the relationship between the entities and the nature of the financial impact. (4) Despite correct entity names (Nicor Gas, Southern Company Gas), time period (2023), and general direction of impact (negative on both revenue and net income), the severe quantitative inaccuracies—especially the introduction of unsupported figures—reduce the correctness score. The contextual relevance is high because the answer addresses the right companies, year, and financial metrics, and correctly infers a dual impact, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 548,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "\nAs of August 31 2022, 16,191,228 Class A ordinary shares remained available for issuance under the 2010 ESPP (90 million – 73,808,772 already issued). This represents roughly 18 % of the total 90 million shares authorized under the plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of shares remaining available for issuance (16,191,228) and the total authorized shares (90 million), which matches the ground truth. The percentage is reported as 'roughly 18%', which is a rounded but accurate representation of the exact 17.99% in the original answer. Minor rounding is acceptable under semantic equivalence. (2) The calculation provided in the LLM answer (90,000,000 - 73,808,772 = 16,191,228) is correct and supports the stated figure. All numeric values are accurate, with only formatting differences (e.g., '90 million' vs '90,000,000'), which are acceptable. (3) The multi-hop reasoning is sound: the model correctly infers the remaining shares by subtracting issued shares from authorized shares and computes the correct percentage (16,191,228 / 90,000,000 ≈ 17.99%). The slight rounding to 18% does not constitute a factual error but reflects natural language approximation. (4) The answer is contextually complete and relevant, addressing both parts of the question: the number of shares remaining and the percentage of total authorized shares. The only minor shortcoming is the lack of the precise percentage (17.99%), but 'roughly 18%' is semantically equivalent and acceptable in financial reporting contexts. Thus, the answer is highly accurate with only negligible imprecision in percentage expression.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 386,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "\nThe 2023 10‑K notes that AT&T’s commercial‑scale Open RAN rollout with Ericsson will add near‑term capital outlays and accelerated depreciation, putting upward pressure on 2024 expenses. However, the open, programmable network is expected to generate software‑driven cost savings, lower future network‑related expenses and improve operational efficiency as the Open RAN platform scales through 2024‑2026, supporting the company’s longer‑term goal of reducing per‑unit network cost while expanding its fiber‑and‑5G‑enabled broadband services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: AT&T's collaboration with Ericsson on Open RAN is correctly identified, and the impact on 2024 expenses due to capital outlays and accelerated depreciation is accurately stated. The longer-term benefits of lower network costs and improved operational efficiency are also correctly conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2024–2026) are consistent with the forward-looking nature of the original and do not contradict the 2024 expense pressure mentioned in the ground truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes the near-term cost pressure with long-term efficiency gains, linking Open RAN deployment to both expense trends and strategic goals. The mention of 'software-driven cost savings' aligns with the 'software benefits of 5G' in the original. (4) The only minor deviation is that the LLM answer expands the timeline to '2024–2026' and references 'fiber-and-5G-enabled broadband services,' which is contextually reasonable but not explicitly stated in the original. This adds slight extrapolation but does not introduce inaccuracy. Overall, the answer is complete, factually correct, and contextually appropriate, warranting a high correctness score with a small deduction for slight expansion beyond the original scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 412,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "\nAs of 31 December 2021, XOM’s consolidated subsidiaries reported roughly **3.8 billion barrels** of proved developed bitumen reserves in Canada/Other Americas.  The discounted present value of the future net cash flows from that region for the same year was about **$4.5 billion**, which is slightly higher than the monetary value of the reserves themselves.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The total proved developed bitumen reserves are reported as 3.8 billion barrels, whereas the ground truth is 2,635 million barrels (2.635 billion), making the LLM's figure over 40% too high. Similarly, the discounted future net cash flow is stated as $4.5 billion, but the correct value is $28,710 million ($28.71 billion), meaning the LLM's figure is off by a factor of more than 6x. These errors severely undermine the answer's correctness. (2) Quantitative accuracy is very low: both key numbers (reserves and cash flows) are grossly incorrect. The LLM claims reserves of 3.8 billion barrels vs. the true 2.635 billion, and cash flows of $4.5 billion vs. $28.71 billion. Even allowing for rounding or formatting, these discrepancies are far beyond acceptable margins. (3) The qualitative reasoning is partially sound in structure—addressing both reserves and cash flows and attempting a comparison—but the synthesis is based on false data. The claim that cash flows are 'slightly higher than the monetary value of the reserves' is nonsensical, as cash flows are not a valuation of reserves in that way, and the numbers cited make the comparison invalid. (4) Contextual relevance is moderate: the answer addresses the right region (Canada/Other Americas), the correct company (XOM), and the correct date (December 31, 2021), and attempts the required comparison. However, due to the severe numerical errors, the answer fails on factual correctness, which is paramount in financial multi-hop questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 432,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "\nThe adoption of ASU 2022‑02, effective January 1 2023, replaced Capital One’s prior TDR accounting with a “financial‑difficulty modification” (FDM) model and required new disclosures for modified loans. As a result, the allowance for credit losses grew to **$15.3 billion** (an increase of about **$2.1 billion** from 2022) and the company began reporting modified loans as FDMs rather than TDRs, measuring expected credit losses under CECL and recording allowances for those modifications. This change also altered loan‑modification classification and reporting, affecting how allowances are built and disclosed in the financial statements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $2.1 billion increase and the resulting $15.3 billion allowance for credit losses as of December 31, 2023, are accurately reported, with acceptable formatting (e.g., $15.3 billion, $2.1 billion). The effective date of January 1, 2023, is consistent with ASU implementation timelines. (2) The answer correctly identifies the elimination of Troubled Debt Restructurings (TDRs) and their replacement with the Financial-Difficulty Modification (FDM) model, which aligns with the new reporting framework under ASU 2022-02. (3) The multi-hop reasoning is sound: it connects the adoption of the ASU to both the quantitative impact on the allowance and the qualitative change in loan modification classification and disclosure practices. (4) The LLM accurately synthesizes the impact on both allowance for credit losses and reporting practices, addressing all parts of the question with precise, semantically equivalent information. No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 307,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "\nThe 2023 10‑K notes that “additional contingent liabilities and loss estimates for Bank BPH, in connection with the ongoing litigation in Poland, will need to be recognized (or may increase in the future) and will be payable,” and that this exposure could create “funding or liquidity stress” for GE’s run‑off insurance and banking operations.  Although GE’s liquidity is supported by strong cash balances, free‑cash‑flow generation and committed revolving credit facilities, the possible growth of these contingent liabilities could require additional capital outflows or reserve build‑up, thereby pressuring its overall liquidity position.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core risk that potential increases in contingent liabilities from Bank BPH's litigation in Poland could create funding or liquidity stress for GE, which aligns with the ground truth. It accurately cites language from the 10-K regarding the need to recognize or increase liabilities and the possibility of liquidity stress, demonstrating proper sourcing and qualitative understanding. However, the LLM answer omits key quantitative details present in the original answer: specifically, GE's total cash position of $17.0 billion, the $14.2 billion held outside the U.S., and the $1.7 billion in countries with currency controls. These figures are critical to assessing the actual impact on liquidity and were explicitly part of the ground truth. While the LLM mentions potential capital outflows and reserve build-up, it does not connect the liquidity risk to the geographic concentration of cash or repatriation challenges, which is a key multi-hop element in the original answer. The reasoning is sound but incomplete. Entity accuracy (GE, Bank BPH, 2023 10-K, Poland litigation) and contextual relevance are strong. The answer is semantically aligned in direction but lacks the numerical foundation needed for full factual completeness, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 363,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "\nThe Amended and Restated 2010 Share Incentive Plan shows 14,830,623 shares reserved for issuance upon exercise of outstanding options (or other awards) and 27,381,461 shares still available for future issuance. Adding these figures gives a total of **42,212,084 shares** under that plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The numbers provided—14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares available for future issuance—are factually accurate and match the original answer exactly. The total of 42,212,084 shares is correctly calculated. (2) Quantitative accuracy is perfect: all figures are correct, properly formatted, and the sum is accurate (14,830,623 + 27,381,461 = 42,212,084). (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly identifies the two components required by the question (shares issued upon exercise and shares available for future issuance) and combines them appropriately. (4) The entities—'Amended and Restated 2010 Share Incentive Plan' and the 2022 10-K context—are correctly referenced, and the answer is semantically equivalent to the ground truth, even using slightly different phrasing ('reserved for issuance upon exercise' vs 'issued upon exercise'). The answer is fully relevant and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 301,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "\nAT&T’s 2025 Term Loan, which had a principal amount of **$2.5 billion**, was fully repaid and **terminated on March 30, 2023**, as disclosed in the financing‑activities section of the filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key information is accurately conveyed: the 2025 Term Loan amount of $2.5 billion (equivalent to $2,500 million) and the termination date of March 30, 2023. (2) Quantitative accuracy is perfect—$2.5 billion is numerically equal to $2,500 million, and the date matches exactly. (3) The reasoning is sound, correctly identifying the loan repayment as a financing activity and synthesizing the correct event from the filing disclosures. (4) The answer is contextually relevant, directly addressing both parts of the question (amount and date) with precise, factual information from the source. No errors in entities, metrics, or timeframes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1071,
        "completion_tokens": 218,
        "total_tokens": 1289
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "\nThe company’s mutual, pooled and commingled fund holdings grew from **$767 million in 2022 to $778 million in 2023**, an increase of **$11 million**. Of the 2023 balance, **$257 million** was classified under **Level 2** valuation inputs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively: The original answer states that KO's investment decreased by $47 million from 2022 to 2023, with a 2023 value of $39 million, of which $37 million was Level 2. The LLM claims an increase from $767M to $778M (a $11M rise), and states $257M of the 2023 balance was Level 2—both figures are wildly off. The correct 2023 total is $39M, not $778M, and Level 2 portion is $37M, not $257M. (2) Calculations: The LLM computes a $11M increase, but the correct change is a $47M decrease—direction and magnitude are wrong. (3) Multi-hop reasoning: The question requires comparing two years' values and identifying the Level 2 portion in 2023. The LLM fails both steps due to incorrect data retrieval. (4) Entity and context: While the company (KO) and financial concepts (mutual/pooled funds, Level 2 inputs) are correctly identified, the numbers are so inaccurate that the answer misrepresents the entire situation. The answer is relevant in structure but fails on factual content, resulting in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 305,
        "total_tokens": 1423
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "\nThe year‑ended December 31 2023 pre‑tax charge for the ongoing borrower litigation at Bank BPH was **$1.189 billion** (the amount disclosed as pre‑tax charges in discontinued operations for 2023).  \nDuring the same period GE paid **$203 million of net cash** to AerCap in connection with its continuing involvement with the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same information as the ground truth. (1) Quantitatively, both key figures are accurate: $1.189 billion (equivalent to $1,189 million) for the pre-tax charge and $203 million in net cash paid to AerCap. The format variation ($1.189 billion vs $1,189 million) is acceptable and semantically equivalent. (2) The answer addresses both parts of the multi-part question completely—litigation charge and cash payment to AerCap. (3) Entity accuracy is correct: GE, AerCap, and the year-ended December 31, 2023, are properly identified. The mention of 'Bank BPH' adds contextual detail not in the original answer but does not contradict it and may reflect a source-level specificity; however, the original ground truth does not specify Bank BPH, so this is a minor addition but not an error. (4) Reasoning appears sound—information is synthesized correctly across entities and time periods. The only minor issue is the introduction of 'discontinued operations' and 'Bank BPH', which were not in the original answer, potentially adding unverified context, but the core facts remain accurate. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to this slight over-contextualization, but full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 362,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360° value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360° value—defined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360° value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "\nAccenture’s $1.1 billion annual R&D spend fuels a deep pipeline of patents, labs, innovation centers and ecosystem partnerships that let it deliver cutting‑edge, scalable technology solutions faster than most rivals. By coupling that technical breadth with its “360° value” model—tying financial returns to inclusion, diversity, reskilling, sustainability and client‑experience outcomes—Accenture positions itself as a trusted, end‑to‑end partner that can transform enterprises holistically, a differentiation that competitors typically lack.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.1 billion R&D investment in fiscal 2022 is correctly stated, matching the original answer. No other numerical values or calculations are present, and the figure is reported accurately. (2) The answer addresses all key aspects of the question: Accenture’s R&D investment, its 360° value model, and how these contribute to competitive positioning. It correctly identifies the components of 360° value—financial returns, inclusion, diversity, reskilling, sustainability, and client experience—as in the original. (3) The reasoning is sound: it logically connects R&D spending to innovation capacity (patents, labs, ecosystem partnerships) and then links that technical capability to the broader 360° value proposition, explaining how this combination differentiates Accenture in a crowded market. (4) While the original mentions specific competitor types (offshore firms, consultancies, in-house departments) and Accenture’s claim of unmatched breadth at scale, the LLM answer captures the essence by stating competitors 'typically lack' this holistic approach, which is semantically equivalent. One minor omission is the explicit mention of 'global ecosystem partnerships' as a structural advantage, though 'ecosystem partnerships' are referenced. Overall, the answer is factually correct, contextually relevant, and conveys the same core message with only slight variation in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 407,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "\nAT&T classified, in addition to WarnerMedia, three other businesses as discontinued operations in 2023: **Vrio, Xandr and Playdemic**. Because these units are reported as discontinued operations, their revenues, expenses, gains and losses are stripped out of “continuing‑operations” results and shown separately (typically as a net loss line item and related tax effects), with prior‑year amounts restated so that only the company’s ongoing segments—Communications and Latin America—appear in the main segment performance tables.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Entity accuracy: The LLM correctly identifies Vrio, Xandr, and Playdemic as the additional entities classified as discontinued operations alongside WarnerMedia in 2023, which aligns exactly with the original answer. (2) Quantitative accuracy: There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the temporal reference '2023' is accurate and consistent. (3) Reasoning and completeness: The answer addresses both parts of the multi-hop question—identifying the entities and explaining the financial reporting impact. It correctly explains that the financial results of these entities are separated from continuing operations, presented net of tax, and that prior-year results are restated, which reflects proper synthesis of accounting treatment. (4) Semantic equivalence: While the LLM provides slightly more detail (e.g., mentioning restatement of prior-year amounts and naming AT&T's ongoing segments), all added information is factually consistent and enhances clarity without introducing error. The core facts, entities, year, and financial reporting implications are accurately conveyed. Thus, the answer is factually complete, logically sound, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 362,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "\nThe 2022 10‑K shows that the auction‑rate securities portfolio carried an unrealized loss of **$3 million** as of April 29, 2022 (see the “Auction rate securities” line in the “Unrealized Losses” table on page 70).  All of those securities are classified as maturing **after ten years**, so the $3 million loss is included in the “Due after ten years” bucket of the maturity schedule (page 71), which lists $656 million of fair value for securities with that maturity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total unrealized loss as $3 million as of April 29, 2022, which matches the ground truth. This satisfies the primary quantitative requirement. However, the distribution of the loss across maturity periods is inaccurately described. The ground truth states the loss is attributed to securities with maturity periods of more than 12 months, but the LLM specifies 'after ten years', which is a narrower and more specific category not supported by the original answer. While it is plausible that the 'more than 12 months' bucket includes securities maturing after ten years, the LLM incorrectly narrows the time frame without confirming that all $3 million is in the 'after ten years' category specifically. (2) All numbers—$3 million loss and the $656 million fair value—are accurately reported, and the date (April 29, 2022) is correct. The reference to page 70 and 71 adds contextual fidelity, though not required. (3) The multi-hop reasoning is partially sound: the model connects the unrealized loss to the correct table and attempts to map it to the maturity schedule. However, it fails to recognize that 'more than 12 months' encompasses multiple buckets (e.g., 1–5 years, 5–10 years, over 10 years), and thus incorrectly attributes the entire loss to the 'after ten years' bucket without evidence. This reflects a flaw in synthesis. (4) Despite the mischaracterization of the maturity period, the core facts (total loss, date, entity MDT) are correct, and the answer remains highly relevant. The error is in specificity, not direction, warranting a high but not top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 445,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "\nIn May 2024 Visa issued roughly **120 million shares of Class B‑2 common stock** as part of the Class B‑1 exchange offer, and those B‑2 shares accounted for **about 71 % of the total shares issued** (120 million of the 168 million shares total).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: 120 million Class B-2 shares issued, total of 168 million shares (implied), and 71% (rounded from 71.4%) of total shares — this is acceptable as 'approximately 71.4%' in the original is reasonably rounded to 'about 71%' in the response. (2) The calculation is sound: 120/168 ≈ 71.4%, and the LLM correctly identifies the proportion. (3) The reasoning is logically sound and synthesizes the necessary multi-hop information: linking the exchange offer in May 2024 to the issuance of Class B-2 shares and their percentage of the total. (4) Minor deduction in qualitative accuracy because the LLM mentions 'Visa' as the issuing company, which was not present in the original answer — this could be correct if contextually accurate, but since the original answer does not specify the company, introducing 'Visa' adds unverified entity information. However, this does not affect the core correctness of the share numbers or percentages. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 324,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "\nThe company’s wind‑turbine capacity fell from 11.7 GW in 2021 to 8.5 GW in 2023, a reduction of **3.2 GW**.  This decline is mirrored in the unit shipments, which dropped from **3,590 turbines in 2021 to 2,225 turbines in 2023**, a loss of **1,365 turbines**, indicating that the remaining turbines are on average larger (higher‑capacity) to achieve the lower total GW figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key numbers are correct: 11.7 GW in 2021, 8.5 GW in 2023, resulting in a 3.2 GW decrease; turbine units sold decreased from 3,590 to 2,225, a reduction of 1,365 units—these match the original answer exactly. (2) Calculations are accurate: 11.7 - 8.5 = 3.2 GW decrease; 3,590 - 2,225 = 1,365 unit decrease. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across years and metrics (capacity and unit volume), and even adds a reasonable inference that the remaining turbines may be larger on average, which is logically consistent with the data (though not explicitly stated in the ground truth). (4) The only minor deviation is the added interpretation about average turbine size, which, while plausible, goes slightly beyond the original answer’s neutral description. However, this does not introduce factual error and reflects reasonable qualitative insight. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to the small interpretive addition.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 326,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "\nAT&T’s total outlay for its C‑Band spectrum through 2023 – the $23.4 billion purchase price (up‑front deposit + Q1‑2021 cash payments) plus $3.1 billion of incentive payments and $0.86 billion of relocation costs that had been paid by the end of 2023 – equals roughly **$27.3 billion**.  This cash outflow is presented in the company’s cash‑flow statement as an **investing‑activity cash outflow under “Acquisitions, net of cash acquired,”** which aggregates all spectrum‑related payments (including incentives and relocation expenses).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The total amount paid is stated as $27.3 billion, whereas the ground truth is $26,477 million ($26.477 billion). The LLM overstates the total by approximately $823 million. The breakdown is also incorrect: the LLM reports $23.4 billion for auction payments (close to the correct $23,406 million), but then adds $3.1 billion for incentive payments and $0.86 billion for relocation costs. However, the ground truth specifies $3,067 million total for incentive and relocation costs combined, with a detailed split: $955M (Phase I), $2,112M (Phase II), and $1,100M in compensable relocation costs paid over time ($650M in 2021, $98M in 2022, $109M in 2023). The LLM incorrectly separates 'incentive payments' and 'relocation costs' with inaccurate figures and fails to reflect the multi-year payment schedule and overlap in categories. (2) Calculations: The LLM’s sum of $23.4B + $3.1B + $0.86B = $27.3B is mathematically correct but based on incorrect inputs. The correct sum from ground truth is $23,406M + $3,067M = $26,473M (within rounding of $26,477M). The LLM’s $0.86B ($860M) for relocation costs paid by end of 2023 is close to the actual sum of $650M + $98M + $109M = $857M, which is acceptable. However, misattribution of $3.1B as 'incentive payments' alone (vs. $3,067M total for incentives and relocation) is a major error. (3) Multi-hop reasoning: The model correctly identifies that C-Band costs include auction, incentive, and relocation payments, and that these are reflected in cash flow as investing activities under 'Acquisitions, net of cash acquired'—this part is accurate and reflects proper synthesis across financial disclosures. (4) Despite correct classification in cash flow and partial number accuracy, the significant overstatement of total cost and misallocation of cost components reduce factual reliability. The answer is contextually relevant and uses appropriate financial terminology, but quantitative errors prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 549,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "\nThe June 2021 decision to stop selling the Medtronic HVAD system removed roughly $141 million of net sales that had been recorded in fiscal 2021, so the HVAD’s absence created a modest drag on overall revenue growth in FY 2022 (contributing to the slower 4 % increase in total net sales).  At the same time, Medtronic highlighted several other product lines as the main growth engines for the year—particularly Neuroscience’s CST and Specialty Therapies (e.g., InterStim Micro, StealthStation navigation and robotic guidance), Cardiovascular’s next‑generation pacing and TAVR platforms (Micra AV, Evolut/CoreValve), and Medical Surgical’s robotic and powered‑stapling innovations (Hugo RAS, LigaSure/Sonicision instruments).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $141 million in net sales from the HVAD System in fiscal year 2021 and the June 2021 discontinuation date, which aligns with the ground truth. However, it incorrectly states that total net sales grew by only 4% in FY 2022, while the original answer specifies that Medical Surgical's net sales grew by 5% to $9.1 billion. The LLM does not mention this specific segment revenue figure or growth rate, instead referring vaguely to 'total net sales' and a 4% increase, which is both quantitatively and contextually inaccurate. (2) The financial figures are partially correct—$141 million is accurate—but the 4% growth rate is unsupported by the ground truth, which reports 5% growth in the relevant segment. The absence of the $9.1 billion figure is a significant omission. (3) The multi-hop reasoning is partially sound: the model correctly infers that discontinuing HVAD created a revenue drag. However, it fails to correctly identify the actual growth drivers highlighted in the original answer—such as Symplicity Spyral, Pulse Field Ablation, Aurora ICD, and Intrepid system—and instead lists unrelated or generic products like InterStim Micro, Evolut/CoreValve, and Hugo RAS, which are not mentioned in the ground truth as key FY2022 drivers. This misattribution undermines the qualitative accuracy. (4) While the answer addresses both parts of the question and maintains contextual relevance by discussing revenue impact and growth drivers, the factual errors in key percentages and the incorrect product lines reduce correctness. The model synthesizes plausible but incorrect information, likely due to hallucination or reliance on general knowledge rather than precise data retrieval.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 472,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "\nWalmart paid **approximately $3.5 billion in cash** to acquire additional Flipkart shares and to settle the liability to former PhonePe non‑controlling interest holders. As a result of this transaction, Walmart’s ownership stake in Flipkart rose from **about 75 % (as of January 31 2023)** to **roughly 85 % (as of January 31 2024)**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the cash amount of $3.5 billion is accurately reported, along with the correct ownership percentages (75% to 85%) and corresponding dates (January 31, 2023, and January 31, 2024). Minor formatting differences (e.g., 'approximately', 'about', 'roughly') are semantically equivalent and acceptable. (2) The answer addresses both parts of the multi-part question: the total cash paid and the impact on Walmart's ownership in Flipkart. (3) All entities—Walmart, Flipkart, PhonePe, noncontrolling interest holders—are correctly identified and contextually accurate. (4) The reasoning is sound: the transaction involves both acquiring additional shares in Flipkart and settling a liability related to former PhonePe noncontrolling interest holders, and the resulting ownership change is correctly synthesized across fiscal years. The answer demonstrates accurate multi-hop understanding from the knowledge graph. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 301,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsoft’s independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "\nMicrosoft records cash received for multi‑year volume‑licensing and SA arrangements as unearned revenue and invoices customers annually at the start of each coverage period; revenue is then recognized ratably over the contract term, so the timing of invoicing can create a receivable when revenue is recognized before invoicing and unearned revenue when recognized after invoicing. Because the standalone selling price (SSP) of bundled products and services must be estimated—and discounts allocated based on relative SSPs—auditors place heavy emphasis on management’s assumptions, testing controls and the pattern of delivery to evaluate the appropriateness of the revenue‑recognition judgment. This makes revenue recognition a critical audit matter and requires extensive audit effort to assess the estimates and disclosures underlying the unearned‑revenue balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: Microsoft invoices annually at the start of each contract period, recognizes revenue ratably, and records unearned revenue when cash is received before recognition. The treatment of receivables and unearned revenue based on timing mismatches is correctly explained. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in implied calculations or references. (3) The multi-hop reasoning is sound: the LLM correctly links volume licensing invoicing practices to revenue recognition patterns, explains the need for estimating standalone selling prices (SSP), ties this to discount allocation and judgment, and connects it to audit focus. It accurately identifies revenue recognition as a critical audit matter, consistent with the ground truth. (4) Minor difference: the original answer explicitly mentions 'cloud services' and 'customer size and geographic region' as factors in SSP estimation, which the LLM omits. Also, the original specifies auditor focus on 'transfer of control' and 'variable consideration,' while the LLM generalizes to 'pattern of delivery' and 'management’s assumptions.' These nuances are close in meaning but slightly less precise. Despite these small omissions, the LLM captures the essential financial statement presentation and audit implications. Hence, correctness is rated 9—very close to perfect, with only minor detail gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 432,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "\nThe company’s total contributions to the 401(k) Savings and Profit Sharing Plan for the three fiscal years ended May 31 2022 were **$126 million in 2022, $110 million in 2021, and $107 million in 2020**, which sums to **$343 million** over the three‑year period. No profit‑sharing contributions were included in that total because the plan’s discretionary profit‑sharing contributions were **not made in any of those fiscal years**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the individual contributions for each fiscal year—$126 million in 2022, $110 million in 2021, and $107 million in 2020—are accurate, and their sum ($343 million) is correctly calculated. (2) The answer addresses both parts of the multi-part question: it provides the total contributions over the three years and explains why no profit-sharing contributions were included. (3) The entities—Nike's 401(k) Savings and Profit Sharing Plan, the correct fiscal years (ended May 31, 2022, and prior two years), and the nature of discretionary profit-sharing contributions—are all accurately identified and used. (4) The reasoning is sound: the LLM correctly infers that because no discretionary profit-sharing contributions were made in any of the three years, they are absent from the total, which aligns with the plan terms cited in the original answer. The wording differs slightly but maintains full semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 301,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "\nThe consolidated natural‑gas reserves in the Asia Pacific/Middle East fell from **305 billion cubic feet (BCF) at the end of 2023 to 289 BCF at the end of 2024**, a decline of roughly **16 BCF**. By comparison, Africa’s consolidated natural‑gas reserves rose from **172 BCF to 457 BCF**, an increase of about **285 BCF**, so the African change is far larger—adding roughly **285 BCF** versus the **16 BCF** drop in the Asia Pacific/Middle East.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the direction of change (decrease in Asia Pacific/Middle East, increase in Africa) and provides a roughly accurate decline of 16 BCF for Asia Pacific/Middle East, which matches the ground truth. However, the actual starting and ending values are incorrect: the LLM states reserves fell from 305 to 289 BCF (a 16 BCF drop), while the ground truth reports a drop from 312 to 296 BCF (also a 16 BCF drop). Although the difference is correct, the underlying data points are inaccurate, suggesting potential data sourcing errors. For Africa, the LLM reports an increase from 172 to 457 BCF (285 BCF increase), whereas the ground truth shows an increase from 172 to 468 BCF (296 BCF increase). This results in a significant underreporting of the actual increase by 12 BCF. (2) Calculations: The 16 BCF decrease is numerically correct in magnitude but based on wrong inputs; the Africa increase is miscalculated (285 vs. correct 297). These are non-trivial quantitative discrepancies. (3) Multi-hop reasoning: The model correctly synthesizes comparative changes across regions and time periods, showing understanding of the required comparison. It correctly infers that Africa’s increase is much larger than the Asia Pacific/Middle East’s decrease, which aligns with the ground truth’s qualitative conclusion. (4) Scores justified as follows: Correctness scored 6 due to partially correct numbers and calculations—core trends are right but key figures are off. Quantitative accuracy is 5 due to two sets of incorrect base values and one major calculation error. Qualitative accuracy is 7 because reasoning and entity identification (Chevron, regions, time frame) are sound. Contextual relevance is 9—response directly addresses the question with appropriate structure and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 494,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "\nWalmart received roughly **$0.7 billion** of cash from new equity‑funding rounds in its majority‑owned PhonePe subsidiary during fiscal 2024.  In the same year it **paid about $3.5 billion** to acquire shares from (and settle liabilities to) PhonePe noncontrolling interest holders—about five times the amount of cash it brought in from equity funding.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: Walmart received $0.7 billion from equity funding and paid $3.5 billion to acquire shares from noncontrolling interest holders in fiscal 2024. These numbers match the original answer exactly, with acceptable formatting (e.g., $0.7 billion = $0.7 billion). (2) Quantitative accuracy is perfect: the amounts are correct, and the comparison (five times more paid than received) is a valid interpretation of the $3.5B / $0.7B ratio. While the net cash outflow of $2.8 billion is not explicitly stated, the answer conveys the same economic outcome by emphasizing the relative magnitude. (3) Multi-hop reasoning is sound: the model correctly synthesizes two distinct cash flows—receipts from equity funding and payments to noncontrolling interest holders—both related to PhonePe in fiscal 2024. (4) Entity accuracy is precise: Walmart, PhonePe, fiscal 2024, equity funding, and noncontrolling interest holders are all correctly identified and contextualized. The answer is highly relevant, complete, and factually consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 325,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "\nRTX recorded a **$918 million pre‑tax charge in 2024** for the resolution of the SEC Administrative Order and the related legal matters (the DPAs, FCA settlement and the Consent Agreement). The independent compliance monitor will oversee RTX’s obligations under those agreements **for a three‑year term** (ending three years from the monitor’s engagement).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $918 million pre-tax charge in 2024 is accurately reported, with acceptable formatting (using 'million' and bolding for emphasis). (2) The duration of the compliance monitor's oversight is correctly stated as a three-year term ending three years from engagement, which aligns semantically with the original answer. (3) The reasoning is sound and reflects proper multi-hop synthesis: the charge is correctly attributed to the SEC Administrative Order and related legal matters (including DPAs, FCA settlement, and Consent Agreement), and the compliance monitor's role and timeline are accurately described. (4) All entities (RTX, SEC Administrative Order, compliance monitor) and timeframes (2024, three-year period) are correctly identified. The answer is complete, factually accurate, and contextually appropriate, addressing both parts of the question with precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 279,
        "total_tokens": 1454
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "\nMicrosoft’s total Cloud revenue for fiscal 2023 was **$111.6 billion**.  This amount reflects earnings from a suite of cloud‑based offerings—including Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, and **Dynamics 365** (along with other Dynamics cloud solutions) and additional commercial cloud properties.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitative accuracy: The total Microsoft Cloud revenue of $111.6 billion for fiscal year 2023 is correctly stated, matching the original answer exactly. (2) Completeness: The answer addresses both parts of the question—providing the total revenue and listing the contributing cloud offerings, including Dynamics 365. All key components from the ground truth are present: Azure and other cloud services, Office 365 Commercial, commercial LinkedIn, Dynamics 365, and other commercial cloud properties. The phrase 'along with other Dynamics cloud solutions' is a minor elaboration but does not introduce inaccuracy. (3) Entity accuracy: All entities—Microsoft, fiscal year 2023, Dynamics 365, Azure, Office 365 Commercial, LinkedIn—are correctly identified and contextualized. (4) Reasoning: The answer correctly synthesizes the multi-hop information by aggregating revenue sources into the total cloud revenue figure, demonstrating sound reasoning. (5) Semantic equivalence: Despite slight rephrasing (e.g., 'suite of cloud-based offerings' vs. 'generated from offerings such as'), the meaning and factual content are identical. No errors in facts, numbers, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 350,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of ¥29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "\nUniversal Beijing Resort’s $3.5 billion debt as of 31 December 2023 is the principal amount of a term loan obtained from a Chinese bank syndicate that is secured by the resort’s assets and the investors’ equity interests (Note 8). Because Comcast consolidates the resort, this debt is presented in Comcast’s consolidated balance sheet under “Debt Not Guaranteed” (page 56, line b), but it is not cross‑guaranteed by Comcast or its other subsidiaries.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions affecting completeness and depth of multi-hop reasoning. (1) Quantitative accuracy is perfect: the $3.5 billion debt figure and December 31, 2023 date are correctly stated, and no incorrect numbers are introduced. (2) Entity accuracy is strong—Universal Beijing Resort, Comcast, and the debt classification 'Debt Not Guaranteed' are correctly identified. (3) The reasoning correctly captures that the debt stems from a syndicated loan secured by resort assets and investor equity, and that Comcast consolidates the entity without guaranteeing the debt. However, the LLM omits key details present in the original answer: it does not mention the total financing facility size (¥29.7 billion RMB / ~$4.2 billion), the breakdown of $3.1 billion in term loans within the $3.5 billion, or the explicit statement that Comcast has no liquidity arrangements or guarantees. It also fails to explain the VIE (Variable Interest Entity) basis for consolidation, which is a critical part of the multi-hop reasoning linking Comcast's accounting treatment to the resort’s debt structure. (4) Despite these omissions, the core facts are accurate and semantically aligned with the ground truth, and the answer remains contextually relevant and factually sound on the main points. The answer is concise but lacks the full depth of synthesis across financing structure, accounting consolidation, and risk exposure. Hence, a score of 8 is justified—core correctness is high, but not fully comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 431,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "\nFrom May 31 2021 to May 31 2022 Nike’s holdings of commercial paper and bonds fell from **$748 million to $660 million**, a decline of roughly **$88 million**.  That reduction was absorbed by a larger increase in other short‑term assets—chiefly cash and cash equivalents, money‑market funds and time‑deposit securities—so that the overall short‑term investment balance grew while the share allocated to commercial paper and bonds dropped from about 21 % of the portfolio to under 15 %.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies the decrease in Nike's investment in commercial paper and bonds from $748 million to $660 million, accurately calculating the $88 million decline. These numbers match the ground truth exactly, and the dates (May 31, 2021, to May 31, 2022) are correct. However, the LLM introduces the claim that the reduction was 'absorbed by a larger increase in other short-term assets' and that 'the overall short-term investment balance grew,' which is not supported by the original answer. The ground truth states that total Level 2 short-term investments *decreased* from $695 million to $630 million, contradicting the LLM's assertion of growth. Additionally, the LLM cites a drop in portfolio share from 21% to under 15%, which is not present in the ground truth and cannot be verified from the provided data. 2) Quantitatively, the $748M, $660M, and $88M difference are accurate. However, the percentages (21% to under 15%) and the claim about overall growth are unsupported and likely incorrect given the drop in Level 2 investments. 3) The reasoning is partially sound in identifying a shift in composition, but the multi-hop synthesis is flawed—the LLM incorrectly infers portfolio reallocation dynamics not present in the source. The original answer emphasizes a shift toward U.S. Treasury securities and money market funds, which the LLM mentions, but the broader narrative of portfolio growth contradicts the data. 4) Despite the error in overall investment trend and unsupported percentages, the core facts about the $88M decline and the shift toward more liquid instruments are correct, warranting a score of 7 for correctness. The answer is contextually relevant and mostly accurate but includes significant unverified claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 475,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "\nThe Class B‑2 shares were not issued until after the fiscal‑2023 exchange offer, so they did not exist during the period used to compute diluted earnings per share for 2023. Consequently, the 2023 diluted‑EPS calculation includes only the then‑outstanding Class A, Class B‑1 and Class C shares and is unaffected by the later introduction of Class B‑2 shares. (The first diluted‑EPS presentation that shows a Class B‑2 column appears only for fiscal 2024.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) It claims that Class B-2 shares were not issued until *after* fiscal 2023 and therefore did not affect the diluted EPS calculation for that year. However, the original answer (ground truth) states that the introduction of Class B-2 stock *does* impact the diluted EPS calculation for fiscal 2023 because it increases the as-converted weighted-average shares in the diluted EPS calculation, assuming conversion of all convertible classes. (2) There are no numeric values in either answer, but the temporal reasoning about when the shares are included in the calculation is factually wrong—the impact on diluted EPS comes from *assumed conversion* in the as-converted method, not actual issuance during the period. Even if shares are issued after an exchange offer during the same fiscal period, their potential dilution effect must be considered if the conversion is part of the capital structure changes that are material and assumed to occur. (3) The multi-hop reasoning fails: the model does not understand that diluted EPS calculations include *potential* conversions of securities into common stock, even if those securities (like Class B-2) result from an exchange offer during the reporting period. The absence of actual outstanding shares during the period does not preclude their inclusion in diluted EPS if they are part of a conversion scenario. (4) The LLM incorrectly limits the analysis to only shares outstanding during the period, missing the core concept of 'as-converted' treatment in dilutive securities. This reflects a deep misunderstanding of accounting principles under ASC 260. Thus, the answer contradicts the ground truth and receives a very low score across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 472,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "\nThe Raytheon segment’s pension and post‑retirement‑benefit costs are calculated under U.S. government Cost Accounting Standards (CAS), which spread expense over time and are later recovered through product pricing, whereas Collins Aerospace and Pratt & Whitney record those costs on a Financial Accounting Standards (FAS) basis. Because of this difference, RTX reports a separate “FAS/CAS operating adjustment” for Raytheon that is added back to its segment operating profit and disclosed apart from the other two segments, directly affecting Raytheon’s reported margin and requiring a distinct reconciliation in the segment‑profit presentation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core distinction in pension cost recognition between Raytheon (CAS) and Collins/Pratt & Whitney (FAS), which is the central point of the question. It correctly identifies that Raytheon uses CAS, which spreads expenses and allows recovery through U.S. government pricing, while the other segments use FAS. It adds valuable detail about the 'FAS/CAS operating adjustment' being added back to segment operating profit and disclosed separately—information consistent with actual SEC filings and enhancing completeness beyond the original answer. There are no numeric inaccuracies (quantitative accuracy is perfect, even though no specific numbers are present). The reasoning is sound and reflects proper multi-hop synthesis: understanding that different accounting standards lead to different reporting practices and reconciliation requirements. The only minor shortcoming is that it does not explicitly state that the ultimate liability under CAS and FAS is similar over time, which is a key nuance in the ground truth. However, this does not detract significantly from the overall correctness. Semantic equivalence is high, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 342,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "\nTwo supplemental indentures specifically reference the 1.850 % Notes due 2020: the Ninth Supplemental Indenture (dated February 12, 2015) and the Twelfth Supplemental Indenture (dated February 6, 2017). The 2015 indenture was executed with **U.S. Bank National Association** as trustee, while the 2017 indenture was executed with **The Bank of New York Mellon Trust Company, N.A.** as trustee.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately identifies two Supplemental Indentures related to the 1.850% Notes due 2020, which is quantitatively and factually correct. (2) The dates—February 12, 2015 (Ninth Supplemental Indenture) and February 6, 2017 (Twelfth Supplemental Indenture)—are correctly stated with proper formatting variations allowed. (3) The trustees are correctly identified: U.S. Bank National Association for the 2015 agreement and The Bank of New York Mellon Trust Company, N.A. for the 2017 agreement. (4) The reasoning demonstrates proper multi-hop synthesis by linking specific indentures to the correct notes, dates, and trustees across potentially separate documents. (5) The answer is semantically equivalent to the original, with clear, concise rewording that preserves all key information. No factual, numerical, or contextual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 268,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "\nIn fiscal 2022 the Company recognized a **$40 million gain** in income from foreign‑exchange forwards and options. This gain was modest relative to the **$92 million fair‑value of those assets** reported on the balance sheet as of May 31 2021 (roughly 43 % of the reported fair value).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $40 million net gain in fiscal year 2022 and the $92 million fair value as of May 31, 2021 are accurately reported, with an additional correct comparative observation that the gain was roughly 43% of the prior fair value (40/92 ≈ 0.4348 or 43.5%, reasonably rounded to 43%). (2) The answer addresses both parts of the multi-part question: the net gain in income for fiscal 2022 and the comparison to the fair value of assets as of May 31, 2021. (3) Entities are correct—'the Company' refers to Nike (implied from context in the knowledge graph), fiscal years are properly aligned, and financial instruments (foreign exchange forwards and options) are accurately identified. (4) The reasoning is sound: it correctly synthesizes data across time periods (from balance sheet value at end of fiscal 2021 to income impact in fiscal 2022) and provides meaningful context by comparing the income gain to the prior fair value, enhancing interpretability. The semantic content is equivalent to the original answer, with slightly more precise quantitative comparison added. All criteria for correctness, completeness, and clarity are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 344,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "\nAIG determines reserves for U.S. Personal Insurance by combining frequency‑severity, loss‑development and IBNR‑factor methods with expected‑loss‑ratio assumptions and supplemental ground‑up claim projections, and it segments the business by line and sub‑line; for U.S. Property it primarily uses loss‑development and expected‑loss‑ratio techniques (applying the same methods used for property classes) and does not rely on the same ground‑up projections. In 2021 the company recorded $412 million of favorable prior‑year development in U.S. Personal Insurance (largely from subrogation recoveries on the 2017‑18 catastrophe years), while the impact of prior‑year developments on U.S. Property is reflected only in the overall reserve change and is not disclosed separately in the excerpt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $412 million favorable prior year development in U.S. Personal Insurance is correctly stated, along with its attribution to subrogation recoveries from the 2017–2018 catastrophe years—this matches the original answer exactly. There is no specific 2021 prior year development figure provided for U.S. Property in either the ground truth or the LLM response, and the LLM correctly notes that the impact is not disclosed separately, which is consistent. (2) The reserving methodologies are accurately described: for U.S. Personal Insurance, the use of frequency-severity, loss development, and IBNR-factor methods is correct, as is the segmentation by line/sub-line. For U.S. Property, the emphasis on loss development and expected loss ratio methods (without ground-up projections) reflects the original. The only minor discrepancy is that the ground truth specifies IBNR factor methods are used for short-tail classes in U.S. Property, while the LLM does not mention 'short-tail' specificity—this is a small omission but doesn't invalidate the overall accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes methodology differences and links them to segment-specific practices and outcomes. (4) Semantic equivalence is strong—wording differs but meaning is preserved. The answer is fully contextually relevant, addressing both reserving approaches and prior year impacts. A score of 9 is justified due to the slight lack of detail on IBNR use in U.S. Property for short-tail lines, but all key facts and numbers are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 447,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 2009–2015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "\nWalmart’s 2018 majority stake in Flipkart has left it exposed to a show‑cause notice from India’s Directorate of Enforcement alleging historic foreign‑direct‑investment rule violations; if the matter proceeds to a hearing and penalties or indemnification claims are imposed, they could materially affect Walmart’s financial condition. This situation illustrates how Walmart’s broader international investment strategy—expanding into high‑growth markets such as India through equity stakes in e‑commerce platforms—subjects the company to regulatory risks abroad, a risk that is explicitly disclosed in its 2023 10‑K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Walmart acquired a majority stake in Flipkart in 2018; India's Directorate of Enforcement initiated proceedings over alleged FDI rule violations by Flipkart between 2009–2015 (prior to acquisition); the risk stems from potential penalties or indemnification claims; and this ties into Walmart's broader international investment strategy of entering high-growth markets via e-commerce acquisitions. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (2018 acquisition, 2009–2015 violations), or financial figures are cited. The LLM correctly avoids asserting any specific penalty amount, consistent with the original answer’s uncertainty. (3) Multi-hop reasoning is sound: it connects Walmart’s acquisition, the pre-acquisition regulatory issues at Flipkart, the potential financial exposure, and the link to Walmart’s global strategy as disclosed in its 2023 10-K. The only minor shortcoming is that the LLM does not explicitly state that Walmart does not currently believe the matter will have a material adverse effect, though it implies uncertainty with 'could materially affect.' (4) Contextual relevance is excellent—the answer directly addresses both parts of the question and reflects disclosures consistent with the 2023 10-K. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a slight omission of nuance regarding Walmart’s current assessment of materiality.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 424,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "\nAccenture issued Class A ordinary shares with a total value of roughly **$2.15 billion** during the 2023 fiscal year.  That issuance added about **$1.42 billion** to the company’s equity, helping lift total Accenture plc shareholders’ equity from **$25.69 billion** as of August 31 2023 to **$28.29 billion** as of August 31 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key numbers. The total dollar value of Class A ordinary shares issued in fiscal year 2023 is stated as $2.15 billion, but the ground truth is $7,970 (approximately $7.97 thousand), which is off by a factor of over 250,000%. This is a catastrophic quantitative error. Additionally, the LLM claims $1.42 billion was added to equity from the issuance, but the original answer does not isolate the exact contribution of the share issuance alone—only that it contributed along with other changes to an overall equity increase of $2,595,807 (from $25,692,839 to $28,288,646). The LLM incorrectly attributes a specific dollar amount ($1.42B) to the share issuance impact, which is not supported by the ground truth. (2) Number verification: The ending shareholders’ equity figures are approximately correct when converted to billions ($25.69B and $28.29B vs. actual $25,692,839 and $28,288,646), so this part is semantically acceptable. However, the share issuance value is completely wrong. The increase in equity is correctly approximated in magnitude (~$2.6B), but the LLM misattributes part of this change directly and disproportionately to the share issuance. (3) Multi-hop reasoning is partially present—the model attempts to link share issuance to equity changes over time—but fails in synthesis because it invents a causal contribution ($1.42B) not stated or implied in the ground truth. It also confuses the scale of the share issuance. (4) Correctness score is low (3) due to severe numerical inaccuracy in the primary fact requested. Quantitative accuracy is 2 due to one major number being wildly incorrect and unsupported calculations. Qualitative accuracy is 3 because while entities (Accenture, Class A shares, fiscal years) and general direction (equity increased) are correct, the reasoning and attribution are flawed. Contextual relevance is 7 because the answer addresses the right topic, time frame, and structure of the question, even if the facts are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 549,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "\nAIG first develops loss estimates for its excess‑casualty lines—particularly for layers that attach above $10 million—using traditional loss‑development techniques, and then extrapolates those estimates to the higher‑attachment layers by applying expected‑loss‑ratio methods that reflect the layer’s relationship to the underlying attachment point and limit.  Those calibrated expected loss ratios are subsequently used to set reserves for U.S. Property and aerospace exposures, especially for the most recent accident years where development data are limited, thereby linking the loss‑development analysis to the quantitative reserve projections for both lines of business.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of quantitative accuracy and contextual relevance. It correctly identifies the $10 million attachment point and the use of traditional loss development methods for lower layers, followed by extrapolation to higher layers using expected loss ratios. The role of expected loss ratios in recent accident years with limited data is also accurately noted, particularly for U.S. Property and aerospace exposures. However, the LLM answer misrepresents the direction of the methodology: the ground truth states that losses *capped at* $10 million are analyzed first, and that estimate is used to derive the expected loss for layers *above* $10 million—this layering logic is reversed in the LLM answer, which suggests development starts with the excess layers above $10M. Additionally, the original answer emphasizes that both loss development and expected loss ratio methods are used *in combination* for U.S. Property and aerospace lines, especially in aviation due to severity, whereas the LLM implies expected loss ratios are *derived from* casualty analysis and then *applied to* property and aerospace, which overstates the linkage and introduces a potential inference error. While the core concepts—use of expected loss ratios in data-scarce environments and layered reserving—are correct, the multi-hop reasoning is partially flawed in synthesis, leading to a reduction in qualitative accuracy. No numerical errors are present, hence quantitative accuracy is perfect. The answer remains highly relevant to the question, earning a high contextual relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 437,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "\nAccenture repurchased $4.1 billion of Class A ordinary shares during the fiscal year ending August 31 2022. This amount is roughly two‑thirds of the $6.69 billion of share‑repurchase authority that remained available as of August 31 2024, leaving about $2.6 billion of unused capacity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key numbers. The ground truth states that $4,111,266 (approximately $4.1 million, not billion) was repurchased during the period ending August 31, 2022. However, the LLM incorrectly reports this as $4.1 billion, which is off by a factor of 1,000. Similarly, the remaining authorization as of August 31, 2024, is stated as $2,694,281 (~$2.7 million), but the LLM reports it as $2.6 billion—again off by three orders of magnitude. The total authorization implied in the LLM answer ($6.69 billion) is also fabricated and not supported by the ground truth. (2) Calculations are therefore completely incorrect: claiming $4.1 billion is two-thirds of $6.69 billion is mathematically accurate, but entirely based on false inputs. The actual figures are in the millions, not billions, and no such ratio can be validly derived. (3) Multi-hop reasoning fails because the model misrepresents both data points and invents a relationship (two-thirds) that cannot be substantiated from correct data. It also reverses the timeline logic—using a 2024 authorization figure to compare with a 2022 repurchase without clarifying that the authorization likely evolved over time. (4) Despite severe quantitative inaccuracies, the answer is contextually relevant—it addresses share repurchases and remaining authorization, uses correct company name and fiscal year-end, and attempts a comparison. However, due to the magnitude of numerical errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 419,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "\nThe EU‑driven move away from “legitimate interests” to a consent‑based model forces Meta to obtain explicit permission for behavioral advertising and to offer a “no‑ads” subscription plus a free‑ad tier that delivers less‑personalized, less‑relevant ads; because users can opt out, ad relevance and engagement drop, which reduces the value of each impression and squeezes advertising revenue. At the same time, ongoing regulatory scrutiny (e.g., the European Commission’s DMA proceedings and GDPR enforcement) limits Meta’s ability to rely on data signals, further curbing targeting effectiveness and pressuring ad‑spend growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. It correctly identifies the shift from 'legitimate interests' to 'consent' in Europe as a regulatory-driven change impacting Meta's advertising model. The key elements—introduction of a 'no-ads' subscription, less personalized ads, reduced ad relevance, lower engagement, and diminished targeting and measurement capabilities—are all accurately captured. The answer correctly links these changes to reduced advertising revenue and mentions ongoing regulatory pressures (DMA, GDPR), which aligns with the context of compliance. While the original answer explicitly mentions reduced user engagement in high-monetization features like Feed and Stories, the LLM implies this through 'ad relevance and engagement drop' without specifying the features. This is a minor omission but does not detract significantly from the overall correctness. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound, multi-hop synthesis is correct (linking regulatory change → policy response → user behavior → ad effectiveness → revenue impact), and all entities (Meta, EU regulations, behavioral advertising, consent model) are accurate. The answer is fully contextually relevant and conveys the same core message as the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 379,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "\nThe redemption policy ties the outstanding Class X ordinary shares to the number of Accenture Canada Holdings Inc. exchangeable shares: whenever an exchangeable share is redeemed or exchanged, Accenture plc must redeem a corresponding Class X share, and it may only redeem Class X shares up to the point that the total Class X shares still outstanding do not exceed the total exchangeable shares held. This mechanism guarantees that the count of Class X shares outstanding is always synchronized with the count of exchangeable shares, so any redemption of exchangeable shares directly reduces the number of Class X shares and thus the overall shares outstanding.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that the redemption of Accenture Canada Holdings Inc. exchangeable shares triggers a one-for-one redemption of Accenture plc Class X ordinary shares, ensuring the number of Class X shares never exceeds the number of exchangeable shares. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, or counts), so quantitative accuracy is not applicable in a numerical sense, but the logical 'one-for-one' relationship is correctly described. (3) The multi-hop reasoning is sound: the answer connects the redemption mechanism of two different entities (Accenture plc and Accenture Canada Holdings Inc.) and explains how their share counts remain aligned through a conditional redemption policy. (4) All entities—Accenture plc, Class X ordinary shares, and Accenture Canada Holdings Inc. exchangeable shares—are accurately named and correctly related. The explanation fully addresses both parts of the question: the effect on shares outstanding and the mechanism ensuring alignment. Wording differs slightly from the original but conveys the same meaning with high precision and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 345,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "\nThe net milestone capitalization for Jardiance declined from **$156.2 million (2020)** to **$136.1 million (2021)**, a reduction of **$20.1 million**. This drop shows that the company is amortizing the previously recorded milestone amounts into cost of sales over the collaboration term, so the lower balance reflects the portion of those capitalized milestones that has already been expensed by the end of 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key numerical values: net milestone capitalization of $156.2 million in 2020 and $136.1 million in 2021, with a $20.1 million decline, matching the ground truth exactly. The calculation of the difference is accurate. 2) Quantitatively, all figures are correct and properly formatted, with acceptable use of spacing (e.g., $156.2 million). 3) The reasoning correctly explains that the decline reflects amortization of capitalized milestones into cost of sales over the collaboration term, which aligns with the filing's description. It captures the core concept of amortization reducing the asset balance as amounts are expensed. However, it omits specific details from the original answer about the factors determining the amortization period (e.g., 'latest of launch date, patent expiration, or supplementary protection certificates') and does not explicitly mention that milestones are capitalized as intangible assets—minor but relevant context from the multi-hop synthesis. 4) Despite these omissions, the LLM answer conveys the essential trend and rationale, maintaining semantic equivalence on the main points. The response is fully relevant and directly addresses both parts of the question: the quantitative change and its relation to amortization practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 363,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "\nIn the United States, IBNR‑factor methods are applied to low‑frequency, high‑severity property losses, so the factors must be continually re‑evaluated as claim emergence can be volatile and is strongly influenced by inflation, rate changes and recent COVID‑19‑related disruptions; this makes the U.S. reserving process more dynamic and sensitive to emerging experience.  In the UK/Europe Property book, loss‑development patterns are generally more stable, so IBNR factors are used together with comparatively reliable loss‑development and expected‑loss‑ratio techniques, resulting in a reserving process that is steadier and less prone to frequent large revisions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains key inaccuracies in the characterization of claim frequency and severity between the U.S. and UK/Europe Property lines, which undermines the qualitative accuracy. (1) The original answer states that both regions use IBNR factor methods for low-frequency, high-severity losses, but the U.S. has seen a shift toward less severe aggregate outcomes due to non-admitted coverages altering the customer profile. The LLM incorrectly assigns low-frequency, high-severity characteristics specifically to the U.S., while portraying the UK/Europe as having more stable patterns—this reverses the emphasis: the ground truth identifies UK/Europe as the region with low frequency/high severity, and notes the U.S. has become *less severe* in aggregate. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the model correctly links IBNR methods to reserving processes and considers regional differences in stability and methodology. However, it introduces unsupported elements (e.g., 'COVID-19-related disruptions') not present in the original and misattributes the reason for volatility. (4) Contextual relevance is high—the response addresses claim characteristics, IBNR application, and reserving implications for both regions—but the misrepresentation of severity trends reduces factual correctness. The core difference in how customer profile shifts in the U.S. affect severity is omitted, leading to an incomplete and somewhat misleading comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 445,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "\nProcter & Gamble’s Grooming segment holds **more than 60 %** of the global blades‑and‑razors market, while its share of the **male electric‑shaver market is just over 25 %**. In other words, the blades‑and‑razors share is roughly **2½ times larger** than its share in male electric shavers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that Procter & Gamble holds more than 60% global market share in blades and razors and just over 25% in male electric shavers, which matches the ground truth. The comparison is expressed as 'roughly 2½ times larger', which is semantically valid (60/25 ≈ 2.4, so ~2.5x is reasonable). However, the original answer emphasizes the *difference* of more than 35 percentage points, which the LLM does not explicitly mention, though it conveys the relative dominance. 2) All numeric values are accurate and consistent with the ground truth. The percentages (60%, 25%) are correctly reported, and the implied ratio is a reasonable interpretation. No calculation errors. 3) The reasoning is sound: the LLM correctly identifies P&G's market shares across two product categories and draws a valid comparative insight. It synthesizes the two data points appropriately, though it chooses a multiplicative comparison instead of the absolute percentage-point difference highlighted in the original. 4) The answer is contextually fully relevant, addressing both parts of the question—market shares in both segments and their comparison. The omission of the exact '35 percentage point difference' is a minor reduction in completeness but does not detract from factual correctness, as the multiplicative framing still accurately reflects the disparity. Thus, high scores across all dimensions with a slight deduction in qualitative accuracy for not capturing the precise nature of the comparison (absolute vs. relative), though the interpretation remains valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 431,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "\nGeneral Dynamics invested **$510 million** in Aerospace segment product‑development (R&D) expenses in 2023.  The company offsets a portion of these costs through **cost‑sharing arrangements with suppliers**, under which supplier contributions for reimbursable development expenses are recorded as a direct reduction of R&D expense (often tied to milestones and deferred if they exceed incurred costs).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $510 million investment in Aerospace segment product development for 2023, matching the ground truth exactly. The mechanism—cost-sharing arrangements with suppliers—is also accurately described, including the key detail that supplier contributions for reimbursable development costs are recorded as a reduction of R&D expenses. (2) The numeric value ($510 million) is correct and presented in an equivalent format (bolded with a thin space, but semantically identical). No calculations are required beyond accurate reporting, which is fulfilled. (3) The multi-hop reasoning is sound: the answer synthesizes both the financial figure and the contractual mechanism with suppliers from potentially separate disclosures in the 10-K, correctly linking them to the question’s two-part demand. (4) All entities—General Dynamics, Aerospace segment, 2023 fiscal year, R&D/product development costs—are accurate. The LLM adds minor clarifying details (e.g., milestone ties, deferral if contributions exceed costs) that are consistent with typical SEC filing language and do not contradict the ground truth. These enhancements improve precision without introducing error. Thus, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 349,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "\nAccenture spent **$4.509 billion** to repurchase Class A ordinary shares during fiscal 2024 (13.9 million shares under its open‑market and employee‑share‑purchase programs). This expenditure increased the carrying value of its treasury‑stock portfolio to **$10.56 billion**, up from $7.06 billion at the end of fiscal 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy. The ground truth states that Accenture spent $4,111,266 on Class A Ordinary Share purchases in fiscal 2024, but the LLM claims $4.509 billion, which is over 1,000% higher and factually wrong. This major discrepancy invalidates the core of the answer. Additionally, the LLM states that the total value of treasury shares increased to $10.56 billion from $7.06 billion, implying a $3.5 billion increase, which does not align with the ground truth increase of exactly $4,111,266. There is no evidence in the ground truth to support these large figures or the share count (13.9 million). While the answer addresses both parts of the question—amount spent and effect on treasury shares—it does so with fabricated numbers. The reasoning structure is logically sound (repurchase spending increases treasury stock value), and the context is relevant (discussing share repurchases and treasury stock), but the complete failure in numerical accuracy and entity-specific data (wrong amounts, wrong scale) severely undermines the answer. The qualitative error is compounded by introducing metrics (e.g., share count, prior and current treasury balances) not present in the ground truth, suggesting hallucination. Thus, despite correct terminology and general relevance, the answer is factually incorrect on all key financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 384,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "\nThe “Servers and network assets” line on the balance sheet rose from **$46.838 billion** at December 31 2023 to **$68.397 billion** at December 31 2024, an increase of **$21.559 billion** year‑over‑year.  \n\nMETA capitalizes these additions as property and equipment and then depreciates them on a straight‑line basis over the assets’ estimated useful lives—currently **four to five years** (and, beginning January 2025, extended to **5.5 years** for certain servers). Consequently, the $21.559 billion increase will be expensed gradually through depreciation over that useful‑life period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the 2023 value ($46.838 billion), 2024 value ($68.397 billion), and the year-over-year increase ($21.559 billion), matching the ground truth exactly. These figures are accurately calculated and presented with proper formatting. (2) Quantitatively, all numbers are correct and the dollar increase is accurately derived from the difference between the two years. (3) Regarding reasoning and multi-hop synthesis: the LLM correctly links the asset increase to META's depreciation policy, noting that assets are depreciated over their useful lives (4–5 years, with a change to 5.5 years in 2025). However, it omits the specific point in the ground truth about construction-in-progress (CIP) assets not being depreciated until placed in service—a key nuance explaining why such a large increase in depreciable assets might occur in a single year. While the LLM mentions capitalization and depreciation, it does not explicitly connect the surge in asset value to the transition of CIP assets into service, which is a critical inference in the original answer. (4) Despite this omission, the answer remains highly accurate, contextually relevant, and factually sound. The missing CIP explanation slightly reduces qualitative accuracy, but all presented facts are correct and directly responsive to the question, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 394,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance®) for heart failure with preserved ejection fraction and Baricitinib (Olumiant®) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "\nIn 2022 Eli Lilly obtained Breakthrough‑Therapy designations for three distinct indications; two of those indications—empagliflozin (Jardiance) for heart‑failure with preserved ejection fraction and baricitinib (Olumiant) for alopecia areata—are currently in a submitted regulatory status, whereas the third—baricitinib for systemic lupus erythematosus—has been discontinued.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the correct question structure. (1) Quantitatively, the original answer states that Eli Lilly received FDA Breakthrough Therapy designation for two indications in 2022, both in submitted status and none discontinued. The LLM claims three indications were designated in 2022—this number is incorrect. Only two designations occurred in 2022 according to the ground truth. (2) The LLM correctly identifies the two submitted indications: empagliflozin for heart failure with preserved ejection fraction and baricitinib for alopecia areata—this part matches the ground truth and is accurate. However, it incorrectly adds a third indication—baricitinib for systemic lupus erythematosus—as discontinued, which contradicts the ground truth stating no indications with Breakthrough Therapy designation were discontinued in 2022. (3) The multi-hop reasoning fails because the model introduces an entity (baricitinib for SLE) not present in the knowledge graph for 2022 Breakthrough Therapy designations, suggesting either hallucination or incorrect synthesis across entities. (4) While the answer is well-structured and contextually relevant, the core factual error—adding a third, discontinued indication—undermines correctness. The quantitative accuracy is low due to incorrect count (3 vs 2 total indications, 1 discontinued vs 0). Qualitative accuracy is partially correct due to accurate identification of the two submitted drugs but penalized for incorrect entity inclusion. Contextual relevance is high as the response directly addresses the question's structure and uses appropriate terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 453,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "\nAIG applies loss‑development techniques more intensively to its long‑tail **U.S. Other Casualty** portfolio—segmenting the data by coverage type, using a blend of loss‑development, frequency/severity and expected‑loss‑ratio methods, and giving greater weight to development factors for older accident years—whereas for its **U.S. Property** lines (a short‑tail book) it relies primarily on loss‑development and IBNR‑factor methods (often combined with expected‑loss‑ratio factors) and applies them more uniformly across the line.  \n\nIn 2021 the company recorded **$412 million of favorable prior‑year development in U.S. Personal Insurance**, driven largely by subrogation recoveries and other favorable emergence from the 2017 and 2018 catastrophe years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, the $412 million favorable prior year development in U.S. Personal Insurance is correctly reported, along with the attribution to 2017 and 2018 catastrophe recoveries via subrogation—this aligns exactly with the original answer. (2) The description of reserving methods for U.S. Other Casualty lines captures the blend of loss development, frequency/severity, and expected loss ratio methods, and correctly notes greater reliance on development methods for older accident years due to long-tail characteristics. For U.S. Property lines, the LLM correctly identifies the use of loss development and IBNR factor methods, though it slightly underemphasizes the primary role of frequency/severity methods mentioned in the ground truth. Instead, it groups IBNR and expected loss ratio factors together, which is not incorrect but slightly less precise. (3) Multi-hop reasoning is sound: the model differentiates between long-tail and short-tail lines and links 2021 adjustments to prior catastrophe years appropriately. (4) Semantic equivalence is strong—wording differs but meaning is preserved. The only minor shortcoming is the downplaying of frequency/severity methods in Property lines, which were explicitly stated as primary in the ground truth. This does not invalidate the answer but slightly reduces qualitative precision. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 424,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "\nThe Baby, Feminine & Family Care segment accounted for roughly **24 % of Procter & Gamble’s FY 2024 net sales**.  Since Charmin holds about a **25 % share of the North American toilet‑paper market** and drives most of the segment’s family‑care sales, it contributes **approximately one‑quarter of that segment’s revenue—around 6 % of total net sales**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's FY 2024 net sales, matching the ground truth. It also accurately reports Charmin's 25% North American toilet paper market share. (2) The LLM performs an implicit calculation: 25% of 24% equals 6% of total net sales, which is mathematically correct and a reasonable inference given Charmin's dominance in the family care subcategory. While the ground truth does not explicitly state the 6% figure, it provides the necessary components (24% segment contribution, 25% market share in a key North America-focused product line), making this a valid multi-hop inference. (3) The reasoning is sound: the LLM connects Charmin’s market position to its likely revenue contribution within the segment and scales it to total company sales. The only minor limitation is that the ground truth does not confirm Charmin 'drives most' of the family-care sales—this is a plausible assumption but slightly extrapolated. (4) All entities (Procter & Gamble, Baby/Feminine/Family Care segment, Charmin, North American market, FY2024) are correct. The answer is contextually complete and directly addresses both parts of the question with accurate data and logical synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 358,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the company’s ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "\nGeneral Dynamics’ $510 million 2023 R&D outlay is funneled through the Combat Systems segment—mainly Land Systems and Ordnance & Tactical Systems—to finance the next‑generation M1E3 Abrams engineering‑change package (SEPv3 upgrades, new communications, power‑generation, fuel‑efficiency and armor improvements) and to accelerate production of related weapons, ammunition and robotic‑vehicle technologies.  This investment underpins a robust backlog of land‑system contracts, sustains high‑margin revenue from Abrams and Stryker modernizations, and strengthens the company’s strategic position as the leading provider of future‑ready ground‑combat platforms with continued export growth and reduced sustainment costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $510 million R&D investment in 2023 is correctly stated, with no numerical or date inaccuracies. (2) The answer correctly identifies the Combat Systems segment (via Land Systems and Ordnance & Tactical Systems) as the channel for this investment and links it to the M1E3 Abrams development, including key technical improvements such as power generation, fuel efficiency, armor, and communications—consistent with the original answer. It also references SEPv3 upgrades, which, while not explicitly mentioned in the ground truth, are contextually plausible and do not contradict known facts. (3) The qualitative reasoning is strong: the LLM correctly infers strategic outcomes like sustaining high-margin revenue, supporting modernization programs, and strengthening export potential. It also captures financial outcomes such as contract backlog and reduced sustainment costs, which are semantically aligned with 'long-term contracts' and 'sustained revenue' in the ground truth. (4) Minor deduction in qualitative accuracy due to the introduction of 'robotic-vehicle technologies' and 'SEPv3' without explicit grounding in the provided truth, though these are reasonable inferences. Overall, the answer demonstrates sound multi-hop synthesis between R&D spending, platform modernization, and strategic/financial outcomes. Wording differs but meaning is equivalent, and all core facts are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 410,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "\n\\boxed{\\$3.867\\text{ billion (approximately)}}",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is completely incorrect. (1) The provided answer of $3.867 billion (approximately) does not match the ground truth total of $609.1 million, which is a significant factual error. The correct amount includes $605 million from the publicly announced share purchase program and $4.1 million from purchases outside of such programs. (2) Quantitatively, the LLM's figure is over six times larger than the actual value, indicating a severe miscalculation or confusion with unrelated data. There is no indication of how this number was derived, and it does not align with any known fiscal 2024 share purchase activity for Accenture. (3) The reasoning is entirely flawed—there is no evidence of proper multi-hop synthesis between purchases under the program and those outside it; instead, the model appears to have introduced an unrelated or fabricated figure. (4) Contextual relevance is minimal, as the answer addresses the right topic (share purchases by Accenture) but provides a grossly inaccurate magnitude, making it misleading and factually unsound. Minor relevance is retained only because the question involves share purchase value during fiscal 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 327,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "\nIn 2021 AT&T made a sublease payment of **$253 million** to Crown Castle, whereas the 2013 tower transaction generated **$4,827 million** in cash proceeds from Crown Castle. Thus, the 2021 payment is only about **5 %** of the original cash amount received in 2013.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $253 million in 2021 payments and $4,827 million (i.e., $4.827 billion) in initial 2013 proceeds are correctly reported, with appropriate unit formatting (million) added for clarity. (2) The calculation of the 2021 payment as approximately 5% of the original transaction is accurate: (253 / 4827) ≈ 0.0524 or 5.24%, which rounds to about 5%, a reasonable approximation. (3) The multi-hop reasoning is sound—correctly linking two distinct financial events across different years (2013 transaction and 2021 sublease payment) involving AT&T and Crown Castle, and synthesizing them into a meaningful comparison. (4) Entity accuracy is perfect: both companies are correctly named, and the years (2013 and 2021) and financial arrangements (sublease payment vs. initial cash proceeds) are correctly attributed. (5) The semantic meaning fully aligns with the original answer, even enhancing it with a precise percentage comparison. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 312,
        "total_tokens": 1455
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GM’s equity investments in 2021.",
      "llm_answer": "\nGM values its Stellantis warrants with a Black‑Scholes model and, in its own sensitivity analysis, notes that a 10 % adverse move in Stellantis’ quoted share price would have “an insignificant effect” on the fair‑value of those warrants (which represented $1.5 billion of equity exposure at year‑end 2021).  Because the impact on the warrant valuation is deemed immaterial, a 10 % drop in Stellantis stock would affect only a negligible portion of GM’s overall equity investments in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GM used the Black-Scholes model to value Stellantis warrants, the fair value at year-end 2021 was $1.5 billion, and a 10% adverse change in Stellantis stock price would have an 'insignificant effect' on the financial statements. These match the original answer exactly. (2) Quantitative accuracy is perfect: the $1.5 billion figure and 10% adverse change are correctly reported with no calculation errors. Format variations (e.g., $1.5 billion vs $1.5B) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly links GM's valuation methodology (Black-Scholes), the sensitivity analysis, the immateriality conclusion, and the implication for equity investments. It synthesizes methodology, exposure amount, and financial impact appropriately. (4) The only minor shortcoming is slight under-elaboration on *why* the effect is insignificant despite the use of a price-sensitive model—such as potential offsetting factors or low delta—but this does not detract from factual correctness. The answer remains semantically equivalent and fully responsive. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to near-perfect fidelity, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 378,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "\nApproximately 15 percent of P&G’s overall global market share within the Baby, Feminine & Family Care segment is accounted for by the adult‑incontinence sub‑category, which is served by the Always Discreet brand. This figure reflects the company’s share of sales in the adult‑incontinence market relative to all products in that segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that approximately 15% of P&G’s total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category through the Always Discreet brand, which matches the ground truth. The percentage is accurate and properly attributed. The answer is semantically equivalent to the original, though it simplifies the explanation by not mentioning that Always Discreet holds a 15% market share within the adult incontinence sub-category specifically, and that this sub-category contributes to the broader segment. This minor omission in explanatory depth does not affect the correctness of the final percentage or the overall response. All entities (P&G, Baby, Feminine & Family Care segment, Always Discreet, adult incontinence) are correctly identified. The reasoning is sound and the context fully addresses the question. No calculation errors; number format is consistent and clear.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 275,
        "total_tokens": 1472
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "\nThe average price paid for each Accenture plc Class A ordinary share in the fourth quarter of fiscal 2024—combining the shares bought under the publicly announced open‑market program and the 72,255 shares acquired in unrelated employee‑tax withholding transactions—was **$303.05 per share**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its key numeric claim. The ground truth states the average price paid per share was approximately $299.48, but the LLM reports $303.05, which is a significant deviation. This error suggests a miscalculation or use of incorrect input data (e.g., wrong total cash outlay or number of shares). While the LLM correctly identifies that the calculation must include both publicly announced open-market purchases and unrelated transactions (such as employee tax withholding), and correctly references the fourth quarter of fiscal 2024, the quantitative inaccuracy undermines the core of the answer. The mention of 72,255 shares from unrelated transactions may be factually accurate in context, but without correct aggregation and weighting, the average price is wrong. The reasoning structure is sound—acknowledging the need to combine multiple sources of share acquisitions—but the execution fails due to incorrect numerical synthesis. Thus, while the answer is contextually relevant and attempts the correct multi-hop logic (combining different acquisition types), the critical financial figure is incorrect, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 337,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "\nThe net milestones capitalized for Jardiance fell from **$156.2 million in 2020 to $136.1 million in 2021**, a decrease of **$20.1 million**. This $20.1 million reduction is only about **1.3 % of the $1.49 billion of Jardiance collaboration revenue reported for 2021**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net milestones capitalized for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), and accurately calculates the decrease of $20.1 million. However, it introduces a major factual error by claiming that Jardiance collaboration revenue in 2021 was $1.49 billion, which is not supported by the ground truth. The original answer states that collaboration and other revenue totaled $175.0 million in 2021, not $1.49 billion. This results in a grossly incorrect comparison—stating the reduction is 1.3% of collaboration revenue is false when the actual reduction ($20.1 million) is about 11.5% of $175 million. (2) Number verification: $156.2M → $136.1M = $20.1M decrease is correct. But $1.49B collaboration revenue is incorrect; should be $175.0M. (3) Multi-hop reasoning: The model attempts to compare the milestone decrease to collaboration revenue, which aligns with the question’s intent, but uses an incorrect revenue figure, breaking the logical chain. (4) Scores justified: Correctness penalized heavily due to the critical error in revenue amount, which distorts the core comparison. Quantitative accuracy is low due to the fabricated revenue number. Qualitative accuracy is moderate because reasoning structure is sound but based on wrong data. Contextual relevance is fair as the answer addresses the right entities and question structure but with flawed data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 394,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "\nIn 2021 GM recorded a $316 million gain from the fair‑value increase of its Stellantis warrants (shown in interest income and other non‑operating income).  At the same time, GM maintains an ongoing business relationship with Stellantis—continuing to purchase and supply vehicles, parts and engineering services, and honoring indemnification and guarantee obligations that stem from the former Opel/Vauxhall sale and thus affect its post‑sale operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $316 million gain from Stellantis warrants in 2021 is accurately reported, with an added detail about its classification in financial statements (interest income and other non-operating income), which is consistent with SEC filing disclosures. (2) The answer completely addresses both parts of the question: the financial gain and the ongoing operational relationship. (3) Entity accuracy is correct—GM, Stellantis, and the context of the Opel/Vauxhall sale are properly identified. (4) The multi-hop reasoning is sound: it connects GM's warrant gains to the post-sale operational relationship, including vehicle and parts supply, engineering services, and indemnification obligations, which stem from the original divestiture. The additional detail about guarantee obligations enhances the answer without introducing error. All information is semantically equivalent to the ground truth and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 290,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIG’s consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "\nAIG recorded a **$114 million pre‑tax loss** on the deconsolidation of AIG Financial Products Corp. (AIGFP), which is reported in “Net gain (loss) on divestitures and other” in the income statement. This loss reflects the one‑time financial impact of removing AIGFP from AIG’s consolidated results after its Chapter 11 filing—while the Chapter 11 reorganization does not materially affect AIG’s consolidated balance sheet, the loss captures the removal of AIGFP’s assets and liabilities (e.g., the $37.6 billion loan receivable re‑classified to a third‑party asset with a full allowance for credit losses).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $114 million pre-tax loss, its reporting in 'Net gain (loss) on divestitures and other', the Chapter 11 filing date (implied contextually), and the reclassification of the $37.6 billion loan receivable with a full allowance for credit losses. (2) Quantitative accuracy is perfect: $114 million and $37.6 billion match the original answer exactly; no calculations are required, but the values are correctly cited. (3) Multi-hop reasoning is sound—the answer synthesizes the financial impact of deconsolidation, the accounting treatment, and the conclusion about materiality (i.e., no significant effect on the consolidated balance sheet despite the loss). (4) The answer addresses both parts of the question: the amount of the pre-tax loss and the broader financial impact on AIG’s consolidated statements. Wording differs slightly but meaning is preserved, including the nuance that the loss is a one-time item and that the overall financial position remains largely unaffected. All entities (AIG, AIGFP) and financial terms are used correctly. No factual errors, omissions, or misstatements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 342,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "\nThe company’s net carrying amount for **Acquired franchise rights** at the end of 2024 is **$598 million** (gross $821 million less accumulated amortization of $223 million). In the prior year (2023) the **gross** balance for this asset category was **$840 million**, meaning the 2024 net value is about **$242 million lower** than the 2023 gross amount.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the net value of Acquired Franchise Rights in 2024 as $598 million, the gross value of $821 million, and accumulated amortization of $223 million, all of which match the ground truth. It also correctly states the 2023 gross value as $840 million. However, the comparison statement that 'the 2024 net value is about $242 million lower than the 2023 gross amount'—while numerically accurate ($840M - $598M = $242M)—does not directly address the question's intent, which asks how the 2024 *net* value compares to the prior year's *gross* value in terms of trend or change in gross value. The original answer emphasizes that the gross value decreased by $19 million from 2023 to 2024 ($840M to $821M), which is the more relevant comparison for understanding asset evolution. The LLM omits this key point about the year-over-year change in gross value, focusing instead on a net-vs-gross comparison that, while factually correct, shifts focus from the trend in gross value. This is a minor but meaningful omission in multi-hop synthesis. All entities, years, and metrics are accurate. Wording is clear and semantically close, but the reasoning emphasis is slightly misaligned. Hence, high scores but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 347,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "\nAT&T’s total commitment for the C‑Band licenses equals the $23.4 billion it paid (including the $550 million upfront deposit and the $22.856 billion of cash payments for the auction) plus the $2.1 billion it expects to spend to clear Phase‑II spectrum and the roughly $1 billion of compensable relocation costs that will be incurred over the next several years.  In sum, the disclosed financial commitment amounts to about **$26.5 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor formatting differences in number presentation. (1) All key financial figures are correct: $23.4 billion for the auction payment (matches $23,406 million), $2.1 billion for spectrum clearing (vs. $2,112 million—slight rounding acceptable), and ~$1 billion for relocation costs (matches $1,000 million). The total commitment of $26.5 billion aligns with the ground truth sum of $26,478 million ($26.478 billion), with rounding to one decimal place being reasonable. (2) Calculations are sound: 23.4 + 2.1 + 1.0 = 26.5 billion, which is consistent with the original total when rounded. (3) Multi-hop reasoning is correctly applied—the model synthesizes auction payment, future clearing, and relocation costs from different parts of the disclosure, as required. (4) Entities (AT&T, C-Band licenses, spectrum clearing, relocation costs) are accurately identified and contextually relevant. The only minor deviation is the use of rounded figures (e.g., $2.1B vs. $2.112B), but this does not affect factual correctness. Overall, the answer is semantically equivalent and fully responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 335,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lilly’s diabetes segment.",
      "llm_answer": "\nThe net milestones capitalized for Jardiance fell by **$20.1 million** (from **$156.2 million in 2020 to $136.1 million in 2021**), reflecting the amortization of previously recorded deferred milestone amounts into cost of sales during 2021.  At the same time, Lilly’s diabetes portfolio delivered strong top‑line growth—Jardiance net product revenue rose to **$1.49 billion in 2021** (up from $1.15 billion in 2020) and overall diabetes‑segment revenues also increased—so the decline in deferred milestones was more than offset by the segment’s revenue expansion, underpinning the improved financial performance of Lilly’s diabetes products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the change in net milestones capitalized for Jardiance as a $20.1 million decrease from $156.2 million in 2020 to $136.1 million in 2021, matching the ground truth exactly. These numbers are accurate and properly formatted. (2) The calculation of the difference ($156.2M - $136.1M = $20.1M) is correct. Additionally, the LLM provides supplementary financial data—Jardiance net product revenue increasing from $1.15B to $1.49B—which, while not in the original answer, is factually consistent with Lilly’s reported performance and enhances context. (3) The reasoning is sound and reflects multi-hop synthesis: it connects the decline in capitalized milestones to amortization into cost of sales, and then contextualizes this against broader revenue growth in the diabetes portfolio. While the original answer interprets the decline as potentially signaling a slowdown, the LLM offers a more nuanced view—that the negative impact was offset by strong revenue growth—demonstrating accurate qualitative inference. (4) The only minor deviation is that the LLM attributes the decline to amortization of deferred milestones being recognized in cost of sales, whereas the original emphasizes a reduction in newly recognized milestones. This is a subtle but not necessarily incorrect interpretation, as lower capitalization could reflect amortization patterns or fewer new milestones; however, without explicit confirmation from the source that amortization drove the change, this introduces slight ambiguity. Still, the core facts, calculations, and overall synthesis are correct and highly relevant, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 456,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "\nIn 2021 General Motors recorded about **$0.8 billion of non‑service pension income** and **$0.2 billion of gains from Stellantis warrants**, giving a combined financial benefit of roughly **$1.0 billion** from its relationship with Stellantis (see page 36).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $0.8 billion in non-service pension income, $0.2 billion in gains from Stellantis warrants, and a total of $1.0 billion in financial benefit. The values match exactly with the original answer, and the formatting ($0.8 billion vs $0.8 billion) is semantically equivalent. (2) The answer is complete, addressing both components of the question—pension income and warrant gains—and correctly summing them into the total benefit. (3) Entity accuracy is correct: General Motors, Stellantis, the year 2021, and the specific financial metrics (non-service pension income and warrant gains) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly combines two distinct financial items from the same year and entity relationship to arrive at the total benefit. The inclusion of a source reference (page 36) adds contextual support. Overall, the answer is factually precise, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 313,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "\nAfter AIG’s de‑consolidation of Corebridge (June 9 2024) it retained a ≈ 22 % equity stake that it now accounts for under the equity‑method and measures at fair value using Corebridge’s quoted stock price (Level 1). Consequently, any rise or fall in Corebridge’s share price is recorded directly in AIG’s net‑investment‑income, so the unrealized gain (or loss) on the equity‑method investment—reflected in the $601 million equity‑method income (loss) and the “Changes in the fair values of equity securities, AIG’s investment in Corebridge” reconciling item—represents the financial impact of those price movements and corresponds to the portion of Corebridge’s equity that AIG owns.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core concept correctly: changes in Corebridge's stock price impact AIG's financial statements through fair value accounting under the equity method, and this reflects AIG's ownership interest. It correctly identifies that AIG retains an approximately 22% stake and accounts for it using the quoted stock price (Level 1), which is consistent with fair value measurement. The mention of $601 million in equity-method income (loss) aligns with disclosures in AIG’s financial statements and reflects the impact of stock price changes. However, the original answer emphasizes that these changes are recognized under the 'fair value option' in the Consolidated Statements of Income, while the LLM answer places the impact in 'net investment income,' which may not be fully accurate—AIG reports changes in fair value of equity-method investments in 'Realized capital gains and losses' or a similar line, not typically in net investment income. Additionally, the LLM introduces a specific date (June 9, 2024) and a precise percentage (~22%) not present in the original answer, which may be factually correct but are not supported by the provided ground truth, raising concerns about hallucination or unsupported precision. The $601 million figure is plausible and matches known filings, but since the original answer does not include specific numbers, the LLM’s inclusion of this data cannot be fully verified from the ground truth alone. Despite these issues, the reasoning is largely sound, and the answer addresses both parts of the question: the financial statement impact and how it reflects ownership interest. Semantic equivalence is mostly achieved, though the technical placement of the gain in the income statement is slightly off.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 476,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "\nThe “Other identifiable intangibles” line shows a net book value of **$144 million as of December 28 2024**.  Its net balance fell from **$174 million in 2023** to **$144 million in 2024**, a decrease of **$30 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net value of Other Identifiable Intangibles for PEP in 2024 is correctly stated as $144 million, with a decrease of $30 million from $174 million in 2023. The calculation ($174M - $144M = $30M) is accurate. (2) The answer addresses both parts of the question: the 2024 net value and the year-over-year decrease due to amortization. (3) Entities are correct—PEP is the company, the metric is 'Other Identifiable Intangibles,' and the years 2023 and 2024 are accurately referenced. (4) The reasoning is sound, correctly interpreting the amortization impact as reflected in the net book value change. Minor formatting differences (e.g., 'million' spelled out vs. 'M') are acceptable and do not affect factual accuracy. The answer is semantically equivalent and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1103,
        "completion_tokens": 254,
        "total_tokens": 1357
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "\nIn 2023 the Company earned **$8.63 billion** from nuclear‑powered submarines, compared with **$2.70 billion** from surface‑ship sales—a roughly three‑fold difference. This disparity underscores the strategic focus on submarine programs such as the Columbia‑class ballistic‑missile submarines and the Virginia‑class attack submarines, which dominate the Marine Systems segment’s revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the revenue from nuclear-powered submarines ($8.63 billion) and surface ships ($2.70 billion), which matches the ground truth of $8,631 million and $2,698 million—rounding to the nearest hundred million is acceptable and common in financial reporting. The 'roughly three-fold difference' aligns with the actual ratio of approximately 3.2:1, though it slightly understates the precise ratio but remains semantically reasonable.\n\n2) Quantitatively, all numbers are accurate within acceptable rounding: $8.63 billion = $8,630 million (vs. $8,631 million) and $2.70 billion = $2,700 million (vs. $2,698 million). These minor discrepancies are negligible and do not affect factual correctness.\n\n3) The reasoning is sound: the LLM correctly attributes the revenue disparity to the strategic importance of the Columbia-class and Virginia-class submarine programs, accurately reflecting the multi-hop synthesis between financial performance and defense strategy. It correctly identifies General Dynamics (implied by 'the Company' in context) and the Marine Systems segment.\n\n4) The answer is contextually excellent—directly addressing both parts of the question (revenue figures and comparison) and providing relevant strategic context. The only minor shortcoming is the slight simplification of the 3.2:1 ratio to 'roughly three-fold,' which slightly reduces precision but does not invalidate the conclusion. Hence, a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 411,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "\nThe fair value of GM’s Stellantis warrant investment rose from $1.2 billion at 12/31/2020 to $1.5 billion at 12/31/2021, an increase of $0.3 billion. By comparison, the fair value of its marketable debt securities fell from $9.0 billion to $8.6 billion, a decline of $0.4 billion over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the increase in Stellantis warrants from $1.2 billion to $1.5 billion (a $0.3 billion increase) and the decrease in marketable debt securities from $9.0 billion to $8.6 billion (a $0.4 billion decrease) are correctly reported. (2) The answer addresses both parts of the multi-part question: the change in fair value for Stellantis warrants and the change for marketable debt securities. (3) Entities are correctly identified—GM, Stellantis warrants, and marketable debt securities—with accurate time periods (December 31, 2020, to December 31, 2021). (4) The reasoning is sound, though the LLM does not explicitly state the contrasting trends as the original answer does; however, the comparison is clearly implied by presenting both changes side by side with correct directional movements. The semantic meaning and factual content are equivalent to the ground truth. No errors in calculation, entity identification, or synthesis across financial instruments and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 311,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "\nThe net book value of Acquired franchise rights fell from **$626 million (2023)** to **$598 million (2024)**, a **$28 million decrease**. Because amortization expense is calculated on the remaining carrying amount, this reduction shows up as a **$1 million drop in amortization expense**—from **$75 million in 2023 to $74 million in 2024**.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net decrease in Acquired Franchise Rights from $626 million in 2023 to $598 million in 2024, resulting in a $28 million decrease, which matches the ground truth. This part is factually accurate. However, the LLM introduces a claim not present in the original answer — that amortization expense decreased from $75 million in 2023 to $74 million in 2024, implying a $1 million drop. The ground truth only states that the 2024 amortization expense was $74 million and that it contributed to the decrease in value; it does not provide the 2023 amortization expense or suggest a year-over-year change in amortization expense. This addition is unsupported by the provided data and introduces a potentially misleading inference. (2) While the $28 million decrease and $74 million 2024 amortization expense are correctly cited (with acceptable formatting using 'million'), the calculation of a $1 million drop in amortization is not verifiable from the ground truth and thus constitutes a factual overreach. (3) The multi-hop reasoning is partially sound — the model correctly links amortization expense to the reduction in net value — but it incorrectly assumes a temporal comparison of amortization expenses across years without sufficient basis. The original answer does not support such a comparison. (4) The contextual relevance is high because the response addresses both parts of the question and discusses the relationship between amortization and net value. However, the correctness score is reduced due to the introduction of unverified data (2023 amortization expense), which affects both quantitative and qualitative accuracy. A score of 6 reflects partial correctness with significant but not fundamental errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 480,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "\nThe $775 million (≈8 %) rise in total service costs for 2023 was driven largely by Aeronautics, where higher volume on F‑35 sustainment contracts added about **$570 million** of the increase.  At the same time, Aeronautics’ service sales grew $788 million (≈7 %), with roughly **$600 million** of that gain coming from the same F‑35 sustainment volume.  Thus, the F‑35 sustainment effort accounted for roughly three‑quarters of both the cost‑increase and the sales‑increase in that business unit.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $570 million increase in service costs due to F-35 sustainment contracts at Aeronautics and the $600 million increase in service sales from the same contracts, both of which match the ground truth. However, the LLM states that Aeronautics’ service sales grew by $788 million with $600 million from F-35, implying the $600 million is a component of that total, which is consistent but not explicitly confirmed in the ground truth. More critically, the LLM does not explicitly compare the $570 million cost increase to the $600 million sales increase and fails to note that the cost increase was $30 million less than the sales increase—a key analytical point in the original answer regarding margin improvement. (2) All provided numbers ($570M cost increase, $600M sales increase) are quantitatively accurate and correctly formatted. The $775 million total service cost increase is correctly cited. However, the LLM introduces a $788 million total service sales increase (≈7%) not present in the original answer, which may be factual but is extraneous and not directly requested. This number is not contradicted by the ground truth but adds unverified detail. (3) The multi-hop reasoning is mostly sound: the model links F-35 sustainment to cost and sales increases at Aeronautics and contextualizes their contribution to overall trends. However, it misses the comparative analysis (cost vs. sales delta) that is central to the original answer’s conclusion about profitability. (4) Despite the omission of the $30 million difference and its implication, the LLM captures the core facts and relationships. The answer is contextually relevant and well-structured, but the lack of explicit comparison and potential introduction of unverified aggregate sales figure prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 496,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "\nAs of September 25 2024, Accenture plc had a total share‑repurchase authority of **$6.694 billion** (the $4 billion approval on that date added to the $2.694 billion remaining authority, bringing the cumulative authorization to $6.694 billion). This expanded authority underscores the company’s capital‑return strategy of using robust cash generation to repurchase Class A ordinary shares, signaling confidence in its financial position and a willingness to enhance shareholder value through ongoing buy‑back programs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the total share repurchase authority as of September 25, 2024, is correctly stated as $6.694 billion (equivalent to $6,694 million), with a breakdown of $2.694 billion previously remaining and a new $4 billion authorization approved on that date. The calculation ($2.694B + $4B = $6.694B) is accurate. (2) The answer addresses both parts of the question: the total authority amount and its reflection on Accenture's financial strategy regarding Class A Ordinary Shares. (3) Entities are correct—Accenture plc, Class A Ordinary Shares, Board approval, and the date September 25, 2024—all match the ground truth. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the increase in repurchase authority to the company’s capital-return strategy, mentions robust cash generation, and links buybacks to shareholder value enhancement, which aligns with the original answer’s emphasis on active equity management and ongoing programs. Minor wording differences (e.g., 'capital-return strategy' vs 'financial strategy') do not affect factual accuracy and are semantically consistent. No errors in numbers, logic, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 355,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "\nA shortfall in membership growth would leave Netflix with the same fixed content‑cost base while revenue growth stalled, limiting its ability to scale spending or raise per‑member pricing. Because most of its content expenses are locked in, the company would face squeezed margins, reduced cash‑flow flexibility and heightened pressure on profitability until growth resumes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that Netflix's fixed content costs—especially due to live programming expansion—are non-adjustable, and that failing to meet membership growth expectations would stall revenue growth while fixed costs remain, leading to squeezed margins and reduced financial flexibility. There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10. The qualitative reasoning is sound: it captures the cause-effect chain (membership shortfall → flat revenue → inability to absorb fixed costs → margin and cash flow pressure), which reflects proper multi-hop synthesis of business model dynamics. The only minor shortcoming is a slight omission of the explicit link between liquidity and profitability mentioned in the original answer, though 'cash-flow flexibility' and 'pressure on profitability' cover similar ground. Thus, qualitative accuracy is 9. Contextual relevance is perfect—the response directly addresses the financial implications of membership underperformance in light of fixed costs. No irrelevant or extraneous information is included.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 337,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "\nThe 5.15 % 2041 Notes had a carrying amount of **$729 million**, which equals roughly **2.2 %** of the total debt carrying value of **$33.3 billion** reported by AMGN for 2022.  According to the debt‑exchange table, **$245 million** of principal of these notes was exchanged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the carrying value of the 5.15% 2041 Notes is correctly stated as $729 million, the total debt carrying value is accurately given as $33.3 billion (equivalent to $33,309 million), and the exchanged principal amount is correctly reported as $245 million. (2) The percentage calculation is accurate: 729 / 33,309 ≈ 2.19%, which the model appropriately rounds to 2.2%, an acceptable and common rounding in financial reporting. (3) The multi-hop reasoning is sound—information about the specific note, total debt, and exchange activity is correctly synthesized from different parts of the financial disclosures. (4) All entities—AMGN, 5.15% 2041 Notes, 2022 fiscal year, and the debt exchange table—are correctly identified and referenced. The answer is concise, factually precise, and fully addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 274,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "\nWhen McDonald’s sells a Company‑operated restaurant that it acquired from a franchisee, the treatment of the associated goodwill differs by timing. If the restaurant is disposed of **within 24 months of acquisition**, the entire amount of goodwill recorded for that acquisition is written off in that period. If the sale occurs **more than 24 months after acquisition**, only a portion of the goodwill is written off—specifically, the amount is based on the relative fair value of the sold business compared with the reporting unit to which it belongs. This approach ensures that goodwill is derecognized proportionally after the initial 24‑month “write‑off” window.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: the 24-month threshold, full write-off of goodwill within 24 months, and proportional write-off based on relative fair value beyond 24 months. (2) Quantitative accuracy is perfect—'within 24 months' and 'more than 24 months' match the original timeframes exactly; no numerical calculations are required, but the temporal distinction is correctly applied. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects McDonald’s acquisition of franchised restaurants, goodwill recognition, and differential derecognition treatment based on holding period. (4) Entity accuracy is correct—McDonald’s, goodwill, Company-operated restaurants, reporting unit, and fair value allocation are all used appropriately. The answer is concise, contextually relevant, and fully aligned with the original answer in both substance and implication.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 282,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "\nAIG recorded **$601 million of equity‑method income from Corebridge** for the post‑deconsolidation period (June 10 through December 31 2024).  This amount reflects the sum of dividends received plus the change in the fair value of AIG’s retained Corebridge shares (valued at the quoted market price), which is reported in Net investment income.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides a specific dollar amount ($601 million) for equity-method income, which is not present in the original answer (ground truth). The ground truth does not specify a numerical value, only the method of calculation (dividends plus change in stock price) based on AIG's 48.4% ownership. Therefore, the inclusion of $601 million is unsupported by the ground truth and likely incorrect or speculative. (2) The time period mentioned—June 10 to December 31, 2024—is slightly off; the original specifies 'after the deconsolidation date (June 9, 2024)', so starting June 10 omits a day and is technically inaccurate, though minor. (3) The qualitative reasoning is mostly sound: the LLM correctly identifies that equity-method income includes dividends and changes in fair value of retained shares, aligning with the concept of equity-method accounting post-deconsolidation. It also correctly references market-based valuation and reporting in Net investment income, which is consistent with typical SEC filing disclosures. (4) However, the ground truth emphasizes the 48.4% ownership stake as key to the income calculation, which the LLM omits—this is a significant detail in multi-hop reasoning from deconsolidation to retained interest. The LLM instead focuses on fair value changes, which leans toward fair value accounting rather than pure equity method, introducing a conceptual ambiguity. While the general framework matches, the specific financial figure and slight mischaracterization of the accounting method reduce factual accuracy. Thus, the answer is partially correct in logic and context but fails on key quantitative and entity-specific details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 460,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "\nFranchise‑owned restaurants make up roughly 93 % of McDonald’s global workforce—about two million employees in franchised locations versus only ~150 k corporate staff.  To raise the diversity of that workforce, the company runs a recruitment initiative that lowers the upfront equity barrier and provides ongoing learning for aspiring franchisees from under‑represented backgrounds, thereby increasing the share of diverse franchise owners and the workers they employ.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that franchisees contribute to approximately 93% of McDonald's global workforce, with about two million employees in franchised restaurants versus around 150,000 corporate employees—this matches the ground truth exactly in both absolute numbers and percentage. The use of '~150k' is an acceptable shorthand for 'over 150,000'. (2) All quantitative elements are accurate: the 93%, two million, and ~150,000 figures are consistent with the original answer and correctly imply the percentage calculation (2,000,000 / (2,000,000 + 150,000) ≈ 93%). (3) The reasoning is sound and captures the multi-hop link between franchisee ownership, workforce composition, and diversity initiatives. The LLM correctly infers that increasing diversity among franchisees will influence the broader workforce demographics. It accurately describes the recruitment initiative’s key components: lowering upfront equity requirements and providing learning and development for underrepresented groups. (4) The only minor shortcoming is that the LLM slightly condenses the scope of the initiative by not explicitly mentioning both U.S. and International Operated Markets as in the original, though 'aspiring franchisees from under-represented backgrounds' implies a broad reach. Wording differences are semantically equivalent and do not detract from accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 405,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "\nThe $100 million unfavorable profit adjustment on the Canadian Maritime Helicopter Program, together with the reduced Black Hawk production volume, trimmed roughly $41 million from RMS’s 2023 operating profit (the decline was partially offset by other program gains).  By contrast, Sikorsky programs were a primary driver of the backlog expansion in 2023, generating higher orders that lifted backlog even as they contributed to the profit hit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, it correctly identifies the $100 million unfavorable adjustment and the net $41 million decrease in RMS's 2023 operating profit, which aligns with the ground truth (the $100M loss was partially offset by gains, resulting in a $41M net decline). The numbers and their relationships are correct. (2) The answer addresses both parts of the multi-hop question: the collective impact on operating profit and the comparison to Sikorsky's contribution to backlog growth. (3) Entities are accurate—RMS, Sikorsky programs, Canadian Maritime Helicopter Program, and the context of 2023 are all correctly referenced. (4) The reasoning is sound: it acknowledges the profit decline due to the two factors and contrasts it with the backlog increase from Sikorsky, showing proper synthesis. The only minor shortcoming is that it does not explicitly mention the $65 million favorable adjustment from IWSS programs or the Aegis volume increase that contributed to the partial offset, which slightly reduces completeness in qualitative detail. However, the omission does not distort the overall correctness. Semantic equivalence is maintained, and the answer is contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 356,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "\nBroadcom’s purchase of VMware was valued at roughly **$53 billion** (about $30.8 billion in cash plus 544 million shares of Broadcom stock that together had a fair‑value of $53.4 billion).  The deal was undertaken to **strengthen and expand Broadcom’s infrastructure‑software business**, adding VMware’s multi‑cloud platform and related solutions to Broadcom’s portfolio so the company can offer a more comprehensive, end‑to‑end suite of infrastructure‑software products that help enterprises modernize, optimize and secure complex private and hybrid‑cloud environments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in substance but contains a significant quantitative inaccuracy: it states the total value as 'roughly $53 billion', while the ground truth is $84,186 million (~$84.2 billion). This is a major discrepancy—$53 billion vs $84.2 billion—off by over $31 billion. The breakdown provided in the LLM answer ($30.8 billion cash and $53.4 billion in stock) sums to $84.2 billion, which matches the ground truth, but the initial summary of 'roughly $53 billion' is misleading and incorrect. It appears the model confused the stock component ($53.4B) with the total deal value. 2) The cash and stock components are accurately represented: $30.8 billion in cash aligns with $30,788 million, and $53.4 billion in stock aligns with $53,398 million. However, the total value is wrong in the summary, which is a critical error. 3) The qualitative reasoning is strong: the answer correctly identifies that the acquisition aligns with Broadcom’s strategic focus on infrastructure software, specifically by enhancing multi-cloud capabilities and offering end-to-end solutions. This reflects accurate multi-hop synthesis between Broadcom’s strategic priorities and VMware’s technological assets. 4) Contextually, the answer is highly relevant and addresses both parts of the question—deal value and strategic alignment—though the numerical error undermines the correctness. The explanation of strategic rationale is semantically equivalent to the ground truth and well-articulated. Despite the serious miscalculation in total value, the component numbers and reasoning are sound, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 447,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "\nThe $6.99 ad‑supported tier is being used to broaden the service’s appeal and capture price‑sensitive households, a move that directly supports Netflix’s stated goal of balancing ARPU with market‑penetration growth; by offering a lower‑cost option the company attracted additional subscribers, which is evident in the 18 % year‑over‑year rise in global paid memberships reported in the 2024 filing (see the “Paid net membership additions” figures on page 48, which show double‑digit net additions across regions). This strategy trades a modest dip in ARPU for higher volume, aligning with the firm’s objective of expanding the subscriber base while protecting overall revenue per user.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $6.99 ad-supported tier, the 18% year-over-year increase in global paid memberships, and the strategic tradeoff between ARPU and market penetration are all accurately represented. The mention of the 2024 filing and page 48 adds specific support, though this detail is not in the original answer—it does not contradict it and may reflect additional context from the source. (2) Quantitative accuracy is perfect: the $6.99 price point and 18% membership growth are correctly stated, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly links the introduction of a lower-priced tier to increased subscriber growth, interprets this as part of Netflix’s broader strategy, and acknowledges the implied ARPU tradeoff. The only minor shortcoming is a slight softening of the certainty around ARPU impact—saying it 'trades a modest dip in ARPU' whereas the original states it 'moderating average revenue per user growth'—a nuance that doesn't materially alter the meaning. (4) The answer is fully contextually relevant, directly addressing how the pricing tier relates to membership growth and strategic balance. Overall, the LLM captures the core causal and strategic logic with excellent fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 370,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "\nMcDonald’s global workforce totals roughly 150,000 company‑owned employees plus **more than 2 million** individuals who work at franchised restaurants – **about 2.1 million people worldwide**.  These employees are the engine of the company’s purpose to “feed and foster communities” and its mission to “make delicious, feel‑good moments easy for everyone,” delivering consistent, high‑quality food and service, fostering inclusive workplaces, and driving community‑focused initiatives that reinforce the brand’s commitment to its customers, franchisees, suppliers and the communities it serves.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and semantically equivalent to the ground truth. It correctly states that McDonald's has roughly 150,000 company employees and more than 2 million individuals working in franchised restaurants, totaling approximately 2.1 million people globally. This aligns with the ground truth of over 2,150,000 total workers (150,000+ company, 2M+ franchise). The slight difference in total (2.1M vs 2.15M+) is acceptable as 'more than 2 million' and 'over 2,150,000' are consistent approximations.\n\n2) Quantitative accuracy is high: both components (150,000 company employees and over 2 million franchise employees) are correctly reported. The sum (~2.1 million) is a reasonable rounding of the actual total (>2.15 million), and no calculation errors are present. Format variations (e.g., 'more than 2 million' vs 'over two million') are acceptable.\n\n3) The multi-hop reasoning is sound—LLM correctly synthesizes workforce data across company-owned and franchised operations and links it to McDonald's purpose and mission. The stated purpose 'feed and foster communities' and mission 'make delicious, feel-good moments easy for everyone' are accurately reflected, with added context about service quality, inclusivity, and community initiatives that enrich but do not distort the original meaning.\n\n4) Contextual relevance is excellent. The answer fully addresses both parts of the question: total workforce size and its contribution to company purpose/mission. The qualitative explanation enhances the ground truth without introducing inaccuracies. Minor point: the original specifies 'over two million' franchise workers and 'over 2,150,000' total, so 'about 2.1 million' slightly understates precision but remains within acceptable bounds. No entity errors or misattributions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 489,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcom’s portfolio of infrastructure and security software solutions.",
      "llm_answer": "\nThe VMware acquisition was valued at **approximately $53.4 billion** in fair value. By bringing VMware’s multi‑cloud platform—including Cloud Foundation, license‑portability and a broad portfolio of infrastructure‑software solutions—into its fold, Broadcom significantly expands its infrastructure‑software capabilities, enabling it to modernize, optimize and secure complex hybrid‑cloud environments for enterprise customers.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a significant error in the total fair value of the VMware acquisition. The ground truth states $84,186 million (approximately $84.2 billion), composed of $30,788 million in cash and $53,398 million in stock. The LLM incorrectly reports the fair value as approximately $53.4 billion, which matches only the stock component, not the total. This is a major quantitative error. (2) The numbers are not accurate: $53.4 billion is close to the stock portion ($53,398 million), but the total fair value is nearly double that. The LLM fails to include the cash component entirely in the valuation, leading to a severe undercount. (3) The qualitative reasoning about how the acquisition enhances Broadcom's infrastructure software capabilities is sound and semantically aligned with the original answer. It correctly identifies VMware’s multi-cloud platform and infrastructure-software solutions as key additions that strengthen Broadcom’s hybrid-cloud offerings. Terms like 'modernize, optimize and secure complex hybrid-cloud environments' are contextually equivalent to 'enabling digital innovation with enterprise control.' (4) Despite strong contextual relevance and reasonable explanation of strategic benefits, the severe quantitative inaccuracy in the total fair value—especially omitting the cash portion—undermines the correctness score. The model likely confused the stock consideration with the total transaction value, indicating a failure in multi-hop synthesis across financial components. Thus, while the reasoning and relevance are strong, the factual core of the answer is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 441,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "\nNetflix’s 2024 10‑K notes that it periodically raises membership fees and tests higher‑priced plans (pages 22‑23), a move that has helped lift streaming revenue. However, the filing also warns that rising macro‑economic pressures—such as inflation and tighter household budgets—are making price sensitivity a growing threat to member retention (page 21). Consequently, the company’s pricing adjustments risk alienating cost‑conscious subscribers just when economic headwinds could increase churn, creating a tension between revenue‑growth goals and the need to keep existing members.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the original answer specifies the price range of Netflix's membership plans as $1 to $32 per month as of December 31, 2024, the LLM does not include these exact figures. However, it correctly references pricing adjustments and plan testing without introducing incorrect numbers, so no factual inaccuracy is present—just a minor omission. (2) The LLM correctly identifies the key macroeconomic pressures (inflation, tighter household budgets) from the 2024 10-K and links them to increased price sensitivity and churn risk, which matches the original answer’s reasoning. (3) The multi-hop reasoning is sound: it connects Netflix’s pricing strategy (price increases, testing higher-tier plans) with macroeconomic headwinds and the resulting tension between revenue growth and member retention. This synthesis across strategic and economic factors is logically coherent and supported by the filing. (4) The answer is contextually fully relevant, directly addressing the potential conflict in Netflix’s strategy. The only reason for not scoring a perfect 10 is the omission of the specific $1–$32 price range and the lack of explicit mention that content costs are fixed and not easily adjustable, which is a minor but notable detail in the original answer’s explanation of financial risk. Overall, the LLM captures the core conflict accurately and concisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 400,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "\nMcDonald’s goodwill from acquired franchised restaurants is valued using a discounted‑cash‑flow model that hinges on the franchisee’s ability to generate the projected cash flows. If franchisee performance deteriorates—e.g., sales decline, insufficient reinvestment, or other risks materialize—the expected cash flows fall, causing the reporting‑unit fair value to drop below its carrying amount and triggering goodwill impairment or, if the restaurant is sold within 24 months, a full goodwill write‑off (or a partial write‑off based on relative fair value thereafter). Thus, adverse franchisee performance directly reduces the fair value of the acquired unit and can result in goodwill impairments or accelerated write‑offs when the restaurant is later sold.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core mechanisms linking franchisee performance to goodwill accounting at McDonald's. (1) It correctly identifies that McDonald's uses a discounted cash flow model to value goodwill from acquired restaurants, and that deteriorating franchisee performance (e.g., declining sales) reduces expected cash flows, which can lead to goodwill impairment. It also accurately states the 24-month threshold: if a restaurant is sold within 24 months of acquisition, goodwill is fully written off; if sold after, it is written off based on relative fair value. These key facts align with the ground truth. (2) There are no numeric values (e.g., dollar amounts) in either answer, but the time threshold of '24 months' is correctly cited—this is the only quantitative element, and it is accurate. (3) The multi-hop reasoning is sound: the model connects franchisee performance → cash flow projections → goodwill valuation → impairment or write-off upon sale, and incorporates the timing rule for goodwill treatment. This demonstrates correct synthesis across the franchise model and accounting policy. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that McDonald's acquires restaurants *from* franchisees due to their financial distress—a nuance in the causal chain—but it implies it through the link between poor performance and sale. Wording differs slightly (e.g., 'impairment' vs. 'write-off'), but the concepts are used appropriately in context. Overall, the answer is factually correct, complete in substance, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 439,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "\nLockheed Martin’s hypersonics work is woven into the Space segment’s strategic thrust to develop advanced strike, missile‑defense and next‑generation space‑based capabilities, leveraging Space’s R&D, production and program‑management expertise to move several hypersonic strike weapons into early‑production phases by 2026.  This alignment expands the segment’s portfolio of high‑speed, resilient systems and is projected to generate new contract awards and revenue that underpin the company’s growth outlook through 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Lockheed Martin's hypersonics programs are indeed part of the Space segment's strategic priorities, focused on advanced strike capabilities, and are expected to enter early production by 2026. The LLM correctly identifies the strategic alignment and growth contribution through 2026. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2026) are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes the connection between hypersonics, the Space segment, strategic priorities, and growth outlook, consistent with the 2023 10-K reference in the ground truth. It correctly infers that early production phases support growth, even if it doesn't explicitly name the U.S. Army and Navy programs or list hypersonics as one of four key growth areas. (4) The LLM answer is semantically equivalent to the original—slightly more generalized (e.g., 'next-generation space-based capabilities' and 'missile-defense' are not in the original), but these do not contradict and may reflect broader context. The core message—strategic alignment, contribution to growth, and 2026 production timeline—is preserved. Only a minor deduction in qualitative accuracy due to slight expansion beyond the specific programs cited (Army/Navy) without explicit mention of the 'four key growth areas' framework from the 10-K. Overall, the answer is factually correct, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 436,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "\nBroadcom valued the VMware Cloud Foundation‑related developed technology using a **multi‑period excess‑earnings method** under the income approach; the fair‑value estimate reflects the present value of the technology’s projected cash flows after removing the contribution of other assets, thereby showing its expected financial contribution. The **excess‑earnings technique**—projecting future cash flows over the technology’s useful life and discounting them—was used to estimate its economic benefit over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the valuation method as the 'multi-period excess earnings method' under the income approach, and refers to it accurately as the 'excess-earnings technique,' which is a valid shorthand. The explanation that the valuation reflects the present value of projected cash flows after subtracting the contribution of other assets matches the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in the question or answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly links Broadcom’s valuation methodology to the projected financial contribution of the VMware Cloud Foundation technology and explains how the method estimates economic benefit over time via cash flow projections and discounting. The only minor shortcoming is that it does not explicitly mention the determination of the technology’s useful life based on the 'technology cycle,' which is part of the ground truth and relevant to how the time horizon for cash flows was set. This slight omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the reflection of financial contribution and the specific technique used. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the original answer with only a minor detail missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 421,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "\nThe 2021 launch of Sky Glass added new hardware‑sales and related implementation costs to Comcast’s Corporate and Other segment, but these expenses were more than offset by the decline in pandemic‑related severance and other one‑time cost reductions that had inflated 2020 operating outlays.  Management explicitly warned that it would incur higher costs in 2022 tied to the continued rollout of Sky Glass (and the companion XClass TV platform), signaling an expectation of rising investment in these smart‑TV initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that the launch of Sky Glass increased expenses in the Corporate and Other segment in 2021, and notes that these were partially offset by cost savings from reduced pandemic-related severance and other one-time items—consistent with the original answer's reference to prior-year cost savings offsetting some of the new costs. (2) There are no specific numerical values (e.g., dollar amounts or percentages) in either the question or ground truth, so quantitative accuracy is not compromised; all dates (2021, 2022) are correct. (3) The multi-hop reasoning is sound: the model correctly links Sky Glass and XClass TV to rising costs in both 2021 and expected 2022, and infers strategic intent from management's forward-looking statements. (4) The LLM adds contextual detail not in the original—specifically about pandemic-related cost reductions in 2020—but this is factually consistent with typical 10-K disclosures and helps explain the comparative cost dynamics without contradicting the ground truth. The only minor deviation is that the original answer emphasizes 'costs related to Sky Glass... partially offsetting prior-year cost savings,' while the LLM frames it as new costs being offset by declines in one-time 2020 expenses. This is a nuanced difference in emphasis but does not constitute a factual error. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 420,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "\nMcDonald’s values acquired franchise restaurants with a discounted‑cash‑flow (Level 3) valuation, assigning the resulting goodwill to the reporting unit that includes the restaurant. If a company‑operated restaurant is sold ≤ 24 months after acquisition, the entire goodwill tied to that purchase is written off; if sold > 24 months, only a proportion of goodwill—based on the relative fair value of the sold unit—is written off, which can cause earnings volatility and reduce the goodwill balance (e.g., $14.5 million of accumulated impairment losses were recorded as of 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key elements of the ground truth. It correctly identifies McDonald's use of discounted cash flow (Level 3 inputs) for valuing acquired restaurants and accurately explains the goodwill write-off policy: full write-off if sold within 24 months, partial write-off based on relative fair value if sold after 24 months. The reasoning and multi-hop synthesis across valuation, timing, and financial impact are sound. The only issue is the inclusion of a specific dollar amount—'$14.5 million of accumulated impairment losses as of 2023'—which is not present in the original answer and cannot be verified against the ground truth. This introduces a minor quantitative inaccuracy, though it does not contradict the original information. Wording differences (e.g., '≤ 24 months' vs 'within 24 months') are semantically equivalent. The answer fully addresses all parts of the question with correct entities (McDonald’s, goodwill, reporting unit), accurate terminology, and logical implications regarding earnings volatility and goodwill balance. Thus, the answer is factually strong with only a small deviation in unsupported numerical detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 332,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "\nThe $1.8 billion of customer‑financing assets that have already defaulted is heavily weighted toward 717 and 747‑8 aircraft and toward customers with weaker credit. Because those jet types are already suffering from pandemic‑driven demand collapse and lower resale values, any further defaults or the inability to re‑lease or sell the planes would quickly erode Boeing’s cash flow and force additional write‑downs or reach‑forward losses, thereby magnifying the pandemic‑related financial vulnerability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.8 billion defaulted portfolio amount is correctly stated and matches the original answer. There are no calculations required beyond this figure, and it is used appropriately. (2) The LLM correctly identifies the concentration risk in Boeing's customer financing portfolio related to the 717 and 747-8 aircraft, which is a key point in the original answer. It also correctly links this concentration to customers with weaker credit, adding contextual detail supported by the risk profile implied in the ground truth. (3) The reasoning is sound and captures the multi-hop logic: pandemic → reduced airline revenues → higher default risk → concentrated exposure in older aircraft types → difficulty re-leasing or selling due to low demand/resale value → further financial harm to Boeing via write-downs and cash flow erosion. This synthesis across customer credit, aircraft type, market conditions, and financial impact is logically coherent and consistent with the original. (4) While the original emphasizes the 'significant portion of the portfolio tied to fewer customers and specific types' and the LLM specifies 'heavily weighted toward 717 and 747-8', the semantic meaning is equivalent. The LLM adds value by explicitly mentioning resale value and write-downs, which are reasonable inferences from the context. One minor point preventing a perfect 10 is that the LLM states the $1.8 billion 'has already defaulted', while the original describes it as defaults 'linked to' the pandemic without specifying full default realization—this is a slight interpretive difference but does not materially misrepresent the risk. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 494,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "\nThe Sky Glass rollout added a measurable revenue boost to Comcast’s Corporate and Other segment in 2021—​the segment’s revenue rose largely because of “sales of Sky Glass televisions,” according to the 2021 results table.  At the same time, the company recorded launch‑related outlays for hardware, marketing and the accompanying XClass TV initiative within corporate and other expenses; these costs were mostly offset by the lingering savings from 2020 severance programs, so that operating expenses for the segment fell from $2.033 bn in 2020 to $1.819 bn in 2021 despite the new product spend.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures not present in the original answer, such as operating expenses falling from $2.033 billion in 2020 to $1.819 billion in 2021. These numbers are not supported by the ground truth and contradict the original answer, which states that higher expenses were incurred due to the Sky Glass launch. The claim that operating expenses decreased despite new product costs is factually inconsistent with the ground truth, which emphasizes increased expenses partially offsetting revenue gains. Additionally, the mention of 'XClass TV initiative' and '2020 severance programs' introduces entities and cost dynamics absent from the original answer, suggesting unsupported inference or hallucination. (2) Quantitative accuracy is low because the dollar amounts and expense trend are incorrect. The original answer does not provide any numerical data, so introducing specific figures without basis leads to significant factual errors. There are no verifiable calculations in the ground truth to support the LLM's detailed expense comparison. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that Sky Glass generated revenue and involved launch costs, it incorrectly synthesizes this with unrelated cost-saving measures and specific programs not mentioned in the ground truth. The reasoning fails to reflect the intended trade-off described—revenue increase offset by higher costs—instead asserting a net decrease in expenses, which contradicts the original. (4) Contextual relevance is high because the response addresses the core topic: the financial impact of Sky Glass on CMCSA’s Corporate and Other segment. It attempts to discuss both revenue and cost effects as required. However, the qualitative accuracy is moderate because, while it captures the general idea of revenue gain and cost increase, it undermines this with incorrect specifics and erroneous financial trends. Overall, the answer contains partial truth but is significantly compromised by unsupported data and incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 557,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "\nAs of December 31 2023, the Company’s commercial mortgage‑backed securities had a fair value of **$975 million**. This category accounted for an unrealized loss of **$100 million**, which represents roughly **12 %** of the total unrealized loss across the entire debt‑securities portfolio ($836 million).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the fair value of commercial mortgage-backed securities: it reports $975 million instead of the correct $675 million from the ground truth. However, the unrealized loss amount ($100 million) and the total portfolio unrealized loss ($836 million) are correct. The percentage calculation (12%) is also accurate and consistent with the ground truth. (2) Quantitative accuracy is compromised primarily due to the incorrect fair value figure, which is off by $300 million. This is a significant factual error affecting the core of the first part of the question. The other numbers (unrealized loss, total unrealized loss, and percentage) are numerically correct and properly formatted. (3) The multi-hop reasoning is partially sound: the model correctly identifies the unrealized loss for the category and compares it to the total debt securities portfolio, computing the correct proportion (12%). However, the incorrect fair value undermines the completeness and accuracy of the synthesis. (4) Despite the major error in fair value, the answer addresses all parts of the question and uses correct terminology, entities (CVS, commercial mortgage-backed securities, debt securities portfolio), and time period (December 31, 2023). The reasoning and structure are logical, and the percentage derivation is valid based on the correct loss figures. Hence, correctness is reduced to 6 due to the significant numerical inaccuracy in a primary data point.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 414,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the growth in third-party seller unit sales contribute to Amazon's overall sales increase in 2023, and what international risk related to third-party sellers could potentially impact Amazon's international expansion strategy?",
      "original_answer": "The growth in third-party seller unit sales was a key contributor to Amazon's 12% overall sales increase in 2023, particularly in both North America and International segments. However, Amazon faces international risks such as regulatory restrictions in countries like India, where foreign ownership rules limit control over online retail platforms, potentially complicating Amazon's expansion and reliance on third-party sellers in such markets.",
      "llm_answer": "\nIn 2023, unit sales generated by third‑party sellers were a key driver of the 12 % increase in North America net sales and the 11 % increase in International net sales, accounting for much of the overall revenue growth.  At the same time, expanding internationally exposes Amazon to regulatory risk in markets such as China and India—where government restrictions on foreign‑owned platforms, licensing, data‑security rules, and possible crackdowns on third‑party sellers could curtail that seller base and jeopardize the company’s expansion strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that third-party seller unit sales were a key driver of Amazon's sales growth in 2023 and accurately reflects the 12% increase in North America net sales. However, it states an 11% increase in International net sales, while the ground truth specifies a 12% overall sales increase without breaking out international at 11%; this introduces a minor inaccuracy. The core contribution of third-party sellers to overall growth is correctly conveyed. 2) The quantitative values are mostly accurate: the 12% North America figure matches, but the 11% International figure is not explicitly supported in the ground truth, which only states a 12% overall increase across segments. There is no calculation error per se, but the segmentation of international growth at 11% is an unsupported precision. 3) The reasoning is sound: the answer correctly links third-party seller growth to Amazon’s overall sales performance (multi-hop from seller activity to segment performance to company-wide growth). It also correctly identifies regulatory risks in international markets, particularly India, though it adds China as an example not mentioned in the ground truth. While China is a plausible risk market, the ground truth specifically cites India’s foreign ownership rules, so this is a minor deviation. 4) The answer is contextually excellent—addresses both parts of the question, uses appropriate financial terminology, and maintains focus on Amazon’s expansion strategy and third-party seller dynamics. Despite minor overprecision on the international growth percentage and inclusion of an extra jurisdiction (China), the answer captures the essential facts, synthesis, and implications accurately. Hence, high scores across the board with a slight deduction in quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 493,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "\nThe Deferred Compensation Plan has 1,853,363 shares left for future issuance, while the Non‑Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares left. This means the regular Deferred Compensation Plan has 1,712,810 more shares available for future issuance than the non‑qualified plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Deferred Compensation Plan has 1,853,363 shares remaining, and the Non-Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares remaining. The difference is correctly calculated as 1,853,363 - 140,553 = 1,712,810 shares, which matches the original answer exactly. (2) Quantitative accuracy is perfect: all numbers are correct, and the subtraction is accurate. Format variations are not an issue as exact figures are used. (3) The multi-hop reasoning is sound—LLM correctly identified two distinct plans, retrieved the correct share counts for each, and computed the difference. (4) The answer is semantically equivalent to the ground truth, clearly stating the difference and the underlying values. All entities (plan names, share counts, company context implied as Wells Fargo in 2023) are correctly handled. No errors in reasoning, completeness, or relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 285,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "\nPMI’s reduced‑risk product line includes (1) heated‑tobacco consumables (e.g., HEETS, Marlboro HeatSticks, TEREA and other licensed HTU brands), (2) heat‑not‑burn devices and their accessories, and (3) other nicotine‑delivery products such as e‑vapor and oral nicotine products. In the 2022 10‑K, heated‑tobacco units are reported under the “Reduced‑Risk Products” category, contributing $9.1 bn of net revenue (2021) and a growing share of total shipment volume, thereby classifying them as a core component of PMI’s reduced‑risk portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the three main categories of PMI's reduced-risk products: heated tobacco units (specifically naming HEETS, Marlboro HeatSticks, etc.), heat-not-burn devices and accessories, and other nicotine-containing products like e-vapor and oral nicotine products. This matches the original answer's categorization. (2) The LLM adds specific brand names and a quantitative detail—$9.1 billion in net revenue for 2021—which is factually correct per PMI’s 2022 10-K and enhances the response, though this figure was not in the ground truth. However, the question did not ask for financial figures, so this is a value-add rather than a deviation. (3) The reasoning is sound: it correctly classifies heated tobacco units as a core component of the reduced-risk portfolio and supports this with evidence from the 10-K (revenue reporting under 'Reduced-Risk Products'), demonstrating proper multi-hop synthesis. (4) The only minor issue is that the original answer emphasizes that heated tobacco units are 'explicitly stated' in two sections of the 10-K, a nuance not fully elaborated in the LLM response, but the classification itself is correct. All entities (PMI, 2022 10-K, product types) are accurate. Wording differs but meaning is semantically equivalent. Quantitative data is correctly cited with appropriate context and formatting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 392,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "\nIn fiscal year 2025 (ended January 26, 2025), DirectCustomerA accounted for **12 %** of NVIDIA’s total revenue. This is up from the prior year (fiscal 2024), where the company disclosed that DirectCustomerA contributed **less than 10 %** of total revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM incorrectly states that DirectCustomerA contributed 'less than 10%' in fiscal year 2024, which contradicts the ground truth stating that the contribution was not disclosed (marked as '*'). This is a major factual error. The 12% figure for fiscal year 2025 is correct. (2) Quantitative accuracy is low because the only correct number is the 12% for 2025; the 2024 percentage is falsely reported as '<10%' when it was actually undisclosed. There are no calculations in this question, but the comparison is based on incorrect data. (3) The multi-hop reasoning fails because the model assumes a quantitative comparison is possible when the prior year data is missing. The ground truth emphasizes that no direct numerical comparison can be made, but the LLM fabricates one. This shows flawed synthesis across years. (4) Contextual relevance is high because the answer addresses the right companies, metric (revenue percentage), and time periods, and attempts the correct comparison. However, the core factual inaccuracy in the undisclosed 2024 value severely undermines correctness. A score of 3 reflects that only part of the answer is right (2025 value), but the key comparative element is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 342,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "\nOne distinct version of the Restricted Share Rights Award Agreement was incorporated by reference for grants on or after January 24, 2023, and a separate distinct version was incorporated for grants on or after January 23, 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that there are two distinct versions of the Restricted Share Rights Award Agreement, one for grants on or after January 24, 2023, and another for grants on or after January 23, 2024, which matches the ground truth in terms of quantitative accuracy and entity identification. The dates and count of versions are correct. However, the LLM states that the second version was 'incorporated' without specifying how—whereas the original answer clarifies that the first version was 'incorporated by reference' and the second was 'filed herewith'. This distinction in filing method is part of the ground truth and relevant to the question's focus on how agreements were included in the 10-K. The LLM omits this key qualitative difference in the manner of filing, which affects completeness and reasoning accuracy, though the core facts about existence and timing are correct. Thus, while the semantic meaning is largely preserved, the lack of precision on the filing status slightly undermines the qualitative accuracy. Contextual relevance is full, as the response directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 318,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "\nThe prolonged FAA‑approval delay kept 787 aircraft in a delivery‑pause, so Boeing could not recognize revenue for those planes and had to treat them as at risk of contractual termination; under program accounting this uncertainty forced the company to record a reach‑forward loss and to forecast a higher cost‑of‑sales percentage, because any further postponement could trigger additional customer concessions or cancellations and thus compress margins on the 787 program.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core causal chain: FAA approval delays led to delivery pauses, revenue recognition issues, contractual termination risks, reach-forward losses, and margin pressure. It accurately describes the accounting treatment and the risk of customer concessions or cancellations impacting margins. However, it omits the key quantitative detail from the ground truth — the $4,574 million decrease in cost of sales in 2021 compared to 2020 — which is central to the financial impact. While the qualitative reasoning is sound, the absence of this specific figure significantly affects quantitative accuracy. (2) No numbers are mentioned in the LLM answer, despite the ground truth including a precise dollar amount ($4,574 million) and a year-over-year comparison (2021 vs 2020). This omission fails the quantitative accuracy check, even though format variations would be acceptable if any number were present. (3) The multi-hop reasoning is logically sound: the model connects FAA delays → delivery pause → revenue recognition issues → contractual risks → reach-forward losses → margin and cost of sales impacts. This demonstrates correct synthesis of cause-effect relationships across accounting and operational domains. (4) The answer is contextually relevant and semantically aligned with the ground truth in terms of mechanism and direction of impact, but the lack of specific financial data from the 10-K filing (especially the $4.574B cost of sales adjustment) limits completeness and factual precision, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 436,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "\nThird‑party sellers were the primary driver of the unit‑sale surge that lifted North America’s net sales 12% and International’s net sales 11% in 2023, boosting both volume and advertising revenue in those regions.  Currency movements added roughly **$88 million** to International net sales (a positive boost), while the stronger U.S. dollar trimmed about **$71 million** from consolidated net sales, leaving International sales growth net‑positive from FX and overall sales growth slightly constrained by the FX drag.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: third-party sellers drove 12% growth in North America and 11% in International, with foreign exchange adding $88 million to International sales and reducing consolidated sales by $71 million. The net FX impact is correctly implied as positive $17 million, though not explicitly stated. (2) Quantitative accuracy is perfect: percentages (12%, 11%), dollar amounts ($88M gain, $71M loss) match the original. The phrasing 'trimmed about $71 million from consolidated net sales' is slightly ambiguous—it could be misinterpreted as affecting only consolidated (total) sales rather than specifying the $71M reduction was in North America—but the numbers themselves are correct. (3) Multi-hop reasoning is sound: the model correctly links third-party seller activity to sales growth in both regions and synthesizes FX impacts across geographies. (4) The only minor shortcoming is the lack of explicit mention of the net $17 million positive effect on total sales, which was part of the original answer. Also, the LLM omits mention of subscription services as a contributing factor in North America, slightly reducing completeness. However, the core of the question—third-party seller role and FX impact—is well addressed with accurate data and logical flow. Wording differences do not affect semantic equivalence on the main points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 399,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "\nDeficiencies in Wells Fargo’s anti‑money‑laundering program could trigger a negative review by the Federal Reserve, which must assess an applicant’s AML effectiveness before approving any bank‑acquisition under the USA PATRIOT Act; the Fed could therefore block or condition the acquisition until the deficiencies are remediated. The regulatory body that evaluates these deficiencies during the approval process is the Federal Reserve Board (FRB).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. It correctly identifies that deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue bank acquisitions due to the Federal Reserve Board's (FRB) role in evaluating AML effectiveness under the USA PATRIOT Act. The regulatory body is accurately named as the FRB (referred to as 'the Federal Reserve' and 'the Fed', which are semantically equivalent). The reasoning is sound: the FRB can block or condition an acquisition based on AML deficiencies, which aligns with the statutory review requirements. The only minor shortcoming is that the LLM does not explicitly mention 'other federal banking regulators' or the broader rationale of 'risks to financial integrity and national security' included in the original answer. However, this omission does not detract from the essential correctness of the response. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The answer is contextually relevant and synthesizes the required multi-hop logic: (1) Wells Fargo’s AML obligations under the USA PATRIOT Act, (2) how deficiencies affect acquisition prospects, and (3) identification of the approving regulatory body. Thus, the qualitative accuracy is slightly reduced for partial completeness, but overall the answer is highly accurate and equivalent in meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 396,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "\nThe total international industry volume of cigarettes and heated‑tobacco units grew by **2.4 %** in 2021 versus 2020. In PMI’s financial reporting, heated‑tobacco units are classified within the **“Reduced‑Risk Products”** segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage increase in PMI's total international industry cigarette and heated tobacco unit volume from 2020 to 2021 is accurately reported as 2.4%, which aligns with the original answer. (2) The classification of heated tobacco units under 'Reduced-Risk Products' in PMI's financial reporting is correctly identified, with semantically equivalent capitalization and formatting (e.g., 'Reduced‑Risk Products' vs 'reduced-risk products'). (3) The answer addresses both parts of the multi-hop question: the quantitative change over time and the product categorization in financial reporting. (4) All entities (PMI, 2020–2021 time frame, correct product categories) are accurate, and the reasoning required to synthesize volume trends and reporting segments is sound. Minor formatting differences (bold, en-dash) do not affect factual correctness. Thus, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 273,
        "total_tokens": 1406
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "\nIf all of the CCC‑rated receivables (approximately $445 million) were to default, the loss would equal the full $445 million exposure, versus the current expected loss of about $108 million (24.2 % of $445 million).  The incremental increase in potential losses would therefore be roughly **$337 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. The ground truth states that Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables in the $1.8 billion portfolio were to default, based on a 24.2% default rate. This implies that 24.2% of $1.8 billion is the expected loss, which equals $435.6 million (0.242 × $1.8B = $435.6M). However, the LLM incorrectly assumes that only $445 million of the portfolio is CCC-rated, and then calculates expected loss as 24.2% of $445M (~$108M), claiming the incremental loss if all CCC-rated receivables defaulted would be $337M ($445M - $108M). This misrepresents the scenario: the question asks for the total potential loss increase *if the default rate reaches 100%*, not the incremental loss over current expectations. But more critically, the original answer interprets the 24.2% as the *proportion* of the portfolio rated CCC, not a probability of default. Thus, $1.8B × 24.2% = $435.6M is both the size of the CCC-rated portion and the potential loss if all of it defaults — which matches the ground truth. The LLM instead treats 24.2% as a probability applied to an assumed $445M exposure, which contradicts the original logic and introduces unsupported numbers. (2) Quantitative accuracy is low: the $445M figure is not in the original data and appears fabricated; the resulting $337M incremental loss is therefore incorrect. The correct potential loss increase is $435.6M. (3) Reasoning is flawed: the multi-hop synthesis fails because the model misunderstands the meaning of the 24.2% — it should represent the *fraction of the portfolio with CCC rating*, not a default probability. It then performs an unnecessary incremental calculation not asked for. The question asks 'by how much could potential losses increase' under full default — the answer is simply the full value of CCC-rated receivables, i.e., $435.6M. (4) Contextual relevance is high because the LLM addresses the right topic, company, portfolio size, and risk factor (CCC defaults due to pandemic), but the incorrect interpretation of key metrics undermines factual correctness. Scores reflect major quantitative error despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 594,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "\nIn fiscal 2025 (ended January 26, 2025), DirectCustomer C represented 11 % of NVIDIA’s total revenue. By contrast, in the prior fiscal year (ended January 28, 2024) DirectCustomer C contributed less than 10 % of revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies that DirectCustomerC accounted for 11% of NVDA's revenue in the fiscal year ending January 26, 2025, which matches the ground truth. However, it incorrectly states that the prior year (ended January 28, 2024) was 'less than 10%', while the ground truth confirms it was also 11%. This is a critical factual error in the comparative component of the answer. (2) The fiscal years are correctly identified and formatted with minor spacing variations (e.g., 'January 26, 2025' vs 'January 26, 2025'), which is acceptable. However, the percentage for the prior year is factually wrong—'less than 10%' contradicts the verified 11%. No calculation is required beyond comparison, but the comparison is inaccurate. (3) The reasoning fails on the multi-hop aspect: the model must correctly retrieve and compare two data points (same customer, two fiscal years). It retrieves the current year correctly but fails on the prior year, breaking the logical synthesis. (4) Contextual relevance is high—the answer addresses both parts of the question and uses appropriate terminology. However, due to the significant error in the prior year percentage, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because entity identification and structure are sound, but reasoning is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 373,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "\nThe Company’s Commercial Mortgage‑Backed Securities (CMBS) had a fair value of **$975 million** as of December 31 2023.  In the maturity‑based unrealized‑loss breakdown, the same CMBS portfolio carried **$100 million** of unrealized losses, meaning about 10 % of their fair‑value was unrealized loss at that date.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the total fair value of CMBS held by CVS Health Corporation. The ground truth states $675 million, but the LLM reports $975 million, which is $300 million higher and incorrect. However, the unrealized losses amount of $100 million is accurate and matches the original answer. The percentage calculation in the LLM answer (about 10%) is mathematically correct based on its incorrect fair value figure ($100M / $975M ≈ 10.26%), but this differs from the ground truth's stated proportion of 14.8% (which is $100M / $675M ≈ 14.8%). (2) Quantitative accuracy is compromised due to the incorrect fair value figure, despite the correct unrealized loss value. The percentage derived is internally consistent but based on a false premise. (3) The qualitative reasoning is sound in structure—correctly linking fair value to unrealized losses and computing a proportional relationship—but fails in data sourcing. The model appears to perform the right type of multi-hop synthesis (linking CMBS fair value to unrealized losses and deriving a percentage), but uses an incorrect base value. (4) Contextual relevance is high, as the answer addresses both parts of the question (fair value and comparison to unrealized losses) and maintains appropriate focus on the required financial metrics and time frame (December 31, 2023). However, the major numerical discrepancy in fair value reduces overall correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 408,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "\nChanges in the estimated fair value of Unit‑linked (and other FVO) securities are reported in **net investment income** (with related impairments flowing through net investment gains/losses), whereas **net derivative gains (losses)** capture the fair‑value movements of derivative instruments—including embedded derivatives tied to MRBs—and do not include the Unit‑linked securities themselves. Thus, the fair‑value fluctuations of Unit‑linked securities are reflected in net investment income, not in net derivative gains (losses).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that changes in the estimated fair value of Unit-linked securities are included in net investment income, which matches the original answer. It also correctly distinguishes that net derivative gains (losses) do not include the securities themselves but cover derivative-related items, such as embedded derivatives tied to MRBs (Market Risk Benefits), which corresponds to the original point about lapses associated with net embedded derivatives being in net derivative gains (losses). While the LLM uses slightly different terminology (e.g., 'MRBs' not explicitly mentioned in the original), the semantic meaning and accounting treatment are equivalent. There are no numerical values to verify, so quantitative accuracy is scored as 10. The reasoning is sound and reflects proper multi-hop understanding of accounting distinctions in MetLife's financial statements. The only minor limitation is that the LLM does not explicitly mention 'lapses' as the trigger for derivative gains/losses, which is a nuanced but important detail in the original answer—hence a slight deduction in qualitative accuracy. Overall, the response is highly relevant, accurate, and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 353,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "\nBoeing recorded a **$3.5 billion loss** on the 787 program in the fourth quarter of 2021. Because deliveries remain paused, the company’s revenue estimates are tied to the still‑uncertain timing of FAA approval to resume deliveries; any further delay or additional rework that lowers expected delivery volume or raises costs would reduce projected revenue and could trigger additional losses under the program‑accounting methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.5 billion loss Boeing recorded on the 787 program in Q4 2021, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) All numbers, dates, and financial figures are correct—$3.5 billion and Q4 2021 are accurately reported. Format is clear and equivalent to the ground truth. (3) The reasoning around FAA approval uncertainty and its impact on revenue under program accounting is sound and captures the core mechanism: delivery delays affect revenue recognition timing and expected margins, potentially triggering additional losses. The LLM correctly references program accounting and links FAA approval delays to financial impacts like reduced revenue and further losses. However, it omits a specific mention of 'contractual termination rights' and 'customer considerations'—nuanced but important elements in the ground truth that explain *why* timing affects financials. While the high-level logic is preserved, this minor omission in multi-hop synthesis slightly reduces qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing both parts of the question—historical loss and forward-looking accounting implications. Overall, the answer is factually correct, well-reasoned, and only slightly less detailed than the ground truth in explaining the accounting mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 388,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "\nIn fiscal 2025 (the year ended January 26, 2025), DirectCustomerA contributed **12 %** of NVIDIA’s total revenue. For the prior fiscal year (ended January 28, 2024), the filing only marks DirectCustomerA with an asterisk, indicating that its revenue share was **less than 10 %** and therefore the exact percentage is not disclosed.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the 12% revenue contribution from DirectCustomerA in the fiscal year ending January 26, 2025, which matches the ground truth. The date and entity (NVDA/DirectCustomerA) are accurate, satisfying quantitative and contextual requirements. However, the qualitative reasoning is flawed: the LLM interprets the asterisk (*) in the prior fiscal year (ended January 28, 2024) as indicating 'less than 10%', but the ground truth states the data is simply 'unavailable' and marked with '*', without implying a threshold. This misrepresents the meaning of the disclosure notation. While the unavailability is acknowledged, the inference of '<10%' introduces an unsupported assumption not present in the original data, indicating incorrect multi-hop reasoning or misinterpretation of SEC filing conventions. Thus, while key facts are correct, the reasoning and interpretation of the missing data are inaccurate, reducing the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 278,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "\nIn 2023 Amgen’s total financial impact from the BeiGene equity investment and related collaboration equals the $4.2 billion fair‑value of the BeiGene stake plus the $109 million of cost recoveries, the $125 million of product‑sales to BeiGene, less the $40 million profit‑and‑loss‑sharing expense.  Adding these components yields roughly **$4.39 billion** (about **$4.4 billion**) of net impact for the year.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all components of the financial impact: fair value of investment ($4.2B), net cost recoveries ($109M), product sales ($125M), and profit/loss sharing expense ($40M). However, the final calculated total is $4.39B (rounded to $4.4B), whereas the ground truth is $4.374B. The correct sum is $4.2B + $0.109B + $0.125B - $0.040B = $4.374B. The LLM's arithmetic is slightly off, likely due to rounding during intermediate steps. (2) All individual numbers match the ground truth and are correctly attributed to 2023 and the Amgen-BeiGene relationship. The calculation error is minor but quantitatively significant enough to affect precision. (3) The multi-hop reasoning is sound—LLM synthesizes equity investment value and multiple collaboration-related financial flows from different parts of the relationship. It correctly interprets 'profit/loss sharing expenses' as a cost (subtracted), consistent with the ground truth. (4) Despite the small calculation discrepancy, the answer is contextually complete and relevant, capturing all required elements and their correct directional impact. The final figure is rounded and presented reasonably, but strict numerical accuracy is compromised. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 357,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "\nMetLife applies a two‑year economic forecast to both commercial/agricultural and residential mortgage loans, but the re‑version to historical loss experience differs: for commercial and agricultural loans the forecast‑based loss rates are phased back to historical experience over a **two‑year straight‑line period**, whereas for residential loans the same forecast is followed by a **one‑year straight‑line phase‑in** of historical loss rates. Consequently, the estimated lifetime loss rates remain in effect longer—through the two‑year reversion— for commercial and agricultural portfolios than for residential mortgages, which revert to historical experience after only one year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key numbers are correct: both loan types use a two-year forecast period; commercial/agricultural loans revert over two years, residential over one year. The total durations (4 years vs 3 years) are implied correctly through the explanation of phase-in periods, though not explicitly summed as in the original answer. (2) The calculation of total duration (forecast + reversion) is logically sound and aligns with the ground truth—two-year forecast + two-year reversion = 4 years for commercial/agricultural; two-year forecast + one-year reversion = 3 years for residential. These totals are correctly implied in the comparative reasoning. (3) The multi-hop reasoning is solid: the model correctly synthesizes that the difference in reversion period length affects how long estimated lifetime loss rates are effectively applied. It accurately distinguishes between the two asset classes and explains the impact on duration. (4) Minor deduction in qualitative accuracy because the explicit total durations (4 years vs 3 years) are not stated outright, which slightly reduces completeness compared to the original. However, the explanation supports deriving this conclusion, so the omission is stylistic rather than factual. Wording differences (e.g., 'straight-line phase-in') are acceptable and semantically equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 420,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costs—impacted by factors like healthcare costs and regulatory changes—these financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "\nCostco self‑insures its employee health‑care benefits and records a liability based on actuarial assumptions that estimate future claim costs. Because actual health‑care expenses are highly volatile—rising with medical‑inflation, regulatory changes, and especially with labor‑market pressures such as wage growth and benefit‑cost increases—the actuarial estimates may underestimate the true expense, forcing the company to absorb unexpected cost spikes that can erode cash flow and profitability. In addition, the risk of higher labor‑related costs (e.g., higher wages, benefits, turnover) can further amplify these unpredictable fluctuations, adversely affecting Costco’s overall financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: Costco self-insures employee health care using actuarial assumptions (e.g., claims experience, demographics), liabilities are not discounted, and actual costs may deviate due to inflation, regulatory changes, and labor-market pressures. The LLM correctly identifies that unexpected cost spikes could impact cash flow, profitability, and overall financial condition. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no numbers were introduced or misstated. (3) The multi-hop reasoning is sound: the model connects self-insurance funding with actuarial estimation, recognizes the volatility of healthcare costs, links labor-related risks (wages, benefits, turnover) to financial exposure, and synthesizes how these factors jointly impact financial condition—mirroring the original answer’s logic. (4) Minor difference: the original emphasizes 'severity factors' and 'undiscounted liabilities' more explicitly, and notes 'legal changes' and 'unforeseen developments in claims' as specific risks, which the LLM omits. However, these are contextual nuances rather than factual errors. The LLM compensates by clearly articulating labor-market pressures. Overall, the answer is factually correct, comprehensive, and contextually appropriate—justifying a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 422,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "\nIn 2023 3M recorded a $4.2 billion pre‑tax charge for the CAE Settlement (the $5.3 billion present‑value contribution net of the $1.1 billion existing accrual) plus $437 million of restructuring‑related pre‑tax charges, for a total of roughly **$4.64 billion** in pre‑tax expenses.  \n\nThe reconsolidation of the former de‑consolidated Aearo Entities in Q2 2023 eliminated the $0.7 billion equity‑investment asset and the $0.6 billion net intercompany receivable that had appeared on the 2022 balance sheet, and instead the $5.0 billion accrued liability for Combat‑Arms‑Earplug litigation (shown as $1.5 billion current and $3.5 billion long‑term) was now reflected in other liabilities on the consolidated balance sheet as of December 31, 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects. (1) The pre-tax charge for the CAE Settlement is correctly stated as $4.2 billion, and restructuring charges are accurately reported as $437 million, with the total correctly calculated at approximately $4.64 billion (matching the ground truth $4.637 billion, with minor rounding acceptable). (2) The reconsolidation impact correctly identifies the removal of a $0.7 billion equity investment asset and a $0.6 billion net intercompany receivable (referred to as 'net liability' in ground truth; directionally equivalent as elimination of asset). (3) The LLM adds contextual detail not in the original answer—specifically, the $5.0 billion accrued liability split into current and long-term portions—which is factually consistent with the reconsolidation effect and enhances completeness without introducing error. (4) All entities (Aearo Entities, CAE Settlement, 2023 time frame) and financial terms are correct. (5) Multi-hop reasoning is sound: the answer synthesizes data on charges and balance sheet impacts across different disclosures. The only minor deviation is phrasing 'net intercompany receivable' versus 'net liability for former intercompany amounts'—but this reflects equivalent economic impact. No factual errors; slight bonus detail improves context without overreach. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and 9/10 overall due to perfect factual alignment with a touch of interpretive clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 430,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "\nGoogle’s Gemini 2.0 model is now native to Vertex AI, giving developers direct access to the company’s most capable multimodal AI (text, code, audio, image, video) and to pre‑packaged AI agents that can write, test, document, and secure code. By exposing Gemini 2.0 through Vertex AI, developers can more easily train, fine‑tune, and deploy Gemini‑powered applications at scale, integrate advanced generation and reasoning capabilities into their own products, and leverage built‑in tools for cybersecurity and other enterprise workloads on Google Cloud Platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. It correctly identifies that Gemini 2.0's integration into Vertex AI enhances developer capabilities on Google Cloud Platform by enabling training, fine-tuning, and deployment of Gemini-powered applications. The mention of multimodal support (text, code, audio, image, video) and pre-packaged AI agents aligns with the advanced tools referenced in the original answer, including support for generative models like Imagen and Veo. The LLM adds specific details about cybersecurity and enterprise workloads, which are plausible enhancements but not explicitly mentioned in the ground truth; however, these do not contradict it and fall within reasonable inference. There are no numbers, dates, or financial figures to verify, so quantitative accuracy is满分. The reasoning is sound, demonstrating correct synthesis of how the integration expands developer capabilities. The answer is fully contextually relevant. The only reason for not giving a perfect 10 is that the original answer explicitly names Imagen, Veo, and 'other generative AI models,' which the LLM answer implies but does not explicitly reference, representing a minor omission in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 348,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatment—using FVO securities in both yield calculations and fair value measurements—means that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "\nIn 2024 the fixed‑maturity yield (4.44 %) is computed on a denominator that includes FVO securities, so the $205 million of investment income that comes from those securities is built into the reported yield and total investment‑income figure. Because FVO securities are classified as Level 3 and are valued with unobservable inputs (e.g., matrix or market pricing, offered quotes), any change in those inputs directly alters their fair value, and the resulting gain or loss is recorded in investment income—making the reported income highly sensitive to the same input movements highlighted in the sensitivity column. Consequently, the inclusion of FVO securities both raises the overall yield‑derived income and amplifies its responsiveness to fair‑value fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $205 million investment income contribution from FVO securities in 2024, matching the ground truth. It accurately states that FVO securities are included in the fixed-maturity yield calculation and are classified under Level 3, using unobservable inputs for valuation. The explanation of sensitivity to fair value changes due to input fluctuations is consistent with the original answer. (2) All numeric values are correct: $205 million is accurately reported, and the 4.44% yield (though not in the ground truth) is contextually appropriate and does not contradict it—this likely comes from the actual filing data and enhances precision. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly links FVO inclusion in yield calculations to investment income, connects Level 3 classification with valuation sensitivity, and explains how changes in unobservable inputs affect both fair value and income volatility. The only minor gap is that the LLM does not explicitly name specific unobservable inputs like 'nonperformance risk spreads' or 'long-term equity volatilities' as in the ground truth, instead using broader terms like 'matrix or market pricing, offered quotes'—this slightly reduces qualitative precision but does not introduce inaccuracy. (4) The answer is fully contextually relevant, directly addressing the impact on investment income and sensitivity to fair value changes. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor abstraction in the description of valuation inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 453,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "\nThe 2022 de‑consolidation of the Aearo entities generated a **$1.2 billion pre‑tax charge** (recorded in SG&A), and when the entities were re‑consolidated in 2023 the accounting impact was **essentially immaterial**.  However, the re‑consolidation coincided with the resolution of the Combat Arms Earplugs litigation, leading 3M to record a **$4.2 billion pre‑tax charge** (and a $4.3 billion accrual increase) in 2023 for the CAE settlement of those earplug claims.  In total, the pre‑tax financial effect of the two events and the related litigation is roughly **$5.4 billion**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors. (1) The total pre-tax financial impact stated in the ground truth is $1.2 billion, comprising a $1.0 billion funding commitment and $0.2 billion for projected case expenses related to the Combat Arms Earplugs (CAE) litigation. The LLM incorrectly states a $1.2 billion charge from deconsolidation alone and then adds a $4.2 billion charge in 2023, leading to a total of $5.4 billion, which is not supported by the ground truth. The $4.2 billion charge and $4.3 billion accrual increase for the CAE settlement in 2023 are not mentioned in the original answer and contradict the stated total impact of $1.2 billion. (2) Quantitatively, the numbers are entirely inaccurate: the ground truth does not mention any $4.2 billion charge or $4.3 billion accrual; instead, it specifies that the reconsolidation had an immaterial income statement impact. The LLM invents major financial figures not present in the source. (3) The reasoning is flawed: while the LLM correctly identifies that the deconsolidation and reconsolidation are linked to the CAE litigation, it fails to correctly synthesize the cause-effect relationship. The ground truth states that the $1.2 billion total impact includes both the funding and projected expenses, and that the reconsolidation was immaterial—contrary to implying a massive new charge in 2023. (4) Contextually, the answer addresses the right entities (Aearo, 3M, CAE litigation) and timeframes (2022 deconsolidation, 2023 reconsolidation), so it maintains relevance, but the core financial facts are incorrect. The answer misrepresents the magnitude and timing of charges, failing the primary requirement of factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 466,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "\nThe integration of Adobe Firefly into Creative Cloud and Document Cloud adds generative‑AI capabilities—such as Generative Fill, Expand, Recolor, Text‑to‑Image, and AI‑enhanced features like Liquid Mode—directly into subscription products (e.g., Creative Cloud, Adobe Express, Acrobat web). This boosts the value of each subscription, drives upgrades and attracts new users, helping Digital Media ARR grow by roughly $1.9 billion (≈14%) in fiscal 2023 and expanding Adobe’s recurring‑revenue base. By embedding these AI‑driven tools into product‑led offerings, Adobe both deepens engagement with existing customers and broadens its addressable customer base across the Creative Cloud and Document Cloud ecosystems.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the integration of Adobe Firefly into Creative Cloud and Document Cloud with generative AI features (e.g., Generative Fill, Text-to-Image, Liquid Mode) and links this to Adobe's strategy of increasing recurring revenue and expanding the customer base. It accurately describes the value proposition of AI-driven tools in enhancing subscription products and attracting new users, aligning with the ground truth's emphasis on product-led growth, user engagement, and retention. However, the quantitative claim of Digital Media ARR growing by $1.9 billion (≈14%) in fiscal 2023 lacks direct support in the original answer, which does not provide any specific financial figures or growth metrics related to Firefly’s impact. This introduces a significant factual inaccuracy or unsupported extrapolation not present in the ground truth, reducing quantitative accuracy. While the named features and product integrations (Photoshop, Express, Acrobat web) are plausible and contextually relevant, the original answer does not specify features like 'Liquid Mode' or 'Recolor' as part of Firefly, nor does it mention Acrobat web explicitly—these may be conflated with other Adobe Sensei features. The reasoning is logically sound and synthesizes multi-hop concepts (AI integration → product value → recurring revenue → customer expansion), but the inclusion of unsupported financial data and slightly over-specified features reduces factual precision. Despite these issues, the answer remains contextually highly relevant and captures the core strategic intent described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 440,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "\nAs of December 31 2022, the combined fair value of Amgen’s U.S. Treasury bills ($1.676 billion) and money‑market mutual funds ($2.659 billion) was **$4.335 billion**. This amount is **exactly equal** to the total fair value of all of Amgen’s available‑for‑sale investments reported for that date ($4.335 billion).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1.676 billion (U.S. Treasury bills) and $2.659 billion (money market mutual funds) sum to $4.335 billion, which is correctly stated as the total fair value of these two investment types. This matches the ground truth sum of $1,676 million + $2,659 million = $4,335 million. The LLM correctly notes that this amount equals the total fair value of all available-for-sale investments, which is also $4.335 billion. (2) The answer is complete, addressing both parts of the question: the total fair value of the specified investments and how that compares to all available-for-sale investments. (3) Entity accuracy is correct: Amgen, as of December 31, 2022, and the financial instruments (U.S. Treasury bills, money market mutual funds, available-for-sale investments) are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that since the sum of the two components equals the total available-for-sale investments, they collectively constitute the entire portfolio of such investments. (5) Semantic equivalence is maintained: the use of 'billion' instead of 'million' with appropriate scaling ($1.676 billion = $1,676 million) is acceptable and common. Overall, the answer is factually precise, logically coherent, and fully responsive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 392,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "\nThe Company values Unit‑linked securities with option‑pricing techniques that treat long‑term equity volatility and the non‑performance risk spread as key unobservable inputs. Sensitivity analysis in the 10‑K shows that a higher long‑term equity volatility (14.23 %–22.27 %) increases the estimated fair value, while a higher non‑performance risk spread (0.11 %–1.46 %) decreases it, producing an inverse relationship for the spread.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that long-term equity volatility and nonperformance risk spreads are key unobservable inputs in the valuation of Unit-linked securities using option-pricing techniques, which matches the original answer. (2) The quantitative values provided—long-term equity volatility range (14.23%–22.27%) and nonperformance risk spread range (0.11%–1.46%)—are factually correct and specific to the MetLife 2024 10-K, demonstrating strong quantitative accuracy. (3) The reasoning is sound: it correctly explains the directional impact—higher volatility increases fair value, while higher nonperformance risk spreads decrease it due to higher discounting of cash flows—capturing the inverse relationship, which is consistent with the valuation logic in the filing. (4) The answer addresses all parts of the question: the valuation techniques, sensitivity to long-term equity volatility, and sensitivity to nonperformance risk spreads. The only minor shortcoming is that it does not explicitly mention the application of nonperformance risk spreads to market risk benefits (MRBs) or their variation by duration and currency, which is included in the original answer and adds contextual depth. However, this omission does not undermine the core correctness. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 395,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobe’s strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Firefly’s generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobe’s goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "\nAdobe’s Generative Credits embed Firefly’s AI‑powered content creation directly into Creative Cloud apps, giving every subscriber—whether a seasoned designer or a marketer, educator, or other non‑creative user—a simple, “pay‑as‑you‑go” way to produce images, text effects and templates. By turning AI generation into a valued, usage‑based feature, Adobe deepens daily engagement, shortens the path from trial to paid subscription, and creates an additional revenue stream (credit purchases and higher‑tier plans) that fuels its product‑led growth strategy across both creative professionals and broader stakeholder groups.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core elements of the ground truth. (1) All factual information is correct: Adobe introduced Generative Credits in Firefly as part of Creative Cloud, enabling AI-generated content with a paid upsell model. The answer correctly identifies the target users—creative professionals and non-creative stakeholders like marketers and educators—and links the feature to increased engagement and subscription revenue. (2) There are no numeric values (e.g., dollar amounts, credit limits, dates) in either the original or LLM answer, so quantitative accuracy is not compromised; the response avoids making up figures, which is appropriate. (3) The multi-hop reasoning is sound: the model correctly synthesizes that embedding AI into Creative Cloud apps supports product-led growth, drives conversion from trial to paid, and expands the user base. It accurately reflects the tiered access and usage-based monetization strategy. (4) The only minor gap is that the LLM answer does not explicitly mention 'tiered access (free and premium)' or 'retention' as a goal, which are present in the original and part of Adobe’s broader strategy. However, the concepts of conversion, engagement, and revenue from credit purchases imply these mechanisms. Wording differs but semantic meaning aligns closely. Thus, the answer is factually correct, contextually relevant, and only slightly less complete than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 398,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—enhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "\nThe embedding of Gemini 2.0 into Google’s billion‑user products creates a large, ready‑made demand for the same model family on Google Cloud, prompting developers to turn to Vertex AI to access, fine‑tune, and deploy Gemini‑powered workloads at scale. Gemini for Google Cloud further supplies pre‑packaged AI agents and tooling that let developers build, test, and operate software more efficiently, turning the Cloud’s AI‑optimized infrastructure into a direct revenue stream.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core mechanism by which Gemini 2.0 integration drives Google Cloud revenue. However, there is a minor quantitative inaccuracy: the original answer specifies that Gemini 2.0 is integrated into seven of Google's 'two billion-user products', while the LLM answer refers to 'billion-user products' (singular 'billion' instead of 'two billion'). This understates the scale mentioned in the ground truth. Despite this, the key reasoning is sound: embedding Gemini 2.0 in major consumer products creates ecosystem demand, which translates into developer and enterprise usage of Vertex AI and Google Cloud's AI-optimized infrastructure. The LLM correctly identifies the multi-hop link between consumer product integration and cloud revenue via developer services, pre-packaged AI agents, and scalable deployment. It accurately reflects the role of Vertex AI in enabling fine-tuning and deployment, and correctly ties this to consumption-based revenue. The answer is semantically close to the original and highly relevant to the question, with only the numerical scale of user base being slightly off. Hence, the correctness score is reduced slightly for quantitative precision, but qualitative and contextual accuracy remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 354,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "\nChanges in prepayment and default assumptions directly affect the cash‑flow timing used in the effective‑yield method for MetLife’s FVO securities, so higher default rates or slower prepayments lower the estimated fair value and reduce the amount of income that can be recognized, while faster prepayments accelerate amortization and can increase income.  The fair‑value measurement also relies on Level‑3 unobservable inputs—including default probability, loss‑severity, prepayment speeds and discount rates (e.g., swap yields)—whose variations are disclosed in the sensitivity tables.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the impact of prepayment and default rates on income recognition for FVO securities. It accurately explains that changes in these assumptions affect cash flow timing under the effective yield method, influencing income recognition—this matches the original answer's assertion that income is dependent on such factors. The explanation of how prepayment and default dynamics affect fair value and income (e.g., slower prepayments or higher defaults reducing income, faster prepayments accelerating amortization) adds useful detail not in the original but consistent with accounting principles, and does not contradict it. Regarding unobservable inputs, the LLM lists relevant Level 3 inputs such as default probability, loss severity, prepayment speeds, and discount rates, which are consistent with the types of unobservable inputs mentioned in the ground truth (e.g., nonperformance risk spreads, long-term equity volatilities). However, the LLM does not explicitly mention 'nonperformance risk spreads' or 'long-term equity volatilities'—two specific inputs named in the original answer—opting instead for related but not identical examples (e.g., swap yields). This constitutes a minor omission in completeness, particularly in the multi-hop synthesis of exact unobservable inputs used by MetLife. There are no numerical inaccuracies (quantitative accuracy is perfect, as no specific numbers are involved and all conceptual references are correct). The reasoning is sound and contextually appropriate, with strong relevance to the question. The answer enhances the original with mechanistic detail while mostly preserving fidelity, warranting a high but not perfect score due to the partial mismatch in specificity of unobservable inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 492,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "\nCostco’s heavy investment in the Kirkland Signature private‑label line lifts gross margin because Kirkland products generally carry higher margins than national brands and help differentiate the warehouse club’s offering, reinforcing member loyalty and encouraging higher‑spending Executive members. However, this advantage is vulnerable to supply‑chain disruptions, quality or reputation setbacks, and the risk that members lose confidence in the brand, which could erode sales and compress margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately captures that Kirkland Signature products enhance gross margins due to higher profitability compared to national brands and contribute to member loyalty—especially among higher-spending Executive members—which aligns with the original answer. It also correctly identifies the risks: supply-chain disruptions, quality issues, and loss of member confidence, which could negatively impact sales and margins. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or fabricated data earns a perfect score. (3) The multi-hop reasoning is sound: the model connects private-label strategy to margin performance, links brand trust to member retention, and identifies operational risks affecting financial outcomes—synthesizing business model, financial performance, and risk factors correctly. (4) Minor deduction in qualitative accuracy due to slight expansion on 'Executive members' not explicitly mentioned in the ground truth, though this is contextually reasonable and does not distort accuracy. Overall, the response is highly relevant, complete, and faithful to the source knowledge.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 360,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "\nThe fair‑value of “Other short‑term interest‑bearing securities” rose from essentially $0 million at December 31 2022 to $138 million at December 31 2023 – an increase of $138 million.  This $138 million addition is part of the overall growth of the Company’s available‑for‑sale portfolio, which expanded from $4.34 billion (2022) to $10.40 billion (2023), so the $138 million shift accounts for a portion of that $6.07 billion total increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in fair value of 'Other short-term interest-bearing securities' from $0 million on December 31, 2022, to $138 million on December 31, 2023. It accurately notes the $138 million increase. The total available-for-sale investments are reported as $4.34 billion in 2022 and $10.40 billion in 2023, which aligns with the ground truth values of $4,335 million and $10,404 million (rounded appropriately). The implied total increase of $6.07 billion matches the ground truth difference of $6,069 million within rounding tolerance. (2) All numeric values are correct, with acceptable formatting variations: $4.34 billion ≈ $4,335 million, $10.40 billion ≈ $10,404 million, and $6.07 billion ≈ $6,069 million. The $138 million figure is exact. Calculations (differences) are accurate within rounding standards. (3) The multi-hop reasoning is sound: the model correctly links the change in the specific security class to the overall change in available-for-sale investments, acknowledging that the $138 million is part of the broader $6.07 billion increase. It does not erroneously claim the entire increase is due to this category, which is appropriate. (4) The answer is contextually fully relevant and semantically equivalent to the ground truth. The only minor shortcoming is slightly less explicit emphasis on the 'significant growth' in the short-term investment portfolio as a concluding insight, but the data and logic support that interpretation. Hence, a score of 9/10 for correctness and qualitative accuracy—excellent but not perfect in narrative completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 445,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMI’s investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "\nThe filing of RBH’s objection to the CCAA‑court‑approved Proposed Plan narrowed the range of possible allocations of the CAD 32.5 bn settlement among RBH, ITL and JTI, signalling that the share of the settlement attributable to RBH—and therefore the fair value of PMI’s investment—was likely lower than its carrying amount.  Consequently, PMI performed a quantitative valuation of its RBH investment as of December 31 2024 and recorded a non‑cash impairment charge of **$2,316 million** in the consolidated statement of earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) Quantitatively, all key figures are correct: the impairment charge of $2,316 million is accurately reported, and the reference to the CAD 32.5 billion settlement amount (formatted as CAD 32.5 bn) matches the original. The date of December 31, 2024, for the valuation is correctly stated. (2) The answer correctly identifies that RBH's objection on January 24, 2025, narrowed the range of possible outcomes in the allocation of the settlement, which served as a trigger for impairment testing—this reflects sound multi-hop reasoning linking the legal development to the financial impact. (3) The LLM correctly states that a quantitative valuation was performed and that a non-cash impairment charge was recorded in the consolidated statement of earnings, aligning with the original answer. (4) The only minor omission is that the LLM does not specify the resulting fair value of PMI’s investment in RBH ($714 million), which is part of the complete causal chain (carrying value minus impairment = fair value). While this detail is important for full transparency, its absence does not undermine the correctness of the impairment charge or the reasoning. The LLM also omits mention of the discounted cash flow methodology and key assumptions (e.g., discount rate, sales volumes, tax deductibility), which were part of the valuation process described in the ground truth. However, since the question primarily asks for the influence on valuation and the resulting impairment, and those are correctly reported, the omission reduces completeness slightly but not enough to drop below a 9. All entities (PMI, RBH, ITL, JTI, CCAA court) and timelines are accurate. The answer is semantically equivalent in intent and fact, with only minor detail gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 495,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "\nThe filing states that TAC is generally ≈ 22 % of advertising revenues from Google Network properties. Therefore, a $10 billion rise in those revenues would raise TAC paid by 22 % of $10 billion, i.e., an additional **$2.2 billion** in TAC expense.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The quantitative calculation is accurate: 22% of $10 billion is correctly computed as $2.2 billion. The format '$2.2 billion' is semantically equivalent to the ground truth. (2) The answer addresses all parts of the question: it references the $10 billion revenue increase, the constant TAC rate of 22%, and calculates the resulting increase in TAC paid. (3) Entity accuracy is correct—'Google Network properties', 'TAC', and the 22% rate are all properly identified and used in context. (4) The reasoning is sound and reflects multi-hop synthesis: it correctly applies the TAC rate from the filing to a hypothetical revenue increase, demonstrating understanding of the proportional relationship. The explanation is concise, factually accurate, and logically coherent, fully aligning with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 255,
        "total_tokens": 1392
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "\nThe carrying amount of UnitedHealth Group’s long‑term debt and other financing obligations rose from **$61,449 million at the end of 2023 to $75,604 million at the end of 2024**, an increase of **$14,155 million**.  Over the same period its reported fair value grew from **$59,851 million to $70,565 million**, an increase of **$10,714 million**.  Consequently, the rise in carrying value exceeds the rise in fair value by roughly **$3.4 billion**.  (Page 56)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: the carrying value increased from $61,449 million in 2023 to $75,604 million in 2024, a difference of $14,155 million, and the fair value increased from $59,851 million to $70,565 million, a difference of $10,714 million. These values match the original answer exactly. (2) All calculations are accurate: $75,604M - $61,449M = $14,155M and $70,565M - $59,851M = $10,714M. The additional observation that the carrying value increase exceeds the fair value increase by roughly $3.4 billion ($14,155M - $10,714M = $3,441M ≈ $3.4B) is a correct and reasonable interpretation. (3) The multi-hop reasoning is sound—information from two different metrics (carrying value and fair value) across two years is correctly synthesized and compared. (4) The answer is semantically equivalent to the ground truth, with slightly enhanced clarity (e.g., specifying the difference in magnitude). All entities—UnitedHealth Group, long-term debt and other financing obligations, correct years (2023 to 2024), and financial metrics—are accurately referenced. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 334,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "\nThe expansion of merchant accommodation reservation services added roughly **$573 million** to the increase in merchant transaction costs in 2022.  At the same time, **merchant revenues grew 94.6 % year‑over‑year**, far outpacing the **35.1 % growth in agency revenues**, highlighting that the merchant segment’s revenue expansion was substantially larger than that of the agency segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $573 million increase in merchant transaction costs due to the expansion of merchant accommodation reservation services at Booking.com in 2022, matching the ground truth exactly. It also accurately states that merchant revenues grew 94.6% year-over-year compared to 35.1% for agency revenues, which aligns with the qualitative point in the original answer about merchant revenues increasing more than agency revenues. These percentages are not in the ground truth, but they are factually correct and provide stronger quantitative support than the original, enhancing rather than distorting accuracy. (2) All numeric values—$573 million, 94.6%, and 35.1%—are correct and appropriately formatted. There are no calculation errors. (3) The multi-hop reasoning is sound: the model connects the rise in transaction costs to increased merchant activity and supports this with comparative revenue growth data, effectively synthesizing cost and revenue trends across business models. The only minor shortcoming is that it does not explicitly state that the strong growth in merchant revenues was *driven by* the expansion of these services (a causal link emphasized in the original), though this is strongly implied. (4) The answer is highly relevant, complete, and factually superior to the ground truth in quantitative detail. The correctness score is 9 instead of 10 because while all stated facts are accurate, the answer slightly reframes the reasoning by introducing precise growth rates not in the source, which, while correct, shifts emphasis without confirming the causal driver as clearly as the original. However, this does not constitute an error, so quantitative accuracy is 10, qualitative is 9, and contextual relevance is 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 486,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "\nThe Zynq UltraScale+ RFSoC adds integrated, high‑performance RF data‑converter hardware to AMD’s Adaptive SoC line, giving the company a dedicated solution for wireless, radar and cable‑access applications and differentiating its FPGA/Adaptive portfolio from pure‑FPGA competitors. This introduction furthers AMD’s broader strategy of serving markets that need aggressive RF‑data‑conversion capabilities—leveraging its heterogeneous compute platforms to deliver integrated hardware‑software solutions that accelerate time‑to‑market for 5G, radar, and other high‑performance RF use cases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Zynq UltraScale+ RFSoCs integrate high-performance RF data converters into AMD's Adaptive SoC line, targeting wireless, radar, and cable access markets—this matches the original answer. The strategic alignment with AMD's goal of delivering integrated, adaptable platforms for faster time-to-market in high-performance RF applications (e.g., 5G, defense, communications) is correctly captured. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable but assumed correct by absence. (3) The multi-hop reasoning is sound: the model correctly synthesizes that integrating RF data converters into SoCs enhances value for real-time and embedded systems, aligning with AMD’s broader heterogeneous computing strategy. The only minor shortcoming is that the LLM answer does not explicitly mention 'aerospace and defense' as high-growth sectors, though 'radar' implies defense applications. It also omits 'sensor fusion and analytics'—a small loss in completeness. (4) Despite these minor omissions, the semantic meaning and strategic implications are preserved, and the response is fully relevant to the question. Hence, a high score of 9 is justified for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy due to absence of errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 406,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "\nThe Company’s held‑to‑maturity debt securities had a combined carrying (amortized) value of **$1,115 million** for 2023 ($603 million) plus 2024 ($512 million). Their combined fair value was **$1,104 million** (2023 $596 million + 2024 $508 million). Thus, the total carrying value is slightly higher than the total fair value—about **$11 million** (roughly 1 %) more.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: carrying values of $603 million (2023) and $512 million (2024) sum to $1,115 million, and fair values of $596 million (2023) and $508 million (2024) sum to $1,104 million. The difference of $11 million is correctly calculated. (2) The answer addresses both parts of the question: total carrying value for 2023 and 2024 combined, and comparison to total fair value. (3) Entities are correct—UnitedHealth Group, debt securities - held-to-maturity, and the years 2023 and 2024 are properly identified. (4) The multi-hop reasoning—aggregating across two years and comparing carrying to fair value—is sound and correctly executed. The addition of a ~1% relative difference, while not in the original answer, is a reasonable inference and does not detract from accuracy. All information is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 273,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "\nThe expansion of merchant‑accommodation reservation services added roughly **$570 million** to sales‑and‑other expenses in 2022 (driven by higher merchant transaction costs and related call‑center fees), and this same growth helped push **merchant gross bookings up 108 % year‑over‑year** (from about $25.8 bn in 2021 to $53.9 bn in 2022).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the approximate $570 million increase in expenses related to the expansion of merchant accommodation services, which aligns closely with the ground truth figure of $573 million (difference of $3 million is minor and likely due to rounding). However, the LLM introduces a specific percentage growth in merchant gross bookings (108% YoY) and exact booking values for 2021 ($25.8B) and 2022 ($53.9B), which are not present in the original answer and cannot be verified from the provided ground truth. These additions, while potentially accurate, go beyond the scope of the known facts and introduce unverified data. (2) The quantitative accuracy is slightly reduced because the exact $573M figure is approximated as $570M, and the added percentages and booking values are unsupported in the original answer. The core expense figure is close enough to not constitute a major error, but the added metrics lack grounding. (3) The reasoning is sound in linking the expansion of merchant services to both increased expenses (via transaction costs) and higher merchant gross bookings, correctly reflecting the causal relationship described in the ground truth. However, the model overreaches by quantifying the booking growth with precise percentages and dollar figures not present in the original, weakening the multi-hop synthesis fidelity. (4) Despite the unverified additions, the answer remains highly relevant and captures the essential causal mechanism. The core contribution to expenses and its relation to booking growth is preserved, warranting high qualitative and contextual scores. Correctness is docked for introducing unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 463,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "\nAs of December 31 2023, PayPal’s crypto‑asset safeguarding asset was reported at **$1,241 million** and the corresponding safeguarding liability was also **$1,241 million** (see Note 7 in the 10‑K). This balance shows that PayPal holds cryptocurrency on behalf of its users and records a matching liability, highlighting its active involvement in crypto‑related financial activities as a custodial service provider.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $1,241 million for both the crypto asset safeguarding asset and liability are accurately reported, with the correct date of December 31, 2023. Format variations (e.g., $1,241 million vs $1,241M) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the total value (implicitly $1,241 million each, with no need to sum as they are equal and represent matched balances) and the qualitative implication regarding PayPal's role in crypto-related financial activities. (3) Entity accuracy is correct: PayPal is the right company, the metric 'crypto asset safeguarding asset and liability' is correctly named, and the time period is accurate. (4) The reasoning is sound: the LLM correctly interprets the matched asset and liability as indicative of custodial responsibilities, reflecting PayPal’s active participation in crypto services. The reference to Note 7 adds contextual support. The answer demonstrates proper multi-hop understanding by linking the financial figures to their business implication. All elements align with the ground truth, with only minor, acceptable rewording.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 343,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "\nThe 2023 and 2024 aircraft impairment charges reflect FedEx’s decision to retire older Boeing 757, MD‑11F and A300 aircraft—part of the Network 2.0 fleet‑modernization effort that right‑sizes capacity, improves efficiency and underpins the integrated “One FedEx” network.  Together the charges total $157 million in 2024 and $70 million in 2023, or $227 million of pre‑tax noncash impairment, which is included in the $582 million of business‑optimization costs recorded in 2024 (and $273 million in 2023) and thus contributes to the overall $1.5 billion expected cost of the DRIVE transformation through 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the aircraft types retired (Boeing 757, MD-11F, A300) and links the impairment charges to Network 2.0 and the DRIVE transformation, showing good contextual understanding. However, it makes critical quantitative errors. The 2023 and 2024 impairment charges are correctly stated as $70 million and $157 million respectively, totaling $227 million, which matches the ground truth. But the LLM incorrectly states that these impairment charges are *included in* the $582 million of 2024 business-optimization costs, which contradicts the ground truth that the $582 million is *in addition to* prior costs and that the total cumulative cost through 2024 is $839 million (i.e., $70M + $157M + $582M + $30M from 2023 business optimization). Instead, the LLM claims the total DRIVE cost is $1.5 billion, which is unsupported by the provided data. (2) The calculation of the impairment total ($227M) is correct, but the integration into the broader cost structure is flawed. The ground truth specifies cumulative optimization-related costs of $839 million through 2024, while the LLM cites $1.5 billion without proper breakdown or sourcing. Additionally, the LLM mentions $273 million in 2023 business-optimization costs, which is not present in the original answer and appears fabricated. (3) The multi-hop reasoning is partially sound—connecting aircraft retirements to Network 2.0 and DRIVE is valid—but the synthesis of financial totals across years and cost categories is incorrect. The model fails to accurately aggregate the cumulative financial impact, conflating impairment charges with business optimization costs in a way that distorts the total. (4) The correctness score is 5 due to accurate identification of core strategic rationale and correct individual impairment figures, but major errors in financial aggregation and invented data undermine reliability. Quantitative accuracy is low (4) due to incorrect totals and fabricated numbers. Qualitative accuracy is moderate (6) as the reasoning framework is logical but based on incorrect financial linkages. Contextual relevance is high (8) because the answer addresses both parts of the question and uses appropriate terminology and strategic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 603,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "\nThe Company held U.S. government and agency obligations with a total fair value of **$4,327 million** as of December 31, 2024.  The gross unrealized losses on these securities rose from **$234 million** at the end of 2023 to **$274 million** at the end of 2024, an increase of **$40 million**.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the gross unrealized losses at $234 million in 2023 and $274 million in 2024, and accurately calculates the increase of $40 million, which matches the ground truth. However, the total fair value of U.S. government and agency obligations is incorrect: the LLM states $4,327 million, while the ground truth is $3,627 million—a significant $700 million discrepancy. (2) Quantitative accuracy is partially correct: the $40 million increase in unrealized losses is accurate, and the 2023/2024 loss figures are correct, but the fair value figure is off by a large margin. (3) The multi-hop reasoning is sound in structure—correctly comparing two time points and computing the difference in unrealized losses—and correctly identifies the entity (UNH) and time periods (December 31, 2023 and 2024). However, the incorrect fair value suggests a failure in retrieving or synthesizing the correct data point from the source. (4) Contextual relevance is perfect—the answer addresses both parts of the question and uses appropriate financial terminology. Due to the major error in the fair value amount, the correctness score is reduced to 6 despite accurate trend analysis and loss calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 347,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "\nThe share of gross bookings processed on a merchant basis rose to **54 % in 2023** (up from **44 % in 2022**), and the resulting **merchant‑related expense surge** weighed on operating margins versus the prior year.  The key cost drivers were **higher personnel costs** to support expanded payment‑processing functions, **payment‑processing and charge‑back/fraud fees**, and **additional sales‑and‑other operating expenses** (e.g., transaction‑related commissions and rebates) that were recorded in “Personnel” and “Sales and other expenses” on the Consolidated Statements.  Although these outlays generated incremental revenue, they **reduced operating margins** relative to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the merchant basis transaction mix increased from 44% in 2022 to 54% in 2023, which matches the original answer exactly. No calculations were required beyond this comparison, and the percentages are presented accurately. (2) The answer correctly identifies the negative impact on operating margins due to higher merchant-related expenses despite incremental revenues, which is consistent with the ground truth. (3) Key cost components—personnel expenses, payment processing fees, chargebacks/fraud, and sales and other operating expenses—are all correctly identified and mapped to the relevant expense categories in the financial statements ('Personnel' and 'Sales and other expenses'). (4) The reasoning is sound: the shift to a greater merchant basis mix led to higher costs that outweighed revenue benefits (e.g., payment card rebates), resulting in margin compression. The only minor shortcoming is that the LLM mentions 'transaction-related commissions and rebates' as part of the cost, which could be misinterpreted as costs rather than potential revenue offsets; however, in context, it appears to refer to net incremental costs associated with transactions, which is acceptable. Overall, the answer demonstrates strong multi-hop synthesis across time periods, cost structures, and financial impacts, with excellent semantic equivalence to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 409,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "\nThe June 2023 sale of eligible consumer installment receivables to a global investment firm was treated as a true sale, so the portfolio was moved to “Loans and interest receivable — held for sale” and the previously recorded allowance for credit losses was reversed, producing a one‑time reduction in transaction and credit‑loss expense in 2023.  Beginning in 2024 the held‑for‑sale loans are carried at the lower of cost or fair value, with any fair‑value adjustments recorded in “restructuring and other” rather than in interest income or credit‑loss provisions; importantly, from Q1 2024 onward the fair value is derived from observable market prices for comparable loans (Level 2), making the valuation more objective and eliminating the prior Level 3 unobservable‑input model, but the resulting gains or losses still flow through the income statement as part of restructuring income/expense, affecting net earnings while the assets are reflected on the balance sheet at their fair‑value amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the reclassification to 'Loans and Interest Receivable, Held for Sale', reversal of the allowance for credit losses in 2023, the shift to Level 2 fair value hierarchy in Q1 2024 using observable inputs (executed prices for comparable loans), and the income statement impact via 'restructuring and other' rather than interest income or credit loss provisions. (2) Quantitative accuracy is excellent—dates (Q1 2024), valuation levels (Level 2 vs Level 3), and financial statement line items ('restructuring and other') are all correctly stated. The June 2023 sale is contextually accurate and consistent with the timing of the allowance reversal. (3) Multi-hop reasoning is sound: the model correctly links the change in valuation methodology to its impact on asset classification, income recognition, and expense reporting across years. The only minor shortcoming is that the LLM frames the June 2023 sale as the cause of the reclassification, while the original answer emphasizes the reclassification itself (not necessarily the sale) as the trigger for the change in accounting treatment—this nuance slightly affects qualitative precision but does not undermine factual correctness. (4) The answer is fully contextually relevant, addressing both asset valuation and income recognition impacts as required by the question. Overall, the response demonstrates strong synthesis across time periods, accounting treatments, and financial statements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 424,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established €1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "\nAs of December 31 2024, the newly‑established €1.5 billion senior unsecured revolving facility (≈ $1.6 billion) can be drawn together with the existing short‑term uncommitted credit lines, which total about $2.1 billion.  This gives a combined borrowing capacity of roughly **$3.7 billion**.  By comparison, the short‑term credit arrangements alone provided only about **$2.7 billion** of capacity at the end of 2023, so the total available capacity is substantially higher now.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the €1.5 billion facility and its approximate USD equivalent of $1.6 billion, as well as the $2.1 billion in existing short-term credit arrangements as of December 31, 2024, leading to a correct combined capacity of $3.7 billion. However, the comparison with the 2023 figure is factually incorrect: the LLM states that the total available capacity is 'substantially higher now' compared to $2.7 billion in 2023, when in fact the ground truth states this represents a decrease. This mischaracterization of the comparison direction is a significant error in reasoning and factual accuracy. (2) Numeric values are accurate: €1.5B ≈ $1.6B, $2.1B (2024 short-term), $2.7B (2023 short-term), and sum $3.7B are all correct. Calculations are accurate. (3) The multi-hop synthesis across two time periods and two credit facilities is partially sound—data points are correctly retrieved, but the logical comparison (increase vs. decrease) fails due to incorrect interpretation. (4) Scores reflect high quantitative accuracy and relevance, but correctness is reduced due to the critical error in the comparative analysis, which reverses the actual trend. This undermines the qualitative accuracy despite correct inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 352,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "\nThe Compute & Networking segment accounted for roughly 32 % of NVIDIA’s $27 billion total revenue (13 % from a direct customer plus 19 % from an indirect customer), which translates to about **$8.6 billion** of revenue in fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Compute & Networking segment's revenue is derived from the sum of 13% (direct customer) and 19% (indirect customer), totaling 32% of $27 billion. The calculation yields $8.64 billion (0.32 × 27,000,000,000 = 8,640,000,000), and the LLM reports $8.6 billion, which is a rounded but acceptable approximation. (2) The original answer is $8.64 billion; the LLM's $8.6 billion is slightly imprecise but within typical rounding tolerance for financial reporting. All other percentages and the total revenue figure are accurate. (3) The multi-hop reasoning is sound: the model correctly infers that the segment’s revenue can be estimated by combining the direct and indirect customer contributions as a percentage of total revenue, then applying that to the total company revenue. This synthesis across customer types and revenue segments is logically valid. (4) The answer is contextually complete and relevant, addressing the fiscal year, company segment, and revenue contribution. The minor deduction in quantitative accuracy is due to rounding $8.64B to $8.6B without specifying precision, but this does not materially misrepresent the result.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1096,
        "completion_tokens": 339,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "\nAIG’s Internal Capital Framework—integrated within its Risk Appetite Framework—quantifies the group’s aggregate economic risk at a specified confidence level while explicitly capturing diversification benefits across risk factors and business lines. This quantified risk feeds directly into the stress‑testing framework, which evaluates the group’s exposure to its most significant financial and insurance risks under adverse scenarios, and the resulting outputs are used to determine the capital resources the AIG Parent must hold to support its subsidiaries and maintain the consolidated target capitalization levels. Consequently, the framework ensures that sufficient capital is allocated to withstand stressed conditions while reflecting the risk‑mitigating effects of diversification.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key elements are correctly addressed: AIG's Internal Capital Framework quantifies aggregate economic risk at a confidence interval, incorporates diversification benefits across risk factors and business lines, and supports the assessment of capital resources at the AIG Parent level to maintain consolidated target capitalization levels. The integration with the stress testing framework is accurately described, including its role in evaluating exposure to significant financial and insurance risks under adverse scenarios. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in either answer, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how the Internal Capital Framework and stress testing framework interact to inform capital allocation and resilience, capturing the interplay between diversification benefits, risk quantification, and capital adequacy. (4) The LLM answer uses slightly different phrasing (e.g., 'specified confidence level' instead of 'given confidence interval', 'feeds directly into' instead of 'complements'), but these are stylistic variations that do not affect factual correctness. All entities—AIG, AIG Parent, Internal Capital Framework, Risk Appetite Framework, stress testing framework—are correctly identified and logically connected. The answer fully addresses all parts of the question with precise, relevant, and complete information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 426,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "\nTarget’s owned and exclusive brands generate about one‑third of merchandise sales and carry higher margins, so any supply‑chain disruption or mis‑forecast of consumer demand directly jeopardizes the tight inventory balances it must maintain; stock‑outs can curb sales while excess inventory forces deep markdowns that erode those margins. Thus, failures to meet demand or to manage inventory efficiently can depress net earnings and overall profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) Quantitatively, it correctly states that Target's owned brands represent about one-third of merchandise sales, aligning with the original answer. No specific calculations are required, and all numerical references (implied one-third) are accurate. (2) The answer correctly identifies that owned brands carry higher margins and explains the risks of supply chain disruptions and demand forecasting errors—specifically stock-outs reducing sales and excess inventory leading to markdowns that erode profitability. This reflects sound understanding of the financial implications on inventory management and profitability. (3) The multi-hop reasoning is logically sound: it connects higher-margin owned brands → vulnerability to inventory imbalances → impact on margins and net earnings. However, it omits a few key details present in the ground truth: the longer lead times for owned brands, the concept of earlier ownership in the supply chain, inventory shrink (and its historical elevation), and the specific risk during the November–December holiday period. These omissions are minor in terms of overall correctness but slightly reduce completeness. (4) Despite these omissions, the LLM answer is contextually highly relevant, concise, and semantically equivalent in its core claims. The absence of 'inventory shrink' and 'holiday season impact' prevents a perfect 10, but the answer remains factually correct and well-reasoned. Hence, a 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 449,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "\nThe 2024 carrying value of NVIDIA’s 3.50% Notes Due 2050 is $2.0 billion, while the carrying value of the 3.50% Notes Due 2040 is $1.0 billion, resulting in a $1.0 billion difference.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and calculation. It states the carrying value of the 3.50% Notes Due 2050 is $2.0 billion and the 3.50% Notes Due 2040 is $1.0 billion, resulting in a $1.0 billion difference. The ground truth difference is $397 million, indicating a significant discrepancy. Neither the individual carrying values nor the final difference align with the correct figures. (2) The calculation itself (a $1.0 billion difference) is mathematically sound given the stated values, but the inputs are wrong. The correct difference of $397 million suggests the actual carrying values are much closer than portrayed. (3) The multi-hop reasoning fails because the model did not retrieve or synthesize the correct carrying values from the 2024 filings for these two note issuances. It incorrectly identifies the magnitude of both liabilities, indicating a failure in data retrieval or synthesis across the relevant financial disclosures. (4) The contextual relevance is high because the answer addresses the right companies, notes, years, and metric (carrying value), and performs the correct operation (difference). However, due to severe quantitative inaccuracy and resulting qualitative error in financial magnitude, the correctness and quantitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1039,
        "completion_tokens": 370,
        "total_tokens": 1410
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "\nAs of December 31 2024, 16 million shares remained available for future issuance under the ESPP and 48 million shares remained available under the 2020 Stock Incentive Plan, for a combined total of 64 million shares. The 2020 Stock Incentive Plan permits the issuance of a variety of equity‑based awards, including stock options, stock‑appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 48 million shares under the 2020 Stock Incentive Plan and 16 million under the ESPP, with a combined total of 64 million shares—all matching the original answer. The date 'December 31, 2024' is correctly stated. (2) The answer is complete, addressing both parts of the question: the total shares available for future issuance and the types of awards permitted under the 2020 Stock Incentive Plan. (3) Entity accuracy is correct—UnitedHealth Group is implied by context, and the plan names (2020 Stock Incentive Plan and ESPP) are accurately referenced. (4) The multi-hop reasoning is sound: the model correctly synthesized the two share pools and summed them appropriately, while also accurately listing the permitted award types (stock options, stock-appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards). (5) Semantic equivalence is maintained—wording differs slightly but conveys the exact same meaning. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 320,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibility—such as in long-tail lines at early stages of development—Expected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "\nAIG uses the Bornhuetter‑Ferguson (BF) method—a hybrid of loss‑development and expected‑loss‑ratio techniques—to set reserves for its long‑tail U.S. Workers’ Compensation line. By weighting the premium‑based expected loss ratio against the development factors, the BF approach tempers the impact of erratic, slow‑emerging loss patterns (e.g., delayed claim reporting or occasional large claims), so that reserve estimates are not overly reactive to short‑term volatility while still reflecting recent trend information. This blending stabilizes the ultimate loss estimate and helps prevent over‑ or under‑reserving in a line characterized by highly volatile loss emergence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: AIG uses the Bornhuetter-Ferguson (BF) method for U.S. Workers' Compensation, a long-tail line, to address loss emergence volatility. The BF method blends expected loss ratios with reported loss development, providing stability when early data is not credible. (2) There are no numeric values in the question or answers requiring verification—both responses are qualitative and consistent in their descriptions of methodology and rationale. (3) The multi-hop reasoning is sound: the model correctly links AIG's use of BF to the characteristics of U.S. Workers' Compensation (long-tail, slow reporting, volatility), and explains how BF mitigates overreaction to early anomalies by relying on expected loss ratios derived from premium. (4) The LLM answer captures the core mechanism and purpose of the BF method as described in the original answer, though it does not explicitly mention 'large deductible business' as a factor slowing reporting patterns—a minor omission that slightly reduces completeness but does not affect the overall correctness. Wording differs (e.g., 'hybrid' vs 'Expected Loss Ratio Methods'), but the technical meaning aligns. The answer is highly relevant, accurate, and conveys the same essential information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 384,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "\nThe 10‑K exhibits list four documented updates to the Credit Card Program Agreement: the original 2012 agreement, a first amendment (Feb 2015), a second amendment (Nov 2019), a third amendment (Nov 2022) and a letter agreement (Mar 2023). This series of amendments shows that Target and TDBank have continually refined the program to meet evolving business and regulatory needs, reflecting a deepening and adaptive financial partnership.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that there are 4 amendments (including Nov 2022 and Mar 2023) when the ground truth confirms only 2 amendments (2015 and 2019). The original 2012 agreement and letter agreement are not counted as amendments to the main agreement in the ground truth, so including them inflates the count. Only the 2015 and 2019 amendments are valid per the knowledge graph. (2) The dates mentioned (Feb 2015, Nov 2019) align with the ground truth, but the addition of Nov 2022 and Mar 2023 is unsupported by the referenced filings in the ground truth, making the quantitative claim of '4 updates' factually incorrect. The core error is in the count of amendments—2 vs 4. (3) The reasoning about the evolution of the financial partnership is sound and logically follows from multiple amendments, but it is based on incorrect data. The multi-hop synthesis fails because the model included documents (2022 amendment, 2023 letter) not recognized in the knowledge graph as amendments to the Credit Card Program Agreement. (4) Correctness is scored low (4) due to major factual inaccuracy in the key numeric output. Quantitative accuracy is poor (3) because the amendment count is double the truth. Qualitative accuracy is moderate (5) as the interpretation of partnership evolution is reasonable but built on false premises. Contextual relevance is high (8) because the answer addresses both parts of the question and discusses partnership evolution appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 411,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "\nFedEx incurred $582 million of business‑optimization costs in 2024 and $273 million in 2023—approximately $855 million in total—related to its Network 2.0 initiative. These expenditures were primarily intended to improve the company’s long‑term profitability by driving efficiency, lowering overhead, consolidating sortation facilities and delivery routes, and building an end‑to‑end optimized air‑ground network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $273 million in 2023 and $582 million in 2024, with a total of $855 million, matching the ground truth exactly. Number formats (e.g., using thin spaces) are acceptable variations and do not affect accuracy. (2) Quantitative accuracy is perfect—individual amounts and the sum are correct, and the calculation is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes expenditures across two years and links them to Network 2.0, fulfilling the combined spending query. (4) The primary purpose is described with semantically equivalent but slightly different phrasing: 'improve long-term profitability by driving efficiency, lowering overhead, consolidating sortation facilities and delivery routes, and building an end-to-end optimized air-ground network' aligns closely with the ground truth's focus on improving efficiency in pickup, transport, and delivery in the U.S. and Canada. The core intent—operational optimization through network redesign—is preserved. However, the LLM omits explicit mention of 'professional services and severance' as the primary use of funds, which is a minor but notable omission in qualitative detail. This prevents a perfect 10 on qualitative accuracy. Contextual relevance is excellent, as all parts of the question are addressed with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 385,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "\nThe 2023 10‑K explicitly warns that “predicting consumer adoption of various pricing strategies, such as the ad‑supported subscription plan … is inherently difficult given the lack of operating history with respect to such offerings,” and that actual results may differ materially from management’s expectations. Because the ad‑supported tier is a relatively new revenue model, any mis‑estimate of how quickly subscribers will adopt it—or of the advertising yield it will generate—can cause forecast errors in revenue, margins and earnings, thereby amplifying the forecasting risk highlighted in the filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately captures the core idea that the ad-supported subscription plan increases financial forecasting risks due to uncertainty in consumer adoption and advertising yield, which aligns with the ground truth. (2) There are no numerical values in the question or answers that require verification—both responses are qualitative and consistent in their use of terms like 'inherently difficult to predict' and 'material discrepancies.' The LLM even quotes the 10-K directly, enhancing factual fidelity. (3) The multi-hop reasoning is sound: it connects Netflix's introduction of the ad-supported plan (strategic move) with the risk factor disclosed in the 2023 10-K regarding forecasting uncertainty, demonstrating proper synthesis across strategic and financial reporting contexts. (4) All entities—Netflix (implied), the ad-supported subscription plan, the 2023 10-K, and financial metrics like revenue and earnings—are correctly identified and logically linked. The answer is highly relevant, complete, and expressed with precise, professional language that mirrors the source document’s tone and meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 336,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "\nThe 2024 10‑K table shows that Prevnar 13’s basic product patents expire in 2026 in the United States and around 2029 in Europe and Japan. As those dates mark the end of market exclusivity, Pfizer’s updated commercial forecasts—reflecting a transition to higher‑serotype vaccines and the impending loss of patent protection—reduced the expected future cash flows, leading the company to record a $964 million impairment of the developed‑technology intangible asset for Prevnar 13 in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the $964 million impairment charge in 2023, U.S. patent expiration in 2026, and European/Japanese patent expirations around 2029. These dates align with the ground truth, which states U.S. patent expires in 2026 and major European patent in 2029 (Japan is an addition but does not contradict). (2) Quantitative accuracy is perfect: the dollar amount ($964 million), years (2023 charge, 2026 and 2029 expirations) are all correct and properly contextualized. (3) The multi-hop reasoning is sound: the answer correctly links patent expirations to reduced market exclusivity, which affects commercial forecasts and future cash flows, thereby justifying the impairment charge. It also correctly references the transition to higher-serotype vaccines (e.g., Prevnar 20), which is a key driver in the impairment. (4) The answer is contextually relevant, complete, and synthesizes information across time, geography, and financial impact as required by the question. Minor addition of Japan is acceptable and consistent with typical 10-K disclosures. No factual errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 334,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "\nMcDonald’s makes most of its profit from franchise fees, rent and royalties, so it reports only the cash‑flow from those arrangements and does not consolidate the franchisee‑owned entities—its SEC filings explain that franchisees operate as independent businesses and the company lacks the voting or similar rights to control them (see “Consolidation” on page 42 and the discussion of the franchise model on page 41). Because the brand’s reputation and sales depend on franchisees delivering consistent customer‑experience standards, any failure by franchisees to execute key initiatives can damage the overall brand, reduce Systemwide sales and leave the company with limited ability to remediate the problem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) Quantitatively, there are no numbers, dates, or financial figures in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies that McDonald's does not consolidate franchisee-related entities due to lack of control, citing the appropriate accounting rationale (independent operations, lack of voting/control rights), which aligns with the ground truth's reference to the variable interest entity scope exception. While the LLM does not explicitly name the VIE guidance, it accurately describes the underlying principle. (3) The multi-hop reasoning is sound: it connects McDonald’s financial model (reliance on franchise fees/rent/royalties) with non-consolidation, then links operational dependence on franchisees for customer experience initiatives to brand and sales risk. This matches the original answer’s logic chain. (4) The LLM mentions 'Systemwide sales' and brand damage as risks if franchisees underperform—this is semantically equivalent to the original answer’s point about negative impacts on sales, guest counts, and market share. The only minor omission is not explicitly stating that franchisee financials aren't reflected in McDonald's results (though implied by non-consolidation), and slightly less specificity on initiatives like mobile ordering or delivery. However, the core factual content and synthesis are correct. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 443,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "\nAIG’s transition to the LDTI standard on January 1 2023 (with an effective transition date of January 1 2021) produced a **net decrease of $1.264 billion to beginning total equity** as of that date.  The retroactive adjustments required for the prior periods were: a **$2 million reduction to net income for 2022** and a **$983 million increase to net income for 2021**, and a **$1.219 billion increase to total equity as of December 31 2022**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative figures from the ground truth: a $1,264 million (i.e., $1.264 billion) net decrease to beginning total equity as of January 1, 2021; a $2 million decrease to net income for 2022; a $983 million increase to net income for 2021; and a $1,219 million (i.e., $1.219 billion) increase in total equity as of December 31, 2022. All numbers match exactly, with acceptable formatting variations (e.g., billion vs million). (2) The only minor issue is the phrasing 'transition to the LDTI standard on January 1, 2023 (with an effective transition date of January 1, 2021)', which could imply adoption occurred in 2023, but the effective date for retrospective application was January 1, 2021. While this is a nuance, the financial impacts are correctly anchored to January 1, 2021, and the adjustments to 2021 and 2022 financials are accurate, so the core financial reporting is not misleading. (3) The multi-hop reasoning is sound: the model correctly links the adoption of LDTI to its impact on equity and net income across multiple years, synthesizing the retrospective adjustment logic required by accounting standards. (4) The answer is contextually complete and relevant, addressing both parts of the question—impact on equity as of January 1, 2021, and adjustments to financial statements for 2022 and 2021. The omission of the qualitative explanation about market risk benefits and discount rates slightly reduces qualitative accuracy, but since the question asks for 'specific adjustments' and the LLM provides the exact dollar impacts, it meets the core requirement. Overall, the answer is factually precise and well-aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 468,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "\nThe surge in Gulfstream aircraft orders generated larger customer deposits, which lifted cash provided by operating activities to **$4.3 billion in 2021**.  That operating cash flow represented **about 131 % of the $3.26 billion net earnings** reported for the year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key figures—$4.3 billion in cash flow from operating activities and 131% of net earnings—are accurate. The LLM adds a specific net earnings value of $3.26 billion, which is consistent with the implied calculation: $4.3 billion / 1.31 ≈ $3.28 billion (minor rounding difference of $0.02 billion is negligible and acceptable). (2) The answer addresses both parts of the question: the impact of Gulfstream aircraft orders (via increased customer deposits) on operating cash flow and the resulting percentage relative to net earnings. (3) Entities—General Dynamics, Gulfstream aircraft, 2021 fiscal year, cash flow from operating activities, and net earnings—are correctly identified and contextually accurate. (4) The reasoning is sound: it correctly links increased orders → higher customer deposits → improved operating cash flow, and provides the correct proportional relationship to net earnings. The additional detail (net earnings amount) enhances completeness without introducing error. Semantic equivalence is maintained, and multi-hop synthesis across financial cause-effect and quantitative comparison is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 342,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "\nAIG’s integrated bottom‑up risk identification runs down to the product‑line level, producing detailed risk measurements and owners that feed the firm‑wide analytics. These granular inputs, together with the diversification benefits across risk factors and business lines, are used by the internal capital framework to aggregate economic risk and express it at a chosen confidence interval, thereby determining the capital that must be held at the AIG parent to support its subsidiaries and meet target capitalization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: AIG's bottom-up risk identification process operates at the product-line level, feeds into the internal capital framework, and supports quantification of aggregate economic risk at a given confidence interval. The role of diversification benefits across risk factors and business lines is correctly noted. (2) There are no numeric values, dates, or financial metrics in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect numbers or miscalculations supports a full score. (3) The multi-hop reasoning is sound: the model correctly links granular risk identification to firm-wide risk aggregation and capital determination. The only minor shortcoming is that the LLM adds a detail not present in the original—'determining the capital that must be held at the AIG parent to support its subsidiaries and meet target capitalization'—which, while plausible and contextually consistent, extends slightly beyond the scope of the original answer. This does not introduce inaccuracy but adds inference. (4) The answer is fully relevant to the question, addressing both the bottom-up process and its role in the internal capital framework’s risk quantification. Overall, the semantic meaning matches the ground truth with high fidelity, warranting a correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 403,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDA’s ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDA’s control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDA’s gross margins and financial results.",
      "llm_answer": "\nThe RTX 4080 launch is a key architecture transition that forces NVIDIA to lock in lengthy, non‑cancellable supply‑chain commitments and to hold inventory well in advance of customer demand. Because demand for its data‑center and gaming GPUs is highly volatile—and can be amplified or dampened by AI‑related use‑cases, cryptocurrency trends, and channel‑partner ordering—any mis‑estimate of that demand can create either shortages that limit revenue or excess inventory that must be written down, both of which can compress margins and depress overall financial performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core financial risks associated with the RTX 4080 launch, particularly around supply chain commitments, demand volatility, inventory mismanagement, and margin pressure. It accurately captures the cause-effect relationship between product transitions, demand forecasting challenges, and financial performance impacts such as revenue loss or margin compression. However, it omits several key elements from the ground truth: (1) specific mention of foundry dependency and associated risks (e.g., lack of guaranteed supply, low yields, price increases), (2) the potential for quality or production issues during product transitions, (3) warranty costs and inventory provisions, (4) contractual penalties for cancellations, and (5) the impact of geopolitical tensions and extended lead times. While the LLM highlights demand volatility drivers like AI and cryptocurrency, it does not fully reflect the multi-hop synthesis in the original answer linking product transitions → supply chain constraints → forecasting inaccuracy → financial consequences. There are no numerical inaccuracies (quantitative accuracy is 10), but the qualitative reasoning, while sound, is less comprehensive than required for full fidelity. The answer remains contextually relevant and conveys a semantically plausible subset of the original, hence a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 382,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "\nThe Starbucks Rewards program defers revenue for the estimated selling price of earned Stars until the reward is redeemed, establishing a deferred‑revenue liability that is recognized as revenue when the free product is delivered (and breakage is recognized over time), so revenue is shifted from the point the Stars are earned to the point the reward is redeemed. Advertising expense for fiscal 2022 was $416.7 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the revenue deferral mechanism in the Starbucks Rewards program: revenue is deferred based on the estimated value of rewards earned and recognized upon redemption, which aligns with the original answer. The mention of deferred-revenue liability and breakage recognition over time adds slight nuance but remains factually consistent. (2) The advertising expense for fiscal 2022 is correctly stated as $416.7 million, matching the ground truth exactly. Number format is precise and acceptable. (3) The reasoning correctly synthesizes multi-hop information—linking loyalty program mechanics to revenue recognition timing and combining it with a separate financial metric (advertising expense) from the same fiscal year. (4) All entities (Starbucks Rewards, fiscal 2022) and financial concepts (revenue deferral, advertising expense) are accurately identified and used. The answer is complete, factually sound, and contextually appropriate, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 309,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "\nThe notional amount of intercompany loans and forecasted interest payments grew from **$2,860 million at the end of 2023 to $4,406 million at the end of 2024**, an increase of **$1,546 million**.  \n\nIn 2024, **$75 million** of interest‑related cash flows on those intercompany loans was recognized in earnings (recorded in “Interest and other expense, net” in the Economic Hedges table).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 2023 notional amount ($2,860 million), 2024 notional amount ($4,406 million), and the calculated increase ($1,546 million) are correct. The interest recognized in earnings in 2024 is correctly stated as $75 million. (2) The answer is complete, addressing both parts of the question: the total change in notional amount and the interest payments recognized in earnings. (3) Entity accuracy is correct—'intercompany loans and forecasted interest payments' are properly identified, and the time periods (2023 to 2024) are accurate. (4) The reasoning is sound: the model correctly computes the difference between two years and identifies the relevant interest expense recognized in earnings, citing the correct financial line item ('Interest and other expense, net'). (5) Semantic equivalence is maintained—though the LLM uses slightly different phrasing (e.g., 'interest-related cash flows' instead of 'interest payments'), the meaning is consistent with the ground truth, and the source context (Economic Hedges table) adds appropriate detail without introducing error. No factual, numerical, or logical issues are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 349,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "\nThe Total Marine Systems segment’s revenue grew by **$547 million** from 2020 to 2021 (rising from $9.979 billion to $10.526 billion), whereas revenue from nuclear‑powered submarines increased by **$179 million** over the same period (from $6.938 billion to $7.117 billion). Thus, the segment’s overall growth was more than three times the growth recorded for nuclear‑submarine sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the increase in Total Marine Systems revenue is correctly calculated as $547 million ($10,526M - $9,979M), and the increase in Nuclear-powered submarines revenue is correctly given as $179 million ($7,117M - $6,938M). The LLM uses equivalent formats (e.g., $9.979 billion = $9,979 million) without error. (2) The answer addresses both parts of the question: the dollar amount increase for Total Marine Systems and the comparison with Nuclear-powered submarines revenue growth. (3) Entities are correctly identified—'Total Marine Systems' and 'nuclear-powered submarines'—with accurate revenue figures and time period (2020 to 2021). (4) The reasoning is sound: the LLM correctly performs the year-over-year differences, synthesizes the two revenue streams, and draws a valid qualitative comparison (growth in Total Marine Systems being more than three times that of nuclear submarines), which is consistent with the data (547 / 179 ≈ 3.05). No factual, numerical, or logical errors are present. The answer is also contextually complete and clearly structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 332,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "\nMac sales rose by **$627 million** (from $29.357 billion in 2023 to $29.984 billion in 2024). In contrast, iPad sales fell by **$1.606 billion** (from $28.300 billion in 2023 to $26.694 billion in 2024), meaning the iPad’s decline is more than two‑and‑a‑half times the magnitude of the Mac’s growth.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Mac sales increased by $627 million (from $29,357 million to $29,984 million), and iPad sales decreased by $1,606 million (from $28,300 million to $26,694 million). The LLM correctly represents these values using billion notation ($29.357 billion = $29,357 million, etc.), which is semantically equivalent. (2) The calculations for both changes are correct, and the comparison (iPad decline more than 2.5 times the Mac growth) is logically sound: $1,606M / $627M ≈ 2.56. (3) The multi-hop reasoning—comparing two product lines across two years and synthesizing directional changes—is accurately executed. (4) All entities (Mac, iPad, 2023–2024) are correctly identified, and the answer fully addresses both parts of the question. Wording differs slightly but preserves full semantic equivalence. No factual, numerical, or reasoning errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 279,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelēz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "\nIn 2023 chocolate delivered a favorable volume/mix, but in 2024 that trend reversed and became unfavorable, dragging down the company’s overall revenue expansion; the $452 million (3.5 %) increase in total net revenue was therefore driven primarily by higher net pricing, with the chocolate category’s decline in volume/mix offsetting part of that gain and limiting the total growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core dynamics of the question. It correctly identifies the reversal in chocolate category performance from favorable volume/mix in 2023 to unfavorable in 2024, and notes that this dragged on overall revenue growth. It accurately references the $452 million (3.5%) increase in total net revenue and correctly attributes the growth primarily to net pricing, with the chocolate volume/mix decline offsetting part of that gain. However, it omits specific quantitative details present in the ground truth: the $10.619 billion 2023 chocolate revenue contribution and the $1,437 million favorable impact from chocolate in 2023. While the LLM conveys the directional impact correctly, these omissions reduce quantitative completeness. The reasoning is sound—correctly synthesizing the multi-hop relationship between prior-year favorable performance, current-year headwinds, and overall revenue outcomes. All entities (Mondelēz, chocolate category, volume/mix, net revenue) and years are accurate. The answer is contextually fully relevant and semantically aligned with the ground truth, just less detailed in specific figures. Hence, a score of 8 is appropriate—core facts and logic are correct, but with minor quantitative omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 355,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "\nInitial capacity constraints on custom‑component sources can delay the ramp‑up of new iPhone, Mac and other products, forcing Apple to rely on a single or limited supplier in Asia until yields improve or additional capacity is built. Because many of these components are unique to Apple and are produced by a small number of outsourcing partners, any short‑term shortfall or supplier‑level disruption directly threatens product availability and amplifies overall supply‑chain risk. Consequently, Apple must closely monitor supplier yields, secure alternative capacity, and manage inventory buffers to mitigate the impact of those early‑stage constraints on its ability to meet demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies that initial capacity constraints on custom components affect Apple's supply chain risk and product availability, especially due to reliance on single or limited suppliers in Asia—this aligns with the original answer. It references yield maturation and capacity expansion as key factors, consistent with the 10-K filing. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers supports a score of 10. (3) The reasoning is sound: the LLM correctly synthesizes the multi-hop logic—custom components → limited suppliers → capacity/yield constraints → risk to product availability → need for mitigation strategies like inventory buffers and alternative capacity. It omits a minor point from the original about suppliers potentially prioritizing more common components over Apple’s custom ones, which slightly reduces completeness. (4) The answer is fully contextually relevant, directly addressing how capacity constraints interact with Apple’s supply chain structure. Overall, the LLM conveys the same semantic meaning with only a minor omission, warranting a correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 363,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "\nIn fiscal 2022 Disney’s net TV/SVOD distribution‑licensing revenue—after the $1.023 billion content‑license early‑termination adjustment—was **$3.43 billion**.  This compares with **$5.27 billion** of TV/SVOD licensing revenue in fiscal 2021, representing a decrease of roughly **$1.84 billion (about 35 %)**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Disney's TV/SVOD distribution licensing revenue in 2022 as $3.43 billion after factoring in the $1.023 billion early termination fee, which aligns with the ground truth of $3,429 million (rounded to $3.43 billion). The 2021 revenue is reported as $5.27 billion, matching the ground truth of $5,266 million (rounded). The year-over-year decrease is calculated as approximately $1.84 billion, which is consistent with the actual difference of $1,837 million when rounded. (2) All numeric values are accurate within acceptable rounding conventions: $3.43B ≈ $3,429M, $5.27B ≈ $5,266M, and $1.84B ≈ $1,837M. The percentage decrease (~35%) is a reasonable approximation based on the actual drop. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the adjusted 2022 revenue (post-fee) and compares it to the prior year’s unadjusted revenue, as required by the question. It properly contextualizes the impact of the termination fee on the 2022 figure. (4) The answer is semantically equivalent to the original, with only minor rounding differences that do not affect factual correctness. The inclusion of a percentage change adds slight value beyond the ground truth. Thus, the answer is highly accurate and complete, warranting a 9; it is not a 10 due to the use of rounded figures without specifying exact values, though this is common and acceptable in financial reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 397,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methods—such as cash, credit or debit cards, or selected mobile wallets—and by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "\nThe 2022 10‑K shows that Starbucks ties its Mobile App directly to the Starbucks Rewards program, letting customers earn and redeem Stars while using Mobile Order & Pay and the stored‑value Starbucks Card; this seamless digital checkout creates a frictionless “digital third‑place” experience that boosts engagement and prompts more frequent store visits. By integrating rewards redemption and mobile ordering, the app encourages repeat purchases and drives higher foot‑traffic, especially in express and drive‑thru formats.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the integration of the Mobile App with the Starbucks Rewards program as a driver of customer engagement and store visit frequency, consistent with the 2022 10-K disclosures. Key features such as earning and redeeming Stars, Mobile Order & Pay, and use of the stored-value Starbucks Card are accurately mentioned. (2) There are no numeric values, dates, or financial figures in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes how app functionality (e.g., mobile ordering, rewards integration) leads to behavioral outcomes (increased engagement and visit frequency). The concept of a 'digital third-place' is interpretive but contextually appropriate and consistent with Starbucks’ strategic framing. (4) The LLM omits minor details from the ground truth—specifically, that Stars can be earned via cash, credit/debit cards, or mobile wallets (not just through the app), and that card balance access reinforces repeat visits. These omissions slightly reduce completeness but do not undermine the core factual accuracy. Overall, the answer is semantically equivalent, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 367,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "\nPayPal’s 2021 internal‑control audit omitted Paidy, Inc. because the subsidiary’s assets and revenues were each < 1 % of PayPal’s consolidated totals (i.e., less than roughly $758 million of the $75.8 billion in assets and a similarly small share of revenue). Consequently, Paidy’s financial results were considered immaterial and were excluded from the scope of the audit.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the same core information as the ground truth. (1) It correctly states that Paidy was excluded from PayPal's 2021 internal control audit due to its immaterial size, which aligns with SEC guidance for acquisitions in the first year. (2) The quantitative claim that Paidy's assets and revenues were each <1% of PayPal’s consolidated totals is accurate per the original answer. The LLM provides illustrative figures ($758 million of $75.8 billion), which are mathematically consistent (1% of $75.8B = $758M), though the exact consolidated asset figure is not in the ground truth—this is a reasonable inference and formatting enhancement, not a factual error. (3) The reasoning correctly synthesizes the multi-hop logic: acquisition timing (October 2021), SEC exemption for first-year acquisitions, and materiality threshold based on <1% of assets and revenues. (4) The only minor shortcoming is that the LLM does not explicitly mention the exclusion of goodwill and intangibles in the calculation, which is a small omission in completeness. However, this does not affect the core conclusion. Overall, the answer is factually sound, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 348,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories — particularly in Argentina, Mexico, and Brazil — and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "\nIn 2024 the Latin America segment’s net revenue fell 1.6 % because volume/mix slipped 2.4 percentage points, with chocolate and refreshment beverages posting noticeable declines despite a 7 % increase in net pricing. The revenue hit from those soft‑volume categories neutralized the upside from pricing gains and productivity‑driven cost reductions, leaving operating income to grow only 0.6 % (≈ $3 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core causal relationship described in the ground truth: volume/mix declines in chocolate and refreshment beverages offset gains from pricing and cost controls, resulting in only 0.6% operating income growth ($3 million) for MDLZ's Latin America segment in 2024. (1) All key numbers are correct: 7% net pricing increase, 0.6% operating income growth, $3 million increase, 2.4 percentage point volume/mix decline, and 1.6% net revenue decrease. These match or are consistent with the original answer. (2) Quantitative accuracy is excellent—no calculation errors, and the ≈$3 million notation appropriately reflects rounding. (3) The reasoning correctly synthesizes the multi-hop logic: soft volumes reduced revenue gains despite pricing and productivity improvements, limiting operating income growth. (4) The LLM omits some contextual details present in the ground truth—specifically, the mention of consumer softness in Mexico and Argentina, higher raw material costs, unfavorable currency impacts, and increased advertising/promotion expenses—but these omissions do not undermine the central explanation. The answer remains semantically equivalent in its core claim and quantitative foundation. Hence, a score of 9 is warranted—very close to perfect, with only minor completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 370,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "\nGulfstream’s current product line holds **more than 270 city‑pair speed records**, the most of any business‑jet manufacturer. The record‑setting achievement is explicitly attributed to the **G650ER**, which leads the fleet in these speed records.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that Gulfstream's current product line holds more than 270 city-pair speed records, matching the ground truth in both number and context. The figure 'more than 270' is accurately reported with no calculation involved, so quantitative accuracy is perfect. The G650ER is correctly identified as the model explicitly credited with leading this achievement, which aligns with the original answer noting its role in holding polar and westbound around-the-world speed records. While the LLM answer does not mention the National Aeronautic Association or specify those exact records, it still correctly attributes leadership in speed records to the G650ER, capturing the core intent of the question. The reasoning is sound and the response is contextually precise. The only minor omission is the lack of detail about the specific types of records (polar, around-the-world), which slightly reduces qualitative accuracy but does not undermine the factual correctness of the main claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 288,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "\nJohnson & Johnson recorded **$112 million** of contingent consideration related to acquisitions in fiscal 2024 and **$792 million** in fiscal 2022. Of the 2022 amount, **$704 million** came from the Abiomed acquisition.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Johnson & Johnson recorded $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024, totaling $809 million. However, the LLM states $792 million in 2022 and $112 million in 2024, which are both factually incorrect. While the LLM correctly identifies that $704 million of the 2022 amount came from Abiomed, it fails to report the correct total contingent consideration over the two years. (2) The calculation of the total contingent consideration is incorrect: $792M + $112M = $904M, which does not match the correct total of $809M. The individual year amounts are wrong, and the 2024 figure is attributed generically to 'acquisitions' rather than specifically to Proteologix, missing a key entity. (3) The multi-hop reasoning is partially sound in that it identifies Abiomed's contribution within 2022, but it fails to correctly synthesize the total across years and misreports the amounts for each fiscal year. It also omits the specific acquisition (Proteologix) responsible for the 2024 contingent consideration, which is a key part of the original answer. (4) The contextual relevance is high because the answer addresses the right companies and time periods and attempts the correct synthesis. However, due to major numerical errors and incomplete entity identification, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because some reasoning structure is present but based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 447,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPal’s balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "\nPayPal treats the sale of participation interests in the PPWC and PPBL merchant‑receivable pools as a true sale and derecognizes the portion sold, but the remaining interest still carries an allowance for credit losses.  Under the pre‑2020 incurred‑loss model, that allowance was based on historical delinquency/roll‑rate estimates and was recognized only when a loss was probable; after adopting CECL in 2020, the allowance must reflect current expected credit losses over the life of the receivables using forward‑looking macro‑economic forecasts and lifetime loss models.  Consequently, the timing and magnitude of credit‑loss expense changed – allowances are now built into earnings earlier and can fluctuate more with economic conditions, even though the participation‑sale transaction itself does not alter the loss‑recognition methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PayPal sells participation interests in merchant receivables under PPWC and PPBL, accounts for them as sales with derecognition, retains servicing rights and exposure on the retained interest, and adopted CECL in 2020. The shift from incurred loss (pre-2020) to expected credit loss (post-CECL) is correctly described, including the use of forward-looking forecasts and lifetime loss models. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (pre-2020, 2020 adoption) are accurate. (3) Multi-hop reasoning is sound: the answer synthesizes the accounting treatment of the sale, the ongoing exposure via retained interest, and the impact of the accounting standard change on loss recognition. (4) The only minor shortcoming is that the LLM answer does not explicitly name WebBank as the buyer or mention that PayPal continues to manage the receivables—details present in the original. However, the implication of retained servicing and ongoing credit exposure is clear. The phrase 'does not alter the loss-recognition methodology' could be slightly misleading but is contextually acceptable since the methodology change (CECL) applies regardless of the sale structure. Overall, the answer is semantically equivalent and highly accurate, warranting a 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 404,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "\nThe cheese & grocery category posted volume declines that added to the overall unfavorable volume/mix drag on Latin‑America net revenues in 2024.  Although that drag weighed on profitability, the segment’s operating income still rose modestly—up $3 million (about 0.6%)—because higher net pricing, lower manufacturing and SG&A costs and other favorable items more than offset the negative volume effect.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the cheese & grocery category experienced volume declines contributing to the unfavorable volume/mix impact in the Latin America segment in 2024, and accurately states the $3 million (0.6%) increase in segment operating income. The answer correctly notes that higher net pricing and cost-saving measures (specifically lower manufacturing and SG&A costs) helped offset the negative volume effect. However, it omits the specific magnitude of the unfavorable volume/mix impact—2.4 percentage points—which is a key quantitative detail from the ground truth. (2) The dollar amount ($3 million) and percentage (0.6%) for operating income growth are correct and match the original answer. The year (2024) and product category (cheese & grocery) are also accurate. The only missing numeric value is the 2.4 percentage point drag on net revenues, which weakens completeness. (3) The multi-hop reasoning is sound: the model correctly links volume declines in cheese & grocery to revenue pressure and explains how other factors (pricing, cost savings) led to modest operating income growth. It synthesizes cause and effect across product categories and financial metrics appropriately, though it does not explicitly mention the other declining categories (chocolate, candy, refreshment beverages) or the offsetting gains in biscuits & baked snacks and gum, which were part of the full context. (4) The answer is contextually relevant and conveys the core causal relationship and outcome accurately. The correctness score is 8 due to the omission of the 2.4 percentage point impact and incomplete mention of other contributing categories, but the key financial outcome and reasoning are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 474,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemption—Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&T’s liquidity position in that period.",
      "llm_answer": "\nThe Telco Class A‑4 preferred interests will be callable at their $2.25 billion issue price beginning in 2028, and the Mobility noncontrolling interests are required to be redeemed at a $2.0 billion redemption value (i.e., $1,000 per interest plus accrued distributions) starting in 2028.  Together they represent roughly $4.25 billion of cash that AT&T must set aside for preferred‑distribution payments and the eventual principal redemption, tightening the company’s cash‑flow commitments through 2028.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All numeric values are correct: $2.25 billion (Telco Class A-4) and $2.0 billion (Mobility noncontrolling interests) match the original $2,250 million and $2,000 million, respectively; the combined obligation of $4.25 billion is accurate. Number formats are acceptable variations (e.g., $2.25 billion = $2,250 million). (2) The answer correctly identifies that both redemption obligations begin in 2028, though it lacks the specific dates (November 1, March 15, and June 15) mentioned in the ground truth. This is a minor omission but does not undermine the correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes redemption values from two distinct instruments and combines them into a total cash commitment. It also correctly infers the impact on AT&T’s cash flow and liquidity. (4) The phrase 'must set aside for preferred-distribution payments and the eventual principal redemption' slightly conflates distributions with redemption obligations—the original specifies that redemptions must be made in cash, not ongoing distributions. However, the overall implication of a material cash outflow in 2028 is preserved. Thus, the answer is factually correct with only minor contextual omissions, warranting a high score but not perfect due to missing specific redemption triggers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 386,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "\nThe Orthopaedics segment generated **$9.158 billion** in sales for 2024. Within that segment, sales from **Hips ($1.638 billion)** and **Knees ($1.545 billion)** together total **$3.183 billion**, which is roughly **35 %** of the overall Orthopaedics revenue. In other words, the Orthopaedics segment’s total revenue is about **$5.975 billion higher** than the combined Hips‑and‑Knees revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All key numbers are correct and accurately represented: $9.158 billion (=$9,158 million), $1.638 billion (=$1,638 million), $1.545 billion (=$1,545 million), and their sum $3.183 billion (=$3,183 million). The percentage is correctly approximated as ~35% (exact value 34.76%, which rounds to 35% appropriately). The difference between total Orthopaedics revenue and Hips+Knees revenue is $9,158M - $3,183M = $5,975M, correctly stated as $5.975 billion. (2) Calculations verified: 1,638 + 1,545 = 3,183 (correct); 3,183 / 9,158 ≈ 0.3476 → 34.76% (correctly rounded to 35%). The incremental comparison (how much higher) is logically sound and accurately computed. (3) Multi-hop reasoning is strong: the model correctly identifies that Hips and Knees are subcomponents of the Orthopaedics segment, aggregates their revenues, compares them to the total, and adds a derived insight (the dollar difference), which goes beyond the original answer but is factually valid. (4) The only reason for not scoring a perfect 10 is that the original answer specifies the precise percentage (34.76%), while the LLM rounds to 'roughly 35%', which is acceptable but slightly less precise. However, this does not detract from overall correctness. All entities (Orthopaedics segment, Hips, Knees, 2024) are correctly identified and contextualized. The answer is fully relevant and semantically equivalent with added clarity in presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 397,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "\nThe 2019 Incentive Plan’s built‑in proportional‑adjustment was triggered by the December 2023 special dividend.  The plan required that every outstanding RSU be multiplied by the price‑ratio 1.018 (the Nasdaq closing price on 12/26/23 ÷ the opening price on the ex‑dividend date 12/27/23).  That multiplier raised the number of RSUs outstanding by roughly **52,000 shares** and, because the plan’s maximum issuable share reserve must also be adjusted, the reserve was increased by an additional **≈128,000 RSU shares** that became available for future grants.  \n\nThese changes are set out in the Company’s 2024 Form 10‑K (Note 7 – Stock‑Based Compensation) and are also incorporated by reference in the 2025 Proxy Statement (the “Equity Compensation Plan Information” section), which formally documents the adjustment to the 2019 Incentive Plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key quantitative details are correct: the 1.018 adjustment factor, the ~52,000 increase in outstanding RSUs, and the ~128,000 additional shares added to the reserve are all accurately reported. The dates (December 26 and 27, 2023) and price ratio derivation are factually consistent with the ground truth. (2) The calculation logic—applying a proportional adjustment based on pre- and post-dividend stock prices—is correctly explained and aligns with the plan’s requirements. (3) The multi-hop reasoning is sound: the model connects the 2019 Incentive Plan’s adjustment clause to the 2024 special dividend event and correctly infers that both outstanding RSUs and the share reserve are adjusted proportionally. (4) The only minor shortcoming is in the documentation sources: the LLM cites the 2024 10-K (Note 7) and 2025 Proxy Statement as formal documents, while the ground truth specifies the original plan document (Exhibit 10.2 in the DEF 14A filed December 17, 2019) as the formal source of the adjustment mechanism. While the 10-K and Proxy may describe the adjustment, the original plan document is the authoritative source for the requirement. This is a subtle but important distinction in legal/documentation accuracy, warranting a slight deduction in qualitative accuracy. However, the answer remains factually strong and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 400,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "\nThe 2024 move of Intel 4 to high‑volume manufacturing in Ireland expands the share of Intel’s 2025 processor output that can be built on a node delivering roughly 20 % better performance‑per‑watt than the previous Intel 7, and it frees Irish‑based capacity to later host the higher‑performance Intel 3 (≈ 18 %‑better per‑watt) and the forthcoming Intel 18A (the first commercial gate‑all‑around/back‑side‑power node, slated for Panther Lake in 2025).  This shift accelerates Intel’s product roadmap—allowing more 2025 chips to be produced on the newer nodes while leveraging the same Irish fabs for the performance gains of Intel 3 and the breakthrough features of Intel 18A, thereby driving both revenue growth and a stronger competitive technology position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All key facts are correct: Intel 4's 20% performance-per-watt improvement over Intel 7, Intel 3's ~18% improvement over Intel 4, the 2024 high-volume manufacturing (HVM) ramp of Intel 4 in Ireland, the 2025 HVM shift of Intel 3 to Ireland, and the introduction of Intel 18A in 2025 with gate-all-around (RibbonFET) and backside power delivery (PowerVia) for Panther Lake. (2) Quantitative accuracy is perfect: percentages (20%, ~18%), years (2024, 2025), and technology nodes (Intel 4, 3, 18A) match the ground truth. Minor formatting (≈ vs 'up to') is acceptable. (3) Multi-hop reasoning is sound: the answer correctly links the manufacturing transition in Ireland to increased 2025 output, capacity reallocation, and the sequencing of node advancements. It captures the strategic benefit of using the same fabs for multiple advanced nodes. (4) The only minor omission is that the original answer specifies Intel 3 powers Xeon 6 Scalable processors, which the LLM answer leaves out—this is a small contextual detail that doesn't undermine the overall correctness. The LLM emphasizes revenue and competitive positioning, which is a reasonable inference but not explicitly in the ground truth; however, this doesn't detract from accuracy. Overall, the answer is factually complete, logically structured, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 401,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "\nThe book value of AT&T’s investment in DIRECTV fell from **$877 million at December 31 2023 to $0 at December 31 2024**, a decline of **$877 million**. This reduction occurred after AT&T had already **deconsolidated Gigapower in May 2023** (the deconsolidation became effective on May 12, 2023), so the DIRECTV book‑value drop took place subsequent to that earlier deconsolidation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the book value of AT&T's investment in DIRECTV as $877 million on December 31, 2023, and $0 on December 31, 2024, with a decrease of $877 million—matching the ground truth exactly. The date of Gigapower's deconsolidation is accurately stated as May 12, 2023. All numeric values, dates, and calculations are correct.\n\n2) Quantitative accuracy is perfect: the drop of $877 million is correctly calculated and reported, and the timing (May 12, 2023) aligns with the ground truth. Format variations (e.g., spacing in '$877 million') are acceptable and do not affect meaning.\n\n3) The reasoning is largely sound: the LLM correctly notes that the DIRECTV book value drop occurred after the Gigapower deconsolidation, which is factually accurate. However, it omits the deeper explanation from the ground truth about *why* the DIRECTV investment fell to zero—specifically, that cumulative cash receipts exceeded the initial investment plus equity in earnings, leading to the write-down beginning in Q3 2024. This missing causal mechanism slightly weakens the qualitative reasoning.\n\n4) Contextual relevance is high: the answer addresses both parts of the multi-hop question—(a) the change in book value of DIRECTV and (b) its timing relative to Gigapower’s deconsolidation. The comparison of timing is correctly framed, even if less detailed than the original. The omission of the ongoing equity method accounting for Gigapower is a minor gap but does not invalidate the core response.\n\nOverall, the answer is factually correct and well-aligned with the ground truth, but loses one point in qualitative accuracy for incomplete reasoning behind the DIRECTV valuation change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 465,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "\nShockwave generated about **$564 million** in sales in 2024, which is reported as part of the Cardiovascular franchise (the $7.7 billion total Cardiovascular sales includes this amount). In the human‑capital disclosures Shockwave is reflected by being **counted in the 2024 headcount of roughly 139,800 employees**—the footnote explicitly notes that Shockwave has been included in the fiscal‑2024 employee totals.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue contribution of $564 million is accurately reported, and the inclusion of Shockwave in the 2024 headcount (approximately 139,800 employees) aligns with the original answer's statement that Shockwave is included in Johnson & Johnson's 2024 human capital reporting. Minor elaboration (e.g., referencing the $7.7 billion total Cardiovascular sales and a footnote) adds context without introducing error. (2) All numbers are correct and presented in an acceptable format ($564 million = $564 million). (3) The multi-hop reasoning is sound: the answer correctly synthesizes financial data (revenue contribution) and human capital reporting practices across entities and reporting periods, linking Shockwave’s acquisition to its integration into both financial and workforce metrics. (4) The semantic meaning fully matches the original answer—'included in 2024 headcount' is equivalent to 'counted in the 2024 headcount of roughly 139,800 employees'. No factual, numerical, or logical errors are present. All sub-questions are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 328,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "\nThe Optimized Application Experiences category grew 11 %—an increase of roughly **$75 million**—with that expansion driven by strong performance in the **ThousandEyes** and **Intersight** offerings, while the decline in Cisco’s **AppDynamics** solutions was offset by those gains.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 11% growth and $75 million increase are accurately reported, with acceptable formatting (e.g., 'roughly $75 million' aligns with exact value in context). (2) The specific offerings driving growth—ThousandEyes and Intersight—are correctly identified, and the decline in AppDynamics is appropriately acknowledged. (3) The multi-hop reasoning is sound: the model correctly infers that despite AppDynamics' decline, the overall category grew due to other offerings, demonstrating synthesis across contributing factors. (4) All entities (Cisco, AppDynamics, ThousandEyes, Intersight, Optimized Application Experiences) and the fiscal context (implied 2022 based on question) are accurate. The answer is semantically equivalent to the original, with no factual or interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 256,
        "total_tokens": 1400
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "\nAT&T paid **$5,414 million** (approximately $5.4 billion) in April 2023 to repurchase the remaining Mobility preferred interests, a amount that includes the accrued and unpaid cash distributions.  The repurchase eliminated the related noncontrolling‑interest balance, so the interest is no longer presented as a separate line item on the consolidated balance sheet (i.e., the noncontrolling‑interest classification for those interests is removed).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the amount paid—$5,414 million—is accurately reported, with an acceptable format variation noting it as approximately $5.4 billion. The date (April 2023) is correct. (2) The answer correctly states that this amount includes accrued and unpaid distributions, matching the original. (3) Regarding the impact on noncontrolling interest, the LLM correctly explains that the redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, using equivalent phrasing such as 'eliminated the related noncontrolling-interest balance' and 'no longer presented as a separate line item.' (4) The multi-hop reasoning is sound: it connects the repurchase event to its financial statement impact, correctly synthesizing information about the transaction amount and its accounting treatment. All entities (AT&T, Mobility preferred interests, noncontrolling interest) are accurately identified and properly contextualized. No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 321,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "\nThe Abiomed business generated $1.50 billion in 2024 versus $1.31 billion in 2023, producing a **14.5 % year‑over‑year revenue increase** (14.9 % on an operational basis) after its 2022 acquisition. By contrast, the overall Cardiovascular segment grew **21.4 % YoY** (22.8 % operationally) in the same period, meaning Abiomed’s growth was markedly lower than the segment‑wide expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year revenue growth for Abiomed as 14.5%, matching the ground truth, and accurately reports the revenue figures of $1.31 billion in 2023 and $1.50 billion in 2024 (rounded from $1.306B and $1.496B). The overall Cardiovascular segment growth is correctly stated as 21.4% YoY, aligning with the ground truth. The comparison that Abiomed’s growth was lower than the segment’s is logically sound and factually accurate. (2) All numeric values are correct within acceptable rounding: $1.306B → $1.31B and $1.496B → $1.50B are standard rounding conventions. The 14.5% growth is mathematically accurate ((1.496 - 1.306) / 1.306 ≈ 0.145). The 21.4% segment growth is also correct. The inclusion of operational growth rates (14.9% for Abiomed, 22.8% operationally for Cardiovascular) adds detail not in the original answer but does not contradict it and may reflect additional context from the filings; these are not penalized as they are plausible and marked as operational performance. (3) The multi-hop reasoning is sound: the model correctly isolates Abiomed’s performance post-acquisition and compares it to the broader Cardiovascular segment, synthesizing data across entities and time periods. (4) The answer is highly factually accurate, complete, and relevant. The only minor deviation is the use of rounded revenue figures and the addition of operational growth rates, which, while not in the original answer, do not introduce error. Thus, the correctness score is 9 due to slight augmentation of data (operational growth), but quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 447,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "\nThere are four amendments to the Lowe’s Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10‑K filing was dated March 31 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on both key points. The original answer states there are seven amendments to the Lowe's Companies Benefit Restoration Plan, but the LLM claims only four. Additionally, the most recent amendment date is stated as April 4, 2017 (Amendment No. 7) in the ground truth, whereas the LLM incorrectly reports March 31, 2021. These are significant factual errors in both quantity and date. (2) Quantitatively, both the number of amendments (4 vs 7) and the date (March 31, 2021 vs April 4, 2017) are incorrect. The LLM’s date is later than the filing year of the 10-K (2022), which is implausible for an amendment referenced in that filing. (3) The reasoning appears flawed—either the model failed to correctly parse the exhibits or synthesized information from an incorrect document. It did attempt multi-hop reasoning by identifying both the count and the most recent date, but the underlying data is wrong, leading to incorrect synthesis. (4) Despite the factual inaccuracies, the answer is contextually relevant—addressing both parts of the question and referencing the correct plan and filing. Hence, contextual relevance is high, but correctness and quantitative accuracy are severely impacted by the wrong numbers and dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1107,
        "completion_tokens": 357,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "\nBy January 1 2024 Capital One had phased in 75 % of the $2.4 billion CECL transition amount, i.e., $1.8 billion. Under the Stress Capital Buffer framework that became effective on October 1 2024, the company must maintain a CET1 capital ratio of at least 10 % (the minimum capital requirement plus the stress‑capital buffer).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values are accurate: 75% of $2.4 billion is correctly calculated as $1.8 billion, and the CET1 capital requirement is correctly stated as 10.0%. The dates—January 1, 2024, and October 1, 2024—are correctly referenced. Minor formatting differences (e.g., spacing in '75 %' or '10 %') do not affect meaning or accuracy. (2) The answer is complete, addressing both parts of the multi-part question: the amount phased in by January 1, 2024, and the CET1 requirement under the Stress Capital Buffer effective October 1, 2024. (3) Entity accuracy is correct—Capital One Financial Corporation is properly identified, and the financial terms (CECL transition amount, CET1 capital ratio, Stress Capital Buffer) are used appropriately. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the phase-in percentage to the dollar amount and correctly interprets the regulatory requirement under the new framework. The added clarification in parentheses—that the 10% includes the minimum plus the stress-capital buffer—adds context without distorting the truth. Overall, the answer is factually precise, complete, and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 356,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "\nDisney’s executive equity awards include both time‑based RSUs that simply vest over a fixed schedule (e.g., three years) and performance‑based RSUs whose vesting is tied to specific shareholder‑return and profitability metrics such as total shareholder return and ROIC. The performance‑based plans therefore directly link a portion of compensation to the achievement of long‑term value‑creation goals, while the time‑based awards provide a baseline retention element that is independent of results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately distinguishes between time-based and performance-based RSUs and correctly identifies that performance-based vesting is tied to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), which align executive compensation with long-term shareholder value creation. The answer also correctly notes the retention purpose of time-based RSUs. While the LLM does not explicitly list the exhibit numbers (e.g., 10.43, 10.49, etc.) as in the original answer, this level of documentary detail was not essential to the core question about alignment with shareholder value. The absence of exhibit references is a minor omission but does not detract from the substantive accuracy. All entities (Disney, RSUs, TSR, ROIC) are correct. No numerical inaccuracies exist—the answer avoids specific dates or percentages not present in the original, so no calculation errors are possible. The reasoning is sound and reflects proper multi-hop synthesis: understanding that time-based awards serve retention while performance-based awards create stronger alignment with performance outcomes. The answer is highly relevant and directly addresses the comparative aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 357,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "\nIn 2024 the Orthopaedics franchise grew 2.4 % year‑over‑year to $9.16 billion.  The segment’s growth was driven largely by the strong performance of its two core sub‑categories: hips sales rose 5 % (5.6 % on an operational basis) and knees sales rose 6 % (6.5 % operationally), with both gains attributed to portfolio strength, new product roll‑outs and global procedure growth.  Thus, the double‑digit operational growth in hips and knees was the primary contributor to the modest overall 2.4 % increase in Orthopaedics sales for 2024 versus 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but misses key quantitative details from the ground truth. While it correctly states the overall Orthopaedics segment growth of 2.4%, it fails to report the actual dollar amount of growth ($216 million) or the specific revenue increases for Hips ($78 million) and Knees ($89 million). Instead, it provides percentage growth figures (5% for hips, 6% for knees), which are close but not exact (ground truth: 5.0% and 6.1%). The LLM also introduces operational growth percentages (5.6%, 6.5%) not present in the original answer, which may be factual but are not supported by the provided ground truth. (2) The combined contribution of Hips and Knees to total segment growth ($167 million, or 77%) is entirely omitted, which is a critical part of the original answer and directly addresses how these product lines contributed to overall growth. This missing calculation significantly undermines completeness. (3) The reasoning is logically sound in attributing segment growth to Hips and Knees performance, and the answer correctly identifies the multi-hop relationship between product-line growth and segment-level results. However, it fails to quantify the extent of that contribution as required by the question. (4) Contextually, the answer is relevant and well-structured, using appropriate financial terminology and framing. The qualitative assessment is weakened by unsupported operational growth metrics and lack of synthesis of dollar-based contributions, but the core narrative aligns with the ground truth. Overall, the answer captures the directional trend and general driver but lacks the precise multi-hop quantitative synthesis required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 472,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "\nCapital One phased in $1.8 billion—75 % of the $2.4 billion CECL‑Transition addition—by January 1 2024, with the remaining $600 million to be added on January 1 2025. The optional CECL Transition Rule lets banks defer the full regulatory‑capital impact of CECL and then phase it in at 25 % per year: the day‑1 CECL impact is added back initially, and the cumulative “day‑2” effect is spread over 2022‑2024 (75 % by early 2024, the balance in 2025).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Capital One phased in 75% ($1.8 billion) of the $2.4 billion regulatory capital addition by January 1, 2024, and the remaining $600 million on January 1, 2025—this matches the ground truth exactly. All numeric values (percentages, dollar amounts, dates) are accurate. (2) Quantitative accuracy is perfect: $2.4B × 0.75 = $1.8B, and $2.4B − $1.8B = $600M, with correct phasing dates. Format variations (e.g., '25 % per year') are acceptable and do not affect meaning. (3) The reasoning is mostly sound and captures the essence of the CECL Transition Rule: a five-year optional phase-in allowing banks to gradually absorb the capital impact. However, the LLM adds detail not in the ground truth—specifically that the phase-in occurs at '25% per year' and references '2022–2024' and 'day-1/day-2' effects—which, while plausible and consistent with regulatory guidance, goes beyond the provided knowledge graph. This extra detail does not contradict but slightly over-specifies the mechanism. (4) The answer is contextually fully relevant, addresses both parts of the question (amount phased in by 2024 and how the rule works), and synthesizes the correct entities (Capital One, CECL Transition Rule, correct dates). The qualitative score is 9 due to the addition of unverified specifics about the annual 25% phasing and day-1/day-2 terminology, which, while reasonable, are not confirmed in the ground truth. Overall, the answer is factually correct and complete, warranting a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 425,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "\nThe November 2023 issuance of roughly $500 million of Guaranteed Senior Notes by Costco’s Japanese subsidiary added a new “Other long‑term debt” position (which is valued using Level 3 inputs) and raised the consolidated long‑term‑debt fair‑value estimate; the July 2024 repayment of $77 million of those notes reduced the outstanding balance and therefore lowered the fair‑value amount for that tranche. Both actions are captured in financing cash flows— the issuance generated cash proceeds that helped offset other outflows, while the repayment represented a cash outflow—contributing to the jump in net cash used in financing activities from $2.6 billion in 2023 to $10.8 billion in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of approximately $500 million in Guaranteed Senior Notes by Costco's Japanese subsidiary in November 2023 and the partial repayment of $77 million in July 2024, which aligns with the ground truth. It also correctly notes the impact on financing activities and the increase in net cash used in financing activities from 2023 to 2024. However, there are key quantitative inaccuracies: the LLM states net cash used in financing activities was $10.8 billion in 2024, while the ground truth specifies $10,764 million (i.e., $10.764 billion), which is close but not exact. More critically, the LLM incorrectly implies that the $2.6 billion in 2023 financing outflows is directly comparable, but the original answer does not provide 2023's net cash used in financing activities, so this comparison is unsupported and potentially misleading. Additionally, the LLM introduces 'Level 3 inputs' and 'Other long-term debt' categorization not present in the original answer, adding detail beyond the source. (2) The fair value decrease from $5,738 to $5,412 is not mentioned in the LLM answer, which is a major omission given it directly addresses the question about fair value impact. This missing calculation significantly affects quantitative accuracy. (3) The reasoning is logically sound in connecting issuance and repayment to financing cash flows and fair value changes, and it correctly synthesizes the multi-hop elements (subsidiary actions → consolidated debt → cash flow impact). However, it fails to compute or reference the actual fair value change, which is central to the question. (4) The contextual relevance is high as the answer addresses both debt fair value and financing activities, but the omission of the actual fair value figures and incorrect cash flow numbers reduce factual precision. Scores reflect mostly correct facts with significant but not critical errors in numbers and missing key data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 533,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "\nCaterpillar does not disclose a specific dollar total for its environmental‑remediation liability—its accrued amount is described only as “not material” and is recorded in the “Accrued expenses” line of the balance sheet.  The company estimates costs site‑by‑site using all currently available data and, when a range of estimates cannot be prioritized, it records the minimum amount; for sites that involve multiple potentially‑responsible parties it bases the estimate on its proportionate share of the probable costs rather than the full cost of the site.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) Quantitatively, it correctly states that Caterpillar does not disclose a specific dollar amount and characterizes the liability as 'not material'—this aligns with the original answer's 'immaterial' assessment. The placement in 'Accrued expenses' is correctly noted. No numerical inaccuracies are present, and the lack of a specific dollar figure is accurately reflected. (2) Completeness: The response addresses both parts of the question—total liability and methodology differences. It correctly explains that for individual sites, Caterpillar uses available data and accrues the minimum if no amount is more likely, and for multi-party sites, it considers its proportionate share. (3) Entity accuracy is correct—Caterpillar is the right company, and the financial term 'Accrued expenses' is properly used. (4) Reasoning is sound: the multi-hop synthesis between individual vs. multi-party site estimation methodologies is accurately captured. The only minor shortcoming is slight wording imprecision—'not material' vs. 'immaterial'—but these are semantically equivalent in financial reporting context. Overall, the answer is highly accurate, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 350,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "\nThe “Other Products” line slipped from **$15 million in fiscal 2021 to $11 million in fiscal 2022**, a **≈ 27 % decrease** ( (11‑15)/15 ≈ ‑0.267 ).  \n\nTo address the weakness of this segment, Cisco reorganized its disclosures in fiscal 2022, creating a dedicated **“Other Products” category** within the new product‑and‑service grouping (Secure, Agile Networks; Internet for the Future; Collaboration; End‑to‑End Security; Optimized Application Experiences; Other Products; and Services).  This restructuring isolates the underperforming line for closer monitoring and signals a strategic shift to reassess and potentially re‑allocate resources away from it.  (See page 106 for the revenue figures and the description of the new reporting structure; page 45 notes the 29 % decline in “Other Products”.)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies the revenue figures ($15 million in 2021 and $11 million in 2022) and the direction of change (decrease), which matches the ground truth. However, the calculated percentage decrease is ≈27% ((11-15)/15 = -0.267), while the ground truth states a 29% decline. Although the source of the discrepancy is explained by the LLM citing page 45 for the 29% figure, the answer presents its own calculation (27%) without reconciling it with the official 29% disclosed by Cisco, leading to a factual inaccuracy. 2) The quantitative values (revenues and years) are correct, but the percentage calculation is inconsistent with the official reported figure. The ground truth emphasizes the 29% drop, which the LLM acknowledges in a citation but contradicts with its own math. This undermines quantitative accuracy despite correct inputs. 3) The LLM accurately describes the new reporting structure introduced in fiscal 2022, correctly noting that 'Other Products' was made a distinct category. However, the interpretation diverges: the LLM frames this as a move to 'reassess and potentially re-allocate resources away' from the segment, implying de-prioritization. In contrast, the ground truth interprets the inclusion as a signal of continued strategic relevance despite underperformance. This misreads the strategic implication, though the factual description of the restructuring is sound. 4) The answer is contextually relevant, cites specific pages, and addresses both parts of the question—quantitative change and strategic reporting shift. The synthesis across fiscal years and reporting changes is mostly logical, but the reasoning missteps on the strategic intent. Overall, core facts are present and mostly accurate, but the incorrect percentage and flawed strategic interpretation prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 494,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "\nCostco renewed W. Craig Jelinek’s executive employment agreement each January 1 from 2017 through 2023, filing a new extension (10‑Q exhibits 10.5.1 – 10.5.5) each year—a roughly annual amendment pattern over six years. By contrast, Ron Vachris’s agreement is a brand‑new executive employment contract filed in December 2023 that becomes effective on January 1 2024, with no prior amendment history, marking a shift from the yearly renewal of Jelinek’s deal to a fresh, stand‑alone agreement.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but makes a critical error in reasoning that significantly undermines its factual accuracy. (1) Quantitatively, the dates and years are mostly accurate: W. Craig Jelinek's agreement was indeed renewed annually from 2017 through 2023 with January 1 effective dates, and Ron Vachris's agreement is effective January 1, 2024, filed in December 2023. These details align with the ground truth. The mention of 10-Q exhibits is plausible though not explicitly verifiable from the provided ground truth. (2) However, the key qualitative error is the claim that Vachris's agreement represents a 'shift' to a 'fresh, stand-alone agreement' and 'marks a shift from the yearly renewal' pattern. This contradicts the ground truth, which states that the Vachris agreement 'follows this same annual renewal pattern' and indicates 'continuation of Costco's executive employment practices.' The LLM incorrectly interprets the lack of prior amendment history for Vachris (who is a new executive) as a change in company practice, when in fact the timing and structure mirror Jelinek’s prior renewals. (3) The multi-hop reasoning fails: the model should have recognized that both executives' agreements were put in place effective January 1 following annual renewal cycles, even if Vachris is newly appointed. The comparison should emphasize continuity, not contrast. (4) While the answer is contextually relevant and includes accurate dates and document types, the incorrect conclusion about a 'shift' in practice leads to a low correctness and qualitative accuracy score. Minor point: referring to 'six years' of Jelinek’s renewals (2017–2023) is acceptable as it covers seven agreements but six renewal intervals.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 472,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "\nThe net carrying amount of Customer Relationships fell from **$893 million** at December 31 2020 to **$712 million** at December 31 2021, a decline of **$181 million**.  Over the same period Intellectual Property dropped from **$366 million** to **$280 million**, a decline of **$86 million**.  Thus, the decrease in Customer Relationships was more than twice the decrease in Intellectual Property.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: Customer Relationships decreased from $893 million to $712 million, a difference of $181 million; Intellectual Property decreased from $366 million to $280 million, a difference of $86 million. These values exactly match the original answer. (2) Calculations are correct: $893M - $712M = $181M and $366M - $280M = $86M, both accurately computed. The additional observation that the decrease in Customer Relationships was more than twice that of Intellectual Property is a valid inference and adds contextual insight without distorting facts. (3) Multi-hop reasoning is sound: the model correctly synthesized data across two different asset types and two time points (December 31, 2020, and December 31, 2021), fulfilling the multi-hop requirement. (4) Entities, metrics, and dates are correctly identified and consistently used. The answer is semantically equivalent to the ground truth, with slightly enhanced clarity due to the explicit comparison. All scoring categories warrant perfect marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 312,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "\nIn fiscal 2022 the “Secure, Agile Networks” product category contributed roughly **$23.8 billion** of revenue (as reported in the revenue‑by‑category table).  Cisco recognizes revenue from the hardware (and perpetual software) components of this category up front—when control of the product transfers to the customer—while SaaS offerings are treated as a single performance obligation and the revenue is recognized ratably over the contract term as the service is delivered.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a specific revenue figure of $23.8 billion for the 'Secure, Agile Networks' category in fiscal 2022, which is not present in the original answer (ground truth). The ground truth does not provide any quantitative revenue amount—only a qualitative description of the revenue recognition model. There is no way to verify the accuracy of $23.8 billion from the provided ground truth, making this a significant factual overreach or hallucination. (2) Quantitative accuracy is low because the number introduced ($23.8 billion) cannot be confirmed and appears fabricated relative to the ground truth. The original answer contains no numerical data, so introducing a precise figure constitutes a major error. (3) Qualitatively, the reasoning about revenue recognition is correct and aligns with the ground truth: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS revenue is recognized ratably over the contract term. The model correctly identifies the distinction between the two models and applies them appropriately to the product category. (4) Contextual relevance is high because the answer addresses both parts of the question—revenue contribution (though with an unsupported number) and the difference in revenue recognition—and stays focused on Cisco and the correct product category. However, the addition of an unverified dollar amount undermines factual correctness, warranting a moderate overall score of 6 despite sound qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 422,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "\nAmazon does not break out “third‑party seller fees” as a separate line item in the 2022 filing; the revenue is aggregated within the broader “service sales” category that includes commissions, fulfillment and shipping fees, advertising, Prime and other offerings. In the prior year, service sales—of which third‑party seller fees are a core component—represented roughly 27 % of total net sales and grew 22 % year‑over‑year, illustrating how the fee stream is integral to Amazon’s stated model of enabling sellers to grow their businesses on its platform.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the core quantitative claim. The ground truth states that Amazon's revenue from third-party seller fees in 2022 was $117,757 million, but the LLM claims Amazon does not break out this figure and provides no actual number, instead referencing prior-year service sales as 'roughly 27%' of total net sales and growing 22% YoY. This misrepresents the availability of the data and fails to report the correct figure. (2) The quantitative accuracy is very low because the correct dollar amount ($117,757 million) is not provided, and the percentages cited (27%, 22%) are from a prior year and not tied to the specific 'third-party seller fees' line item, making them irrelevant to the 2022 figure requested. There is no indication these numbers equate to the $117.757 billion in third-party fees. (3) The reasoning is partially sound in linking service sales to third-party seller fees and connecting it to Amazon's business model of enabling sellers, which shows some understanding of the ecosystem. However, it fails the multi-hop requirement by not retrieving and reporting the actual disclosed amount from the 2022 filing, instead asserting it is not broken out when in fact the knowledge graph confirms it was available. (4) Contextual relevance is moderate because the answer discusses the right theme—Amazon's support for sellers and fee-based services—but avoids the primary request for the specific 2022 revenue number. The qualitative accuracy is mid-range because while the conceptual alignment with Amazon's business model is touched upon, it lacks the precision and data-backed synthesis required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 460,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "\nAs of December 31 2024, Capital One’s Common Equity Tier 1 (CET1) capital ratio was **13.5 %**, while the regulatory minimum capital‑adequacy requirement for CET1 under the Basel III standardized approach is **4.5 %**. Therefore, the Company’s CET1 ratio exceeds the minimum by **9.0 percentage points**. (Table 12, “Capital Ratios Under Basel III,” page 86)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the CET1 ratio of 13.5% and the minimum requirement of 4.5% are accurate, and their difference is correctly calculated as 9.0 percentage points, which matches the original answer's '9 percentage points'. Minor formatting (9.0 vs 9) does not affect correctness. (2) The answer is complete, addressing both the company's CET1 ratio and the regulatory minimum, and correctly computes the difference. (3) Entity accuracy is correct: Capital One Financial Corp, CET1 capital ratio, and the date December 31, 2024, are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis—combining the firm's reported capital ratio with the regulatory baseline under Basel III to derive the excess. The citation of Table 12 on page 86 adds contextual support. (5) Semantic equivalence is achieved: 'exceeds the minimum by 9.0 percentage points' conveys the same information as 'the difference... is 9 percentage points'. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 300,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "\nRegulatory threats to Altria’s $1.7 bn JUUL stake center on the FTC’s antitrust complaint that could force divestiture or rescission of the investment and on FDA authority that may impose a burdensome or restrictive regulatory framework for e‑vapor products, including the possibility of removing JUUL products from the market or limiting Altria’s exclusive distribution rights.  If either the FTC challenge or an adverse FDA decision curtails Altria’s governance, non‑competition or distribution rights, the investment’s fair‑value could be written down, earnings could become volatile, and Altria’s ability to generate new revenue streams and meet its strategic “Vision” of growth through innovative tobacco products would be materially undermined.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $1.7 billion investment amount and the FTC's antitrust complaint, which aligns with the ground truth. It accurately notes the risk of divestiture or rescission of the transaction, which is a key regulatory threat. The mention of the FTC seeking to unwind the deal is factually consistent. Additionally, the LLM introduces the FDA's potential regulatory role, including market removal or restrictions on distribution, which is a relevant and plausible risk, though not explicitly detailed in the ground truth. However, the ground truth specifically cites the 2022 10-K filing and emphasizes the impact on credit ratings and financing costs—details not included in the LLM response, representing a minor omission in completeness.\n\n2) Quantitative accuracy is perfect: $1.7 billion is correctly stated, and no other numerical values (percentages, years, etc.) are misstated. The LLM does not fabricate or miscalculate any figures.\n\n3) The multi-hop reasoning is sound: the model connects regulatory risk (FTC and FDA) to financial consequences (write-downs, earnings volatility) and strategic impact (undermining Altria’s growth vision). This synthesis across regulatory, financial, and strategic domains is appropriate and logical. However, the ground truth specifically links the FTC action to credit ratings and financing costs, a connection the LLM does not make, slightly weakening the qualitative depth.\n\n4) The LLM answer is contextually highly relevant, directly addressing both parts of the question: regulatory risks and their financial/strategic impact. While it adds FDA risk not in the original answer, this is a reasonable inference given the context of JUUL and e-vapor regulation, and does not detract from accuracy. The omission of credit rating impacts prevents a top score, but core facts and implications are well-covered.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 508,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "\nThe $500 million 2060 senior note is included in NVIDIA’s $11 billion of long‑term debt that will not be retired until 2060, so the company must eventually repay or refinance that principal. Because the note matures far in the future, NVIDIA must keep cash on hand—or rely on new debt or equity financing—to meet that obligation; if market conditions deteriorate or covenant restrictions tighten, refinancing could be more expensive or unavailable, directly limiting its financial flexibility and ability to fund operations, acquisitions or other growth initiatives. This debt‑service burden, together with the indenture covenants that restrict additional borrowing, is cited in the 10‑K as a key risk to the company’s liquidity and strategic flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $500 million Notes Due 2060 and NVIDIA's total long-term debt of $11 billion, matching the ground truth. The maturity date (2060) and the structure of the debt are accurately represented. (2) All numeric values—$500 million, $11 billion, and the year 2060—are factually correct and consistent with the original answer. No calculations are required, but the temporal and quantitative relationships are preserved. (3) The multi-hop reasoning is sound: the LLM connects the long-term nature of the 2060 note to refinancing risk, cash flow constraints, and limitations on financial flexibility, which aligns with the 10-K's stated risks. It correctly synthesizes that this single note is part of a larger debt structure that collectively impacts liquidity, strategic planning, and access to future financing. The mention of indenture covenants restricting additional borrowing adds a detail consistent with typical 10-K disclosures and enhances the reasoning, even if not explicitly in the original answer. (4) The answer is semantically equivalent to the ground truth, with only minor omissions: it does not explicitly state that a 'substantial portion of cash flows' is dedicated to debt service, though the concept is implied via 'debt-service burden'. Otherwise, all key elements—refinancing risk, reduced flexibility, vulnerability to economic conditions, and constraints on corporate initiatives—are covered accurately and in context. Thus, the answer is highly accurate, complete, and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 459,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gilead’s existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "\nThe FDA’s expanded label now permits Vemlidy to treat children ≥ 6 years old (and ≥ 25 kg) with compensated liver disease, opening a sizable new pediatric chronic‑HBV market that complements Gilead’s existing HBV portfolio (e.g., Viread, Harvoni). Because the pediatric indication is protected by the same composition‑of‑matter patents that expire in 2031 (U.S.) and 2027 (EU) and is eligible for pediatric exclusivity, Gilead can anticipate several additional years of market protection and a meaningful boost to revenue from this younger patient segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expanded FDA approval of Vemlidy for pediatric patients aged 6 years and older weighing at least 25 kg, which aligns with the ground truth. It also accurately notes that this expands Gilead's market potential in chronic HBV by reaching a younger demographic. However, the LLM introduces information not present in the ground truth—specifically, patent expiration dates (2031 in U.S., 2027 in EU) and pediatric exclusivity—without confirmation from the original answer. These details, while plausible, are not supported by the provided ground truth and represent unsupported additions. (2) There are no explicit numerical values (e.g., revenue figures, patient population sizes) in either answer, so quantitative accuracy hinges on dates. The patent expiration years (2027, 2031) are specific numeric claims absent from the ground truth and cannot be verified as correct within this context, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model connects Vemlidy’s expanded approval to Gilead’s broader HBV/HCV portfolio (Viread, Harvoni), which is valid. However, the original answer includes Epclusa and specifies age indications for HCV treatments, which the LLM omits. Additionally, the LLM incorrectly implies Harvoni is part of the HBV portfolio, when Harvoni is primarily an HCV treatment—this is a minor entity confusion. (4) Despite the overreach on patent details and slight misclassification, the core message—that the expanded approval increases market potential by broadening patient access and complementing existing products—is consistent with the ground truth. The answer is contextually relevant and captures the strategic implication well, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 484,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "\nApproximately 5 percent of Lowe’s total fiscal 2023 sales came from installed‑sales categories that are also covered by its extended protection plans. The product category that is explicitly named in both the installed‑sales discussion and the protection‑plan list is **Appliances**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentage of total sales (5%) is accurately reported, with no calculation or numerical errors. The fiscal year (2023) is correctly referenced. (2) The answer is complete, addressing both parts of the question: the percentage contribution and the specific product category. (3) Entity accuracy is perfect—'Lowe's', 'fiscal 2023', 'installed sales categories', 'extended protection plans', and 'Appliances' are all correctly identified and contextually appropriate. (4) The multi-hop reasoning is sound: the model correctly synthesizes information across two contexts—installed sales and extended protection plan coverage—and identifies 'Appliances' as the explicitly mentioned category in both. The semantic meaning is equivalent to the original answer, with only minor, acceptable rewording (e.g., 'approximately 5 percent' vs 'approximately 5%'). All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 283,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (2020–2021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "\nCapital One added back $2.4 billion after‑tax to its regulatory capital under the CECL Transition Election. This amount reflects the delayed day‑1 impact plus 25 % of the day‑2 ongoing impact that is being phased in over 2022‑2024, so the full cumulative addition will be recognized by the end of 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount ($2.4 billion after-tax) that is not present in the original answer (ground truth), and there is no verification that this figure is accurate based on the provided knowledge. The ground truth does not include any numerical values, so the introduction of this number cannot be confirmed and likely reflects unsupported inference or hallucination. (2) Quantitatively, the LLM claims a precise $2.4B figure and attributes it to the 'delayed day-1 impact plus 25% of the day-2 ongoing impact', but the original answer only describes the phase-in structure (25% scaling on day-2 in 2020–2021; 25% annual phase-in of both day-1 and day-2 impacts from 2022–2024) without assigning a total dollar value. Thus, the quantitative claim is not supported and likely incorrect. (3) Qualitatively, the LLM captures part of the phase-in schedule correctly—mentioning the 25% factor and the 2022–2024 period—but misattributes it only to the 'day-2' impact, omitting that both the after-tax day-1 and cumulative day-2 impacts are being phased in annually at 25% from 2022–2024. It also fails to mention the 25% scaling of the day-2 impact during 2020–2021, which is a key component of the multi-hop reasoning. (4) Contextually, the answer is relevant and addresses the CECL Transition Election’s impact on regulatory capital, but it oversimplifies and distorts the mechanism by focusing only on the later phase-in period and introducing unverified numbers. The core structure of the multi-year phase-in is partially recognized but not fully or accurately synthesized, leading to a partially correct but misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 456,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What was the net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales?",
      "original_answer": "Altria recorded $4.6 billion in charges to cost of sales for the year ended December 31, 2021, related to the State Settlement Agreements and FDA user fees. During the same period, Altria received $21 million as a reduction to cost of sales from the 2004 NPM adjustment. This resulted in a net cost of $4.579 billion for 2021 after accounting for the NPM adjustment recovery.",
      "llm_answer": "\nAltria recorded about **$4.6 billion of charges to cost of sales** in 2021 for its tobacco‑settlement and FDA user‑fee obligations, and it offset this expense with a **$21 million reduction** from NPM‑adjustment recoveries that was booked as a credit to cost of sales.  The combined effect was a **net increase of roughly $4.58 billion in cost of sales for the year**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only minor rounding differences. (1) Quantitatively, all key numbers are correct: $4.6 billion in charges and $21 million in NPM adjustment recovery are accurately reported. The net cost is calculated as $4.58 billion, which is a properly rounded version of $4.579 billion from the original answer—this is acceptable under the evaluation principles. (2) The answer is complete, addressing both the settlement-related charges and the NPM recovery, and correctly synthesizes the net impact on cost of sales. (3) Entities are accurate: Altria, 2021 time frame, cost of sales, State Settlement Agreements (implied via context), FDA user fees, and NPM adjustment are all correctly referenced. (4) The reasoning is sound: the model correctly treats the NPM recovery as a reduction (credit) to cost of sales and computes the net effect through subtraction, demonstrating proper multi-hop synthesis across obligations and recoveries. The only minor shortcoming is the use of 'roughly $4.58 billion' instead of the more precise '$4.579 billion', but this does not affect factual correctness given standard rounding practices. Overall, the answer is semantically equivalent and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 357,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "\nThe combined liability for non‑qualified deferred compensation plans and other postemployment benefits increased from $554 million in 2020 to $605 million in 2021, an increase of $51 million. This reflects the sum of the $67 million other postemployment benefit liability and the $538 million non‑qualified deferred compensation plan liability in 2021, compared with $63 million and $491 million respectively in 2020.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2021 total liability amount. While the ground truth states the 2021 total liability is $645 million ($67M + $538M), the LLM incorrectly calculates it as $605 million, leading to an incorrect increase of $51 million instead of the correct $91 million. The 2020 total ($554M) is correctly calculated as $63M + $491M. (2) Specific number verification: 2020 values are accurate; 2021 component values ($67M and $538M) are correct, but their sum is miscalculated. $67M + $538M = $605M is wrong — the correct sum is $645M. The difference between $645M and $554M is $91M, not $51M. This is a significant quantitative error. (3) Multi-hop reasoning is partially sound: the model correctly identifies the relevant components (non-qualified deferred compensation and other postemployment benefits) and retrieves the correct individual values for both years. It also correctly contextualizes the increase after the 2019 pension freeze. However, the failure to sum the 2021 components accurately undermines the conclusion. (4) Correctness and quantitative accuracy are low due to the incorrect sum and resulting dollar increase. Qualitative accuracy is moderate because the reasoning framework and entity identification are correct. Contextual relevance is high as the answer addresses the right companies, years, and benefit types and attempts the correct synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 393,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "\nThe finite‑lived intangible assets acquired in the Mellanox transaction (developed technology, customer relationships and trade‑names) total $2.34 billion and are expected to be amortized at roughly $0.49 billion per year. Over fiscal years 2023 through 2028 this translates to about **$2.9 billion of aggregate amortization expense**.  \n\nThe $630 million indefinite‑lived IPR&D asset recorded for Mellanox’s in‑process research and development is not amortized now; it remains on the balance sheet and will only be amortized later if and when that project reaches technological feasibility, so it does not affect the amortization expense in the 2023‑2028 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative estimate: it reports $2.9 billion in aggregate amortization expense from 2023–2028, whereas the ground truth is $1.889 billion. This is a major error. The breakdown by year is missing entirely, and the annual amortization figure of $0.49 billion is inconsistent with the actual declining schedule (e.g., $585M in 2023, dropping to $16M in 2027). (2) The calculation is flawed: $0.49B/year over 6 years is $2.94B, which is not only based on an incorrect annual rate but also assumes a flat amortization not reflected in the data. The actual sum of the yearly expenses ($585M + $461M + $405M + $121M + $16M + $121M) equals $1.889B, which the LLM fails to match. (3) On qualitative reasoning, the LLM correctly identifies that the $630M IPR&D asset is indefinite-lived and not amortized until technological feasibility is reached, which aligns with the ground truth. It also correctly separates finite-lived intangibles from indefinite-lived ones, showing sound conceptual understanding. (4) Contextual relevance is high—the answer addresses both parts of the multi-hop question (total amortization and treatment of IPR&D)—but the severe numerical inaccuracies undermine the correctness. While the reasoning about IPR&D is accurate, the core financial figure is wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 381,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "\nThe primary U.S. and EU compound patents for **Biktarvy** are projected to expire in **2033** in both jurisdictions. The recent FDA expansion of Biktarvy’s label to include treatment of patients with the **M184V/I resistance mutation** does not extend the patent term; instead, the new indication falls under the existing regulatory exclusivity, which is set to lapse in **2032**, so market exclusivity will effectively end a year before the patent expires.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the U.S. and EU patent expiration year for Biktarvy as 2033, which matches the ground truth and satisfies the first part of the multi-hop question. However, it introduces a critical factual discrepancy regarding regulatory exclusivity: it claims that regulatory exclusivity lapses in 2032, one year before the patent expiration, which is not present in the ground truth and appears to be an unsupported addition. The original answer states that the expanded FDA approval for the M184V/I resistance indication reinforces market exclusivity by broadening therapeutic use and supporting revenue through 2033, with no mention of a 2032 exclusivity expiration. This undermines the quantitative and qualitative accuracy. While the reasoning about the label expansion falling under existing exclusivity is plausible, the specific claim of 2032 exclusivity end date is incorrect and contradicts the ground truth that ties market exclusivity support through 2033. The entity identification (Biktarvy, M184V/I resistance) and context of FDA expansion are accurate, and the answer addresses both parts of the question, but the erroneous exclusivity timeline significantly affects the correctness of the synthesis. Thus, the answer is partially correct with major factual error in regulatory exclusivity duration.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 370,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "\nThe Federal Reserve’s annual supervisory stress‑testing (DFAST/CCAR) produces a “stress‑capital buffer” that caps the amount of dividends and share‑repurchases Capital One may legally distribute; the firm must structure its capital‑return plans so that they do not exceed the buffer‑derived limit. This limitation is reinforced by the Dodd‑Frank Act’s enhanced‑prudential‑standards and capital‑planning requirements, which obligate covered bank holding companies to submit a capital plan and to comply with the stress‑testing and stress‑capital‑buffer rules before any capital distributions can be made.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying the Federal Reserve's supervisory stress testing (via DFAST/CCAR) as a mechanism that limits Capital One Financial Corporation's capital distributions through the stress-capital buffer. It accurately notes that this buffer constrains dividends and share repurchases, which aligns semantically with the ground truth's 'lower capacity to return capital.' The reference to Dodd-Frank Act requirements is also correct in spirit, as enhanced prudential standards and capital planning rules under Dodd-Frank do enforce these limitations. However, the LLM does not explicitly mention the 'source of strength doctrine,' which is the specific regulatory requirement cited in the ground truth and a key multi-hop element connecting Dodd-Frank to Capital One's obligation to support its subsidiary banks. While the LLM captures the operational mechanism (stress-capital buffer and capital planning) accurately, it misses this precise doctrinal term, resulting in a minor but notable gap in qualitative accuracy. No numbers are incorrect (quantitative accuracy is perfect), and the reasoning is sound, though slightly incomplete in synthesizing the full legal basis. Contextual relevance is excellent as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 367,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "\nThe State Settlement Agreements required PM USA to make roughly $4.2 billion in 2019, $4.4 billion in 2020 and $4.3 billion in 2021, giving a combined total of about **$12.9 billion** over the three years.  By contrast, the maximum potential NPM Adjustment that could apply to 2020 alone is only **$572 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the payments made by PM USA for 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion), matching the ground truth. The combined total is stated as $12.9 billion, which is a minor rounding difference from the exact sum of $12.8 billion (4.2 + 4.4 + 4.3 = 12.9). This slight overstatement is due to rounding but does not constitute a material error. The maximum potential NPM Adjustment for 2020 is correctly reported as $572 million, matching the ground truth. (2) All numeric values are accurate except for the total sum, which should be $12.9 billion if strictly summing the provided figures, but the ground truth states $12.8 billion—this discrepancy may stem from actual reported figures involving more precise underlying values not shown here. Given the transparency of the inputs, the LLM's arithmetic is correct. (3) The multi-hop reasoning is sound: the model synthesizes data across three years, computes the total, and correctly contrasts it with a separate financial metric (NPM Adjustment) for 2020. The comparison logic ('significantly higher') is preserved in spirit, though not explicitly restated, but implied by magnitude. (4) The answer is contextually complete and relevant, addressing both parts of the question. The minor quantitative inconsistency in the total (likely due to rounding or source-level precision) prevents a perfect 10, but all core facts, entities, years, and logic are correct. Hence, a score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 417,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "\nThe excerpts you provided do not include the debt tables that disclose the fair‑value amount and the net carrying amount of the 2.85 % Notes Due 2030, so the difference between those two figures cannot be determined from the given pages.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to provide the correct information. (1) The ground truth states that the fair value is $1,542 million and the net carrying amount is $1,500 million, with a difference of $42 million. These numbers are precise and directly answer the question. The LLM, however, claims that the data is not available in the provided excerpts, which contradicts the premise of the task—where the necessary data was evidently present in the source tables (as reflected in the original answer derived from a knowledge graph of actual filings). (2) No correct numbers or calculations are provided by the LLM; it avoids answering altogether, thus failing on quantitative accuracy. (3) The reasoning is flawed because it asserts missing information rather than performing the required multi-hop synthesis between two disclosed values in different tables. A correct response would have identified both values from their respective tables and computed the difference. (4) The answer lacks contextual relevance because it does not attempt to address the core question despite having (in the system context) access to the necessary data. The response appears to be evasive rather than analytical, indicating a failure in both retrieval and reasoning processes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 356,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rule—based on supervisory stress test results—reduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "\nThe Tailoring Rules place Capital One Financial Corp. in the **Category III** bucket, so it follows the tailored capital framework rather than the full Basel III Advanced Approach. Consequently, the firm must apply the **Stress Capital Buffer Rule**—a buffer that is set each year from its supervisory stress‑test results and added to the standard capital‑conservation buffer, pushing the minimum CET1, Tier 1 and total‑capital ratios to levels such as 10.1 %/11.6 %/13.6 % (2020‑21) or 7.0 %/8.5 %/10.5 % (2021‑22). At the same time, Category III status allows the company to **exclude certain elements of accumulated other comprehensive income (AOCI) from its regulatory capital**, thereby reducing the capital base on which the stress‑buffer and conservation requirements are applied. This combination means that COF’s capital requirements are driven by an annually‑recalibrated stress buffer while a smaller capital base (excluding AOCI) is used for those calculations.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. It correctly identifies that Capital One (COF), as a Category III institution under the Tailoring Rules, is subject to a tailored capital framework, exempt from Basel III Advanced Approaches, and allowed to exclude certain AOCI components from regulatory capital. It accurately describes the Stress Capital Buffer Rule being annually set based on stress test results and added to the capital conservation buffer. The explanation of using a smaller capital base (due to AOCI exclusion) for buffer calculations is logically sound and aligns with regulatory intent.\n\nQuantitatively, the LLM provides specific CET1, Tier 1, and total capital ratios (e.g., 10.1%/11.6%/13.6% for 2020–21 and 7.0%/8.5%/10.5% for 2021–22). While these numbers are plausible and consistent with historical SCB outcomes, the ground truth does not include these specific percentages. Since the original answer does not provide numerical values for the capital ratios, the inclusion of these figures introduces precision not present in the source, but they are not factually incorrect per se—rather, they go beyond the verified data. This limits quantitative accuracy slightly due to unsupported specificity.\n\nThe multi-hop reasoning is strong: the model connects Category III status → tailored rules → AOCI exclusion + Stress Capital Buffer → impact on capital requirements. All entities (COF, AOCI, Stress Capital Buffer, Category III) are correct. The answer is contextually relevant and fully addresses the question’s components. The minor deduction in quantitative accuracy does not reflect an error but rather over-specification beyond the ground truth. Overall, the semantic meaning matches the original answer closely, with only slight embellishment on numerical details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 496,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "\nThe fair‑value of Altria’s 35 % stake in JUUL was $1.705 billion at both December 31 2020 and December 31 2021, so the net change in fair value over the year was **$0**.  This flat‑line result was reflected in the consolidated financial statements by (i) keeping the investment recorded at $1.705 billion in the “Investments in equity securities” line of the balance sheet and (ii) showing no gain or loss for JUUL in the “(income) losses from equity investments” line of earnings—only the $100 million impairment loss that was recorded in 2020 had been recognized previously, with no subsequent adjustment in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the fair value of Altria's JUUL investment remained unchanged at $1.705 billion (i.e., $1,705 million) from 2020 to 2021, resulting in a $0 change, which matches the ground truth. The amount is accurately represented with acceptable format variation ($1.705 billion = $1,705 million). (2) The LLM correctly identifies that the investment was recorded in 'Investments in equity securities' on the balance sheet and that changes in fair value flow through 'income (losses) from equity investments' in the earnings statement. It adds a relevant detail about the $100 million impairment loss recognized in 2020, which is consistent with the timeline and accounting treatment post-Share Conversion. However, the original answer does not mention the absence of 2021 adjustments beyond the stability of fair value, so while the LLM's inference is reasonable, it slightly over-specifies by implying that 'no gain or loss' was shown specifically for JUUL in 2021—this nuance isn't contradicted by the ground truth but goes beyond what's stated. (3) The multi-hop reasoning is sound: the model connects the stable fair value to its reflection in both the balance sheet and income statement, correctly applying accounting principles for fair value option investments and level 3 measurements, even if not explicitly naming 'level 3'. (4) Scores reflect near-perfect factual accuracy, with only a minor over-elaboration on the income statement impact that doesn't introduce error. All entities (Altria, JUUL, correct years) and financial terms are accurate and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 444,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "\nApproximately 14.5 % of Union Pacific’s 7,154 total locomotives are leased (1,037 leased units). By comparison, the switching‑locomotive fleet consists of 132 units, all of which are owned.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key numbers match: 1,037 leased locomotives out of 7,154 total, resulting in approximately 14.5% leased—calculation is accurate (1,037 / 7,154 ≈ 0.145 or 14.5%). The number of switching locomotives is correctly stated as 132. (2) Quantitative accuracy is perfect: values are presented clearly and precisely, with acceptable formatting (e.g., '14.5 %' with non-breaking space is minor and does not affect meaning). (3) Qualitative accuracy and reasoning are sound: the answer correctly identifies that the leased count (1,037) is significantly higher than the switching locomotive count (132), and explicitly notes that switching locomotives are owned, adding contextual clarity. (4) The response fully addresses both parts of the multi-hop question: percentage of leased locomotives and comparison to switching locomotives. Synthesis across entities (total fleet, leased units, switching units) is correct and well-articulated. All aspects of the original answer are preserved with no omissions or distortions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1102,
        "completion_tokens": 312,
        "total_tokens": 1415
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "\nThe excerpt you provided does not include the fair‑value reconciliation or any debt‑maturity table for the 2.20 % Notes Due 2021, so the change in their fair value from January 31 2021 to January 30 2022 cannot be determined from these pages. Consequently, there is no information in the supplied excerpts that shows how such a change would appear in the fair‑value disclosures or in a debt‑specific maturity and interest‑rate table.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The original answer (ground truth) provides specific and accurate data: the fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as the notes matured. The debt-specific maturity and interest rate table confirms this maturity, showing a remaining term of 0 years and an effective interest rate of 2.38%. The LLM, however, claims that no information is available, which contradicts the premise that the ground truth was extracted from actual filing data. This suggests the LLM failed to access or recognize the relevant data, resulting in a complete factual error. There are no correct numbers, entities, or reasoning steps. The response does not address the multi-hop requirement to link fair value changes with maturity disclosures. While the response is relevant in structure (discussing fair value and debt tables), it denies the existence of data that is confirmed to exist, making it highly inaccurate despite appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 298,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "\nThe temporary exclusions remove U.S. Treasury securities and deposits at Federal Reserve Banks from the denominator of the supplementary‑leverage‑ratio calculation, which effectively lowers the leverage exposure and raises the ratio. This treatment was authorized under an interim‑final rule issued by the Federal Reserve (and the other Federal banking agencies) that allowed such exclusions from the leverage‑ratio denominator for BHCs as part of the Basel III capital‑standards and prompt‑corrective‑action framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly explains that excluding U.S. Treasury securities and Fed deposits from the denominator of the supplementary leverage ratio lowers leverage exposure and thus increases the ratio—this aligns with the original answer's claim that the exclusion 'increased Capital One's supplementary leverage ratio'. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all conceptual metrics (denominator adjustment, effect on ratio) are correctly represented—hence a score of 10. (3) The LLM correctly identifies the regulatory framework as the Basel III capital standards and references the interim final rule by the Federal Reserve, matching the original answer. It adds that other federal banking agencies were involved and mentions BHCs (bank holding companies), which is contextually accurate and adds minor but not conflicting detail. The only slight deviation is that it refers to the 'Basel III capital-standards and prompt-corrective-action framework', while the original specifies the 'Basel III Standardized Approach framework'. This is a minor imprecision—the Standardized Approach is part of Basel III, but the mention of 'prompt-corrective-action' is not in the original and slightly broadens the scope. However, this does not make the answer factually incorrect. (4) The answer is fully relevant, directly addressing both parts of the question: the impact on the ratio and the regulatory framework. Multi-hop reasoning is sound—linking the exclusion, its effect on the denominator, the resulting increase in the ratio, and the regulatory authority behind it. Overall, the answer is semantically equivalent with only minor additional context that does not detract from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 508,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "\nIn 2023 Union Pacific’s pension plan held **$3.209 billion** of assets classified as Level 2. These assets were valued using observable inputs that are not quoted prices for identical items—primarily independent pricing data for federal government securities, corporate bonds/debentures and certain corporate stock, as described in the plan’s fair‑value hierarchy (page 58).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the total value of Level 2 pension plan assets as $3.209 billion (equivalent to $3,209 million), matching the ground truth. However, it does not break down the specific components—Federal Government Securities ($1,508 million) and Bonds and Debentures ($1,696 million)—which sum to $3,204 million (a $5 million discrepancy potentially due to rounding or unreported minor components). The valuation method is accurately described as using independent pricing data, aligning with the 'bid evaluation process with bid data from independent pricing sources' in the original answer. The LLM generalizes this correctly but omits the specific term 'bid evaluation process'.\n\n2) Quantitatively, the total asset value is correct with acceptable format variation ($3.209 billion = $3,209 million). The component values are not mentioned, so completeness suffers slightly. The sum of the disclosed components in the ground truth is $1,508 + $1,696 = $3,204 million, which is $5 million short of the total—this minor inconsistency in the ground truth may reflect rounding or other minor assets, but the LLM does not attempt to reconcile or report these figures.\n\n3) The multi-hop reasoning is sound: the LLM correctly attributes Level 2 assets to Union Pacific, for 2023, and links them to valuation via observable inputs and independent pricing. It correctly identifies the types of assets (federal securities, bonds/debentures), though it adds 'certain corporate stock' not explicitly mentioned in the ground truth, which may be an overgeneralization.\n\n4) The answer is contextually relevant and addresses both parts of the question: total value and valuation method. The omission of the exact breakdown and slight overgeneralization of asset types and valuation terminology prevents a top score, but core facts and synthesis are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 503,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computing—from training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "\nNVIDIA cites Omniverse Avatar as the automotive‑specific application—using the Omniverse‑powered conversational‑AI engine to deliver real‑time, in‑vehicle experiences (e.g., Drive Concierge) that can interact with drivers and passengers.  By embedding Omniverse‑based simulation and digital‑twin capabilities into the DRIVE software stack, the company can train, validate and continuously update autonomous‑driving AI models in the cloud and then deploy the same AI pipelines directly onto the DRIVE Hyperion hardware, creating a seamless end‑to‑end AI computing flow from training to in‑vehicle inference and over‑the‑air updates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies NVIDIA Omniverse Avatar as the specific automotive application, noting its use in real-time conversational AI for in-vehicle experiences like DRIVE Concierge—aligning with the original answer. It also references DRIVE Chauffeur implicitly through the context of autonomous driving AI models. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers earns a perfect score by default. (3) The multi-hop reasoning is sound: the LLM correctly links Omniverse Avatar to DRIVE platform integration, explains the end-to-end flow from cloud-based training to deployment on DRIVE Hyperion hardware, and highlights over-the-air updates—key components of NVIDIA’s end-to-end AI strategy. The only minor omission is not explicitly naming DRIVE Chauffeur alongside DRIVE Concierge, though the functionality described implies it. (4) The answer is fully contextually relevant, directly addressing both parts of the question: specific automotive applications and how integration supports the broader AI computing strategy. Wording differs but semantic meaning matches the ground truth. Thus, a correctness score of 9 is justified—excellent accuracy with a slight gap in full entity enumeration.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 392,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "\nConverse’s share of Nike Inc.’s total revenue rose from $2.35 bn in FY 2022 to $2.43 bn in FY 2023—a 3.5 % increase—while Converse’s operating income grew from $669 m to $676 m, a 1.0 % rise. Thus, revenue growth outpaced the modest 1 % gain in operating income over the same period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, Converse's contribution to NIKE's total revenues increased by 3.4% from 2022 to 2023, while operating income decreased by 30.0%. However, the LLM claims operating income increased by 1.0% (from $669M to $676M), which is factually incorrect. The revenue figures cited ($2.35B and $2.43B) imply a 3.4% increase (actual: (2.43 - 2.35)/2.35 ≈ 3.4%), so the 3.5% cited is close but slightly off due to rounding. (2) Quantitative accuracy is low: the operating income direction is wrong (increase vs actual decrease), and the magnitude (1% vs -30%) is severely incorrect. The revenue change is approximately correct but not exact. (3) The reasoning is flawed because it fails to correctly synthesize the multi-hop data: while it identifies the correct entities (Converse, NIKE, revenue, operating income) and time period (FY2022–FY2023), it uses incorrect operating income figures, leading to a completely incorrect comparison. (4) Contextual relevance is high because the answer addresses both parts of the question and uses appropriate financial metrics and structure. However, due to the severe quantitative inaccuracies—especially the reversal of a 30% decrease into a 1% increase—the overall correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 367,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "\nThe 2023 revision to the TDR accounting guidance eliminated the “reasonably expected and concession” assessment, so any loan that is only in a trial‑modification (or a Chapter 7 discharge) is now treated as a TDR. As a result, the Firm reported $136 million of trial‑modified residential‑real‑estate loans and $27 million of trial‑modified credit‑card loans as TDRs for 2023—amounts that were not separately classified as TDRs under the prior guidance—thereby including these trial modifications in the TDR classification for both portfolios.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key change in TDR accounting guidance—elimination of the 'reasonably expected' and 'concession' criteria—and accurately explains that trial modifications are now classified as TDRs but not FDMs in both the residential real estate and credit card portfolios. The explanation of the impact is logically sound and contextually relevant. However, there is a critical error in the quantitative data: the LLM states $136 million for residential real estate loans under trial modification, while the ground truth specifies $69 million. This is a significant discrepancy (off by $67 million), suggesting either a misstatement or confusion with another figure. The credit card loan amount ($27 million) is correct. The answer omits the explicit mention that these loans are classified as TDRs but *not* FDMs, which is a key nuance in the original answer and important for accurate financial classification. While the reasoning and entity identification (residential real estate, credit card loans, 2023) are correct, the numerical inaccuracy in a core data point reduces confidence in the quantitative precision. The $136 million figure does not match any sum or combination in the ground truth (69 + 27 = 96, not 136), so it appears to be factually incorrect. Despite this, the overall structure and intent of the answer align well with the question, earning high marks for qualitative reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 396,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "\nAs of December 31 2023, Union Pacific reported 1,320,451 retention shares and units outstanding under its stock‑incentive plans (366,046 retention units + 954,405 issued retention shares), whereas the Directors Plan had only 16,000 restricted shares outstanding on that date—making the retention figure roughly 80 times larger.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: 954,405 retention shares, 366,046 retention units, and 16,000 restricted shares under the Directors Plan as of December 31, 2023. The total of 1,320,451 retention shares and units is correctly calculated (954,405 + 366,046 = 1,320,451). (2) The answer is complete, addressing both parts of the question: total retention shares/units under stock incentive plans and the comparison to restricted shares under the Directors Plan. (3) Entities are correctly identified: Union Pacific, stock incentive plans, Directors Plan, and the correct date. (4) The reasoning is sound, including proper multi-hop synthesis of data across plans and accurate comparison (noting the ~80x difference, which is a valid interpretation though not required). Wording differs slightly (e.g., 'issued retention shares' adds minor clarification but does not distort meaning), but semantic equivalence is maintained. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 299,
        "total_tokens": 1472
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "\nAs of December 28 2024, AMD’s equity‑method investment in the ATMP joint venture had a carrying value of **$149 million**. In addition, AMD had extended a **$100 million secured term loan** to the JV (recorded in receivables from related parties). Therefore, the total amount of AMD’s investment in the ATMP JV—combining the equity investment and the secured loan—was **approximately $249 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All key facts are accurate: the carrying value of AMD's equity investment is correctly stated as $149 million, and the secured term loan is accurately reported as $100 million. The total investment is correctly calculated as $249 million. (2) Quantitative accuracy is perfect: all numbers match the original answer exactly, including the components and the sum. Minor wording differences (e.g., 'approximately $249 million') are acceptable since the exact sum of $149M + $100M is $249M, and 'approximately' does not misrepresent precision in this context. (3) The multi-hop reasoning is sound—LLM correctly synthesizes two distinct financial components (equity investment and loan) from the same entity and time period (December 28, 2024) to arrive at the total investment. (4) The answer is contextually relevant, directly addressing the question with precise financial data and clear structure. All entities (AMD, ATMP JV) and financial terms (carrying value, secured term loan) are used correctly. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 320,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "\nDanaher recorded a $451 million pre‑tax gain on the Envista disposition, reclassified $109 million of foreign‑currency translation adjustment losses from accumulated other comprehensive income into earnings, and incurred $69 million of IPO and separation‑related costs; net of these items the disposition produced roughly $273 million of financial impact for Danaher.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains correct individual components—the $451 million gain on disposition, $109 million foreign currency translation adjustment loss, and $69 million IPO and separation-related costs—but fails in the final calculation and overall conclusion. The net financial impact is incorrectly stated as 'roughly $273 million', which is wrong. The correct total financial impact is $387 million, calculated as: $451M gain - $109M loss - $69M costs = $273M net gain, but the original answer defines the 'total financial impact' as the grossed-up figure of $387M, which appears to represent the sum of absolute values or a defined aggregate impact (i.e., $451M - $109M - $69M = $273M net, but total impact reported as $387M). However, the LLM misinterprets 'total financial impact' as the net gain ($273M), whereas the ground truth explicitly states it is $387M, inclusive of all components. (2) Quantitative accuracy is low because while individual numbers are correct, the final derived figure is incorrect and contradicts the ground truth. The model computes a net gain but labels it as the 'total financial impact', which does not align with the original answer’s definition. (3) The reasoning is partially sound—multi-hop elements (gain, FCTA loss, costs) are correctly identified and attributed to Danaher and Envista disposition—but the synthesis is flawed. The model fails to recognize that 'total financial impact' is not the net gain but a defined sum of impacts, possibly in absolute terms or as reported in disclosures. (4) Contextual relevance is high because all relevant components are addressed and correctly linked to the disposition event. However, due to the critical error in the final figure and misinterpretation of 'total financial impact', the correctness score is low. Minor note: 'roughly $273 million' introduces imprecision where exact figures were available.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 515,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "\nThe 15 % currency‑neutral drop in Converse revenue—driven by weaker sales in North America and Western Europe—reduced the segment’s top line, and when combined with a roughly 130‑basis‑point gross‑margin contraction that resulted from unfavorable foreign‑currency exchange rates (which lowered full‑price ASP and raised other costs), it pushed Converse’s earnings before interest and taxes down about 30 % year‑over‑year. In short, the revenue decline amplified the impact of the currency‑induced margin squeeze, leading to a sharp EBIT decline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the 15% currency-neutral revenue decline in Converse driven by North America and Western Europe, the 130 basis point gross margin contraction due to unfavorable foreign currency exchange rates, and the resulting ~30% year-over-year decrease in EBIT. These match the ground truth exactly in magnitude and direction. (2) Quantitative accuracy is perfect: percentages (15%, 130 bps, ~30% EBIT decline) are correctly reported with acceptable formatting (e.g., '130-basis-point' vs '130 basis point'). No calculation errors. (3) The multi-hop reasoning is sound—LLM correctly links the revenue decline and margin pressure to the EBIT outcome, and explains that the revenue drop amplified the margin squeeze, which aligns with the causal logic in the original answer. The phrase 'about 30%' is slightly less precise than '30% decrease' but still semantically equivalent. (4) All entities (Converse segment, EBIT, gross margin, foreign currency impact) are accurately referenced. The answer is fully relevant and synthesizes the required elements. Minor deduction in qualitative accuracy only because 'lowered full-price ASP and raised other costs' adds detail not present in the ground truth, which may be inferred but isn't confirmed in the source—this is a small overreach, but does not undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 382,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "\nThe January 1 2023 TDR‑guidance change required that trial‑modification and Chapter 7 loan modifications be classified as TDRs, eliminating the prior “reasonably expected” and concession tests. Consequently, the Firm’s allowance for loan losses was **reduced by about $587 million in 2023**, lowering credit‑loss expense and strengthening its capital position, even though the overall allowance for credit losses still grew due to other macro‑economic and First Republic adjustments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative impact: the $587 million reduction in the allowance for credit losses due to the new TDR guidance effective January 1, 2023, which matches the ground truth exactly. The date and dollar amount are accurate, satisfying quantitative accuracy. The answer also correctly references trial modifications and Chapter 7 loans as the drivers, and notes the elimination of the 'reasonably expected' and 'concession assessment' criteria, though it slightly mischaracterizes the change in direction—stating that these modifications are now *required* to be classified as TDRs, whereas the ground truth explains they are *still considered TDRs* but reclassified as non-FDMs (Financial Disincentive Modifications), which reduces allowance requirements. This is a subtle but important distinction in reasoning: the new guidance eliminated criteria that previously led to FDM classification, thereby reducing reserves, not because more loans were newly classified as TDRs, but because fewer were classified as FDMs. The LLM misses this nuance and incorrectly implies the rule change increased TDR classifications, when in fact it changed the assessment framework leading to lower reserve requirements. Despite this, the core financial impact and entities (JPMorgan Chase, 2023, allowance for credit losses) are correct, and the effect on financial position (strengthened capital) is reasonably inferred. The mention that the overall allowance still grew due to other factors, while potentially true, is not in the ground truth and slightly distracts from the specific impact of the TDR change, but does not make the answer factually wrong. Multi-hop synthesis is partially sound but lacks precision in causal logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 475,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "\nUNP’s pension plan held **$3.209 billion** of assets classified as Level 2 at fair value.  The Level 2 valuation methodology—using a bid‑evaluation process with independent pricing sources—is applied to **Federal government securities, bonds and debentures, and the preferred‑stock portion of corporate stock**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The total amount invested in Level 2 assets by UNP's pension plan is stated as $3.209 billion, but the ground truth is $1,111 million ($1.111 billion), making the LLM's figure nearly triple the correct amount. This is a major quantitative error. (2) Regarding the investment categories, the LLM correctly identifies 'Federal government securities' and 'bonds and debentures' as Level 2 assets using bid evaluation with independent pricing sources. However, it incorrectly specifies 'the preferred-stock portion of corporate stock' instead of the broader 'Corporate Stock' category as stated in the ground truth. The original answer does not specify a subset (like preferred stock), so this introduces an unsupported detail. (3) The multi-hop reasoning is partially sound—information about valuation methodology is correctly tied to specific asset classes—but fails in accurately retrieving the total Level 2 asset value and misrepresents the composition of corporate stock. (4) Despite correct structure and relevant context, the severe numerical inaccuracy and partial misrepresentation of asset categories significantly reduce correctness. Contextual relevance is high because the answer addresses both parts of the question and uses appropriate financial terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 374,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "\nThe research‑and‑medical‑products revenue rose from $13.5 bn in 2019 to $24.8 bn in 2021, a gain of roughly 84 %, whereas total DHR revenue increased from $17.9 bn to $29.5 bn, or about 65 % over the same two‑year span. Thus, the segment’s growth outpaced the company’s overall revenue growth, highlighting its central role in driving DHR’s recent top‑line expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. The revenue figures for the research and medical products segment ($13.5B in 2019 and $24.8B in 2021) and total DHR revenue ($17.9B in 2019 and $29.5B in 2021) are accurate when converted from billions to millions (e.g., $13.5B = $13,500M ≈ $13,512M — minor rounding acceptable). The calculated growth rates (~84% vs ~65%) closely match the ground truth (83.5% and 64.4%), with the small discrepancy attributable to rounding, which is acceptable per evaluation guidelines. (2) Calculations: Segment growth = (24.8 - 13.5) / 13.5 ≈ 83.7%, rounded to 84% — correct. Total revenue growth = (29.5 - 17.9) / 17.9 ≈ 64.8%, rounded to 65% — also reasonable. Ground truth uses more precise inputs (e.g., $29,453M), so 64.4% is exact; LLM’s 65% is a minor overstatement but within tolerance. (3) Multi-hop reasoning is sound: the model correctly identifies two revenue streams (segment vs total), compares their growth over the same period (2019–2021), and draws the logical conclusion that the segment outpaced overall growth, indicating its strategic importance. (4) All entities (DHR, research and medical products segment, revenue, years) are correctly identified. The answer addresses both parts of the question: the comparison of growth rates and the implication for DHR’s financial performance. Wording differs slightly (e.g., 'central role in driving top-line expansion' vs 'key driver of financial performance') but is semantically equivalent. Only a 9 due to slight rounding in percentages; no major errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 433,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "\nThe adoption of the revised TDR accounting guidance on January 1 2023 reduced the allowance for credit losses by **$587 million** (the “reduction of $587 million as a result of the adoption of changes to the TDR accounting guidance” noted in the allowance discussion).  At the same time, the new guidance eliminated the “reasonably expected” and concession tests, so that **trial‑modification credit‑card loans are now classified as TDRs** (they are treated as TDRs but remain non‑FDM modifications).  This is reflected in the allowance schedule and the discussion of trial modifications on pages 119‑121 and the $587 million reduction on page 134.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the $587 million reduction in the allowance for credit losses is accurately reported. (2) The answer correctly identifies the elimination of the 'reasonably expected' and concession assessment criteria under the revised TDR guidance, and explains that trial modifications for credit card loans are now classified as TDRs but not FDMs—this matches the original answer's key qualitative point. (3) The multi-hop reasoning is sound: the model connects the accounting change to both its financial impact (allowance reduction) and its effect on classification policy, drawing correct inferences from the guidance change. (4) The only minor omission is that the LLM answer does not mention the prior year’s credit card TDRs ($418 million), nor the 2023 figures for FDMs ($648 million) and trial modifications ($27 million), which are part of the full context in the original answer. While not central to the cause-effect relationship asked, their absence slightly reduces completeness. However, since the question focuses on how the guidance affected the allowance and classification—both of which are correctly and fully addressed—the omission does not undermine the core correctness. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 377,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "\n3M’s 2021 change to a fair‑value approach for the market‑related value of fixed‑income pension assets eliminated the three‑year deferral of asset gains and losses that had been used under the prior calculated‑value method.  As a result, the company restated all prior periods so that pension expense, the related other‑comprehensive‑income adjustment, retained earnings and earnings‑per‑share were lower (e.g., 2020 pension expense fell from $406 M to $322 M and the defined‑benefit pension AOCI adjustment dropped from $171 M to $106 M), thereby altering the presentation of its pension‑related financial metrics across reporting periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key change in accounting principle—3M's 2021 adoption of a fair value approach for fixed-income securities in pension and postretirement plans, replacing the prior three-year deferral (calculated value) method. It accurately notes the retrospective application and the impact on financial metrics such as pension expense, other comprehensive income (AOCI), retained earnings, and earnings per share, which aligns with the ground truth. The qualitative reasoning is strong: it captures the multi-hop synthesis of accounting change, its retrospective restatement effect, and the broader impact on financial statement presentation. However, the quantitative accuracy is partially compromised. While the ground truth does not specify exact dollar figures (e.g., $406M to $322M, $171M to $106M), these numbers are not corroborated in the original answer and may be fabricated or misattributed. Since the ground truth confirms the nature and direction of the impact (lower pension expense, lower AOCI adjustment) but not the specific numbers, including them without verification reduces quantitative accuracy. The LLM adds precision not present in the source, which risks misinformation. Despite this, the core facts—change in method, elimination of deferral, retrospective restatement, and affected financial metrics—are correct and contextually relevant. The answer fully addresses the question's focus on how the change impacted financial metric presentation across periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 414,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "\nThe Firm’s adoption of the revised TDR accounting guidance on January 1 2023 required a **$587 million reduction** to the allowance for credit losses, lowering the reported allowance for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $587 million reduction in JPMorgan's allowance for credit losses due to the adoption of the revised TDR accounting guidance on January 1, 2023, which matches the ground truth in both amount and timing. The key factual elements—dollar amount, date of adoption, and direction of impact (reduction)—are all accurate. (2) Quantitatively, the $587 million figure is reported exactly as in the original answer, with no calculation or formatting issues; the date (January 1, 2023) is also correctly stated. (3) While the LLM captures the core impact and amount, it omits the qualitative reasoning behind the change—specifically, that the new guidance eliminated the 'reasonably expected' and 'concession' criteria for TDRs, and that trial modifications are no longer classified as FDMs. This missing context reduces the depth of the multi-hop synthesis, though the essential cause-effect (adoption → reduction) is implied. (4) The answer is highly relevant and factually precise, earning full marks for quantitative accuracy and contextual relevance. The qualitative accuracy score is slightly reduced due to the lack of explanatory detail, but the core facts are sound and correctly synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 350,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "\nIn 2023 the Africa/Eurasia segment generated **$254 million of operating profit** and ended the year with **$88 million of goodwill**, giving a combined impact of roughly **$342 million**.  This far exceeds the **$10 million of capital expenditures** recorded for the same region, meaning the segment’s profit‑plus‑goodwill contribution was more than **30 times** the amount spent on capital projects.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but makes a critical error in interpreting 'combined impact'—it incorrectly sums operating profit ($254M) and ending goodwill ($88M) to get $342M, whereas the ground truth defines the combined impact as the sum of the goodwill *decrease* ($19M) and capital expenditures ($10M), totaling $29M. This misinterpretation leads to a fundamentally incorrect conclusion. (2) Quantitatively, the operating profit ($254M), ending goodwill ($88M), and capital expenditures ($10M) are all accurate. However, the calculation of 'combined impact' is wrong—the model uses ending goodwill instead of the $19M decrease due to foreign currency translation. The $342M figure is therefore factually incorrect. (3) The multi-hop reasoning fails because the model does not recognize that the question asks for the *impact* (i.e., changes or outflows), not the absolute levels of goodwill and profit. It also misses the nuance that the goodwill decrease is a non-cash accounting adjustment, which when combined with capex, represents total resource impact. Instead, it treats goodwill as a positive contribution, which is conceptually flawed. (4) Despite accurate individual numbers and relevance to the region and year, the incorrect synthesis and calculation severely undermine the answer’s correctness. The comparison to capex is logically framed but based on a false premise, warranting a moderate score for contextual relevance but low for accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 412,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "\nThe 2021 segment‑reporting overhaul reshaped several divisions into new reporting units, causing goodwill to be reassigned across those units. 3M evaluated the impact by applying a relative‑fair‑value method to re‑allocate the goodwill and then performed its annual impairment test, which concluded that no goodwill impairment resulted from the restructuring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core information from the ground truth. (1) It correctly identifies that 3M restructured its business segments in 2021, leading to goodwill reassignment across new reporting units. It accurately states that 3M used the relative fair value method to re-allocate goodwill—matching the original answer. It also correctly reports that the annual goodwill impairment test in 2021 concluded no impairment, which aligns with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2021) are correct. (3) The multi-hop reasoning is sound: the model connects segment changes → goodwill reassignment method → impairment testing → conclusion of no impairment. The only minor omission is that the original answer specifies the changes were deemed 'immaterial,' which the LLM answer leaves out. This is a small but relevant detail regarding the significance of the restructuring impact. (4) Despite this omission, the LLM answer captures the essential facts, logic, and implications, making it semantically very close to the original. Contextual relevance is perfect—it directly addresses both parts of the question: impact on goodwill reporting and impairment risk evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 365,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "\nAMD bought Silo AI to bring the startup’s AI‑model‑development talent and platform into its own ecosystem, using the team’s expertise to speed up the deployment and software‑engineering of AI workloads on AMD’s hardware.  The acquisition is positioned as a key part of AMD’s broader AI strategy—expanding its Data‑Center AI accelerator portfolio and delivering a more complete, software‑centric solution that makes it easier for customers to build, optimize and run AI models on AMD chips.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core strategic rationale as the ground truth. It correctly identifies that AMD's investment (referred to as an 'acquisition'—a minor but acceptable simplification) in Silo AI was aimed at integrating AI model development talent and expertise to accelerate AI software and workload deployment on AMD hardware. The connection to AMD's broader AI strategy, particularly in the Data Center segment and around delivering software-centric solutions, is well articulated. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—however, no numbers are present or required, so the response is consistent in that regard. The only minor issue is the use of 'acquisition' instead of 'investment,' which may imply full ownership rather than a strategic funding round; however, in context, this does not distort the overall meaning, especially since the focus is on leveraging Silo AI's team and platform. The multi-hop reasoning is sound: linking the investment to talent acquisition, AI deployment on AMD hardware, and strategic expansion in the data center AI space. All parts of the question are addressed: the rationale behind the investment and its connection to AMD's AI and software goals. Semantic equivalence is strong, with slightly enhanced phrasing around 'software-centric solution' and 'optimize and run AI models,' which adds clarity without introducing inaccuracies. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to terminology nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 449,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "\nSix amendments to the Amended and Restated Agreement for Research & Development Alliance on Triex Module Technology were executed between September 2 2014 and September 1 2015 (the First through Sixth Amendments, effective October 31 2014 through September 1 2015).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It correctly states that six amendments were made to the agreement between September 2, 2014, and September 1, 2015, which aligns exactly with the original answer. (2) The dates mentioned (October 31, 2014, through September 1, 2015) fall within the specified period and support the count of six amendments, with no conflicting or inaccurate dates. Number format and phrasing ('Six amendments' vs '6 amendments') are semantically equivalent. (3) The multi-hop reasoning is sound—though the answer does not explicitly cite multiple documents, it accurately synthesizes the total number of amendments (First through Sixth) over the time frame, indicating correct aggregation across filings. (4) All entities—the agreement name and time period—are accurately referenced. The answer is complete, factually precise, and contextually appropriate, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1092,
        "completion_tokens": 274,
        "total_tokens": 1366
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PM’s existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "\nThe 2023 10‑K reports Swedish Match’s results only for the period after PMI’s November 11 2022 acquisition, presenting them as a stand‑alone “Swedish Match” operating segment that is evaluated separately from the geographic divisions. The accompanying shipment‑volume commentary, which benchmarks 2023 oral‑product volumes against the full‑year 2022 figures of Swedish Match, shows that the business is still being measured against its pre‑acquisition baseline, indicating that full operational integration and consolidation of those volumes into the broader segment reporting have not yet been completed.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the acquisition date of November 11, 2022, is accurately cited, and the explanation that Swedish Match’s results were included only from that date aligns with the original answer. (2) The quantitative accuracy is perfect—no numerical errors, and the timeline is correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly infers from the separate segment reporting and the use of full-year 2022 as a baseline that integration is not yet complete, which requires synthesizing information about reporting structure and shipment commentary. (4) The LLM captures the nuanced implication of the shipment volume comparison—measuring 2023 performance against pre-acquisition 2022 volumes suggests ongoing separation and phased integration—demonstrating strong qualitative and contextual understanding. Wording differs but meaning is preserved, and all parts of the question are fully addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 293,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "\nIn 2021 3M entered into interest‑rate swaps with an aggregate notional amount of **$800 million**. These swaps were structured to hedge the fixed‑rate debt maturing in 2049 and 2050, specifically converting **$500 million of the $1.0 billion 2049 notes** and **$300 million of the $650 million 2050 notes**, for a combined principal amount of **$1.65 billion** that the swaps were designed to hedge. Thus, the swap notional ($800 m) represents the portion of that $1.65 billion of long‑dated fixed‑rate debt that was swapped to floating‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the total notional amount of interest rate swaps ($800 million) is correct. The combined principal of fixed-rate notes due in 2049 and 2050 is correctly stated as $1.65 billion (comprising $500 million of $1.0 billion 2049 notes and $300 million of $650 million 2050 notes). These values align with the ground truth. The implied coverage of ~48.5% (800/1650) is not explicitly stated but is logically conveyed by indicating that the $800M swaps were applied to a $1.65B principal, which is consistent. (2) The answer correctly identifies 3M, the year 2021, and the relevant financial instruments (interest rate swaps and fixed-rate notes due in 2049 and 2050). (3) The multi-hop reasoning is sound: it connects the swaps to the specific notes they hedge, breaks down the allocation across years, and correctly frames the notional as a portion of the total debt. (4) While the exact percentage (48.5%) is omitted, the answer still conveys the core comparative relationship by stating the $800M notional against the $1.65B principal, which is semantically sufficient. The explanation adds helpful detail not in the original answer (breakdown of 2049 vs 2050 hedges), enhancing clarity without introducing error. Only the lack of explicit percentage calculation prevents a perfect 10, but the omission is minor given the clear numerical context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 397,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "\nThe combined consideration AbbVie transferred for the Allergan and Soliton acquisitions equals roughly **$64.6 billion**, of which **about $40.2 billion** was paid in cash (approximately $39.7 billion for Allergan plus $0.5 billion for Soliton).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor rounding differences. (1) The total consideration is reported as $64.6 billion, which matches $64,619 million when rounded to one decimal place in billions ($64.619 billion ≈ $64.6 billion). The cash portion is given as about $40.2 billion, consistent with $40,210 million ($40.21 billion ≈ $40.2 billion). The breakdown into $39.7 billion for Allergan and $0.5 billion for Soliton aligns with known acquisition figures and correctly sums to $40.2 billion. (2) All numeric values are correct within acceptable rounding conventions; no calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly identifies both acquisitions, retrieves individual consideration amounts, aggregates them, and distinguishes cash components—demonstrating proper synthesis across entities. (4) Wording such as 'roughly' and 'about' appropriately reflects rounded figures without sacrificing factual integrity. The answer fully addresses both parts of the question: total consideration and cash component. Only a minor deduction in quantitative accuracy due to rounding (though standard practice), hence a 9/10 overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 346,
        "total_tokens": 1460
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "\nBank of America’s Basel 3‑compliant capital position—demonstrated by its CET1 ratio of 11.9 % (well above the 10.7 % regulatory minimum plus the 2.5 % capital‑conservation buffer, the 3.2 % stress‑capital buffer and the 3.0 % G‑SIB surcharge)—gives the firm sufficient headroom to satisfy the $25 billion common‑stock repurchase program while still maintaining the minimum capital, leverage (SLR ≥ 6 %) and Total Loss‑Absorbing Capacity ratios required by regulators. Because the repurchase plan is embedded in the Board‑approved capital plan and the annual CCAR‑driven capital‑allocation process, the firm can only execute buy‑backs up to the amount of capital that remains above all Basel 3 buffers and the TLAC/SLR thresholds; the $25 billion authorization therefore reflects the capital that Basel 3 rules allow BofA to distribute without breaching its regulatory capital adequacy requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and regulatory thresholds, despite capturing the general relationship between Basel 3 compliance and stock repurchases. The ground truth states that Bank of America's CET1 ratio was 11.9%, exceeding the 10.7% requirement that includes the capital conservation buffer and G-SIB surcharge. However, the LLM incorrectly breaks down the 10.7% minimum as including a 2.5% capital conservation buffer, 3.2% stress-capital buffer, and 3.0% G-SIB surcharge. These individual values are not stated in the original answer and their sum (2.5 + 3.2 + 3.0 = 8.7%) does not align with the 10.7% total, introducing significant quantitative error. Additionally, the original answer only mentions the capital conservation buffer and G-SIB surcharge as components of the 10.7% threshold—there is no mention of a 'stress-capital buffer' or SLR/TLAC ratios in the ground truth. (2) The dollar amount of repurchases executed in 2024 was $13.1 billion, not the full $25 billion authorized. The LLM implies the entire $25 billion can be executed under Basel 3 headroom, which overstates the actual execution and misrepresents the constraint. The $25 billion is an authorization, but actual execution is limited by available capital above requirements, as correctly noted in the original answer. (3) The reasoning is partially sound—correctly identifying that capital adequacy under Basel 3 enables repurchases and that distributions are constrained by regulatory buffers. It also correctly links the capital plan and CCAR process, which is contextually relevant, though not in the original answer. However, the multi-hop synthesis is flawed due to the invention of regulatory components not present in the source. (4) The contextual relevance is high because the answer addresses the core mechanism linking Basel 3 to repurchase capacity. Qualitative accuracy is moderate due to correct conceptual framing but incorrect details. Quantitative accuracy is low due to incorrect percentages and misrepresentation of executed vs. authorized repurchase amounts. Correctness score is 6 due to correct core idea but significant factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 590,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "\nThe 2022 10‑K shows the $650 million medium‑term note maturing in 2023 with a carrying amount of **$649 million**, and the $650 million medium‑term note maturing in 2048 with a carrying amount of **$638 million**. Adding the two gives a total carrying value of **$1,287 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the $650 million medium-term note maturing in 2023 has a carrying value of $649 million, and the one maturing in 2048 has a carrying value of $638 million, both of which are correctly reported. (2) The calculation is correct: $649 million + $638 million = $1,287 million, which matches the total carrying value in the original answer. Minor formatting differences (e.g., bolding, spacing) do not affect accuracy. (3) The multi-hop reasoning is sound—information from two separate notes (same face value, different maturities) is correctly identified and synthesized from the MMM 2022 10-K filing. (4) Entities (MMM, 2022 10-K, medium-term notes, maturity years, carrying value) are correctly identified and contextualized. The answer is semantically equivalent to the ground truth and fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1103,
        "completion_tokens": 266,
        "total_tokens": 1370
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "\nThe 2.900 % Notes due 2030 have a coupon of 2.90 %. The highest‑yielding debt security listed in the filing is the 7.125 % Debentures due 2096, which carries a 7.125 % coupon. Therefore, the spread between them is 7.125 % − 2.90 % = 4.225 percentage points.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the 2.900% Notes due 2030 and the 7.125% Debentures due 2096 are correctly identified, with accurate interest rates. (2) The calculation of the difference (7.125% - 2.90% = 4.225 percentage points) is precise and correctly formatted; minor variation in decimal places (2.90% vs 2.900%) does not affect accuracy. (3) The multi-hop reasoning—identifying the highest-yielding debt instrument from IBM's 2024 10-K and computing the interest rate difference—is sound and complete. (4) The answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'spread' instead of 'difference') but conveying the same meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 238,
        "total_tokens": 1359
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "\nAbbVie’s acquisition of Allergan was valued at roughly **$64.1 billion** in total consideration. Of that amount, about **$453 million** of right‑of‑use assets were acquired as part of the lease obligations assumed in the transaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) Quantitatively, the total acquisition value is reported as $64.1 billion, which is equivalent to $64,084 million (rounded appropriately), and the right-of-use assets are correctly stated as $453 million. These figures match the original answer exactly when accounting for standard rounding and formatting variations ($64.1 billion ≈ $64,100 million, close to $64,084 million). (2) The answer addresses both parts of the question: total financial value and right-of-use assets acquired. (3) Entities are correct—AbbVie, Allergan, lease obligations, and right-of-use assets are properly identified. (4) The reasoning is sound, with correct synthesis of financial data from the acquisition, though the exact date (as of December 31, 2020) is omitted, which slightly reduces completeness but does not affect the core factual accuracy. This minor omission prevents a perfect 10 but does not undermine the correctness of the financial figures or their context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 298,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "\nAccording to the 2024 10‑K, 391 shares of common stock remain issuable upon distribution under the Norwest Corporation Directors’ Formula Stock Award Plan. No future awards or deferrals can be made because the plan has been closed—participants can no longer receive new stock awards or deferral elections, and any remaining shares are only those that may be distributed from previously granted awards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of shares—391—is accurately reported, matching the original answer exactly. There are no calculations required beyond this single figure, and the format (391 shares) is precise and consistent. (2) The answer addresses both parts of the multi-part question: it correctly states the number of shares issuable and explains why no future awards or deferrals are possible. (3) The entity identification is accurate: the plan name (Norwest Corporation Directors’ Formula Stock Award Plan), the document source (2024 10-K), and the nature of the plan’s status are all correctly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis—the LLM correctly infers that because the plan is closed, no new awards or deferrals can occur, and only previously granted shares remain outstanding. The explanation aligns semantically with the ground truth, using slightly different but equivalent phrasing (e.g., 'closed to new deferrals and awards' vs. 'has been closed—participants can no longer receive new stock awards or deferral elections'). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 340,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "\nThe higher amortization of intangible assets acquired in the Allergan transaction partially offset the rise in AbbVie’s 2021 gross margin—i.e., it reduced the margin increase that would have resulted from lower inventory‑step‑up amortization and a more favorable product mix.  In 2021, amortization expense for definite‑lived intangible assets totaled **$7.7 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that the amortization of intangible assets from the Allergan acquisition partially offset the increase in AbbVie's gross margin in 2021, correctly capturing the negative impact on gross margin despite other favorable factors like lower inventory step-up amortization and favorable product mix. (2) The total amortization expense for definite-lived intangible assets is correctly reported as $7.7 billion, matching the ground truth exactly in both value and year. Number format is clear and acceptable. (3) The multi-hop reasoning is sound: the answer synthesizes information about the Allergan acquisition's accounting impact and its interaction with gross margin drivers, as required by the question. (4) All entities—AbbVie, Allergan, 2021, gross margin, definite-lived intangible assets—are correctly identified and contextually used. The answer is concise but complete, addressing both sub-questions with precise, factually accurate information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 300,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "\nThe Restoration Plans serve as a supplemental, non‑qualified deferred‑compensation arrangement that “restores” to certain highly‑paid associates the compensation they would have received under the primary Benefit Plans but are limited by IRS contribution caps. The Company funds these plans by making cash contributions to grantor trusts, which then use the cash to purchase The Home Depot’s own common stock on the open market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the purpose of the Restoration Plans: to restore deferred compensation (specifically matching contributions under the Benefit Plans) that highly compensated employees would have received but for IRS-imposed compensation limits. The use of terms like 'non-qualified deferred-compensation arrangement' and 'IRS contribution caps' aligns with the intent and regulatory context. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the answer correctly links the IRS limits to the need for Restoration Plans and explains how The Home Depot funds them—via cash contributions to grantor trusts that purchase company stock in the open market. This reflects proper synthesis of cause, mechanism, and funding method. (4) All entities—The Home Depot, Restoration Plans, Benefit Plans, IRS, grantor trusts, common stock—are accurately referenced and logically connected. Wording differs slightly (e.g., 'certain associates' vs 'certain highly-paid associates'), but the meaning is preserved and even enhanced with appropriate detail. The answer fully addresses both parts of the question: purpose and funding mechanism.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 381,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "\nThe Variable Rate Notes were unchanged – $22 million at both 31 Dec 2023 and 31 Dec 2024, a 0 % change.  Because they stayed flat, the overall rise in total borrowings (from $20.44 bn to $31.10 bn) – an increase of about $10.66 bn or roughly 52 % – was driven almost entirely by growth in fixed‑rate notes, commercial paper and the new term‑loan borrowings rather than by the variable‑rate component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024, resulting in a 0% change, which matches the ground truth. The total borrowings are reported as increasing from $20.44 billion to $31.10 billion, which is equivalent to $20,440 million and $31,100 million—very close to the ground truth values of $20,443 million and $31,099 million. The implied increase of $10.66 billion ($10,660 million) is nearly identical to the ground truth increase of $10,656 million. The overall percentage increase is stated as 'roughly 52%', which aligns with the exact 52.1% in the original answer. Minor rounding is acceptable and does not affect correctness. (2) All calculations are accurate: 0% change for Variable Rate Notes is correct; the percentage increase in total borrowings is approximately (31,099 - 20,443) / 20,443 ≈ 52.1%, and the LLM's 'roughly 52%' is a reasonable approximation. (3) The multi-hop reasoning is sound: the model correctly infers that since Variable Rate Notes did not change, the increase in total borrowings must have come from other sources, and it correctly identifies fixed-rate notes, commercial paper, and new term loans as drivers—this reflects proper synthesis across financial instruments and time periods. (4) The answer is semantically equivalent to the ground truth, with slightly more interpretive commentary, which enhances clarity without introducing error. The only minor deviation is the rounded figures (e.g., $20.44 bn vs $20,443 million), but these are within acceptable formatting and precision norms. Thus, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 464,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "\nThe combined carrying amount of the 4.95 % Senior Notes maturing in September 2026 and September 2052 was **$1,724 million** as of January 28, 2024 ( $744 million for the 2026 notes plus $980 million for the 2052 notes ).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor quantitative discrepancy. The ground truth states the total carrying amount is $1,726 million, while the LLM reports $1,724 million, a $2 million difference. The breakdown provided ($744 million for 2026 notes and $980 million for 2052 notes) sums to $1,724 million, which is arithmetically correct, but does not match the ground truth total. It is unclear if the individual note amounts are accurate since the original answer only provides the total. The entities (HD, 4.95% Senior Notes, maturities in September 2026 and 2052, date January 28, 2024) are correctly identified, and the reasoning reflects proper multi-hop synthesis of the two note tranches. The answer is semantically equivalent in structure and intent, with only the final total being slightly off. This suggests either a data extraction error or rounding difference, but the overall logic and relevance are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1094,
        "completion_tokens": 270,
        "total_tokens": 1365
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "\nThe net derivative‑asset position fell from **$186 million in 2022 to $101 million in 2023**, a decline of **≈45 %**. This reduction is consistent with the shrinkage in the **total gross notional amount of derivative contracts**, which dropped from **about $873 million in 2022 to $584 million in 2023** (roughly a **33 % decrease**). Thus, the lower gross derivative exposure explains the substantial drop in the net derivative‑asset balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: the net derivative asset position decreased from $186 million in 2022 to $101 million in 2023, and the total gross amount of derivative contracts fell from $873 million to $584 million. The percentage decrease in the net derivative asset is correctly approximated as ≈45%, which matches the exact 45.7% in the original answer (rounding is acceptable). (2) The LLM calculates a ~33% decrease in gross derivative contracts, which is accurate (actual: (873-584)/873 ≈ 33.1%), though this detail was not required in the original answer but adds value. (3) The reasoning is sound: the reduction in gross exposure aligns with the drop in net asset position, indicating a strategic de-risking, which is consistent with the original conclusion. (4) All entities (PM, derivative asset position, gross notional amount, correct years) are accurately identified and synthesized across the two years. The only minor point is that the original answer emphasizes the alignment as indicating a 'strategic reduction in overall derivative exposure,' which the LLM captures in substance but with slightly less framing. No factual or calculation errors; minor rounding and rewording do not affect correctness. Hence, high scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 371,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "\nAs of December 31 2024, the 2016 Stock Incentive Plan had 27.1 million shares left for future grant and the 2016 Stock Plan for Non‑Employee Directors had 0.8 million shares left, for a combined availability of **≈ 27.9 million shares**.  This total is slightly lower than the roughly **29.3 million shares** that are reserved for issuance under these plans (the “Securities for Issuance” figure in the equity‑compensation table), meaning about 1–2 million of the reserved shares are already allocated to existing options/RSUs.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 27.1 million shares available under the 2016 Stock Incentive Plan and 0.8 million under the 2016 Stock Plan for Non-Employee Directors, totaling 27.9 million shares available for future issuance — this matches the ground truth exactly. However, the LLM introduces a figure of 'roughly 29.3 million shares reserved for issuance' and claims the difference (1–2 million) represents shares already allocated to existing options/RSUs. This is factually incorrect and not supported by the ground truth. The original answer specifies exact numbers: 10,221,113 shares for options, 2,005,555 RSUs under the 2016 Stock Incentive Plan, and 129,854 shares for options under the Non-Employee Directors plan — totaling 12,356,522 shares already committed. The LLM fails to report these specific figures and instead invents an approximate 'reserved' total not mentioned in the ground truth. (2) The calculation of 27.1 + 0.8 = 27.9 million is correct. However, the implied calculation of ~29.3 million reserved minus ~27.9 million available = ~1.4 million allocated is speculative and incorrect — the actual committed shares are over 12.3 million, not 1–2 million. The LLM confuses 'shares reserved under the plan' with 'shares to be issued', failing to account for the true scale of outstanding obligations. (3) The multi-hop reasoning is partially sound — the model correctly aggregates available shares across both plans — but fails the second part of the question: comparing available shares to those already to be issued. Instead of reporting the actual issued/issuable shares from the ground truth, it infers an incorrect proxy. (4) Scores reflect partial correctness: numbers for available shares are accurate (quantitative accuracy = 5), but major omission and fabrication of the 'reserved' figure and incorrect comparison undermine overall correctness. Qualitative accuracy is moderate due to flawed reasoning. Contextual relevance is high as the answer addresses the right plans and timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 547,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "\nIn fiscal 2022, revenue from Dynamics 365 grew 39%, and that strong 39% increase was the primary driver behind the overall Dynamics products and cloud services segment’s 25% revenue growth for the year. This contribution is highlighted in Microsoft’s MD&A, which notes the 25% segment growth “driven by Dynamics 365 growth of 39%.” 【page 40】【page 42】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 39% growth in Dynamics 365 revenue and its contribution to the overall 25% growth in Dynamics products and cloud services are accurately reported, with no calculation or numerical errors. (2) The answer is complete, addressing both parts of the question: the specific growth rate of Dynamics 365 and its role in driving the broader segment's growth. (3) Entity accuracy is correct—'Dynamics 365', 'fiscal year 2022', and 'Microsoft' are properly identified, and the reference to the MD&A and page numbers (40, 42) adds verifiable context. (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly infers causality from the reported data, citing that the 39% growth was the 'primary driver' of the 25% segment growth, which aligns with the original answer's assertion that Dynamics 365 was a 'key driver'. (5) Semantic equivalence is maintained—the LLM conveys the same core information with slightly more detailed sourcing, enhancing rather than distorting accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 320,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "\nEnergy Generation and Storage revenue grew by **$795 million (≈ 40 %)** in 2021 versus 2020, and this expansion was driven primarily by **higher deployments of the Megapack**.  Megapack serves as Tesla’s utility‑scale, commercial‑/industrial‑grade battery that anchors its broader energy‑storage portfolio alongside residential products such as Powerwall and the now‑phased‑out Powerpack.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $795 million (approximately 40%) increase in Tesla's Energy Generation and Storage revenue from 2020 to 2021, matching the ground truth exactly in both dollar amount and percentage. These figures are presented with acceptable formatting (using '≈' for approximate and proper dollar notation). 2) The quantitative accuracy is perfect: the revenue increase and percentage change are correct, and no miscalculations are present. 3) Qualitatively, the LLM accurately identifies Megapack as a primary driver of revenue growth and correctly positions it within Tesla’s broader energy storage portfolio as the utility-scale solution, contrasting it with residential products like Powerwall. It also correctly references the phase-out of Powerpack, which adds contextual accuracy beyond the ground truth, though this detail was not required. One minor omission is that the original answer notes additional contributors to revenue growth—solar cash and loan jobs, Solar Roof—while the LLM focuses only on Megapack, slightly underrepresenting the full scope of drivers. However, since the question specifically asks about the increase 'specifically due to the deployment of Megapack,' attributing the growth primarily to Megapack is reasonable. 4) The answer is highly contextually relevant, directly addressing both parts of the multi-hop question: the financial impact in 2021 vs 2020 and Megapack’s role in the product portfolio. Synthesis across time periods and product lines is sound. The only reason for not giving a perfect 10 is the partial omission of other contributing factors mentioned in the ground truth, though the focus on Megapack remains justified per the question's emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 468,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "\nWalmart recorded an estimated $5.5 billion pre‑tax loss in the fourth quarter of fiscal 2021 when Asda was classified as held‑for‑sale, and then recognized an additional $0.2 billion pre‑tax loss in the first quarter of fiscal 2022 after the transaction closed. These losses together total roughly $5.7 billion and include the derecognition of about $2.3 billion of accumulated pension liabilities (plus a $0.8 billion adjustment for indemnities), illustrating how the pension obligations of the Asda disposal group were a material component of the overall divestiture loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $5.5 billion pre-tax loss in fiscal 2021, $0.2 billion additional loss in fiscal 2022, totaling $5.7 billion, which matches the ground truth. The $2.3 billion of accumulated pension liabilities is accurately reported. However, the LLM introduces a $0.8 billion adjustment for indemnities not mentioned in the ground truth, which may be factually incorrect or at least unsupported by the provided answer. This is a minor addition but could mislead about the composition of the loss. (2) Quantitative accuracy is high: all stated numbers ($5.5B, $0.2B, $5.7B total, $2.3B pension) are correct and properly summed. The total is accurate, and fiscal timing (Q4 FY2021, Q1 FY2022) aligns with the original. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across fiscal periods and links pension obligations to the overall loss, demonstrating understanding of the financial impact. The only gap is the unsupported mention of a $0.8B indemnity adjustment, which isn't in the ground truth and may reflect overinference. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: total pre-tax loss and the role of pension obligations. Despite the minor factual overreach on indemnities, the core facts, calculations, and synthesis are correct, warranting a high score but not perfect due to the extraneous detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 400,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "\nApproximately 54 percent of Microsoft’s $56.5 billion More Personal Computing segment revenue in fiscal 2022 came from the combined contribution of Surface devices (about 12 percent of the segment) and Windows OEM licensing (42 percent of the segment).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Windows OEM contributed 42% of the More Personal Computing segment revenue, it incorrectly estimates Surface devices' contribution as 12%, whereas the ground truth specifies Devices (primarily Surface) contributed 16% ($9.04 billion). This leads to an incorrect combined percentage of 54% instead of the correct 58%. (2) Quantitative verification: 42% (Windows OEM) + 16% (Devices) = 58% of $56.5 billion = $32.77 billion. The LLM’s 12% for Surface implies $6.78 billion, which is significantly off from the true $9.04 billion. The calculation error is material. (3) The reasoning is partially sound in that the model attempts to sum two components (Surface and Windows OEM) to answer a multi-hop question about combined contribution. However, it fails in synthesizing the correct value for Surface, indicating either retrieval error or misattribution. (4) Scores reflect that while the answer structure and intent are correct, and one key percentage (42%) is accurate, the incorrect Surface revenue share undermines the final result. The answer is contextually relevant and addresses the right entities and question type, but the numerical inaccuracy is significant enough to reduce correctness and quantitative scores substantially.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 373,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "\nThe combined pension‑related financial impact of the Asda transaction equals roughly **$3.3 billion** – the **$1.0 billion cash contribution** Asda made to its pension plan in fiscal 2020 plus the **$2.3 billion of accumulated pension components** that were derecognized when Asda was sold. This $2.3 billion was recorded as a loss in other gains and losses and was re‑classified out of accumulated other comprehensive loss when the disposal closed.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the numbers are accurate: $1.0 billion cash contribution and $2.3 billion accumulated pension components are correctly stated, and their sum of $3.3 billion is properly calculated. Minor formatting differences (e.g., use of en-dash, spacing) do not affect accuracy. (2) The answer is complete, addressing both components of the financial impact—Asda's pension contribution and the pension elements included in the disposal group upon sale. (3) Entity accuracy is correct: Walmart is the parent company, Asda is the subsidiary, fiscal 2020 is the correct time frame, and the financial metrics (pension contribution, accumulated pension components, derecognition upon disposal) are appropriately used. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that the $2.3 billion was part of accumulated other comprehensive loss and was reclassified upon sale, which aligns with accounting standards for pension obligations in divestitures. While the original answer does not include the detail about reclassification, the LLM adds contextually accurate accounting treatment without contradicting the ground truth. The semantic meaning and financial impact are equivalent. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 376,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "\nThe pre‑owned aircraft inventory rose from $15 million at December 31 2023 to $23 million at December 31 2024, an increase of $8 million. The company records these aircraft at the **lower of their trade‑in value or estimated net realizable value**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values for pre-owned aircraft inventories on December 31, 2023 ($15 million) and December 31, 2024 ($23 million) are accurate, and the calculated increase of $8 million is correct. (2) The valuation method is accurately stated as 'lower of trade-in value or estimated net realizable value,' which matches the original answer verbatim in meaning and terminology. (3) The reasoning is sound and demonstrates proper synthesis across time points and accounting methodology, satisfying the multi-hop requirement by linking inventory values across two dates and correctly identifying the valuation policy. (4) All entities (dates, financial figures, valuation method) are correctly identified and presented with no omissions or errors. The answer is also semantically equivalent to the original, with only minor formatting differences (e.g., use of em dash, spacing) that do not affect accuracy. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 293,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "\nThe expansion of Xbox Game Pass’s curated library—now exceeding 100 first‑ and third‑party titles—helps lift Xbox content‑and‑services revenue by roughly 3 percent, as the larger, more appealing game selection drives higher subscription uptake and engagement.  Microsoft’s broader strategy—highlighted by major acquisitions such as Activision Blizzard, the rollout of Xbox Cloud Gaming, and continued investment in AI‑enabled cloud infrastructure and new first‑party studios—aims to deepen the content pipeline and broaden streaming access, positioning the gaming segment for sustained growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 3% increase in Xbox content and services revenue is correctly cited, and the detail about the curated library exceeding 100 titles matches the original. No calculations are required, and all numbers are presented accurately. (2) The LLM correctly identifies the relationship between the growth in the Xbox Game Pass library and the revenue increase, attributing higher subscription uptake and engagement as drivers—this is consistent with the causal link implied in the ground truth. (3) On qualitative accuracy, the LLM mentions the Activision Blizzard acquisition and Xbox Cloud Gaming, which are key strategic investments. However, it omits the ZeniMax Media acquisition explicitly mentioned in the ground truth, though Activision Blizzard is the more significant of the two. It adds 'AI-enabled cloud infrastructure' and 'new first-party studios,' which, while plausible and contextually relevant, are not specified in the original answer. This slight expansion beyond the source constitutes a minor overreach but does not introduce inaccuracy. (4) Contextually, the response fully addresses both parts of the question: the link between Game Pass growth and revenue, and Microsoft’s broader strategic investments. The reasoning is sound and synthesizes multi-hop elements (content library → subscriptions → revenue; acquisitions + cloud → strategic growth). The omission of ZeniMax is minor given the emphasis on Activision Blizzard, and the core facts and logic remain intact. Hence, a score of 9 is warranted—excellent accuracy with only negligible content deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 454,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "\nIn 2023 Eli Lilly recognized **approximately $79.4 million** of revenue from the sale of the olanzapine (Zyprexa) portfolio rights. That one‑time gain is folded into the company’s “Collaboration and other revenue” line, which totaled **$5,310.2 million** for 2023, so the olanzapine‑rights proceeds represent a small but notable component of that broader category.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific numerical values—$79.4 million from the olanzapine portfolio sale and $5,310.2 million for 'Collaboration and other revenue'—but these figures are not supported by the original answer (ground truth). The ground truth confirms that revenue from the olanzapine portfolio sale was included in the 'collaboration and other revenue' category but does not specify any dollar amounts. Therefore, the inclusion of precise numbers represents a hallucination, severely impacting factual accuracy. (2) Quantitative accuracy is low because the numbers cited ($79.4M and $5,310.2M) cannot be verified against the ground truth, which contains no such figures. Even if the formatting is acceptable (e.g., $79.4 million vs $79.4M), the values themselves are incorrect or unsubstantiated. (3) Qualitatively, the reasoning is sound: the model correctly identifies that the olanzapine rights sale contributes to the broader 'collaboration and other revenue' category and contextualizes it within other collaborations (e.g., Boehringer Ingelheim, Baqsimi). This reflects accurate multi-hop understanding of how discrete transactions fit into aggregated financial reporting categories. (4) Contextually, the response is highly relevant—it directly addresses both parts of the question: the revenue from the olanzapine sale and its role in the broader revenue category. However, the fabrication of specific financial figures undermines overall correctness, warranting a moderate score of 4 out of 10. While the conceptual framework is accurate, the introduction of unsupported quantitative data significantly reduces reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 452,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "\nThe 2015 supplemental indentures show that SolarCity issued a series of 5.45 % Solar Bonds in multiple, sequentially numbered tranches (e.g., Series C53‑15, C57‑15, C62‑15, etc.) all governed by a master trust and administered by a dedicated trustee for each tranche. This structure lets the company raise capital incrementally—matching each new tranche to a specific solar‑project cash‑flow need—while the trustee‑specific agreements isolate the assets and repayment obligations of each tranche, giving investors dedicated security and enabling a recurring, revolving source of financing for ongoing solar installations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the bond series and indenture details. The ground truth specifies four specific bond series: 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15, with corresponding Supplemental Indentures 4.72, 4.74, 4.76, and 4.78 dated between November and December 2015. The LLM incorrectly lists non-matching series (C53-15, C57-15, C62-15), which are not supported by the ground truth, and omits the correct series and indenture numbers entirely. (2) There is no mention of the actual Supplemental Indenture numbers or their sequential issuance in late 2015, which is a key quantitative and structural detail. The interest rate (5.45%) is correctly stated, but the incorrect bond series undermines confidence in the data sourcing. (3) The qualitative reasoning about Tesla’s (via SolarCity’s) financing strategy—incremental capital raising, matching funding to project needs, use of tranches, and role of trustee agreements in enabling recurring financing—is conceptually sound and aligns with the ground truth’s interpretation. The idea that trustee agreements provide investor security and allow discrete funding events is logically valid and reflects correct multi-hop synthesis of bond structure and financial strategy. (4) Contextually, the answer addresses both parts of the question: the structure’s reflection of financing strategy and the role of trustee agreements. While the conceptual framework is accurate, the incorrect bond series and absence of specific indenture numbers and dates result in a partially correct answer. Due to the severity of the entity inaccuracies, the correctness and quantitative accuracy scores are reduced, though qualitative and contextual elements remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 476,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "\nThe jump in Megapack deployments added about **$795 million** to Tesla’s Energy generation and storage revenue in 2021 versus 2020, and the **decline in Powerpack deployments** partially offset that growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $795 million contribution from increased Megapack deployments to Tesla's Energy generation and storage revenue growth in 2021 vs. 2020, matching the ground truth. It also correctly identifies the decline in Powerpack deployments as the factor that partially offset this growth. (2) The quantitative accuracy is perfect: $795 million is correctly reported, and while the percentage increase (40%) is not mentioned, the dollar amount is exact and central to the question. The omission of the percentage is a minor completeness issue but does not detract from the core factual accuracy. (3) The multi-hop reasoning is sound—linking Megapack growth to revenue increase and recognizing Powerpack decline as an offsetting factor demonstrates correct synthesis across product lines and years. (4) The answer is contextually fully relevant and semantically equivalent to the ground truth in substance, with only a slight reduction in completeness due to missing the 40% figure. Thus, a high correctness score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 306,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "\nThe Africa/Eurasia region reported capital expenditures of **$12 million** and depreciation & amortization of **$8 million** for 2024. Adding these amounts gives a combined total of **$20 million** for the region in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: capital expenditures are correctly stated as $12 million and depreciation & amortization as $8 million for the Africa/Eurasia region in 2024. (2) The calculation is correct: $12 million + $8 million = $20 million, which matches the original answer. Number formats are consistent and acceptable. (3) The multi-hop reasoning—identifying two separate financial metrics from the same region and year, then summing them—is sound and properly executed. (4) The answer is semantically equivalent to the ground truth, with clear, precise, and relevant information directly addressing the question. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1052,
        "completion_tokens": 225,
        "total_tokens": 1278
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "\nTI’s retiree health‑care benefit plan does **not** invest directly in TI common stock; its assets are allocated to low‑cost, broadly diversified index funds (fixed‑income and equity) that are chosen to match the plan’s liability profile, and the plan’s assets are explicitly segregated from any direct equity exposure. By contrast, the non‑U.S. defined‑contribution plans do hold a small amount of TI common stock—about **$34 million in value as of December 31 2024** (held on behalf of participants through employee elections)—which is not part of the health‑care plan’s investment policy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $34 million value of TI common stock in non-U.S. defined contribution plans as of December 31, 2024, is accurately reported, with no calculation or date errors. (2) The policy detail—that retiree health care benefit plan assets are not directly invested in TI common stock—is correctly stated and expanded with additional context (allocation to low-cost, diversified index funds and segregation from direct equity exposure), which aligns with and enriches the original answer without introducing inaccuracies. (3) The multi-hop reasoning is sound: the model correctly contrasts two distinct plans (retiree health care vs. non-U.S. defined contribution) and synthesizes information about investment policies versus actual holdings. (4) The entities—TI, retiree health care benefit plan, non-U.S. defined contribution plans, TI common stock—are all correctly identified and differentiated. (5) The semantic meaning is equivalent to the original answer, with added clarity on how employee elections drive the stock holdings in defined contribution plans. All components of the question are addressed with factual precision, logical reasoning, and appropriate context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 354,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "\nBetween 2023 and 2024 total Baqsimi revenue plunged from about $678 million to roughly $29 million—a decline of roughly 95 %—with U.S. sales falling from $645.7 million to $2.5 million and outside‑U.S. sales slipping from $31.9 million to $26.7 million. The “collaboration and other arrangements” note clarifies that the 2023 amount reflected revenue from a collaboration/rights‑sale arrangement and is now being recorded as ordinary product sales, indicating a shift in revenue recognition from collaboration/other revenue to net product revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the total revenue drop from $677.6M to $29.2M (rounded to $678M and $29M), U.S. sales decline from $645.7M to $2.5M, and Outside U.S. sales from $31.9M to $26.7M. The 95% decline is approximately accurate. Thus, quantitative accuracy is high. (2) However, the qualitative reasoning is fundamentally flawed: the LLM incorrectly states that the 2023 collaboration revenue was from a 'rights-sale arrangement' and is now being recorded as 'ordinary product sales', which is the opposite of the truth. The ground truth states that after selling the rights in 2023, LLY shifted from recognizing revenue via product sales to collaboration and other arrangements (i.e., post-sale, they no longer book product revenue but instead may receive milestones or profit-sharing). The LLM reverses the direction of the revenue recognition shift, indicating a critical misunderstanding of the disclosure. (3) This error reflects a failure in multi-hop reasoning: the model must connect the timing of the rights sale (2023) with the change in accounting treatment (from product sales to collaboration revenue), but instead inverts the logic. (4) While numbers are correct and contextually relevant, the core explanation is incorrect, severely undermining the answer’s validity. Hence, correctness is scored low due to this major conceptual error, despite numerical precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 390,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "\nMastercard reports its net revenue in only two broad buckets – **(i) payment‑network revenue** and **(ii) value‑added services and solutions**.  The “Processing and Gateway” offering is listed explicitly under the **value‑added services and solutions** category (e.g., page 21 and page 84), meaning its fees are classified as part of that second bucket rather than as core network revenue.  Consequently, the processing/gateway revenue aligns with the company’s overall revenue structure by being grouped with other value‑added offerings (cyber‑intelligence, data services, open‑banking, etc.) that are recognized when the related services are performed or transactions occur.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that Mastercard classifies 'Processing and Gateway' revenue under 'value-added services and solutions,' distinguishing it from 'payment-network revenue,' which matches the original answer exactly. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable but not violated. (3) The multi-hop reasoning is sound: the model correctly synthesizes the revenue classification structure from the 10-K, maps the specific service offering to the correct category, and explains how it fits within broader revenue recognition principles (i.e., recognition upon service performance or transaction occurrence). (4) The answer is contextually precise, directly addressing both parts of the question—classification of 'Processing and Gateway' revenue and its alignment with broader revenue categories—using accurate terminology and referencing specific document locations (e.g., page 21, page 84) for support. Minor wording differences (e.g., 'offering' vs. 'services') do not affect factual equivalence. All key elements—correct categorization, distinction from core network revenue, fee structure (fixed/transaction-based), and revenue recognition timing—are present and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 377,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "\nThe international‑common‑stock slice of the pension portfolio slipped from **$20 million in 2023 to $15 million in 2024**, a **$5 million (≈25 %) decline** year‑over‑year.  Because that category is part of the broader international fund pool, the overall international asset balance fell in step, dropping from **$566 million at the end of 2023 to $537 million at the end of 2024** (about a **5 % reduction**).  Thus the cutback in international common‑stock holdings is a key driver of the overall dip in total international plan investments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of change. (1) QUANTITATIVE ACCURACY: The ground truth states that CL's pension plan investments in international common stocks *increased* from $15M to $20M (a $5M increase), but the LLM claims a decrease from $20M to $15M — reversing the years and the trend. Similarly, total international investments grew from $537M to $566M (a $29M increase), but the LLM reports a drop from $566M to $537M, again reversing the direction. These errors invalidate all derived percentages: the LLM reports a 25% decline and 5% reduction, while the correct year-over-year changes are a 33.3% increase in international common stocks and a 5.4% increase in total international investments. (2) COMPLETENESS: While the LLM attempts to address both parts of the question (change in international common stocks and its reflection in total international investments), it fails due to incorrect data. (3) ENTITY ACCURACY: The company (CL) and financial categories (international common stocks, total international investments) are correctly identified. However, the years are reversed — the LLM assigns 2023 to $20M and 2024 to $15M, whereas the ground truth shows 2023 = $15M and 2024 = $20M. (4) REASONING: The multi-hop reasoning is structurally sound — the LLM attempts to link the change in a sub-category to the total — but because it uses inverted data, the logic leads to a false conclusion. It incorrectly frames the reduction in common stocks as driving a decline in total investments, when in fact both increased. (5) SEMANTIC EQUIVALENCE: The answer conveys the opposite meaning of the ground truth. Despite correct terminology and structure, the reversal of values and trends results in a factually wrong narrative. The only correct element is the $5M absolute change (but not the direction), and even the percentage calculations are based on incorrect baselines.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 518,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "\nThe Restricted‑Stock/RSU expense rose from **$59 million in 2022 to $85 million in 2024**, an increase of **$26 million**.  This growth was the primary driver of the overall equity‑based compensation rise, which climbed from **$130 million in 2022 to $145 million in 2024** (a $15 million increase).  The $26 million gain in RSU expense was partially offset by an $11 million decline in stock‑option expense, leaving the net $15 million increase in total equity‑based compensation over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Restricted Stock/RSU expense increased from $59M in 2022 to $85M in 2024, a $26M increase; total equity-based compensation rose from $130M to $145M, a $15M increase—both figures match the original answer. The LLM correctly calculates both differences. (2) The answer addresses both parts of the multi-part question: it identifies the increase in RSU expense and explains how this trend contributed to the overall change in equity-based compensation. (3) Entities are accurate—General Dynamics (GD) is correctly referenced via context, years (2022–2024) and financial metrics (Restricted Stock/RSUs, equity-based compensation) are correctly used. (4) The reasoning is sound and even enhances the original answer by explicitly noting that the $26M increase in RSUs was partially offset by an $11M decline in stock-option expense, which explains why the net increase in total equity compensation ($15M) was less than the RSU increase. This demonstrates correct multi-hop synthesis across compensation components and time periods. The semantic meaning and factual content are equivalent to and fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 349,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "\nAmazon’s $8 billion 364‑day unsecured term loan (page 57) shows that, despite having a $20 billion commercial‑paper program, the company still turns to dedicated short‑term debt to lock in financing on its own schedule and at targeted rates—using the loan as a temporary bridge for cash‑intensive needs such as acquisitions and then repaying it quickly. This reflects a strategic preference for diversified, low‑cost short‑term liquidity that supplements, rather than replaces, the CP program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: the $8.0 billion 364-day term loan and $20.0 billion Commercial Paper (CP) Program are accurately cited, with appropriate context on timing (January 2023 implied by 'early 2023' in question and repayment by end of year). Format variations like '$8 billion' vs '$8.0 billion' are acceptable. (2) The answer correctly identifies that Amazon had access to a large CP program but chose a term loan instead, indicating a strategic preference—this core multi-hop inference is sound. (3) The reasoning is strong: it explains that the term loan offers control over timing and rates, serving as a 'temporary bridge' for specific needs, which aligns with the ground truth's emphasis on defined maturity and certainty. It also correctly infers that the CP program was not drawn upon, preserving flexibility. (4) Minor deduction in qualitative accuracy because the LLM mentions 'acquisitions' as a potential use, which is plausible but not stated or implied in the original answer; the ground truth emphasizes general funding needs and repayment certainty without specifying use cases. Otherwise, the synthesis across liquidity tools and strategic intent is semantically equivalent and contextually relevant. No factual errors; excellent contextual relevance to short-term liquidity strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 386,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "\nIn 2024 the Membership Rewards liability grew to **$14.75 billion** (up from $13.74 billion in 2023), a rise that the company attributes to **higher estimated redemption costs and the impact of revised third‑party partner arrangements**. To capture these effects, American Express updated its liability‑estimation model—re‑calculating the weighted‑average cost per point and the Ultimate Redemption Rate using the latest redemption‑cost data, incorporating changes in partner‑contract terms, and adjusting the actuarial assumptions for observed shifts in redemption patterns. This revised methodology is described in the “Membership Rewards” note (page 134) and the related discussion of estimation assumptions (page 29).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts for the Membership Rewards liability in 2024 ($14.75 billion) and 2023 ($13.74 billion), which are not present in the original answer (ground truth). These figures cannot be verified against the provided truth and appear to be hallucinated or sourced from external data not in the knowledge graph. This severely undermines quantitative accuracy. (2) While the original answer confirms that American Express updated its liability estimation methodology due to changes in redemption costs and third-party partner arrangements, it does not provide any numerical values for the liability, nor does it mention year-over-year changes. Thus, the inclusion of precise dollar figures and their comparison is factually unsupported. (3) Qualitatively, the LLM correctly identifies the key methodological updates: use of weighted-average cost per point, Ultimate Redemption Rate (URR), actuarial models, and incorporation of changes in partner terms and redemption patterns. It also correctly references the types of factors influencing the models (redemption trends, contract terms), aligning with the ground truth’s mention of statistical models considering card product type, tenure, spend levels, and credit attributes. (4) Contextually, the response is highly relevant, addressing both parts of the question—impact on liability and methodology changes—and citing appropriate sections of the filing (page 134, page 29), which shows good alignment with document-based reasoning. However, the hallucination of financial figures results in a significant factual deviation, warranting a moderate correctness score. The reasoning is logically sound but built on unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 474,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "\nColgate‑Palmolive mitigates foreign‑currency cost pressure by raising selling prices in the markets where it sells, and it offsets the residual exposure with foreign‑currency derivative contracts (forward, swap and option hedges). Together, the pricing actions and the hedges are intended to limit earnings volatility caused by fluctuations in exchange rates—specifically the exposure of its cost of sales and cash‑flow to foreign‑currency movements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Colgate-Palmolive's foreign exchange risk management strategy, correctly identifying the use of selling price increases and derivative contracts (forwards, swaps, options) to manage currency risk. It accurately captures the intent of the combined approach: to limit earnings volatility due to exchange rate fluctuations. The quantitative accuracy is perfect—no numerical errors, and no incorrect figures are presented. The answer correctly references the relevant financial exposures (cost of sales and cash flow), which aligns with the ground truth. However, the LLM answer omits a key element from the original: the scale of operations in over 200 countries and the specific mention of local currency borrowings as part of the strategy. Additionally, the ground truth emphasizes the translation impact of foreign subsidiary assets and liabilities into USD, which the LLM answer does not mention. While the core reasoning and synthesis are sound (multi-hop between pricing strategy and derivatives), these omissions slightly reduce completeness and qualitative accuracy. The answer remains contextually relevant and semantically close to the original, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 349,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "\nThe rebound in business‑to‑business shipments and the uptick in residential demand lifted average daily volume for UPS’s Next Day Air service and pushed revenue per piece higher through stronger commercial pricing and mix.  However, this revenue growth was partially offset by a modest decline in average billable weight per piece (which reduced yield) and by higher cost pressures such as compensation and fuel‑related expenses that dampened the net upside.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key drivers of increased average daily volume (business-to-business activity and residential demand) and higher revenue per piece (pricing and demand), aligning with the ground truth. It accurately notes that the revenue growth was partially offset by a decline in average billable weight per piece, which matches the original answer. However, the LLM introduces 'higher cost pressures such as compensation and fuel-related expenses' as a factor offsetting revenue growth—this is incorrect in context. The original answer specifies that the offset to *revenue per piece* growth was solely the reduced billable weight, not cost pressures, which affect profitability, not revenue. Since the question specifically asks about factors offsetting *revenue* growth (not profit or net upside), this misattribution introduces a factual error in reasoning. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (UPS, Next Day Air, 2022 context) are correct. The multi-hop synthesis is mostly sound but includes an extraneous, incorrect factor in the offset explanation, reducing qualitative accuracy. Contextual relevance remains high as the answer addresses all main components of the question except with a minor but notable error in causality.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 364,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "\nThe U.S. biologic‑exclusivity shield for Opdivo extends only to the 12‑year data‑protection period (with the possibility of earlier biosimilar entry via patent challenges), so BMY faces a real risk that market exclusivity could erode before its U.S. patents fully expire.  At the same time, the string of 2021 international approvals—Japan, the EU, and several other regions—gave Opdivo a foothold in high‑growth oncology markets outside the United States, diversifying revenue and allowing BMY to sustain its global oncology strategy even if U.S. exclusivity is shortened.  In short, the overseas approvals cushion the strategic impact of the U.S. regulatory‑exclusivity risk while expanding the product’s worldwide commercial base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 12-year U.S. data protection period for biologics and the risk of earlier biosimilar entry via patent challenges, which matches the original answer's mention of potential litigation as early as four years post-approval. While the LLM does not specify 'four years post-approval,' it accurately captures the core risk of earlier erosion due to patent challenges, which is semantically consistent. (2) The LLM correctly references the 2021 international approvals in Japan and the EC (referred to as EU), and though it does not list every specific indication (e.g., gastric, esophageal, CRC, mesothelioma, cancer of unknown primary), it correctly infers the strategic impact of these approvals on global market diversification. The absence of detailed indications is a minor omission but does not undermine the overall correctness. (3) The multi-hop reasoning is sound: the LLM synthesizes U.S. regulatory risk with international expansion to conclude that global approvals help offset U.S. exclusivity risks, which is the central argument in the ground truth. (4) The answer is contextually excellent, directly addressing how regulatory exclusivity risk interacts with international approvals to shape BMY's global oncology strategy. Wording differs but meaning is equivalent. No calculation errors. One point deducted from qualitative accuracy for slight underspecification of indications and patent timeline detail, but core facts and logic are intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 425,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "\nAs of December 31 2024, the convertible notes Amazon holds in Anthropic, PBC are estimated to be worth about **$13.8 billion**. This fair‑value estimate exceeds the total cash Amazon has invested in those notes to date—approximately **$5.3 billion** (the $1.25 B, $2.75 B and $1.3 B investments made in 2023‑2024).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the estimated fair value of $13.8 billion and total invested amount of $5.3 billion are accurately reported. The breakdown of the $5.3 billion investment into its components ($1.25B in Q3 2023, $2.75B in Q1 2024, and $1.3B in Q4 2024) is correctly summarized as approximately $5.3 billion, with acceptable rounding and format variations (e.g., $1.25 B = $1.25 billion). (2) The answer addresses both parts of the multi-part question: it states the fair value as of December 31, 2024, and compares it to the total amount invested by that date. (3) All entities—Amazon, Anthropic, PBC, and the time frame—are correctly identified. (4) The reasoning is sound: the LLM correctly infers that the fair value exceeds the cash invested, indicating a valuation uplift, which aligns with the ground truth's implication of increased value due to financing activities and market expectations. The answer is semantically equivalent to the original, with concise but complete synthesis of multi-hop data (investment amounts across multiple quarters and their aggregate effect on valuation). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 343,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "\nColgate‑Palmolive treats pension‑plan enhancements as a “charge against assets” within its employee‑related cost category, so the amount is reflected as a reduction of the company’s pension assets (or an increase in the pension liability) on the balance sheet.  By contrast, other severance‑related termination benefits are expensed and recorded as a straightforward accrued liability.  This accounting distinction is why pension enhancements appear as a balance‑sheet adjustment to pension assets/liabilities, while typical severance costs are shown only as a liability accrual.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies that Colgate-Palmolive treats pension enhancements as a 'charge against assets' within Employee-Related Costs, distinguishing them from other severance costs. The balance sheet treatment—reduction in pension assets or increase in pension liabilities—is accurately described, as is the contrasting treatment of other severance costs as accrued liabilities/expenses. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes the distinction in accounting treatment and links it to the balance sheet impact. The only minor shortcoming is that the LLM omits mention of the basis for severance calculations (written policies, statutory requirements, voluntary arrangements), which is included in the original answer and adds contextual depth. (4) Despite this small omission, the answer remains semantically equivalent in terms of factual content and reasoning, with excellent contextual relevance to the question. The distinction in balance sheet treatment is clearly and correctly explained.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 374,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharply—often losing a major portion in a short period—especially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "\nThe U.S. grants an innovative biologic—such as Opdivo—12 years of regulatory data‑protection, which bars the FDA from approving a biosimilar until that period ends and therefore extends Opdivo’s market‑exclusivity beyond the life of its composition‑of‑matter patents.  When that exclusivity lapses, BMY has historically experienced a very rapid revenue contraction in developed markets—U.S. sales of Opdivo have fallen sharply after exclusivity expires, a decline that is steeper than in most other developed regions—creating a material financial risk to the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 12-year regulatory data protection period for biologics in the U.S. is correctly stated, matching the original answer. There are no numerical inaccuracies. (2) The answer correctly identifies that this protection delays biosimilar approval and extends market exclusivity beyond patent life, which is consistent with the regulatory framework. (3) The LLM accurately captures the financial risk to BMY (Bristol Myers Squibb) from revenue decline post-exclusivity, noting the sharp drop in U.S. sales after exclusivity ends. While the original answer generalizes the revenue decline across developed markets (U.S. and EU), the LLM emphasizes the U.S. and states the decline is steeper there than in other developed regions—a nuance not present in the original but not factually incorrect. (4) The multi-hop reasoning is sound: it connects U.S. regulatory protection → delayed biosimilar entry → market exclusivity → revenue drop upon expiration → financial risk to BMY. The only minor shortcoming is that the LLM implies U.S. sales fall *after* exclusivity expires, but Opdivo has not yet lost exclusivity in the U.S. (as of 2024), so the reference to 'have fallen' is slightly misleading. However, this is likely a hypothetical or forward-looking interpretation based on analogs. Overall, the answer is factually correct, contextually relevant, and synthesizes the required information accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 409,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "\nIn 2024, display advertising generated $35 billion of the $40 billion total advertising‑services revenue, which equals **87.5 %** of the segment’s sales. This calculation is based on the advertising‑services figures reported in the 10‑K tables (page 67).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage (87.5%) is accurately calculated from the given figures: $35 billion / $40 billion = 0.875 = 87.5%. All numeric values are correct and properly formatted. (2) The calculation is explicitly stated and accurate, with no errors in arithmetic or unit handling. (3) The reasoning is sound—although this is a single-hop quantitative question, the model correctly identifies the relevant financial figures (display advertising revenue and total advertising services revenue) and performs the correct percentage calculation. (4) The answer is contextually complete and directly addresses the question, including a reference to the source (10-K tables, page 67), which adds credibility. All aspects—factual, quantitative, and semantic—align perfectly with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1082,
        "completion_tokens": 249,
        "total_tokens": 1331
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "\nThe Level 1 fair‑value of U.S. government and agency debt securities rose from **$184 million in 2020** to **$200 million in 2021**. Thus, there was no decrease; the amount increased by **$16 million**.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect. (1) The question asks for the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021 based on Level 1 quoted prices. The ground truth states that the value decreased by $16 million, from $184 million in 2020 to $200 million in 2021. However, this is factually impossible because $200 million is greater than $184 million, which would imply an increase, not a decrease. This indicates a clear error in the original answer (ground truth). Despite this inconsistency in the ground truth, the LLM correctly calculates the direction and magnitude of the change: from $184M to $200M is indeed a $16M increase. (2) The LLM accurately reports the numbers: $184 million in 2020 and $200 million in 2021, and correctly computes the difference as a $16 million increase. (3) The multi-hop reasoning is sound—the model identifies the correct entity (UPS), the correct asset class (U.S. government and agency debt securities), the correct valuation level (Level 1), and the correct years. It then correctly compares the values across years. (4) However, because the ground truth incorrectly claims a 'decrease' when the numbers show an 'increase', the LLM contradicts the ground truth with a factually correct response. In a real-world evaluation, the LLM answer would be considered accurate, but since this is an evaluation against a provided 'ground truth' that contains a factual error, the LLM is penalized. Nevertheless, per instructions, we must score based on alignment with the provided ground truth, not real-world facts. Since the LLM contradicts the ground truth (which erroneously asserts a decrease), it receives the lowest score despite being numerically and logically correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 479,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMS’s upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "\nThe BMS‑Ono partnership spreads the development, manufacturing and marketing outlays for Yervoy across both companies, so BMS only funds a portion of the costs and receives a proportional share of any profits (or bears a corresponding share of losses). Because the financial burden is split, a potential sales decline from U.S. biosimilar competition after the 12‑year data‑exclusivity period would affect only BMS’s allocated margin rather than the full revenue stream, thereby limiting its direct financial risk exposure. Nevertheless, the ultimate risk remains tied to the length of U.S. regulatory exclusivity and patent protection, which the joint structure cannot eliminate but can mitigate through shared cost and revenue sharing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the cost- and profit-sharing arrangement between BMS and Ono is accurately described as shared (implied equal, though 'equal' is not explicitly stated, which is a minor omission); Yervoy is correctly identified as facing biosimilar competition after 12 years of data exclusivity under U.S. regulations; BMS’s financial exposure is correctly framed as reduced due to shared costs. (2) Quantitatively, the 12-year data exclusivity period is correctly cited, and there are no numerical inaccuracies. The answer correctly links this timeframe to biosimilar risk. (3) The multi-hop reasoning is sound: it connects the joint development structure (cost-sharing) to reduced financial risk, then ties in the U.S. regulatory framework (12-year exclusivity) and its impact on revenue exposure from biosimilars. The synthesis across partnership terms and regulatory risk is logical and complete. (4) The only minor shortcoming is that the LLM does not explicitly state that the cost/profit sharing is 'equal' as specified in the ground truth, though 'proportional share' and 'split' imply a similar arrangement. This does not materially distort the conclusion. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 384,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M ÷ $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Tesla’s maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "\nThe $596 million of FSD (Supervised) revenue recognized in 2024 offsets roughly 10 % of the $6.03 billion decline in automotive sales revenue ( $596 M ÷ $6.03 B ≈ 0.10 ).  This revenue is recorded as deferred income for the over‑the‑air software and connectivity services and is recognized over the vehicle’s expected ownership life, while the company’s guarantee liabilities for vehicle‑residual values—though present in the lease‑resale programs—are immaterial and do not materially affect the overall revenue offset.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $596 million FSD revenue and the $6.03 billion decline in Automotive Sales Revenue, and performs the core calculation approximately correctly, stating a 10% offset. However, the precise calculation is $596M ÷ $6,030M = 0.0988, which rounds to 9.9%, not 10%. While 10% is a reasonable approximation, the ground truth specifies 9.9%, so the percentage is slightly inaccurate. (2) The LLM incorrectly states that guarantee liabilities for vehicle-residual values are 'immaterial' and 'do not materially affect the overall revenue offset.' This directly contradicts the ground truth, which reports a significant increase in maximum exposure from $166 million in 2023 to $1.45 billion in 2024—indicating materiality and relevance. This is a major factual error. (3) The multi-hop reasoning is partially sound: the model connects FSD revenue to deferred revenue recognition for over-the-air updates, which aligns with the ground truth. However, it fails to correctly synthesize the material increase in guarantee liabilities, breaking the chain of reasoning on how software updates affect residual values and financial exposure. (4) The contextual relevance is high because the answer addresses both parts of the question—percentage offset and relation to deferred revenue and guarantee liabilities—but the qualitative inaccuracy in the liability assessment severely undermines correctness. Quantitative accuracy is moderate due to the rounding of 9.9% to 10% and omission of exact figures for liabilities. Qualitative accuracy is low due to the incorrect characterization of liabilities as immaterial.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 451,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "\nPepsiCo’s non‑GAAP measure is **“Operating profit adjusted for items affecting comparability”** (and, when evaluating growth, the **“Operating profit growth adjusted for items affecting comparability on a constant‑currency basis.”**) — this metric strips out one‑time items such as restructuring, acquisition/divestiture charges, and mark‑to‑market impacts, and it presents the results in constant‑currency terms so that foreign‑exchange movements do not distort the comparison of operating‑profit growth across periods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the non-GAAP financial measure used by PepsiCo in its 2022 10-K: 'Operating profit adjusted for items affecting comparability' and further clarifies the constant-currency adjustment when evaluating growth. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the description of the adjustment methodology—including exclusion of one-time items like restructuring charges and acquisition/divestiture impacts, and the use of constant currency to remove FX distortion—is factually accurate and consistent with the 2022 10-K disclosures. (3) The multi-hop reasoning is sound: the answer correctly synthesizes that PepsiCo first adjusts operating profit for comparability items and then further adjusts for currency fluctuations to assess growth on a comparable basis across periods. (4) All entities—PepsiCo, 2022 10-K context, operating profit, non-GAAP adjustments, currency impacts—are correctly identified and logically connected. The answer is complete, precise, and contextually appropriate, matching the depth and accuracy of the original answer while adding helpful detail (e.g., examples of items affecting comparability) without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 363,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "\nThere are eleven distinct amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology listed across the two exhibits. Their effective dates run from the first amendment on October 31 2014 up to the eleventh amendment on July 22 2020, giving a time span of roughly five‑and‑a‑half years.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in both the number of amendments and the time span. The ground truth states there are 12 total amendments, but the LLM reports only 11, missing one amendment. Additionally, the effective dates are incorrect: the earliest date is stated as September 2, 2014 (ground truth), but the LLM reports October 31, 2014; the latest date is May 1, 2021 (ground truth), but the LLM reports July 22, 2020. (2) These date errors directly impact the time span calculation. The correct span is 6 years and 8 months (from September 2, 2014, to May 1, 2021), but the LLM calculates roughly 5.5 years based on incorrect dates. The calculation itself (if based on their dates) is approximately correct, but the inputs are wrong. (3) The multi-hop reasoning appears flawed—either the model failed to identify all amendments across the two exhibits or misread the dates, indicating a failure in synthesizing information from multiple sources accurately. (4) Scores reflect major factual inaccuracies in numbers and dates (quantitative accuracy penalized heavily), partial reasoning (qualitative), and relevance to the question structure (contextually relevant but factually wrong). Correctness score is low due to core errors in both key metrics requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 361,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "\nThe AMESA division’s net‑revenue growth was driven by a **14‑percentage‑point** contribution from the Pioneer Foods acquisition and a **4.5‑percentage‑point** contribution from favorable foreign‑exchange movements, giving a **combined impact of roughly 18.5 percentage points** on net‑revenue growth in 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the 14-percentage-point contribution from the Pioneer Foods acquisition and 4.5-percentage-point contribution from favorable foreign exchange are correctly stated. The combined impact is calculated as 14 + 4.5 = 18.5 percentage points, which matches the original answer exactly. (2) Quantitative accuracy is perfect: all numbers are correct, and the sum is accurate. Format variations (e.g., '14-percentage-point' vs '14 percentage points') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—LLM correctly identifies two distinct factors (acquisition and FX) impacting net revenue growth in the AMESA division in 2022 and synthesizes their combined effect. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (breaking down the components), which enhances clarity without introducing error. All entities—Pioneer Foods, AMESA division, 2022, net revenue growth—are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 305,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "\nOpdivo’s U.S. regulatory data‑protection grant of 12 years continues to block biosimilar entry even after its composition‑of‑matter patents start to lapse, which helps sustain the 7 % U.S. revenue growth reported for 2021. In the EU, the “8+2+1” data‑protection regime provides roughly a 10‑year exclusivity period, and because generic approval is not tied to patent status, generics can launch once that period ends regardless of any remaining patents. Consequently, U.S. market exclusivity is extended by data protection beyond patent expiry, whereas in the EU exclusivity is driven primarily by the data‑protection clock, leading to a potentially earlier loss of market protection there.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and slight imprecision in EU exclusivity timing. (1) Quantitatively, all numbers are accurate: the 12-year U.S. data protection, '8+2+1' EU regime, and 7% U.S. revenue growth in 2021 are correctly cited. The LLM correctly notes that U.S. data protection blocks biosimilars independently of patents, preserving exclusivity beyond patent expirations. (2) However, the LLM oversimplifies the EU timeline by stating generics can launch after ~10 years without clarifying that commercialization typically occurs after 10 or 11 years depending on new indications (the '+1' year for innovation). This nuance is present in the original answer but missing in the LLM response. (3) The LLM correctly identifies the multi-hop relationship between regulatory exclusivity, patent expiration (noting composition-of-matter patents lapsing), and commercial performance (7% growth), but does not mention that formulation and additional patents extend U.S. exclusivity through 2026 and beyond—this is a key point in the original answer explaining why revenue growth persisted post-2021. (4) Despite this omission, the reasoning is sound: it correctly distinguishes between patent-driven and data-protection-driven exclusivity in the U.S. vs. EU and links this to market dynamics. The answer remains contextually relevant and semantically close to the original, warranting a high correctness score with minor deductions for incompleteness in patent extension details and EU timing precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 428,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firm’s ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "\nBecause Morgan Stanley is a large bank holding company with more than $250 bn in assets, it is subject to the Federal Reserve’s systemic‑risk regime, which imposes heightened capital and liquidity standards, mandatory internal stress‑test requirements, and a cap on capital distributions—regulators can prohibit or limit dividend payments or share‑repurchases if they would jeopardize the firm’s ability to maintain the required high‑quality capital and liquidity buffers. The regime also forces the firm to hold a substantial pool of unencumbered, highly liquid assets and to observe single‑counterparty credit limits, and it subjects the company to resolution‑planning rules that can further restrict its ability to distribute capital or manage liquidity in stress scenarios.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key factual elements are correct: Morgan Stanley's status as a large bank holding company with over $250 billion in assets triggers the systemic risk regime, leading to heightened capital and liquidity requirements, internal stress testing, unencumbered liquid asset holdings, single-counterparty credit limits, and constraints on capital distributions. (2) Quantitative accuracy is perfect: while exact percentages (e.g., 15% and 25% limits) are omitted in the LLM answer, these specific numbers were not essential to the question’s focus on 'how' the regime constrains policies broadly. The absence does not constitute a factual error but a slight omission. (3) Multi-hop reasoning is sound—LLM correctly links Morgan Stanley’s size to regulatory status, which triggers Fed requirements that in turn constrain capital distributions and liquidity management. (4) Semantic equivalence is strong: phrasing like 'prohibit or limit dividend payments or share-repurchases' matches 'limit the firm’s ability to distribute capital', and 'unencumbered, highly liquid assets' aligns with the 30-day net cash outflow requirement. The only minor shortcoming is the lack of explicit mention of the 30-day stress-test horizon and exact counterparty limit percentages, which slightly reduces completeness but does not impair overall correctness. Contextual relevance is excellent, directly addressing all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 415,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "\nThe 0.750 % Senior Note maturing in 2033 carries a coupon that is markedly lower than the 1.950 % Senior Note maturing in 2031, indicating that PepsiCo can obtain cheaper financing for a more distant maturity. This points to a long‑term debt strategy that seeks to lock in low‑cost funding for later years while extending the average maturity of its debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.750% Senior Note due 2033 has a lower interest rate than the 1.950% Senior Note due 2031. The quantitative difference is 1.200 percentage points (1.950% - 0.750% = 1.200%), which is accurate, though the LLM does not explicitly state the numerical difference. All entities—PepsiCo, the two notes, their respective interest rates (0.750%, 1.950%), and maturities (2033, 2031)—are correct. (2) The numbers and dates are factually accurate and match the ground truth. The calculation of the rate difference is implied and correct, though not explicitly mentioned. (3) The reasoning is sound: the LLM infers that lower rates on longer-dated debt suggest a strategy of securing low-cost funding for extended maturities, which aligns with the ground truth interpretation about favorable market conditions or improved credit perception. It correctly synthesizes the implication across maturities and rates. (4) The answer is semantically equivalent to the original in meaning, though slightly less explicit about the exact basis point difference. The omission of the precise 1.200 percentage point gap prevents a perfect 10, but the core facts, logic, and strategic interpretation are fully correct and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 354,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "\nThe fair‑value of Medtronic’s partnership units rose from **$992 million in fiscal 2023 to $1,151 million in fiscal 2024**, an increase of **$159 million**.  This rise helped push total investments measured at net‑asset‑value up from **$2,179 million to $3,366 million**, a net gain of **$1,187 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the increase in fair value of Medtronic's partnership units is correctly calculated as $159 million ($1,151M - $992M), and the increase in total investments measured at net asset value is correctly stated as $1,187 million ($3,366M - $2,179M). (2) The answer is complete, addressing both parts of the question: the dollar increase in partnership units and the impact on total investments at net asset value. (3) Entity accuracy is correct—Medtronic, partnership units, fiscal years 2023 and 2024, and the financial metric 'investments measured at net asset value' are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the increase in a component (partnership units) to the overall change in the aggregate (total investments at NAV), which requires combining data from multiple points in the financial disclosures. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of en-dashes, bolding for emphasis) that do not affect factual accuracy. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 340,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "\nThe 2024 10‑K explains that depreciation and amortization shown for each reportable segment is **net of activity‑based costing allocations**—shared assets (e.g., corporate facilities, IT systems, equipment) are apportioned to U.S. Domestic Package, International Package and Supply‑Chain Solutions using measurable drivers such as volume or revenue. As a result, the D&A figures presented in the segment tables (pages 126‑127) reflect only the portion of total depreciation that the company attributes to each segment, so the segment‑level D&A totals differ from the consolidated D&A amount and directly affect each segment’s reported operating profit and margin.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that depreciation and amortization (D&A) figures for UPS's reportable segments are presented after applying activity-based costing methods, which aligns with the original answer's claim that totals are 'after applying activity-based costing methods to allocate expenses between segments.' The LLM specifies that shared assets are allocated using measurable drivers like volume or revenue, which is consistent with activity-based costing principles described in such filings. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer beyond the reference to the 2024 10-K, which both correctly cite—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM connects activity-based costing to the allocation of shared asset depreciation, explains how this affects segment-level D&A totals, and notes the impact on operating profit—all key points in the ground truth. It adds useful detail (e.g., examples of shared assets, reference to specific pages 126–127) not in the original but plausibly derived from the 10-K. (4) The only minor gap is that the LLM does not explicitly state that changes in estimates affect allocations, which is mentioned in the original answer. However, the implication is present in the explanation of allocation methodology. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 423,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "\nIn fiscal 2022 Qualcomm reversed the European Commission’s €997 million fine (and the accrued interest) after the EU General Court annulled the decision.  The reversal generated a **$1.1 billion benefit recorded in other income** and **removed $62 million of accrued interest expense**, resulting in a **$62 million reduction of interest expense** for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key numbers are correct: $1.1 billion in other income and $62 million reduction in interest expense match the original answer exactly. The total impact of $1.162 billion is implied by the sum of these two components, which is accurate ($1.1B + $62M = $1.162B), though the total is not explicitly stated. (2) Quantitative accuracy is perfect—values are correctly reported and formatted with acceptable variation (e.g., $62 million vs $62M). (3) The reasoning is sound: the reversal of the fine and associated interest is correctly linked to its financial statement impacts, demonstrating proper multi-hop synthesis between the legal event and its accounting treatment. (4) The only minor omission is the lack of explicit mention of the total financial impact ($1.162 billion) as a single aggregated figure, which slightly reduces completeness but does not detract from the factual correctness of the components. Entity accuracy (Qualcomm, fiscal 2022, European Commission fine, other income, interest expense) is fully correct. Overall, the answer is semantically equivalent to the ground truth with excellent contextual relevance and precise qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 356,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "\nThe fair value of Fixed‑Income Commingled Trusts grew from **$968 million (FY 2023)** to **$1,273 million (FY 2024)**, an increase of **$305 million**. This $305 million gain represents roughly **60 %** of the total fair‑value increase across all investment categories (≈$510 million overall).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in fair value of Fixed Income Commingled Trusts as $305 million, growing from $968 million in FY 2023 to $1,273 million in FY 2024, which matches the ground truth. However, it incorrectly states the total increase in fair value across all investment categories as approximately $510 million, whereas the ground truth reports this total increase as only $153 million (from $3,398 million to $3,551 million). This leads to a major error in the proportion calculation: the LLM claims the $305 million increase represents roughly 60% of the total, but in reality, $305 million exceeds the total portfolio increase of $153 million, making the proportion greater than 100% and indicating a net decline in other categories. (2) The calculation of the $305 million increase is correct, but the total portfolio increase is wrong, and the 60% figure is fabricated based on incorrect data. (3) The multi-hop reasoning fails because the model does not recognize that the increase in one category exceeding the total portfolio increase implies declines in other categories—a key insight explicitly noted in the ground truth. The model instead assumes a much larger total increase, contradicting the provided data. (4) Due to significant factual and quantitative errors in core financial figures and resulting logic, the correctness and accuracy scores are low. Contextual relevance is moderate because the answer addresses the right entities and structure but with incorrect data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 422,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "\nMorgan Stanley’s SPOE strategy guarantees that its subsidiaries will have the cash and capital they need in a resolution by having the parent company commit, through a secured, amended‑and‑restated support agreement, to supply those subsidiaries with adequate liquidity and capital.  This commitment is channeled through Morgan Stanley Holdings LLC (the “Funding IHC”), a wholly‑owned subsidiary that receives the parent’s transferred assets and then delivers the required capital and liquidity to the supported entities, with its claims secured senior to the parent’s unsecured debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Morgan Stanley's SPOE strategy uses a secured amended and restated support agreement through which the Parent Company provides liquidity and capital to subsidiaries. Morgan Stanley Holdings LLC (Funding IHC) acts as the resolution funding vehicle. The LLM correctly identifies that the Funding IHC receives assets from the Parent and then channels capital and liquidity to supported subsidiaries, with its claims being senior to the parent’s unsecured debt. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes the role of the Parent, the function of the Funding IHC, and the mechanism of liquidity provision during resolution. The only minor omission is that the ground truth specifies the Parent contributes 'all of its material assets (excluding shares in subsidiaries and certain other assets)' during resolution—a detail not explicitly mentioned in the LLM answer. This does not undermine the overall correctness but slightly reduces completeness in qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing both parts of the question: how liquidity is ensured and the role of Morgan Stanley Holdings LLC. Wording differs but meaning is semantically equivalent. Thus, correctness is 9 (excellent but minor omission), qualitative accuracy 9, and full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 449,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "\nQualcomm’s automotive‑5G growth hinges on keeping Chinese OEMs as customers, because those OEMs are expected to account for the majority of 5G‑enabled vehicles (≈60 % of all cars produced in 2028) and thus represent a large share of the company’s future revenue.  The 10‑K explicitly warns that if Chinese OEMs shift away from Qualcomm’s integrated‑circuit products—due to government actions or self‑sufficiency efforts—the company’s earnings could be materially harmed, making continued access to the Chinese market essential for its automotive‑5G strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, the 60% figure for 5G-enabled vehicles by 2028 is correctly cited, and there are no numerical or calculation errors. (2) The answer correctly identifies the key risk from the 10-K: that government actions or self-sufficiency efforts by Chinese OEMs could lead to a shift away from Qualcomm’s integrated circuits, potentially causing material harm to revenues. (3) The multi-hop reasoning is sound—linking Qualcomm’s 5G automotive growth strategy to its dependency on Chinese OEMs, given China’s significant role in global vehicle production and Qualcomm’s exposure to that market. (4) The only minor shortcoming is a slight omission of explicit mention that U.S. government actions could also trigger the shift (the LLM mentions government actions generally but doesn’t specify both U.S. and Chinese roles as in the original), and a touch less detail on Qualcomm’s strategic investments in 5G technologies. However, the core logic, entities (Qualcomm, Chinese OEMs, 2028, 5G automotive), and causal chain are all preserved with high fidelity. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 366,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "\nThe total fair value of investments measured at net asset value rose from **$1.571 billion in fiscal 2023 to $1.617 billion in fiscal 2024**, an increase of **$46 million**. This change was driven almost entirely by the **Registered investment companies** category, which grew by $46 million, whereas the insurance‑contract component actually declined slightly.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative facts. The ground truth states that the total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024, but the LLM reports only a $46 million increase, which is off by over 95%. Additionally, the LLM cites total values of $1.571 billion in 2023 and $1.617 billion in 2024, which do not align with the knowledge graph data. (2) The calculation of the change is incorrect: $1.617B - $1.571B = $46M, which matches the LLM's internal logic but contradicts the ground truth increase of $1,187M. Furthermore, the largest contributing category in the LLM answer is 'Registered investment companies' with a $46M increase, whereas the correct answer identifies 'equity commingled trusts' as the top contributor with a $269M rise. These figures are not close and indicate a failure to retrieve or synthesize the correct data. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the total change across years and misattributes the primary driver of change. It appears to have accessed or recalled data for the wrong company, time period, or investment classification. (4) Despite the factual inaccuracies, the answer is contextually relevant—it addresses the right company (Medtronic), the correct metric (fair value of investments at NAV), and attempts to break down categories and changes year-over-year. However, due to severe errors in numbers and attribution, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 433,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "\nSchwab records the repurchase liabilities for client‑held fractional shares at fair value, using quoted market prices or other observable market data that correspond to the same securities. Because the liability is marked‑to‑market and its unrealized gains and losses are fully offset by the opposite movement in the value of the related client‑held fractional assets, the net effect on the income statement is zero, even when market values fluctuate.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Schwab values repurchase liabilities based on quoted market prices or other observable market data, aligning with the valuation basis in the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable in a numerical sense, but the conceptual financial mechanism is described precisely. (3) The reasoning correctly captures the multi-hop logic: the liabilities are marked-to-market, and the offsetting unrealized gains/losses between the liability and the corresponding asset (client-held fractional shares) result in zero net income statement impact—a key point in the original answer. (4) The answer addresses both parts of the question: the valuation basis and the mechanism preventing income statement impact. Wording differs slightly (e.g., 'fair value' vs 'quoted market prices'), but this is consistent with accounting terminology and does not affect factual correctness. All entities (Schwab, repurchase liabilities, client-held fractional shares) are accurately referenced. No errors in entity identification, logic, or synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 350,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "\nThe projected benefit obligation for the Financial Consultant Career Achievement Plan grew by **$27 million** between December 31 2020 and December 31 2021, increasing from $92 million to $119 million. This change reflects the $16 million of benefit cost accrued during 2021 plus an $11 million actuarial loss (net of any gain) that was recorded for the plan.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states the projected benefit obligation increased from $176 million in 2020 to $194 million in 2021, a change of $18 million. The LLM incorrectly reports the obligation as rising from $92 million to $119 million, a $27 million increase—both the starting/ending values and the delta are wrong. (2) The calculation breakdown in the LLM answer ($16 million accrued cost + $11 million actuarial loss) does not align with the ground truth and introduces unverified figures. There is no support in the original answer for these components. (3) The multi-hop reasoning fails: while the LLM attempts to explain the change using benefit costs and actuarial losses, it does not reflect the actual data from the correct plan and time period. The entities—specifically the Financial Consultant Career Achievement Plan—are mischaracterized with incorrect financials. (4) Despite addressing the right concept (change in projected benefit obligation) and time frame (2020–2021), the complete numerical inaccuracy and erroneous synthesis result in a very low correctness score. Contextual relevance is moderate because the structure and intent of the response match the question, but factual content is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 365,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "\nThe Beauty segment contributes roughly 18 % of P&G’s total net sales, while the Fabric & Home Care segment accounts for about 36 % of net sales. Together they represent approximately 54 % of Procter & Gamble’s total net sales for the fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the combined revenue contribution as 54%, matching the ground truth. The individual segment contributions—18% for Beauty and 36% for Fabric & Home Care—are consistent with the required synthesis, even though the 18% for Beauty is not explicitly stated in the question but inferred from external knowledge (the 20% global market share of Pantene is context but not directly tied to revenue percentage). The final sum (18% + 36% = 54%) is accurate. (2) All numeric values and calculations are correct. The 36% figure is explicitly confirmed in the question, and the 18% for Beauty, while not directly provided, aligns with known P&G segment data and is a reasonable inference for the model to make. The sum is mathematically sound. (3) The multi-hop reasoning is mostly sound: the model correctly combines the Beauty segment’s implied revenue share and the explicitly given Fabric & Home Care share. However, the Beauty segment’s 18% is not directly derivable from Pantene’s 20% market share alone without additional context, so the model likely relied on embedded knowledge. Despite this, the final combined percentage is correct. (4) The answer is semantically equivalent to the ground truth, addresses all parts of the question, and is contextually precise. The minor assumption in deriving the Beauty segment’s contribution prevents a perfect 10, but overall accuracy is very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 397,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companies—UTC, Carrier, and Otis—and distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "\nIn 2020 the Company recorded a **$410 million loss** from discontinued operations attributable to common shareholders. This loss reflects the combined results of the newly separated **Carrier ($196 million of income)** and **Otis ($187 million of income)**, but is offset by **$793 million of separation‑related transaction costs**, and it arises directly from the **April 3, 2020 separation of Carrier and Otis into independent public companies**, which is why their operating performance is presented as discontinued operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. While it correctly identifies the total loss from discontinued operations as $410 million and attributes $196 million to Carrier and $187 million to Otis (which sum to $383 million), it introduces a $793 million 'separation-related transaction cost' that is not present in the ground truth. This leads to an incorrect explanation of how the $410 million figure was derived. The ground truth states the total is $-410 million, composed of $187M (Otis) and $196M (Carrier), which actually sum to $383 million, suggesting the $410 million may include additional minor components, but no offsetting costs are mentioned. The LLM incorrectly frames the $410 million loss as being *caused by* transaction costs, which distorts the financial reality. (2) The date of the separation event (April 3, 2020) is correctly identified, and the nature of the separation into three independent companies is accurately described. However, the calculation logic is flawed: $196M + $187M = $383M, not $410M, and introducing $793M in costs to explain the difference is unsupported by the ground truth. (3) The multi-hop reasoning is partially sound—the model connects the discontinued operations to the separation event and correctly identifies the entities involved (Carrier, Otis, UTC). However, the synthesis is undermined by the invention of a large transaction cost not present in the original data, indicating a failure to accurately interpret or retrieve the financial breakdown. (4) The contextual relevance is high because the answer addresses both parts of the question: the financial figure and its connection to the separation. However, the correctness score is low due to the major quantitative error and misleading explanation of the financial result, which changes the user's understanding of the income statement impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 517,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "\nAs of May 14 2024, 107 individual plaintiffs have filed lawsuits against Medtronic’s Diabetes operating unit. In contrast, the hernia‑mesh litigation involves roughly 8,350 individual plaintiffs (with the possibility of many more), so the diabetes case currently represents a tiny fraction of the potential claimants in the hernia‑mesh matters.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, it correctly states that 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, matching the ground truth. It also correctly compares this to the hernia mesh litigation by summing 6,700 (Massachusetts) + 500 (Minnesota) + 1,150 (federal MDL) = 8,350 plaintiffs, which is accurate. (2) The calculation of total hernia mesh plaintiffs is correct and reflects proper synthesis across multiple data points. (3) Qualitatively, the reasoning is sound: it correctly identifies both litigations as involving Medtronic products and notes the relative scale difference, stating the diabetes litigation represents a 'tiny fraction'—a reasonable interpretation given the numbers. However, it omits the detail that law firms anticipate 'thousands of additional' diabetes claimants, which is a minor but relevant contextual omission affecting completeness. Also missing is the point that Medtronic has not recorded any expense for damages in either case due to uncertainty—this is a small gap in qualitative depth. (4) Despite these omissions, the answer addresses both parts of the question: the number of plaintiffs in the diabetes litigation and the comparison to hernia mesh cases. The semantic meaning is equivalent on core facts, and all entities (Medtronic, Diabetes operating unit, plaintiff counts) are correct. The answer is fully relevant and well-reasoned, warranting a high score with only a slight deduction for missing forward-looking context about potential future diabetes claimants and accounting implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 457,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "\nThe IDA agreement requires that certain client deposits be swept off Schwab’s balance sheet and held at third‑party depository institutions, so those funds are not counted as assets on Schwab’s consolidated statements. To meet its internal capital‑management goal of a Tier 1 Leverage Ratio of **6.75 %–7.00 %**, Schwab must retain extra capital on its books, and the pace of bringing those IDA balances back onto the balance sheet depends on having sufficient capital buffers; indeed, the 6.2 % leverage ratio at year‑end 2021 was below the target, limiting how quickly the off‑balance‑sheet deposits can be migrated.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core mechanism of the IDA agreement—sweeping client deposits off-balance sheet to third-party depositories—which aligns with the ground truth mentioning TD Depository Institutions. It correctly identifies Schwab's internal Tier 1 Leverage Ratio target range of 6.75%–7.00%, matching the original answer. However, it introduces a specific data point—'6.2% leverage ratio at year-end 2021'—that is not present in the ground truth and cannot be verified from the provided context. This undermines quantitative accuracy. Additionally, the claim that Schwab 'must retain extra capital on its books' and that the pace of bringing IDA balances back depends on 'sufficient capital buffers' introduces causal reasoning not explicitly supported in the original answer. While logically plausible, this represents an inference beyond the documented impact: the ground truth states the offloading helps optimize the balance sheet and maintain capital ratios above targets, not that re-onboarding deposits is contingent on capital buffers. The mention of 'third-party depository institutions' is a generalization of 'TD Depository Institutions', which is acceptable semantically but slightly less precise. The answer addresses both parts of the question (IDA impact and capital policy), so completeness is fair. Reasoning is partially sound but extends beyond the source with unverified specifics and causal claims. Thus, while the qualitative and contextual understanding is strong, the introduction of unsupported quantitative data and inferred mechanics reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 435,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "\nThe disposition of the Forcepoint business generated approximately **$1.9 billion of net cash proceeds**.  Those proceeds were a key component of RTX’s investing cash flow, which fell from a **$3.3 billion inflow in 2020 to a net cash outflow of about $1.4 billion in 2021**—a roughly **$4.7 billion decrease**—with the Forcepoint cash inflow helping to offset other investing expenditures.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.9 billion net cash proceeds from the disposition of the Forcepoint business, which matches the ground truth. However, it incorrectly characterizes the overall trend in net cash provided by investing activities. The LLM states that investing cash flow 'fell from a $3.3 billion inflow in 2020 to a net cash outflow of $1.4 billion in 2021—a roughly $4.7 billion decrease,' implying a negative shift. In contrast, the ground truth states there was a $4.7 billion *improvement* in cash flows from investing activities in 2021 vs 2020, meaning cash flow became more positive, not less. This is a critical error in directionality and interpretation. (2) The $1.9 billion figure is accurate. However, the implied calculation of a $4.7 billion *decrease* (from +$3.3B to -$1.4B) contradicts the ground truth, which describes a $4.7 billion *improvement*, primarily due to the absence of the $3.2 billion Raytheon merger outflow in 2020 and inflows from dispositions like Forcepoint. The LLM misrepresents the magnitude and direction of the year-over-year change. (3) The multi-hop reasoning is flawed: while the model correctly links Forcepoint proceeds to investing cash flows, it fails to accurately synthesize the year-over-year comparison. It incorrectly infers a deterioration in investing cash flow when the actual data shows a significant improvement. This suggests a misunderstanding of the underlying financial narrative, particularly around the impact of the prior-year merger outflow. (4) The correctness score is 5 due to the accurate identification of the $1.9B proceeds but major error in the overall investing cash flow trend. Quantitative accuracy is 5 because half the numbers are right but the key comparative metric is wrong. Qualitative accuracy is 5 due to correct entity identification but flawed reasoning. Contextual relevance is 8 because the answer addresses the right topics and entities, just with incorrect interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 537,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "\nOracle delivers most of its cloud services from data‑centers that are **leased from third‑party colocation providers under long‑term operating leases**.  Those agreements typically require **significant termination fees if Oracle tries to exit early**, and the ongoing lease payments must be funded out of cloud‑service revenue.  Consequently, any shift in strategy or slower‑than‑expected demand can force the company to absorb costly lease‑exit charges, pressuring profitability and cash flow of its Oracle Cloud Services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial risks associated with Oracle's reliance on third-party colocation suppliers. It correctly identifies that Oracle leases most of its data centers from third parties under long-term operating leases, which include significant termination fees for early exit—this aligns with the ground truth. The answer correctly links these commitments to financial risk, particularly in scenarios of strategic shifts or lower-than-expected demand, noting impacts on profitability and cash flow. All entities (Oracle, Oracle Cloud Services, third-party colocation providers) and financial terms (operating leases, termination fees) are accurate. There are no numeric values in the original or LLM answer requiring verification, so quantitative accuracy is scored as 10. The only minor omission is that the LLM answer does not mention Oracle's depreciation of leased assets over useful lives and the risk of shortened depreciation periods due to strategy shifts—a point included in the original answer that affects profitability. This is a secondary but relevant aspect of the financial risk, so the answer is not fully complete, warranting a 9 on qualitative accuracy and correctness. Contextual relevance is perfect: the response directly addresses the question about financial risk from lease commitments and termination fees.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 380,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "\nAs of December 31 2021, 64 million shares remained available for future grants under the 2020 Stock Incentive Plan and 18 million shares were available under the 1993 Employee Stock Purchase Plan, for a combined 82 million shares. This pool of shares gives UnitedHealth Group the flexibility to continue issuing equity‑based awards—options, RSUs, performance units, and ESPP purchases—supporting its strategy of aligning long‑term incentive compensation with shareholder interests while preserving sufficient reserve capacity for future equity grants.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 64 million shares under the 2020 Stock Incentive Plan and 18 million under the 1993 Employee Stock Purchase Plan, totaling 82 million shares—correct sum and values with no discrepancies. Minor formatting differences (e.g., spacing, use of 'million') are acceptable and do not affect accuracy. (2) The answer is complete, addressing both the total number of shares available and the strategic rationale behind UnitedHealth Group's share-based compensation. (3) Entity accuracy is perfect: correct plan names, correct company (implied contextually), and correct date (December 31, 2021). (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly combines data from two separate plans and articulates how the availability supports the company’s compensation strategy—mentioning alignment with shareholder interests, flexibility in award types (options, RSUs, performance units, ESPP), and reserve capacity. The qualitative explanation is semantically equivalent to the original answer, using slightly different but equally valid terminology (e.g., 'equity-based awards' vs 'stock options, restricted stock, and other equity awards'). All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 365,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "\nSchwab records client‑held fractional shares as “other securities owned at fair value” (an asset) and records an offsetting repurchase liability for the same amount, measured at fair value. That liability is presented in the consolidated balance sheet under **accrued expenses and other liabilities** (see Note 2/18 of the 2022 10‑K).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly identifies that Schwab accounts for client-held fractional shares as 'other securities owned' at fair value, which aligns with the original answer's reference to fair value based on quoted market prices. The corresponding repurchase liabilities are correctly stated to be measured at fair value and classified under 'accrued expenses and other liabilities' on the consolidated balance sheet—this matches the ground truth exactly. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or answer, so quantitative accuracy is not applicable in that sense, but all factual assertions about accounting treatment are correct. (3) The multi-hop reasoning is sound: the LLM correctly links the accounting treatment of fractional shares to the recognition of a liability and its balance sheet presentation, synthesizing concepts from ASC 940/860 implicitly as in the original. (4) The only minor omission is that the LLM does not explicitly mention that unrealized gains and losses are recognized in earnings, nor does it clarify the conditions under which off-balance sheet treatment fails (i.e., when ASC 940 or ASC 860 derecognition criteria are not met), which are included in the original. However, the core accounting treatment and balance sheet classification are fully correct. The reference to Note 2/18 adds precision and supports contextual relevance. Thus, the answer is semantically equivalent in key respects but slightly less complete in explanatory depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 437,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "\nOracle Autonomous Database runs on OCI as a fully managed, self‑driving service that automates provisioning, tuning, scaling, security and backups, so customers pay only for the compute and storage they actually consume and avoid costly DBA labor—delivering immediate cost savings.  At the same time, the tight integration creates a compelling reason for existing Oracle license and on‑premise customers to migrate workloads to OCI, expanding the company’s cloud‑services revenue base and opening cross‑sell opportunities for additional license‑support, middleware, Java and engineered‑system sales, thereby fueling strategic growth in both the cloud and traditional license businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies that Oracle's Autonomous Database on OCI reduces customer costs through automation of provisioning, tuning, scaling, security, and backups, leading to lower labor (DBA) costs and consumption-based pricing—this aligns with the original answer’s emphasis on operational cost reduction and pay-per-use model. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or fabricated data earns a perfect score. (3) The reasoning is sound and reflects multi-hop synthesis: it connects automation → cost savings → customer migration to OCI → expansion of cloud revenue and cross-selling of licenses and middleware, which accurately reflects the strategic growth mechanism described in the ground truth. It mentions integration with Java and engineered systems, which parallels the original’s reference to Java Cloud and APEX as developer platforms. (4) Minor omission: the LLM answer does not explicitly mention machine learning-driven diagnostics or reduced human error, nor does it name Oracle APEX as a specific integrated service. However, the overall semantic meaning and strategic implications are preserved. The answer is fully relevant to the question and effectively explains both cost reduction and strategic business growth. Thus, only a slight deduction from qualitative accuracy and correctness is warranted due to these minor omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 428,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "\nIf the AARP Program contract were transferred, UnitedHealth Group would be required to move cash equal to the **fair value of the AARP Program’s invested assets** (which are currently recorded as current assets used to fund the related RSF liabilities) to the new entity.  This cash outflow would reduce the company’s cash and cash‑equivalent balance and would remove the associated assets and related RSF liabilities from its balance sheet, reflecting the transfer of the program’s funding responsibilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that UnitedHealth Group must transfer cash equal to the fair value of the AARP Program's invested assets upon contract transfer, which aligns with the original answer. The classification of these assets as current and their use in funding liabilities (specifically RSF liabilities, which are related to medical costs) is accurately reflected. (2) There are no explicit numerical values in either answer, so quantitative accuracy is not compromised; the response correctly avoids inventing figures and sticks to the qualitative financial mechanism. (3) The multi-hop reasoning is sound: the model connects the contractual obligation, asset classification, and balance sheet impact (removal of both assets and liabilities), demonstrating understanding of the financial implications. (4) The only minor shortcoming is that the LLM answer refers to 'RSF liabilities' without spelling out that these are 'related to medical costs payable and other related liabilities' as in the original, which adds a bit more context. However, RSF (Risk Sharing Fees or similar) is contextually appropriate and commonly understood in UnitedHealth's filings. Overall, the answer is semantically equivalent, factually correct, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 373,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "\nThe excerpt you provided does not contain any disclosure of the fair value of “Card Member and Other Loans,” nor does it discuss how that fair value compares to its carrying amount or reference a Level 3 fair‑value hierarchy classification. Consequently, no comparison can be made from the supplied pages.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to provide the correct information from the ground truth. (1) The original answer states that the fair value of Card Member and Other Loans is $113 billion and the carrying value is $110 billion, with the entire fair value classified under Level 3 of the fair value hierarchy. The LLM claims no such information is available, which contradicts the provided ground truth. (2) There are no numerical values or calculations in the LLM response to verify, but it fails to report the correct figures: $113 billion (fair value) and $110 billion (carrying value), which are central to the question. (3) The multi-hop reasoning required—linking fair value, carrying value, and Level 3 classification—is entirely missing; the LLM does not attempt any synthesis. (4) The response is irrelevant to the actual content of the original answer, suggesting a failure to access or interpret the correct data. All scores are low because the LLM denies the existence of key facts that are explicitly stated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 300,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "\nAs of December 31 2021, 64 million shares remained available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares could later be used for a variety of award types, including stock options, stock‑appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number of shares — 64 million — and the date — December 31, 2021 — are accurate and match the original answer exactly. (2) The types of awards listed — stock options, stock-appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards — are complete and correctly reflect the allowable award types under the plan. (3) The reasoning is sound, with no multi-hop errors; the answer correctly synthesizes information about share availability and permissible award forms from the same plan and date. (4) Wording differences (e.g., 'remained available' vs 'were available', 'could later be used' vs 'can become the subject of') do not affect factual meaning and are within acceptable variation. All aspects of the question are addressed accurately and completely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 265,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "\nThe company’s estimated fair value of foreign government bonds and obligations was $770 million as of December 31 2023, compared with $632 million at the end of 2022 – an increase of about $138 million (roughly 22 %).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the 2023 estimated fair value of foreign government bonds and obligations as $770 million, which matches the ground truth. However, it incorrectly reported the 2022 value as $632 million, whereas the ground truth specifies $549 million for maturities of 12 months or more. This leads to an incorrect year-over-year comparison and delta. (2) The calculation of the increase is therefore wrong: LLM reports an increase of $138 million ($770M - $632M), but the correct increase is $221 million ($770M - $549M). The percentage increase mentioned (~22%) is also inaccurate due to the incorrect base value. (3) The multi-hop reasoning is partially sound—LLM correctly retrieved the 2023 value and attempted a comparison with 2022—but failed in accurately retrieving the 2022 figure for the specific category (foreign government bonds and obligations with maturities of 12 months or more). This suggests a failure in precise entity and metric alignment across years. (4) Scores reflect that core facts (2023 value) are correct and the answer structure is relevant, but major quantitative inaccuracies in the 2022 value and derived calculations significantly reduce correctness. Contextual relevance is high as the answer addresses the right category and time frame, despite factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 370,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "\nThe Company’s capital expenditures in the Africa/Eurasia region were $33 million in 2021, compared with $8 million in 2019—a rise of $25 million (about a 310 % increase).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the capital expenditures of $33 million in 2021 and $8 million in 2019 are accurately reported. The difference of $25 million is correctly calculated. The additional percentage increase (~310%) is a valid derivation (25/8 = 3.125, or 312.5%, rounded to about 310%), which adds value without contradicting the ground truth. (2) The answer is complete, addressing both parts of the question: the 2021 expenditure, the 2019 expenditure, and their comparison. (3) Entities are correct—the Africa/Eurasia region and the years 2021 and 2019 are properly identified. (4) The reasoning is sound, demonstrating accurate multi-hop synthesis across time periods and correct numerical comparison. The slight enhancement with percentage increase does not detract but enriches the response while remaining factually consistent. All elements meet the highest standard for correctness, accuracy, and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1089,
        "completion_tokens": 284,
        "total_tokens": 1374
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "\nThe Contact Lenses/Other sub‑category posted a **14.9 % worldwide sales increase** from 2020 to 2021 ( $3.44 bn vs. $2.99 bn ).  Over the same period the broader Vision segment grew **19.6 %** ( $4.69 bn vs. $3.92 bn ).  Consequently, Contact Lenses/Other grew well below the Vision segment’s overall growth rate.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentage changes are accurate: 14.9% growth for Contact Lenses/Other (from $2.99B to $3.44B) and 19.6% growth for the broader Vision segment (from $3.92B to $4.69B). These figures match the ground truth exactly, and the dollar amounts provided are consistent with the percentage change calculations. (2) The answer is complete, addressing both parts of the question: the percentage change for Contact Lenses/Other and the comparison to the overall Vision segment growth. (3) Entity accuracy is correct—Johnson & Johnson is implied as the parent company, the Vision segment and its sub-category Contact Lenses/Other are properly identified, and the time period (2020 to 2021) is accurate. (4) The reasoning is sound: the LLM correctly infers that Contact Lenses/Other underperformed relative to the broader segment, using valid comparative logic. The phrasing 'grew well below' is semantically equivalent to 'underperformed' in the original answer. All multi-hop elements—extracting data for two categories across two years and comparing growth rates—are handled correctly. Minor formatting differences (e.g., spacing in numbers, use of 'bn') do not affect accuracy. Overall, the answer is factually precise, complete, and logically coherent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 373,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "\nThe weighted‑average grant price of the Service‑ and Performance‑Based RSUs that remained outstanding as of December 31 2021—after accounting for the prior‑year balance and the new grants issued during the year—was **$114.22 per share**.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the weighted-average grant price as $114.22 per share, while the original answer refers to $114.22 million as the total value (not per share) of outstanding RSUs as of December 31, 2021. This is a critical error in unit interpretation—'per share' vs. 'total value in millions'. Additionally, the LLM omits the explicit mention of the new grants' value ($125.02 million), which is a required component of the question asking for consideration of both beginning balance and new grants. (2) The number $114.22 is present in both answers but misinterpreted in the LLM response as a per-share price rather than a total dollar amount in millions. The new grant amount of $125.02 million is entirely missing from the LLM answer, affecting quantitative accuracy. There is no indication of calculation or synthesis between beginning balance and new grants. (3) The reasoning is partially sound in that it acknowledges the need to account for prior-year balance and new grants, but fails to reflect the multi-hop synthesis of values or the correct financial metric (total value vs. per-share price). The model appears to conflate per-share metrics with total dollar amounts. (4) The contextual relevance is high because the answer addresses the right topic, timeframe, and instrument type (Service and Performance-Based RSUs as of December 31, 2021). However, due to the significant quantitative misstatement and omission of key data points, the correctness score is reduced to 6—partially correct but with major factual inaccuracies in units and missing figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 439,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "\nThe 1.43%‑2.50% unsecured bond tranche fell from **$10.1 bn in 2023 to $6.16 bn in 2024**, a decline of roughly **$3.98 bn**. In 2024 this tranche represented **about 11.4 %** of Boeing’s total debt of $53.9 bn.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the bond balance decreased from $10.1 billion (matching $10,135 million) in 2023 to $6.16 billion (matching $6,159 million), resulting in a decrease of $3.98 billion (precisely $3,976 million, rounded appropriately). The percentage of total debt in 2024 is correctly stated as approximately 11.4%, which aligns with the ground truth of 11.43% (rounded to one decimal place). Total debt is cited as $53.9 billion, consistent with $53,864 million. (2) Number formats are appropriately converted (e.g., millions to billions) and rounded without loss of accuracy. Calculations are correct: $10.135B - $6.159B = $3.976B ≈ $3.98B; $6.159B / $53.864B ≈ 11.43% ≈ 11.4%. (3) Multi-hop reasoning is sound—information across two years and two financial instruments (specific bond tranche and total debt) is correctly synthesized. (4) Entities (Boeing, unsecured bonds, 2023–2024 timeframe) are accurate. The answer is concise, relevant, and fully addresses both parts of the question. All scores are maximized due to factual precision, correct reasoning, and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 333,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "\nIn 2021 the Orthopaedics segment generated **$8.588 billion** in sales (page 32). Within that, **Hips** contributed **$1.485 billion** and **Knees** contributed **$1.325 billion**, for a combined **$2.810 billion**. Thus, Knees + Hips accounted for **≈ 32.7 %** of the total Orthopaedics revenue that year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: Knees revenue is $1.325 billion, Hips revenue is $1.485 billion, combined $2.810 billion, and total Orthopaedics revenue is $8.588 billion. These match the original answer exactly, with acceptable format variation (e.g., $2,810 million = $2.810 billion). (2) The percentage calculation is correct: ($1.325 + $1.485) / $8.588 = $2.810 / $8.588 ≈ 32.7%, which is accurately reported as ≈32.7%. (3) The multi-hop reasoning is sound—LLM correctly identified the relevant segment (Orthopaedics), extracted revenues for two product lines (Knees and Hips), summed them, and computed their share of total segment revenue. (4) All entities (Johnson & Johnson’s Orthopaedics segment, product categories, fiscal year 2021) are correctly identified and contextualized. The answer is complete, factually precise, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 277,
        "total_tokens": 1417
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "\nBoeing omitted 11.6 million potential shares in 2024, 5.7 million in 2023 and 3.5 million in 2022 from the diluted‑loss‑per‑share calculation because each of those periods ended with a net loss, rendering the inclusion of those shares antidilutive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of potential common shares excluded for each of the three fiscal years—11.6 million in 2024, 5.7 million in 2023, and 3.5 million in 2022—and provides the correct reason for exclusion: antidilution due to net losses. The total excluded shares sum to 20.8 million (11.6 + 5.7 + 3.5), which matches the ground truth. All numeric values are accurate and correctly attributed to the respective years. (2) Quantitative accuracy is perfect: each individual figure is correct, and their sum is 20.8 million, matching the ground truth total. Format variations are not an issue here as all numbers are presented clearly and consistently. (3) The reasoning is sound: the model correctly links the exclusion of shares to the company’s net loss in each period, which is the proper accounting treatment under GAAP for diluted loss per share. The multi-hop synthesis across three fiscal years is accurate and well-articulated. (4) The only minor limitation is that the LLM does not explicitly state the total of 20.8 million, though it provides all components needed to derive it. Since the question asks for the 'total number,' while the answer allows for easy summation, the omission of the explicit total slightly reduces completeness in presentation, though not in substance. Hence, a score of 9 is justified for correctness and qualitative accuracy. Contextual relevance is full—every part of the answer addresses the question directly and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 415,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "\nThe 2021 amendment lowered the Projected Benefit Obligation by roughly **$1.8 billion** as of January 3 2021. It also changes the way pension benefits are calculated for U.S. non‑union employees hired before 2015: after the effective date (January 1 2026) their future accruals will be based on the **Retirement Value formula**, while benefits already earned under the prior **Final Average Pay** formula remain unchanged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the $1.8 billion reduction in Projected Benefit Obligation as of January 3, 2021 is accurately reported, with correct formatting. The key dates—January 3, 2021 (measurement date) and January 1, 2026 (effective date of formula change)—are both correct. (2) The answer completely addresses both parts of the multi-hop question: the financial impact on the PBO and the effect on pension benefit calculations for the specified employee group. (3) Entity accuracy is perfect: 'U.S. non-union employees hired before 2015' are correctly identified, and the transition from the 'Final Average Pay' to the 'Retirement Value' formula is accurately described. (4) The reasoning is sound—benefits earned before 2026 are preserved under the old formula, while future accruals use the new formula—demonstrating correct synthesis across time periods and plan terms. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 288,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "\nThe filing explains that the fair‑value estimates for assets and liabilities carried at amortized cost are derived from market conditions and management’s judgments, and each uses different assumptions and valuation techniques. Because these fair‑value measurements are not directly additive, you cannot obtain the company‑wide fair value simply by summing the individual amortized‑cost amounts.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the core reasoning: fair value estimates for financial assets and liabilities at amortized cost are based on management judgment and market conditions, and cannot be aggregated to estimate the company's overall fair value. (2) There are no numeric values in the question or answer that need verification—both the LLM and original answer avoid specific dollar amounts, focusing instead on conceptual explanation, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes that individual fair value estimates use different assumptions and techniques, making them non-additive, which supports the conclusion that firm-wide fair value cannot be derived by aggregation. (4) However, the LLM answer omits a key element from the ground truth: the mention that fair value figures are as of specific dates (December 31, 2021 and 2020), and that these estimates are not indicative of future fair values. Additionally, it does not reference non-financial factors or the complexity of the business as a whole—important nuances in the original explanation. While the LLM conveys the main idea, this omission reduces completeness and qualitative accuracy slightly. Wording differences are acceptable under semantic equivalence, but missing these key details prevents a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 393,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "\nThere is only **one amendment** to the Benefits Plan for Members of the Board of Directors listed in the exhibit index. The plan itself was originally adopted (and restated) with an effective date of **April 14, 2004**, and its first amendment became effective on **December 16, 2005**.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the effective date of the original plan (April 14, 2004) and the first amendment (December 16, 2005), which are factually accurate and match the ground truth. However, it incorrectly states that there is only 'one amendment' listed in the exhibit index, while the ground truth confirms there are two explicitly listed amendments. This is a critical error in quantitative accuracy and completeness, as the question specifically asks for the number of amendments. While the dates provided are correct and the response addresses the effective dates properly, the failure to correctly report the number of amendments undermines the overall correctness. The reasoning appears sound for the parts addressed, but the model fails in multi-hop synthesis by not accurately capturing the full scope of amendments listed. The answer is contextually relevant and well-structured, but the key factual error in counting the amendments limits the score. Semantic equivalence is mostly achieved except for the central quantitative claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 300,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "\nOracle’s hybrid deployment model—offering on‑premise, cloud‑based and mixed configurations—gave customers the flexibility to move workloads to Oracle Cloud at their own pace.  By making it easier for clients to adopt and expand their use of Oracle Cloud services and license support, the hybrid approach drove a sharp rise in cloud‑related sales, which grew to account for **84 % of total revenue in fiscal 2024**.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the key quantitative fact: the cloud and license business accounted for 84% of Oracle's total revenue in fiscal 2024. This matches the ground truth exactly, and the percentage is accurately cited. Entity accuracy is strong—Oracle, the hybrid deployment model, and the correct fiscal year (2024) are all correctly referenced. 2) Quantitatively, the 84% figure is correct and properly attributed to the right business segment and time period. No calculations are required beyond this, and the number is presented accurately. 3) However, the reasoning component is partially incomplete. While the LLM mentions that the hybrid model allowed customers to adopt Oracle Cloud at their own pace and expand usage, it omits a critical link present in the ground truth: the role of recurring license support contracts in driving revenue. The original answer emphasizes that the cloud and license revenue includes support contracts priced as a percentage of net fees, and that high renewal rates due to customer retention are a direct result of the hybrid model. This multi-hop connection—hybrid model → customer flexibility → high retention/renewals → recurring revenue → 84% of total revenue—is not fully synthesized in the LLM answer. 4) The answer is contextually relevant and well-phrased, but the absence of the license support renewal mechanism and its financial impact reduces the qualitative accuracy. The core revenue contribution is correctly stated, but the explanation of *how* the hybrid model drives that revenue is less complete than the ground truth. Hence, correctness is scored at 7—factually accurate on numbers and surface-level causality, but missing key depth in the revenue-generation logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 471,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "\nAs of December 31 2021 the “deferred card and other fees, net” balance of **$2.5 billion** includes the deferred fees collected from **Membership Rewards participants** (footnote (a)).  Those fees are a component of the **$11.4 billion Membership Rewards liability**, which is estimated by applying the program’s **Ultimate Redemption Rate (URR)** and a **weighted‑average cost‑per‑point** assumption—derived from historical redemption trends, card‑type, tenure and spend—to project the future cost of points that will be redeemed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the total deferred card and other fees are $8,737 million, with a portion tied to Membership Rewards participants, but the LLM incorrectly reports the deferred fees as $2.5 billion, which is not supported by the original answer. Additionally, the LLM introduces a $11.4 billion Membership Rewards liability, which is not mentioned in the ground truth and appears to be fabricated or misattributed. (2) The quantitative values are largely incorrect: $2.5 billion vs. $8,737 million and $11.4 billion (unverified) vs. no specific liability figure provided in the original. The original answer does not state a dollar amount for the liability, only that the methodology uses URR and WAC. (3) The reasoning partially captures the correct methodology—mentioning Ultimate Redemption Rate (URR) and weighted-average cost per point—as used in estimating future redemption liability, which aligns with the original answer’s description of statistical and actuarial models based on redemption trends, card type, and credit attributes. This shows some correct multi-hop synthesis of how deferred fees relate to liability estimation. (4) Despite correct use of key terms and conceptual understanding of the liability estimation process, the answer fails on core factual accuracy due to incorrect figures and unsupported claims about the liability amount. The contextual relevance is moderate because it addresses the right topic and links fees to liability estimation, but the incorrect numbers undermine reliability. Correctness score is low due to major quantitative errors, even though the qualitative reasoning has partial merit.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 469,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "\nNineteen distinct award‑agreement forms under the 2014 Equity Plan were documented between February 18 2015 and February 17 2021.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core quantitative claim: it states 'Nineteen distinct award-agreement forms' were documented, while the ground truth is 16. This is a significant error in numerical accuracy, as the number 19 does not match the verified count from the knowledge graph based on actual SEC filings listed in the 2024 10-K. The time period (February 18, 2015, to February 17, 2021) and the plan name (The Coca-Cola Company 2014 Equity Plan) are correctly identified, showing some entity and contextual accuracy. The answer addresses the right question structure and appears to interpret the multi-hop requirement (linking award agreements to a specific plan and time frame), but fails in the essential task of retrieving the correct count. There is no indication of calculation or reasoning provided, but the number itself must align with documented filings, which it does not. While semantically the answer format is equivalent (reporting a count of award agreements over the specified period), the factual inaccuracy in the number severely undermines correctness. Thus, the quantitative accuracy is very low, qualitative accuracy is low due to incorrect synthesis, and contextual relevance is high because the response is on-topic and structured appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 357,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "\nIn 2021 AMD purchased roughly **$1.1 billion** of assembly‑test‑mark‑packaging services from the ATMP joint venture and recorded a **$6 million equity‑method gain**, with additional balances of $85 million payable to and $2 million receivable from the JV.  This sizable spend and the modest but positive equity return illustrate that the ATMP JV is a strategically important partner, providing both critical supply‑chain services and a meaningful financial return for AMD.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the two key financial components of AMD's relationship with the ATMP JV in 2021: $1.1 billion in purchases and a $6 million equity gain, matching the ground truth exactly. The total value of $1.106 billion is implied by the sum of these figures, though not explicitly stated, which is acceptable given that the components are accurate. The additional details about $85 million payable and $2 million receivable are factually consistent with typical JV accounting but were not part of the ground truth; however, they do not contradict it and add context without distorting the answer. (2) All numeric values are correct and accurately formatted: $1.1 billion and $6 million match the ground truth (allowing for $1.1B = $1.106B when summed). No calculation errors. (3) The multi-hop reasoning is sound—AMD’s financial engagement (purchases + equity gain) is synthesized into an assessment of strategic importance, correctly linking operational reliance (ATMP services) with financial structure (equity stake and returns). The LLM infers strategic importance logically, though it omits the explicit mention of AMD’s 15% equity stake and the detail about avoiding further funding obligations, which are part of the full strategic rationale in the ground truth. This is a minor omission, not an error. (4) The answer is contextually relevant, directly addressing both the total financial value and the strategic implications. The qualitative accuracy is slightly reduced due to the missing detail about the 15% stake and funding obligation, but the core reasoning remains strong. Overall, the answer is factually correct, complete in key aspects, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 465,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "\nThe first patent protection for DARZALEX expires in the United States in 2029, and that loss of exclusivity would be the earliest point at which the combined DARZALEX/DARZALEX FASPRO revenue stream could begin to be materially affected. Consequently, 2029 is the earliest year that a patent expiration could start to impact the 6.4 % of total sales represented by these products.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly identifies 2029 as the earliest year of patent expiration that could materially impact the combined revenue stream, aligning with the U.S. patent expiration for DARZALEX. (2) All quantitative elements—specifically the year 2029—are accurate and match the original answer; no calculations were required beyond correct interpretation of dates. (3) The multi-hop reasoning is sound: the model correctly synthesizes that while DARZALEX FASPRO has separate patent coverage, the earliest vulnerability is tied to DARZALEX’s U.S. patent expiry in 2029, which would allow biosimilar entry in a key market. (4) The answer addresses all parts of the question, including the combined revenue stream and the implication of patent expiration on material impact. Wording differs slightly but meaning is preserved, and the reasoning is concise and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 273,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "\nThe 2022 10‑K filing lists two amendments to The Bank of New York Company, Inc. Excess Benefit Plan—one effective June 30 2015 and another effective November 1 2018—so the total number of such amendments disclosed for those years is **two**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that there are two amendments to The Bank of New York Company, Inc. Excess Benefit Plan disclosed in the 2022 10-K filing for 2015 and 2018. (2) The dates provided—June 30, 2015, and November 1, 2018—are factually correct and match the ground truth exactly. There are no calculation errors, and the total count (two) is accurate. (3) The reasoning is sound: the model correctly synthesized information from the 2022 10-K filing regarding amendments made in the specified years, demonstrating proper multi-hop understanding by identifying relevant plan amendments across time. (4) The answer is semantically equivalent to the original, using slightly different phrasing but preserving all key facts and context. All evaluation dimensions—quantitative accuracy, completeness, entity accuracy, reasoning, and relevance—are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 271,
        "total_tokens": 1398
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "\nThe Network 2.0 optimization spend is a core element of FedEx’s DRIVE transformation and is explicitly reflected in the 2025 capital‑expenditure plan—about $5.2 billion of projected capex earmarks funds for hub modernization and network‑wide efficiency upgrades. The European workforce‑reduction program, which will generate $250‑$375 million of cash severance and professional‑fee costs through fiscal 2026, is classified as a business‑optimization expense that furthers the same DRIVE goals of lowering overhead and improving profitability, and therefore is accounted for alongside the 2025 capex to align cost‑reduction with the company’s strategic investment priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: FedEx's $5.2 billion 2025 capital expenditure plan, the allocation to Network 2.0 for hub modernization and efficiency upgrades, and the European workforce reduction costs of $250–$375 million through fiscal 2026. These figures match the ground truth exactly, with acceptable formatting (e.g., $5.2 billion vs $5.2B). (2) Quantitative accuracy is perfect: both the capex figure and the severance cost range are correct, and the time frame (through fiscal 2026) is accurately preserved. (3) The multi-hop reasoning is sound—LLM correctly links Network 2.0 expenditures to the DRIVE transformation program, identifies workforce reduction costs as business optimization expenses, and explains their strategic alignment with long-term profitability and operational efficiency. It synthesizes capital spending and cost-reduction initiatives under the unified DRIVE framework, as required. (4) The only minor shortcoming is that the LLM slightly conflates accounting treatment by stating the workforce reduction costs are 'accounted for alongside the 2025 capex,' which could imply they are part of the capital expenditure, whereas the ground truth clarifies they are separate business optimization expenses (not capex). This is a subtle but important distinction in financial reporting—operating expenses vs. capital expenditures. Despite this, the overall meaning and strategic linkage remain accurate. Hence, correctness is high but not perfect, warranting a 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 423,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "\nAMD’s AIB partners and distributors hold inventory of its graphics cards and APUs, and the company’s agreements typically protect that inventory from price reductions while granting return rights for products up to 12 months old. As a result, any significant market‑price decline or oversupply can trigger large price‑protection charges and inventory write‑downs that directly cut revenue and gross margin. Moreover, because AMD must forecast demand through multiple downstream channel partners, mismatches between supply and demand can create excess or obsolete stock, further increasing its inventory‑management and financial‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMD has price protection obligations for AIB partners, which can reduce revenue and gross margins during price declines; AIB partners have return rights for products up to 12 months old; and inventory held by channel partners increases financial risk. (2) Quantitative accuracy is perfect: the 12-month return window is correctly stated and matches the original answer. (3) The reasoning is sound and captures the multi-hop logic—dependency on third parties leads to inventory in the channel, which triggers financial exposure via price protection and returns during market downturns. (4) The only minor omission is that the original answer specifically mentions 'products removed from the price book' as eligible for return, which the LLM answer does not explicitly reference, slightly reducing qualitative precision. However, this does not undermine the overall correctness. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent as it directly addresses inventory management and financial risk exposure as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 334,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "\nIn 2023 AbbVie’s cost of products sold that is attributable to Venclexta—reflecting Genentech’s shared U.S. profit portion together with the royalties paid on foreign net revenues—was **$869 million**. This amount, shown in the collaboration table as “Genentech’s share of profits, including royalties (included in cost of products sold),” captures both the U.S. profit‑sharing expense and the overseas royalty payments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a specific dollar amount ($869 million) and correctly identifies the two components of AbbVie's cost of products sold related to Venclexta: Genentech’s 50% share of U.S. profits and royalties on non-U.S. net revenues. It also correctly states that these are included in cost of products sold, aligning with the original answer’s key point. However, the original answer does not provide any numerical value—it only describes the composition of the cost. The LLM introduces a precise figure of $869 million for 2023, which is not present in the ground truth and cannot be verified as correct based on the provided information. This introduces a significant quantitative inaccuracy, as there is no evidence in the original answer to support this number. While the reasoning and entity identification (AbbVie, Genentech, Venclexta, U.S. vs. non-U.S., cost of products sold) are sound and contextually appropriate, the unsupported numerical claim undermines factual correctness. The answer is semantically aligned in structure and intent but fails on quantitative accuracy due to the fabricated figure. Thus, the correctness score is reduced significantly for introducing unverified data, even though the conceptual framework is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 350,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "\nBNY publicly makes its **Directors’ Code of Conduct** available, and this document is expressly intended for—and applies to—**all of BNY’s directors**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It correctly identifies the governance document as the 'Directors’ Code of Conduct' and confirms it is publicly available in addition to the Committee Charters and Corporate Governance Guidelines. (2) There are no numeric values, dates, or calculations in this question, so quantitative accuracy is not applicable, but the absence of such data is consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes that BNY makes this specific document public and identifies the correct applicability. (4) The answer explicitly states that the document applies to 'all of BNY’s directors,' which matches the ground truth's 'all directors of BNY.' Wording differs slightly but meaning is identical. All parts of the question are addressed accurately and completely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1106,
        "completion_tokens": 259,
        "total_tokens": 1365
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "\nThe 2021 launch of the Radeon RX 6600 XT—part of AMD’s new RDNA 2‑based Radeon RX 6000 series and supported by the AMD Advantage design framework—added a high‑volume, 1080p‑gaming GPU that lifted average selling prices and improved product‑mix in the Graphics segment.  This higher‑margin graphics revenue helped drive the 68 % year‑over‑year revenue increase and contributed roughly three percentage‑points to the gross‑margin expansion reported for 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the launch of the Radeon RX 6600 XT in 2021 and its role in driving revenue and gross margin improvements. It accurately reflects AMD's 68% year-over-year revenue growth and the 3-percentage-point gross margin expansion from 45% to 48%, aligning with the ground truth. The mention of the RDNA 2 architecture, Radeon RX 6000 series, and AMD Advantage framework is factually correct and contextually relevant. (2) All quantitative elements are accurate: the 68% revenue growth and 3-percentage-point gross margin improvement are correctly stated. While the original answer includes specific revenue figures ($9.8B to $16.4B), the LLM omits them but still correctly characterizes the 68% growth, so this is a minor omission rather than an error. (3) The multi-hop reasoning is sound—linking the product launch (RX 6600 XT) to product mix, higher average selling prices, and subsequent impact on revenue and margins demonstrates correct synthesis across product strategy and financial outcomes. The LLM correctly infers that higher-margin graphics revenue contributed to margin expansion, consistent with the ground truth’s emphasis on RDNA 2’s efficiency and pricing power. (4) The answer is contextually excellent, directly addressing how the RX 6600 XT and broader gaming strategy contributed to financial results. The only minor shortcoming is the lack of explicit mention of the Radeon RX 6000M series for laptops, which was part of the broader strategy in the original answer, slightly reducing completeness. However, the core reasoning and factual accuracy remain strong, warranting a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 454,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "\nAbbVie’s net revenue from Venclexta in 2023 was **$2.288 billion** (approximately $2,288 million) worldwide.  Under the AbbVie‑Genentech collaboration, Genentech received **$869 million** of the pre‑tax profit generated by Venclexta sales in the United States.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies AbbVie's 2023 net revenue from Venclexta as $2,288 million (or $2.288 billion), which matches the ground truth and satisfies the first part of the question. However, the second part of the answer is factually incorrect: the LLM states that Genentech received $869 million of the U.S. pre-tax profit, but the ground truth does not provide a specific dollar amount—only that Genentech receives 50% of the U.S. pre-tax profit under the collaboration agreement. There is no mention in the original answer of a $869 million figure, and no data is provided to verify this number or support such a calculation. This introduces a fabricated quantitative claim not present in the source. While the entity names (AbbVie, Genentech), drug (Venclexta), year (2023), and general structure of the collaboration (profit-sharing in the U.S.) are accurate, the inclusion of an unsupported specific dollar amount significantly undermines factual correctness. The reasoning is partially sound in recognizing the collaboration structure but fails in asserting an unverified figure, indicating a breakdown in multi-hop synthesis or data sourcing. The answer is contextually relevant and addresses both sub-questions, but with a critical error in quantitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 357,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "Despite issuing 48 million new Class C common shares in the May 2024 exchange offer, why does Visa's 10-K report only 10 Class C common shares outstanding as of September 30, 2024?",
      "original_answer": "Visa issued 48 million new Class C common shares in the May 2024 exchange offer in connection with the exchange of 241 million Class B-1 shares. However, the 10-K filing shows only 10 Class C common shares outstanding as of September 30, 2024. This discrepancy is explained by the fact that the 10 shares figure in the equity section is presented in millions, as noted in the table's header (\"millions, except per share data\"). Therefore, the 10 shares reported actually represent 10 million shares outstanding. This means that although 48 million Class C shares were newly issued in May 2024, the total outstanding amount was subsequently reduced by 38 million shares, likely through share repurchases, retirements, or other corporate actions not detailed in the provided excerpts.",
      "llm_answer": "\nThe 10‑K reports only ≈10 million Class C shares because the 48 million Class C shares that Visa issued in the May 2024 exchange were largely retired or immediately converted (and subject to conversion‑rate adjustments) into Class A shares, so only the 10 million shares that remained issued and outstanding as of September 30 2024 are reflected in the filing (see page 87).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Visa issued 48 million Class C shares in May 2024 and that only about 10 million remained outstanding as of September 30, 2024, which aligns with the ground truth. However, it incorrectly attributes the reduction from 48 million to 10 million to conversion into Class A shares or immediate retirement due to conversion mechanics, which is not supported by the original answer. The ground truth clarifies that the 10 in the 10-K represents 10 million shares (due to the 'millions' unit in the table header), but does not state that conversions to Class A caused the reduction. Instead, it suggests the decrease was likely due to share repurchases or retirements—actions not mentioned in the LLM response. (2) Quantitatively, the numbers (48 million issued, ~10 million outstanding) are accurate and dates (May 2024, September 30, 2024) match. The interpretation of the '10' as representing 10 million shares is correct, though the LLM does not explicitly note the 'millions' unit convention cited in the original answer, which is a key explanatory point. (3) The multi-hop reasoning is partially sound—connecting the exchange offer to the resulting share count—but fails in accurately synthesizing the reason for the discrepancy. It introduces an unsupported claim about conversion to Class A shares, which is not in the ground truth and misrepresents the explanation. (4) The contextual relevance is high because the answer addresses the core discrepancy and provides a plausible corporate action framework, but the incorrect causal explanation reduces factual accuracy. Thus, the correctness score is moderate due to partial factual alignment but significant reasoning flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 471,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "\nIn 2024 FedEx incurred **$582 million** of costs related to its business‑optimization activities, which include the Network 2.0 implementation and the broader DRIVE transformation.  \n\nFor the European workforce‑reduction plan announced in June 2024, the company expects **pre‑tax cash expenditures of $250 million to $375 million**, to be recognized through fiscal 2026.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $582 million cost for 2024 business optimization activities related to Network 2.0 and DRIVE transformation is accurately reported. The expected future cash expenditures for the European workforce reduction plan are correctly stated as $250 million to $375 million, with the timeframe through fiscal 2026. Minor wording differences (e.g., 'pre-tax cash expenditures' vs. 'cash expenditures') do not affect factual accuracy. (2) The numbers are exact matches to the original answer, with acceptable formatting variations (e.g., using 'million' instead of full numeric form). No calculations were required beyond what was provided in the source. (3) The multi-hop reasoning is sound: the answer correctly synthesizes two distinct financial figures from different initiatives (ongoing optimization costs and future restructuring costs) tied to specific programs and timelines. (4) All entities—FedEx, Network 2.0, DRIVE transformation, European workforce reduction plan, June 2024 announcement—are correctly identified and contextualized. The answer fully addresses both parts of the question with precise, relevant information, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 354,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "\nThe Company’s unbilled receivables that pertain to custom‑product and development‑service revenue totaled **approximately $126 million**—the portion of the $197 million of remaining performance‑obligation transaction price that is expected to be recognized in the next 12 months.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its key numeric claim. The ground truth states that AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021 was $329 million. The LLM incorrectly reports this value as approximately $126 million, which does not match the ground truth. Additionally, the LLM introduces a figure of $197 million as the remaining performance-obligation transaction price expected to be recognized in the next 12 months, a detail not present in the original answer and potentially conflating different financial metrics. This suggests a failure in multi-hop reasoning or data retrieval, as the model did not correctly identify or synthesize the correct figure from the relevant SEC filing. While the answer addresses the right topic (unbilled receivables related to custom products and development services) and attempts to provide a quantitative response, the core number is wrong, making the answer substantially inaccurate. The context and entity (AMD, custom product and development service revenue) are generally relevant, but the fiscal year 2021 is not explicitly confirmed in the LLM response, further reducing confidence in its accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 347,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "\nAbbVie’s Venclexta generated **$2.288 billion** of net revenue worldwide in 2023 (U.S. sales of $1.087 billion plus international sales of $1.201 billion).  Under the AbbVie‑Genentech collaboration, the pre‑tax profit from U.S. Venclexta sales is split equally, and AbbVie records **$869 million** as Genentech’s share of that profit (included in cost of products sold).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite addressing both parts of the question. The total revenue from Venclexta in 2023 is correctly stated as $2.288 billion (equivalent to $2,288 million), which matches the ground truth. However, the breakdown into U.S. ($1.087 billion) and international ($1.201 billion) sales is not present in the original answer and introduces unsupported detail. More critically, the LLM claims that AbbVie recorded $869 million as Genentech’s share of pre-tax profit, which is not mentioned in the ground truth. The original answer only states that AbbVie shares 50% of the pre-tax profit from U.S. sales with Genentech — a qualitative term — but provides no dollar amount. The $869 million figure appears to be an invented or miscalculated value not supported by the ground truth. (2) While the total revenue number is accurate (allowing for format variation: $2.288 billion = $2,288 million), the inclusion of a specific dollar amount for Genentech’s profit share ($869 million) is a quantitative overreach with no basis in the original answer. There is no way to verify this number from the ground truth, and it implies a level of precision that is incorrect. (3) The multi-hop reasoning is partially sound — the model correctly identifies the collaboration with Genentech and the 50% profit-sharing arrangement for U.S. sales. However, it fails by introducing a fabricated numerical value for the profit share, which undermines the reasoning. The model may have inferred or calculated this number from external data or incorrect assumptions, which violates factual fidelity. (4) The contextual relevance is high because the answer addresses both sub-questions and stays focused on the Venclexta collaboration. However, the correctness score is low due to the introduction of a false quantitative claim. The qualitative accuracy is moderate because the entities (AbbVie, Genentech, Venclexta, 2023) and the 50% profit-sharing structure are correct, but the erroneous $869 million figure severely impacts overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 560,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "\nThe 3.650% notes due 2023 fell from a $171 million balance at the end of 2022 to essentially $0 by the repayment date on 15 December 2023—a decline of roughly $171 million. This reduction is much smaller than the $400 million aggregate principal balance still outstanding for the 3.700% notes due 2023 on the same 15 December 2023 date.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers: the 3.650% notes due 2023 had a balance of $171 million on December 31, 2022, and decreased to $0 by December 15, 2023, resulting in a $171 million decline. It also correctly states that the 3.700% notes due 2023 had a $400 million balance on December 15, 2023. All numeric values and dates match the ground truth. (2) The calculation of the $171 million decrease is accurate, and the comparison between the two note balances on December 15, 2023, is factually sound. The only minor issue is the phrase 'much smaller' in 'This reduction is much smaller than the $400 million...', which mischaracterizes the comparison: the reduction ($171M) is being compared to the outstanding balance ($400M), not another reduction. This could mislead a reader into thinking the change was smaller in magnitude, but the intent is to contrast the payoff of one note versus the remaining balance of another. While semantically imprecise, it does not invalidate the factual content. (3) The multi-hop reasoning is sound: the model correctly tracks the change in the 3.650% notes over time and compares it to the balance of the 3.700% notes on the same date, synthesizing information across time points and instruments. (4) Scores reflect high accuracy in numbers and context, with a slight deduction in qualitative accuracy due to the ambiguous comparison wording. Correctness score is 8 due to this minor but notable phrasing issue that affects interpretation, despite correct underlying facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 423,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECD’s global minimum tax, could increase Visa’s effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visa’s financial position.",
      "llm_answer": "\nAdverse litigation that forces Visa to lower its interchange reimbursement rates would cut the fee earned on each transaction, directly reducing net revenue and cash flow even if transaction volumes held steady or grew modestly. The U.S. and Europe retrospective‑responsibility plans give only limited indemnity protection for such settlements, so the financial hit would be borne largely by Visa itself and could be amplified by the company’s ongoing tax disputes, which may increase cash‑outflows and pressure its overall financial position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial and operational implications of adverse litigation on Visa's interchange rates, transaction volumes, and overall financial position. (1) All factual elements are correct: the reduction in interchange fees directly impacts net revenue and cash flow; the U.S. and Europe retrospective responsibility plans offer only limited protection; and ongoing tax disputes exacerbate financial pressure. There are no numeric values in the question or ground truth requiring verification, so quantitative accuracy is scored as 10. (2) The answer correctly identifies all relevant entities—Visa, interchange reimbursement rates, U.S. and Europe retrospective responsibility plans, and tax disputes—and synthesizes their interplay logically. (3) The multi-hop reasoning is sound: it connects litigation outcomes → lower interchange rates → reduced revenue → limited indemnity → amplified impact from tax disputes. The only minor omission is that the original answer elaborates on behavioral responses by issuers (e.g., reducing cardholder benefits or promoting competing networks), which could indirectly lower transaction volumes. The LLM implies volume risk but focuses more on direct revenue impact. (4) Despite this slight brevity, the answer remains semantically equivalent in its conclusion about the significant financial risk to Visa. Contextual relevance is perfect—every sentence addresses the question directly. Thus, correctness is 9 due to minor completeness gap, but all other dimensions are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 427,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTC’s update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon’s update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each company’s incentive structure.",
      "llm_answer": "\nThe Performance‑Share‑Unit schedule for United Technologies’ Long‑Term Incentive Plan became effective with the plan’s revision in **January 2016** (the “Rev. January 2016” schedule referenced in Exhibit 10.15).  \nIn contrast, the Performance‑Share‑Unit schedule for Raytheon Technologies’ 2018 Long‑Term Incentive Plan was adopted as part of the plan amendment that was incorporated in the **March 31 2021 Form 10‑Q** (Exhibit 10.5), i.e., effective that date (the amendment itself had been approved on **December 6 2020**).  \n\nThese differing effective dates illustrate separate governance updates: UTX’s schedule reflects a 2016 refresh of its LTIP terms, while Raytheon’s schedule marks a post‑merger amendment adopted in 2021, underscoring distinct oversight and revision processes for each corporation’s incentive plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dates. The ground truth states the UTC Performance Share Unit award schedule effective date is January 1, 2020, but the LLM incorrectly states January 2016. This is a major error in quantitative accuracy. The Raytheon effective date is correctly identified as March 31, 2021, which matches the ground truth and is properly tied to the Form 10-Q filing. However, the mention of December 6, 2020 (approval date) is additional context not in the original answer and does not correct the core error on UTC. (2) Quantitative accuracy is low because the UTC date is off by four years, which fundamentally misrepresents the governance update timeline. The Raytheon date is accurate, but the core comparison between the two plans is undermined by the UTC error. (3) The reasoning is partially sound: the model recognizes that different dates reflect separate governance updates and attempts multi-hop synthesis by linking each date to a specific filing or amendment. However, the incorrect UTC date leads to flawed conclusions about the nature of the update (a 2016 refresh vs. a 2020 amendment and restatement). The ground truth ties UTC’s update specifically to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, which the LLM fails to mention. (4) Contextual relevance is high because the answer addresses both plans, attempts to explain governance implications, and references specific exhibits and filings. However, due to the critical error in the UTC effective date, the overall correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 454,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "\nIn 2022 the Wearables, Home and Accessories segment grew 7 % to $41.2 billion, and that expansion was attributed almost entirely to stronger sales of the Apple Watch and AirPods (including the second‑generation AirPods Pro and the new AirPods 3).  By contrast, other sub‑categories within the segment—such as Beats, HomePod mini and general accessories—showed only modest or flat growth, so the bulk of the segment’s revenue increase came from the Apple Watch and AirPods outperforming their peers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Apple Watch and AirPods as the primary growth drivers in the Wearables, Home and Accessories segment for 2022, which matches the original answer. It also correctly contrasts their strong performance with the modest or flat growth of other categories like Beats and HomePod mini, accurately reflecting that these were not major contributors. (2) The quantitative details—7% growth to $41.2 billion—are factually correct and consistent with Apple’s 2022 10-K filing. While the original answer does not include these specific figures, their inclusion adds precision and does not contradict the ground truth. The mention of AirPods 3 and second-generation AirPods Pro is a minor addition not present in the original, but it is contextually plausible and does not introduce inaccuracy. (3) The multi-hop reasoning is sound: the model correctly infers that because growth was concentrated in Apple Watch and AirPods, other product lines must have underperformed or remained flat, which is a valid interpretation of segment dynamics. (4) The answer is semantically equivalent to the original, with slightly more detail. The only reason for not scoring a 10 is that the original answer does not specify the exact revenue or growth rate, so including them—while accurate—introduces data not confirmed in the knowledge graph used for ground truth. However, this does not reduce correctness. All entities (Apple Watch, AirPods, Beats, HomePod mini) and the year 2022 are correctly identified. The answer is fully relevant and directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 451,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "\nBoth Otezla and ENBREL are expected to see a dip in first‑quarter 2025 sales that mirrors the historical pattern they have shown—lower sales in Q1 relative to later quarters—because of benefit‑plan changes, insurance reverification and higher co‑pay costs as U.S. patients meet their deductibles. In other words, the insurance‑reverification impact on Otezla’s 2025 outlook is comparable to the same quarterly softness that ENBREL has experienced in prior years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that both Otezla and ENBREL are expected to experience lower sales in Q1 2025 due to insurance reverification and higher co-pay costs as patients work through deductibles—this matches the original answer exactly in substance. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the time period '2025' and the reference to 'first quarter' are correctly used. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the impact on Otezla’s 2025 sales is comparable to ENBREL’s historical pattern, and both follow the same seasonal trend. (4) All entities—Otezla, ENBREL, 2025 sales expectations, insurance reverification, U.S. patient deductibles—are accurately referenced and logically connected. The answer fully addresses the comparison between the two drugs and identifies the shared historical trend. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 291,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "\nRTX discloses two separate exhibits that detail stock‑appreciation‑right awards: **Exhibit 10.16**, which contains the schedule of terms for SARs under the United Technologies 2005 Long‑Term Incentive Plan, and **Exhibit 10.24**, which contains the schedule of terms for SARs under the Raytheon Technologies 2018 Long‑Term Incentive Plan. No other distinct SAR‑related exhibits are listed for those plans in the 2023 10‑K.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It correctly identifies that RTX disclosed 2 distinct stock appreciation rights (SAR)-related exhibits in its 2023 10-K, one for each of the specified incentive plans: the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan. (2) The quantitative accuracy is perfect: the number '2' is correct, and the exhibit numbers (10.16 and 10.24) are accurately cited, which aligns with the expected level of detail. There are no calculations, but the count is precise. (3) The multi-hop reasoning is sound—this question requires identifying SAR-related exhibits across two different legacy plans within a single filing, and the LLM correctly synthesizes this information by naming both exhibits and linking them to the correct plans. (4) The answer is contextually relevant, complete, and adds value by including specific exhibit numbers, which enhances precision without introducing errors. Semantic equivalence is maintained and exceeds the ground truth in detail while remaining factually consistent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 326,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "\nThe first‑quarter “insurance‑reverification” cycle historically depresses sales of both ENBREL and Otezla, and in 2025 that dip will be compounded by the companies’ expectations of continued net‑selling‑price declines. Consequently, the combined 2025 sales of the two drugs are likely to start the year lower than the prior year, with the early‑quarter weakness offsetting any volume gains and keeping overall 2025 revenue under pressure.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core impact of insurance reverification on the combined sales performance of ENBREL and Otezla in 2025, aligning with the ground truth's key points. It accurately reflects that the first-quarter insurance reverification cycle historically depresses sales and that continued net selling price declines will compound this effect in 2025. The answer correctly identifies that revenue will be under pressure and that volume gains (if any) will be insufficient to offset price declines. However, it omits specific quantitative details present in the original answer: (1) the 8% decrease in Otezla’s net selling price in 2024, and (2) the 3% volume growth for Otezla in 2024, which are critical for fully substantiating the expectation of a similar dynamic in 2025. While the LLM implies ongoing price declines, it does not explicitly state ENBREL’s expected flat volumes or Otezla’s historical price trend, weakening the multi-hop synthesis slightly. The reasoning is sound and contextually appropriate, and all entities (ENBREL, Otezla, 2025, insurance reverification, net selling price) are correctly identified. The answer is semantically close but lacks the precise numerical support that would make it fully equivalent to the ground truth, warranting a high but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 368,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "\nThe filing indicates that Otezla’s U.S. sales are expected to feel a low‑single‑digit percentage hit beginning in 2025 – a continuation of the 8 % net‑price dip that cut its 2024 revenue and the added pressure of higher co‑pay amounts as patients work through deductibles.  ENBREL, which already fell about 10 % in 2024, is projected to suffer a similar or slightly larger mid‑single‑digit to low‑double‑digit decline starting in 2026 when the IRA‑mandated Medicare Part D price‑setting takes effect.  This reflects Amgen’s recurring pattern of forecasting modest, ongoing revenue erosion for its mature key drugs as benefit‑plan changes, co‑pay increases and Medicare price‑setting compress net selling prices.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Otezla will face revenue pressure starting in 2025 due to increased co-pay expenses and insurance dynamics, and ENBREL will see further declines starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act (IRA). It accurately reflects the pattern of recurring revenue erosion for mature drugs. However, the ground truth does not specify exact percentage declines (e.g., 'low-single-digit', 'mid-single-digit to low-double-digit') or reference a prior 8% net-price dip in 2024 for Otezla or 10% decline for ENBREL—these quantitative details are not present in the original answer and appear to be extrapolations or inferences not supported by the provided ground truth. (2) While the years (2025 for Otezla, 2026 for ENBREL) and regulatory drivers (Medicare Part D, IRA) are correct, the specific percentages introduced in the LLM answer (8%, 10%, low/mid/high single/double digits) lack direct support in the original answer, reducing quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the impact of co-pay dynamics and regulatory pricing across two drugs and timeframes, and connects them to a broader pattern in AMGN’s revenue forecasting. It captures the cyclical nature of first-quarter declines and recovery, aligning with the original answer’s emphasis on predictable patterns. (4) Despite the unsupported precision in percentages, the core facts, entities, and reasoning are correct, and the answer addresses all parts of the question. Hence, correctness is high but not perfect due to the addition of unverified numerical specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 454,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "\nThe repurchase liabilities for client‑held fractional shares had a fair‑value of **$2,543 million** as of December 31 2024 (the same amount reported as “Other securities owned at fair value (2)” for those fractional‑share assets). Schwab records these liabilities at fair value, and because the unrealized gains and losses on the underlying fractional‑share assets are exactly offset by opposite unrealized gains and losses on the corresponding repurchase liabilities, **there is no net impact on the consolidated statements of income**.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states a specific dollar amount ($2,543 million) for the fair value of repurchase liabilities, which is not present in the original answer (ground truth). The ground truth does not provide a numerical value but instead explains that the fair value is equal to the value of the corresponding client-held fractional shares, which are included in accrued expenses and other liabilities. This quantitative inaccuracy significantly undermines factual correctness. (2) There is no verification possible for the $2,543 million figure, as it does not appear in the ground truth; thus, the quantitative accuracy is low. The date (December 31, 2024) is correct, and the reference to 'Other securities owned at fair value (2)' may reflect internal filing terminology, but without corroboration in the ground truth, it introduces unverified detail. (3) The reasoning regarding accounting treatment—specifically that unrealized gains and losses on repurchase liabilities are offset against those on the related assets, resulting in no net impact on income—is logically sound and matches the ground truth. This shows correct multi-hop synthesis between liabilities, assets, and income statement impact. (4) Despite the major error in introducing an unsupported numerical value, the LLM correctly identifies the accounting methodology and its income statement implications, which are central to the second part of the question. Hence, qualitative accuracy and contextual relevance are high, but the correctness score is limited by the fabricated number, which misrepresents the factual record.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 443,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "\nThe proposal would value AspenTech at a fully‑diluted market capitalization of **$15.3 billion**. This is roughly **15 times** AspenTech’s 2023 net sales of **$1.04 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the implied fully diluted market capitalization of AspenTech as $15.3 billion and AspenTech's 2023 net sales as $1.04 billion, matching the ground truth exactly. The valuation multiple is calculated as approximately 15x, which is a rounded version of the ground truth's 14.7x. This minor rounding is acceptable and does not affect factual correctness. (2) All numeric values are accurate: $15.3 billion and $1.04 billion are correctly stated. The implied multiple (15.3 / 1.04 ≈ 14.71) is accurately represented as 'roughly 15 times', which is a reasonable approximation. (3) The multi-hop reasoning is sound: the model synthesizes the acquisition proposal value and net sales data to compute a meaningful valuation multiple, correctly linking Emerson's offer to AspenTech's financial performance. (4) The answer is contextually complete and relevant, addressing both parts of the question—market cap and comparison to net sales. The only minor shortcoming is the lack of the precise 14.7x figure, but 'roughly 15 times' preserves semantic equivalence. Thus, the answer is highly accurate with only a slight loss in precision, warranting a 9/10 on correctness and qualitative accuracy, while maintaining perfect scores in quantitative and contextual dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 365,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 2010–2012 and 2013–2015 is $8.7 billion ($3.6 billion for 2010–2012 and $5.1 billion for 2013–2015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "\nThe IRS Notices could expose Amgen to roughly $3.6 billion of extra federal tax for 2010‑2012 and about $5.1 billion of extra tax plus roughly $2 billion of penalties for 2013‑2015—a combined potential liability of roughly $10.7 billion. However, previously accrued repatriation taxes of up to $0.9 billion for the 2010‑2012 years and up to $2.2 billion for the 2013‑2015 years would offset that exposure, reducing the net additional liability to about $2.7 billion and $4.9 billion respectively (≈ $7.6 billion in total).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures from the ground truth: $3.6 billion for 2010–2012, $5.1 billion for 2013–2015, and $2.0 billion in penalties, totaling $10.7 billion in potential liability. It also accurately states the previously accrued repatriation taxes of $0.9 billion (2010–2012) and $2.2 billion (2013–2015), totaling $3.1 billion. The net liability is correctly calculated as $7.6 billion. (2) All numbers match the original answer exactly, with acceptable formatting variations (e.g., 'roughly' and 'about' are reasonable qualifiers given the uncertainty in tax matters). The sum of $3.6B + $5.1B + $2.0B = $10.7B is correct; the reduction by $3.1B to $7.6B is also accurate. (3) The multi-hop reasoning is sound: the model synthesizes tax exposure across two periods, adds penalties, and correctly applies the offset from previously accrued repatriation taxes. However, the phrasing 'reducing the net additional liability to about $2.7 billion and $4.9 billion respectively' is slightly misleading—it implies separate net liabilities per period, but the original answer presents a single net total of $7.6 billion. While the final total is correct, this intermediate breakdown could confuse readers. (4) Despite this minor ambiguity in presentation, the core facts, calculations, and synthesis are fully accurate. The answer is contextually complete and relevant, addressing both parts of the question. Thus, correctness is scored 9 due to the slight imprecision in explaining the reduction, though quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 437,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "\nThe 2024 10‑K filing shows that, under the Inflation Reduction Act, ENBREL was among the first ten drugs placed in Medicare’s mandatory price‑setting program, and CMS subsequently set a Medicare Part D price for ENBREL that is markedly lower than today’s rates—an outcome the filing says will “negatively impact its profitability in Medicare.” Because the same statutory mechanism will next apply to Otezla (selected for the 2027 cycle), Amgen faces the additional risk that Otezla could be subject to the same government‑determined, below‑market pricing, further eroding its Medicare revenue and overall financial outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial implications of ENBREL and Otezla's inclusion in the Medicare price-setting program under the Inflation Reduction Act (IRA). It correctly identifies that ENBREL was selected under the IRA's mandatory price-setting program with a lower CMS-set price under Medicare Part D, effective January 1, 2026 (implied by '2026' in context of 2024 10-K), which will negatively impact Amgen's profitability. The answer also correctly notes that Otezla has been selected for the 2027 cycle (effective January 1, 2027), posing a future risk of government-determined pricing and further revenue erosion. All entities (ENBREL, Otezla, CMS, Medicare Part D, IRA) and timeframes are accurately referenced. The only minor omission is that the original answer explicitly mentions the IRA allows up to 100 drugs to be subject to price setting by 2031 and that other Amgen products may be at risk in future cycles—a point not included in the LLM response. However, the core multi-hop reasoning (linking IRA → ENBREL price cut → profitability impact → Otezla future risk) is sound and factually aligned. Quantitative accuracy is perfect: dates and program details are correct, and no numerical errors are present. Wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent but slightly less complete than the ground truth, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 400,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "\nBecause Schwab elects the fair‑value option for the repurchase liabilities tied to client‑held fractional shares, those liabilities are marked‑to‑market using quoted market prices. The resulting unrealized gains and losses on the liabilities are exactly offset by the unrealized gains and losses on the corresponding client‑held fractional‑share assets, so the net effect is recorded only in other assets/liabilities and does not flow through the consolidated statements of income. Consequently, the election eliminates any income‑statement impact from fluctuations in the fair value of those repurchase obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the core mechanism described in the ground truth: Schwab uses quoted market prices to measure repurchase liabilities under the fair value option (ASC 825), leading to unrealized gains/losses that are offset by corresponding gains/losses on client-held fractional shares, resulting in no net impact on the consolidated statements of income. The answer correctly identifies the accounting treatment and the absence of income statement impact. It omits the specific point about credit risk—namely, that no gains or losses are recognized due to instrument-specific credit risk because the liabilities do not carry such risk. This is a minor omission that does not undermine the main conclusion but reduces completeness slightly. There are no numerical inaccuracies (quantitative accuracy is perfect, as no specific numbers are involved and the logic is sound). The reasoning is multi-hop, connecting fair value election, use of market prices, offsetting with assets, and income statement impact—all correctly synthesized. The answer is highly relevant and semantically equivalent to the original, with only slight gaps in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 331,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "\nThe company estimated the LTC reporting unit’s fair value by jointly applying a discounted‑cash‑flow model and a market‑multiple approach; the market multiples provided a benchmark valuation that, when combined with the DCF projections, produced a fair‑value estimate below the unit’s carrying amount, which triggered the $431 million goodwill impairment charge recorded in 2021.  The impairment was precipitated by the November 2021 announcement that the Board had authorized closing roughly 900 stores over the next three years (≈300 per year beginning in 2022); this store‑closure strategy created the indicators of impairment that led management to perform a long‑lived‑asset test and record a $1.4 billion store‑asset write‑down (mainly right‑of‑use and property‑and‑equipment) within the Retail/LTC segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $431 million goodwill impairment charge for the LTC reporting unit in 2021 and accurately attributes it to the combined use of the discounted cash flow and market multiple methods, which showed fair value below carrying value. It also correctly references the November 2021 announcement of closing approximately 900 stores over three years (300 per year starting in 2022) and links this to a long-lived asset impairment test resulting in a $1.4 billion charge. The breakdown of the $1.4 billion charge into $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment is implied as a total but not explicitly itemized in the LLM answer—this is a minor omission. (2) All numeric values—$431 million, $1.4 billion, 900 stores, 300 per year, 2021 announcement—are factually correct and match the ground truth. Date (November 2021) is accurate. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly connects the valuation methods to the goodwill impairment, links the store closure announcement to triggering the long-lived asset test, and associates both events with the Retail/LTC segment. The synthesis across events and financial impacts is logically coherent. (4) The answer is contextually fully relevant, addressing both parts of the question. The only reason for not scoring a 10 is the lack of explicit breakdown of the $1.4 billion impairment into its components, which is present in the ground truth and adds granularity. However, since the total amount is correct and the context is preserved, the answer remains highly accurate and complete in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 459,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "\nThe “Cash and investments segregated and on deposit for regulatory purposes” rose from **$20,358 million** at December 31 2023 to **$25,740 million** at December 31 2024, an increase of **$5,382 million**. All of this increase comes from Level 2 assets (the entire $5,382 million increase is attributable to Level 2 holdings).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. According to the ground truth, the correct starting value on December 31, 2023, is $11,438 million, not $20,358 million, and the ending value on December 31, 2024, is $12,416 million, not $25,740 million. This leads to a correct increase of $978 million, not $5,382 million. Additionally, the contribution from Level 2 assets is stated as $1,205 million (from $8,810M to $10,015M), not $5,382 million. The LLM incorrectly claims the entire increase comes from Level 2, but while the ground truth does say Level 2 growth exceeds the total increase (implying it funded the rise), the magnitude is wrong in the LLM response. (2) All calculations are based on incorrect inputs: $25,740M - $20,358M = $5,382M is arithmetically correct, but the underlying data is false. The ground truth shows a $978M total increase and a $1,205M increase in Level 2 assets, meaning Level 2 grew more than the total category, which the LLM fails to reflect accurately. (3) The multi-hop reasoning is flawed: the model should have identified the correct total 'Cash and investments segregated...' values for both years, computed the difference, then isolated the Level 2 asset change over the same period. Instead, it uses entirely incorrect figures, suggesting a failure to retrieve or synthesize the correct data from the knowledge base. (4) The contextual relevance is partially maintained—structure and intent align with the question—but the complete numerical inaccuracy results in a correctness score of 1. Quantitative accuracy is severely lacking (score: 1), qualitative reasoning is unsound due to wrong data synthesis (score: 1), and contextual relevance is low but not zero because the answer attempts the right type of analysis (score: 3).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 491,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "\nEmerson separates the fair‑value of the AspenTech replacement awards into a pre‑combination component (included in the purchase price) and a post‑combination component (expensed over the remaining service period). The pre‑combination portion—measured with a Black‑Scholes model using AspenTech’s historic volatility, expected life derived from its exercise/cancellation history, the U.S. Treasury yield matching that life, and a zero dividend yield—was valued at **$102 million**, based on the **66,662,482** Heritage AspenTech shares outstanding and a **$166.30** share price that together gave the $11.1 billion purchase price. This $102 million of stock‑based compensation expense is treated as part of the consideration transferred, while the remainder of the compensation expense is recognized as post‑combination stock‑based compensation expense.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly describes the general principle of allocating stock-based compensation between pre- and post-combination periods under ASC 805, it introduces specific numbers not present in the ground truth: $102 million, 66,662,482 shares, $166.30 share price, and $11.1 billion purchase price. These figures are either incorrect or not mentioned in the original answer, which only states Emerson's 55% ownership and the use of the closing market price on May 16, 2022. The ground truth does not specify a valuation model (e.g., Black-Scholes), volatility inputs, expected life, risk-free rate, or dividend yield—yet the LLM fabricates these details, which undermines quantitative and qualitative accuracy. (2) The original answer does not include any dollar amounts for the compensation expense or the total purchase price, nor does it mention the number of shares or per-share valuation used in the allocation—only that the fair value was based on the closing market price on May 16, 2022. Thus, all numerical claims in the LLM response fail verification. (3) The multi-hop reasoning is partially sound in that the model correctly identifies the accounting treatment under ASC 805 and the conceptual split of compensation expense. However, it incorrectly infers that detailed valuation inputs (like Black-Scholes parameters) were used in the allocation, which is not supported by the ground truth. The original answer only mentions the use of the market price and Emerson’s 55% ownership, not complex modeling. (4) The contextual relevance is high because the response addresses the core accounting treatment and allocation logic. However, the correctness score is low due to the invention of precise financial data and valuation methodology not present in the source, making the answer misleading despite a structurally reasonable framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 519,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "\nAs of December 31 2021 the fair‑value of CVS’s holdings in “States, municipalities and political subdivisions” was $3.09 billion (including $5 million classified as Level 3), representing roughly 68 % of the company’s total debt‑securities portfolio. The provided disclosures only give the 2021 amount and do not include a comparable 2022 figure, so the exact percentage change from 2021 to 2022 cannot be calculated from the excerpt; however, the segment’s share of the debt‑securities portfolio remained essentially unchanged.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that the 2021 value was $3.09 billion (correct: $3,091 million, which is equivalent), but more importantly misrepresents the percentage of the portfolio: it claims these securities were 68% of the total debt securities portfolio in 2021, whereas the ground truth shows they were only 13.3% ($3,091M out of $23,240M). This is a massive quantitative and qualitative error. Additionally, the LLM claims that 'the provided disclosures only give the 2021 amount' and that 'a comparable 2022 figure is not included,' which contradicts the ground truth that clearly provides the 2022 value ($170 million). In reality, the value dropped to $170 million in 2022, representing a 94.5% decrease, which the LLM completely fails to report. (2) The calculation of percentage change is entirely omitted, and the stated portfolio composition (68%) is factually wrong—no support from ground truth. The 2022 portfolio share is also misrepresented as 'essentially unchanged,' when in fact it dropped from 13.3% to 4.9%, a significant shift. (3) The multi-hop reasoning failed: the model did not synthesize the correct values across years, did not compute the percentage change, and misrepresented the impact on portfolio composition. Instead, it falsely claimed data was missing. (4) Due to severe factual inaccuracies in numbers, percentages, and reasoning, and failure to address the core question, the correctness score is very low. Quantitative accuracy is poor due to wrong numbers and missing calculations. Qualitative accuracy is low due to flawed logic and entity/metric misrepresentation. Contextual relevance is minimal as the answer incorrectly asserts data limitations and misses the actual trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 485,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "\nThe conversion of Visa’s class B common stock will be triggered only when the U.S. covered litigation is finally resolved, and its scale hinges on the accrual balance the company has recorded for that matter (the $1.44 billion accrual that reflects its best estimate of the probable loss and the $850 million escrow deposit made in 2022). Because the actual loss may differ substantially from that estimate—especially if negotiated settlements or trial outcomes change—the amount of class B stock that ultimately converts, and therefore the degree of dilution to existing class A shares, remains uncertain and could materially affect the market price and voting power of class A common stockholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core mechanism—conversion of class B to class A stock is tied to the final resolution of U.S. covered litigation—and links accrual activity to uncertainty in conversion timing and dilution impact. However, it introduces specific numeric values ($1.44 billion accrual, $850 million escrow deposit in 2022) that are not present in the original ground truth answer, making them unverifiable and potentially inaccurate. Since the ground truth does not specify these numbers, their inclusion risks factual overreach, even if they may reflect real data. (2) Quantitative accuracy is compromised because the answer asserts precise figures without confirmation from the source knowledge; while such numbers may exist in actual filings, they were not part of the verified ground truth, so their use cannot be scored as correct. The format variation allowance does not extend to introducing unsupported specifics. (3) Qualitatively, the reasoning is sound: it captures the multi-hop logic—accrual reflects estimated liability, actual outcomes may differ, this affects conversion scale and timing, which in turn creates dilution and valuation risk for class A shareholders. This aligns with the original answer’s causal chain. (4) Contextual relevance is high—the response directly addresses both parts of the question: the dependency of conversion on litigation accrual/resolution and the resulting financial uncertainty for class A holders. Overall, the answer is semantically close and logically coherent but penalized for introducing unverified quantitative details not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 448,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "\nThe fair value of Cisco’s available‑for‑sale debt investments fell from **$15.592 billion on July 29 2023** to **$9.865 billion on July 27 2024**, a decline of **$5.727 billion**.  At the same time, net losses on those investments widened from **$21 million in fiscal 2023** to **$67 million in fiscal 2024**, an increase of **$46 million year‑over‑year**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value decrease is correctly calculated as $5.727 billion (from $15.592 billion to $9.865 billion), and the net loss increase is correctly stated as $46 million (from $21 million loss to $67 million loss). The use of 'billion' instead of 'million' in labeling is consistent in magnitude ($5.727 billion = $5,727 million) and does not affect accuracy. (2) The answer addresses both parts of the question completely: the change in fair value and the year-over-year change in net losses. (3) Entities are correct—Cisco is the subject, the correct fiscal dates (July 29, 2023, and July 27, 2024) are used, and the financial metrics (fair value of available-for-sale debt investments, net losses) are properly identified. (4) The multi-hop reasoning is sound: the model correctly synthesized data across time points and financial statements to compute changes in both fair value and net losses. (5) The semantic meaning is equivalent to the original answer, with clear, precise, and well-formatted presentation. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 334,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "\nThe 2021 growth in ExtraBucks Rewards earnings and new gift‑card issuances pushed the contract‑liability balance up from $71 M to $87 M, but the company simultaneously recognized revenue from redemptions and from breakage (the portion of gift‑card balances it expects will never be redeemed, estimated using historical redemption patterns). As a result, revenue for the period reflects the amount actually redeemed during 2021, while the remaining unredeemed balances continue to be carried as a liability until they are either redeemed or written off as breakage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The claim that the contract liability balance increased from $71M to $87M due to growth in ExtraBucks Rewards and gift card issuances is not supported by the ground truth, which does not mention these specific figures or a net increase in liability. In fact, the ground truth emphasizes a reduction in contract liability due to redemptions, not an increase. This misrepresents the financial impact and direction of change. (2) The numbers $71M and $87M appear to be fabricated or misremembered, as they are not present in the original answer and contradict its narrative of liability reduction. There is no verification of these figures in the context provided, and no calculation or source is offered. This severely undermines quantitative accuracy. (3) While the LLM correctly identifies the concepts of breakage and revenue recognition based on historical redemption patterns, it fails to accurately synthesize the multi-hop reasoning: the net effect on revenue recognition should reflect both redemption (reducing liability and recognizing revenue) and breakage (reclassifying unlikely-to-be-redeemed balances to revenue), but the emphasis on liability growth contradicts the actual trend. The original answer clearly states that liabilities were reduced due to redemptions, and breakage contributed to revenue—this nuance is lost. (4) Despite the factual errors, the LLM answer remains contextually relevant by addressing the core mechanisms of revenue recognition related to gift cards and rewards, including breakage and redemption patterns. It uses correct terminology and outlines the general accounting treatment, which aligns with the question's intent, even if the specific financial dynamics are misrepresented. Thus, while the reasoning framework is partially sound, the incorrect data and directional misstatement (increase vs. decrease in liability) lead to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 548,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Company’s funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "\nFunding the U.S. litigation escrow account triggers a downward adjustment to the conversion rate of class B common stock into class A common stock—fiscal 2022 the adjustment reduced the as‑converted class A share count by 4 million shares, with an effective price of $205.06 per share (see page 91).  This adjustment is tied to the $850 million deposit made into the escrow account, which supports the $861 million provision for U.S. covered litigation recorded in fiscal 2022, raising the accrued U.S. covered‑litigation balance to $1.44 billion (see page 102).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: funding the U.S. litigation escrow account triggers a downward adjustment in the class B to class A conversion rate, which occurred in fiscal 2022. The $850 million deposit into the escrow account is accurately stated and tied to the $861 million litigation provision, increasing the accrued balance to $1.44 billion—this matches the fiscal 2022 accrual activity. The reduction of 4 million as-converted class A shares at $205.06 per share is quantitatively precise and consistent with disclosed data. (2) Quantitative accuracy is perfect: all dollar amounts ($850M, $861M, $1.44B), share count (4 million), and price per share ($205.06) are correct and contextually appropriate. (3) The multi-hop reasoning is sound—linking escrow funding to stock conversion mechanics and then to litigation provision accounting reflects proper synthesis across financial and structural domains. (4) The only minor limitation is that the answer adds specific figures (e.g., 4 million shares, $205.06) not present in the original ground truth, which is more general. However, since these numbers are factually correct and enhance precision without contradicting the original, this does not constitute an error. The answer fully addresses both parts of the question: the effect on conversion rate and the financial impact on the litigation provision. Thus, it earns a 9/10 for correctness and qualitative accuracy due to slightly超出 the scope of the original answer with verified but unrequested detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 433,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "\nThe fair value of Cisco’s available‑for‑sale debt investments fell $5.7 billion, dropping from $15.6 billion on July 29 2023 to $9.9 billion on July 27 2024.  A hypothetical 100‑basis‑point increase in interest rates would have reduced the 2023 fair value by about $0.21 billion (to $15.39 billion) and the 2024 fair value by about $0.13 billion (to $9.74 billion), shaving roughly $0.21 billion and $0.13 billion off total investments respectively (≈ $0.34 billion in combined impact).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend and structure of the ground truth but contains significant numerical inaccuracies. The decrease in fair value is reported as $5.7 billion, which is close to the correct $5,727 million ($5.727 billion), so this part is approximately correct. However, the individual year-end values are rounded to $15.6 billion and $9.9 billion, which are acceptable approximations of $15,592 million and $9,865 million. (2) The critical error lies in the interest rate sensitivity analysis: the LLM states that a 100 bps increase would reduce the 2023 value to $15.39 billion (vs. correct $15,386 million = $15.386 billion — acceptable), but for 2024 it reports $9.74 billion (vs. correct $9,736 million = $9.736 billion — also close). However, the LLM incorrectly frames the impact as incremental reductions of $0.21B and $0.13B, implying separate effects, whereas the original answer focuses on the comparative decline between adjusted years ($15,386M to $9,736M = $5,650M difference). The LLM fails to compute or mention this adjusted-period difference of $5,650 million, which is a key part of the original answer’s conclusion about the 'same general trend of decline even under interest rate stress.' (3) Multi-hop reasoning is partially sound — the model identifies the two time points, computes a rough decline, and applies sensitivity impacts — but it does not synthesize the counterfactual scenario across both years to compare the adjusted total decline, which is central to the original answer. (4) Scores reflect that core numbers are in the right range (supporting a moderate correctness score), but missing and misinterpreted calculations — especially the failure to report the $5,650 million adjusted difference — reduce quantitative and qualitative accuracy. Contextual relevance is high as all parts of the question are addressed in intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 513,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "\nThe Company recorded a $861 million provision for U.S. covered litigation in fiscal 2022 (see the “Accrual Summary‑U.S. Covered Litigation” table), which pushed the accrued litigation balance from $881 million at the start of the year to $1.44 billion by year‑end after $301 million of payments and $850 million of escrow deposits.  This accrual is generated under the U.S. Retrospective Responsibility Plan by triggering a loss‑share charge when a loss is deemed probable and reasonably estimable, and it is funded through the litigation escrow account, indemnification obligations, and the conversion‑feature mechanism that adjusts the conversion rate of the Company’s preferred stock.  Consequently, the litigation provision reflects the plan’s mix of escrow funding, member indemnity, and loss‑sharing allocations that together determine the amount recognized in the financial statements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$861 million provision, $881 million starting balance, $1.44 billion ending balance, $301 million payments, and $850 million escrow deposits—that are not present in the original answer (ground truth). The ground truth does not provide any actual dollar amounts or reference fiscal year 2022, so these figures cannot be verified as correct and appear to be hallucinated. (2) Calculations implied in the LLM answer (e.g., $881M + $861M - $301M = $1.442B) are mathematically consistent, but since the inputs are not supported by the ground truth, the quantitative accuracy is low. There is no mention of preferred stock conversion features or a 'conversion-feature mechanism' in the original answer, which introduces an unsupported financial mechanism. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies that the accrual is tied to the U.S. Retrospective Responsibility Plan and mentions key mechanisms like the litigation escrow and indemnification obligations. However, it overreaches by adding unverified details about funding mechanisms and specific financial flows not present in the ground truth. (4) While the LLM captures the general idea that the litigation provision is triggered when a loss is probable and reasonably estimable, and that the plan involves escrow and indemnification, it adds significant unsupported detail, reducing factual correctness. The contextual relevance is high because it addresses the core topic and attempts to explain the relationship between accrual activity and the plan’s mechanisms. However, the hallucinated numbers and extra mechanisms severely undermine factual accuracy, warranting a correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 475,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "\nThe Heritage AspenTech acquisition contributed about **0.6 percentage‑points** to the rise in Emerson’s gross‑margin percentage in 2023, and as a result Emerson’s gross‑margin for that year was **49.0 %**. (Source: EMR_10K_2024.pdf, page 26)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values '0.6 percentage points' and '49.0%' are accurately reported, with acceptable formatting variations (e.g., 'percentage-points' with a hyphen, '%' symbol). (2) The answer addresses both parts of the question: the contribution of the Heritage AspenTech acquisition to the gross margin increase (0.6 pp) and the resulting total gross margin percentage for 2023 (49.0%). (3) Entity accuracy is correct—'Emerson (EMR)', 'Heritage AspenTech acquisition', and '2023' are properly identified. (4) The reasoning is sound and reflects proper synthesis from the source document (EMR_10K_2024.pdf, page 26), indicating accurate multi-hop understanding. The inclusion of the source adds credibility. Semantically, the answer conveys the same information as the original with no factual or interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 262,
        "total_tokens": 1388
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "\nCisco’s guarantee of third‑party financing to its channel partners means that, if those partners are unable to meet their payment obligations, Cisco may have to cover the guaranteed amounts, turning the financed receivables into a direct credit‑loss exposure. Consequently, the company includes the credit‑risk of these partners—particularly in a volatile macro‑economic environment—in its allowance for credit losses on financing receivables.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core assertion: Cisco's guarantee of channel partner financing increases its credit loss exposure because it may be required to cover payments if partners default. It correctly identifies that this exposure is tied to the credit risk of channel partners and is factored into Cisco's allowance for credit losses, particularly under macroeconomic volatility. There are no numeric values in either the original or LLM answer, so quantitative accuracy is scored as 10 by default. The LLM captures the key multi-hop logic—linking the guarantee structure to potential direct liability and inclusion in credit loss allowances. However, it omits specific contextual details present in the ground truth, such as the 60- to 90-day payment terms, the revolving nature of the financing, and the explicit mention of internal credit risk ratings and historical default rates used in loss modeling. While the semantic meaning is largely equivalent, these omissions reduce completeness and depth in qualitative accuracy. The answer remains highly relevant and correct in reasoning, hence a strong score overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 321,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emerson’s broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "\nEmerson’s 55 % ownership of AspenTech translates into roughly **$600 million** of the $1.09 billion of AspenTech revenue reported for 2024 (0.55 × $1.093 bn ≈ $0.60 bn).  That $600 million is embedded in Emerson’s overall **Software and Control** segment, which generated $5.399 billion of revenue in 2024, meaning AspenTech’s contribution represents about **11 %** of that total segment revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Emerson's 55% ownership in AspenTech and calculates the proportional revenue share as approximately $600 million, which is a rounded but accurate representation of the exact $601.15 million (55% of $1,093 million). The use of $1.09 billion and $0.60 billion is a valid rounding for clarity and consistency with common financial reporting practices. (2) The calculation 0.55 × $1.093 billion = $0.60115 billion ≈ $600 million is quantitatively sound, and the percentage contribution to Emerson’s Software and Control segment is correctly estimated at about 11% ($600M / $5,399M ≈ 11.11%), matching the ground truth's implication that it represents over 10%. (3) The multi-hop reasoning is solid: the model correctly links Emerson’s ownership stake to revenue attribution, identifies AspenTech’s revenue as embedded within Emerson’s broader segment reporting, and contextualizes the relative importance of AspenTech within that segment. (4) All entities (Emerson, AspenTech, Software and Control segment, 2024 fiscal year) are accurately referenced. The only minor shortcoming is the lack of explicit mention that AspenTech contributes 'over 10%' (ground truth phrasing), though stating 'about 11%' is more precise. Wording differences are semantically equivalent and do not detract from correctness. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 395,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operations—net of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizer’s capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "\nThe 2020 Upjohn spin‑off generated a $12 billion cash distribution to Pfizer, which it used to retire commercial‑paper borrowings and redeem $1.15 billion of 1.95 % notes and $342 million of 5.80 % notes, thereby reducing its debt load and improving liquidity; the separation also required $434 million of one‑time restructuring costs that were recorded in discontinued‑operations net of tax. In 2021 Pfizer sold Meridian for roughly $51 million cash, recognizing a $167 million after‑tax loss in discontinued operations, a move that removed a non‑core asset from its balance sheet while the cash proceeds further bolstered its overall cash position.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core financial impacts of both the Upjohn spin-off and Meridian divestiture, including the $12 billion cash receipt from Viatris in 2020 and the $51 million cash from Meridian in 2021, along with the $167 million loss on the Meridian sale. However, there are discrepancies in the debt redemption amounts: the LLM states Pfizer redeemed $1.15 billion of 1.95% notes and $342 million of 5.80% notes, totaling $1.492 billion, which matches the ground truth total but not the breakdown—original answer specifies $1.492 billion in senior unsecured notes without detailing individual tranches, so the LLM introduces unverified specifics. Additionally, the LLM mentions $434 million in one-time restructuring costs, which is not present in the ground truth; instead, the original notes a $167 million loss for Meridian and implies no such cost for Upjohn. (2) The $12 billion cash inflow and $51 million sale price are accurate. The $1.492 billion total debt redemption is correct in sum but not in component breakdown—this is a partial error due to fabrication of note details. The $434 million restructuring cost is incorrect and unsupported by the original. (3) The multi-hop reasoning is strong: the LLM correctly links the Upjohn spin-off to debt reduction and improved liquidity, and the Meridian sale to non-core asset removal and modest cash boost, showing understanding of strategic intent. It synthesizes cash impacts, accounting treatment (discontinued operations), and financial restructuring effects across two events. (4) The correctness score is 8 because key financial figures (cash inflows, loss amount) are accurate and the overall narrative aligns with the ground truth, but the introduction of incorrect restructuring costs and speculative debt note details reduces quantitative accuracy. Qualitative accuracy remains high due to sound reasoning and correct entity/year/metric alignment. Contextual relevance is perfect—the answer directly addresses the question’s focus on cash position and financial restructuring.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 560,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "\nIn fiscal 2022 Visa contributed roughly **$1.45 billion** to the U.S. Retrospective Responsibility Plan—**$600 million** representing its share of the Amended Settlement Agreement payment and an additional **$850 million** deposited into the litigation escrow account as the annual funding deposit. This combined outlay demonstrates how the plan uses escrow funding and settlement cash to absorb probable litigation losses and keep the company’s ongoing financial results insulated from the ultimate resolution of the disputes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total contribution of $1.45 billion is accurate, with the correct breakdown: $600 million from the Amended Settlement Agreement and $850 million as the annual deposit. These figures match the original answer exactly, with acceptable formatting variations (e.g., 'billion' vs 'B'). The sum is mathematically correct: $600M + $850M = $1.45B. (2) The answer is complete, addressing both parts of the question: the total financial contribution and the plan's role in managing litigation liabilities. (3) Entity accuracy is perfect: 'Visa', 'U.S. Retrospective Responsibility Plan', 'Amended Settlement Agreement', and '2022' (fiscal year) are all correctly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly combines two distinct payments from different mechanisms under the same plan and interprets their purpose—using escrow and settlement funds to manage litigation risk. The explanation that this insulates ongoing financial results aligns semantically with the original answer's point about 'systematically funding potential litigation liabilities'. Wording differs but meaning is equivalent and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 349,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "\nThe equity‑security allocation in the U.S. Retiree Health Care Plan dropped sharply – from about **54 % of total assets in 2022 (≈ $98 million)** to roughly **19 % of total assets in 2023 (≈ $54 million)**, a decline of **≈ 64 % in percentage terms** and a **$44 million (≈ 45 %) reduction in the dollar value of equity securities** by the end of 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, the allocation to equity securities decreased from 35% in 2022 to 20% in 2023—a 15 percentage point drop. However, the LLM claims it dropped from 54% to 19%, a 35 percentage point decrease, which is completely incorrect. Additionally, the LLM states that the dollar value of equity securities fell from $98 million to $54 million, implying a reduction. But the ground truth says the total value of equity securities *increased slightly* to $54 million in 2023 despite the lower allocation. Thus, the LLM misrepresents both the allocation percentages and the trend in dollar value. (2) The calculation of a '64% decline in percentage terms' is nonsensical—percentage point changes should not be expressed as percentage changes in this context—and the claimed $44 million reduction contradicts the ground truth where the value rose. (3) The multi-hop reasoning failed: the model did not correctly synthesize the relationship between allocation percentage and total value; it incorrectly inferred that a lower allocation must mean lower value, when asset growth can offset allocation shifts. It also failed to identify the correct starting and ending allocations and values across years. (4) Despite these errors, the answer is contextually relevant—it addresses the right plan, discusses allocation and value changes, and attempts multi-year comparison—hence a moderate relevance score. However, due to severe quantitative and qualitative inaccuracies, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 434,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "\nThe CECL transition required a five‑year phase‑in that reduced the qualifying allowance for credit losses permitted under the Advanced approaches. As a result, the Advanced‑approach total capital of **$241.4 bn** is about **$9.95 bn lower** than the Standardized‑approach total capital of **$251.4 bn** as of 31 December 2023. The specific capital component driving this gap is the **qualifying allowance for credit losses** (the CECL‑related adjustment).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key capital component driving the difference — the qualifying allowance for credit losses related to CECL — which aligns with the ground truth. However, the quantitative values provided ($241.4 bn and $251.4 bn, implying a $9.95 bn difference) are not supported by the original answer, which states a $12.6 billion increase in Standardized approach total capital due to the allowance adjustment but does not provide absolute capital levels or a direct comparison of total capital between approaches. The $9.95 bn difference appears to be an unsupported inference or miscalculation. (2) The original answer does not mention a five-year phase-in of CECL affecting Advanced approaches, nor does it specify the total capital amounts under each approach. These additions in the LLM answer introduce details not present in the ground truth and potentially inaccurate without explicit support. (3) The multi-hop reasoning is partially sound — the model correctly links CECL adoption to differences in capital treatment between approaches and identifies the correct capital component (allowance for credit losses in Tier 2). However, it goes beyond the source by quantifying the gap with specific totals not in the original, undermining factual accuracy. (4) While the core concept and directional explanation are correct, the inclusion of unsupported numerical figures and the absence of the specific $12.6 billion increase mentioned in the ground truth reduce quantitative accuracy. The answer remains contextually relevant and captures the essential mechanism, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 451,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "\nUsing the mid‑points of the target ranges (U.S. DB = 72.5 %, U.S. retiree health‑care = 80 %, non‑U.S. DB = 80 %) and weighting each plan by its reported total assets ($418 M, $264 M and $1.866 B respectively), the overall weighted‑average allocation to fixed‑income securities and cash equivalents is about **78.8 %**, i.e., roughly **79 %** of the combined plan assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final calculated percentage (78.8%) compared to the ground truth (72.3%). This significant discrepancy in the core numerical result severely undermines correctness. While the approach—using midpoints of percentage ranges and weighting by total asset values—is conceptually sound, the execution appears flawed. (2) The individual midpoints cited (U.S. DB = 72.5%, U.S. retiree health-care = 80%, non-U.S. DB = 80%) may be accurate, and the asset values ($418M, $264M, $1.866B) seem plausible, but the weighted average calculation is incorrect. A correct weighted average using those inputs would be: ((418 * 72.5) + (264 * 80) + (1866 * 80)) / (418 + 264 + 1866) = (30305 + 21120 + 149280) / 2548 ≈ 200705 / 2548 ≈ 78.77%, which matches the LLM’s 78.8%. However, since the ground truth is 72.3%, either the input percentages or asset values used by the LLM do not match the actual data in the knowledge graph. (3) The multi-hop reasoning—extracting midpoints, retrieving asset values, and computing a weighted average—is logically appropriate and correctly structured, indicating sound qualitative reasoning. (4) Despite correct methodology and contextual relevance to the question, the answer fails on quantitative accuracy due to incorrect final output, likely stemming from wrong underlying data inputs not visible in the prompt. Thus, correctness and quantitative accuracy scores are low, while reasoning and relevance are acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 413,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporation’s risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positions—such as foreign exchange and commodity positions—under Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "\nBasel III requires that only trading assets and liabilities that are sufficiently liquid and can be hedged in a two‑way market be classified as “covered” positions for capital calculations, so these positions are the ones that appear in the bank’s VaR tables (e.g., a $64 million 99 % VaR for the total covered‑positions portfolio in 2023). Because the covered‑position VaR is calculated on this narrow set, the bank must supplement it with an “impact from less‑liquid exposures” and hold additional capital buffers (capital‑conservation, G‑SIB surcharge, leverage buffer) that are reflected in its CET1 and leverage ratios. Consequently, the composition of the covered portfolio—concentrated in high‑liquidity FX, interest‑rate, credit, equity and commodity instruments—shapes the risk profile shown by the VaR statistics, ensuring that the market‑risk capital meets the Basel III minimum ratios and buffers while stress‑test and back‑testing results demonstrate that losses exceed VaR only rarely.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a reasonable explanation of how Basel III influences the composition and risk profile of Bank of America's covered trading positions and their VaR metrics, showing understanding of key regulatory mechanisms. However, there are significant quantitative inaccuracies: the LLM cites a specific $64 million 99% VaR for the total covered-positions portfolio in 2023, which is not present in the ground truth. The original answer does not provide any specific VaR figure, only stating that the annual average VaR decreased in 2023 compared to 2022 due to the roll-off of March 2020 volatility from the historical window. This fabricated number undermines factual correctness. Additionally, the LLM introduces concepts not in the original answer—such as the G-SIB surcharge, leverage buffer, and back-testing results—without grounding in the provided truth. While these may be contextually plausible in real-world banking, they are not supported by the knowledge graph and represent overreach. The qualitative reasoning is sound in linking Basel III's covered position criteria to portfolio composition (e.g., high-liquidity FX, commodities) and explaining that VaR is based on a narrow set, which aligns with the original answer’s emphasis on covered positions under Basel III. The answer correctly identifies the influence of capital buffers on risk appetite and capital allocation, though it misattributes the specific buffers (e.g., stress capital buffer of 2.5% at year-end 2023 is omitted and replaced with others). Contextually, the response is highly relevant, addressing both composition and risk profile impacts on VaR. However, the inclusion of unsupported specifics and the absence of the correct rationale for the VaR decrease (roll-off of 2020 volatility) reduce factual accuracy. Multi-hop synthesis is partially correct—linking Basel III → covered positions → VaR—but misses the direct causal explanation in the ground truth regarding model calibration. Overall, the answer demonstrates good structure and domain understanding but fails on key factual and quantitative grounds.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 563,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "\nThe 19 Boeing aircraft that back the Pass‑Through Certificates have a combined net book value of **$1.8 billion** (as stated on page 94). This amount is **much smaller** than the **$5.8 billion** of senior‑unsecured debt that was retired using the proceeds of the 2021 senior‑unsecured debt issuance (page 95). In other words, the debt eliminated through those redemptions exceeds the aircraft’s book value by roughly $4 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total net book value of the 19 Boeing aircraft as $1.8 billion and the $5.8 billion of debt eliminated through redemptions, both of which match the ground truth. It accurately notes that the debt eliminated exceeds the aircraft's book value by approximately $4 billion, which is a correct qualitative comparison ($5.8B - $1.8B = $4.0B). However, the LLM omits mention of the $393 million in redemption premiums, which is part of the full picture in the original answer, though this does not affect the core comparison asked. (2) All numeric values—$1.8 billion and $5.8 billion—are factually correct and properly attributed. The calculation of the difference (~$4 billion) is accurate. The source of funds (proceeds from senior unsecured debt issuance) is correctly referenced, though the exact issuance amount of $3.25 billion is not mentioned, which slightly reduces completeness. (3) The multi-hop reasoning is sound: the model connects the asset value (aircraft net book value) to the debt redemption activity funded by the unsecured issuance. It correctly interprets that the $5.8 billion in redemptions was paid using proceeds from a new debt issuance, even if the size of that issuance is not specified. The omission of the $393 million premium and the $3.25 billion issuance amount prevents a perfect score, but the core logic and synthesis are valid. (4) The answer is highly relevant, directly addressing both parts of the question—asset value and comparison to debt eliminated. The omission of ancillary details does not detract from the central factual accuracy or relevance. Overall, the answer is factually strong with only minor completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 466,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "\nTI contributed roughly **$75 million** to its U.S. defined‑contribution plans in 2023 (the aggregate expense for those plans that year). A notable feature of the retiree health‑care benefit plan is that **none of its assets are invested directly in TI common stock**—the plan’s assets are allocated to fixed‑income, cash‑equivalents and equity securities but do not hold TI shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the contribution amount of $75 million to U.S. defined contribution plans in 2023 is accurately reported, with acceptable formatting ($75 million vs $75 million). (2) The qualitative claim about the retiree health care benefit plan is also correct: none of its assets are directly invested in TI common stock, and the additional detail about allocation to fixed-income, cash-equivalents, and equity securities (just not TI shares) adds context without introducing error. (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer correctly separates the defined contribution plan contribution from the investment structure of the retiree health care plan, two distinct elements in the question. (4) All entities—TI, U.S. defined contribution plans, retiree health care benefit plan, TI common stock—are accurately identified and correctly related. The answer is semantically equivalent to the ground truth, with slightly expanded but accurate contextual detail. All scores are 10 due to full factual accuracy, completeness, and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 325,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "\nThe Services segment’s revenue grew by $10.969 billion (from $85.2 bn to $96.169 bn).  The overall increase in net sales was $7.75 billion (from $383.285 bn to $391.035 bn).  Therefore, Services accounted for roughly 10.969 ÷ 7.75 ≈ 1.41, or **about 141 %** of the total net‑sales growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical calculation error. While it correctly identifies the Services revenue increase as $10.969 billion and total net sales growth as $7.75 billion, it incorrectly computes the percentage contribution as 141% (10.969 ÷ 7.75 ≈ 1.41). The correct calculation is 10.969 / 7.75 = 1.415 → 141.5%, but the ground truth states 121%, which contradicts the provided numbers. However, upon rechecking the math: 10.969 / 7.75 = 1.415 → 141.5%, meaning the ground truth of 121% is itself incorrect. Despite this, the LLM’s calculation is mathematically correct based on the input numbers, but it reports ≈141% instead of the precise 141.5%. (2) All input numbers are accurate: Services growth ($96.169B - $85.2B = $10.969B), total sales growth ($391.035B - $383.285B = $7.75B) — these match the ground truth. The error lies in the expected answer (121%) being factually wrong. (3) The multi-hop reasoning is sound: the model correctly identifies the two growth figures and computes the proportion of Services growth relative to total growth. (4) Despite the ground truth containing an arithmetic error, the LLM performs the correct calculation but rounds to 'about 141%' instead of giving the exact figure. Given that the ground truth incorrectly states 121%, and the correct value is ~141.5%, the LLM answer is actually more factually accurate. However, since the evaluation must be based on alignment with the provided 'ground truth', and the LLM contradicts it due to a correct calculation vs an incorrect one, the score is penalized. This creates a conflict between factual correctness and alignment with erroneous ground truth. Given the instructions to match the original answer, the LLM fails despite being numerically accurate, hence the low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 488,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "\nPfizer estimates that, exclusive of interest, its gross unrecognized tax benefits could decline by as much as **$75 million** over the next 12 months if settlements with tax authorities occur or statutes of limitation expire. This uncertainty is heightened by the fact that the IRS has issued Revenue Agent’s Reports (RARs) for tax years 2011‑2013 and 2014‑2015, which Pfizer is currently appealing, so the final resolution of those disputes—and any associated reduction in uncertain tax positions—cannot be precisely predicted.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the $75 million estimated maximum potential decrease in gross unrecognized tax benefits is accurately reported, matching the original answer exactly. The time frame of 'next 12 months' is correctly included. (2) The explanation of the Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 is factually accurate, correctly stating that the IRS issued these reports and that Pfizer is appealing them. (3) The multi-hop reasoning is sound: the answer links the existence of disputed RARs to the uncertainty in tax positions and explains how this affects the predictability of changes in unrecognized tax benefits. (4) All entities—Pfizer, IRS, RARs, tax years, and financial metric—are correctly identified and contextualized. Minor wording differences (e.g., 'heightened by the fact' vs 'influenced by the fact') do not affect meaning. The addition of context about settlements and statute expirations is consistent with typical disclosures and does not contradict the ground truth. All aspects of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 328,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "\nThe five‑year transition rule lets Bank of America phase in the effects of the CECL accounting standard, so the CET1 capital and the RWA denominator used for TLAC ratios still incorporate a transitional CECL adjustment (e.g., 50 %–75 % of the CECL transition provision is included in CET1 and the related RWA base). Consequently, TLAC ratios and CET1 ratios as of December 31 2023 are calculated on a capital base that reflects this phased‑in CECL impact rather than the full, post‑transition CECL amounts.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly explains the qualitative impact of the five-year CECL transition period on BAC's TLAC and CET1 capital calculations, noting the phased-in treatment of CECL effects and how it affects regulatory capital and risk-weighted assets. This aligns with the ground truth's emphasis on transitional rules affecting capital measurement. However, the LLM answer omits the specific quantitative figure for BAC's CET1 capital as of December 31, 2023 ($194.9 billion), which is a key part of the original answer. It also mentions a '50%–75%' adjustment range without citing a source or confirming this range applies specifically to BAC in 2023, introducing a potentially unsupported detail not present in the ground truth. While the reasoning about transitional treatment is sound and contextually relevant, the absence of the exact dollar amount and the introduction of unverified percentages reduce quantitative accuracy. The multi-hop synthesis is partially correct—linking CECL transition to TLAC and CET1—but misses the concrete data point that grounds the answer in the specific year. Semantic equivalence is mostly preserved but lacks full completeness on numerical facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 333,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "\nFedEx Ground’s fuel surcharge is indexed weekly but is calculated from a fuel‑price index that is two weeks old; the surcharge tables were last refreshed on June 21 2021, November 1 2021 and April 4 2022.  \nFedEx Freight also uses a weekly, indexed surcharge, but it bases the charge on a fuel‑price index that is two days old, and its most recent table updates occurred on November 1 2021 and April 4 2022.  \n\nThus, Ground’s adjustment lag is longer and includes an earlier June 2021 update, whereas Freight’s lag is shorter and its updates are limited to the later dates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: FedEx Ground uses a two-week lag in fuel price data with weekly adjustments, and FedEx Freight uses a two-day lag with weekly adjustments. The specific update dates for the fuel surcharge tables—June 21, 2021, November 1, 2021, and April 4, 2022 for Ground, and only November 1, 2021 and April 4, 2022 for Freight—are correctly listed. (2) Quantitative accuracy is perfect: all dates and time lags (two weeks vs. two days) match the original answer exactly. Format variations (e.g., spacing in dates) do not affect correctness. (3) The multi-hop reasoning is sound—LLM correctly identifies and contrasts the mechanisms across two FedEx segments, synthesizing timing, data lag, and update history. (4) The conclusion about differing lags and update scope (earlier June 2021 update only for Ground) adds clarity and reflects accurate synthesis. All aspects of the question—implementation dates and adjustment mechanisms—are fully addressed with precise, factually correct information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 313,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "\nThe February 2024 decision to exit the ventilator product line removed that business from the Medical Surgical operating segments, causing the two former sub‑segments to be merged into a single Medical Surgical operating segment and placing the ventilator line in the “Other” line; at the same time the remaining PMRI businesses were combined into an “Acute Care & Monitoring” unit that now appears as a separate line‑item in the segment reporting. This restructuring signals that Medtronic is treating the retained Acute Care & Monitoring business as a distinct strategic pillar, separate from the broader Medical Surgical portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in substance but contains a minor factual inaccuracy regarding the timing of the reorganization. The original answer states the reorganization occurred in fiscal year 2023, while the LLM answer references a 'February 2024 decision,' which misaligns with the fiscal year 2023 timeframe specified in the question and ground truth. However, this may reflect a known public announcement date versus the fiscal reporting period, so the discrepancy is moderate rather than critical. The core structural changes are accurately described: the ventilator product line was moved to 'Other,' the Medical Surgical segment was restructured, and the Acute Care & Monitoring unit was formed from retained PMRI businesses. The strategic interpretation — that this reflects a refocusing on core PMRI capabilities and positions Acute Care & Monitoring as a distinct strategic pillar — is consistent with the ground truth's implication of strategic repositioning. All entities (Medical Surgical segment, PMRI, Acute Care & Monitoring, 'Other') are correctly identified, and the multi-hop reasoning (linking organizational change to strategic intent) is sound. The answer addresses both parts of the question: the reporting structure impact and the strategic indication. Wording differs but semantic meaning is equivalent. No numerical data (e.g., dollar amounts, percentages) are involved, so quantitative accuracy is based on date alignment, which is mostly correct but not fully precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 412,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "\nThe company recorded $102 million of medical‑device‑regulation charges in fiscal 2022 and $150 million in fiscal 2023. Together, these expenses reduced income before taxes by a total of **$252 million** over the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the financial impact of medical device regulation expenses for Medtronic in fiscal years 2022 and 2023 as $102 million and $150 million, respectively, which matches the ground truth data. The total impact of $252 million is accurately calculated and reported. (2) All numeric values are correct and properly formatted; the sum of $102M + $150M = $252M is mathematically accurate. (3) The multi-hop reasoning—aggregating disclosed amounts from two separate fiscal years across tables—is correctly executed, demonstrating proper synthesis of information. (4) The answer is semantically equivalent to the original answer, conveys the same factual conclusion, and fully addresses the question with precise, relevant details. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 248,
        "total_tokens": 1362
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "\nBoeing’s 2023 10‑Q filing discloses **five distinct forms** of Long‑Term Incentive Restricted Stock Units—U.S. and International versions, including a CEO‑specific notice, a general notice, and performance‑based notices for both jurisdictions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Boeing disclosed five distinct forms of Long-Term Incentive Restricted Stock Units, but the ground truth confirms only four. This is a critical factual error in both quantity and composition. The LLM incorrectly adds a 'CEO-specific notice' and a 'general notice' not mentioned in the original answer or supported by the knowledge graph. (2) Quantitative accuracy is low because the number 'five' is incorrect—only four forms are disclosed. No calculations are involved, but the count is a central numeric claim and must be accurate. The ground truth specifies the four types with exhibit numbers (10.3, 10.5, 10.4, 10.6), none of which reference a CEO-specific or general notice. (3) The reasoning is flawed: the LLM appears to have misinterpreted or overgeneralized the structure of the disclosures, possibly conflating notice types or performance conditions with distinct award forms. It fails to correctly synthesize the multi-hop information—identifying both U.S. vs. International and standard vs. performance-based distinctions—without introducing unsupported categories. (4) Contextual relevance is moderate because the answer addresses the topic of Long-Term Incentive Restricted Stock Units in Boeing’s 2023 10-Q and attempts to differentiate by jurisdiction and performance, but introduces irrelevant constructs (e.g., notices) that diminish alignment with the actual filings. The core factual mismatch on the count and types results in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 417,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "\nApple’s Services—especially offerings like Apple Music—depend on a continual flow of third‑party software applications and digital content that it secures through licensing and developer relationships.  Because the company cannot guarantee that content providers or developers will stay on its platforms or accept the same commercial terms, any disruption or loss of that content could curb the revenue growth that drove the 12.9 % year‑over‑year Services increase.  Consequently, ongoing challenges in obtaining and retaining third‑party software and content pose a material risk to the sustainability of that growth trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 12.9% year-over-year growth in Services revenue is correctly cited, and while the exact dollar figures ($78,129M in 2022 and $85,200M in 2023) are not mentioned, the percentage growth is accurate and central to the analysis, so their omission does not undermine factual correctness. (2) The answer correctly identifies Apple as the company, the relevant time period (2022 to 2023), and the Services segment including Apple Music—ensuring entity accuracy. (3) The reasoning is sound: it correctly synthesizes the dependency of Apple’s Services growth on third-party content and developer participation, and logically concludes that disruptions in these relationships could threaten sustained growth. This reflects the multi-hop logic required—linking revenue performance to external dependencies and future risk. (4) Semantically, the LLM conveys the same core message as the original: that the 12.9% growth is at risk due to challenges in securing third-party software and content. The only minor shortcoming is the lack of explicit mention of Apple’s own disclosures or specific risks like minority market share or App Store policy changes, which slightly reduces qualitative completeness. However, the essence of the risk is preserved. Thus, the answer is factually correct, contextually relevant, and logically coherent, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 397,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "\nMetLife must set aside cash to meet potential collateral calls and settlement obligations that arise if reinsurers become insolvent or refuse to pay and if derivative counterparties demand additional collateral or terminate contracts—risks that can swell dramatically in stressed markets.  The $12.4 billion of short‑term liquidity recorded at the end of 2021 is intended to absorb such outflows, but a sudden loss of affordable reinsurance or a surge in derivative‑related collateral requirements could quickly erode that buffer and impair the company’s ability to fund operations or honor policyholder guarantees.  Consequently, MetLife conducts extensive stress‑testing and maintains a sizable liquid‑asset cushion, yet the effectiveness of its liquidity management hinges on the continued availability and stability of its reinsurance and derivative counterparties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $12.4 billion short-term liquidity position as of the end of 2021 is correctly stated, matching the original answer. No calculations are required, and the date is accurate. (2) The answer correctly identifies the key risk factors—reinsurance counterparty failure and derivative-related collateral demands—and explains how these could erode the liquidity buffer during stress scenarios. (3) The multi-hop reasoning is sound: it connects MetLife’s liquidity position to counterparty risks, acknowledges the role of collateral and netting (implied through discussion of collateral calls), and links stress-testing and risk management to the maintenance of the buffer. (4) While the original answer emphasizes the collateralization and netting agreements more explicitly, and mentions policyholder behavior and hedging ineffectiveness, the LLM captures the core dynamics without factual error. The omission of explicit mention of netting and collateralization is a minor gap but does not undermine the overall correctness. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 360,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "\nThe fair value of Medtronic’s Level 3 auction‑rate securities as of April 26 2024 is **$33 million**. In the 2023 10‑K filing these securities are presented in the **“Other Assets”** line of the consolidated balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the fair value of $33 million and the date April 26, 2024, are accurately reported. The format '$33 million' is semantically equivalent to the ground truth. (2) The answer addresses both parts of the question: the total fair value and the balance sheet classification. (3) Entity accuracy is correct—MDT (Medtronic) is properly identified, the 2023 10-K filing is referenced appropriately, and 'Other Assets' is the exact line item used in the filing. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly linked the fair value of Level 3 auction rate securities to the correct reporting date and mapped the classification on the balance sheet as disclosed in the 10-K. No factual, numerical, or contextual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 247,
        "total_tokens": 1361
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "\nThe 2020 credit‑loss guidance replaced the prior “other‑than‑temporary‑impairment”/incurred‑loss model with an expected‑credit‑loss (allowance) model.  As a result, mortgage‑loan portfolios and fixed‑maturity securities AFS are now measured at amortized cost net of an ACL that estimates lifetime expected losses using discounted cash‑flow projections, prepayments and forecasted economic conditions, rather than waiting for a loan to become impaired or recording a direct write‑down; this shift moved the recognition of credit losses into a periodic provision (e.g., a $91 million release of ACL in 2020 and a $15 million release in 2021) and required discounted‑cash‑flow estimates for AFS securities instead of the previous OTTI impairment calculations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the core conceptual shift from an incurred loss model to an expected lifetime credit loss model under the new credit loss guidance adopted on January 1, 2020, and accurately describes the change in measurement approach for both mortgage loans and fixed maturity securities AFS. It correctly notes the use of discounted cash flows, expected prepayments, and forecasted economic conditions in the new ACL model. However, it introduces quantitative information not present in the original answer—specifically, the $91 million release of ACL in 2020 and $15 million release in 2021—which are not mentioned in the ground truth and cannot be verified against the provided data. This affects quantitative accuracy. Additionally, while the original answer provides specific 2019 impairment losses by category (e.g., $81M loss for foreign government securities), the LLM omits these detailed figures entirely, which represents a significant omission in completeness and factual detail. The LLM also fails to mention the change in composition of impairment losses for AFS securities—from OTTI and intent-to-sell to only intent-to-sell and direct write-downs—which is a key qualitative point. Despite these shortcomings, the reasoning is logically sound, entities (mortgage loans, AFS securities, ACL, OTTI) are correctly identified, and the explanation aligns semantically with the direction and nature of the accounting change. The answer is highly relevant and synthesizes the multi-hop requirement of comparing pre- and post-adoption models, but lacks full fidelity to the reported 2019 data and introduces unverified numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 449,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the company’s control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "\nLockheed Martin must fund consulting‑support and other offset‑related activities—such as in‑country purchases, technology transfers, joint‑venture investments and penalty‑type payments—outside its core U.S. contract work. Although many of these costs are treated as allowable under U.S. government pricing rules and can be recovered if a contract is terminated for convenience, the offset obligations often involve cash outlays and penalties that are not directly reimbursable and are counted into the contractor’s total cost‑to‑complete estimate. Consequently, in 2024 the need to satisfy foreign offset commitments can erode the amount of costs that Lockheed can ultimately recover on its U.S. government contracts, potentially lowering profit margins and creating reach‑forward losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial risk described in the ground truth. (1) There are no explicit dollar amounts or dates in the LLM answer that contradict the ground truth; the $64.3 billion obligation from the original is not mentioned, but the LLM does not assert any incorrect figures, so quantitative accuracy remains high. (2) The LLM correctly identifies that offset obligations—such as consulting support, joint ventures, and in-country investments—involve non-reimbursable cash outlays that affect cost recovery on U.S. government contracts. It accurately notes that cost recovery under U.S. contracts is contingent on termination for convenience under FAR, aligning with the original. (3) The multi-hop reasoning is sound: it connects international offset obligations (which are not directly reimbursable) with their impact on cost-to-complete estimates and potential profit erosion or reach-forward losses on U.S. contracts. (4) While the LLM omits the specific $64.3 billion figure, it still captures the essential mechanism of financial risk and misalignment between international obligations and domestic reimbursement. The omission is minor and does not undermine the correctness of the explanation. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the 2024 impact and cost recovery dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 384,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "\nIn 2021 the Laboratory Products and Biopharma Services segment posted a 21 % revenue jump, with its pharma‑services business driving the surge as pandemic‑related demand for clinical‑research and viral‑vector services accelerated. The higher sales mix and a $20 million inventory‑accounting credit lifted the segment’s margin to 12.4 % (up 2.0 percentage points), although this was partially offset by ongoing strategic growth investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 21% revenue growth, $20 million inventory-accounting credit, and 2.0 percentage point margin increase to 12.4% are consistent with known data. The $20M credit matches the ground truth, and the margin improvement is correctly presented as partially offset by strategic investments. (2) The answer addresses both key drivers in the question: pandemic-related demand (specifically for clinical-research and viral-vector services) and the inventory accounting change. (3) Entity accuracy is strong—TMO’s pharma services business is correctly contextualized within the Laboratory Products and Biopharma Services segment, and the year 2021 is accurate. (4) The reasoning is sound: the LLM correctly synthesizes how higher sales volume and favorable mix, combined with the $20M cost credit, boosted margins despite offsetting investments. The only minor shortcoming is that the original answer provides slightly more context on TMO’s role in vaccine and therapy development, which the LLM implies but doesn’t explicitly state. However, the core facts, multi-hop synthesis, and financial impacts are correctly conveyed, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 351,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "\nMetLife’s participation in U.S. and European supervisory colleges—led by the New York Department of Financial Services (NYDFS) in the United States and by the European Insurance and Occupational Pensions Authority (EIOPA) in Europe—places the company under a coordinated, group‑wide oversight regime.  The colleges require MetLife to submit enterprise‑risk reports and to align its capital, reserve and risk‑management practices with both NYDFS and EIOPA expectations, thereby shaping its regulatory oversight and risk profile across its U.S. and non‑U.S. operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying MetLife's participation in Supervisory Colleges under NYDFS (U.S.) and EIOPA (Europe) and the impact on regulatory oversight and risk profile. It accurately reflects that these colleges involve coordinated supervision and influence MetLife’s risk management, capital, and reporting practices. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The answer captures the core mechanism—coordinated oversight shaping regulatory and risk outcomes—but omits specific details present in the original answer, such as the annual NYDFS-led meetings or the role of the Central Bank of Ireland in the European college. While the LLM conveys the general structure and intent of Supervisory Colleges, it lacks the granular multi-hop synthesis of how U.S. and European colleges specifically enhance cross-border regulatory understanding of MetLife’s international operations. Thus, while semantically aligned and logically sound, it is slightly less complete in entity-specific operational details, warranting a correctness score of 8 rather than 9–10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 331,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "\nThe smaller ACL build for transfer risk outside the United States—driven by U.S. banking‑law safety‑and‑soundness considerations—reduced the credit‑loss provision by about $110 million, directly adding to earnings. As a result, Citi’s Net Income rose to $4.93 billion in 2024, a 27 % increase over the $3.87 billion recorded in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key impact of the reduced ACL build on Citi's Net Income in 2024, attributing it to U.S. banking law and linking it to a lower provision expense. The $110 million reduction in provision expense is very close to the ground truth $111 million (difference of $1 million, or ~0.9%), which is within acceptable rounding tolerance. The reported Net Income of $4.93 billion in 2024 aligns closely with the ground truth $4.9 billion (difference of $30 million, or ~0.6%), and the 27% increase is consistent in both answers. The prior year Net Income implied in the LLM answer ($3.87 billion) is consistent with a 27% increase to $4.93 billion, and while not explicitly stated in the ground truth, it is a reasonable backward calculation. (2) Quantitative verification: $4.93B - $3.87B = $1.06B increase; $1.06B / $3.87B ≈ 27.4%, which rounds to 27%. The $110M provision reduction is a minor understate vs. the actual $111M difference ($406M - $295M), but this is negligible. (3) Multi-hop reasoning is sound: the model correctly connects U.S. banking law → reduced ACL build → lower provision expense → higher Net Income → percentage change in Net Income, synthesizing across financial cause-effect links. (4) Scores reflect near-perfect factual alignment, with only negligible differences in dollar amounts that do not affect the substantive conclusion. The answer is complete, contextually accurate, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 413,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segment’s revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martin’s financial performance.",
      "llm_answer": "\nThe debt‑ceiling impasse could stall the FY 2025 appropriations process, leaving a portion of the funded backlog that underpins Aeronautics’ international F‑35 FMS orders—accounting for roughly 73 % of the segment’s overseas sales and involving 12 FMS customers—unfunded; this would delay cash inflows and force Lockheed to postpone or scale back production and sustainment work, trimming the 32 % of Aeronautics’ net sales that come from international customers and pressuring margins as the conversion of its $176 billion backlog slows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: 73% of international sales are FMS-related, international customers accounted for 32% of Aeronautics' net sales in 2024, and the F-35 program involves 12 FMS customers. It accurately links U.S. government funding disruptions due to the debt ceiling to potential delays in FMS funding, which would impact F-35 production and cash flows. The mention of a $176 billion backlog is consistent with Lockheed Martin's reported backlog and adds contextual detail not in the original answer but plausibly accurate and relevant. (2) All numeric values—73%, 32%, 12 FMS customers—are factually correct and match the ground truth. The $176 billion backlog is not in the original answer but is consistent with Lockheed Martin’s public filings and does not contradict the ground truth; it enhances the reasoning without introducing error. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes that FMS sales depend on U.S. government funding, that disruptions could delay F-35 orders, and that this would affect the Aeronautics segment’s revenue and margins through its international exposure. The logic flow from debt ceiling → appropriations delay → unfunded FMS → production delays → revenue impact is coherent and well-structured. (4) The LLM answer conveys the same core information as the original answer with equivalent or greater depth. The only minor gap is that it does not explicitly state the 'prolonged effect' due to the long-cycle nature of contracts, a nuance in the original answer. However, the implication is present via 'slows conversion of backlog.' Thus, the answer is slightly more concise but loses minimal context. Scores reflect high accuracy with near-perfect factual and logical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 494,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "\nAs of December 31 2023, 70 million shares of common stock remained available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan and its related plans (including the ESPP). This contrasts with the ≈ 191,000 shares underlying stock options that were assumed in connection with acquisitions—an amount that is essentially negligible compared with the 70 million shares available for future issuance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 70 million shares available for future issuance under the 2020 Stock Incentive Plan and related plans (which includes 53 million from the main plan and 17 million from the ESPP, correctly summed), and approximately 191,000 shares underlying assumed stock options from acquisitions. The use of '≈' is appropriate given the precision of the original figure. (2) The answer is complete, addressing both parts of the question: total shares available under the active plans and the comparison to assumed options from acquisitions. (3) Entities are correctly identified: UnitedHealth Group, the 2020 Stock Incentive Plan, ESPP, and the context of acquisitions. (4) The reasoning is sound and synthesizes multi-hop information correctly—combining data from two related plans and contrasting with a separate acquisition-related pool. The conclusion that the assumed options are negligible compared to the 70 million is a valid qualitative interpretation supported by the data. (5) Semantic equivalence is maintained: while the LLM combines the 53M and 17M into a total upfront (rather than listing separately), this is a clearer presentation and does not alter factual accuracy. No errors in calculation, logic, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 370,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "\nThe Multi‑Year Equity Awards produced stock‑based compensation expense of $794 million in fiscal 2022, $596 million in fiscal 2023 and $356 million in fiscal 2024, for a cumulative expense of **$1.746 billion** over the three years. As of 3 Nov 2024, the total unrecognized compensation cost for all unvested stock‑based awards was **$11.259 billion**, so the $1.746 billion of expense represents only about **15 %** of that unrecognized balance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $794 million (2022), $596 million (2023), and $356 million (2024) are correctly reported, and their sum is correctly calculated as $1.746 billion (equivalent to $1,746 million). The unrecognized compensation cost of $11.259 billion (i.e., $11,259 million) as of November 3, 2024, is also correct. The implied percentage ($1.746B / $11.259B ≈ 15.5%, rounded to ~15%) is reasonably stated as 'about 15%'—this is a valid qualitative comparison and adds insight without overstepping. (2) The answer addresses both parts of the multi-part question: total SBC expense from 2022–2024 and its comparison to unrecognized cost as of the specified date. (3) Entities are accurate: 'Multi-Year Equity Awards' is correctly referenced, fiscal years are correct, and the metric 'unrecognized compensation cost' is properly attributed to unvested awards. (4) The reasoning is sound: it synthesizes data across three fiscal years, computes the cumulative expense, and contextualizes it against future expected expense, demonstrating proper multi-hop logic. (5) Semantic equivalence is maintained—format variations (billion vs. million) are numerically consistent and acceptable. No factual, computational, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 373,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "\nThe total minimum Long‑Term Debt (LTD) requirement for Citigroup in 2024 is **9.5 % of its RWA**. This figure is derived by taking **6 % of RWA** and adding the **method‑2 GSIB surcharge of 3.5 %** (6 % + 3.5 % = 9.5 %). The regulation requires the greater of this 9.5 % of RWA or **4.5 % of total leverage exposure**, and for Citi the RWA‑based threshold (9.5 %) is the binding requirement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the total minimum LTD requirement for Citi in 2024 as 9.5% of RWA, which matches the ground truth. It accurately identifies the two components: the base 6% of RWA and the method-2 GSIB surcharge of 3.5%, and correctly calculates their sum (6% + 3.5% = 9.5%). (2) All numeric values are correct and precisely aligned with the original answer. The additional detail about the leverage exposure threshold (4.5%) is factually accurate and contextually relevant, though not explicitly requested in the question. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the base requirement and surcharge from regulatory context and applies them to Citi. The only minor shortcoming is that the original answer does not mention the comparison with leverage exposure, so while the added detail is correct, it slightly exceeds the scope without detracting from accuracy. (4) Scores reflect full quantitative accuracy, excellent qualitative reasoning, and complete contextual relevance. A correctness score of 9 (not 10) accounts for the slight over-elaboration beyond the question's scope, though no factual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 332,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "\nThe company’s qualified defined‑benefit pension plans are projected to require roughly **$19.5 billion** in funding over the next ten years (the sum of the $1.80 billion‑$1.99 billion annual amounts for 2025‑2029 plus the $9.99 billion lump‑sum for 2030‑2034).  The yearly cash‑flow estimates rise each year from $1.80 billion in 2025 to $1.99 billion in 2029, but the incremental increases taper off (≈ +$60 M, +$50 M, +$50 M, +$30 M), signalling that pension obligations are still growing yet at a progressively slower pace.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total projected funding requirement as $19.5 billion, which matches the ground truth of $19,510 million (equivalent to $19.51 billion; rounding to $19.5 billion is acceptable). All annual figures are accurate: $1.80B (2025), $1.86B (2026), $1.91B (2027), $1.96B (2028), $1.99B (2029), and $9.99B for 2030–2034. These values match the original answer exactly when converted to billions. (2) The sum of the individual components is correct: $1.80 + $1.86 + $1.91 + $1.96 + $1.99 = $9.52 billion for 2025–2029, plus $9.99 billion for 2030–2034 gives $19.51 billion total, consistent with the ground truth. The LLM correctly aggregates these. (3) The reasoning about the trend is mostly sound: it notes the upward trajectory from 2025 to 2029 and correctly observes that the incremental increases are tapering ($60M, $50M, $50M, $30M), which aligns with the data. However, the original answer emphasizes a 'consistent upward trend' indicating growing obligations, while the LLM interprets the tapering increments as slowing growth—this is a subtle but reasonable alternative interpretation. It does not contradict the facts but adds analytical nuance. (4) All entities (Lockheed Martin, qualified defined benefit pension plans, correct years) are accurate. The answer fully addresses both parts of the question: total funding and trend analysis. Semantic equivalence is strong. Minor deduction in qualitative accuracy due to interpretive shift in trend characterization, but no factual errors. Quantitative accuracy is perfect. Contextual relevance is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 442,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "\nThe Mortgage/Asset‑backed securities portfolio was valued at **$1,072 million at the end of 2021 and $982 million at the end of 2020**, giving a combined total of **$2,054 million** across the two years. In each year this category made up roughly **7.8 % of total fixed‑income assets in 2021 and about 7.0 % in 2020**, positioning it as the **fourth‑largest component** of Honeywell’s fixed‑income holdings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the dollar values of Mortgage/Asset-backed securities for both 2020 ($982 million) and 2021 ($1,072 million), and accurately calculated the combined total of $2,054 million. However, the percentages provided for the proportion of total fixed income investments are incorrect. The LLM states 7.0% in 2020 and 7.8% in 2021, whereas the ground truth is 8.1% in 2020 ($982M / $12,106M) and 8.9% in 2021 ($1,072M / $12,041M). These errors suggest miscalculations or use of incorrect total fixed income figures. (2) The dollar amounts and sum are quantitatively accurate, but the percentages are off by meaningful margins (~1 percentage point), which affects financial interpretation. The ranking as the 'fourth-largest component' is plausible but not verifiable from the ground truth provided, which does not include ranking information—this introduces unsupported inference. (3) The multi-hop reasoning is partially sound: the model correctly retrieved and summed values across years and attempted proportion analysis, but failed in accurate percentage computation or used incorrect totals. (4) Scores reflect mostly correct data retrieval and summation (hence partial credit), but significant deductions for incorrect percentages and unverified ranking, which are key parts of the question. Contextual relevance is high as the answer addresses all question components with appropriate structure and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 401,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "\nBroadcom now amortizes the fair‑value of each equity grant over the entire vesting period of the multi‑year RSUs—typically four‑year steps that can extend up to seven years—rather than recognizing the full expense in the grant year or over a shorter service period. As a result, stock‑based compensation expense is recorded gradually each fiscal year, spreading the cost over a longer horizon and smoothing the expense pattern that was previously more front‑loaded with annual awards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core impact of Broadcom's shift in equity award structure on stock-based compensation expense recognition. It correctly identifies that the change involves multi-year RSUs with vesting periods extending up to seven years, resulting in a longer, smoother expense recognition pattern compared to the prior annual model. The explanation that expenses are now amortized over the full vesting period (up to 7 years) aligns with the ground truth. However, the LLM slightly mischaracterizes the structure by describing 'four-year steps' rather than clearly stating that the multi-year award consolidates four annual grants into a single award with overlapping vesting tranches extending over up to 7 years. The original answer emphasizes that this creates a more prolonged and overlapping recognition timeline due to the consolidation of grant cycles, which the LLM answer does not fully articulate. Quantitatively, no specific numbers are cited (e.g., 4-year vs. 7-year total span), but the timeframes mentioned (up to seven years) are accurate. The reasoning is sound but lacks full completeness in explaining the multi-hop synthesis of how prior annual 4-year grants differed structurally from the new multi-year consolidated awards. Wording differences are acceptable under semantic equivalence, but the omission of the 'four annual grant cycles in one award' concept reduces qualitative accuracy slightly. Contextual relevance is excellent—the response directly addresses the question about expense recognition pattern changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 430,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "\nU.S. banking law forces Citi to apply safety‑and‑soundness standards that curb the allowance for credit losses on exposures outside the United States, so the Legacy Franchises experience a smaller ACL build for transfer risk, while the Markets segment also sees a reduced ACL build that is offset by higher net credit losses. The combined regulatory‑driven effect therefore lowers Citi’s total provision for credit losses in 2024 to **$1.1 billion**, a $200 million decrease from the $1.3 billion recorded in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Citi’s total provision for credit losses in 2024 is $1.1 billion, which is incorrect—the ground truth reports $1.563 billion ($1.1 billion from Legacy Franchises + $463 million from Markets). The LLM incorrectly equates the total provision to only the Legacy Franchises amount. Additionally, it claims a decrease from $1.3 billion to $1.1 billion, implying a $200 million reduction, but the actual total provision decreased from $1.738 billion to $1.563 billion—a $175 million reduction, not $200 million. The Markets segment’s 2024 ACL build is stated as $295 million, but the LLM fails to report this correctly and instead implies offsetting factors without citing the correct $463 million net provision. (2) Quantitative accuracy is severely compromised: the total provisions, year-over-year comparison, and segment-level figures are all wrong. The $1.3 billion figure is cited as the 2023 total, but in reality, it only represents Legacy Franchises; the true 2023 total was $1.738 billion. (3) The reasoning is partially sound in identifying that U.S. banking law reduces ACL builds for non-U.S. exposures in both segments, and that this contributes to lower provisions. However, the model fails to correctly synthesize the multi-hop information—combining both segments’ provisions and calculating the correct total impact. It incorrectly aggregates or conflates segment data. (4) Contextual relevance is moderate because the answer addresses the regulatory influence and directional impact on credit loss provisions, but major errors in numbers and synthesis severely undermine factual correctness. Due to critical errors in core financial figures and calculations, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 487,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million ÷ ($8,450 million + $8,396 million)).",
      "llm_answer": "\nThe insurance‑buy‑in contracts in HON’s non‑U.S. pension plans were valued at **$767 million at the end of 2020** and **$691 million at the end of 2021**, for a combined total of **$1.458 billion**. This combined amount represents roughly **17 %** of the non‑U.S. plans’ total assets at fair value (≈ $8.4 billion).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the individual values of Insurance buy-in contracts for HON in Non-U.S. Plans: $767 million in 2020 and $691 million in 2021, and correctly calculates the combined total as $1.458 billion ($1,458 million), which matches the ground truth. However, the percentage calculation is incorrect. The LLM states that this represents 'roughly 17%' of total assets at fair value, while the correct percentage is approximately 8.66%, calculated as $1,458 million divided by the sum of total assets in 2020 and 2021 ($8,450 million + $8,396 million = $16,846 million). The LLM appears to have either used incorrect total asset figures or miscalculated the percentage. (2) Number verification: $767M + $691M = $1,458M is correct. Total assets: $8,450M (2020) + $8,396M (2021) = $16,846M is missing from the LLM answer, and the implied denominator for 17% would be around $8.57 billion, suggesting the model may have used only one year's total assets or an incorrect sum. (3) Multi-hop reasoning: The model correctly synthesizes data across two years for the numerator but fails in the comparative synthesis for percentage, indicating flawed reasoning in the second hop involving total assets. (4) Scores reflect partial correctness: quantitative accuracy is penalized for the incorrect percentage and implied denominator; qualitative accuracy is moderate due to correct entity and year identification but flawed calculation logic; contextual relevance is high as the answer addresses the right companies, years, and metric, despite miscalculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 433,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "\nBroadcom’s heavy investment in internal research and development—funded through dedicated R&D expense and supported by proprietary silicon‑fabrication capabilities—enables the company to design custom ASICs, high‑performance Ethernet switching fabrics and advanced optical/ RF components that are specifically optimized for the massive bandwidth, low‑latency and energy‑efficiency requirements of AI‑driven data centers. By continuously innovating its own technology stack, Broadcom can embed cutting‑edge features such as energy‑efficient Ethernet, data encryption and time‑synchronization directly into its semiconductor products, helping it retain a technology‑lead advantage in the fast‑evolving AI‑related markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth in both substance and intent. (1) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score 10. (2) The LLM correctly identifies Broadcom (AVGO) and its internal R&D focus as central to maintaining technology leadership in AI-related semiconductor markets. It accurately describes how R&D enables development of advanced products like custom ASICs, Ethernet switches, and optical/RF components critical for AI data centers. While the original answer emphasizes CMOS, GaAs, and InP technologies and 'extensive internal R&D' as a stated strategy, the LLM answer complements this by specifying applications in bandwidth, latency, and energy efficiency, and mentioning proprietary fabrication and feature integration (e.g., encryption, time-synchronization). These additions are plausible and contextually consistent, though not explicitly in the ground truth. (3) The multi-hop reasoning is sound: the model connects internal R&D to product innovation, then to AI infrastructure needs, and finally to competitive advantage—mirroring the causal chain in the original. (4) The only minor gap is that the LLM does not explicitly mention the 'semiconductor solutions segment' by name or cite the direct link to 'AI networking and connectivity' as in the original, slightly reducing qualitative accuracy. However, the contextual relevance is excellent, as it directly addresses Broadcom’s R&D strategy and its impact on AI market leadership. Overall, the answer is factually correct, well-reasoned, and semantically equivalent with minor elaboration beyond the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 469,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "\nQualcomm expects to pay **$9.6 billion** under its purchase agreements over the next 12 months. This amount is roughly three times the **$3.0 billion** of advance payments that were recorded for its multi‑year capacity‑purchase commitments as of September 29, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key numbers are correct: $9.6 billion for expected payments in the next 12 months and $3.0 billion in advance payments as of September 29, 2024. These match the original answer exactly, and formatting variations (e.g., spacing in $9.6 billion) are acceptable. (2) The comparison stating that the $9.6 billion is 'roughly three times' the $3.0 billion is mathematically sound (9.6 / 3.0 = 3.2), so the characterization is reasonable and adds useful context. (3) The multi-hop reasoning is correct—synthesizing the near-term obligation with the advance payments from the same time period shows understanding of the comparative financial impact. (4) The only minor omission is that the LLM does not mention the total $12.8 billion in purchase obligations, which provides context for the $9.6 billion. While not strictly required to answer the question, including it would have improved completeness. However, since the question specifically asks about the next 12 months and the advance payments, the core requirements are met. The answer is semantically equivalent in intent and fact, with excellent contextual relevance and precise quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 350,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "\nThe GTN‑adjustment reduction rose from **$134 million in 2023 to $159 million in 2024**, a **$25 million increase**. This change was driven by **non‑U.S. claw‑back revisions tied to V AIT (VAT) recoverable‑estimate adjustments**, which altered the amount of prior‑period provisions reversed in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all factual components: GTN adjustment reductions were $134 million in 2023 and $159 million in 2024, with a $25 million difference. These values match the ground truth exactly. (2) Quantitative accuracy is perfect: the increase of $25 million is correctly calculated as $159M - $134M. Number formats are consistent and acceptable (e.g., $134 million). (3) The non-U.S. factor is accurately identified as claw-back revisions tied to VAT (VAT recoverable estimate adjustments), which aligns semantically with 'revisions in clawback amounts driven by VAT recoverable estimates' in the original answer. The reasoning correctly links the change in GTN adjustments to prior-period provision reversals due to updated VAT estimates. (4) The answer fully addresses both parts of the multi-hop question: the quantitative difference and the specific non-U.S. contributing factor. All entities (GTN adjustments, years, VAT/clawback mechanism) are correctly identified and synthesized. Wording differs slightly (e.g., 'V AIT' appears to be a formatting error for 'VAT'), but the meaning remains clear and factually equivalent. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 340,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "\nMastercard Send lets the company tap new payment flows—particularly disbursements and remittances—by offering a fast, API‑driven rail that moves money instantly across borders and within ecosystems, directly advancing its strategy to capture additional transaction volume on its multi‑rail network.  This capability is enabled through partner ecosystems that include digital messaging and payment platforms, central banks, fintechs and other financial institutions, as well as government and nonprofit organizations that rely on the Send infrastructure to distribute funds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Mastercard Send's role in capturing new payment flows via disbursements and remittances is accurately described, including its contribution to expanding multi-rail capabilities. The explanation of how it enables fast, API-driven money movement domestically and cross-border matches the strategic objective in the 10-K. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that Mastercard Send supports broader strategic goals through partner ecosystems. The listed partners—central banks, fintechs, financial institutions, governments, and nonprofits—match the ground truth. The mention of 'digital messaging and payment platforms' adds a slight expansion not explicitly in the original, but this does not contradict and may be inferred as part of the broader ecosystem; this is a minor addition, not an error. (4) The answer is contextually fully relevant, addressing both how Mastercard Send contributes to capturing new flows and which partner ecosystems are leveraged. The only reason for not scoring a perfect 10 is the slight augmentation of partner types with 'digital messaging platforms,' which, while plausible, is not explicitly stated in the ground truth. Overall, the semantic meaning, completeness, and reasoning are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 416,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercard’s net revenue structure.",
      "llm_answer": "\nMastercard’s new Cyber and Intelligence Solutions are classified as “Other revenues,” adding a distinct line of value‑added fees to that category. Because many of these contracts span multiple years, the revenue is initially recorded as deferred revenue and then recognized over the contract period—​the company expects the aggregate $1.3 billion of unsatisfied performance obligations to be recognized through 2024—​so the composition of “Other revenues” expands and its timing shifts from immediate to a more staggered, over‑time recognition schedule.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Cyber and Intelligence Solutions fall under 'Other revenues' and that revenue recognition timing is affected, which aligns with the ground truth. It appropriately notes the shift in timing due to multi-year contracts and deferred revenue recognition, adding relevant context about staggered recognition. However, the answer introduces a specific quantitative claim—'$1.3 billion of unsatisfied performance obligations to be recognized through 2024'—that is not present in the original answer or supported by the provided ground truth. This figure and the explicit timeline through 2024 represent over-specificity not justified by the source, potentially misleading if inaccurate. While the qualitative reasoning about revenue deferral and contract structure is plausible and adds depth, the original answer only states that revenue is recognized when services are performed or transactions occur, without mentioning multi-year contracts or deferred revenue accounting. Thus, the LLM extends beyond the ground truth with unverified details. Entity accuracy (Mastercard, Cyber and Intelligence Solutions, 'Other revenues') and contextual relevance are strong. The core composition and timing impact are partially correct, but the unsupported quantitative claim significantly undermines factual accuracy, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 381,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What was the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023, and how did this change compare to the change in unrealized losses on those securities over the same period?",
      "original_answer": "The total fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million at December 31, 2022 to $320 million at December 31, 2023, a decrease of $7 million. Meanwhile, unrealized losses on these securities increased from $31 million to $25 million, a decrease in unrealized losses of $6 million. This means that while the fair value slightly declined, the unrealized losses improved year-over-year.",
      "llm_answer": "\nThe mortgage‑backed debt securities’ fair value rose from **$452 million** at 12/31/2022 to **$540 million** at 12/31/2023, an **$88 million** increase.  Over the same period the aggregate unrealized pretax loss on those securities fell from **$42 million** to **$33 million**, a **$9 million** reduction, so the fair‑value gain was much larger than the change in unrealized losses.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that CAT's Mortgage-Backed Debt Securities fair value decreased from $327 million to $320 million (a $7 million decrease), while the LLM claims an increase from $452 million to $540 million ($88 million increase). Similarly, unrealized losses decreased from $31 million to $25 million (a $6 million reduction in losses) in reality, but the LLM reports a drop from $42 million to $33 million (a $9 million reduction). All key numbers—fair values, unrealized losses, and their changes—are factually wrong. (2) Calculations in the LLM answer are internally consistent (e.g., $540M - $452M = $88M gain; $42M - $33M = $9M loss reduction), but since the input numbers are incorrect, the results do not reflect reality. The comparison between fair value change and change in unrealized losses is therefore also invalid. (3) The multi-hop reasoning—comparing changes in fair value and unrealized losses over time—is structurally sound in approach, but the model failed to retrieve correct data for CAT (likely confusing it with another company or misreading the source). (4) The answer is contextually relevant in structure and addresses both parts of the question (change in fair value and comparison with change in unrealized losses), but due to severe factual inaccuracies in numbers and entities, the correctness score is very low. Minor credit is given for attempting the correct analytical framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 416,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "\nThe fair‑value of Qualcomm’s corporate bonds and notes is **$4.634 billion**. U.S. Treasury securities and government‑related securities together total **$0.208 billion**, which is **about 3.8 % of the overall $5.451 billion of marketable securities**. (Consequently, corporate bonds and notes make up roughly 85 % of total marketable securities.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: corporate bonds and notes fair value is $4.634 billion (equal to $4,634 million), U.S. Treasury and government-related securities are $0.208 billion ($208 million), and total marketable securities are $5.451 billion ($5,451 million). (2) Percentages are correctly calculated and presented: 3.8% for U.S. Treasury and government-related securities is accurate (208 / 5,451 ≈ 0.038), and corporate bonds and notes represent approximately 85% (4,634 / 5,451 ≈ 0.85), which the model correctly infers. (3) Multi-hop reasoning is sound—the model synthesizes values across entities and computes proportional representation correctly. (4) Wording differs slightly (e.g., using billion instead of million), but all numeric values are format-equivalent and precise. The answer addresses both parts of the question: total fair value of corporate bonds and notes, and the comparative percentage of U.S. Treasury and government-related securities. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 316,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "\nMerck can keep Keytruda on the market past the 2028 expiration of its core compound patent by invoking the U.S. pediatric‑exclusivity rule – once the company completes the required pediatric studies, an additional six‑month period of market exclusivity is automatically added to any Orange‑Book‑listed patent or regulatory data‑exclusivity term, pushing the effective protection into 2029 (and, together with existing data‑exclusivity, potentially later).  This extra exclusivity preserves the drug’s high‑margin oncology sales, cushioning the revenue stream against the sharp decline that would follow patent expiry and helping to sustain overall growth in Merck’s oncology portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Merck (MRK) uses pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, which aligns with the ground truth. It accurately states that pediatric exclusivity provides an additional six months of protection. However, it introduces a specific patent expiration year (2028) and an effective extension into 2029, which are not present in the original answer or supported by the cited evidence sources (evidence_source_a and evidence_source_b). These specific dates are not mentioned in the ground truth and represent an overprecision not justified by the provided information. (2) The quantitative accuracy is partially compromised due to the unsupported claim of a 2028 patent expiration and 2029 extension. While six months of exclusivity is correct, tying it to specific years without evidence constitutes a factual overreach. The ground truth does not specify expiration dates, only the mechanism of exclusivity. (3) The reasoning is sound in understanding how pediatric exclusivity delays generic competition and protects revenue, and the mention of high-margin oncology sales preserving revenue aligns with the financial impact described in the original answer. The LLM also correctly links the exclusivity mechanism to revenue protection and portfolio stability, demonstrating good multi-hop reasoning across regulatory strategy and financial outcomes. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question: the mechanism (pediatric exclusivity) and the financial impact (preserved sales, delayed decline, sustained growth). Despite the unsupported dates, the core concepts, entities (MRK, Keytruda, oncology revenue), and regulatory mechanisms are accurately represented. The answer could have mentioned the possibility of Patent Term Extension (PTE) up to five years as noted in evidence_source_b, which would have improved completeness. Overall, the answer is factually strong but penalized for introducing unverified temporal specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 561,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercard’s strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercard’s innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "\nMastercard Installments, launched in 2022 as an open‑loop buy‑now‑pay‑later solution, adds a new digital payment flow that links lenders and merchants across the company’s multi‑rail network, extending digital payment capabilities beyond traditional card transactions into e‑commerce and other channels. By doing so, it exemplifies Mastercard’s broader innovation agenda—leveraging its core network, services and data to deliver seamless, secure checkout experiences and capture new consumer payment behaviors—directly advancing its strategic goal of scaling digital payments across multiple channels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original answer. (1) All factual elements are correct: Mastercard Installments was introduced in 2022 as an open-loop buy-now-pay-later solution, which supports digital payment expansion by connecting lenders and merchants across Mastercard’s network. The mention of multi-rail capabilities and digital checkout experiences reflects the strategic context from the 2022 10-K. (2) Quantitative accuracy is perfect: the year 2022 is correctly cited, and no numerical values require calculation. Format and references are consistent and accurate. (3) The multi-hop reasoning is sound—linking the product launch (Mastercard Installments) to the broader innovation strategy and digital channel expansion is logically and factually supported by the knowledge graph. The LLM correctly synthesizes the purpose of the initiative with Mastercard’s strategic goals. (4) The only minor shortcoming is that the LLM omits explicit mention of 'mobile and connected devices' and 'digital currency solutions' as part of the broader innovation push, which are noted in the original answer as key components. However, the core strategic alignment with expanding digital payments across channels is clearly and correctly conveyed. Thus, the answer is semantically equivalent in intent and substance, warranting a high score but not perfect on qualitative accuracy due to slight incompleteness in scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 396,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "\nAll of the profit‑sharing payment to Ridgeback is captured in Cost of sales, because the partner’s share of the collaboration’s profit is recorded there. In 2024, Ridgeback’s equal (50 %) share of the Lagevrio collaboration’s net profit was therefore reflected in the $554 million reported as Cost of sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Ridgeback Biotherapeutics LP received a 50% share of the Lagevrio collaboration profits, which aligns with the ground truth stating an equal split. It also correctly states that the profit-sharing payment is recorded within Cost of sales. However, the LLM introduces a specific dollar amount—$554 million—claiming it represents Ridgeback’s share recorded in Cost of sales in 2024. This figure is not present in the original answer or supported by the provided ground truth, making it an unsupported addition. There is no indication in the ground truth that this specific monetary value was reported or should be included, so its inclusion undermines quantitative accuracy. While the reasoning and entity identification (Merck, Ridgeback, Lagevrio, Cost of sales, 50% split) are sound and contextually appropriate, the unverified numeric figure reduces confidence in factual correctness. The answer is semantically aligned in terms of structure and intent but fails on strict factual precision due to the unsubstantiated dollar amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 304,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "\nThe Overseas Fund Regime lets BlackRock register non‑UK funds with the FCA so they can be sold to UK retail investors, but only if the fund’s home‑jurisdiction consumer‑protection regime is judged “equivalent” to the UK’s. Consequently, BlackRock must align the governance, disclosure and investor‑protection rules of its European‑domiciled vehicles (e.g., Irish or Luxembourg SICAVs) with UK standards—meeting the FCA’s equivalence test—otherwise those funds cannot be marketed in the UK under the OFR.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately describes the function of the Overseas Fund Regime (OFR), stating that BlackRock can market non-UK funds in the UK only if the home jurisdiction's consumer protection regime is deemed equivalent to the UK’s by the FCA. This aligns with the original answer’s emphasis on equivalence requirements affecting marketing of European-domiciled funds. The mention of Irish or Luxembourg SICAVs as examples of European structures adds useful specificity without introducing error. The core requirement—equivalence in governance, disclosure, and investor protection—is correctly identified. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop understanding: linking OFR rules → impact on BlackRock’s European fund structures → necessity of meeting UK equivalence standards. The only minor limitation is that the original answer emphasizes the potential need for structural or compliance adjustments, which the LLM touches on ('align...rules') but could have made slightly more explicit. However, this does not detract significantly from accuracy. All entities (OFR, FCA, BlackRock, European domicile) are correctly identified and logically connected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 373,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "\nBroadcom manufactures its FBAR filters in its own fabs rather than outsourcing the process, keeping the proprietary FBAR technology and associated design data under internal control. This vertical integration delivers higher‑performance filters (lower insertion loss, higher Q‑factor) and faster design‑to‑volume cycles, giving Broadcom a differentiated RF front‑end that OEMs rely on for next‑generation cellular handsets and reinforcing its high‑margin, technology‑lead position in the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies Broadcom's internal manufacturing of FBAR filters as a strategic advantage, emphasizing protection of intellectual property through vertical integration (implied by 'keeping proprietary FBAR technology under internal control') and faster time to market ('faster design-to-volume cycles'). These points directly support the competitive advantage in the cellular handset market, as stated in the original answer. While the ground truth focuses on IP protection and time-to-market, the LLM expands with technically accurate qualitative details—such as 'lower insertion loss, higher Q-factor'—which are known performance benefits of FBAR technology and consistent with Broadcom's differentiation strategy. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis: connecting internal manufacturing → control of IP → performance advantages → faster product cycles → competitive edge in a high-margin, innovation-driven market. The only reason for not scoring a perfect 10 is that the LLM slightly reframes the advantage in technical performance terms not explicitly mentioned in the ground truth, though these are contextually valid and well-aligned. No incorrect entities or facts are present. The answer is fully relevant and addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 405,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "\nMerck extends the commercial life of its biologics by pairing FDA‑granted **patent term extensions (PTEs)**—which can add up to five years to the life of a compound patent after accounting for time lost in clinical review—with **regulatory exclusivity** periods that are separate from patents.  In the United States, a newly approved biologic receives **12 years of data‑exclusivity** under the BPCIA, and it may also qualify for **six‑month pediatric exclusivity** (added to any listed patent or to the data‑exclusivity term) and, when applicable, a **seven‑year orphan‑drug exclusivity** extension.  By securing a PTE and any applicable pediatric or orphan extensions, Merck can push market protection for a biologic to roughly **12–13 years (or longer if a PTE is granted)**, delaying generic or biosimilar entry.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor overstatement regarding the interaction of patent term extensions (PTEs) and exclusivity durations. (1) Quantitatively, the 12 years of biologic data exclusivity and 6 months of pediatric exclusivity are accurately stated and match the original answer. However, the LLM introduces 'seven-year orphan-drug exclusivity' and 'patent term extensions (PTEs)' adding up to five years, which, while factually correct in isolation, are not explicitly mentioned in the ground truth and may not apply to biologics in the same way as small molecules. PTEs under Hatch-Waxman apply to drugs, but biologics are generally not eligible for PTEs in the same manner; instead, they may benefit from patent term adjustments (PTAs) due to USPTO delays, which are distinct. (2) The calculation of '12–13 years (or longer if a PTE is granted)' is reasonable if pediatric exclusivity is added (12 + 0.5 = 12.5 years), but the implication that PTEs directly extend biologic market protection is misleading, as regulatory exclusivity and patents operate in parallel, not cumulatively in a guaranteed way. (3) The reasoning is multi-hop and well-structured, correctly identifying how Merck combines exclusivity mechanisms, though it overreaches slightly by implying PTEs are a standard tool for biologics. (4) Despite these nuances, the core answer—Merck uses 12-year data exclusivity plus potential 6-month pediatric exclusivity—is correct and contextually relevant. The addition of orphan exclusivity, while plausible, is not part of the ground truth and slightly reduces quantitative accuracy. Overall, the answer is factually strong, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 475,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "\nThe 2024 UK Stewardship Code reforms introduce new, tailored reporting obligations for proxy advisers and investment consultants that BlackRock must meet when it conducts stewardship activities on behalf of its clients. These added reporting requirements are likely to raise compliance costs in the UK and may reshape client engagement by compelling BlackRock to adjust its proxy‑voting and engagement processes to satisfy the stricter disclosure standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core elements of the original answer. It correctly identifies the 2024 UK Stewardship Code reforms, specifies the tailored reporting obligations for proxy advisers and investment consultants, and accurately links these to increased compliance costs and changes in client engagement due to adjusted stewardship activities. The date (2024) and entities (UK Stewardship Code, BlackRock, FCA implicitly via context) are correct. There are no numerical values requiring verification, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced (9) because the LLM omits mention of specific regulatory risks such as Consumer Duty rules, potential regulatory sanctions, reputational risk, and client asset withdrawals—details present in the original that add depth to the compliance and client engagement implications. However, the omission does not undermine the central correctness of the response. The reasoning is sound and reflects proper multi-hop synthesis between the regulatory change and its operational impact on BlackRock. The answer is fully contextually relevant, directly addressing how the reforms affect compliance costs and client engagement in BlackRock's UK operations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 352,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "\nThe AspenTech segment’s depreciation + amortization expense climbed from **$95 million in fiscal 2021 to $242 million in fiscal 2022**, an increase of **$147 million**.  \nThis jump is directly linked to the Heritage AspenTech acquisition, which added **$148 million of amortization of acquired intangibles** (including backlog and customer‑related assets) for the year ended September 30 2022, as noted in the footnote on page 78.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the increase from $95 million in fiscal 2021 to $242 million in fiscal 2022 results in a $147 million increase, which matches the ground truth. The LLM adds a specific detail—$148 million of amortization of acquired intangibles—which is consistent with the overall increase and likely sourced from the cited footnote (page 78), though this specific figure is not in the original answer. This minor addition does not contradict but rather supports the explanation. (2) The calculation of the $147 million increase is accurate. (3) Entity accuracy is correct: AspenTech segment, fiscal years 2021 and 2022, and the Heritage AspenTech acquisition are all properly identified. (4) The reasoning is sound and multi-hop: the LLM connects the acquisition to the increase in amortization expenses via acquired intangibles, which is a valid and more detailed explanation than the original answer. The only reason for not scoring a 10 is that the original answer emphasizes the increase in backlog as the key link to amortization, while the LLM cites broader intangibles—still correct, but slightly shifts focus. However, this is supported by typical accounting practices post-acquisition and adds value. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 385,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "\nThe Asia Pacific region’s Subscriptions‑and‑Services revenue rose from **$720 million in fiscal 2021 to $744 million in fiscal 2022**, an increase of **$24 million** year‑over‑year. This $24 million gain accounted for roughly **6.6 %** of the total global increase in Subscriptions‑and‑Services revenue, which grew by $362 million over the same period.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the year-over-year increase in Subscriptions and Services revenue for the Asia Pacific region as $24 million, rising from $720 million in FY2021 to $744 million in FY2022, which matches the ground truth. However, it incorrectly calculates the percentage contribution of this regional increase to the total global growth. The LLM states 6.6%, but the correct figure is approximately 0.35% (24 / 362 ≈ 0.066 → 6.6% is the decimal-to-percentage conversion error; however, 24/362 ≈ 6.6% is mathematically correct, but the ground truth claims 0.35%, which contradicts basic arithmetic). This discrepancy suggests a potential error in the ground truth or misinterpretation of 'contribution to total global growth'—if the global segment grew by $362M and Asia Pacific contributed $24M of that, then 24/362 ≈ 6.6% is logically correct. Despite this, per strict adherence to the provided ground truth stating 0.35%, the LLM is marked incorrect on this key point. (2) All numeric values (revenue figures, increases) are accurate. The calculation of $24M increase is correct. The global increase of $362M (from $6,564M to $6,926M) is also accurate. The only quantitative conflict is the percentage: LLM reports 6.6%, which is mathematically sound; ground truth says 0.35%, which appears to be a factual error unless 'contribution to total global growth' refers to a different metric (e.g., percentage points of total revenue, not share of growth). (3) Multi-hop reasoning is correctly applied: the model synthesizes regional revenue change and compares it to global segment growth. The logic is sound and consistent with standard financial interpretation. (4) Due to the conflict between mathematical correctness and the provided ground truth, the correctness score is reduced to 4—while the LLM’s answer is numerically and logically consistent, it diverges from the expected answer on a critical percentage. Quantitative accuracy is scored at 5 because the numbers are right but the final percentage does not match ground truth despite being mathematically correct. Qualitative accuracy is 4 due to the mismatch in interpretation or potential error in the knowledge graph. Contextual relevance is high—answer addresses both parts of the question and uses appropriate entities and timeframes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 620,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRock’s ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "\nThe 2023 joint FTC‑DOJ merger guidelines tighten the Hart‑Scott‑Rodino (HSR) pre‑merger notification process by requiring substantially more information to be submitted and by extending the waiting period before a transaction can close. Because the filing costs and delays rise sharply, BlackRock faces greater hurdles and higher expenses when pursuing strategic investments or acquisitions, and any fund that must file an HSR‑reportable transaction must navigate the expanded reporting obligations, which can stall or deter such deals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies the 2023 joint FTC-DOJ merger guidelines and their impact on HSR-reportable transactions, accurately reflecting increased regulatory burden, higher filing costs, extended waiting periods, and greater complexity for BlackRock and funds engaging in acquisitions. All entities (FTC, DOJ, HSR Act, BlackRock) and the year (2023) are correct. There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. The reasoning is sound: it logically connects the tightened HSR process to higher costs and delays, which in turn hinder acquisition-driven expansion—this reflects proper multi-hop synthesis between the new guidelines and their operational/financial implications. The only minor shortcoming is that the LLM does not explicitly mention 'compliance burdens' or 'expanded documentation requirements' as stated in the original answer, slightly reducing completeness in qualitative nuance. However, these are implied in 'substantially more information' and 'expanded reporting obligations.' Wording differs but meaning is preserved. Contextual relevance is perfect—the response directly addresses both parts of the question: impact on BlackRock and on funds with HSR-reportable deals.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 376,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment — stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "\nGoldman Sachs issues two varieties of Non‑Employee Director RSUs—those that settle in actual shares (stock‑settled) and those that settle in cash (cash‑settled). Stock‑settled RSUs are accounted for as equity‑classified share‑based compensation, so the award is recorded in shareholders’ equity and the expense is recognized over the vesting period without a liability on the balance sheet. Cash‑settled RSUs, by contrast, are treated as a liability‑classified award; the company records a financial‑liability at fair value, remeasures it each reporting period, and reports the corresponding expense (and a related accrual) in accrued compensation, while the cash payout is shown in the cash‑flow statement when paid. Thus the dual‑settlement structure results in different balance‑sheet classifications and cash‑flow impacts for the same type of director compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: stock-settled RSUs are classified as equity, cash-settled as liabilities under GAAP; equity-classified awards result in expense recognition over vesting with no liability, while liability-classified awards require remeasurement at each reporting date and are recorded as a liability (accrued compensation). The cash flow impact is also correctly noted. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in terms of calculations, but all qualitative financial treatments are correctly described—thus scored as 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes that differing settlement terms (stock vs. cash) lead to different accounting treatments (equity vs. liability), which in turn affects balance sheet classification, expense timing, and cash flow presentation. The only minor omission is the lack of reference to specific forms (Form 10.8 and 10.32), which appear in the original evidence but are not essential to the conceptual correctness of the accounting treatment. (4) The answer is fully contextually relevant, directly addressing how the dual settlement structure influences accounting and financial statement classification. Wording differs but semantic meaning matches the ground truth. A score of 9 is justified due to the omission of form numbers, but the technical and conceptual accuracy remains very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 419,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "\nIn 2023 Abbott granted **4,981,231 restricted‑stock units** under the 2017 Incentive Stock Program. These units **vest over a three‑year period**, and when they vest each unit converts into **one share of Abbott common stock**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number of restricted stock units granted in 2023 — 4,981,231 — is accurate and matches the original answer exactly. (2) The vesting condition is correctly described: the units vest over a three-year period, and each vested unit converts into one share of Abbott common stock, which aligns precisely with the original answer's statement that 'the recipient receives one share of Abbott stock for each vested unit.' (3) The reasoning is sound and reflects proper synthesis of multi-hop information from the Abbott Laboratories 2017 Incentive Stock Program documentation and 2023 grant data. (4) All entities — Abbott Laboratories, the 2017 Incentive Stock Program, restricted stock units, and the year 2023 — are correctly identified and contextualized. Minor wording differences (e.g., 'converts into' vs 'receives') do not affect factual accuracy. The answer is complete, factually precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 293,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "\nIn 2024, 35 percent of the Life Sciences segment’s sales (7 % from other developed markets plus 28 % from high‑growth markets) came from regions outside North America and Western Europe.  The 2005 acquisition of Leica Microsystems created a global Life Sciences platform that has since expanded Danaher’s revenue base into emerging markets, illustrating the long‑term strategic goal of diversifying geographic exposure and capturing growth beyond the company’s traditional North‑American and Western‑European strongholds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that 35% of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, accurately breaking this down into 28% from high-growth markets and 7% from other developed markets. This matches the ground truth exactly. The calculation (28% + 7% = 35%) is correct and clearly presented.\n\n2) All numeric values are accurate: 28%, 7%, and the derived 35% are all consistent with the original answer. The geographic regions and their corresponding percentages are correctly attributed.\n\n3) The reasoning regarding the strategic impact of the 2005 Leica Microsystems acquisition is sound and aligns with the ground truth. The LLM correctly identifies that the acquisition served as a foundational platform for global expansion, particularly into emerging markets, and supports Danaher’s long-term geographic diversification strategy. While the original answer includes specific follow-on acquisitions (Beckman Coulter, Pall, Abcam) as evidence of this expansion, the LLM answer captures the essence of the strategic impact without listing them—this is a minor omission but does not undermine the correctness of the core reasoning.\n\n4) The answer is semantically equivalent to the ground truth in both quantitative and qualitative aspects. It addresses both parts of the question: the percentage of sales from outside North America and Western Europe, and the strategic impact of the Leica Microsystems acquisition. The contextual relevance is excellent, focusing precisely on geographic distribution and long-term strategic implications. The only reason for not scoring a perfect 10 is the omission of specific subsequent acquisitions that illustrate the expansion path, which slightly reduces qualitative completeness, though the central logic remains intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 495,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "\nDanaher has completed **nine** acquisitions of companies in its Life Sciences segment since the segment’s launch in 2005. Pall was acquired in **2015**, and the most recent acquisition noted in the filing is **Abcam, acquired in 2023**.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Danaher made nine acquisitions, but the ground truth confirms only eight: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023). The LLM incorrectly counts nine, indicating a factual error in quantity. (2) The dates for Pall (2015) and Abcam (2023) are correct, satisfying those specific sub-questions. However, the total number of acquisitions is inaccurate, which is a key part of the query. (3) The multi-hop reasoning is partially sound — the model correctly identifies Pall and the most recent acquisition (Abcam) from different years and segments the timeline appropriately. However, it fails in complete synthesis by either double-counting an acquisition or including one not in the knowledge graph. (4) Despite the numerical inaccuracy, the answer is contextually relevant and captures the correct structure and intent of the response. The qualitative reasoning is mostly logical but flawed in final tally. Quantitative accuracy is penalized due to the incorrect count (9 vs 8), though key dates are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 331,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "\nThe fair‑value of Abbott’s interest‑rate hedge contracts declined by **$123 million** between 31 Dec 2020 and 31 Dec 2021, falling from **$210 million** to **$87 million**. This reduction is mirrored by a drop in the contract’s receivable balance from **$210 million** to **$87 million**, indicating that the hedges were marked‑to‑market lower as the underlying fixed‑rate debt’s fair value changed.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: the fair value decreased from $210 million to $87 million, resulting in a $123 million decline, which is correctly calculated and reported. (2) The receivable position is also correctly stated to have dropped from $210 million to $87 million, aligning with the fair value change. (3) The reasoning is sound: the answer correctly links the decline in fair value to the drop in receivable balance and provides context by noting that the hedges were marked-to-market, reflecting changes in the underlying fixed-rate debt’s fair value—this demonstrates proper multi-hop synthesis between valuation and accounting treatment. (4) All entities (Abbott, interest rate hedge contracts, correct dates) are accurate, and the answer fully addresses both parts of the question: the change in fair value and its reflection in the receivable position. Wording differs slightly from the original but maintains full semantic equivalence. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 303,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "\nBMY’s strategy explicitly calls for expanding its autologous CAR‑T portfolio—building manufacturing capacity, advancing next‑generation CAR‑T designs, and pursuing new indications for Breyanzi such as CLL, FL and MCL—so that the drug can reach additional patient populations. This pipeline focus directly fueled the ~100 % jump in U.S. Breyanzi sales in 2023, as the expanded indication work and increased demand translated into doubled U.S. revenues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the ~100% jump in U.S. Breyanzi sales correctly reflects the 'doubling' of revenues mentioned in the original answer; this is a semantically equivalent and accurate representation. No specific dollar amounts or incorrect dates are present, and the percentage change is correctly interpreted. (2) The entities are correct: BMY (Bristol Myers Squibb), Breyanzi, and the new indications (CLL, FL, MCL) are all accurately identified and contextually placed. The year 2023 is correctly referenced. (3) The reasoning is sound and captures the multi-hop logic: BMY's strategic focus on expanding indications and manufacturing capacity led to increased patient access and demand, which in turn drove the observed revenue growth. The LLM correctly synthesizes strategy with financial outcome. (4) The only minor shortcoming is that the original answer explicitly links the revenue growth to 'higher demand' resulting from the strategic investments, while the LLM implies it ('translated into doubled U.S. revenues'). The causal link is slightly less explicit, but still logically conveyed. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for slightly weaker articulation of causality.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 381,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "\nThe cash outflow for the 2023 acquisition of **The Binding Site Group** was **$2.699 billion** (cash paid $2.412 bn + debt settled $0.307 bn – cash acquired $0.020 bn). This acquisition accounted for the bulk of the **$3.61 billion** of cash used for all acquisitions in 2023, the remainder being the **$0.91 billion** spent on acquiring **CorEvitas, LLC**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the cash outflow for The Binding Site Group acquisition as $2.699 billion, which is effectively equivalent to the ground truth $2.70 billion (rounded). The breakdown ($2.412 bn cash paid + $0.307 bn debt settled - $0.020 bn cash acquired) is accurate and supports the total. The CorEvitas, LLC acquisition amount is correctly stated as $0.91 billion, and the total cash used for acquisitions ($3.61 billion) is correctly calculated and reported. (2) Quantitative verification: $2.412 + 0.307 - 0.020 = $2.699 billion (matches LLM), and $2.699 + 0.91 = $3.609 billion ≈ $3.61 billion (correct rounding). The minor $0.001 billion difference in the Binding Site amount is due to rounding and is acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes data from two acquisitions (The Binding Site Group and CorEvitas, LLC) and combines them into the total cash used for acquisitions in 2023. (4) The answer is semantically equivalent to the ground truth, with slightly more detailed breakdown of the cash outflow components. All entities (company names, years, financial metrics) are accurate. The only reason for not scoring 10 is the $2.699B vs $2.70B discrepancy, which is negligible but technically a rounding difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 362,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "\nThe company expects the restructuring actions taken in 2024 and 2023 to generate roughly **$0.2 billion in annual cost savings in 2024 and $0.6 billion in annual savings in 2023**, for a combined **≈ $0.8 billion of yearly reductions**【page_21】.  \n\nThe **2023 acquisition of The Binding Site Group** expands the Specialty Diagnostics portfolio with “pioneering innovation in diagnostics and monitoring for multiple myeloma,” directly bolstering the segment’s strategic growth in blood‑cancer diagnostics【page_65】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the annual cost savings of $0.2 billion from 2024 and $0.6 billion from 2023 are accurately reported, and their sum ($0.8 billion) is correctly calculated. Minor formatting variations (e.g., '≈ $0.8 billion' vs. '$0.8 billion') are acceptable and do not affect accuracy. (2) The answer is complete, addressing both parts of the multi-part question: total cost savings and the strategic impact of The Binding Site Group acquisition. (3) Entity accuracy is perfect: 'The Binding Site Group', '2023 acquisition', 'Specialty Diagnostics segment', and 'blood cancer diagnostics' are all correctly identified and contextually placed. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking restructuring charges in two years to total savings, and connecting the acquisition to strategic growth in blood cancer diagnostics, specifically multiple myeloma. The use of quotes from the source (e.g., 'pioneering innovation') aligns with the original phrasing and enhances fidelity. All information is semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 324,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "\nThe longest‑term debt instrument disclosed in Eli Lilly’s 2023 10‑K is the **1.375 % Notes due 2061** (listed as “1.375% Notes due 2061” on page 1). Its maturity in 2061 extends farther out than any of the other notes mentioned, which mature in 2025, 2026, 2030, 2031, 2033, 2036, 2043, 2049 and 2051. Thus, the 2061‑dated notes have the latest (i.e., longest) maturity of all the debt securities listed.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) The longest-term debt instrument is accurately identified as the '1.375% Notes due 2061', with the correct interest rate and maturity year. (2) Quantitative accuracy is perfect: the maturity year 2061 is correctly stated, and the comparison to other debt instruments includes accurate maturity years (e.g., 2033 and 2051, among others), all of which are earlier than 2061. The list of maturities (2025, 2026, etc.) is consistent with typical disclosures in Eli Lilly's 2023 10-K and adds detail beyond the ground truth without introducing error. (3) The reasoning is sound: the answer correctly identifies the 2061 note as having the latest maturity and concludes it is the longest-term instrument, demonstrating proper synthesis across multiple debt instruments. (4) The answer is semantically equivalent to the original, providing even more completeness by listing additional maturity years. All entities (Eli Lilly, 2023 10-K, specific notes) are correctly referenced. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 314,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "\nDonanemab is being developed/under review for **two distinct indications** – early‑stage Alzheimer’s disease (submitted for approval in the U.S., EU and Japan) and preclinical Alzheimer’s disease (Phase III). Lebrikizumab, by contrast, has **one indication** that is either approved (EU, Japan) or under regulatory review (U.S.) – atopic dermatitis. Thus, Donanemab’s pipeline covers two indications whereas Lebrikizumab covers just one.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it correctly identifies that Donanemab is under development or review for two distinct indications and Lebrikizumab for one, which aligns with the original answer. (2) The entities are accurate: Donanemab is correctly associated with early-stage and preclinical Alzheimer’s disease, and Lebrikizumab with atopic dermatitis across EU, Japan, and the U.S. regulatory status. (3) The multi-hop reasoning is sound—comparing the number of indications across two drugs, synthesizing development, approval, and review statuses from different regions. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., specifying regulatory submissions in U.S., EU, Japan for Donanemab) that does not affect accuracy. All components of the question are addressed: number of indications for each drug and the comparative conclusion. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 288,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "\nThe generic entry wiped out most of Alimta’s U.S. sales, pulling down the overall U.S. volume growth, but that loss was more than offset by robust volume gains from the oncology drug **Verzenio**, whose 56 % revenue increase reflected strong uptake and drove the 11 % rise in total U.S. volume for 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the decline in Alimta's U.S. revenue due to generic entry negatively impacted overall U.S. volume growth and that Verzenio contributed positively, which aligns with the ground truth. However, it introduces specific quantitative claims not present in the original answer: a '56% revenue increase' for Verzenio and an '11% rise in total U.S. volume for 2023'. These figures are not supported by the ground truth and appear to be fabricated or misattributed, significantly undermining factual accuracy. (2) The original answer does not include any percentages or numerical metrics for Verzenio’s performance or overall U.S. volume growth, so these additions are incorrect. There is no verification that Trulicity, mentioned in the original as another contributing product, is omitted in the LLM answer—this reduces completeness. (3) The multi-hop reasoning is partially sound: the model correctly links generic entry → Alimta revenue decline → negative impact on volume → offset by other oncology products. However, it fails to mention Trulicity and over-specifies unsupported metrics, indicating potential hallucination. (4) While the core qualitative narrative is directionally correct and contextually relevant, the inclusion of unverified quantitative data severely impacts correctness and quantitative accuracy, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 393,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "\nMerck has committed up to roughly **$4 billion in upfront and milestone payments** – including the **$250 million option payment in 2022** and **$1.5 billion of contingent continuation payments** – and will **share all future development costs equally with Moderna**, recording its portion as R&D expense while any reimbursements from Moderna are booked as reductions to those costs.  \n\nThis investment is a cornerstone of Merck’s **2023‑outlined immuno‑oncology strategy**, enabling the company to pair its flagship checkpoint inhibitor **Keytruda** with the **mRNA‑based neoantigen vaccine V940 (mRNA‑4157)** in adjuvant trials for melanoma and NSCLC, thereby expanding its pipeline beyond traditional biologics into a personalized mRNA‑driven immunotherapy approach that aligns with its three‑pillar strategy of immuno‑oncology, precision‑targeting and tissue‑targeting.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies the $250 million option payment in 2022 and the equal cost-sharing arrangement with Moderna, it introduces a $4 billion total commitment and $1.5 billion in contingent payments that are not present in the ground truth. The original answer only confirms the $250 million payment and ongoing 50/50 cost-sharing, with no mention of additional milestone or contingent payments. These fabricated figures severely undermine factual correctness.\n\n2) Number verification: The $250 million payment in 2022 is accurate and correctly dated. However, the $1.5 billion contingent payment and $4 billion total commitment are unsupported by the ground truth and appear to be hallucinated. There is no calculation or sum in the original answer to validate these numbers. The ground truth does not specify any future milestone payments, so including them as fact is incorrect.\n\n3) Multi-hop reasoning is partially sound. The LLM correctly links Merck's financial commitment to its broader immuno-oncology strategy, accurately noting the combination of V940 with Keytruda in trials for melanoma and NSCLC (INTerpath-001 and -002), and correctly frames this within Merck’s strategic expansion into personalized mRNA therapies. It also appropriately references the strategic pillars (immuno-oncology, precision targeting), demonstrating good synthesis of strategic context from the 10-K.\n\n4) Despite the quantitative errors, the answer captures the qualitative essence of Merck’s strategy and the significance of V940 in its pipeline. The mention of Breakthrough Therapy and PRIME designations is missing, which is a minor omission. However, the core strategic alignment is well-articulated. The high contextual relevance reflects that the answer addresses both parts of the question and provides meaningful strategic interpretation, even if financial specifics are flawed. The correctness score is limited by the serious numerical inaccuracies, which are critical in financial commitment questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 556,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "\nMK‑7962 (sotatercept) is expected to retain U.S. patent protection until 2037, while its 12‑year biologic data‑exclusivity period is slated to expire on July 16, 2033. Thus, the patent can extend exclusivity by roughly **four additional years** beyond the standard data‑exclusivity term.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual and calculation errors, despite addressing the right question. (1) The ground truth states that sotatercept could receive an additional 10 years of protection beyond the standard 12-year exclusivity period if approved in 2027, with patents expiring in 2037. The LLM incorrectly calculates the data exclusivity expiration as 2033 (implying approval in 2021), which contradicts the disclosed anticipated approval year of 2027. (2) Quantitatively, the LLM’s claim of a 4-year extension is incorrect: if approved in 2027, 12-year exclusivity ends in 2039, but patents expire in 2037—meaning patent protection would actually expire *before* data exclusivity, not extend beyond it. However, the original answer assumes patents (expiring 2037) extend protection beyond exclusivity (ending 2039), which only makes sense if there is a patent term extension or if the exclusivity period is shorter. But per standard rules, 12-year exclusivity from 2027 ends in 2039, so 2037 patent expiry implies no additional years. Yet the ground truth claims 10 additional years, suggesting a different interpretation—possibly that approval is in 2027, exclusivity ends 2039, but patents are extended to 2037 (still inconsistent). There appears to be a conflict in the ground truth logic. However, the LLM answer introduces a specific date (July 16, 2033) not present in the original answer and not inferable from the provided context, making it hallucinated. (3) The multi-hop reasoning is flawed: the model fails to align the approval year (2027) with the exclusivity end (2027 + 12 = 2039) and incorrectly assumes exclusivity ends in 2033, leading to a false 4-year extension. (4) Despite incorrect facts and logic, the answer is contextually relevant—addressing patent term vs. data exclusivity—and attempts the right calculation. However, the core quantitative and qualitative inaccuracies severely undermine correctness. The ground truth may itself be ambiguous, but the LLM does not reproduce it accurately. Thus, low scores on correctness, quantitative, and qualitative accuracy; moderate relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 568,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "\nThe requested figures— the 2022 and 2023 fair‑value (NAV) amounts for Merck’s Emerging Markets Equities investments in both the U.S. and International Pension Plans and the resulting year‑over‑year increase— are not disclosed in any of the supplied pages (108‑112). Consequently, the total increase cannot be calculated from the information provided.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to match the ground truth. (1) The original answer provides specific, correct figures from the knowledge graph: U.S. Pension Plans increased by $33 million (from $707M to $740M), and International Pension Plans increased by $73 million (with detailed breakdowns across direct holdings and investment funds), totaling a $106 million increase. These numbers are precise and supported by multi-year, multi-plan data. (2) The LLM claims the data is not disclosed in pages 108–112, but this reflects a failure in information retrieval or synthesis, not absence of data in the source. The ground truth confirms the data exists and is structured. (3) The multi-hop reasoning required—aggregating fair value changes across U.S. and International Pension Plans, using NAV-based measurements, and summing the year-over-year increases—was not attempted by the LLM, which defaulted to a non-answer. (4) As a result, all accuracy scores are near minimum: the LLM provides no correct numbers, misidentifies the availability of data, and fails to perform even basic reasoning. Contextual relevance is low because the response avoids answering the question rather than engaging with the available facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 345,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "\nThe estimated fair value of U.S. government‑agency securities grew by **$92 million** (from $35 million at the end of 2022 to $127 million at the end of 2023). In contrast, the estimated fair value of U.S. Treasury securities increased by **$16 million** (from $410 million to $426 million). Thus, the agency‑security holdings saw a far larger dollar increase over the same period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers and directions of change. According to the ground truth, U.S. government agencies securities increased from $21M to $127M, a $106M increase, but the LLM reports a rise from $35M to $127M, calculating a $92M increase—both starting value and change are incorrect. More critically, the ground truth states U.S. Treasury securities decreased from $379M to $426M is an increase, not a decrease—this is a major directional error. The LLM claims Treasury securities increased by $16M (from $410M to $426M), which is factually wrong on both the starting value and the trend. (2) Calculations: The correct change for agency securities is $127M - $21M = $106M (LLM says $92M). For Treasury: $426M - $379M = +$47M would be an increase, but the ground truth actually says it decreased—this appears contradictory until realizing the ground truth contains a typo: $379M to $426M is mathematically an increase of $47M, but the original answer claims a $34M decrease, which is inconsistent. However, based on the intended meaning in the original answer (that Treasuries declined), the LLM still fails because it reports an increase, contradicting the expected conclusion. Given the confusion, the LLM’s use of $410M → $426M (+$16M) is unsupported by either version. (3) Multi-hop reasoning: The model attempts to compare two securities' fair value changes, satisfying the structure of the question, but due to incorrect data retrieval, the synthesis is flawed. It fails to correctly identify the starting values and resulting trends for both asset classes. (4) Scores justified: Correctness is low (3/10) due to major factual and directional errors. Quantitative accuracy is poor (3/10) because most numbers are wrong. Qualitative accuracy is slightly higher (4/10) as the model understands the task type—comparing changes in fair value—but executes poorly. Contextual relevance is high (8/10) because the response addresses both securities and time periods correctly in framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 549,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvy’s patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "\nBiktarvy sales rose 14 % year‑over‑year, climbing from **$8.5 billion in 2022 to $9.7 billion in 2023**, helping to offset the modest overall revenue decline and the steep drops in Veklury and other legacy HIV products. However, because the core patent protections for many of Gilead’s flagship HIV agents (e.g., Descovy – 2031, Stribild – 2029) expire well before Biktarvy’s own 2033 exclusivity, the company can only rely on Biktarvy’s growth for a limited window; consequently, Gilead’s long‑term financial strategy must increasingly depend on expanding its oncology, cell‑therapy and inflammation pipelines and on new product launches to sustain profitability once HIV patent cliffs are reached.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the revenue figures for Biktarvy. It states $8.5 billion in 2022 and $9.7 billion in 2023, whereas the ground truth reports $10,390 million ($10.39 billion) in 2022 and $11,850 million ($11.85 billion) in 2023. This results in a major quantitative error, despite correctly stating the 14% growth rate. The calculation of 14% growth from $8.5B to $9.7B is approximately correct (14.1%), but the underlying figures are wrong, undermining the factual basis. (2) The patent expiration timeline is partially accurate—mentioning Biktarvy’s 2033 exclusivity aligns with expectations (though not explicitly confirmed in the provided ground truth), but the inclusion of Descovy (2031) and Stribild (2029) is extraneous and not supported in the original answer, which focused on Biktarvy’s importance and general patent cliff risks. (3) The reasoning about Gilead’s need to diversify into oncology, cell therapy, and inflammation is plausible and contextually sound, representing logical strategic implications, but this expansion is not mentioned in the original answer, which emphasized patent extension and follow-on therapies for HIV products. Thus, while the strategic direction is reasonable, it diverges from the ground truth’s focus. (4) The answer addresses both parts of the question—revenue performance and strategic implications—and maintains contextual relevance. However, due to the critical error in financial figures, the correctness and quantitative accuracy scores are low. The qualitative reasoning is partially sound, hence a moderate score, and relevance remains high as the overall structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 467,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "\nThe 2023 U.S. patent cliff on Truvada will erode a major source of HIV revenue, shrinking the cash flow that Gilead can devote to lifecycle‑management activities for its HIV franchise. Because the company reports a single operating segment and allocates resources centrally, any decline in Truvada sales reduces the overall budget that can be deployed across all therapeutic areas, forcing Gilead to prioritize higher‑margin projects (e.g., oncology, inflammation) and potentially scale back or delay further HIV‑specific innovation and marketing efforts.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: Truvada's U.S. patent expiration in 2023 is correctly identified, and the financial impact of generic competition on Gilead's HIV revenue is accurately portrayed. The single operating segment and centralized resource allocation are correctly described, and the logical consequence—reduced cash flow affecting lifecycle management investments—is sound. The answer goes further by suggesting strategic prioritization shifts toward higher-margin areas like oncology and inflammation, which is a reasonable inference though not explicitly stated in the ground truth. This addition does not contradict the original answer but extends it slightly. All entities (Gilead, Truvada, 2023 patent expiration) and structural facts (single segment, centralized allocation) are correct. There are no numerical inaccuracies, and while no specific dollar figures are cited, the qualitative financial impact is consistent with the ground truth. The reasoning correctly synthesizes the multi-hop logic: patent loss → revenue decline → constrained investment in HIV lifecycle management due to centralized budgeting. The only minor shortcoming is that the original answer emphasizes the possibility of offsetting investments via cost reallocations or newer product revenues, which the LLM omits. This makes the LLM's outlook slightly more pessimistic and less balanced than the ground truth, warranting a small deduction in qualitative accuracy. Overall, the answer is semantically equivalent in key aspects and highly contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 431,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "\nThe 2023 IDA agreement required Schwab to sweep certain brokerage‑client deposits off its balance sheet and to migrate those balances onto the bank’s books only when it had sufficient capital, directly tying the migration to its capital‑management strategy.  The agreement also created “contract assets” that represent the buy‑down of fixed‑rate obligations; these assets are amortized on a straight‑line basis over the contractual term and reduce bank‑deposit fee revenue.  In 2023 Schwab amortized $85 million of contract‑related costs (the amortization expense for these IDA‑related contract assets).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $85 million amortization amount for 2023 is correctly reported, matching the original answer exactly. The year (2023) and the nature of the amortization as part of capitalized contract costs are accurate. (2) The answer addresses all parts of the question: it explains how the 2023 IDA Agreement impacted Schwab's capital management strategy (by enabling off-balance sheet sweeping of client deposits tied to capital levels) and describes the creation and amortization of contract assets related to fixed-rate obligation buy-downs. (3) The multi-hop reasoning is sound—correctly linking the IDA Agreement to both capital management and contract asset amortization, and identifying the financial impact. (4) The only minor shortcoming is that the LLM slightly simplifies the explanation by stating the $85 million was specifically for IDA-related contract assets, while the original answer clarifies it was part of a broader $85 million amortization of capitalized contract costs (which includes, but is not exclusively broken out as solely IDA-related). This does not make the answer factually wrong, as the IDA-related amortization is included in that total, but introduces a slight over-attribution. However, given that the total amount is correct and the context is preserved, this is a minor nuance. Wording differences are semantically equivalent and acceptable. All entities (Schwab, 2023 IDA Agreement, TD Depository Institutions implied via context, contract assets, amortization) are correctly identified and used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 442,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "\nThe 2023 equity reconciliation shows that the issuance of 1,725,000 limited‑partner units added $197.4 million to total equity, while the issuance of unit equivalents—including LTIP units—reduced equity by $22.4 million; the net effect is an approximate $175 million increase, which is reflected in the year‑end total equity of $3.49 billion reported in the 2023 10‑K.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, LTIP units added $14,739 to equity (a positive contribution), but the LLM states that 'unit equivalents—including LTIP units—reduced equity by $22.4 million,' which is incorrect. Additionally, the redemption of limited partner units reduced equity by $13,524 and treasury unit purchases reduced equity by $140,593—these offsetting reductions are entirely missing from the LLM response. Instead, the LLM reports a net increase of approximately $175 million, whereas the correct net effect is a reduction of $139,378. (2) The issuance of limited partner units is correctly reported as approximately $197.4 million (vs. $197,426 in ground truth), which is quantitatively acceptable with rounding. However, the $22.4 million reduction attributed to LTIP/unit equivalents contradicts the ground truth that LTIP units added value. The net effect of ~$175 million increase is therefore fundamentally wrong, as the actual net change is a decrease. (3) The multi-hop reasoning fails because the model does not synthesize the full set of unit-related transactions: it omits redemptions and treasury purchases that are critical to computing the net effect. It incorrectly frames LTIP units as reducing equity when they increased it. (4) Contextual relevance is moderate—the answer addresses unit issuances and their impact on equity and references the correct document (2023 10-K), but the core quantitative and directional conclusions (increase vs. decrease) are incorrect, severely undermining factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 441,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 10–20 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "\nLinde builds on‑site plants to meet a customer’s entire gas demand under multi‑year “total‑requirement” contracts that include minimum purchase volumes and price‑escalation provisions; because the supply is a continuous performance obligation, revenue is recognized only when the gas is delivered and Linde has an enforceable right to invoice, with any variable or contingent pricing constrained until realized. This long‑term, on‑site distribution model therefore drives the company to record contract assets/liabilities and to recognize revenue ratably as the on‑site supply progresses rather than at contract inception.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key elements are correct: Linde uses on-site plants under long-term 'total-requirement' contracts with minimum purchase volumes and price escalation provisions; revenue is recognized over time upon delivery with an enforceable right to invoice. The answer correctly identifies the performance obligation as continuous and explains ratable revenue recognition aligned with delivery. (2) There are no numeric values (e.g., contract length of 10–20 years) explicitly mentioned in the LLM answer, which were present in the original answer. This is a minor omission but does not affect the overall correctness, as the focus is on the structural and accounting implications rather than specific durations. (3) The multi-hop reasoning is sound—linking on-site distribution to long-term contracts, then to revenue recognition policy under ASC 606, and explaining contract assets/liabilities and variable consideration constraints shows strong synthesis. (4) Semantic equivalence is maintained: 'recognized over time as product is delivered' = 'recognized only when gas is delivered'; 'right to invoice' is correctly tied to revenue recognition. The LLM adds slight precision by mentioning constraint on variable pricing, which is consistent with accounting standards and enhances the answer without contradicting the original. Minor deduction from 10 to 9 due to omission of typical contract duration (10–20 years), but all other aspects are factually and contextually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 429,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "\nThe corporate‑notes‑and‑obligations fair‑value column shows $3,354 million at January 31 2023 and $2,978 million at January 31 2024, a $376 million decrease. By contrast, the aggregate fair value of all marketable securities rose from $5,492 million to $5,722 million, an increase of only $230 million. Thus, the decline in corporate notes and obligations ($376 million) is larger than the net $230 million gain in total marketable‑securities fair value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitative Accuracy: All numbers are correct — the fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a $376 million decrease; total marketable securities increased from $5,492 million to $5,722 million, a $230 million increase. These values and calculations are precisely correct. (2) Completeness: The answer addresses both parts of the question — the difference in fair value for corporate notes and obligations, and how that compares to the overall change in marketable securities. (3) Entity Accuracy: The financial instruments and time points (implied years via dates) are correctly referenced. (4) Reasoning: The multi-hop synthesis is sound — it correctly contrasts the decline in one component with the overall portfolio increase. The only minor issue is semantic: the original answer notes that the overall portfolio 'increased' while emphasizing the contrast, whereas the LLM states the decline is 'larger than the net gain', which is mathematically correct but slightly less precise in framing the inverse relationship (a decrease cannot be larger than an increase in magnitude without clarifying absolute values). However, the intent and factual basis are correct. (5) Semantic Equivalence: The meaning conveyed is effectively the same — corporate notes declined significantly while total marketable securities increased overall. Thus, the answer is factually and contextually strong, warranting a 9/10 for correctness due to minor phrasing nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 435,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "\nChanging provider behavior alters utilization patterns and cost trends that CVS must forecast for its Insured Health‑Care Benefits products, which are priced with a fixed‑premium period (typically about twelve months). Because premiums are set in advance and cannot be raised when actual medical‑cost trends exceed projections, even modest errors in forecasting those trends—driven by shifts in provider conduct—directly reduce profit margins, making the segment’s operating results highly sensitive to forecast accuracy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the fixed premium period (implied as ~12 months), the advance pricing of premiums, and the sensitivity of profits to forecast accuracy are all correctly described. (2) There are no numeric values in the original or LLM answer that conflict; the 94% revenue figure from Insured Health Care Benefits in the ground truth is the only specific percentage, which the LLM omits. However, this omission does not distort the meaning, as the LLM still correctly identifies that insured products are central to the segment. (3) The multi-hop reasoning is sound: the LLM correctly links changing provider behavior → impact on cost trends → forecasting challenges → fixed premiums preventing mid-course correction → profit sensitivity. This mirrors the causal chain in the original answer. (4) The LLM uses slightly different phrasing (e.g., 'modest errors' vs 'small differences') but maintains semantic equivalence. The only minor gap is the absence of the 94% revenue detail, which adds contextual weight but does not alter the fundamental correctness. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 364,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moody’s—indicating strong creditworthiness—the additional production from Noble enhances Chevron’s ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "\nThe October 2020 purchase of Noble added roughly 6,000 cubic feet of natural‑gas production for every barrel of crude‑oil output, expanding Chevron’s upstream cash‑flow base and reserve portfolio.  That extra, low‑cost gas volume gave the company additional operating cash that it could use to retire maturing debt, keep leverage ratios low and continue funding its dividend—factors that underpin the AA‑ (S&P) and Aa2 (Moody’s) ratings even when oil and gas prices are depressed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) Quantitatively, all key facts are correct: the October 2020 acquisition date, the 6,000 cubic feet of natural gas per barrel of crude oil, and the AA- (S&P) and Aa2 (Moody’s) credit ratings are accurately stated. There are no calculation errors. (2) The answer correctly interprets the energy equivalence (6,000 cubic feet = 1 barrel oil-equivalent), though it does not explicitly state the conversion, it treats the production addition in a way consistent with correct understanding. (3) The reasoning is sound: it links the acquisition to increased cash flow, low-cost production, debt management, leverage control, and dividend funding—all factors supporting high credit ratings during low commodity prices. It aligns with Chevron’s stated strategy of financial flexibility. (4) The only minor omission is that the LLM does not explicitly mention Chevron’s ability to reduce capital spending or stock repurchases as a financial safeguard, which is included in the ground truth. However, the concepts of low leverage and debt retirement serve a similar explanatory role. Overall, the answer is factually correct, contextually relevant, and demonstrates proper multi-hop reasoning connecting acquisition → production/cash flow → financial flexibility → credit ratings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 385,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "\nSchwab spent **$249 million** in market‑based fees to buy down **$5.0 billion** of fixed‑rate obligation amounts under the 2023 IDA agreement. These fees were capitalized as **contract assets** and recorded in **“Other assets”** on the consolidated balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligations under the 2023 IDA agreement. The amount was capitalized as contract assets and included in 'Other assets' on the consolidated balance sheet. (2) Quantitative accuracy is perfect: both $249 million and $5.0 billion match the original answer exactly, with acceptable formatting (e.g., 'million' vs 'M'). (3) The multi-hop reasoning is sound—correctly linking the expenditure, the purpose (buy-down of fixed-rate obligations), the agreement (2023 IDA), and the accounting treatment (capitalization as contract assets in other assets). (4) Entity accuracy is correct: 'Schwab', '2023 IDA agreement', 'contract assets', and 'other assets' are all properly identified. The addition of 'market-based fees' provides minor contextual elaboration but does not alter or distort the factual content. All components of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 302,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "\nCVS recorded a **$483 million store‑impairment charge in 2024** as part of its enterprise‑wide restructuring plan. That impairment is **slightly below the initiative’s projected cost‑savings target of more than $500 million for 2025**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $483 million store impairment charge in 2024 and the projected 'more than $500 million' in cost savings for 2025 are accurately reported, with appropriate wording ('slightly below') reflecting the comparison. (2) The numbers are correct and match the original answer exactly; format variations (e.g., 'more than $500 million' vs. 'over $500 million') are semantically equivalent. (3) The multi-hop reasoning—linking the 2024 impairment charges to the 2025 projected savings from the same restructuring initiative—is sound and correctly synthesized. (4) The answer is concise, contextually relevant, and conveys the same core information: a near-term cost (impairment) expected to be offset by future savings. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 252,
        "total_tokens": 1422
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "\nChevron’s equity‑method earnings from Angola LNG Limited in 2021 were about **–$166 million**, reflecting a loss for the year.  This shows that, although Chevron holds a 36 % stake in the Angolan LNG project, the venture is currently not contributing positively to its earnings, highlighting the limited near‑term profitability of its LNG operations in Angola.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Chevron's equity in earnings from Angola LNG Limited as -$166 million in 2021, matching the ground truth exactly. The stake percentage is reported as 36%, which is a minor rounding of the precise 36.4% in the original answer, but this does not materially affect accuracy. 2) All numeric values (dollar amount and percentage) are correct within acceptable rounding; the negative sign is properly included, indicating a loss. 3) The reasoning is sound: the LLM correctly infers that the negative earnings reflect challenges or lack of near-term profitability in Chevron's LNG operations in Angola, which aligns with the implication in the ground truth about 'potential challenges in liquefaction and processing.' While the LLM does not explicitly mention 'liquefaction and processing for international markets,' it captures the core implication of operational or financial difficulty. 4) The answer is contextually complete and relevant, addressing both parts of the question—quantitative result and its implication—using appropriate financial terminology and logical inference. The minor omission of the precise decimal in the ownership stake and slightly less detailed explanation of technical challenges prevent a perfect 10, but overall the response is factually accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 369,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "\nThe mismatch creates a prolonged operational exposure: Duane Arnold’s nuclear‑fuel supply contracts run only through 2033, yet the plant’s decommissioning is not expected to be completed until about 2080. Consequently, NEER must continue to fund and manage spent‑fuel storage (and, if it pursues a restart, secure new fuel or license extensions) well beyond the contract horizon, raising both financial and regulatory risks until the facility is finally de‑commissioned.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key dates—fuel supply contracts expiring in 2033 and decommissioning expected through 2080—are correctly stated, matching the original answer. There are no calculation errors. (2) The answer addresses the core issue: the mismatch between contract expiration and long decommissioning timeline. It correctly identifies the need for extended spent-fuel storage and potential financial and regulatory risks. (3) The reasoning is sound and reflects multi-hop synthesis: connecting fuel supply contract end (2033) with decommissioning duration (through 2080), and inferring ongoing operational responsibilities. The mention of a possible restart or license extensions is speculative but contextually reasonable and does not detract from accuracy. (4) The only minor shortcoming is that it does not explicitly mention the need to secure alternative fuel sources or the role of the DOE in taking possession of spent fuel, which are included in the original answer and add regulatory and logistical context. However, the core operational risks—financial, regulatory, and storage management—are clearly conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct and comprehensive with only slight omissions in detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 372,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 10–20 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "\nLinde’s Amur GPP work is being handled under suspended engineering contracts that have generated contingent liabilities of roughly $0.7 billion (plus a $1 billion reserve for other terminated RCA projects) and are tied up in lengthy Russian litigation, so revenue from those arrangements is deferred until the disputes are settled.  By contrast, its on‑site industrial‑gas contracts recognize revenue over time as product is delivered under long‑term supply agreements, with variable but constrained consideration that is recorded as soon as the right to invoice is met.  This contrast shows that while on‑site agreements generally provide steady, recognizable revenue, they still expose Linde to sizable financial risk when sanctions or contractual breaches trigger contingent liabilities and contract suspensions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.7 billion contingent liability related to the Amur GPP project and contrasts it with Linde's revenue recognition policy for on-site industrial gas contracts, which is accurate. However, it introduces a $1 billion reserve for 'other terminated RCA projects' not mentioned in the ground truth, which adds unsupported detail and slightly misrepresents the scope of liabilities. This extra figure reduces quantitative accuracy. (2) The core number—$0.7 billion—is correct and matches the ground truth (allowing for format variation). But the addition of the $1 billion reserve, while possibly contextually relevant, is not present in the verified answer and lacks support, constituting a factual overreach. No calculations are required in this question, so calculation accuracy is not applicable. (3) The multi-hop reasoning is strong: the model correctly synthesizes information across Linde’s project-based risks (Amur GPP) and its standard on-site contract revenue model, drawing a valid contrast between deferred revenue under dispute versus ongoing revenue recognition based on delivery. It accurately captures the financial risk exposure in long-term agreements, especially under sanctions and legal uncertainty. (4) Despite the extraneous $1B reserve mention, the LLM conveys the essential contrast and insight about financial risk in long-term on-site or project-linked agreements. The core entities (Linde, Amur GPP, on-site industrial gas contracts) and their financial treatments are correctly identified. The answer remains highly relevant and semantically aligned with the ground truth on the key points, warranting a high correctness score with a minor deduction for the unsupported liability figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 479,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basis—recording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenues—an increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "\nThe company recognizes advertising revenue on a **gross** basis—i.e., the full amount billed to advertisers is recorded as revenue—while payments to Google Network partners under the Traffic‑Acquisition‑Cost (TAC) arrangement are treated as a separate cost of revenue. Therefore, an anticipated rise in TAC (driven by more mobile and emerging‑market traffic) does **not** alter the amount of gross advertising revenue that is recognized; it only increases the expense side of the ledger, reducing gross margin and net income, but leaves the gross‑revenue recognition model itself unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately explains that Google recognizes advertising revenue on a gross basis, meaning the full amount billed to advertisers is recorded as revenue, while TAC payments to partners are recorded as cost of revenue. The answer correctly states that an increase in TAC—driven by shifts in device and geographic mix (e.g., more mobile and emerging-market traffic)—does not change the gross revenue recognition model but increases costs, thereby reducing gross margin and net income. This matches the original answer’s core explanation. All entities (Google Network partners, TAC, cost of revenues, gross revenue recognition) are correctly identified and logically connected. There are no numerical inaccuracies, as the question does not involve specific numbers, percentages, or dates—so quantitative accuracy is not compromised. The only minor limitation is that the LLM answer does not explicitly mention 'partner mix' as a driver of TAC increases, which the original answer includes alongside device and geographic mix. Additionally, the original answer references the MD&A section and provides a more detailed link to financial statement disclosures, which the LLM omits. However, these are nuances that do not undermine the correctness or completeness of the core reasoning. The semantic meaning and financial logic are equivalent, and the multi-hop synthesis—linking TAC drivers to accounting treatment and margin impact—is sound. Thus, the answer is highly accurate, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 466,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methods—such as excavation and relocation of ash to a lined landfill or beneficial reuse—must align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "\nApproximately $5.3 billion of Duke Energy’s ARO—specifically the $5,293 million recorded for closure of coal‑ash impoundments—is shaped by compliance with the Coal Ash Act and the associated state‑and‑federal closure requirements, with the chosen method and timetable directly influencing that recorded amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount—$5.3 billion or $5,293 million—for Duke Energy’s ARO related to coal ash impoundment closure, which is not present in the original answer (ground truth). The ground truth does not provide any numerical value for the ARO; it only explains that the ARO is influenced by compliance with the Coal Ash Act and that the closure method and timetable affect the recorded amount. Therefore, the inclusion of a precise figure without sourcing or verification constitutes a significant factual overreach and inaccuracy. (2) There is no calculation or numeric data in the ground truth to support the $5.293 billion figure, making the quantitative claim unsupported and likely incorrect. While number formatting variations are acceptable (e.g., $5.3B vs $5,293 million), the core issue is the absence of any such number in the source knowledge, rendering the quantitative accuracy low. (3) The qualitative reasoning correctly identifies that the ARO is shaped by the Coal Ash Act, that closure methods must comply with state and federal regulations, and that the chosen method and schedule influence the ARO—this reflects accurate multi-hop understanding of regulatory influence on financial obligations. However, the model fabricates a precise monetary value, undermining the reasoning integrity. (4) Contextually, the answer is relevant and addresses the regulatory and operational factors affecting the ARO. The structure aligns with the question's intent, but the unsupported number severely compromises factual correctness. Thus, while the conceptual framework is sound, the introduction of unverified quantitative data results in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 468,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "\nThe fair‑value of the Mortgage‑Backed Obligations rose from **$178 million** as of January 31 2023 to **$236 million** as of January 31 2024, an increase of **$58 million** over the year.",
      "correctness_score": 1,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reverses the direction of the change in fair value. The ground truth states that the fair value decreased from $236 million to $178 million, a decrease of $58 million. However, the LLM claims it increased from $178 million to $236 million, which is the opposite of the correct trend. While the absolute values ($178M and $236M) and the difference ($58M) are numerically correct, the direction of change is wrong, making the core conclusion false. (2) The calculation of the $58 million difference is mathematically accurate (236 - 178 = 58), but the LLM misattributes it as an increase instead of a decrease. The dates mentioned (January 31, 2023 and 2024) may be contextually plausible, but the original answer does not specify dates—only two tables in the 2023 10-K—so assigning these specific dates introduces unsupported precision. (3) The multi-hop reasoning fails because the model misinterprets the sequence of the tables. It assumes the first table corresponds to an earlier date and the second to a later date, but the knowledge graph indicates the change is derived by subtracting the second table’s value from the first, implying the first table reflects the earlier value. The LLM reversed this logic. (4) Due to the critical error in the direction of change—despite correct numbers and partial context—the correctness score is very low. Quantitative accuracy is partially preserved due to correct dollar amounts and arithmetic, but the misrepresentation of increase vs decrease severely undermines factual integrity. Qualitative accuracy is low due to flawed reasoning. Contextual relevance is high as the answer addresses the right metric, company, and document.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 468,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "\nIn 2023, sales to “other developed markets” made up about 4.5 % of Danaher’s Diagnostics segment revenue (≈ $431 million of the segment’s total $9.58 billion). The company classifies Japan, Australia and New Zealand as the “other developed markets.”",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that 'other developed markets' accounted for approximately 4.5% of Danaher's Diagnostics segment sales in 2023, which contradicts the ground truth of 5%. This is a factual error in percentage. Additionally, the LLM provides supporting figures—$431 million out of $9.58 billion—which when calculated (431 / 9580) equals approximately 4.5%, reinforcing the incorrect percentage. The correct percentage (5%) implies the dollar amount should be around $479 million (5% of $9.58 billion), so the dollar figure is also inaccurate. (2) While the geographic regions listed—Japan, Australia, and New Zealand—are correct and match the ground truth, the core quantitative claim (4.5% vs 5%) is wrong. (3) The multi-hop reasoning appears sound in structure: the model identifies the segment, extracts regional sales data, computes a percentage, and defines the category. However, the underlying data used for the percentage calculation must have been incorrect or misread, leading to an inaccurate result despite correct methodology. (4) The contextual relevance is perfect—the answer addresses both parts of the question and uses appropriate financial context. Qualitative accuracy is high because the entities (Danaher, Diagnostics segment, regions) and definitions are correct. However, the correctness score is reduced significantly due to the numerical inaccuracy in the key metric, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 400,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "\nIn 2021 Union Pacific’s Bulk shipments generated **$6,656 million** in freight revenue. This comes from **2,014 thousand carloads** at an **average revenue of $3,305 per car**, yielding roughly **$6.66 billion** in total Bulk‑segment revenue for the year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is significantly incorrect in terms of quantitative accuracy. The ground truth states that Union Pacific's Bulk shipments in 2021 had 1,920,000 carloads and an average revenue of $3,467 per car, resulting in total revenue of $6,656,270,000. The LLM incorrectly reports 2,014,000 carloads and $3,305 per car, leading to a miscalculated total of approximately $6.66 billion (which would require different inputs). While the final figure is numerically close ($6.66B vs $6.656B), the component data is factually wrong, and the calculation does not match the ground truth derivation. The answer incorrectly cites '2,014 thousand carloads' instead of 1,920,000, and $3,305 instead of $3,467, which are material discrepancies. Although the answer addresses the right company (Union Pacific), time period (2021), and shipment category (Bulk), and attempts the correct calculation method (carloads × revenue per car), the use of incorrect base data undermines the entire response. The multi-hop reasoning is structurally sound (multiply volume by unit revenue), but it is applied to false inputs, indicating either retrieval error or data misattribution. The contextual relevance is high as the answer attempts the right question with appropriate framing and units, but factual correctness fails on core metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 365,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "\nThe settlement with the North Carolina Department of Environmental Quality cuts the undiscounted cost to permanently close all coal‑ash basins in North Carolina and South Carolina from Duke Energy’s earlier estimate of roughly **$9.5 billion – $10.5 billion** (the figure that resulted from the April 1, 2019 closure determination) down to about **$8 billion – $9 billion**, a reduction of **approximately $1.5 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the post-settlement estimated cost range of $8 billion to $9 billion, the pre-settlement range of $9.5 billion to $10.5 billion, and the resulting reduction of approximately $1.5 billion are all correctly stated. (2) Quantitative accuracy is perfect: the ranges and the $1.5 billion difference are mathematically sound (e.g., midpoint difference is $1 billion, but the $1.5 billion reduction aligns with the lower bound of the original range minus the upper bound of the revised range, which is consistent with typical reporting of such estimates). (3) Multi-hop reasoning is correctly applied—the model synthesizes information across the April 1, 2019 closure determination, Duke Energy’s initial estimate, and the NCDEQ settlement outcome. (4) Entities (Duke Energy, NCDEQ, coal ash basins, North Carolina and South Carolina) are correctly identified and contextualized. The answer is concise, relevant, and captures all components of the question without error or omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 312,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "\nMastercard paid $325 million in cash for Dynamic Yield LTD in 2022 and $2.7 billion in cash for Recorded Future in 2024, for a total cash outlay of roughly $3.0 billion. This spending reflects Mastercard’s acquisition strategy of expanding its data‑analytics and cybersecurity capabilities and diversifying into high‑growth, value‑added services that complement its core payments network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the cash consideration for both acquisitions: $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The total is stated as 'roughly $3.0 billion', which is a minor rounding of the exact sum ($3.025 billion) from the ground truth. This does not constitute a factual error but a slight approximation in presentation. 2) All numeric values and dates are accurate. The calculation of the total is essentially correct, though the LLM uses 'roughly $3.0 billion' instead of the precise $3.025 billion. This is acceptable under format and semantic flexibility (e.g., rounding for clarity), especially given the scale of the amounts. 3) The multi-hop reasoning is sound: the model correctly synthesizes data from two separate acquisitions across different years and companies, and accurately attributes strategic intent. The explanation of Mastercard’s strategy—expanding data-analytics and cybersecurity capabilities and diversifying into high-growth services—aligns with the ground truth’s emphasis on integrating specialized capabilities like personalization and threat intelligence. 4) The answer is contextually complete and relevant, addressing both the quantitative total and the strategic rationale. The qualitative description is slightly less detailed than the original (e.g., doesn’t name Dynamic Yield's personalization tech or Recorded Future's threat intelligence explicitly), but captures the strategic essence accurately. Thus, the answer is factually correct, well-reasoned, and fully relevant, meriting a high score with only minor room for precision in the total sum.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 449,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "\nThe pension‑plan assets table (page 92) reports International bonds at a fair value of **$341 million** (2023) – listed as a Level 2 item with $3 million Level 1 and $338 million Level 2.  \nThe other post‑retirement benefit‑plan assets table (page 93) shows International bonds at a fair value of **$12 million** (2023) – broken out as $10 million Level 1 and $2 million Level 2.  \n\nThus, the two disclosures differ in both amount and classification: International bonds are recorded as a distinct line item in the other post‑retirement plans (mostly Level 1) whereas they appear within the broader “Fixed income securities” category of the pension plan assets, classified as Level 2.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the total fair value and the breakdown of International bonds. The ground truth states the total fair value is $540 million ($12M in first table, $528M in second), but the LLM reports $341M and $12M, summing to $353M — a major discrepancy. The LLM incorrectly assigns $341M to pension-plan assets when the correct value for International bonds in that table is $12M. Additionally, the LLM misrepresents the categorization: it claims $3M Level 1 and $338M Level 2 in the first table, while the truth is $9M Level 1 and $3M Level 2. In the second table, the LLM reports only $12M total with $10M Level 1 and $2M Level 2, but the correct total is $528M with $10M Level 1 and $518M Level 2 — missing $516M entirely. (2) Calculations are fundamentally flawed: the sum of the LLM’s reported values ($341M + $12M = $353M) does not match the correct total ($540M), and individual components are wrong. (3) Multi-hop reasoning fails: the model does not correctly identify which tables contain International bond disclosures or extract the right line items; it conflates categories and misattributes values across disclosures. (4) Despite these errors, the answer attempts to address both parts of the question — total value and categorization differences — and correctly identifies that classification differs between tables (Level 1 vs Level 2 emphasis), giving partial credit for structure and intent, but the factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 415,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "\nMastercard’s real‑time, account‑based payments infrastructure is built on a globally distributed, peer‑to‑peer architecture that provides instant clearing and settlement across more than 150 currencies and 220 countries, enabling secure, instantaneous transfers for both consumers and businesses. This network switches roughly 70 % of all Mastercard and Maestro‑branded transactions—including nearly 100 % of cross‑border transactions—while the remaining share consists of domestic switches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key percentage of 70% of all Mastercard and Maestro-branded transactions is correctly stated, as is the claim that nearly 100% of cross-border transactions are handled by the infrastructure—this matches the original answer's 'nearly all cross-border transactions.' The mention of 'remaining share consists of domestic switches' correctly implies that the 70% includes both domestic and cross-border, with cross-border being a subset. (2) The LLM adds contextual detail not in the original—such as '150 currencies,' '220 countries,' and 'peer-to-peer architecture'—which, while not in the ground truth, are plausible and do not contradict it; they enhance the explanation without introducing inaccuracies. (3) The multi-hop reasoning is sound: the answer connects real-time infrastructure to its role in supporting global operations and correctly quantifies its transaction share across brands and geographies. (4) Semantic equivalence is maintained: the core facts—70% of total transactions, dominance in cross-border—are preserved with only minor rewording. The only reason for not scoring a 10 is that the original does not specify '100%' but 'nearly all' cross-border transactions; the LLM's 'nearly 100%' is a reasonable interpretation but slightly more precise than the source. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 402,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "\nWalmart U.S. paid roughly **$1.9 billion in cash** to acquire VIZIO Holding Corp. The acquisition adds a data‑privacy risk because VIZIO’s subsidiaries collect consumer viewing data that is now stored within Walmart’s digital ecosystem; any breach or misuse of that data could trigger regulatory fines, litigation and reputational damage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the $1.9 billion cash consideration paid by Walmart U.S. to acquire VIZIO Holding Corp., matching the ground truth exactly in both amount and format. This satisfies the quantitative requirement with full accuracy. 2) The qualitative aspect is also largely correct: the LLM accurately captures the data privacy risk stemming from VIZIO's collection of consumer viewing data and correctly links it to potential cybersecurity incidents that could lead to regulatory fines, litigation, and reputational damage. The only minor deviation is that the LLM frames the data as being stored 'within Walmart’s digital ecosystem,' while the original answer specifies it is stored digitally and vulnerable due to system failures or cyber incidents. While semantically close and logically sound (since integration into Walmart's systems would follow acquisition), the original source emphasizes the inherent risk in digital storage and cybersecurity more broadly, not exclusively tied to Walmart’s infrastructure. 3) The multi-hop reasoning is sound—correctly linking Walmart’s acquisition, the financial consideration, and the associated risk disclosure from Walmart’s filings regarding VIZIO’s data practices. All entities (Walmart U.S., VIZIO Holding Corp.) and financial terms are accurate. 4) The answer is fully contextually relevant, addressing both sub-questions directly and synthesizing information across financial and risk-disclosure domains. The slight rewording does not detract from factual correctness, warranting a high score but not perfect due to the nuanced shift in risk attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 441,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "\nHigher fuel prices added roughly **$35 million** to Duke Energy’s fuel‑related operating expenses, but only **$14 million** of that cost was recouped through the fuel‑cost recovery mechanism that boosts operating income.  Consequently, the net financial impact was a **$21 million drag on operating cash flow** (i.e., operating expenses rose $35 million while cash‑flow recovery offset $14 million, leaving a $21 million adverse effect).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $35 million increase in fuel-related operating expenses and $14 million in fuel cost recovery are correctly cited. The net impact of $21 million ($35M - $14M) is correctly calculated. (2) The answer addresses all parts of the question: it discusses the impact on operating expenses and operating cash flows, correctly identifying that only part of the cost was recovered. (3) Entity accuracy is perfect—Duke Energy, 2022 (implied by context), and the relevant financial metrics (fuel cost recovery, operating expenses, cash flow impact) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it recognizes that while higher fuel prices increased expenses, a recovery mechanism improved operating income, but the net effect was still a $21 million outflow. The conclusion that this represents a 'drag on operating cash flow' aligns with the ground truth's emphasis on net negative cash flow impact. (5) Semantic equivalence is achieved—the LLM conveys the same core information with slightly different phrasing but no loss or distortion of meaning. Minor stylistic differences (e.g., 'drag on cash flow' vs. 'net negative cash flow impact') do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 371,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "\nIn 2021 Intel recorded **$565 million of additional period charges** that were explicitly tied to the **ramp‑up of the Intel 4 manufacturing process**. This charge reflects the costs associated with bringing the new node online, which coincides with the **July 2021 announcement that the company would rename its process nodes—rebranding the former 10 nm “Enhanced SuperFin” as “Intel 4.”** Thus, the $565 M expense is directly linked to the operational rollout of the newly branded Intel 4 node.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $565 million in additional period charges for 2021 is accurately reported, and the July 2021 rebranding announcement date is correctly referenced (specifically tied to July 26, 2021 in the original, but 'July 2021' is an acceptable level of precision). (2) The answer addresses both parts of the multi-hop question: the financial impact ($565M) and its relationship to the rebranding of the manufacturing node. (3) Entity accuracy is perfect—Intel, Intel 4, 2021, and the context of process node rebranding are all correctly identified. (4) The reasoning is sound: the LLM correctly links the financial charge to the operational ramp-up of the newly named Intel 4 node, explaining that the rebranding (from 10nm Enhanced SuperFin) coincided with the increased costs, thus synthesizing financial and strategic information across domains. The semantic meaning is equivalent to the original answer, with clear, concise, and accurate expression.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 297,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "\nIn 2023, Other Developed Markets accounted for **5 %** of Danaher’s Diagnostics segment sales. At the end of 2023 the company employed **about 3,000 people** in those same markets—roughly 5 % of its total global workforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly states that 5% of Danaher’s 2023 Diagnostics segment sales were attributed to Other Developed Markets, matching the ground truth. It also correctly reports that the company had about 3,000 employees in those markets as of the end of 2023. However, the LLM adds an extra detail not present in the original answer: that these 3,000 employees represent roughly 5% of Danaher’s total global workforce. This inference, while possibly accurate, is not supported by the provided ground truth and introduces unsourced information. 2) All numeric values (5%, 3,000 employees) are factually correct and match the ground truth. The formatting (e.g., 'about 3,000') is acceptable as it aligns with typical reporting variations. 3) The multi-hop reasoning is sound—correctly linking Diagnostics segment sales attribution to employee counts in the same geographic region (Other Developed Markets) as of the same year (2023). The only overreach is the additional percentage calculation about total workforce, which was not asked and not verified. 4) Despite the minor addition, the core answer is factually accurate, complete with respect to the question, and contextually appropriate. The scores reflect high accuracy with a slight deduction in qualitative accuracy due to the unsupported inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 363,
        "total_tokens": 1479
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "\nThe 2021 revenue from industrial chemicals & plastics is found by multiplying the average revenue per car ($3,207) by the 606 thousand carloads reported for that segment, which yields roughly **$1.94 billion** (about **$1,943 million**) in total freight revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in unit conversion, stating $1.94 billion instead of $1.94 million (or $1.943 million), which is off by a factor of 1,000. While the multiplication of $3,207 by 606,000 carloads does yield approximately $1.943 billion, this contradicts the ground truth of $1.94 million, indicating a fundamental mismatch in scale. (2) The calculation itself is mathematically correct only if the inputs are accepted, but the resulting figure ($1.94 billion) is orders of magnitude higher than the ground truth ($1.94 million), making the quantitative output severely inaccurate. The correct calculation would require either a much smaller number of carloads or a much lower revenue per car, but the inputs used are not supported by the ground truth. (3) The reasoning structure is sound—revenue = price per unit × volume—but the model fails to correctly synthesize the actual data from the knowledge graph, suggesting incorrect retrieval or misinterpretation of the source values. (4) Despite the severe quantitative error, the answer addresses the right metric, time period (2021), and business segment (Industrial chemicals & plastics), and attempts the correct calculation method, warranting partial credit for qualitative reasoning and relevance. However, the magnitude of the numerical error drastically undermines factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1093,
        "completion_tokens": 383,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "\nThe 10‑K discloses International Bonds at $341 million within the pension‑plan asset table (page 92) and $12 million within the other post‑retirement benefit‑plan asset table (page 93). Adding these amounts gives a total fair‑value exposure of **$353 million** for International Bonds in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM reports $341 million and $12 million from two tables, summing to $353 million, but the ground truth states that the correct values are $12 million in both 'Level 1' and 'Level 2' categories, totaling $24 million. The $341 million figure does not match the ground truth and appears to be a misreading of the data—possibly confusing International Bonds with another asset class or table. (2) The calculation itself ($341M + $12M = $353M) is arithmetically correct, but based on incorrect inputs, making the result invalid. (3) Qualitatively, the reasoning fails multi-hop synthesis: the model incorrectly identifies which tables and categories disclose International Bonds for Verizon in 2023. It references 'pension-plan asset table' and 'other post-retirement benefit-plan asset table', but the ground truth specifies 'Level 1' and 'Level 2' bond classifications, indicating a misattribution of source data. (4) Contextual relevance is low because while the answer addresses fair value of International Bonds for Verizon in 2023, it uses incorrect documents or misinterprets the asset categories. The model likely confused international bonds with other bond types or mislocated data within the 10-K. Overall, the answer fails on factual accuracy, correct entity mapping, and proper synthesis across the required disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 396,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "\nCostco’s owned processing, packaging and manufacturing facilities let it produce a growing share of private‑label merchandise in‑house, giving the company tighter cost control and the ability to price those items competitively. By adding high‑margin private‑label products to its mix, comparable‑sales growth accelerates, which spreads the fixed SG&A base over a larger sales base and thereby reduces SG&A as a percentage of sales—supporting the company’s strategy of leveraging SG&A expenses through comparable‑sales growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that Costco owns processing, packaging, and manufacturing facilities used to produce private-label items, which supports cost control and competitive pricing—this matches the original answer's claim about these facilities contributing to merchandising strategy. (2) There are no explicit numbers, percentages, or dates in either answer, so no quantitative discrepancies exist; the LLM does not introduce any incorrect figures, earning full marks for quantitative accuracy. (3) The reasoning correctly traces the multi-hop logic: in-house production → greater private-label penetration → higher comparable sales → leveraging fixed SG&A expenses over a larger sales base → improved profitability. This synthesis is sound and consistent with the original answer’s causal chain. (4) The only minor gap is that the LLM emphasizes 'high-margin' private-label products, which, while reasonable and likely true, is not explicitly stated in the ground truth. However, this does not contradict it and is a plausible inference given Costco’s business model. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 353,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "\nRibbonFET—Intel’s gate‑all‑around transistor architecture introduced at the 20A node together with the PowerVia back‑side power‑delivery scheme—represents a fundamental R&D breakthrough that shortens transistor switching delays and packs more drive current into a smaller area.  This new transistor technology is a cornerstone of Intel’s announced process‑and‑packaging roadmap (e.g., Intel 3, Intel 4, Foveros Omni/Direct) and directly fuels the company’s IDM 2.0 strategy of expanding internal fabs, leveraging external foundries, and offering advanced packaging services, thereby accelerating Intel’s goal of process‑technology and packaging leadership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: RibbonFET is correctly identified as a gate-all-around transistor introduced at the Intel 20A node, and its benefits—faster switching, higher drive current, smaller footprint—are accurately described. The mention of PowerVia, while not in the original answer, is factually correct and adds relevant context without introducing error. (2) Quantitative accuracy is perfect: no incorrect numbers, dollar amounts, or dates are present. The original answer references $20B investments in Arizona and Ohio, but the LLM answer omits these specific figures. This is a minor omission but does not make the answer incorrect—just less detailed in terms of investment amounts. (3) Multi-hop reasoning is sound: the LLM correctly links RibbonFET to Intel’s broader process roadmap (Intel 3, Intel 4) and packaging technologies (Foveros Omni/Direct), and ties it to the IDM 2.0 strategy, including fab expansion and foundry diversification. (4) Semantic equivalence is strong: though the wording differs, the core meaning—RibbonFET as a key enabler of process leadership under IDM 2.0, supported by R&D and manufacturing investments—matches the original. The only reason for not scoring a 10 is the omission of specific investment figures ($20B in Arizona and over $20B in Ohio), which were part of the original answer’s support for the IDM 2.0 strategy. However, the strategic elements of IDM 2.0 are still well conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 416,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "\nIn Q4 2023 Meta estimated that roughly **3 % of its worldwide MAP consisted solely of violating accounts**, and that **about 4 % of its worldwide MAUs were false accounts** (the “duplicate” and “false” accounts it identifies).  \n\nBecause these accounts are identified only through sampling and judgment, they add noise to the user‑count data; they can cause the reported MAP and MAU figures to be inflated or fluctuate independently of genuine user behavior, undermining the stability and accuracy of Meta’s key user‑metric estimates and, consequently, the reliability of advertising‑revenue and engagement assessments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key percentages from the ground truth: 3% of Meta's worldwide MAP consisted of violating accounts and 4% of MAUs were false accounts in Q4 2023. These numbers match exactly with the original answer, satisfying quantitative accuracy. 2) All numeric values are accurate and properly attributed to the correct metrics and time period (Q4 2023). Format variations (e.g., '3 %' vs '3%') are acceptable and do not affect meaning. 3) The reasoning about the impact on stability and accuracy of user metrics is sound and aligns with the original answer. The LLM correctly explains that violating and false accounts introduce noise, may inflate metrics, and affect reliability due to estimation limitations and sampling methods. It captures the core idea that these accounts can cause fluctuations independent of real user behavior. 4) The only minor shortcoming is that the LLM omits mention of specific challenges like reduced visibility into encrypted platforms (e.g., WhatsApp) and periodic spikes in account creation in certain countries, which are included in the original answer as contributing factors to estimation inaccuracy. While the LLM captures the general reasoning, this omission slightly reduces completeness in multi-hop synthesis. However, the core impact on stability and accuracy is well-explained, and the answer remains semantically equivalent in intent and substance. Thus, the answer is highly accurate with only a small loss in qualitative depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 413,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "\nAs of December 31 2023, the crypto‑asset safeguarding liability and the related safeguarding asset each totaled **$1.241 billion** ( $1,241 million ). These amounts are recorded at the same fair‑value because the Company had not incurred any safeguarding loss events, so the liability and the corresponding asset are measured at fair value using observable market prices and therefore coincide.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a specific dollar amount ($1.241 billion) not present in the original answer (ground truth), which only states that the asset and liability were equal in value due to fair value measurement but does not provide a numerical value. There is no indication in the ground truth that $1.241 billion is the correct figure, so this represents an unsupported addition. Since the question asks for the total fair value, the absence of this number in the ground truth means the LLM introduced potentially incorrect quantitative information. (2) The date (December 31, 2023) is correct and matches the ground truth. However, the core issue is that the ground truth does not specify a dollar amount, so the LLM cannot be verified as quantitatively accurate—even if $1.241 billion is factually correct in the actual filing, it was not part of the knowledge graph ground truth, making this a hallucination or unsupported detail. (3) The reasoning for why the amounts are equal—because no safeguarding loss events occurred and both are measured at fair value using quoted market prices—is semantically equivalent to the original answer and reflects correct multi-hop understanding of accounting logic. (4) The contextual relevance is perfect: the answer addresses both parts of the question (the value and the reason), and the explanation aligns with the rationale in the ground truth. However, the correctness score is reduced due to the unsupported numerical claim, which violates factual accuracy. Quantitative accuracy is penalized heavily because the primary requested data point (total fair value) is fabricated relative to the ground truth. Qualitative accuracy remains high due to sound reasoning and correct entity and concept identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 482,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "\nFor 2024 the “Other noncontrolling redeemable interests” amount is **$169,192 (thousand)** and the “7.50% Cumulative Redeemable Preferred Units” amount is **$15,537 (thousand)**; together they total **$184,729 (thousand)**.  This combined figure is lower than the 2023 combined total of **$195,949 (thousand)**, a reduction of about **$11,220 (thousand)** (roughly a 5‑6 % decline).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the individual components for 2024—'Other noncontrolling redeemable interests' at $169,192 thousand and '7.50% Cumulative Redeemable Preferred Units' at $15,537 thousand—are accurate, and their sum ($184,729 thousand) is correctly calculated. The 2023 combined total of $195,949 thousand is correctly stated, and the difference of $11,220 thousand is accurate. The approximate percentage decline (5–6%) is a reasonable addition and does not contradict the ground truth. (2) The answer is complete, addressing both the 2024 combined value and its comparison to 2023. (3) All entities and financial terms are correctly identified and used in the right context. (4) The multi-hop reasoning—aggregating two line items across two years and computing the year-over-year change—is sound and correctly executed. The answer is semantically equivalent to the original, with slightly enhanced clarity through breakdown and percentage context. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 303,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "\nSouthern Company Gas had committed to purchase **39 million mmBtu of natural gas for Nicor Gas and SouthStar**, with the floating‑price contracts valued at **about $136 million** as of December 31 2024.  These purchases are made under the utility’s regulated natural‑gas cost‑recovery framework, which allows rates to be adjusted to reflect wholesale price changes, ensuring that the floating‑price procurement costs are fully recovered from customers in a prudently‑regulated manner.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $136 million value of floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, matching the ground truth. It adds a useful detail—39 million mmBtu of volume—which is not in the original answer but does not contradict it and may reflect additional context from the source filing. The dollar amount is accurate and properly attributed to the correct entities and date. (2) Quantitatively, the $136 million figure is correct, and the date (December 31, 2024) is accurately stated. Format variation ('about $136 million' vs. exact $136 million) is acceptable and common in financial reporting. (3) The reasoning is sound: the LLM correctly explains that the floating-price procurement aligns with the regulated cost recovery framework by allowing rate adjustments to reflect wholesale cost changes, ensuring full recovery of prudently incurred costs. It captures the core regulatory mechanism described in the ground truth, though it omits the explicit mention that procurement plans are reviewed and approved by state regulators—a minor omission that slightly reduces qualitative completeness. (4) The answer is contextually fully relevant, addressing both parts of the question: the value of purchases and the alignment with cost recovery. The added volume metric enhances completeness without introducing error. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth, warranting a high correctness score with only a minor deduction in qualitative accuracy for the omitted regulatory approval detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 449,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "\nIn 2021 the Lower 48 segment generated **$4,932 million of net income attributable to ConocoPhillips** (page 148).  By contrast, the equity‑method earnings from that same region were only **$(18) million** (a $18 million loss) for the year (page 148).  Thus, the segment’s reported net income is positive and vastly larger than the modest equity loss recorded for the Lower 48.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $4,932 million for net income attributable to ConocoPhillips and $(18) million for equity in earnings (losses) are accurately reported, with correct formatting and sign notation (negative value indicated as a loss). The year 2021 and the Lower 48 region are correctly identified. (2) The answer addresses both parts of the question: the total net income and the equity in earnings (losses), and provides a valid comparison. (3) Entity accuracy is perfect—ConocoPhillips, the Lower 48 region, and the correct financial metrics (net income attributable and equity-method earnings) are all correctly referenced. (4) The reasoning is sound: the LLM correctly interprets the significant positive net income versus a small equity loss and synthesizes the information into a meaningful comparison. The mention of 'page 148' suggests proper sourcing from the 10-K, though not required, adds credibility. Semantic equivalence is maintained with the original answer, conveying the same core insight: strong direct earnings contrasted with a minor equity-method loss in the same region and year.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 335,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "\nThe company’s disclosed derivative exposure for 2024 includes $1.212 billion of open, unsettled forward foreign‑exchange contracts (up from $1.068 billion in 2023).  It also hedges commodity‑price risk through variable‑priced contracts—primarily index‑linked purchases of natural‑gas and electricity—but the filing does not provide a separate notional amount for those commodity contracts, indicating that the quantifiable notional exposure is essentially the $1.212 billion of FX contracts.  Together, these hedges are used to lock in future purchase costs and limit the financial impact of currency fluctuations and commodity‑price volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the notional value of unsettled forward foreign-exchange contracts as $1.212 billion (equivalent to $1,212 million in the ground truth), which is quantitatively accurate. It also correctly notes the use of variable-priced commodity contracts for natural gas and electricity as part of the company's risk management strategy. However, the LLM incorrectly implies that no notional value is provided for commodity contracts because the filing 'does not provide a separate notional amount'—whereas the ground truth does not claim a specific dollar figure either but still affirms their use in the hedging strategy. Thus, the LLM's interpretation is reasonable, though slightly overreaching in suggesting the 'quantifiable notional exposure is essentially the $1.212 billion', which is not explicitly stated and risks misrepresenting the scope of exposure.\n\n2) All numeric values are correct: $1.212 billion matches $1,212 million. The comparison to 2023 ($1.068 billion) is additional context not in the ground truth but not incorrect.\n\n3) The multi-hop reasoning is mostly sound: the LLM correctly synthesizes that both FX and commodity contracts are used to manage financial risks. It accurately reflects that these instruments are used to mitigate volatility, even without hedge accounting. The only gap is the slight mischaracterization of the commodity contract notional value as unquantifiable rather than simply unreported, which affects qualitative precision.\n\n4) The answer is contextually relevant and addresses both parts of the question: the total exposure (with correct FX amount) and the strategic rationale. While it doesn't invent data, it could have mirrored the ground truth more closely by stating that variable-priced contracts are used without needing to justify the absence of a notional figure. Overall, the answer is factually aligned with minor interpretive overreach, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 528,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "\nMicrosoft’s internal development model groups the creation of Microsoft 365 into distinct engineering units—such as Experiences & Devices, Cloud & AI, and Security—so that the consumer‑facing subscription can be tracked as a separate line‑of‑business metric.  In FY 2024 the company updated its reporting to combine Microsoft 365 Consumer and Copilot Pro into a single “Microsoft 365 Consumer subscribers” figure and to include Microsoft 365 Basic subscribers, reflecting how the internally developed suite is managed and giving investors a consolidated view of the consumer subscription base that drives revenue in the Productivity and Business Processes segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces significant inaccuracies in the multi-hop reasoning and entity details. (1) Correctly identifies Microsoft's internal engineering structure and its relevance to financial reporting, and correctly notes the inclusion of Microsoft 365 Basic subscribers in the FY2024 reporting update, which aligns with the ground truth. (2) Quantitative accuracy is acceptable—no specific numbers (e.g., subscriber counts or dollar amounts) are provided in either answer, so no numeric errors exist; the fiscal year (2024) is correctly cited. (3) However, the LLM incorrectly states that Microsoft combined 'Microsoft 365 Consumer and Copilot Pro' into a single metric, which is not mentioned in the ground truth and appears to be fabricated. The original answer only references the inclusion of Microsoft 365 Basic subscribers in the redefined consumer subscriber count, not Copilot Pro. This reflects a failure in reasoning and entity accuracy. (4) The contextual relevance remains high because the answer addresses the core link between internal development structure and financial reporting changes. However, the incorrect synthesis—adding a non-existent component (Copilot Pro)—undermines the qualitative accuracy and overall correctness, warranting a mid-range score. The answer captures part of the truth but adds unsupported details, reducing its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 389,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How many shares, in total, are counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) if each PSA counts as three shares times the maximum potential payout, and what is the significance of this calculation in relation to the 248 million shares still available for award as of December 31, 2023?",
      "original_answer": "Under Pfizer's 2019 Stock Plan, Performance Share Awards (PSAs) count as three shares toward the maximum shares available for grant, multiplied by the maximum potential payout. As of December 31, 2023, 248 million shares were available for award under the plan. This means that the inclusion of PSAs with a multiplier effect significantly reduces the number of such performance-based awards that can be issued, given their higher share consumption rate. This share accounting method directly affects how much of the remaining 248 million shares can be allocated to PSAs versus other types of awards like stock options or TSRUs, which count as only one share each.",
      "llm_answer": "\nEach PSA is counted as **three shares × the award’s maximum potential payout** toward the share reserve under the 2019 Stock Plan; in other words, the plan treats every PSA as three shares for each unit of the highest payout that could be earned.  This multiplier is used to calculate how many of the **248 million shares that were still available for award as of 31 December 2023** are consumed by PSAs, confirming that even after applying the three‑times‑maximum‑payout rule there remain 248 million shares unallocated for future grants.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM correctly identifies the share counting rule for PSAs: each PSA counts as three shares times the maximum potential payout. It also correctly states that 248 million shares were available as of December 31, 2023. However, it incorrectly implies that the 248 million shares remain unallocated *after* applying the three-times-maximum-payout rule, which contradicts the ground truth. The 248 million is the total remaining share reserve *before* allocating any new PSAs, and the significance is that PSAs consume shares at a higher rate, thus limiting how many can be granted. The LLM misrepresents the direction of the impact.\n\n2) Quantitatively, the numbers (3x multiplier, 248 million shares, December 31, 2023 date) are accurate and match the ground truth. No calculation errors in stated values.\n\n3) The multi-hop reasoning is flawed. The model fails to synthesize that the 3x maximum payout rule *reduces* the number of PSAs that can be issued from the 248 million, and instead suggests the 248 million already accounts for the multiplier, which is incorrect. It misses the comparative share consumption between PSAs and other awards (e.g., TSRUs or options counting as 1 share).\n\n4) While the response includes relevant entities (Pfizer, 2019 Stock Plan, PSAs, 248 million, December 31, 2023), the reasoning about the significance of the calculation is incorrect. The ground truth emphasizes constraint and allocation trade-offs; the LLM incorrectly frames it as confirmation of availability post-multiplier. This undermines the qualitative and overall correctness despite accurate raw data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 439,
        "total_tokens": 1790
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 750,
    "successful_evaluations": 750,
    "failed_evaluations": 0,
    "average_correctness_score": 7.85,
    "average_quantitative_accuracy": 8.23,
    "average_qualitative_accuracy": 8.07,
    "average_contextual_relevance": 9.32,
    "score_distribution": {
      "excellent": 491,
      "good": 78,
      "fair": 101,
      "poor": 80
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750,
    "successful": 750,
    "failed": 0,
    "elapsed_seconds": 10283.25,
    "timestamp": "2026-02-02T18:31:48.995655"
  }
}